username,date,retweets,favorites,text,geo,mentions,hashtags,id,;permalink
PriorLab,2020-05-02 19:49,0,1,"PAAD was 88% @ acarrer, we used Foundation Medicine dataset for that rate. Used FM data for KRAS LUAD and COAD too; but I accept still room for refinement.",,@,,"1256732578331197440",https://twitter.com/PriorLab/status/1256732578331197440
mdmanishshah,2020-05-02 19:47,0,3,"That is so wonderful Erin! There is a father/ mother / loved one behind every # COVID statistic! Thank you for reminding us all!! # amazingthings are happening @ nyphospital @ WeillCornell # covid19 @ ASCO @ AACR https://twitter.com/ECMulvey/status/1256690099196178433 …",,@ @ @ @,# # #,"1256732040956981250",https://twitter.com/mdmanishshah/status/1256732040956981250
sidbhat1976,2020-05-02 16:32,1,5,"Training Week #8 completed with a 10.05 miler today. Thanks to those who ran virtually with me. @ sap4good @ JhingranAmit @ LifeatSAP @ 5ForTheFight_ @ AACRFoundation @ AACR pic.twitter.com/PR00alNMIF",,@ @ @ @ @ @,#8,"1256682886746517511",https://twitter.com/sidbhat1976/status/1256682886746517511
OncLive,2020-05-02 16:15,1,2,"Ryan J. Sullivan, MD, of @ harvardmed, shares data from a phase 1 trial on the novel, first-in-class immune checkpoint inhibitor, COM701. # AACR20 http://ow.ly/jmTy50zsCQK",,@,#,"1256678630039662592",https://twitter.com/OncLive/status/1256678630039662592
Genialis,2020-05-02 13:31,0,2,"Miss the @ AACR Annual meeting? Watch on-demand sessions here: https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/ … @ AACRFoundation # cancerresearch # medtwitter",,@ @,# #,"1256637569879564289",https://twitter.com/Genialis/status/1256637569879564289
kRasKickers,2020-05-02 13:28,0,3,"# biomarkers testing provides more hope & saves lives applauding progress for # HER2 # NSCLC # LCSM @ AACR",,@,# # # #,"1256636685401632769",https://twitter.com/kRasKickers/status/1256636685401632769
AACR,2020-05-02 12:45,2,3,"RT @ CancerTodayMag: # ICYMI: At the @ AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis. https://bit.ly/35nNr9b # AACR20 pic.twitter.com/Qlc7OzcH79",,@ @,# #,"1256625771222839296",https://twitter.com/AACR/status/1256625771222839296
OncLive,2020-05-02 12:38,1,1,"Garon Sheds Light on CNS Activity With Capmatinib in MET Exon 14+ NSCLC @ dgsomucla # lcsm # AACR20 http://ow.ly/zDfr50zuZk9",,@,# #,"1256624182424670208",https://twitter.com/OncLive/status/1256624182424670208
MDEdgeTweets,2020-05-02 12:37,0,0,"Lung cancer patients with # COVID19 have a higher rate of death, study says. http://ms.spr.ly/6019TgLUN # AACR2020 pic.twitter.com/FL6Kqs2JFF",,,# #,"1256623739200065543",https://twitter.com/MDEdgeTweets/status/1256623739200065543
DJPinato,2020-05-02 12:31,0,0,"Well done @ DrMSodergren",,@,,"1256622345730621441",https://twitter.com/DJPinato/status/1256622345730621441
CancerTodayMag,2020-05-02 12:30,1,1,"# ICYMI: At the @ AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis. https://bit.ly/2yZkIeK # AACR20 pic.twitter.com/AQDmBaKP85",,@,# #,"1256622001881571329",https://twitter.com/CancerTodayMag/status/1256622001881571329
DrMSodergren,2020-05-02 12:27,1,7,"Next generation immunotherapy on myeloid cells & first saRNA to reach clinical trials. Over a decade of work by @ MiNA_Tx @ imperialcollege @ ImperialNHS @ ImperialSandC @ DJPinato @ CCR_AACR @ AACR https://clincancerres.aacrjournals.org/content/early/2020/05/01/1078-0432.CCR-20-0414 … – bei Imperial College London",,@ @ @ @ @ @ @,,"1256621468781359104",https://twitter.com/DrMSodergren/status/1256621468781359104
KatsuakiMaehara,2020-05-02 12:25,0,4,"Congratulations @ VivekSubbiah & colleagues！ Great work & well deserved.",,@,,"1256620759604064256",https://twitter.com/KatsuakiMaehara/status/1256620759604064256
OncLive,2020-05-02 12:15,1,0,"Data from the TRACERx lung study show that AMP personalized cfDNA detect low-frequency variant DNA accurately and at low assay DNA inputs that are consistent with an MRD setting. # AACR20 http://ow.ly/Idta50zsCmA",,,#,"1256618250353422341",https://twitter.com/OncLive/status/1256618250353422341
Aiims1742,2020-05-02 11:27,4,13,"A case report by @ christine_lovly & @ VUMC_Cancer colleagues, reiterating the observations discussed at # COVID19nCancer session at # AACR20. How to deploy # Immunotherapy in the # COVID19 era will be a steep learning curve. @ COVID19nCCC https://www.medrxiv.org/content/10.1101/2020.04.29.20085738v1 …pic.twitter.com/Ttjbfz3euV",,@ @ @,# # # #,"1256606304015179777",https://twitter.com/Aiims1742/status/1256606304015179777
VivekSubbiah,2020-05-02 11:03,16,39,"Just publishedEditorial by Antoni Ribas @ CD_AACR " Trying for a BRAF Slam Dunk" https://cancerdiscovery.aacrjournals.org/content/10/5/640 … on our paper "Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers" @ AACR # precisionmedicine https://cancerdiscovery.aacrjournals.org/content/10/5/657 …pic.twitter.com/om3uo0f4jB",,@ @,#,"1256600248983654402",https://twitter.com/VivekSubbiah/status/1256600248983654402
CancerResearch,2020-05-02 11:00,2,3,"At # AACR20, a study revealed cancer patients — especially those with blood or lung malignancies, or tumors that have spread throughout the body — have a higher risk of death or other severe complications from # COVID_19 compared with those without cancer.https://bit.ly/3f8c128",,,# #,"1256599438283493381",https://twitter.com/CancerResearch/status/1256599438283493381
AlisonBirtle,2020-05-02 10:56,0,2,"With popcorn ?",,,,"1256598334669836293",https://twitter.com/AlisonBirtle/status/1256598334669836293
BiotechBeau,2020-05-02 10:01,0,2,"@ markgmanfredi",,@,,"1256584634021920768",https://twitter.com/BiotechBeau/status/1256584634021920768
BettayebDr,2020-05-02 09:31,0,0,"Combination of 3 or 4 molecules is not the right path to optimal treatment.",,,,"1256576962052665344",https://twitter.com/BettayebDr/status/1256576962052665344
DrMhidalgo,2020-05-02 09:26,5,30,"Virtual meetings are here to stay. Future likely will include both, virtual and F2F. But the easiness, safeness and reach of virtual meetings is a resource, not an impediment. My personal experience at # AACR20 was juts great. https://twitter.com/Aiims1742/status/1256344592749940748 …",,,#,"1256575704973672454",https://twitter.com/DrMhidalgo/status/1256575704973672454
VeganEarthling,2020-05-02 09:18,0,0,"@ aacr # AnimalProteinCausesCancer # SADDiet # QuitMeat # DitchDairy # CaseinCausesCancer Consumers don't like being lied to.The tobacco industry lied to us! # PlantbasedDiet is the prevention and cure! # TheChinaStudy @ PCRM # DiseasePrevention # CancerPrevention @ _eatingyoualivepic.twitter.com/EXwWd73RYJ",,@ @ @,# # # # # # # # #,"1256573803452420097",https://twitter.com/VeganEarthling/status/1256573803452420097
VeganEarthling,2020-05-02 09:07,0,0,"@ aacr Stop Lying to People! Animal Protein causes # Cancer # QuitMeat # DitchDairy @ PCRM # TheChinaStudy # DiseasePrevention @ _eatingyoualive # CaseinCausesCancer # AnimalProteinCausesCancer # EatPlantbasedDiet # GoVegan https://twitter.com/AACR/status/1253707028897370112 …pic.twitter.com/1ACIbbK0DF",,@ @ @,# # # # # # # # #,"1256571078954156035",https://twitter.com/VeganEarthling/status/1256571078954156035
CancerNetwrk,2020-05-02 08:55,0,3,"This phase I/II trial is comprised of 2 phases, with phase I determining the maximum tolerated dose of palbociclib and phase II determining the clinical benefit rate of treatment with anastrozole, palbociclib, trastuzumab, and pertuzumab. | @ AACR https://www.cancernetwork.com/her2-positive-breast-cancer/phase-iii-trial-evaluate-dual-her2-combination-therapy-hr-her2-breast-cancer …pic.twitter.com/ox2menpfpY",,@,,"1256567892017102848",https://twitter.com/CancerNetwrk/status/1256567892017102848
LefrancJu,2020-05-02 08:32,6,25,"DISCLOSURE : @ BayerPharma AhR inhibitor currently ongoing clinical trials !! @ AACR Congratulations to Ilona Gutcher and the team !!!!! # oncology # immunooncology !pic.twitter.com/yuTR21jCug",,@ @,# #,"1256562088983564288",https://twitter.com/LefrancJu/status/1256562088983564288
annalaucis,2020-05-02 08:06,0,0,"Incentivizes*",,,,"1256555750962483200",https://twitter.com/annalaucis/status/1256555750962483200
annalaucis,2020-05-02 08:06,0,3,"That’s the promised land, @ DrChowdharyMD. We can build a better system that harshly punishes preying on vulnerable patients and incentivized and rewards providing guideline-concordant, evidence-based, high quality care. I have some ideas on how to build it.",,@,,"1256555652543057920",https://twitter.com/annalaucis/status/1256555652543057920
DrChowdharyMD,2020-05-02 07:59,2,3,"Oh my. Thanks for sharing @ PoorviDesaiMD Dream of a day that ppl stop preying on vulnerable patients",,@,,"1256553805048578048",https://twitter.com/DrChowdharyMD/status/1256553805048578048
annalaucis,2020-05-02 07:53,0,2,"That’s another issue - absolutely he has disclosures and conflicts of interest — namely that he’s trying to sell crackers and soup for $249. Shameful.",,,,"1256552489358430208",https://twitter.com/annalaucis/status/1256552489358430208
annalaucis,2020-05-02 07:52,0,3,"I agree with you, @ PoorviDesaiMD. Your interpretation seems correct. This “diet” seems like a scam & we should never encourage cancer patients to restrict calories. I tell my pts it’s the time to eat ice cream etc so the body has enough energy to survive intensive treatment.",,@,,"1256552263612588032",https://twitter.com/annalaucis/status/1256552263612588032
pashtoonkasi,2020-05-02 06:26,16,46,"I was just that there have been manydevelopments in GI malignancies in the last year or so. Manyupdates & of. Won’t you agree? Started (anatomic order); what else you’d addWhat has impressed youAnything # CRCSM # PANCSM # HPBCSM # ESOCSM # ASCO20 # AACR20 pic.twitter.com/dY0wt2NQhL",,,# # # # # #,"1256530413012561921",https://twitter.com/pashtoonkasi/status/1256530413012561921
XRBustelo,2020-05-02 03:13,2,9,"It would be great, wouldn’t it? Detecting multiple cancers in a single blood test. @ nresearchnews talks about it. @ ASEICAnews @ EACRnews @ AACR @ NIH @ EMBO @ CSIC @ WorldwideCancer @ CICancer_com @ NatureCancer @ OvertheHillWalk @ Nunodomin @ CienciaGob @ BBCWorld https://www.nature.com/articles/d42473-020-00079-y …",,@ @ @ @ @ @ @ @ @ @ @ @ @ @,,"1256481900979421185",https://twitter.com/XRBustelo/status/1256481900979421185
OncLive,2020-05-02 02:15,3,3,"Haneen Shalabi, DO, of @ NCIResearchCtr, shares how a novel bispecific CD19/22 CAR T-cell construct appeared to be active and well-tolerated in patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia. # leusm # AACR20 http://ow.ly/fB7I50zsB3q pic.twitter.com/QEseFuvcun",,@,# #,"1256467227043401728",https://twitter.com/OncLive/status/1256467227043401728
Emily_R_Song,2020-05-02 02:09,0,2,"pic.twitter.com/ubVlPtmJEo",,,,"1256465922715521024",https://twitter.com/Emily_R_Song/status/1256465922715521024
PoorviDesaiMD,2020-05-02 01:58,0,2,"Longo listed no disclosures pic.twitter.com/ubETwNdADH",,,,"1256463030549983237",https://twitter.com/PoorviDesaiMD/status/1256463030549983237
OncLive,2020-05-02 01:15,1,2,"The addition of the novel innate immune activator, Imprime PGG, to checkpoint inhibition with pembrolizumab showed pronounced clinical benefit in patients with previously treated metastatic triple-negative breast cancer. @ JohnWayneCI # bcsm # AACR20 http://ow.ly/jtNP50zsAk4",,@,# #,"1256452121228181504",https://twitter.com/OncLive/status/1256452121228181504
Emily_R_Song,2020-05-02 00:16,0,6,"The study is garbage. Valter Longo is a scam artist. @ AACR loses its credibility by allowing these type of bogus studies to be presented at the national conference.",,@,,"1256437318438830080",https://twitter.com/Emily_R_Song/status/1256437318438830080
Subree_UMN,2020-05-01 23:51,0,0,"@ AACR @ ACS_Research @ UMNewshttps://twitter.com/Subree_UMN/status/1256430074821312513 …",,@ @ @,,"1256431042459832321",https://twitter.com/Subree_UMN/status/1256431042459832321
PoorviDesaiMD,2020-05-01 23:50,1,7,"10/10 I personally don’t think @ AACR should be entertaining “fasting mimicking diets” - it will most likely be used as a promo for Longo and @ prolonfmd. # intermittentfasting # cancernutrition # fastingmimickingdiet # prolonfmd # precisionnutrition Thoughts?",,@ @,# # # # #,"1256430887002136577",https://twitter.com/PoorviDesaiMD/status/1256430887002136577
PoorviDesaiMD,2020-05-01 23:50,1,4,"2/10 # AACR20 Abstract CT075 - “Fasting-mimicking diet and hormone therapy modulates metabolic factors to promote breast cancer regression and reduce side effects” So what is a “Fasting-mimicking diet?” A term entirely made up by and TRADEMARKED by Longo.",,,#,"1256430862704533504",https://twitter.com/PoorviDesaiMD/status/1256430862704533504
PoorviDesaiMD,2020-05-01 23:50,5,21,"1/10 I have been following Valter Longo’s work on “fasting-mimicking diets” (FMD) for a while now & feel compelled to share some *serious* concerns with his approach to nutrition during cancer treatment. As of this week he managed to sneak his way into an abstract at # AACR20.",,,#,"1256430857654620161",https://twitter.com/PoorviDesaiMD/status/1256430857654620161
OncLive,2020-05-01 23:15,0,2,"Data showed that in all patients with HER2-negative breast cancer, the predicted probability of pCR with durvalumab plus olaparib and neoadjuvant paclitaxel versus with paclitaxel alone was 37% versus 20%, respectively. @ YaleCancer # AACR20 # bcsmhttps://www.onclive.com/conference-coverage/aacr-2020/adding-durvalumab-olaparib-to-neoadjuvant-chemo-improves-pcr-in-high-risk-her2-negative-breast-cancer …",,@,# #,"1256421925250895872",https://twitter.com/OncLive/status/1256421925250895872
oncologician,2020-05-01 22:57,2,5,"Predictive Biomarkers for IO is a developing field. We recently learned about STK11 and KEAP1 at # AACR2020 .",,,#,"1256417569734459392",https://twitter.com/oncologician/status/1256417569734459392
OncLive,2020-05-01 21:15,1,2,"Patients with pretreated non–small cell lung cancer and EGFR exon 20 insertions demonstrated a 68.7% disease control rate while on poziotinib systemic therapy. @ MDAndersonNews # AACR20 # lcsmhttp://ow.ly/Vp1w50zszVj",,@,# #,"1256391727222579203",https://twitter.com/OncLive/status/1256391727222579203
OncLive,2020-05-01 20:15,1,1,"Edward B. Garon, MD, of @ dgsomucla, discusses how capmatinib demonstrated clinical meaningful activity in patients with advanced non–small cell lung cancer who harbor MET exon 14 mutations. # AACR20 # lcsm http://ow.ly/HCz850zszTZ pic.twitter.com/cBKxfdrHu4",,@,# #,"1256376633277190146",https://twitter.com/OncLive/status/1256376633277190146
OncLive,2020-05-01 19:00,1,1,"Continuous dosing with dabrafenib and trametinib improved PFS compared with intermittent dosing in patients with BRAF mutation–positive advanced melanoma. @ UCSFCancer @ SWOG # AACR20 # melsmhttp://ow.ly/iN9250zsyd3",,@ @,# #,"1256357965398970368",https://twitter.com/OncLive/status/1256357965398970368
PaulaDBos,2020-05-01 18:29,1,10,"Excellent idea by @ CellPressNews to go along @ AACR. Honored to have participated in Cancer Research Week, discussing cancer immunology modeling with @ merghout and Yang-Xin Fu. @ CellReports @ VCUMassey @ VCUresearchhttps://twitter.com/CellPressNews/status/1255842410397040641 …",,@ @ @ @ @ @,,"1256350092459728897",https://twitter.com/PaulaDBos/status/1256350092459728897
RuthHe12,2020-05-01 18:28,4,9,"Very interesting data presented # AACR20 by Dr. Andrew Zhu on Morpheus GO30140 biomarker study " Genomic correlates of clinical benefit from atezo +Bev vs. Atezo in HCC. pic.twitter.com/wSad0GlSlp",,,#,"1256349790956380161",https://twitter.com/RuthHe12/status/1256349790956380161
TheCancerLetter,2020-05-01 18:25,8,17,"With 61,000 people registered, first-ever virtual AACR annual meeting “enthusiastically received,” says @ AACR's President-elect Antoni Ribas ( @ UCLAJCCC) — http://cancerletter.com/articles/20200501_5/ …pic.twitter.com/rIaH8t0XjE",,@ @,,"1256348940431220739",https://twitter.com/TheCancerLetter/status/1256348940431220739
Aiims1742,2020-05-01 18:07,14,52,"There were 61,000 registrants for the virtual @ AACR meeting. A typical in person meeting gets <25,000 attendees. Via Toni Ribas. https://cancerletter.com/articles/20200501_5/ …https://twitter.com/Aiims1742/status/1256209910964072448 …",,@,,"1256344592749940748",https://twitter.com/Aiims1742/status/1256344592749940748
TheCancerLetter,2020-05-01 17:40,2,2,". @ AACR data from China and Europe amount to “two different messages” for cancer patients with # COVID19. ( # COVIDnCancer) http://cancerletter.com/articles/20200501_4/ …pic.twitter.com/9mfFxgcoB2",,@,# #,"1256337616816963585",https://twitter.com/TheCancerLetter/status/1256337616816963585
circulogene_bio,2020-05-01 17:37,1,1,"# Immunotherapy using tumor-infiltrating lymphocytes after # nivolumab shows promise in small Phase I study of # NSCLC patients, presented at 2020 @ AACR. # Oncology # PrecisionMedicine # MolecularDiagnostics # LungCancer # EGFR # PDL1 # TMB # biomarkers # AACR20 https://www.cancerhealth.com/article/customized-immunotherapy-shows-promise-lung-cancer …",,@,# # # # # # # # # # # #,"1256337021804572672",https://twitter.com/circulogene_bio/status/1256337021804572672
CancerResearch,2020-05-01 17:00,0,0,"Dr. Louis P. Voigt of @ sloan_kettering drew attention to the racial and ethnic disparities in treatment outcomes for COVID-19 patients. Read # AACR20 Day 2 recap now https://bit.ly/2YpAyd2",,@,#,"1256327617147400192",https://twitter.com/CancerResearch/status/1256327617147400192
AACR,2020-05-01 16:30,3,9,"During the recent # AACR20 Virtual Annual Meeting I, outcomes in patients with cancer who contracted COVID-19 was the focus of a plenary session that featured an international panel of experts. Read more on the blog: https://bit.ly/35rC1RB pic.twitter.com/BLrF0T3Y3F",,,#,"1256320018083536896",https://twitter.com/AACR/status/1256320018083536896
PortalOnconews,2020-05-01 16:04,1,0,"Apresentado na # AACR20, o estudo I-SPY 2 demonstrou que a combinação de durvalumabe, olaparibe e paclitaxel melhora a pCR em comparação com o padrão de QT NEO no câncer de mama alto risco, HER2-, estágio II/III. O oncologista @ GilbertoAmorim6 comenta -https://tinyurl.com/y94csx92 pic.twitter.com/r0Ywzcif7g",,@,#,"1256313510126067712",https://twitter.com/PortalOnconews/status/1256313510126067712
kRasKickers,2020-05-01 15:36,0,0,"The median overall survival cannot yet be determined for a Fantastic reason: because a majority of # lungcancer patients are still alive! # LCSM",,,# #,"1256306477775511552",https://twitter.com/kRasKickers/status/1256306477775511552
LizCancerHealth,2020-05-01 15:31,3,1,"News from # AACR20: TILs, a new type of # immunotherapy, shows promise for # lungcancer. @ cancerhealthmag @ AACR @ MoffittNews @ MoffittResearch @ IovanceBio # lcsm https://tinyurl.com/yckdrccw",,@ @ @ @ @,# # # #,"1256305324161564672",https://twitter.com/LizCancerHealth/status/1256305324161564672
LaoSaal,2020-05-01 15:29,0,0,"Our ESR1 mutations story presented at # AACR20 picked up in the media https://www.precisiononcologynews.com/cancer/poor-endocrine-therapy-response-primary-breast-cancer-possibly-explained-rare-esr1-mutations#.XqrUSi9h2ek …",,,# #,"1256304773726236672",https://twitter.com/LaoSaal/status/1256304773726236672
FoundationATCG,2020-05-01 14:56,4,19,"We’re proud to be part of the TMB Harmonization Project, a collaborative effort to standardize TMB measurement & advance care for cancer patients. Thanks @ CancerResrch for sharing phase 2 data at # AACR20, showing it’s possible to align on standards for TMB http://ow.ly/wF4j50zu9hv pic.twitter.com/bg7qgABbnR",,@,#,"1256296517859762183",https://twitter.com/FoundationATCG/status/1256296517859762183
JCellBiol,2020-05-01 14:42,0,4,"ICYMI! JCB’s cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has short summaries of articles in this PDF: https://bit.ly/2XYckGS pic.twitter.com/87ZdXPaSG3",,,#,"1256292814176096257",https://twitter.com/JCellBiol/status/1256292814176096257
kellimrasmussen,2020-05-01 14:37,3,5,"# Congratulations to @ hahanson11! Her article # MachineLearning # Methods to Identify Patterns of # Familial Bladder # Cancer was selected as the cover of the upcoming issue of Cancer, Epidemiology Biomarkers, & Prevention @ AACR https://cebp.aacrjournals.org/content/29/5.cover-expansion … @ huntsmancancer @ UofUHealth",,@ @ @ @,# # # # #,"1256291593683824641",https://twitter.com/kellimrasmussen/status/1256291593683824641
CellPressNews,2020-05-01 14:10,1,4,"Want to improve your understanding of individualized # CellBiology? Download the free Cell Press Selection: Advances in Single-Cell Sequencing # AACR20 - https://bit.ly/2SnI1p5",,,# #,"1256284768636977156",https://twitter.com/CellPressNews/status/1256284768636977156
Onconova_ONTX,2020-05-01 14:01,3,13,"May is National Cancer Research Month which highlights the importance of lifesaving research to the millions of people around the world affected by cancer. Visit @ AACR’s site for info and resources: https://bit.ly/2Spd0Bt # ResearchSavesLives # NCRM20pic.twitter.com/tS5EpMozHk",,@,# #,"1256282609048596482",https://twitter.com/Onconova_ONTX/status/1256282609048596482
HTGMolecular,2020-05-01 14:00,0,0,"# HTGMolecular and the American Association for Cancer Research @ AACR celebrate May as Brain Cancer Awareness Month, raising visibility of current research to cure brain and other nervous system cancers. Learn more: https://bit.ly/2yiYdRI # HTGMolecular # AdvancingPrecisionMedicinepic.twitter.com/HHgC7ugtxw",,@,# # #,"1256282333025574912",https://twitter.com/HTGMolecular/status/1256282333025574912
AACR,2020-05-01 14:00,2,4,"Two presentations during the # AACR20 Virtual Annual Meeting I Opening Clinical Plenary highlighted some of the promises and challenges of expanding the use of immunotherapy for patients with breast cancer and patients with prostate cancer, respectively. https://bit.ly/2z4QKFS",,,#,"1256282274296999936",https://twitter.com/AACR/status/1256282274296999936
TempusLabs,2020-05-01 13:53,4,9,"We believe that data should be shared among the healthcare community, advancing the critical research being done to improve patient outcomes. That’s why we support National Cancer Research Month and its effort to show how cancer # ResearchSavesLives. # NCRM20 # NCRM @ AACR pic.twitter.com/beqoJKWrcL",,@,# # #,"1256280562182033411",https://twitter.com/TempusLabs/status/1256280562182033411
NCIMedia,2020-05-01 13:50,13,20,"PRESS RELEASE from @ AACR about @ theNCI: Culturally Tailored Colorectal # Cancer Education Program Improved Awareness and Screening Uptake in Racial/Ethnic Minorities and Rural Populations: https://bit.ly/35nh1LI # CancerDisparities # CancerResearch @ NCICRCHDpic.twitter.com/STJMK3XlP8",,@ @ @,# # #,"1256279944075726848",https://twitter.com/NCIMedia/status/1256279944075726848
JExpMed,2020-05-01 13:33,0,1,"ICYMI! JEM’s cancer collection for # AACR20 (https://bit.ly/3avNaBK ) has new short summaries of articles in this PDF: https://bit.ly/2XYhG4z pic.twitter.com/CUn85oqW8D",,,#,"1256275448008511488",https://twitter.com/JExpMed/status/1256275448008511488
SWOG,2020-05-01 13:32,1,3,"Thanks for the terrific coverage @ OncLive. @ SWOG @ UCSFCancer # AACR20 https://twitter.com/OncLive/status/1256010570765160448 …",,@ @ @,#,"1256275293708234752",https://twitter.com/SWOG/status/1256275293708234752
SWOG,2020-05-01 13:31,0,1,"Our @ SWOG blog Oncology Meetings Made the Switch to Screens https://bit.ly/2KMPsSG Big shout-out to @ AACR and their wild success with # AACR20 More to come in June! pic.twitter.com/iMldjaEzsV",,@ @,#,"1256275018767429632",https://twitter.com/SWOG/status/1256275018767429632
Subree_UMN,2020-05-01 13:28,0,0,"@ AACR @ AACRFoundation @ UMNews @ umnmedschoolhttps://twitter.com/Subree_UMN/status/1256270544451915777 …",,@ @ @ @,,"1256274416226439173",https://twitter.com/Subree_UMN/status/1256274416226439173
EpgntxEinstein,2020-05-01 13:17,1,2,"Great work by @ Amitvermamds and colleagues to protect these vulnerable patients.",,@,,"1256271528712380417",https://twitter.com/EpgntxEinstein/status/1256271528712380417
CarlyHFierce,2020-05-01 13:09,0,1,"ICYMI at # AACR20 - Roche's Tecentriq doesn't amp up Gilead's Yescarta in lymphoma, early study says: https://bit.ly/2WfGen8",,,#,"1256269401302564864",https://twitter.com/CarlyHFierce/status/1256269401302564864
MM_Oncology,2020-05-01 12:48,2,0,"# AACR20 news: Data shed light on severe outcome risk in # cancer patients with # COVID19 - reported by Hongbing Cai at the @ AACR virtual meeting this week, with co-publication in @ CD_AACR # COVID19nCancer # coronavirushttp://bit.ly/2KOV0fk",,@ @,# # # # #,"1256264217004564480",https://twitter.com/MM_Oncology/status/1256264217004564480
LifeSciComms,2020-05-01 12:45,0,1,"In this @ CancerNetwrk article, Compugen’s CMO, Dr. Henry Adewoye, spoke about data presented at # AACR2020 this week. Compugen’s novel # CheckpointInhibitor showed antitumor activity in heavily pretreated patients on its own & as a combo therapy. Read more:https://bit.ly/3d77P0R",,@,# #,"1256263460901576706",https://twitter.com/LifeSciComms/status/1256263460901576706
CancerResearch,2020-05-01 12:40,2,3,"Day 2 of # AACR20, experts at major cancer centers in # COVID_19 hotspots around the world regarding what they’ve learned so far about the novel coronavirus (SARS-CoV-2) and its impact on # cancer patients. Read the recap now https://bit.ly/2YpAyd2",,,# # #,"1256262112906752007",https://twitter.com/CancerResearch/status/1256262112906752007
rachnatshroff,2020-05-01 12:32,1,4,"Completely agree (as always) with @ GIcancerDoc. Still not sure where IO fits. That said, progress is being seen...",,@,,"1256260269652623361",https://twitter.com/rachnatshroff/status/1256260269652623361
RLobb,2020-05-01 12:31,0,0,"# COVID_19 in patients with cancer was an important topic at the recent # AACR20 Virtual Annual Meeting I. Our Cancer Research Catalyst blog presents a roundup of presentations: https://www.aacr.org/professionals/blog/aacr-virtual-annual-meeting-i-a-global-perspective-of-covid-19-in-patients-with-cancer/ …",,,# #,"1256260082268069892",https://twitter.com/RLobb/status/1256260082268069892
AACR,2020-05-01 12:30,1,0,"# ICYMI: The Opening Clinical Plenary Session of the # AACR20 Virtual Meeting I featured two studies that examined strategies to improve responses to BRAF and MEK inhibitors in patients with advanced melanoma. https://bit.ly/2YsxHA7",,,# #,"1256259608177512453",https://twitter.com/AACR/status/1256259608177512453
letswinpc,2020-05-01 12:13,0,0,"We are so grateful for you and your support!",,,,"1256255486552354817",https://twitter.com/letswinpc/status/1256255486552354817
mdmanishshah,2020-05-01 11:53,2,26,"Very excited to play a small part in developing a new treatment for KRAS mutant tumors like # PancreaticCancer and # CRC !! Thank you and @ letswinpc for the forum you have created to promote awareness and advance science! @ AACR @ SU2C @MeyerCancer @ cornellGIcancerhttps://twitter.com/drallysonocean/status/1256243641456250883 …",,@ @ @ @MeyerCancer @,# #,"1256250322533658630",https://twitter.com/mdmanishshah/status/1256250322533658630
MM_Oncology,2020-05-01 11:51,2,1,"# AACR20 news in brief: # NTRK alteration type key for response to # larotrectinib therapy in patients with solid tumors - click below for the details. Data presented by @ DavidHongMD of MD Anderson @ MDAndersonNews @ alexdrilonhttp://bit.ly/2YoW5CT",,@ @ @,# # #,"1256249986460909570",https://twitter.com/MM_Oncology/status/1256249986460909570
GIcancerDoc,2020-05-01 11:43,0,3,"Overall , I think it is safe to say that ~10% or less of patients may see a response of ?durability . IO in this disease remains very challenging .. Data with Cobi + Atezo @ AACR @ MarkYarchoan showed an ORR that is low - but reached its PEP of PFS..",,@ @,,"1256247836611473408",https://twitter.com/GIcancerDoc/status/1256247836611473408
getsilverbacs1,2020-05-01 11:31,0,0,"Please review: https://m.facebook.com/story.php?story_fbid=10221952240226023&id=1560347857&refid=52&__tn__=-R …",,,,"1256244897310404608",https://twitter.com/getsilverbacs1/status/1256244897310404608
MM_Oncology,2020-05-01 11:20,4,3,"# AACR20 news: First results from the # TERAVOLT registry of # ThoracicCancer patients with # COVID19 have been reported at the @ AACR virtual meeting by @ marinagarassino ( @ IstTumori). @ HornLeora @ peters_solange # LCSM # coronavirushttps://bit.ly/3f5EsOe",,@ @ @ @ @,# # # # # #,"1256241976959213573",https://twitter.com/MM_Oncology/status/1256241976959213573
CellPressNews,2020-05-01 11:15,1,2,"We round off # CancerResearchWeek with our final theme # ClinicalCancerResearch. Visit the Cancer Research Hub to access pioneering clinical research, videos, webinars, and collections. We're sorry to have missed you at # AACR2020 in San Diego and can't wait to see you at # AACR2021.",,,# # # #,"1256240712149917696",https://twitter.com/CellPressNews/status/1256240712149917696
CancerNetwrk,2020-05-01 11:02,1,3,"Researchers analyzed pooled data from 159 patients enrolled in 3 larotrectinib trials to assess outcomes stratified by prior lines of therapy and ECOG performance status. | @ AACR https://www.cancernetwork.com/news/outcomes-larotrectinib-prior-therapy-and-performance-status-trk-fusion-cancer …pic.twitter.com/MK8U8ArsZM",,@,,"1256237504140845056",https://twitter.com/CancerNetwrk/status/1256237504140845056
RibonTx,2020-05-01 11:00,1,2,"Melissa Vasbinder discusses PARP7 - a newly discovered cancer vulnerability and RBN-2397, our first-in-class inhibitor which demonstrated striking tumor regressions in preclinical models, and is currently in a PH1 trial. # AACR20 @ oncologytubehttps://twitter.com/oncologytube/status/1255548918907068417 …",,@,#,"1256237159499120642",https://twitter.com/RibonTx/status/1256237159499120642
AML_Hub,2020-05-01 11:00,1,0,"At # AACR20, Jerry MacGeehan presented preclinical and initial clinical data on SNDX-5613, a potent oral inhibitor of the menin-MLL binding interaction, in MLL-r acute leukemias and NPM1 mutated # AML https://buff.ly/3dgQUsX # leusmpic.twitter.com/e14Be265p3",,,# # #,"1256237044591931393",https://twitter.com/AML_Hub/status/1256237044591931393
danielrich21,2020-05-01 10:53,0,0,"It is reasonable to assume pts considered how being in CR would lead to other important outcomes e.g. chance of it being cured, chance of it coming back, improved QoL, etc. Though they valued CR>EFS which illustrates that there is something imp about saying "I'm in remission."",,,,"1256235284762693633",https://twitter.com/danielrich21/status/1256235284762693633
danielrich21,2020-05-01 10:49,0,0,"CR was defined: "your cancer is not able to be detected." We left open the long-term effects (full defs below). We contrasted this to cure + EFS. It is important to note that inherently these studies capture patients' understanding of attributes, not necc attributes themselves.pic.twitter.com/4fRy1QX2is",,,,"1256234172110319620",https://twitter.com/danielrich21/status/1256234172110319620
evilarsan,2020-05-01 10:48,1,2,"We do NOT have the clinical data to make that statement. The current status is that Aspirin is the SOC for # Lynchsyndrome chemoprevention # CAPP2 data is strong and conclusive. More information on other dosing/timing will come from ongoing # CAPP3",,,# # #,"1256234025594871808",https://twitter.com/evilarsan/status/1256234025594871808
CD_AACR,2020-05-01 10:47,1,3,"# NewsInBrief: Liquid Biopsies Make Strides on Cancer Detection. https://bit.ly/3d5cyQx # AACR20 pic.twitter.com/8K7WKxWNKg",,,# #,"1256233679342514180",https://twitter.com/CD_AACR/status/1256233679342514180
CellPressNews,2020-05-01 10:35,2,3,"Access the Cell Press Selection and learn more about single cells, each with their own part to play in development, function, and disease. # AACR20 - https://bit.ly/2z0itb3",,,#,"1256230660135673858",https://twitter.com/CellPressNews/status/1256230660135673858
NRGonc,2020-05-01 10:30,5,12,"May is # NationalCancerResearchMonth. Now more than ever, we recognize the efforts of researchers, physicians, nurses, patients & survivors dedicated to the importance of cancer research. Cancer hasn't stopped for COVID-19 @ AACR # NCRM20 # ResearchSavesLives http://ow.ly/fpba30qCjhx pic.twitter.com/uum8eSzqf6",,@,# # #,"1256229469246894082",https://twitter.com/NRGonc/status/1256229469246894082
TheWonkologist,2020-05-01 10:26,0,0,"Super interesting. Is CR understood to mean long-term response with no recurrence? As opposed to say biochemical or pathological CR? I would assume the former is more meaningful to patients...",,,,"1256228548345462785",https://twitter.com/TheWonkologist/status/1256228548345462785
CancerTodayMag,2020-05-01 10:26,0,1,"# ICYMI: Researchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus. https://bit.ly/2y84Iaf # AACR20 pic.twitter.com/ZAHABh56tt",,,# #,"1256228548219752456",https://twitter.com/CancerTodayMag/status/1256228548219752456
RAMPWorldwide,2020-05-01 10:22,0,0,"Naproxen > Aspirin?",,,,"1256227614643150860",https://twitter.com/RAMPWorldwide/status/1256227614643150860
AstraZeneca,2020-05-01 10:20,9,41,"How can you tell if some cells in our body are bad? Jill Walker (Immuno-Oncology Diagnostic Development) dives into the diagnostics of # ctDNA and how the DNA of cancer cells may help us predict progression in certain cancers # STEM # AACR20 pic.twitter.com/oL2tbL4qJ1",,,# # #,"1256226981928144900",https://twitter.com/AstraZeneca/status/1256226981928144900
danielrich21,2020-05-01 10:17,6,9,"Now out in @ CEBP_AACR. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits. # AML # leusm # patientexperience @ UNC_Lineberger @ corp_UNC @ AACR @ jfpbridges https://cebp.aacrjournals.org/content/29/5/942 … Comments to follow 1/pic.twitter.com/udf8P7K88M",,@ @ @ @ @,# # #,"1256226262621851651",https://twitter.com/danielrich21/status/1256226262621851651
CEBP_AACR,2020-05-01 10:15,0,0,"RT @ AACR: Published in @ CEBP_AACR: Culturally Tailored Colorectal Cancer Education Program Improved Awareness and Screening Uptake in Racial/Ethnic Minorities and Rural Populations. https://bit.ly/3aXV5rQ pic.twitter.com/wAthzrQpzh",,@ @,,"1256225630816997380",https://twitter.com/CEBP_AACR/status/1256225630816997380
HemOncToday,2020-05-01 10:12,2,4,"Phase 3 EMBRACA trial results from # AACR20 - Talazoparib @ pfizer fails to extend overall survival vs. chemotherapy in BRCA-mutated advanced breast cancer https://bit.ly/2VVkpul Jennifer K. Litton, MD @ JenniferLitton @ MDAndersonNewspic.twitter.com/wLxzsu2MHW",,@ @ @,#,"1256224962723172355",https://twitter.com/HemOncToday/status/1256224962723172355
PortalOnconews,2020-05-01 09:57,1,1,"Apesar dos esforços para desencorajar o uso do tabaco entre adolescentes, produtos com sabor, especialmente os e-cigarettes e vaporizadores, permanecem estimulando o consumo entre os jovens. O assunto foi tema de estudo na # AACR20 - https://tinyurl.com/y86xdt8x @ AACR # ONCONEWSpic.twitter.com/QAC6FKHbT9",,@,# #,"1256221223836680192",https://twitter.com/PortalOnconews/status/1256221223836680192
ASCOPost,2020-05-01 09:56,2,0,"I-SPY2 Trial: Durvalumab/Olaparib/Paclitaxel ‘Graduates’ in HER2-Negative Breast Cancer https://www.ascopost.com/news/april-2020/durvalumabolaparibpaclitaxel-graduates-in-her2-negative-breast-cancer/ … # bcsm # oncology # cancer # AACR20 # AACR2020",,,# # # # #,"1256220830935048192",https://twitter.com/ASCOPost/status/1256220830935048192
ElizSMcKenna,2020-05-01 09:36,5,27,"Following our paper published during # AACR20 on the experience in Wuhan, the largest study to date on patients with cancer and # COVID19 in the US now online in @ CD_AACRhttps://twitter.com/CD_AACR/status/1256214247001985026 …",,@,# #,"1256216044550721536",https://twitter.com/ElizSMcKenna/status/1256216044550721536
cancer_navi,2020-05-01 09:20,1,0,"NSCLCの1次治療でアテゾリズマブと化学療法を併用、維持療法でアテゾリズマブの投与は対照群よりOSを有意に延長せず【AACR2020】：がんナビ # 肺がん # アテゾリズマブ # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202005/565401.html …",,,# # #,"1256211944723251200",https://twitter.com/cancer_navi/status/1256211944723251200
cancerassassin1,2020-05-01 09:18,1,7,"Excellent idea @ Aiims1742 - we are seeing the future of large-scale conferencing, with # AACR20 and # ASCO20 serving as models for the rest of # academicmedicine. An additional and no less important benefit + opportunity here for more patient and advocate engagement than ever beforehttps://twitter.com/Aiims1742/status/1256209910964072448 …",,@,# # #,"1256211476475494400",https://twitter.com/cancerassassin1/status/1256211476475494400
Aiims1742,2020-05-01 09:12,3,29,"Scientists discover upsides of virtual meetings. Fresh from # AACR20 virtual meeting (part 1) I concur. Maybe future meetings could offer both options - in person (for scientists needing the in person contact / networking) AND simulcast. @ cancerassassin1https://science.sciencemag.org/content/368/6490/457 …",,@,#,"1256209910964072448",https://twitter.com/Aiims1742/status/1256209910964072448
Rick__Buck,2020-05-01 09:12,3,4,"Please join the @ AACR and the # cancer community in supporting May is National Cancer Research Month. # NCRM20 # ResearchSavesLiveshttps://twitter.com/AACR/status/1256203237008519169 …",,@,# # #,"1256209849169387523",https://twitter.com/Rick__Buck/status/1256209849169387523
AACR,2020-05-01 09:10,2,3,"On the blog: # AACR20 Annual Meeting 2020 kicked off Monday morning in an all-virtual format. https://bit.ly/3d6BFCF",,,#,"1256209269902409729",https://twitter.com/AACR/status/1256209269902409729
CellPressNews,2020-05-01 09:05,1,0,"@ TrendsinPharma "The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial" by Zang and colleagues - https://bit.ly/2VT3rN5 - # CellPressOncology # AACR20",,@,# #,"1256208015356723201",https://twitter.com/CellPressNews/status/1256208015356723201
RibonTx,2020-05-01 09:04,1,3,"Laurie Schenkel discusses preclinical data on RBN012759, the first inhibitor of PARP14, an inflammatory response on par with checkpoint inhibitors - and the role PARP14 plays in the immune-suppressive tumor microenvironment. # AACR20 @ oncologytubehttps://twitter.com/oncologytube/status/1255560743337881600 …",,@,#,"1256207975942930432",https://twitter.com/RibonTx/status/1256207975942930432
MyBioTechniques,2020-05-01 09:00,0,0,"A front-line view of # cancertreatment in the global # COVID19 outbreak provides an insight to the rate of infection and lethality of SARS-CoV-2 infection in cancer patients. # AACR20",,,# # #,"1256206741634715649",https://twitter.com/MyBioTechniques/status/1256206741634715649
medical_xpress,2020-05-01 08:53,16,21,"Aging and diet lead to proteome changes in the intestinal epithelium @ CellReports @ aacr https://medicalxpress.com/news/2020-05-aging-diet-proteome-intestinal-epithelium.html …",,@ @,,"1256205194938978305",https://twitter.com/medical_xpress/status/1256205194938978305
cancerassassin1,2020-05-01 08:35,1,12,"May 1 (May Day) marks the start of National Cancer Research Month. Check out info via the @ AACR - researchers, physicians, patients, advocates, and community members, share your stories here: https://www.aacr.org/about-the-aacr/newsroom/initiatives-and-partnerships/national-cancer-research-month/ … for # NCRM20 # cancerresearch # researchsaveslives # researchpic.twitter.com/AnDSGShof9",,@,# # # #,"1256200530067628032",https://twitter.com/cancerassassin1/status/1256200530067628032
abcam,2020-05-01 08:16,1,2,"As the week comes to an end, we wanted to take a moment to thank you for being a part of our virtual # AACR20 event! While we couldn’t be together in person at the show, we hope that the information we’ve shared will help keep your science moving. pic.twitter.com/sAIMWDBalL",,,#,"1256195672694538241",https://twitter.com/abcam/status/1256195672694538241
OncLive,2020-05-01 08:15,2,1,"Grant A. McArthur, MBBS, PhD, of @ PeterMacCC shares data from the phase 3 IMspire150 trial with atezolizumab plus vemurafenib/cobimetinib in treatment-naïve patients with BRAF V600–mutant advanced # melanoma. # AACR20 # melsm http://ow.ly/cgVW50zsySp pic.twitter.com/uyyrKjDohC",,@,# # #,"1256195470868852736",https://twitter.com/OncLive/status/1256195470868852736
oncoblogger,2020-05-01 03:35,1,2,"# Cancer and # COVID19 took the stage at @ AACR Annual Meeting - @ CancerworldESOhttps://cancerworld.net/spotlight-on/cancer-and-covid-19-took-the-stage-at-aacr-annual-meeting/ …",,@ @,# #,"1256125122290814976",https://twitter.com/oncoblogger/status/1256125122290814976
Hayburysearch,2020-05-01 03:00,0,1,"AACR: Thrive's early blood test doubles real-world cancer screening rates https://bit.ly/3aSNYAZ # AmericanAssociationForCancerResearch # AACR2020 # ThriveEarlierDetection # Cancer # BloodTest # Diagnostics",,,# # # # # #,"1256116348461240320",https://twitter.com/Hayburysearch/status/1256116348461240320
OncLive,2020-05-01 02:15,9,18,"ECOG performance status, cancer type, and type of prior therapy received can predict risk for clinical worsening or death in patients with cancer who contract the # COVID19. @ barlesi @ GustaveRoussy # AACR20 http://ow.ly/Owuy50zsB5D",,@ @,# #,"1256104840691941380",https://twitter.com/OncLive/status/1256104840691941380
survivorship_JP,2020-05-01 02:11,0,0,"笑っちゃうぐらい分からない！ # aacr2020",,,#,"1256103933593841664",https://twitter.com/survivorship_JP/status/1256103933593841664
montypal,2020-05-01 01:48,4,74,"Kids are in bed. Wife sleeping. Time for # AACR20 virtual mtg! Loving the experience - felt like @ ChrisSweens1 @ DanaFarber & Pam Sharma @ MDAndersonNews were in my living room presenting/discussing Imbassador250. Thx @ AACR staff for personal assistance in accessing presentations! pic.twitter.com/9kPdSXQpMi",,@ @ @ @,#,"1256098206326427648",https://twitter.com/montypal/status/1256098206326427648
MLPOncoData,2020-05-01 01:15,0,0,"# AACR2020 Efficacy and safety of larotrectinib in patients with cancer and NTRK gene fusions or other alterations pic.twitter.com/Ftp7BfsOmJ",,,#,"1256089821946228738",https://twitter.com/MLPOncoData/status/1256089821946228738
MLPOncoData,2020-05-01 01:11,0,2,"# AACR2020 Talazoparib in germline BRCA1/2 mutated/HER2- advanced breast cancer, final OS results from randomized Phase 3 EMBRACA trial: talazoparib did not significantly improve OS over CT (HR 0.85; 95% CI 0.67-1.07; P = 0.17) https://www.abstractsonline.com/pp8/#!/9045/presentation/10773 …",,,# #,"1256088776465698817",https://twitter.com/MLPOncoData/status/1256088776465698817
wtarscott,2020-05-01 01:05,0,0,"Curious if these are cancer patients under treatment (chemo? radiation?) or treatment naïve but with cancer or pre-/post-cancer treatment?",,,,"1256087357477883904",https://twitter.com/wtarscott/status/1256087357477883904
MLPOncoData,2020-05-01 01:00,0,0,"# AACR2020 Outcome of cancer patients infected with COVID-19 @ GustaveRoussy : adequate testing and protective measures, along with the low rate of SARS-cov-2-treatment-related AE, justify an optimal management of the cancer patients’ underlying tumor. https://www.abstractsonline.com/pp8/#!/9045/presentation/10935 …",,@,# #,"1256086001346363393",https://twitter.com/MLPOncoData/status/1256086001346363393
MLPOncoData,2020-05-01 00:38,0,1,"# AACR2020 IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer. The combination of atezo + enza did not show an OS improvement vs enza alone. https://www.abstractsonline.com/pp8/#!/9045/presentation/10596 …",,,# #,"1256080556116361216",https://twitter.com/MLPOncoData/status/1256080556116361216
MLPOncoData,2020-05-01 00:34,0,0,"# AACR2020 Evaluation of atezolizumab (A), cobimetinib (C), and vemurafenib (V) in previously untreated patients with BRAFV600 mutation-positive advanced melanoma: Primary results from the phase 3 IMspire150 pic.twitter.com/pOr75R5mHs",,,#,"1256079642823405568",https://twitter.com/MLPOncoData/status/1256079642823405568
OncLive,2020-05-01 00:15,1,5,"Atezolizumab in combination with vemurafenib and cobimetinib was found to significantly improve PFS & produce durable responses versus vemurafenib/cobimetinib alone in treatment-naïve patients with BRAF V600–mutant advanced # melanoma. @ PeterMacCC # AACR20 http://ow.ly/yYJS50zsyGu",,@,# #,"1256074632773488642",https://twitter.com/OncLive/status/1256074632773488642
MayCho_MD,2020-05-01 00:07,2,2,"Very proud of one of the authors, our very own @ DrEdwardJKim @ UCD_Cancer! @ AACR https://twitter.com/LesinskiLab/status/1255887275826786310 …",,@ @ @,,"1256072685169172480",https://twitter.com/MayCho_MD/status/1256072685169172480
MaraCaicedo19,2020-04-30 23:53,0,0,"Dreaming of a North America- Latin America Cancer Research Month How do we improve Cancer Research in Low and Middle Income Countries, ah?! @ AACR_CEO @ AACR @ AACRFoundationhttps://twitter.com/AACR/status/1255957635980914688 …",,@ @ @,,"1256069266920689671",https://twitter.com/MaraCaicedo19/status/1256069266920689671
Mesmer21,2020-04-30 23:18,0,0,"# AACR20 Key IO drugs were definitely a downer- 1)Ph3 Tecentriq+Xtandi failed on OS in mCRPC pts (15.2mo vs 16.6 Xtandi) 2)Ph1/2 Tecentriq+Mek1/2 inhi no response in NCSLC & PDAC 3)Ph1 Part 1 OX40 agt just 1 PR & 1 SD in 45 pts Neoplasms & Part 2 combo w/ PD-L1 had 10% response",,,#,"1256060426829418496",https://twitter.com/Mesmer21/status/1256060426829418496
tjh6844,2020-04-30 22:51,0,0,"# AACR20",,,#,"1256053500288491520",https://twitter.com/tjh6844/status/1256053500288491520
pauldriscoll33,2020-04-30 22:10,0,0,"In case you missed it, here’s the Opening Session video from Monday’s Virtual @ AACR # AACR20 Annual Meeting! https://youtu.be/XfrJYT76Sjg",,@,#,"1256043217474203650",https://twitter.com/pauldriscoll33/status/1256043217474203650
pauldriscoll33,2020-04-30 22:04,0,0,"@ Apple # creativitygoeson virtual backstage with 62,000 # cancerresearchers # AACR20 @ AACR # COVID__19pic.twitter.com/RDVCTbYMCK",,@ @,# # # #,"1256041688595824640",https://twitter.com/pauldriscoll33/status/1256041688595824640
HamidEmamekhoo,2020-04-30 21:26,0,0,"Congratulations @ EricKleinMD ! Well deserved.",,@,,"1256032093768998913",https://twitter.com/HamidEmamekhoo/status/1256032093768998913
pauldriscoll33,2020-04-30 21:16,0,0,"We’ll see you @ AACR booth in 2021!!!",,@,,"1256029668874113026",https://twitter.com/pauldriscoll33/status/1256029668874113026
OncLive,2020-04-30 21:15,2,2,"Results from the GEOMETRY mono-1 study demonstrated antitumor efficacy of and deep and durable responses with capmatinib in 97 patients with advanced NSCLC who harbor MET exon 14 mutations. @ dgsomucla # lcsm # AACR20 http://ow.ly/jLs350zszKh",,@,# #,"1256029340535529472",https://twitter.com/OncLive/status/1256029340535529472
madamscientist,2020-04-30 20:50,0,0,"Thanks!",,,,"1256023260266979329",https://twitter.com/madamscientist/status/1256023260266979329
atlal_abusanad,2020-04-30 20:43,0,5,"# AACR20 concluded a few days ago w/ noteworthy # bcsm No OS w/ olaparib or talazoparib butPFS and tolerabilityNeo durvalumab+olaparib+pacli.pCR vs. pacli. in pt w/HER2-ve BC (Ph2)Oral SERD w/same efficacy as other SERDsIMPRIME+Pembro. may work in mTNBC @ OncoAlert",,@,# #,"1256021318404911110",https://twitter.com/atlal_abusanad/status/1256021318404911110
sadiyarsh,2020-04-30 20:17,0,2,"Many congratulations... @ monishram6 @ madamscientist",,@ @,,"1256014821579001863",https://twitter.com/sadiyarsh/status/1256014821579001863
OncLive,2020-04-30 20:00,1,2,"Results from a phase 2 @ SWOG S1320 trial showed a median PFS of 9.0 months with continuous dosing of dabrafenib/trametinib vs 5.5 months with intermittent dosing in patients with BRAF-mutant advanced # melanoma. # melsm # AACR20 @ UCSFCancerhttp://ow.ly/TtPX50zsyhx",,@ @,# # #,"1256010570765160448",https://twitter.com/OncLive/status/1256010570765160448
krebs_matt,2020-04-30 19:43,3,5,"Highlights from # AACR20 first annual virtual meeting show mixed results for I/O combos, promise for new targets, modalities. Details and analysis in @ BioCentury here:https://www.biocentury.com/article/305048",,@,#,"1256006249243488257",https://twitter.com/krebs_matt/status/1256006249243488257
CrozrX,2020-04-30 18:08,0,0,"Any additional dosing alterations possible and/or planned to get patients to the single agent dosage, and to stay on treatment for longer?",,,,"1255982404042457089",https://twitter.com/CrozrX/status/1255982404042457089
komenla,2020-04-30 17:59,0,0,"First-of-its-kind blood test could improve early detection of # cancer. Results originally presented at # AACR20 show promise, but more development is needed before clinical use: https://qoo.ly/35rwpa",,,# #,"1255980192377511943",https://twitter.com/komenla/status/1255980192377511943
BrasilOncologia,2020-04-30 17:14,2,9,"Nos dias 27 e 28/04, @ AACR realizou o 1º grande evento de # oncologia em formato virtual. Realizamos uma cobertura especial com vídeos, podcasts e diversas notícias dos principais trabalhos apresentados. Acesse https://www.oncologiabrasil.com.br/aacr-2020/ e confira!pic.twitter.com/pLaB9PNC38",,@,#,"1255968798504615937",https://twitter.com/BrasilOncologia/status/1255968798504615937
CrozrX,2020-04-30 17:08,0,1,"Defactinib release optimization. Is this concept applicable with CH5126766? Both drugs?pic.twitter.com/hpuGqeuJ02",,,,"1255967400736051200",https://twitter.com/CrozrX/status/1255967400736051200
Globeseek,2020-04-30 17:07,0,0,"Thanks.. With 1/3 to 1/2 of Americans not having an advanced directive.. It is time to change that. Docs if this is uncomfortable conversation point them to this video. Whatever it takes get it done @ AACR @ ASCO",,@ @,,"1255967143524331523",https://twitter.com/Globeseek/status/1255967143524331523
CrozrX,2020-04-30 17:06,0,1,"When can we expect CRC, pancreatic data, to get full picture of Phase1? In regard to G12C, NSCLC in particular, Mirati MRTX849 had 6 patients, you had only 2. Is it still worth pursuing G12C, somehow optimize CH5126766 release, seems it needs to be higher dosesee Defactinib pic.twitter.com/1YutBphKMn",,,,"1255966737821990912",https://twitter.com/CrozrX/status/1255966737821990912
JExpMed,2020-04-30 16:52,2,4,"Check out this collection of # cancer research articles from our sister journal @ JCellBiol: https://bit.ly/2Vv9GXj # AACR20 pic.twitter.com/iM17FFjIbM",,@,# #,"1255963140694650887",https://twitter.com/JExpMed/status/1255963140694650887
ElsterLaura,2020-04-30 16:51,0,1,"Another engaging day with discussions about the impact of COVID-19 on # cancer patients and the optimization of immunotherapy responses at # AACR20 day 2! Check out Tempus Labs, Inc.'s recap for highlights. https://twitter.com/TempusLabs/status/1255867802654855174 …",,,# #,"1255962932531298314",https://twitter.com/ElsterLaura/status/1255962932531298314
oncologytube,2020-04-30 16:40,0,0,"Andrea Wang-Gillam, MD on Phase I Study of Defactinib: Can We Expand This Study? # AACR # AACR20 @ WUSTLmed http://dlvr.it/RVn58l pic.twitter.com/t0ZIHm0yzn",,@,# #,"1255960130497032192",https://twitter.com/oncologytube/status/1255960130497032192
oneclickfund,2020-04-30 16:31,0,2,"Not perfect: https://www.abstractsonline.com/pp8/#!/9045/sessions/Kidney%20cancer/1 …",,,#,"1255957855301140493",https://twitter.com/oneclickfund/status/1255957855301140493
HemOncToday,2020-04-30 16:18,1,1,". @ theNCI pivots some research activities to # COVID19 amid ‘unprecedented disruption' https://bit.ly/3aSry2A # AACR20 pic.twitter.com/FWRyNr8Ahi",,@,# #,"1255954651637321731",https://twitter.com/HemOncToday/status/1255954651637321731
SusanGKomen,2020-04-30 16:10,3,13,"First-of-its-kind blood test could improve early detection of # cancer. Results originally presented at # AACR20 show promise, but more development is needed before clinical use: https://bit.ly/2KMQ8rp",,,# #,"1255952699369152516",https://twitter.com/SusanGKomen/status/1255952699369152516
CarlyHFierce,2020-04-30 16:08,0,0,"ICYMI at # AACR20 - Roche's triple threat—Tecentriq, Cotellic and Zelboraf—stalls melanoma progression: https://bit.ly/3bSU59E",,,#,"1255952060085940224",https://twitter.com/CarlyHFierce/status/1255952060085940224
PortalOnconews,2020-04-30 15:56,0,3,"O oncologista André Murad é primeiro autor de estudo selecionado para apresentação em pôster no # AACR20 que avaliou o uso da biópsia líquida com PCR digital em gotas (dd-PCR) para decisão terapêutica em tumores sólidos avançados-https://tinyurl.com/ycy6hgue @ AACR @ GbopGroup # ONCONEWSpic.twitter.com/4mBmbMl8xu",,@ @,# #,"1255949191467196424",https://twitter.com/PortalOnconews/status/1255949191467196424
IBCResearch,2020-04-30 15:54,1,3,"Will conference events like @ AACR @ ASCO & such remain virtual or return to in-person? Interesting article tackling this subject. @ OncoAlert # BCSM https://www.citmagazine.com/article/1681584/9-social-distancing-measures-help-large-events-bounce-back?utm_source=newsletter&utm_medium=email&utm_campaign=coronavirusbriefing_&hmSubId=Dc7Ec6qX2LU1&hmEmail=beRR5gpxQ2VbJOJeBaWDGvY9dM7wlVvY0&email_hash=d00d99130e91d1ba7e0dcfcee34c04b8 …",,@ @ @,#,"1255948769201467393",https://twitter.com/IBCResearch/status/1255948769201467393
oncologytube,2020-04-30 15:50,0,0,"Andrea Wang-Gillam, MD on Phase I Study of Defactinib Combined with Pembrolizumab and Gemcitabine # AACR # AACR20 @ WUSTLmed http://dlvr.it/RVmylh pic.twitter.com/lEDUOMAtv8",,@,# #,"1255947552165249024",https://twitter.com/oncologytube/status/1255947552165249024
CD_AACR,2020-04-30 15:30,3,2,"# NewsInBrief: Tumor-Infiltrating Lymphocytes Help Rein In NSCLC. https://bit.ly/2VRqVCv # AACR20 pic.twitter.com/1kR6qeZBXK",,,# #,"1255942526932004865",https://twitter.com/CD_AACR/status/1255942526932004865
JCellBiol,2020-04-30 15:12,0,1,"Check out the cancer research collection from our sister journal @ JExpMed: https://bit.ly/3avNaBK # AACR20 pic.twitter.com/fuRbJ5g5Ky",,@,#,"1255937977177513984",https://twitter.com/JCellBiol/status/1255937977177513984
christeeny513,2020-04-30 15:10,2,3,"4/4: Channel 3: https://aacr20.onlineeventpro.freeman.com/live-stream/15335391/non-coding-rnas-in-cancer … # BCSM # BccWw # OncoAlert # AACR20",,,# # # #,"1255937640035016706",https://twitter.com/christeeny513/status/1255937640035016706
christeeny513,2020-04-30 15:10,1,1,"3/4: Channel 2: https://aacr20.onlineeventpro.freeman.com/live-stream/15335382/new-drugs-on-the-horizon-part-2 … # BCSM # BccWw # OncoAlert # AACR20",,,# # # #,"1255937638881619968",https://twitter.com/christeeny513/status/1255937638881619968
christeeny513,2020-04-30 15:10,0,1,"2/4: Channel 1: https://aacr20.onlineeventpro.freeman.com/live-stream/15335631/Predictive-Biomarkers-for-Immunotherapeutics … # BCSM # BccWw # OncoAlert # AACR20",,,# # # #,"1255937637761703936",https://twitter.com/christeeny513/status/1255937637761703936
christeeny513,2020-04-30 15:10,5,15,"1/4: In case you missed # AACR20, check out the "schedule at a glance" to see what was offered on the 3 live-streamed channels for both days of the virtual conference. Follow the links in this thread to watch the talks. # BCSM # BccWw # OncoAlert https://www.aacr.org/meeting/aacr-annual-meeting-2020/schedule-at-a-glance/ …",,,# # # #,"1255937636381806593",https://twitter.com/christeeny513/status/1255937636381806593
TurnaRay,2020-04-30 15:10,0,0,"@ AACR Project GENIE enters new phase: $36M collab w/nine pharmas. Aim is to obtain clinical & genomic data from 50,000 de-identified patients and use info to aid clinical decisions & advance discoveries https://www.precisiononcologynews.com/cancer/new-iteration-aacrs-project-genie-focuses-real-world-outcomes-enhance-precision-oncology#.XqshWGhKg2w …",,@,#,"1255937549698306050",https://twitter.com/TurnaRay/status/1255937549698306050
CarlyHFierce,2020-04-30 15:07,1,2,"ICYMI at # AACR20 - Novartis up-and-comer capmatinib successfully fights lung cancer in the brain: https://bit.ly/2xqFrro $ NVS # pharma",,,# #,"1255936708907896832",https://twitter.com/CarlyHFierce/status/1255936708907896832
ed_winnick,2020-04-30 15:06,0,1,"From the @ AACR virtual meeting, featuring @ GrailBio and Thrive Earlier Detection. Pan-Cancer Screening Tests Report First Performance Numbers in Undiagnosed Cohortshttps://www.precisiononcologynews.com/liquid-biopsy/pan-cancer-screening-tests-report-first-performance-numbers-undiagnosed-cohorts?utm_source=addthis_shares#.Xqsg-jtAz1Q.twitter …",,@ @,#,"1255936487645995008",https://twitter.com/ed_winnick/status/1255936487645995008
RMilesMD,2020-04-30 15:05,0,0,"# ESR1 mutations predict survival, endocrine therapy failure in early # BreastCancer @ AACR http://ow.ly/niHK50zt1o7 pic.twitter.com/3bGIa9INzM",,@,# #,"1255936264244809735",https://twitter.com/RMilesMD/status/1255936264244809735
TurnaRay,2020-04-30 15:04,0,1,"Vitrakvi not so effective in NTRK alterations other than fusions. # AACR20 by @ ciarzchttps://www.precisiononcologynews.com/cancer/vitrakvi-effectiveness-does-not-extend-ntrk-alterations-beyond-gene-fusions-study-finds#.XqshCGhKg2w …",,@,# #,"1255936012485824513",https://twitter.com/TurnaRay/status/1255936012485824513
CD_AACR,2020-04-30 15:00,0,1,"# NewsInBrief: Sending CAR T Cells after T-cell Malignancies. # AACR20 https://bit.ly/2VOxqpr pic.twitter.com/sbVEC7QdgV",,,# #,"1255935039793135616",https://twitter.com/CD_AACR/status/1255935039793135616
UmutDisel,2020-04-30 14:48,1,5,"Of you look-She will be %100. @ StephenVLiu @ NicoleKuderer @ christine_lovly @ JackWestMD @ CAPLungCancer @ rarecancerproj Mucinous Ca, exsmoker, 60 Y # aacr2020 @ peters_solange @ jsoriamd @ pashtoonkasi @ oncologician @ TargetedOnc @ OncoAlert @ MedscapeOnc @pic.twitter.com/64QRCTSnMj",,@ @ @ @ @ @ @ @ @ @ @ @ @ @pic,#,"1255932166162300929",https://twitter.com/UmutDisel/status/1255932166162300929
CellPressNews,2020-04-30 14:35,4,6,""Comprehensive Analysis of ERK1/2 Substrates for Potential Combination Immunotherapies" by Ding and colleagues in @ TrendsinPharma # CellPressOncology # AACR20 - https://bit.ly/3aQn9gW",,@,# #,"1255928671841538048",https://twitter.com/CellPressNews/status/1255928671841538048
CD_AACR,2020-04-30 14:23,0,2,"# NewsInBrief: Capmatinib Could Alter NSCLC Treatment Landscape. # AACR20 https://bit.ly/2Ym8hnW pic.twitter.com/V0jO5VGEsY",,,# #,"1255925720955658240",https://twitter.com/CD_AACR/status/1255925720955658240
BionestPartners,2020-04-30 14:10,0,0,"Thrive # AACR20 data highlights specificity, sensitivity trade-offs for # cancer # screening. What clinically meaningful cutoff will emerge from the machine-learning based analysis in # CancerSEEK’s registrational trial? https://buff.ly/2SmQhWs pic.twitter.com/kxuL4mIK2d",,,# # # #,"1255922374710636545",https://twitter.com/BionestPartners/status/1255922374710636545
CarlyHFierce,2020-04-30 14:07,0,0,"ICYMI at # AACR20 - Adding Roche's Tecentriq to Xtandi doesn't extend lives in prostate cancer—even in subgroups: https://bit.ly/2y5pDe5",,,#,"1255921609627643906",https://twitter.com/CarlyHFierce/status/1255921609627643906
JillHW,2020-04-30 14:01,0,4,"Exciting to see good news from # AACR20 for people with # EGFR # lungcancer # ResearchMatters # LCSMhttps://twitter.com/StephenVLiu/status/1255704536905367555 …",,,# # # # #,"1255920175947362305",https://twitter.com/JillHW/status/1255920175947362305
RadiologyBiz,2020-04-30 13:55,0,1,"Breakthrough blood test detects cancers before symptoms arise, PET/CT confirms. @ HopkinsMedicine @ GeisingerHealth @ AACR # AACR20 http://ow.ly/cgnI50ztjyh",,@ @ @,#,"1255918623287377920",https://twitter.com/RadiologyBiz/status/1255918623287377920
ReeseFCRC,2020-04-30 13:54,2,12,"Presented at virtual @ AACR: Trovagene’s PLK1 inhibitor, onvansertib, alongside the standard of care, stopped tumors from growing in 7/8 evaluable patients with KRAS-mutated # colorectalcancer # research # crcsm @ fightcrc https://www.fiercebiotech.com/biotech/aacr-early-data-offers-hope-for-kras-mutant-colon-cancer …"",,@ @,# # #,"1255918470576795648",https://twitter.com/ReeseFCRC/status/1255918470576795648
Cortellis,2020-04-30 13:51,4,0,"Novartis presents the preclinical profile of their lead SHP2 allosteric inhibitor TNO-155, currently in Ph1 for the oral treatment of genetically-defined advanced solid tumors either as monotherapy or in combination with other therapeutic agents. # AACR20",,,#,"1255917663899078657",https://twitter.com/Cortellis/status/1255917663899078657
Cortellis,2020-04-30 13:48,1,1,"Ribon Therapeutics presents the preclinical profile of RBN-2397, a first-in-class PARP7 inhibitor with oral antitumor activity dependent on tumor-derived Type 1 IFN signaling, and the first PARP7-targeted agent to enter clinical testing. # AACR20",,,#,"1255916860970864640",https://twitter.com/Cortellis/status/1255916860970864640
JExpMed,2020-04-30 13:45,0,5,"Special collection on # Hematopoiesis and # Leukemia: https://bit.ly/3eUzYtz # AACR20 pic.twitter.com/FXuZ3CyFFt",,,# # #,"1255916089286033408",https://twitter.com/JExpMed/status/1255916089286033408
ADCReview,2020-04-30 13:42,2,2,"Netherlands-based @ Synthon Biopharmaceuticals, developing innovative the anti-HER2 antibody-drug conjugate [vic-] trastuzumab duocarmazine # SYD985 for breast cancer, has been relaunched as @ byondis https://adc.expert/Byondis # ADC # breastcancer @ World_ADC @ ASCO @ AACR @ CPhIWW # biotech",,@ @ @ @ @ @,# # # #,"1255915318058160128",https://twitter.com/ADCReview/status/1255915318058160128
CMM_JHU,2020-04-30 13:41,0,9,"Congratulations Dr. Monish Makena @mnishram6 on your @ AACR Fellowship in the # RaoLab. @ CMM_JHU @ hopkinskimmel @ HopkinsMedicinehttps://twitter.com/madamscientist/status/1255607590685302784 …",,@mnishram6 @ @ @ @,#,"1255915260365508608",https://twitter.com/CMM_JHU/status/1255915260365508608
Ludwig_Cancer,2020-04-30 13:33,1,3,"Ludwig @ UniofOxford’s Xiufei Chen, Jinfeng Chen and Jingfei Cheng tuned into @ AACR’s Virtual Meeting I to catch Ludwig @ HopkinsMedicine’s Nickolas Papadopoulos present some exciting data on Thrive Earlier Detection’s cancer blood test! # AACR20 pic.twitter.com/tVLR5xR0TA",,@ @ @,#,"1255913279068737537",https://twitter.com/Ludwig_Cancer/status/1255913279068737537
MedscapeOnc,2020-04-30 13:23,0,7,"Immunotherapy provided no benefit when added to standard treatment for men with mCRPC. http://ms.spr.ly/6017TgoIx # AACR2020 pic.twitter.com/7gM6NJ0E4P",,,#,"1255910540007952384",https://twitter.com/MedscapeOnc/status/1255910540007952384
CellPressNews,2020-04-30 13:20,2,3,"Vaccine delivery and treatment response is evolving with the use of nanoparticles and immunoimaging. Read about the latest developments in Research Arc on#CancerVaccines. # AACR20 - https://bit.ly/2WbQ0Xv",,,#CancerVaccines #,"1255909796013899782",https://twitter.com/CellPressNews/status/1255909796013899782
BillDiplas,2020-04-30 13:05,0,2,"Key point: “The goal of earlier detection is to identify the presence of cancer at a stage when a treatment is more likely to be successful, thereby offering a better chance of long-term survival”[4/4] # AACR20 https://science.sciencemag.org/content/early/2020/04/27/science.abb9601 …",,,#,"1255906069001445376",https://twitter.com/BillDiplas/status/1255906069001445376
HemOncToday,2020-04-30 13:04,1,0,"News from # AACR20 - A pooled analysis shows Larotrectinib @ BayerPharma effective for adults & children with tropomyosin receptor kinase fusion cancers https://bit.ly/2VOP38w David S. Hong, MD @ DavidHongMD @ MDAndersonNews / Patricia Mucci LoRusso, MD @ YaleMed @ YaleCancerpic.twitter.com/rZbVd0IrH6",,@ @ @ @ @,#,"1255906005503881217",https://twitter.com/HemOncToday/status/1255906005503881217
Hayburysearch,2020-04-30 13:01,0,0,"AACR: Novartis up-and-comer capmatinib successfully fights lung cancer in the brain https://bit.ly/2ydlnZT # Novartis # AACR2020 # Capmatinib # Non-SmallCellLungCancer # BrainMetastases",,,# # # # #,"1255905134137180164",https://twitter.com/Hayburysearch/status/1255905134137180164
RMilesMD,2020-04-30 13:00,0,0,"# Talzenna Misses OS Endpoint in # BRCAPositiveBreastCa — But # PARP inhibitor improved patient-reported outcomes over standard therapy @ JenniferLitton @ MDAndersonNews @ AACR http://ow.ly/blYY50zt0ni @ medpagetoday # Talazoparib # BreastCa",,@ @ @ @,# # # # #,"1255904900384522242",https://twitter.com/RMilesMD/status/1255904900384522242
GenomeWeb,2020-04-30 13:00,2,0,"GenomeWeb and @ PrecOncNews reporters have been covering the # AACR20 Virtual Meeting. Check out our coverage all in one place here: https://www.genomeweb.com/organization/aacr …",,@,#,"1255904846491848704",https://twitter.com/GenomeWeb/status/1255904846491848704
KatsuakiMaehara,2020-04-30 12:55,1,3,"Thank you so much！ Very excited & outstanding sessions！ Looking forward to wait June. @ AACR @ OncoAlertpic.twitter.com/5I97NXUGbf",,@ @,,"1255903510765252608",https://twitter.com/KatsuakiMaehara/status/1255903510765252608
ADCReview,2020-04-30 12:55,1,1,"ADC Review | Journal of Antibody-drug Conjugates likes to congratulate @ ImmunomedicsInc with the approval of sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with # mTNBC. https://adc.expert/Sacituzumab_Govitecan_Trodelvy … @ ASCO @ AACR @ World_ADC # ADC # breastcancer @ Trodelvy",,@ @ @ @ @,# # #,"1255903490053779456",https://twitter.com/ADCReview/status/1255903490053779456
OncoAlert,2020-04-30 12:49,13,27,"Fresh out of # AACR20 Our great @ OncoAlert colleague @ E_de_Azambuja from @ JulesBordet discussing The Circulating Cell-free Genome Atlas Study by Thiel et al. More information at @ ASCOPost https://www.ascopost.com/news/april-2020/cfdna-liquid-biopsy-may-provide-an-early-detection-test-for-patients-with-suspected-cancer/ …pic.twitter.com/bht6HyXbD3",,@ @ @ @,#,"1255902080281296902",https://twitter.com/OncoAlert/status/1255902080281296902
NCIMedia,2020-04-30 12:43,1,3,"A novel CAR-T therapy as studied by an @ theNCI lead researcher was tolerable & resulted in responses among patients with acute lymphoblastic leukemia. Results from the phase 1 trial presented during the @ AACR Virtual Annual Meeting. From @ CancerTherAdvsr: https://bit.ly/3bPzzqE pic.twitter.com/cNgOuYatMM",,@ @ @,,"1255900567089541120",https://twitter.com/NCIMedia/status/1255900567089541120
MdC_UQAM,2020-04-30 12:30,1,3,"Des résultats prometteurs dans la lutte contre le cancer des ovaires présentés au congrès annuel de l’American Association for Cancer Research ( @ AACR). # UQAM @ sciencesUQAM # ImpactRecherche # cancerhttps://bit.ly/2KN5Wuc",,@ @,# # #,"1255897198581239811",https://twitter.com/MdC_UQAM/status/1255897198581239811
RyanNipp,2020-04-30 12:06,6,16,"Core Patient-Reported Outcomes in # Cancer # ClinicalTrials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms. https://clincancerres.aacrjournals.org/content/clincanres/22/7/1553.full.pdf … @ AACR # PROs # PallOnc @ FDAOncologypic.twitter.com/s1XR4Qzrfj",,@ @,# # # #,"1255891332117250049",https://twitter.com/RyanNipp/status/1255891332117250049
Hayburysearch,2020-04-30 12:01,0,0,"AACR: Iovance details early responses to TIL cell therapy in lung cancer https://bit.ly/2zLONPh # IovanceBiotherapeutics # AmericanAssociationForCancerResearch # AACR2020 # CellTherapy # LungCancer # PersonalizedMedicine",,,# # # # # #,"1255889991416283149",https://twitter.com/Hayburysearch/status/1255889991416283149
HemOncToday,2020-04-30 11:59,2,2,"News from # AACR20 - Minimally invasive DETECT-A multicancer blood test useful for screening and guiding management of patients with no cancer history https://bit.ly/35us329 Nickolas Papadopoulos, PhD @ HopkinsMedicine @ hopkinskimmelpic.twitter.com/2j5xzUhvxY",,@ @,#,"1255889526607708161",https://twitter.com/HemOncToday/status/1255889526607708161
LesinskiLab,2020-04-30 11:50,5,16,"Honored to work with this amazing team on # cholangiocarcinoma # immunotherapy @ WinshipAtEmory @ hopkinskimmel @ curecc @ AACR @ sitcancer a step forward with early data in a tough disease.https://twitter.com/MarkYarchoan/status/1255879715212201988 …",,@ @ @ @ @,# #,"1255887275826786310",https://twitter.com/LesinskiLab/status/1255887275826786310
blkstemhero,2020-04-30 11:13,0,1,"The seminars during # AACR20 were really fun! My favorite was the COVID19 and Cancer symposium https://twitter.com/AACR/status/1255565027593146369 …",,,#,"1255877846737747971",https://twitter.com/blkstemhero/status/1255877846737747971
TristanFreefsg,2020-04-30 11:03,2,4,"Miss out on the first @ AACR Virtual Annual Meeting? You can catch up with our Editors' coffee chats from both days at the links below, featuring the editors of @ MyBioTechniques, @ OncologyCentral and @ NanomedZone: Day 1: https://bit.ly/2VQMWBm Day 2: https://bit.ly/2YlqZfa pic.twitter.com/feu0kv0hwd",,@ @ @ @,,"1255875440876584961",https://twitter.com/TristanFreefsg/status/1255875440876584961
ASCOPost,2020-04-30 11:03,6,6,"Cell-Free DNA Liquid Biopsy May Provide an Early Detection Test for Patients With Suspected Cancer https://www.ascopost.com/news/april-2020/cfdna-liquid-biopsy-may-provide-an-early-detection-test-for-patients-with-suspected-cancer/ … # AACR20 # AACR2020 # cancer # oncology",,,# # # #,"1255875304675053571",https://twitter.com/ASCOPost/status/1255875304675053571
AACR,2020-04-30 11:00,3,1,"On the blog: Data presented at # AACR20 showcase two liquid biopsy tests for the early detection of cancer. @ MayoClinic @ HopkinsMedicinehttps://bit.ly/3bSBgDE",,@ @,#,"1255874632755838977",https://twitter.com/AACR/status/1255874632755838977
OncologyCentral,2020-04-30 11:00,2,2,"Catch up on all things # AACR20 in the latest Editor’s round-up on @ OncologyCentral now!",,@,#,"1255874549263958017",https://twitter.com/OncologyCentral/status/1255874549263958017
1stOncology,2020-04-30 10:55,1,0,"A fresh look at the use of # genomics and the changing landscape of clinical practice in the modern # cancer medicine. The next step is to personalize disease management. Read the full story https://www.linkedin.com/pulse/next-breakthrough-insights-our-fight-against-cancer-dr-ronnie/ … # AACR2020 pic.twitter.com/Q3YJJNgweG",,,# # #,"1255873335059193857",https://twitter.com/1stOncology/status/1255873335059193857
CancerNetwrk,2020-04-30 10:55,0,0,"Early results from a phase Ia/b dose escalation trial evaluating the safety and tolerability of CG-806 in patients with relapsed or refractory CLL/SLL or NHL were presented at @ AACR. https://www.cancernetwork.com/chronic-lymphocytic-leukemia/early-results-phase-iab-dose-escalation-trial-cg-806-cllsll-and-nhl …pic.twitter.com/ZPjYyoLasw",,@,,"1255873319859032065",https://twitter.com/CancerNetwrk/status/1255873319859032065
AACR,2020-04-30 10:50,0,2,"RT @ CancerTodayMag: At the @ AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis. https://bit.ly/2WhhTgO # AACR20 pic.twitter.com/gz5pb5bVJ7",,@ @,#,"1255872055406444544",https://twitter.com/AACR/status/1255872055406444544
PacBio,2020-04-30 10:45,0,1,"Will the next # cancer breakthroughs be in # immunotherapy? Tumor microenvironment? # Microbiome? Or early detection & screening? Whatever the result, long-read sequencing can play a pivotal part in the discovery process @ AshbyMere tells @ AmericanLab # AACR20 http://ow.ly/9IHa50zqEtk pic.twitter.com/oLKLJzvEKB",,@ @,# # # #,"1255870794380521472",https://twitter.com/PacBio/status/1255870794380521472
JCellBiol,2020-04-30 10:44,0,3,"Tell us what you think about JCB’s cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) and the new short summaries of articles in this PDF: https://bit.ly/2XYckGS pic.twitter.com/x1FiSblFt9",,,#,"1255870531020173313",https://twitter.com/JCellBiol/status/1255870531020173313
1stOncology,2020-04-30 10:37,2,2,"Sparrow Herbert-Herman Cancer Center, a 1stOncology Healthcare Partner, talks about how # PrecisionMedicine is becoming the method of choice for # cancer patients and how personalized disease management is the next logical step. Read the full story https://www.linkedin.com/pulse/next-breakthrough-insights-our-fight-against-cancer-dr-ronnie/ … # AACR2020 pic.twitter.com/2RypHKb45c",,,# # #,"1255869006415908866",https://twitter.com/1stOncology/status/1255869006415908866
CancerTodayMag,2020-04-30 10:35,0,0,"At the @ AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis. https://bit.ly/2SmjReQ # AACR20 pic.twitter.com/egjbTsKAqp",,@,#,"1255868281321394176",https://twitter.com/CancerTodayMag/status/1255868281321394176
TempusLabs,2020-04-30 10:33,2,1,"Learn what you need to know about new # cancer research discoveries coming out of # AACR20 Virtual Meeting day 2 by reading our recap from our medical affairs team: https://bit.ly/AACRday2recap .pic.twitter.com/CeeTZ4bPyJ",,,# #,"1255867802654855174",https://twitter.com/TempusLabs/status/1255867802654855174
trinity_delta,2020-04-30 10:12,0,0,"# AACR20 # surufatinib presentations: (1) Ph I data in combo w anti-PD-1 toripalimab; (2) PK congruence b/w China & US pts. Pending reg approval, @ HChiMed will launch surufatinib monotherapy for NET in China & start global registration studies in H220 $ HCMhttps://www.trinitydelta.org/companies/chi-med/ …",,@,# #,"1255862661784522753",https://twitter.com/trinity_delta/status/1255862661784522753
ElsterLaura,2020-04-30 10:12,0,1,"@ TempusLabs shared a great recap of # AACR20 day 1, and the important # oncology advancements in the industry.https://twitter.com/TempusLabs/status/1255495408161259524 …",,@,# #,"1255862468787802113",https://twitter.com/ElsterLaura/status/1255862468787802113
AACRFoundation,2020-04-30 10:00,0,0,"On the blog: Data presented at # AACR20 showcase two liquid biopsy tests for the early detection of cancer. https://bit.ly/2Yiu27R",,,#,"1255859517205725185",https://twitter.com/AACRFoundation/status/1255859517205725185
CellPressNews,2020-04-30 10:00,2,3,"Get your free digital copy of Cell Press Selections: Advances in Single-Cell Sequencing # AACR20 - https://bit.ly/3aQqs7B",,,#,"1255859472653746179",https://twitter.com/CellPressNews/status/1255859472653746179
TurvilleBay,2020-04-30 10:00,0,0,"' @ AACR Virtual Annual Meeting I: The Promises and Challenges of Expanding the Use of Immune Checkpoint Inhibitors Through Combination Therapy https://bit.ly/2YpoaKl",,@,,"1255859471735312392",https://twitter.com/TurvilleBay/status/1255859471735312392
MayoCancerCare,2020-04-30 09:45,1,0,"# BloodTest shows promise for predicting cancer, tissue of origin ahead of histologic diagnosis: https://bit.ly/2VOPEqL # CancerBloodTest @ GoHealio # AACR20 # CancerCare",,@,# # # #,"1255855675252621319",https://twitter.com/MayoCancerCare/status/1255855675252621319
CGlideHurst,2020-04-30 09:34,0,2,"# babymathonco!",,,#,"1255852999798292481",https://twitter.com/CGlideHurst/status/1255852999798292481
HeikoEnderling,2020-04-30 09:27,1,27,"# ThrowbackThursday to 11 years ago, official profile picture for my @ AACR Centennial Postdoctoral Fellowship award on tumor dormancy modeling pic.twitter.com/GcAbjRvQrA",,@,#,"1255851226366959619",https://twitter.com/HeikoEnderling/status/1255851226366959619
SilasInman,2020-04-30 09:24,0,1,"RAF-MEK Inhibitor/Defactinib Combo Is Active in KRAS -Mutant Cancers https://www.onclive.com/conference-coverage/aacr-2020/raf-mek-inhibitor-defactinib-combo-is-active-in-kras-mutant-cancers … # AACR20",,,#,"1255850604162953217",https://twitter.com/SilasInman/status/1255850604162953217
CEC_Onc,2020-04-30 09:24,1,0,"Patients with cancer, esp lung or blood cancers, were >5x more likely to have serious complications, require ICU, and die from # COVID19 (18% in LC). As the U.S. tries to reopen, we must take extra steps to protect these vulnerable patients. # AACR20 # lcsmhttps://www.medpagetoday.com/meetingcoverage/aacr/86201 …",,,# # #,"1255850602439024649",https://twitter.com/CEC_Onc/status/1255850602439024649
HemOncToday,2020-04-30 09:12,1,0,"News from # AACR20 - Lorlatinib @ pfizer effective for non-small cell lung cancer with ALK resistance mutations https://bit.ly/2SlU86h Todd M. Bauer, MD @ SarahCannonDocspic.twitter.com/I8NJIgmmap",,@ @,#,"1255847388096364546",https://twitter.com/HemOncToday/status/1255847388096364546
AACR,2020-04-30 09:05,0,6,"On the blog: # AACR20 Annual Meeting 2020 kicked off Monday morning in an all-virtual format. https://bit.ly/3f3nArn",,,#,"1255845626069356546",https://twitter.com/AACR/status/1255845626069356546
DanaFarberNews,2020-04-30 09:00,4,8,"A discussion on why immune checkpoint inhibitors are struggling in # prostatecancer. Dana-Farber's @ ChrisSweens1 discusses his @ AACR plenary presentation on the phase three trial of atezolizumab # immunotherapy: http://ms.spr.ly/6015TgWw7 via @ uromigos # AACR20",,@ @ @,# # #,"1255844355706929157",https://twitter.com/DanaFarberNews/status/1255844355706929157
OncologyCentral,2020-04-30 09:00,2,1,". @ cityofhope’s Yuman Fong tells us about his work recently presented at # AACR20 investigating oncolytic viruses and how they can be translated to the # oncology clinic! Read the full interview below:",,@,# #,"1255844350241787904",https://twitter.com/OncologyCentral/status/1255844350241787904
jamecancerdoc,2020-04-30 08:57,0,1,"Congratulations @ EricKleinMD!!",,@,,"1255843632688631809",https://twitter.com/jamecancerdoc/status/1255843632688631809
diegoah66,2020-04-30 08:55,0,1,"An what was presented in @ AACR pic.twitter.com/9KHdGD8dMq",,@,,"1255843315888652289",https://twitter.com/diegoah66/status/1255843315888652289
ASCOPost,2020-04-30 08:55,0,0,"Study Finds Vape Shops Are Mostly Concentrated in Low-Resource, Minority Communities https://www.ascopost.com/news/april-2020/study-finds-vape-shops-are-mostly-concentrated-in-low-resource-minority-communities/ … # AACR20 # AACR2020",,,# #,"1255843092017668097",https://twitter.com/ASCOPost/status/1255843092017668097
cbtadvisors,2020-04-30 08:46,0,1,"This is about @ Roche announcing results at # ASCO20 of a # clinicaltrial of their anti-TIGIT antibody in combo w their CPI Tecentriq. That's in addition to the monotherapy data for same Ab @ # AACR20. I think we're gonna need a # TIGIT hashtag... cc @ PDRennert @ XBIObserverhttps://twitter.com/bradloncar/status/1255690308798611457 …",,@ @ @ @,# # # #,"1255841038440292352",https://twitter.com/cbtadvisors/status/1255841038440292352
CancerNetwrk,2020-04-30 08:25,0,2,"Updated interim results from the phase Ib/II CLASSICAL-Lung study showed promise for pepinemab in combination with avelumab in patients with advanced stage non-small cell lung cancer. | @ AACR https://www.cancernetwork.com/lung-cancer/interim-results-phase-ibii-classical-lung-study-show-promise-nsclc …pic.twitter.com/QdVfpgDnCc",,@,,"1255835559928434688",https://twitter.com/CancerNetwrk/status/1255835559928434688
OncLive,2020-04-30 08:15,1,3,"The addition of durvalumab and olaparib to neoadjuvant paclitaxel was found to improve pathologic complete response rates compared with paclitaxel alone in patients with high-risk, HER2-negative stage II/III breast cancer. @ YaleCancer # AACR20 # bcsmhttp://ow.ly/zLPp50zsA8q",,@,# #,"1255833073004023809",https://twitter.com/OncLive/status/1255833073004023809
smock2020,2020-04-30 08:11,1,3,"So cool! # BRAF # cancer # AACR20 https://twitter.com/JAX_CKB/status/1255826043556040705 …",,,# # #,"1255832160596041730",https://twitter.com/smock2020/status/1255832160596041730
cancer_navi,2020-04-30 08:02,2,4,"非小細胞肺癌の術後再発の早期発見にctDNAによる微小残存病変の検出は有用【AACR2020】：がんナビ # 肺がん # ctDNA # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565378.html …",,,# # #,"1255829932271263744",https://twitter.com/cancer_navi/status/1255829932271263744
abcam,2020-04-30 07:54,0,0,"Today’s # AACR20 content is a presentation on ‘Identification of melanoma biomarkers in tumor-derived extracellular vesicles” from Elnaz Atabakhsh of our # fireplex team. Learn more here: https://bit.ly/3aoLx8V pic.twitter.com/bDk0AKqe3D",,,# #,"1255827747806556160",https://twitter.com/abcam/status/1255827747806556160
SazMcDowell,2020-04-30 07:22,1,5,"Catching up on some # AACR20 talks today! You can sign up for free to listen to these brilliant talks from the AACR virtual meeting, available till June pic.twitter.com/VEZqo9y4DV",,,#,"1255819719539675136",https://twitter.com/SazMcDowell/status/1255819719539675136
OncologyCentral,2020-04-30 07:00,0,0,"The current pandemic has had a major impact on the oncology field. Read more in our summary of all the # COVID19 data presented at # AACR20",,,# #,"1255814155115745283",https://twitter.com/OncologyCentral/status/1255814155115745283
MihithaA,2020-04-30 06:39,0,0,"Great work !",,,,"1255809072365879301",https://twitter.com/MihithaA/status/1255809072365879301
1stOncology,2020-04-30 06:03,1,1,"# Karyopharm Announces Data from Phase 3 BOSTON Study Selected for Late-Breaking Oral Presentation at the # AACR20 $ KPTI https://www.1stoncology.com/blog/karyopharm-announces-data-from-phase-3-boston-study-selected-for-late-breaking-oral-presentation-at-the-american-society-of-clinical-oncology-2020-virtual-scientific-program1234556770 …",,,# #,"1255800048014684160",https://twitter.com/1stOncology/status/1255800048014684160
1stOncology,2020-04-30 05:54,0,0,"# CytomXTherapeutics Announces Presentations at the # AACR20 $ CTMX https://www.1stoncology.com/blog/cytomx-therapeutics-announces-presentations-at-the-2020-american-society-of-clinical-oncology-virtual-scientific-program1234556755 …",,,# #,"1255797714991734785",https://twitter.com/1stOncology/status/1255797714991734785
1stOncology,2020-04-30 05:49,0,0,"# ArcherDX and # UCL Present New Minimal Residual Disease Surveillance Data from their Collaboration at # AACR20 https://www.1stoncology.com/blog/archerdxucl-present-new-minimal-residual-disease-surveillance-data-from-their-collaboration-at-2020-aacr-virtual-annual-meeting1234556720 …",,,# # #,"1255796425893359616",https://twitter.com/1stOncology/status/1255796425893359616
1stOncology,2020-04-30 05:48,0,0,"# Gracell Reports Data of First-in-human Clinical Trial for Universal # TruUCAR™ # GC027 in Relapsed or Refractory # TCellAcuteLymphoblasticLeukemia at the # AACR20 https://www.1stoncology.com/blog/gracell-reports-data-of-first-in-human-clinical-trial-for-universal-truucar%E2%84%A2-gc027-in-relapsedrefractory-t-cell-acute-lymphoblastic-leukemia-at-the-aacr-virtual-annual-meeting1234556719 …",,,# # # # #,"1255796268686704640",https://twitter.com/1stOncology/status/1255796268686704640
salma_phd,2020-04-30 05:35,0,0,"Congratulations Dr. @ EricKleinMD, well deserved!",,@,,"1255792801046040576",https://twitter.com/salma_phd/status/1255792801046040576
Heer_Lab,2020-04-30 05:24,0,0,"Congratulations. Well deserved!",,,,"1255790138438942720",https://twitter.com/Heer_Lab/status/1255790138438942720
AACR_official,2020-04-30 04:52,42,32,"参加費の返金手続き詳細ページを公開しました。 連絡方法や参加者の皆さんに行っていただくこと、振込のタイミングや注意事項などが掲載されております。 以下よりご確認ください。 https://aacr.jp/2020henkin.html # AACR2020",,,#,"1255781975366922241",https://twitter.com/AACR_official/status/1255781975366922241
PGrivasMDPhD,2020-04-30 03:58,0,0,"Well deserved indeed @ EricKleinMD !! Awesome news!",,@,,"1255768534795206658",https://twitter.com/PGrivasMDPhD/status/1255768534795206658
GeneOnlineNews,2020-04-30 02:47,1,1,"# AACR20 KRAS mutations are the most common oncogenic alterations and finding a cure for this subset would have a huge clinical impact. The AACR virtual conference featured two key studies in this area. # Cancer # KRAS # mutations # GeneOnlinehttps://wp.me/pb0TAP-1li",,,# # # # #,"1255750558880858112",https://twitter.com/GeneOnlineNews/status/1255750558880858112
purebiologics,2020-04-30 02:27,0,0,"@ AlligatorBio , a Swedish company developing mono- and bispecific antibodies for cancer therapy, reports a favourable safety profile for one of its drug candidates during @ AACR Annual Meeting https://alligatorbioscience.se/en/alligator-bioscience-presents-promising-interim-phase-i-data-for-its-bispecific-drug-candidate-ator-1015-at-aacr/ …pic.twitter.com/RefeDp6qi3",,@ @,,"1255745641717927936",https://twitter.com/purebiologics/status/1255745641717927936
healthhashtags,2020-04-30 02:01,0,0,"Today's Health Conferences: # AACR20 http://hcsm.io/healthconfs # hcsm",,,# #,"1255738916893790208",https://twitter.com/healthhashtags/status/1255738916893790208
TargetedOnc,2020-04-30 02:00,0,0,""Looking at subgroups of patients, response rates were maintained across lines of therapy even in heavily pretreated patients who had 3 or more lines of therapy," Dr. Le said. https://www.targetedonc.com/view/patients-with-egfr-exon-20-mutated-nsclc-demonstrate-response-with-poziotinib … # lungcancer # AACR20",,,# #,"1255738756058972161",https://twitter.com/TargetedOnc/status/1255738756058972161
sunnybunny138,2020-04-30 01:55,0,0,"@ AACR https://twitter.com/CNN/status/1255736401754292224 …",,@,,"1255737486120271873",https://twitter.com/sunnybunny138/status/1255737486120271873
Dr_RShatsky,2020-04-30 01:35,0,4,"Ugh the search feature is terrible and doesn’t seem to work. I’m having the same problem",,,,"1255732507556757505",https://twitter.com/Dr_RShatsky/status/1255732507556757505
JacobPlieth,2020-04-30 01:32,1,7,"So we might both be right. Solid tumour data at # AACR20, and Tecentriq NSCLC combo at # ASCO20 $ RHHBY",,,# #,"1255731711956025344",https://twitter.com/JacobPlieth/status/1255731711956025344
madamscientist,2020-04-30 00:51,0,1,"Thanks!",,,,"1255721447131164673",https://twitter.com/madamscientist/status/1255721447131164673
montypal,2020-04-30 00:24,6,14,"Anyone have any tips for searching # AACR20 for disease specific content? Looking for a list of the # kidneycancer & # bladdercancer abstracts n presentations @ OncoAlert @ NazliDizman @ PauloBergerot @ crisbergerot @ PGrivasMDPhD @ neerajaiims @ AACR",,@ @ @ @ @ @ @,# # #,"1255714696713261056",https://twitter.com/montypal/status/1255714696713261056
MathaCMU,2020-04-30 00:07,0,2,"Congrats to both of you!",,,,"1255710438429425669",https://twitter.com/MathaCMU/status/1255710438429425669
ShorBoris,2020-04-29 23:54,1,3,"Excellent example of "precision medicine" approach: only 1-2% of patients with NSCLC carry this mutation. Congrats to Takeda oncology mobocertinib team @ TakedaOncology # AACR20 # mobocertinibpic.twitter.com/8qvxcg8L3X",,@,# #,"1255707042456756224",https://twitter.com/ShorBoris/status/1255707042456756224
StephenVLiu,2020-04-29 23:44,16,37,"# OncoAlert # AACR20 Update on the phase II APOLLO trial of almonertinib (HS-10296) by Prof Shun Lu. Recall this 3rd gen # EGFR TKI was approved in China for T790M+ # NSCLC on 3/18/20. Good CNS efficacy and tolerability. Await phase III in 1L vs gefitinib (accrual complete). # LCSMpic.twitter.com/FFA55Ypgi9",,,# # # # #,"1255704536905367555",https://twitter.com/StephenVLiu/status/1255704536905367555
PacBio,2020-04-29 23:30,1,6,"Will the next # cancer breakthroughs be in # immunotherapy? Tumor microenvironment? # Microbiome? Or early detection &screening? Whatever the result, long-read sequencing can play a pivotal part in the discovery process, @ AshbyMere tells @ AmericanLab # AACR20 http://ow.ly/9IHa50zqEtk pic.twitter.com/Ww2CRSei2N",,@ @,# # # #,"1255700922572984320",https://twitter.com/PacBio/status/1255700922572984320
GeneOnlineNews,2020-04-29 22:06,1,1,"# AACR20 The virtual AACR conference 2020 featured some of the important advances in the field of immunotherapy in the past year. Of course, there is @ Merck's Keytruda in that list. # Cancer # Immunotherapy # Keytruda # GeneOnlinehttps://wp.me/pb0TAP-1lc",,@,# # # # #,"1255680008422674433",https://twitter.com/GeneOnlineNews/status/1255680008422674433
VillalobosMDPhD,2020-04-29 22:03,0,0,"Nice work!",,,,"1255679210292572160",https://twitter.com/VillalobosMDPhD/status/1255679210292572160
TargetedOnc,2020-04-29 22:00,0,2,"“Cohorts 4 and 5b were comprised of patients with MET exon 14 mutations,” Dr. Garon, MD, said, at # AACR20. “In cohort 4, patients had received at least 1 prior line of therapy for advanced disease, whereas patients in cohort 5b were treatment naïve.” https://www.targetedonc.com/view/capmatinib-generates-clinically-meaningful-activity-in-met-exon-14-mutated-nsclc … # lcsm",,,# #,"1255678297104691201",https://twitter.com/TargetedOnc/status/1255678297104691201
MDAndersonNews,2020-04-29 21:51,4,13,"“These data strongly support the importance of clinical testing for NTRK gene fusions in order to identify those patients most likely to benefit from larotrectinib,” says @ DavidHongMD. Learn more about his study presented at # AACR20. http://bit.ly/2ybwnXw # endcancer",,@,# #,"1255675992300978176",https://twitter.com/MDAndersonNews/status/1255675992300978176
juanosoriomd,2020-04-29 21:22,0,1,"Lovly*",,,,"1255668695994638337",https://twitter.com/juanosoriomd/status/1255668695994638337
komenla,2020-04-29 21:05,0,0,"New phase 2 trial results show that addition of Imprime PGG to pembrolizumab is a promising treatment for patients with # metastatic triple-negative # breastcancer # AACR20 https://qoo.ly/35rgbj",,,# # #,"1255664556761919491",https://twitter.com/komenla/status/1255664556761919491
goleylab,2020-04-29 20:55,0,3,"Congrats to all!!",,,,"1255662042058547201",https://twitter.com/goleylab/status/1255662042058547201
BioCentury,2020-04-29 20:46,1,1,"Highlights from the first annual virtual meeting of @ AACR shows mixed results for I/O combos, while new targets and modalities present early promise https://buff.ly/2VRwd0N",,@,,"1255659812517326848",https://twitter.com/BioCentury/status/1255659812517326848
d2merino,2020-04-29 20:45,0,1,"Thank you, Kerry!!! I missed you at the @ AACR AM this year, but I hope to see you againnext year in # DC for # AACR21! And thank you for such great feedback",,@,# #,"1255659536293249030",https://twitter.com/d2merino/status/1255659536293249030
madamscientist,2020-04-29 20:45,0,1,"Thanks, Marija!",,,,"1255659449634750476",https://twitter.com/madamscientist/status/1255659449634750476
marijadebeljak,2020-04-29 20:41,0,2,"Congratulations!! That’s awesome!",,,,"1255658471619510274",https://twitter.com/marijadebeljak/status/1255658471619510274
d2merino,2020-04-29 20:41,0,1,"Thank you, Faruk",,,,"1255658394385612800",https://twitter.com/d2merino/status/1255658394385612800
josephcmurray,2020-04-29 20:21,0,2,"I echo Juan’s sentiments: awesome and very well-deserved! # MBCO!",,,#,"1255653365452857344",https://twitter.com/josephcmurray/status/1255653365452857344
OphiraG,2020-04-29 20:14,0,1,"Inexcusable, really.",,,,"1255651661625819136",https://twitter.com/OphiraG/status/1255651661625819136
MDAndersonNews,2020-04-29 20:04,1,15,"A recent clinical trial led by our @ evilarsan found taking naproxen daily may prevent # colorectalcancer in patients with Lynch Syndrome: https://bit.ly/2zy8Xfn # AACR20 # endcancer",,@,# # #,"1255649067549495305",https://twitter.com/MDAndersonNews/status/1255649067549495305
MM_Alyamani,2020-04-29 20:00,0,0,"Congratulations @ EricKleinMD",,@,,"1255648278504407044",https://twitter.com/MM_Alyamani/status/1255648278504407044
madamscientist,2020-04-29 19:28,0,0,"Thanks, Vasanthi!",,,,"1255640169463472128",https://twitter.com/madamscientist/status/1255640169463472128
cancer_navi,2020-04-29 19:28,0,1,"新規ユニバーサルCAR-T療法TruUCAR GC027による成人の再発・難治性T-ALLのMRD-CR率は80％に【AACR2020】：がんナビ # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565362.html …",,,#,"1255640020901224449",https://twitter.com/cancer_navi/status/1255640020901224449
cancer_navi,2020-04-29 19:27,0,0,"DLBCLへのCAR-T細胞Axi-Celとアテゾリズブマブの併用は管理可能、時間が経ってからの効果向上例も【AACR2020】：がんナビ # びまん性大細胞型B細胞性リンパ腺 # DLBCL # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565363.html …",,,# # #,"1255639804730961920",https://twitter.com/cancer_navi/status/1255639804730961920
cancer_navi,2020-04-29 19:24,0,0,"再発・難治性の小児、若年者のALLにCD19/CD22二特異性CAR-T細胞療法薬が有用な可能性【AACR2020】：がんナビ # AACR20 # ALLhttps://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565364.html …",,,# #,"1255639062251057152",https://twitter.com/cancer_navi/status/1255639062251057152
cancer_navi,2020-04-29 19:23,1,1,"癌の疑いがある人の診断に血中セルフリーDNAのメチル化解析が役立つ可能性【AACR2020】：がんナビ # AACR20 # セルフリーDNAhttps://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565361.html …",,,# #,"1255638754603069440",https://twitter.com/cancer_navi/status/1255638754603069440
frettinglab,2020-04-29 19:20,0,2,"Congratulations!!",,,,"1255638155702734854",https://twitter.com/frettinglab/status/1255638155702734854
Jayman0827,2020-04-29 19:09,0,1,"Congratulations @ EricKleinMD well deserved. RDW would be proud!",,@,,"1255635398623219718",https://twitter.com/Jayman0827/status/1255635398623219718
CancerResearch,2020-04-29 19:00,0,3,"During Day 1 at # AACR20, a new clinical study revealed an improved pathologic complete response (pCR) rates in patients with stage II/III, HER2-negative breast cancer. Read the highlights now https://bit.ly/3bOdbOi",,,#,"1255633003415588871",https://twitter.com/CancerResearch/status/1255633003415588871
OncLive,2020-04-29 18:53,0,2,"COM701 Shows Early Promise as Monotherapy and Combined With Nivolumab in Advanced Solid Tumors @ harvardmed @ MGHCancerCenter @ AACR # AACR20 http://ow.ly/gvhE50zsrkK",,@ @ @,#,"1255631329661792265",https://twitter.com/OncLive/status/1255631329661792265
OncLive,2020-04-29 18:51,1,2,"RAF-MEK Inhibitor/Defactinib Combo Is Active in KRAS-Mutant Cancers @ udai_banerji @ royalmarsdenNHS @ AACR # AACR20 http://ow.ly/7nfG50zsrhn",,@ @ @,#,"1255630898797727744",https://twitter.com/OncLive/status/1255630898797727744
BrasilOncologia,2020-04-29 18:48,0,1,"Dr. Rodrigo Munhoz, oncologista clínico do Hospital Sírio Libanês, faz os # highlights de plenárias clínicas do @ AACR sobre # melanoma, câncer de mama, # câncer de próstata e # COVID19 em pacientes oncológicos. Assista: https://bit.ly/2yeIGm7 # AACR # coronavirus # oncologiabrasilpic.twitter.com/lxIxzXODS8",,@,# # # # # # #,"1255630133454651396",https://twitter.com/BrasilOncologia/status/1255630133454651396
PeyingFong,2020-04-29 18:38,0,1,"Congratulations, @ monishram6 and @ madamscientist!",,@ @,,"1255627596492128261",https://twitter.com/PeyingFong/status/1255627596492128261
ameetchimote,2020-04-29 18:37,0,1,"Congrats to you Monish and your proud mentor, @ madamscientist !",,@,,"1255627246888521728",https://twitter.com/ameetchimote/status/1255627246888521728
big4bio,2020-04-29 18:34,0,1,"Here's a roundup of some research that was presented during # AACR20: https://www.biospace.com/article/aacr-roundup/ …",,,#,"1255626432933289985",https://twitter.com/big4bio/status/1255626432933289985
BioCentury,2020-04-29 18:30,1,0,". @ Thrive_Earlier's prospective study of its multi-cancer blood test at # AACR20 spotlights how specificity trumps sensitivity when screening populations with low disease prevalence. https://buff.ly/3bOpSIN",,@,#,"1255625434819108869",https://twitter.com/BioCentury/status/1255625434819108869
madamscientist,2020-04-29 18:21,0,2,"Thank you, neighbor!",,,,"1255623227897901057",https://twitter.com/madamscientist/status/1255623227897901057
LabPulse1,2020-04-29 17:50,0,0,"Large study supports investigational blood test followed by PET-CT in screening women for cancer, shows 99.6% specificity. # AACR20 # liquidbiopsyhttps://buff.ly/35hf1EL",,,# #,"1255615422382161922",https://twitter.com/LabPulse1/status/1255615422382161922
ZhaozhuQ,2020-04-29 17:45,0,6,"Congrats, Monish and Rajini! Great news we need during this bleak time.",,,,"1255614278134005766",https://twitter.com/ZhaozhuQ/status/1255614278134005766
GervasiLawrence,2020-04-29 17:39,0,0,"Congratulations! Well deserved.",,,,"1255612752581844993",https://twitter.com/GervasiLawrence/status/1255612752581844993
BrasilOncologia,2020-04-29 17:38,2,3,"Dr. Jayr Schmidt Filho, diretor da onco-hematologia do @ acccancercenter , comenta três trabalhos sobre terapia celular com enfoque em onco-hematologia apresentados no @ AACR . Confira: https://bit.ly/35olLkw # AACR # cancer # hematologia # leucemia # oncologiabrasilpic.twitter.com/rDHxbbB3kE",,@ @,# # # # #,"1255612353154088960",https://twitter.com/BrasilOncologia/status/1255612353154088960
JustKoforit,2020-04-29 17:24,1,8,"My dear lab mate, Dr. Monish RAM! Makena @ monishram6 just won this 2 year @ AACR Breast Cancer Research Fellowship... I am extremely proud of this guy. I witnessed his hard work from day 1. CONGRATULATIONS!!!! We will do many great things together. :) # raolab # killingithttps://twitter.com/madamscientist/status/1255607590685302784 …",,@ @,# #,"1255608845495185408",https://twitter.com/JustKoforit/status/1255608845495185408
madamscientist,2020-04-29 17:19,2,85,"So happy for RaoLab postdoc Dr. Monish Makena @ monishram6 @ HopkinsMedicine, who was just awarded a 2 year @ AACR Breast Cancer Research Fellowship for his work on Ca2+ signaling, chemoresistance and DNA damage response in breast cancer. # AACR2020 pic.twitter.com/LcdVgn9Ojc",,@ @ @,#,"1255607590685302784",https://twitter.com/madamscientist/status/1255607590685302784
Dr_Ivanoncologo,2020-04-29 17:18,0,0,"# Cancer | Oncometabolitos y # DDR como blanco para tratar cáncer # AACR2020 https://twitter.com/Martin_AngelMD/status/1255264814659784705 …",,,# # #,"1255607366134968322",https://twitter.com/Dr_Ivanoncologo/status/1255607366134968322
VivekSubbiah,2020-04-29 17:15,0,2,"5/5 H&E; A and up to 3 + brown-chromogenic expression of p-c-Met (Tyr 1234/ 1235) & fatty acid synthase (FAS) in the cytoplasmic compartment of the tumor cells p-STAT3 (Tyr 705) with variable expression up to 3+ translocated to the tumoral nuclei (D) on a scale of 0–3 + # AACR20 pic.twitter.com/ajumPLV4Ms",,,#,"1255606767331020800",https://twitter.com/VivekSubbiah/status/1255606767331020800
VivekSubbiah,2020-04-29 17:15,0,1,"4/5 Top, patient with ASPS who achieved partial response after treatment with PD-1 axis–targeting therapy. Bottom, another patient with ASPS who achieved partial response after treatment with PD-1 axis–targeting therapy. # sarcoma # AACR20 pic.twitter.com/G1y202LdFw",,,# #,"1255606765858799619",https://twitter.com/VivekSubbiah/status/1255606765858799619
VivekSubbiah,2020-04-29 17:15,0,0,"3/5 Types and durations of therapies received by patients with ASPS. Most patients received upfront VEGF-targeted multikinase therapy. # Immunotherapy was introduced late in the course of disease, likely related to entry of these agents into the clinic # AACR20 pic.twitter.com/4Y4vYOPFdN",,,# #,"1255606764470501378",https://twitter.com/VivekSubbiah/status/1255606764470501378
VivekSubbiah,2020-04-29 17:15,0,1,"2/5 Proposed mechanism of ASPS # sarcoma tumorgenesis with potential downstream targets of the ASPSCR1-TFE3 fusion. @ MCT_AACR @ aacr # AACR20 https://mct.aacrjournals.org/content/early/2020/04/21/1535-7163.MCT-19-0579 …pic.twitter.com/efkoRtFdcc",,@ @,# #,"1255606762830532610",https://twitter.com/VivekSubbiah/status/1255606762830532610
VivekSubbiah,2020-04-29 17:15,4,13,"1/5 @ MCT_AACR @ AACR Genomics, Morphoproteomics, & Treatment Patterns of Patients with Alveolar Soft Part # Sarcoma & Response to Multiple Experimental Therapies @ RGroisberg # AACR20 # RareDisease https://mct.aacrjournals.org/content/early/2020/04/21/1535-7163.MCT-19-0579 …pic.twitter.com/g358Sz4iOp",,@ @ @,# # #,"1255606761425428484",https://twitter.com/VivekSubbiah/status/1255606761425428484
NCI_Bogler,2020-04-29 17:04,0,1,"Congratulations # AACR2020 @ AACR_CEO You helped keep the # CancerResearch community moving forward and talking to each other to celebrate advances during a difficult time. Thank you.",,@,# #,"1255603800070635523",https://twitter.com/NCI_Bogler/status/1255603800070635523
CellPressNews,2020-04-29 16:50,2,1,""Immunotherapy for Malignant Glioma: Current Status and Future Directions" by Jin, Chen and colleagues https://bit.ly/2zItCO1 - @ TrendsinPharma # CellPressOncology # AACR20",,@,# #,"1255600258391969792",https://twitter.com/CellPressNews/status/1255600258391969792
JExpMed,2020-04-29 16:50,2,1,"Have you seen our 2020 update on cancer immunology and immunotherapy research? # AACR20 https://bit.ly/2QMJC7f pic.twitter.com/PaR82cKnqV",,,#,"1255600251588706304",https://twitter.com/JExpMed/status/1255600251588706304
DrRajivNShinde,2020-04-29 16:40,3,14,"Really happy to see this presented at virtual @ AACR. Thank you to all the patients and @ udai_banerji for leading this trial. Amazing team support @ ICR_London @ ICR_DDU_IIT @ royalmarsdenNHS @ cancerBRC @ ECMC_UK @ CR_UK # AACR2020 # TeamDDUhttps://twitter.com/udai_banerji/status/1254812370901307393 …",,@ @ @ @ @ @ @ @,# #,"1255597768627892224",https://twitter.com/DrRajivNShinde/status/1255597768627892224
DanaFarberNews,2020-04-29 16:36,1,8,"Presenting author Caron Jacobson, MD, provides comment on the progress and future of # CART cell therapy # AACR20 pic.twitter.com/Vm9730wP9K",,,# #,"1255596898012053504",https://twitter.com/DanaFarberNews/status/1255596898012053504
OncLive,2020-04-29 16:10,0,0,"Cell-Free DNA Detects Adjuvant MRD Positivity and Disease Relapse in NSCLC @ ucl @ AACR # AACR20 # lcsmhttp://ow.ly/sngw50zsgC0",,@ @,# #,"1255590194776027136",https://twitter.com/OncLive/status/1255590194776027136
Rick__Buck,2020-04-29 15:57,0,6,"Thank you again @ cancerassassin1 for all your tweets and being one of our # AACR20 influencers. Missed seeing you in San Diego but this first @ AACR Virtual Meeting helped set the stage for future online # science meetings. Be well and see you virtually for Virtual Meeting II!https://twitter.com/cancerassassin1/status/1255579818667769856 …",,@ @,# #,"1255586943540301824",https://twitter.com/Rick__Buck/status/1255586943540301824
Rick__Buck,2020-04-29 15:50,0,7,"Here is our press release on the final numbers and highlights from # AACR20. This has been an incredible # collaboration from the entire @ AACR team and all presenters! See you June 22-24 for Virtual Annual II! https://twitter.com/AACR/status/1255565027593146369 …",,@,# #,"1255585257862168577",https://twitter.com/Rick__Buck/status/1255585257862168577
webofmeetings,2020-04-29 15:43,0,0,"# AACR20 Are you attending the world-class conference "American Association for Cancer Research Annual Meeting 2020"? Leave your review of 2020 edition @ webofmeetings and share your opinion https://webofmeetings.com/2019/biomedicine/cancer/american-association-for-cancer-research-annual-meeting-2020 … @ AACR",,@ @,#,"1255583617490857992",https://twitter.com/webofmeetings/status/1255583617490857992
drleighellis,2020-04-29 15:43,0,2,"well deserved",,,,"1255583504685060096",https://twitter.com/drleighellis/status/1255583504685060096
NimaSharifiMD,2020-04-29 15:42,14,98,"Sending a warm and hearty congratulations to @ EricKleinMD @ CleClinicMD on being awarded the @ UrologyCareFdn Richard Williams Prostate Cancer Research Excellence Prize! Incredibly well deserved for numerous seminal contributions! @ PCFnews @ CleClinicUro @ CleClinic_GUMRC @ AACR @ ASCOpic.twitter.com/5J5Jwy5bZ3",,@ @ @ @ @ @ @ @,,"1255583181740429314",https://twitter.com/NimaSharifiMD/status/1255583181740429314
cancerassassin1,2020-04-29 15:28,1,12,"Special thanks @ AACR_CEO @ AACRPres @ AACRFoundation @ AACR - even if we couldn't be in San Diego as previously planned, you paved new ways for bringing the # cancerresearch community online these past two days. 'See' you at # AACR20 Virtual Annual Meeting II, June 22-24, 2020. https://twitter.com/cancerassassin1/status/1255579139895164940 …",,@ @ @ @,# #,"1255579818667769856",https://twitter.com/cancerassassin1/status/1255579818667769856
cancerassassin1,2020-04-29 15:26,1,11,"Thank you @ AACR for bringing us together (virtually) to share and learn during this challenging time. Progress in # CancerResearch doesn't & won't stop. Looking forward to Part II in June! # AACR20 Virtual Annual Meeting I Draws More than 61,000 Registrants https://www.aacr.org/about-the-aacr/newsroom/news-releases/aacr-virtual-annual-meeting-i-draws-more-than-61000-registrants/ …",,@,# #,"1255579139895164940",https://twitter.com/cancerassassin1/status/1255579139895164940
Lymphoma_Doc,2020-04-29 15:12,17,15,"New research presented at @ AACR shows people with blood cancers may be twice as likely to die or have severe complications if infected with # COVID19. # MaskUp to save lives. # lymsm # mmsm # leusm # AACR20 https://cancerdiscovery.aacrjournals.org/content/candisc/early/2020/04/24/2159-8290.CD-20-0422.full.pdf …",,@,# # # # # #,"1255575809286385664",https://twitter.com/Lymphoma_Doc/status/1255575809286385664
ResearchAtJeff,2020-04-29 14:59,0,0,"You can also take advantage of opportunities to build your scientific knowledge through virtual scientific seminars offered across departments! Or consider finding a virtual scientific meeting such as @ AACR's virtual meeting!",,@,,"1255572497564610565",https://twitter.com/ResearchAtJeff/status/1255572497564610565
PChavee,2020-04-29 14:52,0,0,"GSK: Our # oncology work is complex, but our goal simple: create potentially transformational medicines to improve patient outcomes. We're presenting our latest research at # AACR20 and celebrating the latest discoveries across # cancerresearch. Find out mo…https://gsk.to/2zF9gFp",,,# # #,"1255570564032446465",https://twitter.com/PChavee/status/1255570564032446465
oncologytube,2020-04-29 14:40,0,0,"Laurie Schenkel on Access to RBN012759 # AACR20 # AACR @ RibonTx http://dlvr.it/RVj5jG pic.twitter.com/zMpOu2ZTLk",,@,# #,"1255567662647656449",https://twitter.com/oncologytube/status/1255567662647656449
juanosoriomd,2020-04-29 14:34,0,1,"Time flies! Thank you so much for those words Dr. Lovli!! I’m sure we will keep in touch. Stay safe!!!",,,,"1255566244775956494",https://twitter.com/juanosoriomd/status/1255566244775956494
AACR,2020-04-29 14:30,28,75,"We are pleased to announce that our first-ever Virtual Annual Meeting attracted a vast worldwide audience, with more than 61,000 registrants from 140 countries. https://bit.ly/2YlLetd # AACR20 pic.twitter.com/iysqebgPMe",,,#,"1255565027593146369",https://twitter.com/AACR/status/1255565027593146369
CellPressNews,2020-04-29 14:30,2,6,"Download your free digital copy of Cell Press Selections: Resistance to # Immunotherapy # AACR20 - https://bit.ly/2W7v7Na",,,# #,"1255565026477453317",https://twitter.com/CellPressNews/status/1255565026477453317
oncologytube,2020-04-29 14:19,0,0,"Melissa Vasbinder on PARP7 Inhibitor Vulnerability in Stress-Signaling Pathways: Is this Going to Impact Treatment Today? @ RibonTx # AACR # AACR20 http://dlvr.it/RVj2Mx pic.twitter.com/ollDwOunV9",,@,# #,"1255562254944071681",https://twitter.com/oncologytube/status/1255562254944071681
GSK,2020-04-29 14:15,9,41,"Our # oncology work is complex, but our goal simple: create potentially transformational medicines to improve patient outcomes. We're presenting our latest research at # AACR20 and celebrating the latest discoveries across # cancerresearch. Find out more: https://gsk.to/2zF9gFp",,,# # #,"1255561234847580160",https://twitter.com/GSK/status/1255561234847580160
MDAndersonNews,2020-04-29 14:14,5,22,"“Our preliminary data suggests that blocking WNT signaling may enable response to checkpoint inhibition in some patients,” says our @ FilipJankuMD of the findings of a recent Phase I # immunotherapy clinical trial: https://bit.ly/3cWDjqt # AACR20 # endcancer",,@,# # #,"1255560988830633985",https://twitter.com/MDAndersonNews/status/1255560988830633985
oncologytube,2020-04-29 14:13,0,0,"Laurie Schenkel on Selective PARP14 Inhibitor Decreasing Pro-tumor Macrophage Function # AACR20 # AACR @ RibonTx http://dlvr.it/RVj1LZ pic.twitter.com/stFgzGx2Iw",,@,# #,"1255560743337881600",https://twitter.com/oncologytube/status/1255560743337881600
BrasilOncologia,2020-04-29 14:12,0,0,"O # larotrectinibe é um inibidor altamente seletivo da TRK que está aprovado no Brasil. Estudo apresentado no @ AACR compartilhou os resultados de eficácia e segurança em # pacientes tratados com a droga. Saiba mais: link https://bit.ly/3aHOSAg # AACR # NTRK # cancerdefusaopic.twitter.com/tDHE04CjRP",,@,# # # # #,"1255560674312441863",https://twitter.com/BrasilOncologia/status/1255560674312441863
BrianUherek,2020-04-29 14:08,0,3,"I don't know, this is looking pretty gosh dang interesting $ AFMD # ASCO2020 # AACR2020 # MorningTrade # AfternoonDelightpic.twitter.com/hmdsLi42DX",,,# # # #,"1255559718124298246",https://twitter.com/BrianUherek/status/1255559718124298246
LChard_FSG,2020-04-29 14:08,6,5,"Myself, @ racheljenkinsOC, @ aabisawyer and @TristanFreeW1 once again sat down to discuss our highlights from day 2 of the @ AACR Virtual Annual Meeting I, have a look at what we had to say https://bit.ly/35eIdwa # AACR2020 # StayHome",,@ @ @TristanFreeW1 @,# #,"1255559625551884290",https://twitter.com/LChard_FSG/status/1255559625551884290
antoniomarraMD,2020-04-29 14:04,0,2,"Well done! Congrats",,,,"1255558467420643328",https://twitter.com/antoniomarraMD/status/1255558467420643328
MyBioTechniques,2020-04-29 14:00,1,1,"A new study presented at the recent # AACR20 has shown initial success of a novel universal CAR-T therapy where previous attempts have failed – in the treatment of T-cell acute lymphoblastic # leukemia.",,,# #,"1255557464759533568",https://twitter.com/MyBioTechniques/status/1255557464759533568
OncologyCentral,2020-04-29 14:00,0,2,"Catch up on all the # COVID19 and # cancer data presented at # AACR20 on @ OncologyCentral now!",,@,# # #,"1255557463392374784",https://twitter.com/OncologyCentral/status/1255557463392374784
oncologytube,2020-04-29 13:56,0,0,"Melissa Vasbinder on PARP7 Inhibitor: New Pre-clinical Data that was Generated @ RibonTx # AACR # AACR20 http://dlvr.it/RVhymF pic.twitter.com/j209p1tPrX",,@,# #,"1255556592759521280",https://twitter.com/oncologytube/status/1255556592759521280
teamoncology,2020-04-29 13:56,0,0,"Thank you for sharing.",,,,"1255556496991141889",https://twitter.com/teamoncology/status/1255556496991141889
CancerTherAdvsr,2020-04-29 13:53,2,1,"Multicancer liquid biopsy test May identify cancer in older women. https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/multi-cancer-liquid-biopsy-older-women-identify-treatment/ … # AACR20",,,#,"1255555790779437057",https://twitter.com/CancerTherAdvsr/status/1255555790779437057
ALKLungCancer,2020-04-29 13:52,3,5,"Thank you @ CharuAggarwalMD for this summary of # COVID19 & # lungcancer patients from # AACR20 # LCSMhttps://twitter.com/OncoAlert/status/1255248119417245697 …",,@,# # # #,"1255555626081628162",https://twitter.com/ALKLungCancer/status/1255555626081628162
MelanomaReAlli,2020-04-29 13:47,0,1,". @ AACR Studies in BRAF-Mutated # Melanoma Show Benefit of Combo # Treatment, Continuous Dosing Strategies https://buff.ly/2ySKnWo @ GenomeWeb",,@ @,# #,"1255554193026408448",https://twitter.com/MelanomaReAlli/status/1255554193026408448
JCellBiol,2020-04-29 13:44,2,6,"New short summaries of articles (https://bit.ly/2XYckGS ) that are part of JCB’s new cancer collection for # AACR20 https://bit.ly/2Vv9GXj pic.twitter.com/zHPacxUPRd",,,#,"1255553440174026756",https://twitter.com/JCellBiol/status/1255553440174026756
ADCReview,2020-04-29 13:42,2,1,"Netherlands-based @ Synthon Biopharmaceuticals, developing innovative the anti-HER2 antibody-drug conjugate [vic-] trastuzumab duocarmazine # SYD985 for breast cancer, has been relaunched as @ byondis https://adc.expert/Byondis # ADC # breastcancer @ World_ADC @ ASCO @ AACR @ CPhIWW # biotech",,@ @ @ @ @ @,# # # #,"1255552930049998849",https://twitter.com/ADCReview/status/1255552930049998849
CancerResearch,2020-04-29 13:30,0,4,"The final virtual sessions of Day 1 of # AACR20 focused on two topics that will be necessary to understand and address if we’re going to improve care for more patients: the tumor microenvironment and microbiota. Read the full recap https://bit.ly/3bOdbOi",,,#,"1255549961070133249",https://twitter.com/CancerResearch/status/1255549961070133249
MayoCancerCare,2020-04-29 13:30,1,1,"# COVID19 Mortality Spikes in Patients With # LungCancer, # BloodCancer — Those with # MetastaticDisease also at special risk for poor outcomes https://bit.ly/2W8fiFX @ medpagetoday # AACR20",,@,# # # # #,"1255549910910480386",https://twitter.com/MayoCancerCare/status/1255549910910480386
oncologytube,2020-04-29 13:26,0,0,"Melissa Vasbinder on PARP7 Inhibitor Targeting a Newly Discovered Cancer Vulnerability @ RibonTx # AACR # AACR20 http://dlvr.it/RVhtN1 pic.twitter.com/B1109LQGhk",,@,# #,"1255548918907068417",https://twitter.com/oncologytube/status/1255548918907068417
circulogene_bio,2020-04-29 13:15,0,1,"# MET inhibitor # capmatinib shows efficacy, durability, safety in # metastatic # NSCLC patients in study presented at @ AACR 2020. # MetExon14 # AACR2020 @ LUNGevity # MolecularTesting # PrecisionMedicine CIRCULOGENE: One Tube, One Week, Complete Results.https://www.healio.com/hematology-oncology/lung-cancer/news/online/%7B97b65a72-c79a-49b8-8bcb-09f7c34f6f75%7D/capmatinib-shows-efficacy-in-lung-cancer-subset-including-patients-with-brain-metastases …",,@ @,# # # # # # # #,"1255546272628436992",https://twitter.com/circulogene_bio/status/1255546272628436992
precisionxray,2020-04-29 13:12,0,1,"This week's # AACR virtual conference was beautifully orchestrated, and we're happy to have attended. We look forward to part two in June! Thank you for such an educational and forward-thinking experience, @ AACR! . . . # AACR20 # PrecisionXRay # CancerResearchpic.twitter.com/nEI0y6OHfR",,@,# # # #,"1255545575002554370",https://twitter.com/precisionxray/status/1255545575002554370
GalMarkel,2020-04-29 13:04,0,0,"Thanks Cassian!",,,,"1255543522331111424",https://twitter.com/GalMarkel/status/1255543522331111424
AACR,2020-04-29 13:00,0,4,"Two presentations during the # AACR20 Virtual Annual Meeting I Opening Clinical Plenary highlighted some of the promises and challenges of expanding the use of immunotherapy for patients with breast cancer and patients with prostate cancer, respectively. https://bit.ly/2YfqT8Y",,,#,"1255542419438911499",https://twitter.com/AACR/status/1255542419438911499
StephenVLiu,2020-04-29 12:59,5,22,"Looking forward to the virtual @ ASCO meeting, with orals and discussion sessions available on demand starting Friday 5/29/20 and broadcast sessions Saturday 5/30/20. Virtual meeting free for ASCO members. # AACR20 set a high bar but excited for # ASCO20! https://meetings.asco.org/am/registration",,@,# #,"1255542305374822400",https://twitter.com/StephenVLiu/status/1255542305374822400
ADCReview,2020-04-29 12:54,1,2,"ADC Review | Journal of Antibody-drug Conjugates likes to congratulate @ ImmunomedicsInc with the approval of sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with # mTNBC. https://adc.expert/Sacituzumab_Govitecan_Trodelvy … @ ASCO @ AACR @ World_ADC # ADC # breastcancer @ Trodelvy",,@ @ @ @ @,# # #,"1255540850446090240",https://twitter.com/ADCReview/status/1255540850446090240
beardjones,2020-04-29 12:53,0,1,"“The time for action is now,” said Voigt at the close of his presentation. “The most vulnerable among us can fall through the safety net if we don’t pay attention.“ # AACR20 https://www.cancertodaymag.org/Pages/cancer-talk/International-Perspectives-on-COVID-19-and-Cancer.aspx …",,,#,"1255540728253513728",https://twitter.com/beardjones/status/1255540728253513728
MaverickNY,2020-04-29 12:53,1,2,"Time to reflect on whether or not anything truly stood out from the crowd at # AACR20... for me, one thing did: https://pxlme.me/xXgwDaYf pic.twitter.com/tHbbXd4mid",,,#,"1255540697031204864",https://twitter.com/MaverickNY/status/1255540697031204864
PerceptronMD,2020-04-29 12:44,0,0,"New Iteration of @ AACR Project GENIE Focuses on Real-World Outcomes to Enhance Precision # Oncologyhttps://www.genomeweb.com/cancer/new-iteration-aacrs-project-genie-focuses-real-world-outcomes-enhance-precision-oncology …",,@,#,"1255538487224348677",https://twitter.com/PerceptronMD/status/1255538487224348677
DavideBernareg1,2020-04-29 12:39,0,0,"Thank you very much Miguel Foronda @ krknrm",,@,,"1255537086133755911",https://twitter.com/DavideBernareg1/status/1255537086133755911
CancerTodayMag,2020-04-29 12:35,0,2,"Researchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus. https://bit.ly/2SinSRy # AACR20 pic.twitter.com/lJBXZGS0nG",,,#,"1255536090787831808",https://twitter.com/CancerTodayMag/status/1255536090787831808
christine_lovly,2020-04-29 12:33,0,2,"Thank you @ juanosoriomd! Hope you are well. Can’t believe @ AACR MBCO was almost a year ago. Please never hesitate to reach out if I can ever be of assistance, my friend! Stay well",,@ @,,"1255535810067210240",https://twitter.com/christine_lovly/status/1255535810067210240
OncologyCentral,2020-04-29 12:31,0,0,"Check out what the Editors of @ OncologyCentral, @ MyBioTechniques and @ NanoMedZone thought of # AACR20 day 2 in our latest coffee chat!",,@ @ @,#,"1255535183408881672",https://twitter.com/OncologyCentral/status/1255535183408881672
ManelEsteller,2020-04-29 12:27,0,10,"It has been a great idea the launching of the American Association for Cancer Research Virtual Annual Meeting I # AACR20 @ AACR_CEO @ AACRPres @ AACR ! Looking forward to its second part on June 22-24! https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/ …pic.twitter.com/G9BRfrh4bw",,@ @ @,#,"1255534201056776193",https://twitter.com/ManelEsteller/status/1255534201056776193
NatureMedicine,2020-04-29 12:27,9,26,"A new paper by Michael Taylor & colleagues shows CSF-delivered # CARTcells exhibit greater therapeutic efficacy as compared to intravenous delivery in # medulloblastoma and PFA # ependymoma xenografts mouse models. https://www.nature.com/articles/s41591-020-0827-2 … # ChildhoodCancer # Immunotherapy # AACR20 pic.twitter.com/fxUzgGRkg3",,,# # # # # #,"1255534098732457984",https://twitter.com/NatureMedicine/status/1255534098732457984
drdonsdizon,2020-04-29 12:26,1,11,"# AACR20 should retire using "patients" when reporting clinical trials. These are volunteers. And we'd get nowhere without them. Ht @ jsparanohttps://twitter.com/IBCResearch/status/1255484688317263873 …",,@,#,"1255533815751159808",https://twitter.com/drdonsdizon/status/1255533815751159808
MM_Oncology,2020-04-29 12:20,2,3,"# AACR20 news: Treatment-associated # pneumonitis more likely in # NSCLC patients treated with ICIs than chemotherapy reports Qi Liu ( @ US_FDA) at # AACR2020, with discussion from @ DrJNaidoo ( @ JohnsHopkins) # Immunotherapy # LCSMhttps://bit.ly/2WaWLsM",,@ @ @,# # # # # #,"1255532352337588225",https://twitter.com/MM_Oncology/status/1255532352337588225
TargetedOnc,2020-04-29 12:02,1,3,"Deep and durable responses were observed in 97 patients with advanced non–small cell lung cancer harboring a MET exon 14 mutation with treatment of capmatinib. https://www.targetedonc.com/view/capmatinib-generates-clinically-meaningful-activity-in-met-exon-14-mutated-nsclc … # AACR20",,,#,"1255527784576954371",https://twitter.com/TargetedOnc/status/1255527784576954371
MCR_AACR,2020-04-29 12:00,1,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/KLSY8mPnqc",,@,#,"1255527315888619521",https://twitter.com/MCR_AACR/status/1255527315888619521
CEBP_AACR,2020-04-29 12:00,0,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/8ga0S1ObyG",,@,#,"1255527315767013379",https://twitter.com/CEBP_AACR/status/1255527315767013379
MCT_AACR,2020-04-29 12:00,0,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/GBgFCS7MyR",,@,#,"1255527315494375425",https://twitter.com/MCT_AACR/status/1255527315494375425
CD_AACR,2020-04-29 12:00,1,1,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/lVebKeDkED",,@,#,"1255527314395447297",https://twitter.com/CD_AACR/status/1255527314395447297
CR_AACR,2020-04-29 12:00,0,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/cIThAmrwaO",,@,#,"1255527314223439884",https://twitter.com/CR_AACR/status/1255527314223439884
CIR_AACR,2020-04-29 12:00,0,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/3iP7sWQYbd",,@,#,"1255527314131169280",https://twitter.com/CIR_AACR/status/1255527314131169280
CAPR_AACR,2020-04-29 12:00,0,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/Nx8CCxOALg",,@,#,"1255527314072449024",https://twitter.com/CAPR_AACR/status/1255527314072449024
CCR_AACR,2020-04-29 12:00,0,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/05lGH2mm0o",,@,#,"1255527313804079106",https://twitter.com/CCR_AACR/status/1255527313804079106
CCR_AACR,2020-04-29 12:00,0,0,"Missed # AACR20 Virtual Annual Meeting I? You can still read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts.pic.twitter.com/nS1SR6BAuI",,@,#,"1255527312449298437",https://twitter.com/CCR_AACR/status/1255527312449298437
ASCOPost,2020-04-29 11:55,0,0,"Continuous vs Intermittent Dabrafenib/Trametinib Dosing in Patients With BRAF-Mutated Melanoma https://www.ascopost.com/news/april-2020/continuous-vs-intermittent-dabrafenibtrametinib-dosing-in-patients-with-braf-mutated-melanoma/ … # AACR20 # AACR2020 # melsm # oncology # cancer",,,# # # # #,"1255526002744332288",https://twitter.com/ASCOPost/status/1255526002744332288
ByLizC,2020-04-29 11:50,2,0,"Thrive has a world-first at # AACR20, but liquid biopsies are still a long way off prime time. https://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-thrive-steals-march …",,,#,"1255524754594959361",https://twitter.com/ByLizC/status/1255524754594959361
cancerassassin1,2020-04-29 11:46,0,2,"# AACR20: real-world evidence highlights https://www.evidencebaseonline.com/users/211204-the-evidence-base/posts/aacr-2020-real-world-evidence-highlights … # evidencebase # realworldevidence",,,# # #,"1255523982650023937",https://twitter.com/cancerassassin1/status/1255523982650023937
CancerNetwrk,2020-04-29 11:40,0,2,"Encouraging interim data were reported from the ongoing phase I clinical trial of STRO-002 regarding safety and anti-tumor activity results in heavily pre-treated patients with ovarian cancer. | @ AACR https://www.cancernetwork.com/ovarian-cancer/updated-interim-data-phase-i-trial-stro-002-show-promise-ovarian-cancer …pic.twitter.com/3uhOvYbFqA",,@,,"1255522249655947265",https://twitter.com/CancerNetwrk/status/1255522249655947265
HemOncToday,2020-04-29 11:32,2,1,"News from # AACR20 - phase 2 study results show Atezolizumab + cobimetinib @ genentech significantly prolonged PFS compared with atezolizumab alone in advanced biliary tract cancer https://bit.ly/3f56R6U Mark Yarchoan MD @ MarkYarchoan @ hopkinskimmel / Zev A. Wainberg MD @ dgsomuclapic.twitter.com/UJijioglOw",,@ @ @ @,#,"1255520414832394245",https://twitter.com/HemOncToday/status/1255520414832394245
EvidenceBaseFSG,2020-04-29 11:31,0,1,"We have summarized our # realworldevidence highlights from the # virtual # AACR20 meeting! Click to read about Project # GENIE, the # TERAVOLT registry and more: https://bit.ly/3eXGosc @ AACR",,@,# # # # #,"1255520000208711688",https://twitter.com/EvidenceBaseFSG/status/1255520000208711688
SWOG,2020-04-29 11:27,4,2,"Thanks for the coverage of our # AACR20 results @ ecancer! AACR 2020: Continuous dosing improves progression-free survival for melanoma patients with common mutations - ecancerhttps://ecancer.org/en/news/17720-aacr-2020-continuous-dosing-improves-progression-free-survival-for-melanoma-patients-with-common-mutations#.Xqmcj0T9vdQ.twitter …",,@,# #,"1255519186937405443",https://twitter.com/SWOG/status/1255519186937405443
TaylorJ_MD,2020-04-29 11:26,4,14,"Thanks @ AML_Hub for disseminating information on # AML! Happy to be a top 10 influencer during # AACR20 with @ lane_andy @ sanamloghavi @ SaWangMD @ IlariaIacobucc1 @ Daver_Leukemia @emilysmithses @ cvigilgonzales @ nycdoc29 and others! # leusmhttps://twitter.com/AML_Hub/status/1255468415357239296 …",,@ @ @ @ @ @ @emilysmithses @ @,# # #,"1255518714667110400",https://twitter.com/TaylorJ_MD/status/1255518714667110400
LeefVan,2020-04-29 11:25,0,1,"It was amazing. Huge thanks to organizers and speakers.",,,,"1255518475059068931",https://twitter.com/LeefVan/status/1255518475059068931
IBCResearch,2020-04-29 11:24,1,7,"Nice overview of # AACR20 presentation on EMBRACAtrial by # MBC pt @ itsnot_pink. Thanks for sharing your insights! # BCSMhttps://twitter.com/OncoAlert/status/1255090061697257472 …",,@,# # #,"1255518324844310529",https://twitter.com/IBCResearch/status/1255518324844310529
KKauffman131,2020-04-29 11:22,0,0,"@ AACR # AACR20 members waiting or trying to access the business mtg - just got notice it will begin at 11:30 a.m. Eastern today 4/29/20 - thx! # ECR # ECP # AACRAMC",,@,# # # #,"1255517861373755394",https://twitter.com/KKauffman131/status/1255517861373755394
abcam,2020-04-29 11:22,1,1,"Annual conferences and meetings such as # AACR20 have been making great efforts to move online, says @ ScienceMagazine, including our own AACR virtual week! https://bit.ly/2zCKRQF Check out our daily online sessions: https://bit.ly/2yAQpun # virtualconference # webinarpic.twitter.com/YE7iY4V2eo",,@,# # #,"1255517706297712642",https://twitter.com/abcam/status/1255517706297712642
RieWeb20,2020-04-29 11:15,0,0,"The link on the website doesn't work.",,,,"1255515952403419139",https://twitter.com/RieWeb20/status/1255515952403419139
AACR,2020-04-29 11:14,5,3,"The # AACR20 Annual Business Meeting of Members will begin at 11:30 a.m. EDT",,,#,"1255515821234929672",https://twitter.com/AACR/status/1255515821234929672
BrasilOncologia,2020-04-29 11:11,0,1,"As mutações STK11 e EGFR estão associadas a uma expressão reduzida de PD-L1 e a um pior prognóstico após ICI, segundo estudo apresentado no @ AACR . Saiba mais: https://bit.ly/3f2oJiT # AACR # STK11 # EGFR # PDL1 # CPNPC # pulmão # imunoterapia # oncologiabrasilpic.twitter.com/AlHHOmBE1y",,@,# # # # # # # #,"1255515078423719938",https://twitter.com/BrasilOncologia/status/1255515078423719938
CellPressNews,2020-04-29 11:10,0,0,"Access the cutting-edge papers advancing our knowledge of using # vaccines to prevent and treat # cancers in the latest Research Arc edition. # AACR20 - https://bit.ly/3cWP1kF",,,# # #,"1255514694007304192",https://twitter.com/CellPressNews/status/1255514694007304192
IEEEembs,2020-04-29 11:09,2,1,"New screening tests and therapies are aiding in the fight against # cancer @ theNCI @ AmericanSociety # genomics # NMR # FDG-PET @ nationwidekids @ AACR # IEEEembs # IEEEpulse https://bit.ly/2za2TcV pic.twitter.com/XIrCHewB1j",,@ @ @ @,# # # # # #,"1255514531440332801",https://twitter.com/IEEEembs/status/1255514531440332801
nehajpancholi,2020-04-29 10:57,0,4,"If you missed the # AACR20 Opening Clinical Plenary Session, you can read my coverage of two melanoma trials presented at the session! https://twitter.com/AACR/status/1255248134353096711 …",,,#,"1255511497155006469",https://twitter.com/nehajpancholi/status/1255511497155006469
CancerTherAdvsr,2020-04-29 10:47,0,0,"Racial and ethnic disparities among patients with cancer and # COVID19. https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/covid19-coronavirus-racial-ethnic-disparities-among-cancer-patients/ … # AACR20",,,# #,"1255509072616591364",https://twitter.com/CancerTherAdvsr/status/1255509072616591364
MDAndersonNews,2020-04-29 10:45,4,14,"A recent MD Anderson-led deep sequencing study of # brainmetastases revealed distinct differences between these tumors and primary brain tumors. Learn more: https://bit.ly/2YdHutV # AACR20 # endcancer",,,# # #,"1255508394762526727",https://twitter.com/MDAndersonNews/status/1255508394762526727
MM_Oncology,2020-04-29 10:30,1,0,"# AACR20 news in brief: Pre-existing mutations in ESR1 increase the risk for endocrine therapy failure in women with primary # BreastCancer, @ lunduniversity study presented by @ malinnd at @ AACR Virtual Annual Meeting I https://bit.ly/2zH76oJ",,@ @ @,# #,"1255504858431488008",https://twitter.com/MM_Oncology/status/1255504858431488008
HemOncToday,2020-04-29 10:27,1,0,"News from # AACR20 - Phase 2 study results show that immune checkpoint inhibitor geptanolimab is effective and safe for patients with relapsed or refractory peripheral T-cell lymphoma https://bit.ly/2zHMXyP pic.twitter.com/uz15cGVAmy",,,#,"1255503895020929030",https://twitter.com/HemOncToday/status/1255503895020929030
jennkwanMDPhD,2020-04-29 10:23,0,1,"Cancer patients with # COVID19 on # immunotherapy (& recent surgery) had the highest death rate/most severe disease. However, n was small (6), thus larger, multi-center, multi-country studies are warranted @ AACR pic.twitter.com/X4VSoOh2Tg",,@,# #,"1255502952959225857",https://twitter.com/jennkwanMDPhD/status/1255502952959225857
TischCancer,2020-04-29 10:11,2,3,"Dr. Adilia Hormigo presented on laser interstitial thermal therapy and avelumab for recurrent # glioblastoma at the @ AACR meeting. https://bit.ly/35qRwtj @ IcahnMountSinaihttps://icahn.mssm.edu/profiles/adilia-hormigo …",,@ @,#,"1255499835039518721",https://twitter.com/TischCancer/status/1255499835039518721
VivekSubbiah,2020-04-29 10:10,2,3,"Here is a thread summarizing the # COVID19nCancer plenary session @ aacr # AACR20. Could not attend the session as I was in clinic. Great to have a quick overview before watching the session this weekend. Thanks @ ADesaiMDhttps://twitter.com/ADesaiMD/status/1255154902504026113 …",,@ @,# #,"1255499717859033090",https://twitter.com/VivekSubbiah/status/1255499717859033090
NormandBlais,2020-04-29 10:10,2,2,"Expérience de @ GustaveRoussy @ barlesi # AACR20. 1300 pts cancer consécutifs testés. 12% de positifs SARS-CoV-2 dont 23% COMPLÈTEMENT ASYMPTOMATIQUES, même avec un cancer en traitement. Pas surprenant qu’il y ait des éclosions facilement... TESTING SVP pic.twitter.com/rOwwGvqewn",,@ @,#,"1255499627450728449",https://twitter.com/NormandBlais/status/1255499627450728449
HemOncToday,2020-04-29 10:06,1,2,"News from # AACR20 - Capmatinib shows efficacy in lung cancer subset, including patients with brain metastases https://bit.ly/2W54rwy Edward B. Garon, MD, MS, @ dgsomucla / Taofeek K. Owonikoko, MD, PhD, MSCR @ teekayowo @ EmoryMedicine @ WinshipAtEmory ,pic.twitter.com/xCd0vDUcgA",,@ @ @ @,#,"1255498799398649861",https://twitter.com/HemOncToday/status/1255498799398649861
JExpMed,2020-04-29 10:05,1,2,"Tell us what you think about JEM’s new cancer collection for # AACR20 (https://bit.ly/3avNaBK ) and the new short summaries of articles in this PDF: https://bit.ly/2XYhG4z pic.twitter.com/BQkauL7l9S",,,#,"1255498336989327373",https://twitter.com/JExpMed/status/1255498336989327373
jennkwanMDPhD,2020-04-29 10:02,0,1,"# COVID19 in # cancer patients, outcomes differ by cancer type/stage @ AACR pic.twitter.com/wyi8jdcWUN",,@,# #,"1255497797392097282",https://twitter.com/jennkwanMDPhD/status/1255497797392097282
fiosgenomics,2020-04-29 10:00,0,2,"For our second poster from AACR 2019, we featured on a poster from @ Genentech. The poster investigated the effects of fusion burden on the expression of key molecular and immune effectors in prostate cancer. Read more about the poster here: https://buff.ly/2Vo14m0 # AACR20 pic.twitter.com/QoxbQr1hlB",,@,#,"1255497240707248129",https://twitter.com/fiosgenomics/status/1255497240707248129
CellPressNews,2020-04-29 10:00,3,2,"Read the latest exciting research on single-cell sequencing in this free Cell Press Selection. # AACR20 - https://bit.ly/2zH3qTY",,,#,"1255497093701079043",https://twitter.com/CellPressNews/status/1255497093701079043
TempusLabs,2020-04-29 09:53,3,6,"Our medical affairs team has compiled a summary of the most important topics and trends they saw at # AACR20 Virtual Meeting day 1. View our recap to read about latest # oncology advancements across the industry: https://bit.ly/AACRday1recap @ AACR pic.twitter.com/e6giJc1wQK",,@,# #,"1255495408161259524",https://twitter.com/TempusLabs/status/1255495408161259524
GautschiOliver,2020-04-29 09:53,19,34,"Impower150 update # AACR20 by Mark Socinski ⁦ @ DMSLung⁩ ⁦ @ barlesi⁩ ⁦ @ TonyMok9⁩ # LCSMpic.twitter.com/yImfOVC0p1",,@ @ @,# #,"1255495391631552516",https://twitter.com/GautschiOliver/status/1255495391631552516
BioWorld,2020-04-29 09:49,0,0,"At a series of new drugs on the horizon sessions at the 2020 American Association for Cancer Research Virtual Annual Meeting I, a variety of companies presented preclinical and clinical data for promising early stage oncology products # AACR20 https://www.bioworld.com/articles/434714-new-drugs-on-the-horizon-highlighted-at-aacr …",,,#,"1255494320704163840",https://twitter.com/BioWorld/status/1255494320704163840
abcam,2020-04-29 09:35,2,1,"Do you have a question from our # AACR20 Abcam experts? We are here to answer! Be sure to submit your questions by Thursday at 5pm BST / 12pm EST. Join us daily as we stream our # AACR20 content online with updates daily, April 27- May 1. Learn more here: https://bit.ly/3aoLx8V pic.twitter.com/avTWtgzX0g",,,# #,"1255490779830763527",https://twitter.com/abcam/status/1255490779830763527
CancerResearch,2020-04-29 09:30,2,13,"Combinations of more than one immunotherapy (IO) drug or combos of IO drugs with current best practice treatments (standard therapies) dominated the morning discussions, notably in one of the most prevalent cancers, breast cancer, at Day 1 of # AACR20. https://bit.ly/3bOdbOi",,,#,"1255489543857491970",https://twitter.com/CancerResearch/status/1255489543857491970
PortalOnconews,2020-04-29 09:25,0,1,"A experiência de # COVID_19 e câncer em pts tratados no Gustave Roussy Cancer Campus, França, foi um dos destaques da # AACR20, em apresentação de Fabrice Barlesi - https://tinyurl.com/y9pedkrh @ AACR # COVID_19 # ONCONEWSnoAACR20 # ONCONEWS # AACR2020 pic.twitter.com/ZQSbEqCwxS",,@,# # # # # #,"1255488399496097793",https://twitter.com/PortalOnconews/status/1255488399496097793
delilah_nya,2020-04-29 09:21,0,1,"今後、新型コロナウイルスについても、がん治療に関係することも新しい情報や対処が出てくると思います。 記事中に登場する大須賀先生 @ SatoruO が、各国のがん患者が感染した場合の重症化リスクについて発信しておられ、 # CancerX の上野先生 @ nuenojpn も # AACR20 についてつぶやいておられます。",,@ @,# #,"1255487422802153473",https://twitter.com/delilah_nya/status/1255487422802153473
BrasilOncologia,2020-04-29 09:18,0,1,"Estudo apresentado no @ AACR demonstrou uma sinergia potente de AZD6738 e olaparib, com redução significativa da carga tumoral nos ratos, fornecendo informações importante para futuros estudos clínicos. Saiba mais: https://bit.ly/2KHfLtF # AACR # câncer # mutacao # PARP # IDHpic.twitter.com/rXqPLfEUfM",,@,# # # # #,"1255486492383809537",https://twitter.com/BrasilOncologia/status/1255486492383809537
AACR,2020-04-29 09:15,4,8,"RT @ CD_AACR: # OnlineFirst: Read: Patients with cancer appear more vulnerable to SARS-COV-2-published to coincide with # AACR20 Virtual Annual Meeting I! https://bit.ly/2W94eIL pic.twitter.com/y5AT0mOf5l",,@,# #,"1255485757697011714",https://twitter.com/AACR/status/1255485757697011714
IBCResearch,2020-04-29 09:10,4,11,"Also heard during # AACR20 "patient failed xyz therapy". Reminder: therapies fail patients, not the other way around! If we could control the cancer's response, we would, but it's not a choice. # BCSM",,,# #,"1255484688317263873",https://twitter.com/IBCResearch/status/1255484688317263873
MM_Oncology,2020-04-29 09:10,1,1,"# AACR20 news in brief: Final overall survival analysis of EMBRACA presented by @ JenniferLitton ( @ MDAndersonNews) finds no benefit for # talazoparib versus # chemotherapy for BRCA-mutated, HER2-negative advanced # BreastCancerhttps://bit.ly/3cVSSyy",,@ @,# # # #,"1255484686312321024",https://twitter.com/MM_Oncology/status/1255484686312321024
EvidenceBaseFSG,2020-04-29 09:05,0,0,"New research , presented at # AACR20, demonstrates that amongst individuals with advanced # NSCLC, past medical history of # pneumonitis was associated with greater incidence of treatment-associated pneumonitis. Read more: https://bit.ly/3f7IiXl @ Syapse @ AdvocateAurora",,@ @,# # #,"1255483262522228737",https://twitter.com/EvidenceBaseFSG/status/1255483262522228737
CD_AACR,2020-04-29 09:00,3,6,"# OnlineFirst: Read: Patients with cancer appear more vulnerable to SARS-COV-2-published to coincide with # AACR20 Virtual Annual Meeting I! https://bit.ly/3f3XF2D pic.twitter.com/Z4RWXcYz5k",,,# #,"1255482013747904512",https://twitter.com/CD_AACR/status/1255482013747904512
AACR,2020-04-29 09:00,0,1,"On the blog: # AACR20 Annual Meeting 2020 kicked off Monday morning in an all-virtual format. https://bit.ly/2YdpyQ1",,,#,"1255482002922442752",https://twitter.com/AACR/status/1255482002922442752
mtmdphd,2020-04-29 08:56,0,2,"1) n=107 likely not large enough for multivariate analysis, 2) XRT & Pneumonitis - see: Pneumonitis incidence in NSCLC Tx'd w/ immunotherapy or chemo in clinical trials & real-world data [Apr 27, 2020 ] Liu et al. # AACR20 CT086 - VCTPL08 - http://ow.ly/Oxpy30qB9U8 # lcsm # irAE",,,# # #,"1255481106473848836",https://twitter.com/mtmdphd/status/1255481106473848836
SyedMAhmedMDPhD,2020-04-29 08:48,0,3,"@ Jbauml @ StephenVLiu . In looking at # COVID19 in # lcsm @ # AACR20, was any data presented on egfr/alk/ros mutation? Is it truly lung cancer that was the risk factor or was lung cancer a surrogate for pre-existing lung disease?",,@ @ @,# # #,"1255479040921743362",https://twitter.com/SyedMAhmedMDPhD/status/1255479040921743362
lisaksheldon,2020-04-29 08:45,1,2,"Cytotoxic chemo in previous 3 months was not associated with death from # COVID19 in France but was associated with clinical worsening - in other studies cytotoxic chemo previous 14 days was associated with more serious events # AACR2020 https://twitter.com/rbashoMD/status/1255288988765696002 …",,,# #,"1255478436992372738",https://twitter.com/lisaksheldon/status/1255478436992372738
JCellBiol,2020-04-29 08:37,1,3,"ICYMI – Special Collection of Reviews on # Cancer Cell Biology # AACR20: https://bit.ly/2SbYfli pic.twitter.com/LZzZy11mu5",,,# #,"1255476181295644673",https://twitter.com/JCellBiol/status/1255476181295644673
lisaksheldon,2020-04-29 08:35,0,0,"@ OncologyNursing # clinicaltrials Can ship oral # cancer agents - injectable agents must be administered at a registered @ FDA site @ theNCI # AACR2020 https://twitter.com/LUNGevity/status/1255249675852156929 …",,@ @ @,# # #,"1255475782396321794",https://twitter.com/lisaksheldon/status/1255475782396321794
imsmd,2020-04-29 08:24,0,0,"Look forward to seeing the entire study in print, but fortunately we got a glimpse at # AACR20: https://www.eurekalert.org/pub_releases/2020-04/tedc-tac042720.php …",,,#,"1255472987580633088",https://twitter.com/imsmd/status/1255472987580633088
ESchattner,2020-04-29 08:18,2,5,"Experimental blood test helped detect women's cancers early, study finds. But it missed many more cancers than it found, raised false alarms, & only looked at ages 65-75, @ MMarchioneAP - https://apnews.com/863e8f4bd759a658785c6eac75372ac2 … @ DrLen # womenshealth # AACR20 @ ScienceMagazinehttps://science.sciencemag.org/content/early/2020/04/27/science.abb9601 …",,@ @ @,# #,"1255471629750206464",https://twitter.com/ESchattner/status/1255471629750206464
lymphomahub,2020-04-29 08:15,2,8,"The @ lymphomahub aims to lift levels of knowledge in # lymphoma and CLL. We are proud to be recognized as a top # lymsm influencer during # AACR20! pic.twitter.com/pDRKMo3Gz0",,@,# # #,"1255470827262193664",https://twitter.com/lymphomahub/status/1255470827262193664
OncLive,2020-04-29 08:10,1,4,"WATCH: Dr. Pusztai on Rationale for the I-SPY 2 Trial With Durvalumab/Olaparib Combo in HER2- Breast Cancer @ YaleCancer @ AACR # bcsm # AACR20 http://ow.ly/bw5H50zrpk1",,@ @,# #,"1255469412288737284",https://twitter.com/OncLive/status/1255469412288737284
DrESHAJ9,2020-04-29 08:08,0,0,"",,,,"1255469049624047620",https://twitter.com/DrESHAJ9/status/1255469049624047620
HopeBailey214,2020-04-29 08:08,0,1,"I am in!",,,,"1255468986667601920",https://twitter.com/HopeBailey214/status/1255468986667601920
NCIResearchCtr,2020-04-29 08:08,3,18,"Haneen Shalabi @ NCI_CCR_PedOnc presented her team's findings at yesterday's virtual # AACR20. Read more https://www.onclive.com/conference-coverage/aacr-2020/bispecific-cd19cd22-car-t-cells-active-in-pediatric-relapsed-all … via @ onclive",,@ @,#,"1255468893507911685",https://twitter.com/NCIResearchCtr/status/1255468893507911685
AML_Hub,2020-04-29 08:06,2,6,"The @ AML_Hub disseminates the latest evidence-based information on acute myeloid # leukemia. Proud to be recognized again as a top # leusm influencer during # AACR20! pic.twitter.com/XVLb5wpEAu",,@,# # #,"1255468415357239296",https://twitter.com/AML_Hub/status/1255468415357239296
Cortellis,2020-04-29 08:01,3,1,"Syndax Pharmaceuticals presents preliminary phase I data for SNDX-5613, their lead menin/MLL interaction inhibitor for the oral treatment of MLL-rearranged (MLL-r) and NPM1-mutant acute leukemias; responses observed in two patients with MLL-r acute leukemia. # AACR20",,,#,"1255467187730558987",https://twitter.com/Cortellis/status/1255467187730558987
TargetedOnc,2020-04-29 08:01,0,0,"Interim findings of the ongoing phase II ZENITH20 trial demonstrated that poziotinib induced a 68.7% disease control rate when used as treatment of patients with pretreated non–small cell lung cancer harboring an EGFR exon 20 insertion. https://www.targetedonc.com/view/patients-with-egfr-exon-20-mutated-nsclc-demonstrate-response-with-poziotinib … # AACR20",,,#,"1255467156638179329",https://twitter.com/TargetedOnc/status/1255467156638179329
pashtoonkasi,2020-04-29 07:59,0,0,"# AACR20 # COVID19 https://twitter.com/fdaoncology/status/1255255876337840133?s=21 …https://twitter.com/FDAOncology/status/1255255876337840133 …",,,# #,"1255466619859591170",https://twitter.com/pashtoonkasi/status/1255466619859591170
Cortellis,2020-04-29 07:51,0,0,"Positive preclinical and FIH data presented for IPN-60090, a potent GLS1 inhibitor for the oral treatment of KEAP1/NFE2L2-mutant NSCLC and ASNS-low HGSOC under joint development by MD Anderson Center and Ipsen. # AACR20",,,#,"1255464621412159496",https://twitter.com/Cortellis/status/1255464621412159496
BursatilBiotech,2020-04-29 07:44,1,1,"Great timing after # AACR20 https://twitter.com/BioStocks/status/1255452175297380354 …",,,#,"1255462847250907136",https://twitter.com/BursatilBiotech/status/1255462847250907136
RousseauMC,2020-04-29 07:40,0,1,"Lung cancer pts seem to do worse as a subgroup. @ AACR # AACR20 Pts with lung cancer, hematologic cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. https://twitter.com/aacr/status/1255143979265323010?s=21 …https://twitter.com/AACR/status/1255143979265323010 …",,@,#,"1255461996482441216",https://twitter.com/RousseauMC/status/1255461996482441216
NanomedZone,2020-04-29 07:38,1,3,"Have a look at the # nanomedicine highlights from the @ AACR virtual Annual Meeting including this Phase II clinical trial using albumin-bound nanoparticle paclitaxel as a salvage therapy for UC https://bit.ly/2Y9qtB1 # AACR2020",,@,# #,"1255461333702762497",https://twitter.com/NanomedZone/status/1255461333702762497
MM_Oncology,2020-04-29 07:32,3,2,"# AACR20 news: Camrelizumab–apatinib has antitumor activity in previously treated # SCLC patients - # PASSION trial data reported by Jie Wang at # AACR2020 # lungcancer # lcsmhttp://bit.ly/2Sfx6xF",,,# # # # # #,"1255459959757844481",https://twitter.com/MM_Oncology/status/1255459959757844481
acarrer,2020-04-29 07:28,0,0,"Nice resource and valuable data. Yet, those rates are still puzzling to me. PAAD ca. 50% doesn't reflect what many people have seen for years. Recent PAAD sequencing data also point in a different direction.",,,,"1255458966827610113",https://twitter.com/acarrer/status/1255458966827610113
1stOncology,2020-04-29 07:17,0,0,"# IntelliaTherapeutics to Present New Preclinical Data from Its # CRISPR/ # Cas9 Programs at the 23rd Annual Meeting of the # AACR20 $ NTLA https://www.1stoncology.com/blog/intellia-therapeutics-to-present-new-preclinical-data-from-its-crisprcas9-programs-at-the-23rd-annual-meeting-of-the-american-society-of-genecell-therapy1234556686 …",,,# # # #,"1255456212130443264",https://twitter.com/1stOncology/status/1255456212130443264
abcam,2020-04-29 07:12,0,2,"Do you have a few minutes? Interested in ICC? Join our # VirtualEvent today for "Introduction to # Immunocytochemistry: principles, protocol steps & troubleshooting” with Antonella Galli. Join us daily as we stream our # AACR20 content, April 27- May 1. https://bit.ly/3aoLx8V pic.twitter.com/a74UO0EFYv",,,# # #,"1255454789036580864",https://twitter.com/abcam/status/1255454789036580864
CharuAggarwalMD,2020-04-29 07:11,2,19,"# AACR20 Part I was a success. Huge congratulations to the entire @ AACR team for this incredible # virtual effort! We look forward to part II in June, w/a special session on # COVID19 in # Cancer. But before that, looking forward to # ASCO20 @ ASCOhttps://twitter.com/AACR/status/1255266090214719488 …",,@ @,# # # # #,"1255454600066404352",https://twitter.com/CharuAggarwalMD/status/1255454600066404352
OncLive,2020-04-29 07:10,0,1,"cfDNA Assay Shows Predictive Value in Detecting Cancer, Tissue of Origin @ MayoClinic @ AACR # AACR20 http://ow.ly/kC4c50zrpdb",,@ @,#,"1255454313234731018",https://twitter.com/OncLive/status/1255454313234731018
biocomafricarsa,2020-04-29 07:08,0,1,"Join # abcam for virtual # AACR20 next week, when Abcam’s scientific experts will discuss how to advance cancer research as well as current industry trends and challenges. New talks and Q&A sessions daily, April 27- May 1. Program here: https://bit.ly/3aoLx8V pic.twitter.com/hki2X183Ng",,,# #,"1255453776787451906",https://twitter.com/biocomafricarsa/status/1255453776787451906
CharuAggarwalMD,2020-04-29 06:58,3,14,"# COVID19 and # Cancer: watch my quick summary on the data presented at # AACR20 by @ marinagarassino # TERAVOLT and @ barlesi talking about the @ GustaveRoussy experience. # LCSM @ OncoAlert @ PennMedicine @ PennMedNewshttps://twitter.com/OncoAlert/status/1255248119417245697 …",,@ @ @ @ @ @,# # # # #,"1255451464237043712",https://twitter.com/CharuAggarwalMD/status/1255451464237043712
pashtoonkasi,2020-04-29 06:52,8,19,"This is huge # Immunotherapy dosing esp amidst on how to exposure of # cancer patients amidst # COVID19 # coronavirus # pandemic. # COVID19nCancer # AACR20 @ US_FDA @ FDAOncology Approves @ Merck # KEYTRUDA # pembrolizumab 400 mg QWeeks # OncoAlert https://www.mrknewsroom.com/news-release/oncology/fda-approves-mercks-keytruda-pembrolizumab-use-additional-recommended-dose-400 …pic.twitter.com/s1oJjN0Ycu",,@ @ @,# # # # # # # # # #,"1255449923446812678",https://twitter.com/pashtoonkasi/status/1255449923446812678
HaydayLab,2020-04-29 06:47,3,6,"The @ AACR and @ AAAS just highlighted our work on the importance of Vδ1 # gdTcells in tumour microenvironment, as a significant contribution to cancer research in the last year. Well done Yin @ dr_yinwu , @ FernandaKyle and team!https://stm.sciencemag.org/content/11/513/eaax9364 …",,@ @ @ @,#,"1255448696478670849",https://twitter.com/HaydayLab/status/1255448696478670849
lgreco_ny,2020-04-29 06:45,0,1,"To me, yes. They seemed to be arguing location of vape/tobacco shops increased risk if cancer. I may have missed it, but I didn't see pollution or exposure to other known carcinogens (like house products) discussed.",,,,"1255447988702412801",https://twitter.com/lgreco_ny/status/1255447988702412801
HaydayLab,2020-04-29 06:41,2,5,"The @ AACR and @ AAAS just highlighted our work on the importance of Vδ1 # gdTcells in tumour microenvironment, as a significant contribution to cancer research in the last year. Well done Yin @ dr_yinwu, @ FernandaKyle and team! # Science # Immunosurveillance # Immunology # Cancerpic.twitter.com/AjEIEZ4yPQ",,@ @ @ @,# # # # #,"1255447149065748485",https://twitter.com/HaydayLab/status/1255447149065748485
KKauffman131,2020-04-29 06:26,0,1,"Luckily you can still catch up on any content you missed with lots of Twitter threads recapping the highlights and recorded on-demand availability of the sessions and posters, post-meeting!",,,,"1255443316889583623",https://twitter.com/KKauffman131/status/1255443316889583623
bradloncar,2020-04-29 06:22,2,9,"STAT story on this Gracell allo data. Definitely one of the more intriguing things we saw at # AACR20. https://www.statnews.com/2020/04/28/off-the-shelf-car-t-therapy-helps-leukemia-patients-in-a-small-first-in-human-trial/?utm_source=STAT+Newsletters&utm_campaign=e936450223-RO_COPY_04&utm_medium=email&utm_term=0_8cab1d7961-e936450223-149530313 …",,,#,"1255442430171766784",https://twitter.com/bradloncar/status/1255442430171766784
OncLive,2020-04-29 06:10,0,0,"WATCH: Nickolas Papadopoulos, PhD, of @ HopkinsMedicine, discusses the results of a study which evaluated a combined modality screening approach in women without a history of cancer. @ AACR # AACR20 http://ow.ly/NFzK50zrphs",,@ @,#,"1255439210124906497",https://twitter.com/OncLive/status/1255439210124906497
healthhashtags,2020-04-29 06:00,1,4,"Top Influencers of # AACR20: @ AACR @ OncoAlert @ weoncologists @ Jbauml @ marinagarassino @ barlesi @ tmprowell More https://hcsm.io/2TPswt7",,@ @ @ @ @ @ @,#,"1255436815928082435",https://twitter.com/healthhashtags/status/1255436815928082435
FauBrigitte,2020-04-29 05:50,0,0,"Tout scientifique gagnerait à connaître les travaux de Béchamp. En voici un condensé (sous forme d'extraits de son livre) il est à la disposition de tout curieux ; téléchargeable gratuitement par ce lien :https://www.bonnes-habitudes.fr/comprendre/polymorphisme-microbien/les-microzymas/ …",,,,"1255434248175091712",https://twitter.com/FauBrigitte/status/1255434248175091712
giusvisc,2020-04-29 05:46,0,1,"Thanks # AACR2020 See you in June for Virtual Annual Meeting II https://twitter.com/AACR/status/1255266090214719488 …",,,#,"1255433295673860097",https://twitter.com/giusvisc/status/1255433295673860097
DrABiondo,2020-04-29 05:34,1,9,"Delighted to be part of the @ ICR_DDU_IIT @ royalmarsdenNHS running three phase 1 trials, results of which were presented at # AACR20 https://twitter.com/DrAbhiPal/status/1254784911535267840 …",,@ @,#,"1255430233982996482",https://twitter.com/DrABiondo/status/1255430233982996482
GLambertiMD,2020-04-29 05:31,3,19,"Our work from @ DanaFarber on correlates of PD-L1 expression in NSCLC just out in @ Annals_Oncology and presented by @ lfspurr at @ AACR.. Thanks @ DrMarkAwad for being such a terrific mentor! And thanks to my co-auth and friends @ BiagioMd @ GRecondoMDhttps://twitter.com/DrMarkAwad/status/1255321439328141314 …",,@ @ @ @ @ @ @,,"1255429410938896384",https://twitter.com/GLambertiMD/status/1255429410938896384
pashtoonkasi,2020-04-29 05:29,3,9,"Interesting to note that while the discussion/data at # AACR20 showed a higher HR for # cancer & # COVID19, (almost ~3), it’s very likely that this potentially may be driven to some extent by other chronic conditions & advanced age. # COVID19nCancer listed as ‘malignant neoplasm’.pic.twitter.com/BPwVl3gQBM",,,# # # #,"1255428917038583808",https://twitter.com/pashtoonkasi/status/1255428917038583808
AML_Hub,2020-04-29 05:24,1,1,"If you missed the @ AACR meeting, click below to view a Twitter Moment created by the @ AML_Hub, providing you with the latest updates in # AML from the meeting: https://twitter.com/i/moments/1255426780778893313 … # leusm # AACR20",,@ @,# # #,"1255427720609247233",https://twitter.com/AML_Hub/status/1255427720609247233
lymphomahub,2020-04-29 05:20,2,2,"Highlights from the @ AACR Annual Meeting 2020 in lymphoma are now available in this @ lymphomahub Twitter Moment https://twitter.com/i/moments/1255424685787041792 … # lymsm # AACR20",,@ @,# #,"1255426596997079041",https://twitter.com/lymphomahub/status/1255426596997079041
OncLive,2020-04-29 05:10,0,0,"TERAVOLT Data Reveal "Unexpectedly High" Mortality in Patients With Thoracic Cancers and COVID-19 @ IstTumori @ AACR # COVID19 # coronavirus # AACR20 http://ow.ly/K0qX50zrpci",,@ @,# # #,"1255424103797981186",https://twitter.com/OncLive/status/1255424103797981186
OncologyCentral,2020-04-29 05:00,4,4,"The latest results from the Circulating Cell-free Genome Atlas study have been presented at # AACR20. Find out more about the latest early detection test studies in our latest news post:",,,#,"1255421566764056576",https://twitter.com/OncologyCentral/status/1255421566764056576
SciSha,2020-04-29 04:31,2,9,"Come on @ AACR , there are MANY guidelines on how to promote # DiversityandInclusion at conferences Here, have one: https://www.womeninresearch.org/wp-content/uploads/2018/02/WIRe-Conference-Speaker-Diversity-Guidelines.pdf … # AACR2020 https://twitter.com/hilaryarobbins/status/1255204168035438605 …",,@,# #,"1255414448963170306",https://twitter.com/SciSha/status/1255414448963170306
BayerPharma,2020-04-29 04:00,3,13,"We’re focused on genomic # cancer testing. These tests may help doctors recommend treatments and clinical trials based on a patient’s unique tumor makeup. Learn about the importance of genomic cancer testing today: http://spr.ly/601914QzP # AACR20 pic.twitter.com/ZLuvR1cAE9",,,# #,"1255406470511951875",https://twitter.com/BayerPharma/status/1255406470511951875
GroupeUNICANCER,2020-04-29 03:43,4,5,"# CanceretCOVID19 : Pr Fabrice @ barlesi de @ GustaveRoussy partage une analyse précoce de la manière dont ce # CLCC s’est adapté pour gérer l’épidémie # COVID19 @ AACR # AACR2020 # OncoAlert # TousEnsemble # cancer # CLCC # Villejuifhttps://twitter.com/GustaveRoussy/status/1255178271995682818 …",,@ @ @,# # # # # # # # #,"1255402370609098758",https://twitter.com/GroupeUNICANCER/status/1255402370609098758
massimo_destro,2020-04-29 03:36,0,0,"Nuovi dati su # Vitrakvi e highlights sul nuovo AhR-inibitore presentati da @ Bayer durante # AACR20. La nostra # ricerca in # oncologia non si ferma. Trovare # nuovesoluzioni é la nostra mission. # scienceforabetterlife il nostro motto. # StrongerTogetherhttps://bayer2019tf.q4web.com/news/news-details/2020/Bayer-to-Highlight-Clinical-Data-on-Vitrakvi-larotrectinib-and-Research-on-Investigational-AhR-Inhibitor-at-AACR-2020-Virtual-Meeting/default.aspx …",,@,# # # # # # #,"1255400476713127937",https://twitter.com/massimo_destro/status/1255400476713127937
OncLive,2020-04-29 02:10,0,0,"WATCH: Dr. DiBiase on Data With DM-CHOC-PEN/Radiation in Cancers Involving the CNS @ WeillCornell @ nyphospital @ AACR # AACR20 http://ow.ly/30pw50zrpfe",,@ @ @,#,"1255378792836726784",https://twitter.com/OncLive/status/1255378792836726784
healthhashtags,2020-04-29 02:00,0,1,"Today's Health Conferences: # AACR20 # depression # aacr2020 http://hcsm.io/healthconfs # hcsm",,,# # # #,"1255376449881755648",https://twitter.com/healthhashtags/status/1255376449881755648
OncLive,2020-04-29 01:10,1,2,"Blood Test Is Feasible for Early Detection Across Multiple Cancers @ HopkinsMedicine @ AACR # AACR20 http://ow.ly/pMmu50zrp9o",,@ @,#,"1255363695712108544",https://twitter.com/OncLive/status/1255363695712108544
gautamkollu,2020-04-29 01:03,0,3,"Detecting cancer early matters. Kudos to the team at Thrive and @ MichaelPellini for their prospective trial showing that a series of blood tests with low false positive rates can safely enable earlier detection of multiple cancers. Congrats! # aacr20 https://twitter.com/EricTopol/status/1255192939791175680 …",,@,#,"1255362058025078784",https://twitter.com/gautamkollu/status/1255362058025078784
Transplant_Doc,2020-04-29 01:01,1,1,"DNA blood test spots cancers in seemingly cancer-free women, but also produces false alarms # AACR20 # cancerscreeninghttps://www.sciencemag.org/news/2020/04/blood-tests-spot-cancers-symptoms-appear-also-produce-false-positives …",,,# #,"1255361494566535170",https://twitter.com/Transplant_Doc/status/1255361494566535170
Transplant_Doc,2020-04-29 01:00,1,1,"Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention @ ScienceMagazine # AACR20 # cancerscreeninghttps://science.sciencemag.org/content/early/2020/04/27/science.abb9601 …",,@,# #,"1255361238722371588",https://twitter.com/Transplant_Doc/status/1255361238722371588
Dr_Ivanoncologo,2020-04-29 00:58,0,1,"# Cancer # COVID19 | Algunos puntos impotentes a considerar del # AACR20 sobre el manejo oncológico durante # COVID__19https://twitter.com/Martin_AngelMD/status/1255132445059346433 …",,,# # # #,"1255360755555274754",https://twitter.com/Dr_Ivanoncologo/status/1255360755555274754
survivorship_JP,2020-04-29 00:25,0,3,"AACR、大好きだーーー！！行けなくなったのは残念だけど、来年、また勉強して、行くから、よろしくねー！ # AACR2020 https://youtu.be/XfrJYT76Sjg",,,#,"1255352475613302785",https://twitter.com/survivorship_JP/status/1255352475613302785
ShieldArtin,2020-04-29 00:13,0,1,"I love the channel replay option. Other than the time difference issue, given # WFH and # remotelearning complications, each time one of the children interrupts, I can pause and/rewind to make sure I don't miss any exciting talks. # AACR2020",,,# # #,"1255349449754390529",https://twitter.com/ShieldArtin/status/1255349449754390529
OncLive,2020-04-29 00:10,2,3,"COVID-19: Practical and Immuno-Oncology Insight in Melanoma and Beyond @ PAscierto @ AACR # coronavirus # COVID19 # AACR20 http://ow.ly/92j550zrp5z",,@ @,# # #,"1255348595362017280",https://twitter.com/OncLive/status/1255348595362017280
AKSnow270332583,2020-04-28 23:57,0,5,"I love the virtual format! My PI has funds to send me to conferences every 3 years. I've attended 2 conferences this week alone: # AACR20 and # TAGC20 The questions are lot better, since the moderator can group related questions and participants can "vote up" questions they like.",,,# #,"1255345537307598852",https://twitter.com/AKSnow270332583/status/1255345537307598852
RadiOncBOTjp,2020-04-28 23:28,13,17,"「注目すべきは、放射線治療を受けたがん患者は、非担がん患者に比較して、(訳注:COVID-19に関して)重症になるかどうかに、統計学的有意差は無かった」 ASTRO(米国放射線腫瘍学会)が # AACR20 (2020年のオンライン開催された米国がん学会)で発表された武漢の大学病院からのデータを引用しています。 https://twitter.com/ASTRO_org/status/1255159593526689792 …",,,#,"1255338062470623232",https://twitter.com/RadiOncBOTjp/status/1255338062470623232
OncLive,2020-04-28 23:10,1,2,"TIL Therapy Elicits Encouraging Activity in Advanced NSCLC @ MoffittNews @ AACR # lcsm # AACR20 http://ow.ly/P2YT50zrp3Q",,@ @,# #,"1255333498577174534",https://twitter.com/OncLive/status/1255333498577174534
oalhalabimd,2020-04-28 23:06,0,0,"Never understood that either! @ AACR https://twitter.com/Jbauml/status/1255250733605236737 …",,@,,"1255332541856387072",https://twitter.com/oalhalabimd/status/1255332541856387072
AACR,2020-04-28 22:55,11,18,"Today’s @ US_FDA approval of an alternative dosing regimen for the immunotherapeutic pembrolizumab was based on results presented at the AACR Virtual Annual Meeting I: https://www.abstractsonline.com/pp8/#!/9045/presentation/10751 … # AACR20 https://twitter.com/FDAOncology/status/1255255876337840133 …",,@,# #,"1255329767487832065",https://twitter.com/AACR/status/1255329767487832065
KristieBuckeye,2020-04-28 22:44,0,1,"I spy a Nobel prize recipient...amazing job @ RamalingamMD & @ teekayowo yesterday, Emory represent! Although I prefer the hugs in person...",,@ @,,"1255327028280266754",https://twitter.com/KristieBuckeye/status/1255327028280266754
NickMarcouxMD,2020-04-28 22:35,0,15,"Thanks to # AACR20 I don’t feel depressed going through my twitter feed for the first time in weeks!",,,#,"1255324843064655874",https://twitter.com/NickMarcouxMD/status/1255324843064655874
CancerResearch,2020-04-28 22:34,1,6,"Still catching up on # AACR20? CRI's @ ArthurBrodsky shares highlights in # immunotherapy from Day 1.https://bit.ly/3bOdbOi",,@,# #,"1255324480047644672",https://twitter.com/CancerResearch/status/1255324480047644672
DrMarkAwad,2020-04-28 22:22,31,76,"Why do some lung cancers have high PD-L1 expression and others are PD-L1 negative? Very talented @ lfspurr and @ GLambertiMD describe clinical & genomic correlates of PD-L1 expression in NSCLC at # AACR2020 talk today and published in @ Annals_Oncology # LCSMhttps://www.sciencedirect.com/science/article/pii/S0923753420360786 …",,@ @ @,# #,"1255321439328141314",https://twitter.com/DrMarkAwad/status/1255321439328141314
OncLive,2020-04-28 22:10,1,1,"Positive Safety Profile Reported for Atezolizumab/Axi-Cel Combo in DLBCL @ DanaFarber @ AACR # lymsm # AACR20 http://ow.ly/gNhq50zrp1t",,@ @,# #,"1255318393047199746",https://twitter.com/OncLive/status/1255318393047199746
AJacomeMD,2020-04-28 21:58,1,2,"cfDNA Liquid Biopsy May Provide an Early Detection Test for Patients With Suspected Cancer @ ASCOPost # AACR2020 https://www.ascopost.com/news/april-2020/cfdna-liquid-biopsy-may-provide-an-early-detection-test-for-patients-with-suspected-cancer/?email=07ee9d287ab4960be81b2326473f47e762888283e48e34649757f5cd2309cfb7&utm_medium=email&utm_source=TAPEN-+2020-0428+-+NON+AD+SWAPPING+-+INTL&bc_md5=cc0f885a9b914fce15fd5b482d03829b#.XqjfIrG-y_0.twitter …",,@,# #,"1255315587343007744",https://twitter.com/AJacomeMD/status/1255315587343007744
SusanGKomen,2020-04-28 21:54,4,7,"New phase 2 trial results show that addition of Imprime PGG to pembrolizumab is a promising treatment for patients with # metastatic triple-negative # breastcancer # AACR20 https://bit.ly/2KEkI6i",,,# # #,"1255314518219149314",https://twitter.com/SusanGKomen/status/1255314518219149314
GeneOnlineNews,2020-04-28 21:27,1,2,"# AACR2020 The breast cancer therapy session featured emerging research in the field, both concerning target identification and clinical trials. Here is an account of key highlights from that discussion. # Cancer # breastcancer # BRCA # PARP # inhibitorhttps://wp.me/pb0TAP-1kN",,,# # # # # #,"1255307634560901122",https://twitter.com/GeneOnlineNews/status/1255307634560901122
LeciaSequist,2020-04-28 21:23,1,17,"Important summary of key # COVID19nCancer data from # AACR2020. Thanks @ CharuAggarwalMDhttps://twitter.com/OncoAlert/status/1255248119417245697 …",,@,# #,"1255306595774476288",https://twitter.com/LeciaSequist/status/1255306595774476288
MDAndersonNews,2020-04-28 21:19,1,13,"“Our preclinical data suggest that IPN60090 may be effective in underserved groups of patients who need better treatment options,” says our Dr. Jeffrey Kovacs: https://bit.ly/2YbTFrc # AACR20 # CancerMoonshot # endcancer",,,# # #,"1255305552344875013",https://twitter.com/MDAndersonNews/status/1255305552344875013
nuenojpn,2020-04-28 21:01,2,7,"【 # AACR20 COVID-19とがん医療のプレナリーの概要と感想, part 2】 COVID-19＆がんになったときの予後不良のリスク - 癌が肺に転移しているか肺がんである - ARDS - 好中球減少症 - １４日以内化学療法",,,#,"1255301192441384969",https://twitter.com/nuenojpn/status/1255301192441384969
nuenojpn,2020-04-28 20:59,2,3,"【 # AACR20 COVID-19プレナリーの概要と感想, part 3】発表データはまだ小さく、選択バイアスがあるかも。各国の経験がかなり異なっているが、これはデーターの収集方法が異なるためだろうか。 疾患別ガイドラインの必要性を感じた。がん患者向けの感染するリスクを定義するアルゴリズムが必要である。",,,#,"1255300743596302336",https://twitter.com/nuenojpn/status/1255300743596302336
OncLive,2020-04-28 20:58,0,1,"Universal Allogeneic CAR T-Cell Product Demonstrates Efficacy in a Cohort of Adult T-ALL @ AACR # AACR20 # leusmhttp://ow.ly/mZpt50zroUR",,@,# #,"1255300277286113284",https://twitter.com/OncLive/status/1255300277286113284
OncLive,2020-04-28 20:55,1,2,"Adopting Multidisciplinary and Evolving Care Plans Are Essential to Treat Cancer and COVID-19 @ Hospital12deOct @ AACR # COVID19 # coronavirus # AACR20 http://ow.ly/983350zroSk",,@ @,# # #,"1255299714679005184",https://twitter.com/OncLive/status/1255299714679005184
nuenojpn,2020-04-28 20:55,3,8,"【 # AACR20 COVID-19とがん医療の プレナリーの概要と感想, part 1】 COVID-19の感染リスクが高くなった要因。 - 3ヶ月以内の化学療法 - PSが低い：虚弱な患者 - 社会経済的地位が低い - 血液学的悪性腫瘍 - 特定の種類の治療法が目立たなかった。免疫療法はリスクとして出てこなかった。",,,#,"1255299592385593346",https://twitter.com/nuenojpn/status/1255299592385593346
iselkholi,2020-04-28 20:45,0,2,"Thanks for making this possible and making it available to everybody!",,,,"1255297243193708545",https://twitter.com/iselkholi/status/1255297243193708545
SWOG,2020-04-28 20:44,2,6,"These are great numbers @ AACR - and so are the blockbuster number of residents. Great planning in short order to make # AACR20 virtual. https://twitter.com/AACR/status/1255266090214719488 …",,@,#,"1255296778259386369",https://twitter.com/SWOG/status/1255296778259386369
UroDocAsh,2020-04-28 20:42,2,22,"Okay, I was not going to announce this till we actually had a cure but here goes: @ Aiims1742 @ VivekSubbiah and @ UroDocAsh have formed a secret society in Harris County. Come join us at happy hour April 1, 2021 to learn what we have been up to @ WSJ # AACR20 https://twitter.com/WSJ/status/1254896880653414412 …",,@ @ @ @,#,"1255296321931665408",https://twitter.com/UroDocAsh/status/1255296321931665408
MaverickNY,2020-04-28 20:37,0,1,"After 2 days of science at # AACR20 VM, am now catching up on what my tweeps are sharing... this is a good place to start - a story via graphics anyone can grasp just looking at the trends https://twitter.com/VincentRK/status/1255133558848413701 …",,,#,"1255294987098632192",https://twitter.com/MaverickNY/status/1255294987098632192
pratt_ed,2020-04-28 20:27,0,2,"An important point made during Q&A of Dr. Bauer's talk: tumor evolution is *not* unidirectional. There is evidence of tumor reversion to earlier genotypes in order to circumvent 2nd line+ therapies. # AACR20 Two examples in BCa https://tinyurl.com/ybk9pogk https://tinyurl.com/ya99v6xs",,,#,"1255292465420140545",https://twitter.com/pratt_ed/status/1255292465420140545
KomodoHealth,2020-04-28 20:25,1,6,". @ washingtonpost reports concerns from @ ASCO, @ AACR, and @ AmericanCancer, on balancing optimal care for cancer patients amid risk of # COVID19. Steep drops in cancer testing, detailed in a report released today by # KomodoHealth, creates more obstacles.https://www.washingtonpost.com/health/2020/04/28/coronavirus-cancer-deathrates/ …",,@ @ @ @,# #,"1255291975948996610",https://twitter.com/KomodoHealth/status/1255291975948996610
NateraOncology,2020-04-28 20:13,0,5,"Thank you organizers of # AACR20 for an excellent virtual meeting, allowing us to access the greatest and latest research on # ctDNA in # cancer. Can’t wait to find out what’s in store for the second half of virtual # AACR2020 in June!",,,# # # #,"1255289035054088193",https://twitter.com/NateraOncology/status/1255289035054088193
pratt_ed,2020-04-28 20:13,0,2,"Both Dr. Bauer & Dr. Abbosh showed that ctDNA can be used to monitor emergent subclones, including those associated with chemoresistance. It will be interesting to see if # LiquidBiopsy can assist therapy selection to minimize resistance and/or control tumor genotype # AACR20",,,# #,"1255288998664290306",https://twitter.com/pratt_ed/status/1255288998664290306
rbashoMD,2020-04-28 20:13,0,6,"Dr. Fabrice Barlesi at Gustave Roussy. Cytotoxic chemotherapy was not associated with increased risk of death due to # COVID19 in cancer patients receiving treatment for curative disease. # AACR2020 pic.twitter.com/gSnnUvdgUv",,,# #,"1255288988765696002",https://twitter.com/rbashoMD/status/1255288988765696002
_TanyaBondar_,2020-04-28 20:04,0,0,"Several groups across the globe reported at the virtual # AACR2020: among cancer patients, those on chemotherapy or with hematological cancer are at higher risk of severe COVID-19. https://twitter.com/ElizSMcKenna/status/1255126175208349697 …",,,#,"1255286916704096256",https://twitter.com/_TanyaBondar_/status/1255286916704096256
graymattersorg,2020-04-28 20:02,0,1,"Current session Covid-19 & Cancer Clinical trials # AACR20 # coronavirus # gmfbrainbuddiespic.twitter.com/wyk4ckgG0A",,,# # #,"1255286334534582274",https://twitter.com/graymattersorg/status/1255286334534582274
DrCFord,2020-04-28 19:56,3,2,"Nice thread on the # ctDNA session at virtual # AACR20- thanks @ pratt_ed # liquidbiopsy # earlydetectionhttps://twitter.com/pratt_ed/status/1255250205810835456 …",,@,# # # #,"1255284890012127232",https://twitter.com/DrCFord/status/1255284890012127232
pratt_ed,2020-04-28 19:55,0,2,"The cyclic structure of Lorlatinib's makes for impressive performance as a tyrosine kinase inhibitor. TKIs are a major and growing area of drug development, accounting for ~20% (>$9 billion) of the current oncology market. # AACR20 pic.twitter.com/2Dj817cpHl",,,#,"1255284626517606400",https://twitter.com/pratt_ed/status/1255284626517606400
AVIVA1950,2020-04-28 19:53,0,0,"Real Time Conference Coverage 2020 # AACR # Virtual Meeting April 28, 2020 Session on @ NCI Activities: # COVID-19 and # Cancer # Research 5:20 PM https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-nci-activities-covid-19-and-cancer-research-520-pm/ … via @ Pharma_BI @ pharma_BI @ AACR @ CureCancerNow @ pharmanews @ BiotechWorld @ theNCI # AACR20 @ StephenJWillia2",,@ @ @ @ @ @ @ @ @,# # # # # #,"1255284126917279744",https://twitter.com/AVIVA1950/status/1255284126917279744
PortalOnconews,2020-04-28 19:53,0,3,"A @ AACR dedicou uma sessão ao tema # COVID_19 e Câncer, como parte da Plenária apresentada na manhã de 28 de abril (VCTPL09). Com participação de pesquisadores de Wuhan, estudo chinês descreveu a experiência de tratar pts de câncer durante a pandemia - https://tinyurl.com/ycyy9dh8 pic.twitter.com/VKo0T3IEMj",,@,#,"1255283917185257473",https://twitter.com/PortalOnconews/status/1255283917185257473
Pharma_BI,2020-04-28 19:49,1,1,"Great coverage by Dr. Stephen J Williams @ pharma_BI @ AACR @ CureCancerNow @ pharmanews @ BiotechWorld @ HopkinsMedicine # AACR20 @ StephenJWillia2https://lnkd.in/eDgngq8",,@ @ @ @ @ @ @,#,"1255283005179990016",https://twitter.com/Pharma_BI/status/1255283005179990016
AVIVA1950,2020-04-28 19:47,0,0,"2020 # AACR # Virtual Meeting April 28, 2020 Symposium: New # Cancer # Drugs on the # Horizon Part 3 12:30-1:25 PM https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-symposium-new-drugs-on-the-horizon-part-3-1230-125-pm/ … via @ Pharma_BI @ StephenJWillia2 @ AACR @ CureCancerNow @ pharmanews @ BiotechWorld @ HopkinsMedicine # AACR20",,@ @ @ @ @ @ @,# # # # # #,"1255282468204294144",https://twitter.com/AVIVA1950/status/1255282468204294144
pratt_ed,2020-04-28 19:46,0,1,"Dr. Abbosh and Dr. Johnson use the nomenclature "ctDNA shedders" versus "ctDNA non-shedders" to differentiate between samples that test pos vs neg at baseline. Not sure how I feel about this as it entrains biological resp w/ LOD of the assay. What do others think? # AACR20",,,#,"1255282391259766787",https://twitter.com/pratt_ed/status/1255282391259766787
pratt_ed,2020-04-28 19:42,0,4,"As an aside, it's *very* exciting to see ctDNA assays being rationally and intentionally integrated into clinical trials. Allows research to focus on the biology w/o struggling with tech limitations, etc in post-hoc analysis. # AACR20",,,#,"1255281147984130050",https://twitter.com/pratt_ed/status/1255281147984130050
pratt_ed,2020-04-28 19:35,0,3,"Now that we have technologies sensitive enough to catch relapse at the earliest stages, how do we interpret & use the data generated? Really interesting work from AstraZeneca using longitudinal ctDNA dynamics to model and predict progression-free survival in NSCLC. # AACR20",,,#,"1255279564219191300",https://twitter.com/pratt_ed/status/1255279564219191300
KKauffman131,2020-04-28 19:35,0,2,"Great presentation @ d2merino! Looked like you collected a lot of interesting data comparison pts & fantastic list of collaborators. Good, steady clip & dynamic tone throughout. Didn't get to stick around for Q&A but again, great job! # AACRAMC alum pride!",,@,#,"1255279429225496579",https://twitter.com/KKauffman131/status/1255279429225496579
UCCancerCenter,2020-04-28 19:33,2,4,"Join the second session of # AACR20 on June 22-24 to hear more about how @ UCCancerCenter researchers # AnswerCancerhttps://twitter.com/AACR/status/1255266092513202178 …",,@,# #,"1255278999460339712",https://twitter.com/UCCancerCenter/status/1255278999460339712
ranjanpathk,2020-04-28 19:29,0,2,"Congratulations to @ AACR for a wonderfully conducted virtual # AACR2020. Of course not ideal but loved the ability to switch between sessions without having to from one hall to the next. Also much easier to see/capture slide contents. # COVID19 # thinkpositive # AcademicTwitter",,@,# # # #,"1255277979917303808",https://twitter.com/ranjanpathk/status/1255277979917303808
RobertFerrisMD,2020-04-28 19:29,0,4,"Great work @ jasonlukemd, Director of the Cancer Immunotherapeutics Center @ UPMCHillmanCC, and thanks to @ AACR for keeping knowledge and scientific exchange flowing during these challenging times",,@ @ @,,"1255277932303585280",https://twitter.com/RobertFerrisMD/status/1255277932303585280
NateraOncology,2020-04-28 19:26,5,10,"Another great talk at the # AACR20 Predictive Biomarkers for Immunotherapeutics session on the use of # ctDNA to predict outcomes from immunotherapies earlier than scans based on RECIST criteria. We are also exploring this through a # TumorINFORMED approach. https://www.natera.com/sites/default/files/ASCO_PMCC_Poster%20Draft_050282019.pdf …",,,# # #,"1255277123582988292",https://twitter.com/NateraOncology/status/1255277123582988292
krknrm,2020-04-28 19:25,2,24,"Thanks # AACR20 - It has been fantastic, I'm amazed of how such gigantic conference has adapted so quickly to the difficulties! I'm grateful for the new interactions and for the outlook of the field, the cancer research community stands strong! See you again in June! https://twitter.com/AACR/status/1255266090214719488 …",,,#,"1255276868284153858",https://twitter.com/krknrm/status/1255276868284153858
yuqincai,2020-04-28 19:24,0,3,"A round of applause # AACR20",,,#,"1255276841549651968",https://twitter.com/yuqincai/status/1255276841549651968
KyleighMrf,2020-04-28 19:21,0,1,"The @ CureMelanoma is grateful to @ aacr for its great virtual meeting and the incredible # leadership of @ CureMelanoma funded # melanoma # clinician # researcher Dr. Toni Ribashttps://twitter.com/AACR/status/1254766640178307072 …",,@ @ @,# # # #,"1255276021881978881",https://twitter.com/KyleighMrf/status/1255276021881978881
FellowsHsl,2020-04-28 19:19,2,5,"Regarding response assessment, ctDNA exhibit more eminent clinical application. Exploratory analysis from FLAURA correlate ctDNA clearance w/ PFS. Could a individualized approach w/ early ctDNA reassessment guide the decision of escalating or de-escalating treatment? # AACR20 pic.twitter.com/qgv3RC5eq1",,,#,"1255275369722269698",https://twitter.com/FellowsHsl/status/1255275369722269698
tmprowell,2020-04-28 19:09,41,110,"# AACR20. Great news for people living with # cancer during # COVID19 # pandemic: pembrolizumab 400 mg every 6 wks granted accelerated approval by FDA today for all existing indications. # advocacy # PatientExperiencehttps://twitter.com/FDAOncology/status/1255255876337840133 …",,,# # # # # #,"1255272919762173953",https://twitter.com/tmprowell/status/1255272919762173953
pratt_ed,2020-04-28 19:08,0,2,"Exciting to see assay benchmarking as a function of total cfDNA input receive increasing focus in # LiquidBiopsy field. Variant allele frequency does not tell the whole story & these kinds of data are critical for selecting the correct test type for a certain sample. # AACR20",,,# #,"1255272714073448449",https://twitter.com/pratt_ed/status/1255272714073448449
NarjustDumaMD,2020-04-28 19:06,4,5,"Check out this video by the amazing Dr. @ CharuAggarwalMD. # OncoAlert # AACR20 https://twitter.com/OncoAlert/status/1255248119417245697 …",,@,# #,"1255272275026292736",https://twitter.com/NarjustDumaMD/status/1255272275026292736
Jasoncology,2020-04-28 19:05,0,0,"# COVID19: Practical and Immuno-Oncology Insight in Melanoma and Beyond https://www.onclive.com/conference-coverage/aacr-2020/covid19-practical-and-immunooncology-insight-in-melanoma-and-beyond … # AACR20",,,# #,"1255271970679271424",https://twitter.com/Jasoncology/status/1255271970679271424
FertigLab,2020-04-28 19:01,0,5,"Thanks @ AACR for a great virtual start. Missing everyone.",,@,,"1255271018031190016",https://twitter.com/FertigLab/status/1255271018031190016
AmgenOncology,2020-04-28 19:00,0,10,"Thank you to @ AACR for creating this wonderful forum. We think the first virtual # AACR20 was a success. See you for part 2 in June!",,@,#,"1255270708575338496",https://twitter.com/AmgenOncology/status/1255270708575338496
OncologyCentral,2020-04-28 19:00,0,0,"The use of # ctDNA early detection and prediction of # cancer is gaining momentum. Find out the latest results presented at # AACR20 on @ OncologyCentral now:",,@,# # #,"1255270571958571010",https://twitter.com/OncologyCentral/status/1255270571958571010
pratt_ed,2020-04-28 18:59,1,3,"Dr. Chris Abbosh's introduction very nicely framed the importance of intervention at the MRD stage. # LiquidBiopsy could allow us to shift the therapeutic window to when disease burden is earlier + guide targeted therapy selection. # AACR20",,,# #,"1255270565964890114",https://twitter.com/pratt_ed/status/1255270565964890114
Rick__Buck,2020-04-28 18:52,1,6,"Thanks to our # AACR20 Influencers and everyone who tweeted about @ AACR Virtual Annual Meeting I! See you again June 22-24 for Virtual Meeting II. https://twitter.com/AACR/status/1255266090214719488 …",,@,#,"1255268673775960064",https://twitter.com/Rick__Buck/status/1255268673775960064
Kamacintosh,2020-04-28 18:50,0,3,"Mortality unexpectedly high among people with lung cancer, COVID-19 # AACR20 # LCSM # lungcancerhttps://www.healio.com/hematology-oncology/lung-cancer/news/online/%7B8d753808-2fdb-40e2-909a-56714a1afe2a%7D/mortality-unexpectedly-high-among-people-with-lung-cancer-covid-19?utm_medium=social&utm_source=twitter&utm_campaign=sociallinks …",,,# # #,"1255268236448448514",https://twitter.com/Kamacintosh/status/1255268236448448514
alexia_zz,2020-04-28 18:47,1,29,"Thank you @ aacr for a fab # aacr20! What an achievement to take the annual meeting online and have such amazing participation. So refreshing to travel to a conference again, even if only virtually Can’t wait for round 2 in June https://twitter.com/AACR/status/1255266090214719488 …",,@,#,"1255267350192033793",https://twitter.com/alexia_zz/status/1255267350192033793
StephenJWillia2,2020-04-28 18:46,1,3,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 28, 2020 Session on Novel # Cancer # Targets and # Therapies 2:35 PM https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-novel-targets-and-therapies-235-pm/ … via @ Pharma_BI @ pharmanews @ pharmalot @ BiotechWorld @ Bioitworld # pharma360",,@ @ @ @ @ @,# # # # #,"1255267092359716871",https://twitter.com/StephenJWillia2/status/1255267092359716871
pratt_ed,2020-04-28 18:44,0,4,"Dr. David Thiel presenting the Circulating Cell-Free Genome Atlas Study being run by GRAIL. ctDNA, matched tissue samples, methylation analyses, CCGA has it all! I am *very* excited to see these data. # AACR20 pic.twitter.com/KH3jo91f3a",,,#,"1255266711776956416",https://twitter.com/pratt_ed/status/1255266711776956416
OncLive,2020-04-28 18:43,1,2,"Clinical Factors Predict Deterioration Among Patients With Cancer, COVID-19 @ barlesi @ GustaveRoussy @ AACR # coronavirus # COVID19 # AACR20 http://ow.ly/gc4B50zriXt",,@ @ @,# # #,"1255266420033835008",https://twitter.com/OncLive/status/1255266420033835008
AACR,2020-04-28 18:42,24,35,"Please join us June 22-24 for # AACR20 Virtual Annual Meeting II. There will be thousands of proffered papers covering the spectrum of cancer research presented in minisymposia and in an e-poster platform. https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …",,,#,"1255266092513202178",https://twitter.com/AACR/status/1255266092513202178
AACR,2020-04-28 18:42,16,84,"That wraps up # AACR20 Virtual Annual Meeting I. Thank you to everyone for following along and tweeting with us. pic.twitter.com/9L1H0PhT4Y",,,#,"1255266090214719488",https://twitter.com/AACR/status/1255266090214719488
sidbhat1976,2020-04-28 18:39,1,3,"Week #7 Training completed. Join me for a virtual 10 miler/HM on May 2. # QuarantineLife # workingfromhome @ AACR @ AACRFoundation # AACR2020 pic.twitter.com/kP4oy7TDnD",,@ @,#7 # # #,"1255265393628905475",https://twitter.com/sidbhat1976/status/1255265393628905475
MaverickNY,2020-04-28 18:38,1,2,"Postcard #2 from # AACR20 with some commentary on new in cell therapies: https://pxlme.me/uWpWXcki Some interesting and different highlights today, which are not w/o controversy either!pic.twitter.com/z2eP6h42KF",,,#2 #,"1255265231347036166",https://twitter.com/MaverickNY/status/1255265231347036166
PortalOnconews,2020-04-28 18:38,0,0,"Apresentado no # AACR20, o estudo fase II SWOG S1320 mostrou que a administração contínua das terapias-alvo dabrafenibe e trametinibe teve impacto na SLP de pts com melanoma irressecável com mutação BRAF V600E/K - https://tinyurl.com/ydxak3uh @ AACR # ONCONEWS # MELANOMA # ONCONEWSnoAACR20pic.twitter.com/qtgTfWwrds",,@,# # # #,"1255265075549569024",https://twitter.com/PortalOnconews/status/1255265075549569024
Martin_AngelMD,2020-04-28 18:37,3,13,"# Metabolism (Oncometabolites) and # DDR as targets to treat # cancer . # AACR20 # OncoAlertpic.twitter.com/58jvSF5Skd",,,# # # # #,"1255264814659784705",https://twitter.com/Martin_AngelMD/status/1255264814659784705
thecancergeek,2020-04-28 18:34,1,3,"We just saw the data today at the # AACR20 virtual meeting showing = safety and efficacy of this different dosing for Pembro, and now its approved! Very timely given desire to decrease exposure to clinic/infusion centers during # COVID19.https://twitter.com/FDAOncology/status/1255255876337840133 …",,,# #,"1255264211556618241",https://twitter.com/thecancergeek/status/1255264211556618241
diegoah66,2020-04-28 18:34,0,3,"Another indication of poor outcomes in hematologic malignancies, as was also published today in @ CD_AACRhttps://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,@,,"1255264072326680576",https://twitter.com/diegoah66/status/1255264072326680576
GailThornt,2020-04-28 18:31,1,1,"# AACR2020 https://twitter.com/StephenJWillia2/status/1255262482496663554 …",,,#,"1255263421345550336",https://twitter.com/GailThornt/status/1255263421345550336
SilasInman,2020-04-28 18:31,1,2,"TIL Therapy Elicits Encouraging Activity in Advanced NSCLC https://www.onclive.com/conference-coverage/aacr-2020/til-therapy-elicits-encouraging-activity-in-advanced-nsclc … # AACR20 # LCSM",,,# #,"1255263360322613248",https://twitter.com/SilasInman/status/1255263360322613248
MDAndersonNews,2020-04-28 18:31,9,18,"“These data strongly support the importance of clinical testing for NTRK gene fusions in order to identify those patients most likely to benefit from larotrectinib,” says @ DavidHongMD. Learn more about his study presented today at # AACR20. https://bit.ly/2ybwnXw # endcancer",,@,# #,"1255263279628333061",https://twitter.com/MDAndersonNews/status/1255263279628333061
StephenJWillia2,2020-04-28 18:27,2,2,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 28, 2020 Session on Evaluating # Cancer # Genomics from Normal Tissues Through Metastatic Disease 3:50 PM https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-evaluating-cancer-genomics-from-normal-tissues-through-metastatic-disease-350-pm/ … via @ Pharma_BI # endcancer @ sloan_kettering @ MDAndersonNews @ NCIGenomics",,@ @ @ @ @,# # # #,"1255262482496663554",https://twitter.com/StephenJWillia2/status/1255262482496663554
d2merino,2020-04-28 18:26,0,1,"Thank you, @ aztezcan!",,@,,"1255262171807744001",https://twitter.com/d2merino/status/1255262171807744001
ElizSMcKenna,2020-04-28 18:26,0,0,"HI MARC!!!!",,,,"1255262033152540675",https://twitter.com/ElizSMcKenna/status/1255262033152540675
didemdioken,2020-04-28 18:23,0,1,"The first @ AACR Annual Meeting and the first midnight conference I attended(time-zone differences). All the presentations I attended were awesome! This meeting was one of the best sides of the isolation. Thank you to everyone involved in the organisation # AACR20 pic.twitter.com/VpseLN5Lse",,@,#,"1255261437225730050",https://twitter.com/didemdioken/status/1255261437225730050
IBCResearch,2020-04-28 18:23,1,0,"# AACR2020 "ESR1 mutations predict survival, endocrine therapy failure in early breast cancer" # BCSMhttps://www.healio.com/hematology-oncology/breast-cancer/news/online/%7B3e77cc9b-bc57-485e-ba60-37352c9017fb%7D/esr1-mutations-predict-survival-endocrine-therapy-failure-in-early-breast-cancer?utm_medium=social&utm_source=twitter&utm_campaign=sociallinks …",,,# #,"1255261342463864832",https://twitter.com/IBCResearch/status/1255261342463864832
YMAbdelhalim,2020-04-28 18:19,0,0,"Incredible!!!",,,,"1255260493264097283",https://twitter.com/YMAbdelhalim/status/1255260493264097283
IBCResearch,2020-04-28 18:18,1,4,"# AACR2020 "Novel immuno-oncology combination demonstrates activity in metastatic triple-negative breast cancer" # BCSMhttps://www.healio.com/hematology-oncology/breast-cancer/news/online/%7Bf27d97f1-33cc-471c-b899-0ae72ad68d03%7D/novel-immuno-oncology-combination-demonstrates-activity-in-metastatic-triple-negative-breast-cancer?utm_medium=social&utm_source=twitter&utm_campaign=sociallinks …",,,# #,"1255260093857366021",https://twitter.com/IBCResearch/status/1255260093857366021
challdreams,2020-04-28 18:13,1,1,"I can highly recommend to sign up for aacr virtual conference # AACR2020 the session this morning Covid-19 and cancer was excellent with a lot of clinical data from around the globe, even some pediatric cases and metrics. Starting tmw the presentations are free on-demand",,,#,"1255258851420618753",https://twitter.com/challdreams/status/1255258851420618753
OncoAlert,2020-04-28 18:10,10,32,"Dear Colleagues, Thank you for a great couple of days of science, all of us at @ OncoAlert are very grateful for your support & for helping in keeping colleagues worldwide # OncoAlert!! Thank you # AACR20 & look forward to Part . Ps. Numbers don't lie, this was a success! Kudos! pic.twitter.com/F4edm9zrVC",,@,# #,"1255258023402131457",https://twitter.com/OncoAlert/status/1255258023402131457
StephenJWillia2,2020-04-28 18:05,1,1,"Live Notes, Real Time Conference Coverage 2020 @ AACR # AACR20 Virtual Meeting April 28, 2020 Session on # COVID19 and # Cancer 9:00 AM https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-covid-19-and-cancer-900-am/ … via @ Pharma_BI @ pharmanews @ CureCancerNow @ BiotechWorld @ CNN",,@ @ @ @ @ @,# # #,"1255256959768571904",https://twitter.com/StephenJWillia2/status/1255256959768571904
aztezcan,2020-04-28 18:05,0,1,"It was a great presentation Diana! Amazing work.",,,,"1255256862406082560",https://twitter.com/aztezcan/status/1255256862406082560
Carefree411,2020-04-28 18:05,0,2,"It’s a wrap! Awesome 2 days of sessions. Thank you for the tweets-especially from our patients and SSP advocates. See you in June! # AACR20",,,#,"1255256737617231872",https://twitter.com/Carefree411/status/1255256737617231872
Tony_Calles,2020-04-28 18:03,0,2,"Amazing! Congratulations for this great move to make science accessible to everyone in very difficult moments. # AACR20",,,#,"1255256371521630209",https://twitter.com/Tony_Calles/status/1255256371521630209
DrXinliLiu,2020-04-28 18:00,0,4,"Dr. Singer of @ theNCI at # AACR2020: new flexibilities for the cancer research committee during # Covid_19 including extended grant deadline and flexibility on extension. https://twitter.com/AACR/status/1255245482928017408 …pic.twitter.com/OkJpBaGRjQ",,@,# #,"1255255540864888833",https://twitter.com/DrXinliLiu/status/1255255540864888833
LizCancerHealth,2020-04-28 17:58,4,4,"Antoni Ribas ( @ UCLAJCCC) & @ AACRPres Elaine Mardis wrap up # AACR20 virtual meeting Part 1. ~60,000 "attendees"! Part 2 coming up June 22-24 pic.twitter.com/zDjJsIDW26",,@ @,#,"1255255145350397952",https://twitter.com/LizCancerHealth/status/1255255145350397952
udafuzan,2020-04-28 17:55,0,0,"Interesting. We hope Myriad will reduce testing cost in the future, since PARPi played a big role in management TNBC pts.",,,,"1255254325007441938",https://twitter.com/udafuzan/status/1255254325007441938
OncoAlert,2020-04-28 17:54,10,25,"As a phenomenal 1st part of # AACR20 wraps up, WE at @ OncoAlert Congratulate & thank @ AACR for putting together a phenomenal meeting, you are all pioneers and the Oncology community will build from here. Thanks to all of our colleagues for the support, stay safe & stay strong pic.twitter.com/T8Cg4ptdzN",,@ @,#,"1255254143675088914",https://twitter.com/OncoAlert/status/1255254143675088914
pashtoonkasi,2020-04-28 17:53,4,14,"# AACR20 more on PARP # BRCA # DNA-Repair https://twitter.com/weoncologists/status/1255247963946921985 …",,,# # #,"1255253762903547905",https://twitter.com/pashtoonkasi/status/1255253762903547905
manjuggm,2020-04-28 17:53,0,1,"Yes, with multiple windows open, not knowing who is is a bit problematic, esp if you switch channels often. You can find out if you open another window and scroll down....",,,,"1255253762714861569",https://twitter.com/manjuggm/status/1255253762714861569
DrXinliLiu,2020-04-28 17:52,0,0,"2nd day # AACR2020 virtual conference. Wonderful update of @ theNCI Deputy Director Dr. Dinah Singer on NCI's effort to combat # COVID19. Cancer researchers are still working, NCI is open for business! https://twitter.com/NCIDirector/status/1255125631295090688 …pic.twitter.com/LZDCEdGSl9",,@,# #,"1255253634390032386",https://twitter.com/DrXinliLiu/status/1255253634390032386
StephenJWillia2,2020-04-28 17:49,1,2,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 28, 2020 Session on @ theNCI Activities: # COVID19 and # Cancer # Research 5:20 PM @ theNCI @ NIH are relaxing grant rules IMPORTANT INFO for researchers! https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-nci-activities-covid-19-and-cancer-research-520-pm/ … via @ Pharma_BI # endcancer",,@ @ @ @ @,# # # # #,"1255252831797477382",https://twitter.com/StephenJWillia2/status/1255252831797477382
ajf324MD,2020-04-28 17:46,1,2,"High yield data today at # AACR20 coming from my mentors and colleagues here at @ MoffittNews # LCSMhttps://twitter.com/Jbauml/status/1255232330127507458 …",,@,# #,"1255252195534163973",https://twitter.com/ajf324MD/status/1255252195534163973
LizCancerHealth,2020-04-28 17:44,4,5,"Dinah Singer discusses @ theNCI response to # COVID19. # AACR20 # coronaviruspic.twitter.com/wTLlwJNPfJ",,@,# # #,"1255251508817530881",https://twitter.com/LizCancerHealth/status/1255251508817530881
d2merino,2020-04-28 17:43,3,6,"The @ CancerResrch # TMB Harmonization Project aims to align across panel TMB values estimated with different commercial tests to ensure consistency across TMB values... this effort is key to help identify patients who are more likely to benefit from # immunotherapies # AACR20 https://twitter.com/MasonIsraelPhD/status/1255250225956040708 …",,@,# # #,"1255251419218808833",https://twitter.com/d2merino/status/1255251419218808833
LizCancerHealth,2020-04-28 17:43,5,6,"Dinah Singer discusses @ theNCI response to # COVID19. # AACR20 # coronaviruspic.twitter.com/RD7Osgnm9D",,@,# # #,"1255251268555210757",https://twitter.com/LizCancerHealth/status/1255251268555210757
MartinStockler,2020-04-28 17:41,0,3,"# AACR20 Program and Abstracts available from @ AACR at https://www.abstractsonline.com/pp8/#!/9045 https://twitter.com/AACR/status/1255248134353096711 …",,@,# #,"1255250771672805378",https://twitter.com/MartinStockler/status/1255250771672805378
HemOncToday,2020-04-28 17:41,2,1,"Blood test shows promise for predicting cancer, tissue of origin ahead of histologic diagnosis http://bit.ly/2Sflefp # AACR20 # cancerscreening @ GrailBiopic.twitter.com/T7uTitGkoB",,@,# #,"1255250762646552577",https://twitter.com/HemOncToday/status/1255250762646552577
Jbauml,2020-04-28 17:41,6,93,"I am not sure what to make of the multiple presentations at # AACR20 that ask for slides to not be posted. I am looking out for it and not posting images of the slides, but its a bit odd in the setting of a meeting that is completely online with free universal access.",,,#,"1255250733605236737",https://twitter.com/Jbauml/status/1255250733605236737
AVIVA1950,2020-04-28 17:39,0,0,"2020 # AACR # Virtual Meeting April 28, 2020 Session on # Evaluating # Cancer # Genomics from # Normal # Tissues Through # Metastatic # Disease 3:50 PM https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-evaluating-cancer-genomics-from-normal-tissues-through-metastatic-disease-350-pm/ … via @ Pharma_BI @ pharma_BI @ AACR @ CureCancerNow @ pharmanews @ BiotechWorld # AACR20 @ StephenJWillia2",,@ @ @ @ @ @ @,# # # # # # # # # #,"1255250331828727810",https://twitter.com/AVIVA1950/status/1255250331828727810
giusvisc,2020-04-28 17:39,1,6,"immunoncology meets precision medicine # AACR2020 @ Annals_Oncology https://www.annalsofoncology.org/article/S0923-7534(20)36078-6/pdf …pic.twitter.com/jWLIDR3hRd",,@,#,"1255250321246490625",https://twitter.com/giusvisc/status/1255250321246490625
MasonIsraelPhD,2020-04-28 17:39,1,1,"TMB is an # immunotherapy biomarker with tumor type agnostic potential. The use of # TMB has been hindered by the fact that commercial labs measure TMB differently. Pleased to see the hard work of the TMB harmonization project presented today at # AACR20 and published in # JITC.pic.twitter.com/w2AUTikbaM",,,# # # #,"1255250225956040708",https://twitter.com/MasonIsraelPhD/status/1255250225956040708
pratt_ed,2020-04-28 17:39,0,4,"Great introduction from Dr. Alberto Bardelli on the potential applications of # LiquidBiopsy. Researchers have really pushed the envelop on assay sensitivity & specificity, enabling longitudinal studies, MRD surveillance, etc that were not possible only a few years ago. # AACR20 pic.twitter.com/4neOZk9zRL",,,# #,"1255250205810835456",https://twitter.com/pratt_ed/status/1255250205810835456
biotechvisigoth,2020-04-28 17:37,0,3,"Study on Thrive’s blood test for early # cancer screening presented today at # AACR2020 # AACR20 https://twitter.com/medcitynews/status/1255206899953344513 …",,,# # #,"1255249864176349190",https://twitter.com/biotechvisigoth/status/1255249864176349190
LUNGevity,2020-04-28 17:36,1,2,"@ theNCI is making accommodations to ensure patients remain safe while participating in @ theNCI -sponsored clinical trials # AACR2020 # AACR20 # LCSMpic.twitter.com/OtN3Jwn3eC",,@ @,# # #,"1255249675852156929",https://twitter.com/LUNGevity/status/1255249675852156929
PritBenny,2020-04-28 17:36,0,3,"Happy to attend my first # AACR2020 virtual meeting. immense data from clinical and experimental front pic.twitter.com/Inr1h4oE5n",,,#,"1255249515713609729",https://twitter.com/PritBenny/status/1255249515713609729
LUNGevity,2020-04-28 17:32,2,9,"@ theNCI is supporting # COVID19-related research efforts. Program announcements in this tweet. Please contact your program officer. # AACR2020 # AACR20 # LCSMpic.twitter.com/1IKrsqoIJT",,@,# # # #,"1255248521692839936",https://twitter.com/LUNGevity/status/1255248521692839936
itsnot_pink,2020-04-28 17:32,5,16,"Here’s what would help patients: If in addition to a lengthy and detailed paper & http://clinicaltrials.gov entry, trialists had a clear 1-page infographic detailing which patients were enrolled, what each arm got & what the average results were. 1/2 # AACR2020 @ OncoAlerthttps://twitter.com/weoncologists/status/1255049047641075713 …",,@,#,"1255248463949897729",https://twitter.com/itsnot_pink/status/1255248463949897729
krknrm,2020-04-28 17:31,0,5,"Agree! Took me a bit to figure out the speaker when jumping from session to session! # AACR20 https://twitter.com/LizCancerHealth/status/1255247633276375041 …",,,#,"1255248386883825666",https://twitter.com/krknrm/status/1255248386883825666
AACR,2020-04-28 17:30,11,19,"The Opening Clinical Plenary Session of the # AACR20 Virtual Meeting I featured two studies that examined strategies to improve responses to BRAF and MEK inhibitors in patients with advanced melanoma. https://bit.ly/2KJN3rO",,,#,"1255248134353096711",https://twitter.com/AACR/status/1255248134353096711
OncoAlert,2020-04-28 17:30,9,24,"Our @ OncoAlert Colleague @ CharuAggarwalMD from @ PennCancer Virtually Live at # AACR20 discussing globalpresentations dealing # COVID19 and # Cancer : # TERAVOLT from @ marinagarassino & The French experience by @ barlesi from @ GustaveRoussy Edited: @ weoncologistspic.twitter.com/yJXXuVGIJV",,@ @ @ @ @ @ @,# # # #,"1255248119417245697",https://twitter.com/OncoAlert/status/1255248119417245697
weoncologists,2020-04-28 17:30,18,33,"Just Outat @ NEJM In metastatic castration-resistant # prostatecancer that had disease progression while on enzalutamide or abiraterone &had alterations in genesw/a role in homologous recombination repair, olaparib was associated w/longer PFS # AACR20 https://www.nejm.org/doi/full/10.1056/NEJMoa1911440?query=RP#.Xqib1upBAuU.twitter …pic.twitter.com/xSv9nSagiN",,@,# # #,"1255247963946921985",https://twitter.com/weoncologists/status/1255247963946921985
LizCancerHealth,2020-04-28 17:28,0,8,"Can't do this at an in-person meeting! Hint to @ AACR: please display current speaker & session in the video player # AACR20 pic.twitter.com/pGYaPHgyRs",,@,#,"1255247633276375041",https://twitter.com/LizCancerHealth/status/1255247633276375041
elfarukpath11,2020-04-28 17:28,0,8,"That was an excellent Presentation by a wonderful colleague, Dr Diana Merino Vega @ d2merino tittled "Allignment of TMB Measured on Clinical samples: Phase 2B of the Friends of Cancer Research TMB Harmonization Project, during the during the @ AACR # AACR20 Virtual Mtg I. # AACRAMCpic.twitter.com/bkPTp77a0q",,@ @,# #,"1255247573398536193",https://twitter.com/elfarukpath11/status/1255247573398536193
pratt_ed,2020-04-28 17:28,0,5,"One major benefit of virtual # AACR20 is that I never miss a session! After a busy morning, finally settling in to watch the 'Early Detection and ctDNA' session # LiquidBiopsy.",,,# #,"1255247442880204807",https://twitter.com/pratt_ed/status/1255247442880204807
demattosarruda,2020-04-28 17:27,3,14,"Patients with cancer appear more vulnerable to SARS-COV-2. Paper published @ CD_AACR # AACR20 # COVID19pic.twitter.com/D6m1xoJzQk",,@,# #,"1255247388937195525",https://twitter.com/demattosarruda/status/1255247388937195525
tmfiesta,2020-04-28 17:25,0,2,"# AACR2020 Today I learned that there are 4 distinct types of fibroblasts in the human breast, and that not all metastatic cells are created equal! (and much more)",,,#,"1255246679525281794",https://twitter.com/tmfiesta/status/1255246679525281794
CancerResrch,2020-04-28 17:22,0,5,"Thank you to all of our wonderful TMB Harmonization Project partners! Without you this project would not be the success it is today. # tmb # AACR2020 https://bit.ly/3bs7mWK pic.twitter.com/jneKWGCKEX",,,# #,"1255246148786442241",https://twitter.com/CancerResrch/status/1255246148786442241
Dr_ZiMingZhao,2020-04-28 17:22,1,3,"Due to the importance of TMB in patients' stratification in immunotherapy, this harmonization and standardization of TMB between WES and panel sequencing is definitely valuable to the field. # AACR20 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174078/ … https://twitter.com/CancerResrch/status/1255241643768328197 …pic.twitter.com/HngrHVrnaL",,,#,"1255245996025675779",https://twitter.com/Dr_ZiMingZhao/status/1255245996025675779
cityofhope,2020-04-28 17:22,2,4,"Our # AACR20 poster presentations are available on-demand. View research presentations by Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, and medical oncologist Mihaela Cristea, M.D. Dr. Fong: https://bddy.me/2yQMx8Y Dr. Cristea: https://bddy.me/3bMZX4o pic.twitter.com/VqLdJWiDx7",,,#,"1255245925917896705",https://twitter.com/cityofhope/status/1255245925917896705
CancerResrch,2020-04-28 17:22,0,2,"To learn more about what we evaluated in Phase 1 of the TMB Harmonization Project, visit: https://jitc.bmj.com/content/8/1/e000147.full … # AACR20",,,#,"1255245917801897985",https://twitter.com/CancerResrch/status/1255245917801897985
AACR,2020-04-28 17:20,6,16,"The NCI Activities: COVID-19 and Cancer Research session is starting now. # AACR20 Virtual Annual Meeting I.",,,#,"1255245482928017408",https://twitter.com/AACR/status/1255245482928017408
lfspurr,2020-04-28 17:20,1,11,"Huge thanks to @ AACR for the opportunity to present our work on genomic correlates of PD-L1 expression today at # AACR20 and to fellow authors @ GLambertiMD @ BiagioMd @ GRecondoMD @ meyersonlab @ DrMarkAwad as well as non-twitter folks for tremendous support and mentorship. 1/3",,@ @ @ @ @ @,#,"1255245436836872194",https://twitter.com/lfspurr/status/1255245436836872194
JFreemanDaily,2020-04-28 17:16,0,0,"Thanks Liz!",,,,"1255244534050668544",https://twitter.com/JFreemanDaily/status/1255244534050668544
LizCancerHealth,2020-04-28 17:14,0,0,"Looks like an updated schedule now shows it at 5:20.pic.twitter.com/MCe7oJ0c8L",,,,"1255244119280099335",https://twitter.com/LizCancerHealth/status/1255244119280099335
wendyr13,2020-04-28 17:13,0,1,"5:20 I believe",,,,"1255243658040881159",https://twitter.com/wendyr13/status/1255243658040881159
russo_cristina,2020-04-28 17:12,0,0,"Same for me. If there's a plan for a delayed start can you please let us know @ AACR? https://twitter.com/JFreemanDaily/status/1255242861999804416 …",,@,,"1255243559336321030",https://twitter.com/russo_cristina/status/1255243559336321030
Leglesszebra,2020-04-28 17:10,0,0,"Excellent!",,,,"1255243019990827008",https://twitter.com/Leglesszebra/status/1255243019990827008
demattosarruda,2020-04-28 17:10,5,17,"At # AACR202 now: Cell free DNA screening tests for early detection of cancer. Specificity should be really high ; methylation studies can discriminate cancer from non cancer # AACR2020 # liquidbiopsy Promissing pic.twitter.com/lAlI3HFlEj",,,# # #,"1255242949190918145",https://twitter.com/demattosarruda/status/1255242949190918145
JFreemanDaily,2020-04-28 17:09,0,3,"Hey @ AACR, is the 5 pm Eastern time # AACR20 session on "NCI Activities: COVID-19 and Cancer Research" going to happen? Only hearing music and seeing AACR advert slides.",,@,#,"1255242861999804416",https://twitter.com/JFreemanDaily/status/1255242861999804416
medwireNews,2020-04-28 17:08,2,3,"No need to forego the end of conference tradition just because the conference isn't traditional Our # AACR2O coverage on @ MM_Oncology continues though so don't forget to check out the site http://bit.ly/2zyNNu3 @ AACR # AACR2020 pic.twitter.com/sCkvGcYQ1A",,@ @,# #,"1255242448521003014",https://twitter.com/medwireNews/status/1255242448521003014
RandiMHernandez,2020-04-28 17:07,1,1,"“The adjusted survival curve of severe events showed that cancer patients who had anticancer treatment in the past 14 days or patchy consolidation at admission were significantly associated with severe events,” Dr Zhang said. # AACR20 https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/covid19-coronavirus-cancer-associated-with-poor-patient-outcomes/ …",,,#,"1255242238814302208",https://twitter.com/RandiMHernandez/status/1255242238814302208
LizCancerHealth,2020-04-28 17:05,8,13,". @ DavidHongMD: site-agnostic Vivtrakvi (larotrectinib) works better for # cancers with NTRK gene fusions vs other mutations. # AACR20 pic.twitter.com/nvBLhcLfXg",,@,# #,"1255241702648012803",https://twitter.com/LizCancerHealth/status/1255241702648012803
CancerResrch,2020-04-28 17:05,3,5,"As complex biomarkers, such as TMB, become more readily incorporated into # oncology care, scientific and regulatory approaches are necessary for alignment on optimal performance thresholds and standards development. # AACR20 https://bit.ly/3bs7mWK pic.twitter.com/Uy6V5vCNbU",,,# #,"1255241643768328197",https://twitter.com/CancerResrch/status/1255241643768328197
CancerResrch,2020-04-28 17:05,0,5,"We evaluated 3 different calibration approaches and evaluated the extent to which these helped align panel TMB values in clinical samples. We found in most of the cases, the 2 TCGA calibration methods helped tighten the spread of panel TMB values # AACR20",,,#,"1255241642573017089",https://twitter.com/CancerResrch/status/1255241642573017089
Pharma_BI,2020-04-28 17:03,0,0,"@ AACR @ CureCancerNow @ pharmanews @ BiotechWorld # AACR20 @ StephenJWillia2 # Cancer: Novel # Targets and # Therapies - Outstanding Real time coverage by Dr. Williamshttps://lnkd.in/e5ijpuJ",,@ @ @ @ @,# # # #,"1255241158403424257",https://twitter.com/Pharma_BI/status/1255241158403424257
shilpaonc,2020-04-28 17:01,0,2,"Thanks @ OncoAlert for featuring our study. Glad to have been a part of this novel # Immunotherapy trial @ robertmeehanMD # AACR2020",,@ @,# #,"1255240823693873153",https://twitter.com/shilpaonc/status/1255240823693873153
CancerResrch,2020-04-28 17:00,1,3,"Phase 1 of the TMB Harmonization Project consisted of an in silico approach that used publicly available WES data from the TCGA project. 11 labs participated and a strong correlation between WES TMB and the panel TMB values was found. # AACR20 https://bit.ly/3bs7mWK pic.twitter.com/paEHUkD2Nf",,,#,"1255240602461130753",https://twitter.com/CancerResrch/status/1255240602461130753
CancerResrch,2020-04-28 17:00,0,1,"The goals of Phase 2 of the TMB Harmonization Project include the creation of a universal reference standard to help calibrate or align TMB scores obtained from different NGS panels and better understand the sources of variability across panels. # AACR20",,,#,"1255240601026605057",https://twitter.com/CancerResrch/status/1255240601026605057
CancerResrch,2020-04-28 17:00,1,2,". @ d2merino on our TMB Harmonization Project: The primary objective is to align-on & publish universal best practices for defining TMB, as well as proposing and executing analytic validation approaches including the alignment against external reference standards. # AACR20",,@,#,"1255240600938524672",https://twitter.com/CancerResrch/status/1255240600938524672
CancerResrch,2020-04-28 17:00,0,1,"For Phase 2B of our TMB Harmonization Project, our primary analysis objective was to assess the empirical variability in the association between the panel TMB values & WES TMB in the clinical samples. # AACR20",,,#,"1255240574388572160",https://twitter.com/CancerResrch/status/1255240574388572160
CancerResrch,2020-04-28 17:00,0,1,"Our secondary analysis objective was to use the clinical data to further investigate 3 calibration approaches that may help align TMB values across NGS panels. # AACR20",,,#,"1255240574195634176",https://twitter.com/CancerResrch/status/1255240574195634176
AVIVA1950,2020-04-28 17:00,0,0,"Live Notes, Real Time Conference Coverage 2020 # AACR # Virtual Meeting April 28, 2020 Session on # Novel # Targets and # Therapies 2:35 PM https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-novel-targets-and-therapies-235-pm/ … via @ Pharma_BI @ AACR @ CureCancerNow @ pharmanews @ BiotechWorld # AACR20 @ StephenJWillia2",,@ @ @ @ @ @,# # # # # #,"1255240451680018432",https://twitter.com/AVIVA1950/status/1255240451680018432
OncologyCentral,2020-04-28 17:00,1,0,"Are # COVID19 patients with thoracic # cancer less likely to be admitted to # ICU? Read more in the latest news from # AACR20",,,# # # #,"1255240371669475337",https://twitter.com/OncologyCentral/status/1255240371669475337
iCharmaine,2020-04-28 16:59,0,2,"# PicturesPlease # SendingAllGoodThings",,,# #,"1255240275770970114",https://twitter.com/iCharmaine/status/1255240275770970114
CancerResrch,2020-04-28 16:55,3,3,"Starting NOW: Phase 2 results from our TMB Harmonization Project is being presented @ AACR's Virtual Annual Meeting. Be sure to follow the conversation w/ # AACR20 and learn more about our project here: https://bit.ly/3bs7mWK",,@,#,"1255239137411698693",https://twitter.com/CancerResrch/status/1255239137411698693
CancerResrch,2020-04-28 16:55,8,12,"Evidence that supports TMB as a predictive biomarker is mounting, where studies in TMB-high tumors, such as melanoma or lung, reveal that elevated TMB have been associated with clinical benefit from # cancer immunotherapies. # AACR20 @ d2merino https://bit.ly/3bs7mWK pic.twitter.com/pOfIKVU8s3",,@,# #,"1255239135838769155",https://twitter.com/CancerResrch/status/1255239135838769155
CancerResrch,2020-04-28 16:55,0,2,"The current gold standard for measuring TMB is WES, but targeted gene panels have shown to also estimate TMB. It's imperative that panel TMB values are reliable & consistent to help predict patients who would benefit from immune checkpoint inhibitors. # AACR20",,,#,"1255239129866162177",https://twitter.com/CancerResrch/status/1255239129866162177
OncoAlert,2020-04-28 16:54,9,18,"Our Colleague @ shilpaonc live from # AACR20 discussing her work on this first in human study of mRNA2416 given intratumorrally alone and in combination with durvalumab in patients with advanced cancers Edited: @ weoncologistspic.twitter.com/2rxks3qi8a",,@ @,#,"1255238958461698050",https://twitter.com/OncoAlert/status/1255238958461698050
LUNGevity,2020-04-28 16:50,5,10,"Great discussion by Dr. Patricia LoRusso @ YaleMed on the NTRK treatment landscape -1st and subsequent line treatment options for NTRK-fusion positive cancers. # AACR2020 # AACR20 # LCSMpic.twitter.com/JI9EBc1qht",,@,# # #,"1255237869356101632",https://twitter.com/LUNGevity/status/1255237869356101632
iselkholi,2020-04-28 16:49,0,0,"An important point raised in the early detection session today at the # AACR20 while going for ctDNA/methylation assays, we should be careful if the healthy individuals harbour a rare undetected tumor or a mutation of risk for the future!",,,#,"1255237669766025218",https://twitter.com/iselkholi/status/1255237669766025218
NatureMedicine,2020-04-28 16:48,12,28,"New study by Crystal Mackall and colls shows intracerebroventricular- or intratumoral-administered # CARTcells exhibit greater therapeutic potency as compared to intravenous delivery, in atypical teratoid/rhabdoid tumor mouse models https://www.nature.com/articles/s41591-020-0821-8 … # ChildhoodCancer # AACR20 pic.twitter.com/WJWe6evIqB",,,# # #,"1255237549896994816",https://twitter.com/NatureMedicine/status/1255237549896994816
RobertoFerrara_,2020-04-28 16:47,5,13,"Genome and immunology as a married couple. Association between genomic alterations and PD-L1 expression # AACR2020 pic.twitter.com/VKlfwIknep",,,#,"1255237159520473089",https://twitter.com/RobertoFerrara_/status/1255237159520473089
SimonAprilMonn,2020-04-28 16:46,3,10,"Great chairing from Dr Fertig @ FertigLab & Dr Turajlic @ SamraTurajlic at "Evaluating Cancer Genomics from Normal Tissues through Evolution to Metastatic Disease" # AACR20 Virtual # science MinisympThanks @ AACR for all efforts making this possible in challenging times! # StaySafe",,@ @ @,# # #,"1255236916246691840",https://twitter.com/SimonAprilMonn/status/1255236916246691840
kRasKickers,2020-04-28 16:45,1,3,"# preventionsaveslives of # Cancer patients. @ AACR # COVID19 # LCSMpic.twitter.com/f0maVNZ3Fv",,@,# # # #,"1255236704056881154",https://twitter.com/kRasKickers/status/1255236704056881154
NateraOncology,2020-04-28 16:44,0,3,"Great to see new data presented at the # AACR20 Early Detection and # ctDNA session supporting the use of clonal variants to detect and monitor # MRD and disease recurrence in lung cancer.",,,# # #,"1255236499802652673",https://twitter.com/NateraOncology/status/1255236499802652673
AriellaHanker,2020-04-28 16:43,0,4,"Presented by @ DavidHongMD: Pts with # NTRK-mutant or amplified tumors do not respond to # larotrectinib. Are these activating mutations? If so, are they weaker than NTRK fusions? Do they affect drug binding? # AACR20 pic.twitter.com/8SluwIlhRy",,@,# # #,"1255236284202864640",https://twitter.com/AriellaHanker/status/1255236284202864640
Jbauml,2020-04-28 16:38,0,3,"They did repeated blood draws among patients receiving IO to classify those as patients that go on to have durable clinical benefit vs those that did not. They found that high baseline ctDNA and lower percentage of CD8 T cells was associated with better survival # LCSM # AACR20",,,# #,"1255235049491968000",https://twitter.com/Jbauml/status/1255235049491968000
emilysmithmeded,2020-04-28 16:38,0,0,"And that's a wrap! Day 2 of # AACR20 done Thanks for following along! # mmsm # lymsm # leusm",,,# # # #,"1255235035243954178",https://twitter.com/emilysmithmeded/status/1255235035243954178
DrYukselUrun,2020-04-28 16:37,4,12,"Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the # COVID19 outbreak! Patients with hematological, lung, or with metastatic cancer had the highest frequency of severe event! @ CD_AACR # AACR20 @ OncoAlert @ DrChoueiri https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …pic.twitter.com/0IVZ4CE9ye",,@ @ @,# #,"1255234604635754496",https://twitter.com/DrYukselUrun/status/1255234604635754496
KristiGravesVA,2020-04-28 16:36,0,2,"Thanks @ tmprowell for highlighting talk by Dr. Voight at # AACR20 on widening disparities in cancer caused by # COVID19. @ GUSurvivorshiphttps://twitter.com/tmprowell/status/1255144970865963012 …",,@ @,# #,"1255234530442719233",https://twitter.com/KristiGravesVA/status/1255234530442719233
Jbauml,2020-04-28 16:36,3,16,"Exciting data presented by @ Barzin_ at # AACR20 on the use of a novel ctDNA assay to predict outcomes for immunotherapy in NSCLC. CAPP-Seq is more sensitive than many commercially available assays. They coupled this with a bulkRNA sequencing called CIBERSORT # LCSM",,@,# #,"1255234468480192516",https://twitter.com/Jbauml/status/1255234468480192516
AML_Hub,2020-04-28 16:33,10,12,"CONGRESS | # AACR20 | Kelly L Bolton, @ sloan_kettering, discusses how oncologic therapy shapes the fitness landscape of clonal hematopoiesis (CH) in solid tumors. If clinically validated, CH may guide risk stratification of transformed myeloid neoplasms like AML & MDS # leusmpic.twitter.com/Nk5HfcJF9R",,@,# #,"1255233695889403904",https://twitter.com/AML_Hub/status/1255233695889403904
RobertoFerrara_,2020-04-28 16:32,14,20,"Beyond CD8 and PD-L1: B-cells and follicular CD4+ T-cells play a role in the response to ICI # AACR2020 # OncoAlertpic.twitter.com/cGPwJfa2FB",,,# #,"1255233367550943235",https://twitter.com/RobertoFerrara_/status/1255233367550943235
TEMT_ICR,2020-04-28 16:32,2,21,"Attending @ AACR’s Virtual Annual Meeting (part 1), one of the biggest cancer conferences of the year, in my PJs. Don’t think I’ll get another opportunity! # ICRatHome goes # International pic.twitter.com/Iw4ItKEC95",,@,# #,"1255233337444241408",https://twitter.com/TEMT_ICR/status/1255233337444241408
gerlach_d,2020-04-28 16:31,12,28,"Larotrectinib shows 95% ORR in patients harboring NTRK1/2/3 gene fusions - would like to see such amazing waterfall plots for other targeted therapies. # AACR20 pic.twitter.com/ufkGDvddCM",,,#,"1255233255604977664",https://twitter.com/gerlach_d/status/1255233255604977664
Annals_Oncology,2020-04-28 16:30,38,68,"# AACR20 @ lfspurr from @ DanaFarber and @ broadinstitute presents on the genomic correlates of PD-L1 expression and response to immunotherapy in NSCLC. You can learn more in this manuscript published in Annals of Oncology: https://www.annalsofoncology.org/article/S0923-7534(20)36078-6/pdf … # LCSM @ GLambertiMD @ meyersonlabpic.twitter.com/xahzpzw5EU",,@ @ @ @ @,# #,"1255232973840007170",https://twitter.com/Annals_Oncology/status/1255232973840007170
OncLive,2020-04-28 16:30,2,5,"Bispecific CD19/CD22 CAR T Cells Active in Pediatric Relapsed ALL @ NCIResearchCtr @ AACR # AACR20 # leusmhttp://ow.ly/JqIZ50zr8mY",,@ @,# #,"1255232890612449283",https://twitter.com/OncLive/status/1255232890612449283
CD_AACR,2020-04-28 16:30,0,1,"# NewsInBrief: COM701 Shows Antitumor Activity, +/− Nivolumab. https://bit.ly/3f43VYy # AACR20 pic.twitter.com/hI2aoEIeU2",,,# #,"1255232842281467911",https://twitter.com/CD_AACR/status/1255232842281467911
TaylorJ_MD,2020-04-28 16:28,2,17,"Nicely presented data from @ sloan_kettering by Dr. Kelly Bolton | Gene-specific effects of therapy on promoting pre-existing # CHIPsm in patients undergoing cancer therapy. Time to start thinking about prevention? # AACR20 # leusmhttps://twitter.com/sloan_kettering/status/1255217743185563652 …",,@,# # #,"1255232535090663437",https://twitter.com/TaylorJ_MD/status/1255232535090663437
Jbauml,2020-04-28 16:28,4,8,"Some patients did have further response after TIL infusion. They also noted some responses after radiographic PD on nivolumab. Dr Creelan also presented a rather dramatic case, indicated here # AACR20 # LCSMpic.twitter.com/IOCcr89vSS",,,# #,"1255232330127507458",https://twitter.com/Jbauml/status/1255232330127507458
Jbauml,2020-04-28 16:25,3,9,"Here is the data on patients enrolled on trial. Interesting to note the high incidence of molecular alterations. This exciting trial was supported by @ SU2C # AACR20 # LCSMpic.twitter.com/ZSWHknI66l",,@,# #,"1255231757089230851",https://twitter.com/Jbauml/status/1255231757089230851
Jbauml,2020-04-28 16:24,17,36,"At # AACR20 Dr Creelan presented data on adoptive TIL therapy for NSCLC. This is a very interesting approach - surgery of a metastatic lesion, ex vivo TIL expansion, nivolumab, lymphodepletion and TIL reinfusion with further nivolumab # LCSMpic.twitter.com/ECHtoEoJTG",,,# #,"1255231400254595074",https://twitter.com/Jbauml/status/1255231400254595074
aabisawyer,2020-04-28 16:21,0,1,"Can't wait to hear the outcomes in our coffee chat tomorrow!",,,,"1255230754138796032",https://twitter.com/aabisawyer/status/1255230754138796032
BentheFidler,2020-04-28 16:21,4,10,"ICYMI earlier, a look at # liquidbiopsy data at # AACR20: Thrive, chasing Grail with a # cancer blood test, finds tumors in seemingly healthy womenhttps://www.biopharmadive.com/news/thrive-grail-liquid-biopsy-detect-cancer-aacr/576901/ …",,,# # #,"1255230606256078849",https://twitter.com/BentheFidler/status/1255230606256078849
gerlach_d,2020-04-28 16:20,0,0,"David Hong on "Efficacy and safety of larotrectinib in patients with cancer and NTRK gene fusions or other alterations" # AACR20",,,#,"1255230384838762497",https://twitter.com/gerlach_d/status/1255230384838762497
ethna7,2020-04-28 16:20,0,1,"",,,,"1255230303259504640",https://twitter.com/ethna7/status/1255230303259504640
AshleyAaroe,2020-04-28 16:18,0,8,"Dog does not like competing with # AACR20 webinar about P13K and PD1 inhibition. pic.twitter.com/3Y1k3WQTuk",,,#,"1255229943325298690",https://twitter.com/AshleyAaroe/status/1255229943325298690
gerlach_d,2020-04-28 16:18,0,0,"A lot of toxicity observed with MEK mono-therapy - James Cleary on Binimetinib # AACR20",,,#,"1255229877940359170",https://twitter.com/gerlach_d/status/1255229877940359170
evilarsan,2020-04-28 16:18,0,1,"I will also add that we had a nice age spread, although overall is a young(er) population compared to the sporadic setting.",,,,"1255229812345634819",https://twitter.com/evilarsan/status/1255229812345634819
evilarsan,2020-04-28 16:16,0,2,"Thanks for your interest! Working on getting the paper out right now, so everybody can look into it closer. The dose levels tested were low: 440 and 220. I can tell you that the safety profile was extremely good. No cardiac events.",,,,"1255229507256160258",https://twitter.com/evilarsan/status/1255229507256160258
LUNGevity,2020-04-28 16:16,5,6,"Durable Immunotherapy Response Estimation by immune profiling and ctDNA-On-treatment (DIRECT-On assay) is a simple blood test that can predict which pts respond to immunotherapy within first 6 months of starting immunotherapy @ Barzin_ @ Stanford @ max_diehn # AACR2020 # AACR20 # LCSMpic.twitter.com/9E8gRBzV8D",,@ @ @,# # #,"1255229444761030656",https://twitter.com/LUNGevity/status/1255229444761030656
pashtoonkasi,2020-04-28 16:14,0,1,"# AACR20 # ClinicalTrials https://twitter.com/CCR_AACR/status/1255225309235986437 …",,,# #,"1255229009274814476",https://twitter.com/pashtoonkasi/status/1255229009274814476
pashtoonkasi,2020-04-28 16:12,0,0,"# AACR20 # TwitterPollhttps://twitter.com/pashtoonkasi/status/1255139739671203840 …",,,# #,"1255228491517374478",https://twitter.com/pashtoonkasi/status/1255228491517374478
petitprez_f,2020-04-28 16:09,2,9,"Nice presentation by Dr Sridhar (AstraZeneca) showing that tertiary lymphoid structures (assessed by gene signatures expression) are associated with response to anti-PD-L1 durvalumab in # NSCLC and UC, extending our results from soft tissue sarcoma and melanoma. # AACR20 pic.twitter.com/ZWZ30ATRIF",,,# #,"1255227649795993604",https://twitter.com/petitprez_f/status/1255227649795993604
JacobPlieth,2020-04-28 16:09,1,6,"$ IOVA off 8%. Surely it’s time for the loonies to start accusing the # AACR20 discussant of being a filthy short seller.",,,#,"1255227571832307715",https://twitter.com/JacobPlieth/status/1255227571832307715
marc_drcell,2020-04-28 16:05,0,4,"I’m watching some excellent # AACR20 presentations and still catching the inspiration - thank you @ AACR for making it happen. https://twitter.com/ElizSMcKenna/status/1254743245726285824 …",,@,#,"1255226770367938562",https://twitter.com/marc_drcell/status/1255226770367938562
TristanFreefsg,2020-04-28 16:04,2,2,"The Evaluating Cancer Genomics from Normal Tissues through Evolution to Metastatic Disease session at the @ AACR Virtual Annual Meeting I has kicked off with a presentation on Single-cell atlas of the Human Breast",,@,,"1255226481560690692",https://twitter.com/TristanFreefsg/status/1255226481560690692
AnjaNitzscheB,2020-04-28 16:03,1,8,"Thread by @ ADesaiMD: Missed # COVID19nCancer plenary in # AACR20 @ AACR? Here’s a thread to catch up on all the fascinating global research presy: @ AACR @ AACRPres # AntoniRibas # LiZhang @ marinagarassino @ barlesi # CarlosGomez # LouisVoigt # HongbingCai cc: @ Onco…https://threadreaderapp.com/thread/1255154902504026113.html …",,@ @ @ @ @ @ @,# # # # # # #,"1255226136373714947",https://twitter.com/AnjaNitzscheB/status/1255226136373714947
SU2Cscience,2020-04-28 16:03,8,13,"Predictive Biomarkers offer a noninvasive approach for prediction of therapeutic benefit from immune checkpoint inhibition in # lungcancer, per # AACR20 presentation by @ max_diehn @ AshAlizadeh on @ SU2C @ LUNGevity @ LungAssociation # LungCancer Dream Teamhttps://standuptocancer.org/research/research-portfolio/dream-teams/lung-cancer-interception-intime-dream-team/ …",,@ @ @ @ @,# # #,"1255226050256175108",https://twitter.com/SU2Cscience/status/1255226050256175108
pashtoonkasi,2020-04-28 16:01,0,0,"More on # ctDNA # AACR20 https://twitter.com/MedTechDive/status/1255224479359348736 …",,,# #,"1255225638081961992",https://twitter.com/pashtoonkasi/status/1255225638081961992
jillfeldman4,2020-04-28 16:01,6,10,"Predictive biomarker for # immunotherapy in # NSCLC # LCSM # AACR20 https://twitter.com/LUNGevity/status/1255224870734045184 …",,,# # # #,"1255225547619291137",https://twitter.com/jillfeldman4/status/1255225547619291137
CD_AACR,2020-04-28 16:00,0,1,"# NewsInBrief: Triple Therapy Better for Advanced Melanoma. https://bit.ly/3cWTvI4 # AACR20 pic.twitter.com/EI1HmRu1Tc",,,# #,"1255225309319892993",https://twitter.com/CD_AACR/status/1255225309319892993
CCR_AACR,2020-04-28 16:00,1,3,"Read the Clinical Trials collection - newly released for the # AACR20 Virtual Annual Meeting I! https://bit.ly/2W6nBCd pic.twitter.com/UEmZK1wAGW",,,#,"1255225309235986437",https://twitter.com/CCR_AACR/status/1255225309235986437
OncologyCentral,2020-04-28 16:00,1,1,"Find out what the Editors of @ OncologyCentral, @ MyBioTechniques and @ NanomedZone thought of day 1 # AACR20",,@ @ @,#,"1255225274603458560",https://twitter.com/OncologyCentral/status/1255225274603458560
LUNGevity,2020-04-28 15:58,3,11,"Tertiary lymphoid structure (TLS) formation in NSCLC may predict response to immunotherapy (durvalumab) thru interaction with tumor micro-environment. Dr. Sriram Sridhar from AstraZeneca # AACR2020 # AACR20 # LCSMpic.twitter.com/ywMmlw63gL",,,# # #,"1255224870734045184",https://twitter.com/LUNGevity/status/1255224870734045184
MedTechDive,2020-04-28 15:56,0,1,"Study results presented at # AACR20 on Tuesday suggest progress for an experimental blood test meant to catch cancer early, when it might be easier to treat. https://bit.ly/2Yf2fW7",,,#,"1255224479359348736",https://twitter.com/MedTechDive/status/1255224479359348736
SilasInman,2020-04-28 15:54,1,1,"FDA Grants Mobocertinib (TAK-788) Breakthrough Designation for EGFR Exon 20-Mutant NSCLC https://www.onclive.com/web-exclusives/fda-grants-mobocertinib-breakthrough-designation-for-egfr-exon-20mutant-nsclc … # AACR20 # LCSM",,,# #,"1255223830483738626",https://twitter.com/SilasInman/status/1255223830483738626
ShaalanBeg,2020-04-28 15:53,0,5,"Pharma misses the point.. If you follow the pharma twitter handles forn # aacr20, you will see they are sticking w promotional 'flyers'.. not adding value to the discussion. Makes me feel they have a hard time finding their 'SoMe 'voice'..",,,#,"1255223644130869250",https://twitter.com/ShaalanBeg/status/1255223644130869250
StephenVLiu,2020-04-28 15:53,11,10,"# OncoAlert # AACR20 Analyses to identify risk factors for severe events such as recent anti-cancer therapy (14d), radiographic findings. IO therapy not a clear risk. Numbers though are small and this is where large ongoing registries (such as # TERAVOLT) will help with perspective.pic.twitter.com/XTfdNTdJqB",,,# # #,"1255223623025135617",https://twitter.com/StephenVLiu/status/1255223623025135617
Dr_Simon_Baker,2020-04-28 15:53,0,0,"Looking forward to this! # AACR2020 pic.twitter.com/zpHWqyoojq",,,#,"1255223557233299463",https://twitter.com/Dr_Simon_Baker/status/1255223557233299463
chuynhMDCM,2020-04-28 15:52,20,42,"Talk from # TRACERx about the use ctDNA in early stage lung cancer to predict patient relapse after surgery, correlating it with minimum residual disease: pre-op ctDNA shedding associated with longer MRD lead-times and shorter DFS times post-op # AACR20 # AACR2020 # lcsmpic.twitter.com/eqtjL1ypV1",,,# # # #,"1255223344569430017",https://twitter.com/chuynhMDCM/status/1255223344569430017
SusanGKomen,2020-04-28 15:51,3,5,"New research results presented at # AACR20 show that cancer patients – especially those with # metastatic disease – are at higher risk of severe illness from # COVID19. Read morehttps://wapo.st/3eU2VWN",,,# # #,"1255223219595993097",https://twitter.com/SusanGKomen/status/1255223219595993097
StephenVLiu,2020-04-28 15:50,3,8,"# OncoAlert # AACR20 Serial scans show # COVID19 related lung changes. Note the fibrosis emerging at day 25. Will long-term sequela impact respiratory function, quality of life? Will this vary by prior lung pathology, prior radiation, prior pneumonitis, etc?pic.twitter.com/XrcRUiRe7e",,,# # #,"1255222845187272714",https://twitter.com/StephenVLiu/status/1255222845187272714
d2merino,2020-04-28 15:49,3,14,"In the "green room" (it's pretty grey...) ahead of the @ AACR # AACR20 presentation on the @ CancerResrch # TMB Harmonization Project. Excited to be representing the collaborative work of such a great group of partners! Don't forget to tune in! Presentation starts at 4:55pm!pic.twitter.com/ILJMIVTej1",,@ @,# #,"1255222717269319682",https://twitter.com/d2merino/status/1255222717269319682
Cortellis,2020-04-28 15:48,3,4,"Amgen presents positive preclinical data for AMG-509, a bispecific antibody targeting STEAP1 and CD3 for the treatment of prostate cancer and Ewing sarcoma # AACR20",,,#,"1255222395469737984",https://twitter.com/Cortellis/status/1255222395469737984
StephenVLiu,2020-04-28 15:47,3,5,"# OncoAlert # AACR20 In 28 patients with cancer and # COVID19, 36% required mechanical ventilation, 29% mortality with 21% still hospitalized. For those discharged, median hospitalization 18.4 days. For those with severe events, median 7 days from COVID diagnosis to event.pic.twitter.com/Gq4j4ivica",,,# # #,"1255222150119776258",https://twitter.com/StephenVLiu/status/1255222150119776258
petitprez_f,2020-04-28 15:47,13,34,"Tertiary Lymphoid Structures as biomarkers of response to immunotherapy, live now # AACR20 ! pic.twitter.com/MTsmp8ezB4",,,#,"1255222074144108546",https://twitter.com/petitprez_f/status/1255222074144108546
nikita_telkar,2020-04-28 15:45,0,2,"# rookie new student mistake - Forgot that North America has several different time zones , and that I have to factor that in when setting reminders for online conference meetings @ AACR # AACR20 @ AcademicChatter",,@ @,# #,"1255221600657555458",https://twitter.com/nikita_telkar/status/1255221600657555458
thecancergeek,2020-04-28 15:45,1,2,"This Duvelisib data from # AACR20 is quite interesting - maybe a future area for us to examine in IBC given the prominent role of M2-like macs in bad biology.",,,#,"1255221518449213447",https://twitter.com/thecancergeek/status/1255221518449213447
ErmiasMd,2020-04-28 15:44,0,0,"Thanks for sharing. Important communication skills.",,,,"1255221438325366784",https://twitter.com/ErmiasMd/status/1255221438325366784
StephenVLiu,2020-04-28 15:44,2,4,"# OncoAlert # AACR20 In the Liang report from @ TheLancetOncol, we saw 1% of # COVID19 patients had cancer. In this Wuhan report from 3 hospitals (1/13/20-2/26/20), it was 2.2% (25% lung, 14% esophageal, 11% breast), 30% stage IV. 60/40 split male/female. 71% community acquired.pic.twitter.com/PF7pTJn9nn",,@,# # #,"1255221243613151232",https://twitter.com/StephenVLiu/status/1255221243613151232
pashtoonkasi,2020-04-28 15:43,10,21,"# AACR20 I think integrating # ctDNA # liquidbiopsies is going to be the new paradigm shift in more efficient trial designs. If you chose MRDsubset of patients, especially for these adjuvant studies, sample size required would be a lot lower since event rate will be high.pic.twitter.com/ltbTc4pISo",,,# # #,"1255221211275177984",https://twitter.com/pashtoonkasi/status/1255221211275177984
sxbegle,2020-04-28 15:41,13,36,"There was # cancer before the pandemic, there is cancer now, and there will be cancer after. Thankfully, some research continues. Progress toward off-the-shelf # CAR_T cells, from Shanghai # biotech, at # AACR20: https://www.statnews.com/2020/04/28/off-the-shelf-car-t-therapy-helps-leukemia-patients-in-a-small-first-in-human-trial/ …",,,# # # #,"1255220707035942915",https://twitter.com/sxbegle/status/1255220707035942915
StephenVLiu,2020-04-28 15:41,6,13,"# OncoAlert # AACR20 More mature data emerging from China. This review by Dr. Zhang at Tongji in Wuhan discusses patients with cancer and # COVID19. Interesting to contrast these with data from US, Italy, Spain, France, etc - some trends just reflect patient populations served.pic.twitter.com/5nxOc3BYb2",,,# # #,"1255220580200177666",https://twitter.com/StephenVLiu/status/1255220580200177666
sridevirajeeve,2020-04-28 15:41,0,1,"Thank you for reminding us that # WordsMatter @ ASCO and @ AACR. I have often unconsciously used phrases like 'pts failed treatment' whereas it's the treatment that failed to work. Time for heightened awareness and correctness in statements. # Onclove # risingfellowhttps://twitter.com/tmprowell/status/1255138226085359617 …",,@ @,# # #,"1255220511602327554",https://twitter.com/sridevirajeeve/status/1255220511602327554
AmritaSule,2020-04-28 15:41,0,18,"Thank you @ aacr for the opportunity! https://twitter.com/YaleCancer/status/1255219823640039427 …",,@,,"1255220496251183106",https://twitter.com/AmritaSule/status/1255220496251183106
threadreaderapp,2020-04-28 15:40,2,4,"Saluti, you can read it here: @ ADesaiMD: Missed # COVID19nCancer plenary in # AACR20 @ AACR? Here’s a thread to catch up on all the fascinating global… https://threadreaderapp.com/thread/1255154902504026113.html … Share this if you think it's interesting.",,@ @,# #,"1255220454371057671",https://twitter.com/threadreaderapp/status/1255220454371057671
md_stewart,2020-04-28 15:40,0,6,"Tune in to # AACR20 virtual minisymposium: predictive biomarkers for immunotherapeutics starting now! We will be showcasing our latest TMB findings at 4:55pm ET. Additional details below. https://twitter.com/CancerResrch/status/1254774827249831936 …",,,#,"1255220265035988997",https://twitter.com/md_stewart/status/1255220265035988997
YaleCancer,2020-04-28 15:38,7,30,"Promising research for # braincancer # coloncancer treatment! . @ amritasule presented study results at # AACR20 showing # PARP and # ATR # DNA repair inhibitors together are more effective than a PARP inhibitor alone. @ RanjitBindra @ SmilowCancer @ YaleMed @ YNHH https://www.abstractsonline.com/pp8/#!/9045/presentation/10551 …pic.twitter.com/qfzig30WOb",,@ @ @ @ @,# # # # # # #,"1255219823640039427",https://twitter.com/YaleCancer/status/1255219823640039427
Pharma_BI,2020-04-28 15:37,0,0,"Scientific reporting by @ StephenJWillia2 @ pharma_BI @ AACR @ CureCancerNow @ pharmanews @ BiotechWorld @ HopkinsMedicine # AACR20 https://lnkd.in/ej5pfnA",,@ @ @ @ @ @ @,#,"1255219730140540934",https://twitter.com/Pharma_BI/status/1255219730140540934
CancerMedMDA,2020-04-28 15:37,1,2,"Don't miss @ DavidHongMD presenting "Efficacy and safety of larotrectinib in patients with cancer and NTRK gene fusions or other alterations," # AACR20 Session CT062, today at 3:20 PM (4:20 PM EDT). @ AACR https://bit.ly/2VAd3fC",,@ @,#,"1255219482982744072",https://twitter.com/CancerMedMDA/status/1255219482982744072
elfarukpath11,2020-04-28 15:35,0,1,"I am doing fine Diana. Best of luck",,,,"1255219131202363394",https://twitter.com/elfarukpath11/status/1255219131202363394
lymphomahub,2020-04-28 15:33,3,5,"CONGRESS | # AACR20 | Jonathan Pachter discusses the synergistic action of the dual PI3K inhibitor, duvelisib, with PD-1 blockage in solid tumor and lymphoma models. A clinical trial of duvelisib + nivolumab in tFL and Richter’s transformation is ongoing # lymsmpic.twitter.com/aJwPboXCDS",,,# #,"1255218589214408705",https://twitter.com/lymphomahub/status/1255218589214408705
AnjaNitzscheB,2020-04-28 15:33,0,2,". @ threadreaderapp please unroll @ ADesaiMD detailed thread to catch up on the fascinating global research presented during # COVID19nCancer plenary in # AACR20 @ AACR. # Cancer care during # COVID19 pandemic.",,@ @ @,# # # #,"1255218546579312643",https://twitter.com/AnjaNitzscheB/status/1255218546579312643
femicanny,2020-04-28 15:32,0,1,"Virtual # AACR20 is the business",,,#,"1255218280136048641",https://twitter.com/femicanny/status/1255218280136048641
TapsiKS,2020-04-28 15:31,2,7,"Waiting for the session to begin! amazing setup for the online meeting... # AACR20 We are presenting our breast atlas work @ nicholas_navin @ MDA_UTHGrad @ KessenbrockLab @ DLawsonlab labs at 3:55EDT!pic.twitter.com/MidhFjnlvt",,@ @ @ @,#,"1255218090922708993",https://twitter.com/TapsiKS/status/1255218090922708993
syinvesting,2020-04-28 15:30,0,3,"Good article from @ JacobPlieth on Gracell's # AACR20 data that validated the anti-CD7 CAR approach: https://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-gracell-validates-novel-car-t-target …pic.twitter.com/0mv0abWm0f",,@,#,"1255217805491929091",https://twitter.com/syinvesting/status/1255217805491929091
sloan_kettering,2020-04-28 15:30,6,9,"Today at 3:50pm tune in to # AACR20's minisymposium "Evaluating # Cancer Genomics from Normal Tissues through Evolution to Metastatic Disease," to hear from @ KellyLBolton on "Oncologic therapy shapes the fitness landscape of # ClonalHematopoiesis." https://bit.ly/2KUbZNH pic.twitter.com/PF7CXsVcvq",,@,# # #,"1255217743185563652",https://twitter.com/sloan_kettering/status/1255217743185563652
Cortellis,2020-04-28 15:29,0,0,"Anti-CD7 CAR T cell therapy (TruUCAR™ GC027) from Gracell Biotechnologies demonstrated clinical efficacy with a very promising early response rate and an acceptable safety profile in patients T-ALL # AACR20",,,#,"1255217621366120452",https://twitter.com/Cortellis/status/1255217621366120452
jillfeldman4,2020-04-28 15:28,6,11,"Dr Zhao discusses Skp2 as a target in # SCLC. Data showing Skp2 pathway is a promising therapeutic strategy to reactivate RB1 and TP53 # AACR20 # LCSMpic.twitter.com/4fvzbujiKH",,,# # #,"1255217442344898574",https://twitter.com/jillfeldman4/status/1255217442344898574
pashtoonkasi,2020-04-28 15:26,3,14,"# AACR20 # ctDNA # LiquidBiopsies key is that if fusions are detected is helpful - doesn’t exclude its presence. Interpret with disease context. # OncoAlert",,,# # # #,"1255216753698840583",https://twitter.com/pashtoonkasi/status/1255216753698840583
mariejoyparsons,2020-04-28 15:24,0,14,"Jumping in for day 2 of # AACR20 ! Loving listen to talks at home so I can enjoy some home made bagels & biscuits pic.twitter.com/nxr1VaGEhS",,,#,"1255216240504836104",https://twitter.com/mariejoyparsons/status/1255216240504836104
joshgoldstein1,2020-04-28 15:22,0,0,"This study from # AACR20 show the potential of so-called liquid biopsies. We are Finding # CuresTogether.https://twitter.com/AACRFoundation/status/1255212828279091201 …",,,# #,"1255215765277605888",https://twitter.com/joshgoldstein1/status/1255215765277605888
kevinjmonahan,2020-04-28 15:21,0,0,"?",,,,"1255215467033178113",https://twitter.com/kevinjmonahan/status/1255215467033178113
kevinjmonahan,2020-04-28 15:20,0,0,"Great to see this phase 1 study... looking forward to seeing more - what was the safety relating to cardiac disease in older patients etc",,,,"1255215424742064136",https://twitter.com/kevinjmonahan/status/1255215424742064136
JacobPlieth,2020-04-28 15:18,1,4,"$ IOVA # AACR20 https://twitter.com/janehses/status/1255205235984908288?s=21 …https://twitter.com/JanEhses/status/1255205235984908288 …",,,#,"1255214777074438144",https://twitter.com/JacobPlieth/status/1255214777074438144
ScripMandy,2020-04-28 15:17,0,2,"I thought this was helpful as well. # AACR20 https://twitter.com/krknrm/status/1255164406431956992 …",,,#,"1255214690818351104",https://twitter.com/ScripMandy/status/1255214690818351104
JacobPlieth,2020-04-28 15:17,1,2,"$ IOVA # AACR20 https://twitter.com/janehses/status/1255204377964535811?s=21 …https://twitter.com/JanEhses/status/1255204377964535811 …",,,#,"1255214631435542534",https://twitter.com/JacobPlieth/status/1255214631435542534
Aiims1742,2020-04-28 15:15,2,12,"Today’s # AACR20 presentation on # COVID19nCancer (and @ CD_AACR paper) is the subject of a @ lauriemcginley2 column. With a special cameo by @ MDAndersonNews All Star physician scientist & cancer survivor @ deb_silverman # Bcsm @ COVID19nCCC https://www.washingtonpost.com/health/2020/04/28/coronavirus-cancer-deathrates/#click=https://t.co/TeSomRnNXM …https://twitter.com/Aiims1742/status/1255130463150264320 …",,@ @ @ @ @,# # # #click,"1255214033768255488",https://twitter.com/Aiims1742/status/1255214033768255488
RousseauMC,2020-04-28 15:13,0,0,"73.5% stage IV disease. Wish we had data on localized disease to guide surgical triage decisions. # AACR2020",,,#,"1255213667345465346",https://twitter.com/RousseauMC/status/1255213667345465346
SU2Cscience,2020-04-28 15:10,1,3,"Investigators on @ SU2C @ LUNGevity @ LungAssociation Dream Team are sharing data on circulating tumor DNA that might pave the way for clinical trials predicated on escalation of adjuvant standard of care in # LungCancer patients following surgery # AACR20 https://standuptocancer.org/research/research-portfolio/dream-teams/lung-cancer-interception-intime-dream-team/ …",,@ @ @,# #,"1255212801401946115",https://twitter.com/SU2Cscience/status/1255212801401946115
OncoAlert,2020-04-28 15:09,0,0,"Thank you @ BenWestphalen !!",,@,,"1255212613996249090",https://twitter.com/OncoAlert/status/1255212613996249090
SWOG,2020-04-28 15:08,2,3,"Thanks for the coverage of our @ SWOG trial results presented at # AACR20, @ jasoncology and @ OncLive! https://www.onclive.com/conference-coverage/aacr-2020/continuous-dabrafenibtrametinib-dosing-improves-pfs-in-braf-melanoma … via @ onclive",,@ @ @ @,#,"1255212380553801728",https://twitter.com/SWOG/status/1255212380553801728
RousseauMC,2020-04-28 15:06,0,0,"35% Mortality in thoracic cancer patients with COVID. 200 patients but 74% were St. IV so to be applied with caution to our decision making about triage of thoracic oncological surgical patients @ AACR # AACR2020 https://twitter.com/LizCancerHealth/status/1255127671295500288 …",,@,#,"1255211917540569089",https://twitter.com/RousseauMC/status/1255211917540569089
ErikaHamilton9,2020-04-28 15:06,4,12,"# AACR20 Dr. Domchek’s discussion of PARPi # EMBRACA: no OS with olaparib or talazoparib in # bcsm, but PFS and tolerability No diff by HR/TNBC, or by platinum, BUT benefit only w/ no chemo in MBC, not there 2nd/3rd line crossover confounds OS, 32% got PARP @ OncoAlertpic.twitter.com/E9chuSZtnK",,@,# # #,"1255211908187242498",https://twitter.com/ErikaHamilton9/status/1255211908187242498
FredNatLab_PDO,2020-04-28 15:05,0,1,"Looking forward to hearing Dr. Singer's talk today at 5PM: @ theNCI Activities – COVID-19 and Cancer Research http://ow.ly/DzGN50zpEJW @ AACR # AACR20 pic.twitter.com/sHtTgXKXGb",,@ @,#,"1255211503306899456",https://twitter.com/FredNatLab_PDO/status/1255211503306899456
SWOG,2020-04-28 15:04,0,0,"Thanks to @ MedPageToday for coverage of @ SWOG results presented yesterday at # AACR20 by Dr. Alain Algazi from @ UCSFCancer. Sometimes the flops are as newsworthy as the wins. Targeted Tx Holiday Flops in Late-Stage Melanomahttps://www.medpagetoday.com/meetingcoverage/aacr/86193 …",,@ @ @,#,"1255211385010573312",https://twitter.com/SWOG/status/1255211385010573312
LUNGevity,2020-04-28 15:04,8,15,"ctDNA measurement thru liquid biopsy over time (frm FLAURA study) predicts progression-free survival & correlates w/ tumor size in EGFR-mutant NSCLC tx w/ osimertinib. Possibility fr monitoring during # COVID19? Dr. Martin Johnson frm Astra Zeneca # AACR2020 # AACR20 # LCSMpic.twitter.com/5utKOMIMZc",,,# # # #,"1255211192018243585",https://twitter.com/LUNGevity/status/1255211192018243585
pashtoonkasi,2020-04-28 15:03,7,16,"# AACR20 ability to predict PFS. With the short t-1/2, of great value to consider. # LiquidBiopsies # ctDNApic.twitter.com/op3g36bnUr",,,# # #,"1255211112787828748",https://twitter.com/pashtoonkasi/status/1255211112787828748
FellowsHsl,2020-04-28 15:02,1,6,"Early cancer detection & ctDNA session: still hold more questions than answers. Specificity was the presenters’ focus but concerns regarding sensibility (including positive patients demanding rule-out tests) & optimal test schedule to magnify cost-effectiveness yet exist. # AACR20 https://twitter.com/AACR/status/1255202650263556099 …",,,#,"1255210838241218564",https://twitter.com/FellowsHsl/status/1255210838241218564
ivybelkins,2020-04-28 15:00,4,10,"@ AstraZeneca Martin Johnson looks at using longitudinal ctDNA to predict progression in 1st line # EGFR # lungcancer patients on # osimertinib # AACR20 # lcsm @ EGFRResisterspic.twitter.com/IRzR9rbado",,@ @,# # # # #,"1255210247947464707",https://twitter.com/ivybelkins/status/1255210247947464707
JExpMed,2020-04-28 15:00,1,1,"Fibroblasts and ascitic cancer cells form metastatic units that promote the dissemination of tumor cells throughout the abdominal cavity. JEM’s cancer collection for # AACR20 (https://bit.ly/3avNaBK ) has new short summaries of articles in this PDF: https://bit.ly/2XYhG4z pic.twitter.com/aEpNLfl413",,,#,"1255210234953465858",https://twitter.com/JExpMed/status/1255210234953465858
AACR,2020-04-28 15:00,3,8,"# AACR20 Virtual Annual Meeting I: Early Detection and ctDNA Session. Chris Abbosh presents: Phylogenetic tracking and minimal residual disease detection using ctDNA in early-stage NSCLC: A lung TRACERx study. pic.twitter.com/dmVDkxM9tt",,,#,"1255210217597476866",https://twitter.com/AACR/status/1255210217597476866
AmgenOncology,2020-04-28 15:00,2,1,"We invite all # AACR20 participants to discover our robust range of modalities designed to address tumor types with high unmet need represented in Amgen’s investigational # anticancer pipeline. Visit the newly refreshed http://AmgenOncology.com . # BiTEtechnology # ImmunoOncologypic.twitter.com/B5i7tE8Db5",,,# # # #,"1255210176837120000",https://twitter.com/AmgenOncology/status/1255210176837120000
JAMANetwork,2020-04-28 15:00,0,0,"Forging New Strategies in the Cure of Human Oligometastatic Cancer from @ JAMAOnc is available free online during the # AACR20 virtual meeting. Read it and other recent # oncology articles from the JAMA Network https://ja.ma/2XQCNWF",,@,# #,"1255210173393711108",https://twitter.com/JAMANetwork/status/1255210173393711108
archerdxinc,2020-04-28 14:59,4,9,"We announced new # MRD surveillance data from the # TRACERx collaboration with @ uclcancer, @ TheCrick & @ CR_UK at # AACR20. Read the release: https://hubs.ly/H0pYrzg0 # AACR2020 pic.twitter.com/M2T6pUSaDN",,@ @ @,# # # #,"1255210114505740293",https://twitter.com/archerdxinc/status/1255210114505740293
Dr_ZiMingZhao,2020-04-28 14:59,1,2,"Great to see appreciation of evolutionary analyses using spatial and longitudinal tumor sampling from solid tumor and liquid biopsy # AACR20, so many clinical applications on the way. https://www.pnas.org/content/113/8/2140.short …https://twitter.com/LUNGevity/status/1255207139766931457 …",,,#,"1255209934498775040",https://twitter.com/Dr_ZiMingZhao/status/1255209934498775040
jillfeldman4,2020-04-28 14:58,4,7,"A significant difference between shedders & non shedders in screening, lead time & DFS. Could pre op status of patient ctDNA be a potential biomarker? Stresses tissue biopsy critical if the ctDNA is negative # AACR20 # LCSMhttps://twitter.com/LUNGevity/status/1255207139766931457 …",,,# #,"1255209915678961664",https://twitter.com/jillfeldman4/status/1255209915678961664
AACR,2020-04-28 14:58,2,8,"Results were presented today during the Early Detection and ctDNA Clinical Plenary Session on the second day of # AACR20 Virtual Annual Meeting I. https://aacr20.onlineeventpro.freeman.com/live-stream/15335386/Early-Detection-and-ctDNA …https://twitter.com/MMarchioneAP/status/1255204865791463424 …",,,#,"1255209699735191558",https://twitter.com/AACR/status/1255209699735191558
CharuAggarwalMD,2020-04-28 14:55,1,15,"Catch this quick summary by @ LeciaSequist from the # TargetedTherapy Oral # LungCancer session on poziotinib and capmatinib # AACR20 @ OncoAlert # LCSMhttps://twitter.com/OncoAlert/status/1255196726446772224 …",,@ @,# # # #,"1255208931405766656",https://twitter.com/CharuAggarwalMD/status/1255208931405766656
tmprowell,2020-04-28 14:53,4,12,"# AACR20. Valuable thread by my friend & # bcsm # advocacy colleague. Drs. @ nlinmd, @ EdKimMDLCI, I, & others wrote about how to include ppl w/ # brainmets in # clinicaltrials (http://bit.ly/2JaWbq6 ), & # cnsmetsworkshop2019 was devoted to this topic. # drugdevelopment # regulatory https://twitter.com/christeeny513/status/1255178094379511813 …pic.twitter.com/StY3nbC3Bj",,@ @,# # # # # # # #,"1255208598440939523",https://twitter.com/tmprowell/status/1255208598440939523
MuhammetOzerMD,2020-04-28 14:53,0,0,"Thank you @ Rick__Buck Great work!! @ AACR",,@ @,,"1255208508020178945",https://twitter.com/MuhammetOzerMD/status/1255208508020178945
MuhammetOzerMD,2020-04-28 14:52,0,0,"Thank you @ cancerassassin1 , we all doing our best",,@,,"1255208329070157824",https://twitter.com/MuhammetOzerMD/status/1255208329070157824
Cait_Stewart,2020-04-28 14:52,0,6,"Interesting discussion about shedders vs non-shedders of ctDNA pre-operatively in the TRACERx study. Plasma ctDNA was better at detecting relapse in patients with pre-op shedding than without. Suggests a specific population where ctDNA could be more beneficial/effective. # AACR20",,,#,"1255208319918227464",https://twitter.com/Cait_Stewart/status/1255208319918227464
HemOncToday,2020-04-28 14:51,1,5,"Novel immuno-oncology combination demonstrates activity in metastatic triple-negative breast cancer Read more: http://bit.ly/3bRXCW0 @ Merck @ Biothera @ ODayMD @ JohnWayneCI # AACR20 pic.twitter.com/wO0Jt8RJbO",,@ @ @ @,#,"1255207906674270208",https://twitter.com/HemOncToday/status/1255207906674270208
UCCancerCenter,2020-04-28 14:49,0,1,"Progress in CAR T therapy to treat T-ALL presented today # AACR20 https://twitter.com/AACR/status/1255172466764386306 …",,,#,"1255207612905390081",https://twitter.com/UCCancerCenter/status/1255207612905390081
coffeemommy,2020-04-28 14:48,3,11,"Tuned back into # AACR20 & immediately learned something: Q: "How do you determine cfDNA-shedder from cfDNA-non-shedder if without in-situ tumor data?" A: "It may not be a shedder/non-shedder question, it may be level of sensitivity of the test." cc: # lcsm # bcsm # crcsm # gyncsm",,,# # # # #,"1255207244037099521",https://twitter.com/coffeemommy/status/1255207244037099521
LUNGevity,2020-04-28 14:47,12,28,"Great discussion by @ AbboshChris on using ctDNA to measure minimum residual disease (MRD) in adjuvant trials for early-stage lung cancer - to predict which pts will relapse after surgery. Results frm TRACERx @ SwantonLab @ SU2Cscience @ LungAssociation # AACR2020 # AACR20 # LCSMpic.twitter.com/DToCKYUfKg",,@ @ @ @,# # #,"1255207139766931457",https://twitter.com/LUNGevity/status/1255207139766931457
MasonIsraelPhD,2020-04-28 14:47,1,1,"Mobo on the move: EGFR exon 20 insertions are a blindspot in targeted therapy options for # NSCLC. Yesterday # Takeda announced # FDA breakthrough for Mobocertinib (TAK-788) in ex20ins mNSCLC. Today at # AACR20 they encored their 2019 # ASCO phase 1/2 data showing a 43% ORR. # lcsmpic.twitter.com/b8JjMMyRIf",,,# # # # # #,"1255207036091985920",https://twitter.com/MasonIsraelPhD/status/1255207036091985920
Rick__Buck,2020-04-28 14:45,1,4,"Here is the latest news from # AACR20>For the first time, a blood test has been shown to help detect many types of # cancer in a study of thousands of people with no history or symptoms of the disease. @ MMarchioneAPhttps://twitter.com/MMarchioneAP/status/1255204865791463424 …",,@,# #,"1255206549800263681",https://twitter.com/Rick__Buck/status/1255206549800263681
SilviaJim_Mor,2020-04-28 14:42,0,0,"It was very interesting!",,,,"1255205753222098945",https://twitter.com/SilviaJim_Mor/status/1255205753222098945
syinvesting,2020-04-28 14:42,2,9,"$ SNDX (+65% intraday) Syndax announced initial Phase 1 data of SNDX-5613 (menin-MLL1 inhibitor) in adults with r/r acute leukemias at # AACR20. Responses (1 CR and 1 PRi) were seen in 2/3 MLL-r patients who achieved '5613 + CYP3A4 inhibitors. PR: http://ir.syndax.com/news-releases/news-release-details/syndax-pharmaceuticals-announces-preclinical-profile-and-initial …pic.twitter.com/bqJ1ioggfk",,,#,"1255205710603776006",https://twitter.com/syinvesting/status/1255205710603776006
Rick__Buck,2020-04-28 14:39,0,4,"Thank you for all you do @ MuhammetOzerMD in the fight against # COVID19 and your kind comments about # AAC20. It has been an entire @ AACR team effort.",,@ @,# #,"1255205005709250560",https://twitter.com/Rick__Buck/status/1255205005709250560
MMarchioneAP,2020-04-28 14:38,3,12,"liquid biopsies for cancer detection? this study put a test to the test. # AACR2020 https://apnews.com/863e8f4bd759a658785c6eac75372ac2 …",,,#,"1255204865791463424",https://twitter.com/MMarchioneAP/status/1255204865791463424
cancerassassin1,2020-04-28 14:38,0,3,"Very glad you have access and are watching; thank you for your work on the frontlines; and above all, stay safe.",,,,"1255204863140671491",https://twitter.com/cancerassassin1/status/1255204863140671491
ranjitbindra,2020-04-28 14:36,0,19,"Excited for our Postdoc’s virtual talk on novel DDR combos against IDH1/2 mutant cancers! Coming up at 250p @ YaleCancer @ AACR # VirtualConference @ AmritaSulepic.twitter.com/6YEwiMnxVe",,@ @ @,#,"1255204202592243713",https://twitter.com/ranjitbindra/status/1255204202592243713
hilaryarobbins,2020-04-28 14:36,3,19,"The # AACR2020 session on cancer early detection & ctDNA was so promising, with results from @ GrailBio, CancerSEEK, and TRACERx. Imagine my disappointment when I realized it was... a # manel With talks about all-female studies no less. @ AACR pic.twitter.com/UQ9xgc97lG",,@ @,# #,"1255204168035438605",https://twitter.com/hilaryarobbins/status/1255204168035438605
krknrm,2020-04-28 14:34,4,8,"Some of the outstanding questions in # ctDNA # AACR20 by Dr Huntsman @ UBC - longitudinal impact, sensitivity, financial burden, and of course some of the advantages arising under the lens of # COVID19pic.twitter.com/kLg08Cuvce",,@,# # #,"1255203824857493506",https://twitter.com/krknrm/status/1255203824857493506
MuhammetOzerMD,2020-04-28 14:33,6,35,"As an # IM resident I am pleased to watch # AACR20 live stream virtual meeting while preparing my shift fighting # COVID19 Thank to all who is making this happen @ AACR @ Rick__Buck @ AACRPres & who increased awareness @ cancerassassin1 @ Aiims1742 @ DrSGraff @ tmprowell @ OncoAlert pic.twitter.com/Dj9U74w9Tm",,@ @ @ @ @ @ @ @,# # #,"1255203460645097474",https://twitter.com/MuhammetOzerMD/status/1255203460645097474
AML_Hub,2020-04-28 14:33,0,2,"CONGRESS | # AACR20 | @ thomas_helleday, @ sheffielduni, discusses targeting MTHFD2 with first-in-class inhibitors for hematological and solid cancers. This inhibition leads to replication stress, reducing AML tumor burden and prolonging survival in mice models # leusmpic.twitter.com/Rm454ohLmV",,@ @,# #,"1255203451753070593",https://twitter.com/AML_Hub/status/1255203451753070593
CancerMedMDA,2020-04-28 14:33,2,2,"Watch online: # AACR20 Session CT061, "Binimetinib in pts w/tumors with NRAS mutations: NCI-MATCH ECOG-ACRIN Cancer Research Group subprotocol EAY131-Z1A." Today at 3:05 PM (4:05 PM EDT). With @ skopetz, Funda Meric-Bernstam, Stanley Hamilton. @ AACR https://bit.ly/2Kstxjw",,@ @,#,"1255203376813367296",https://twitter.com/CancerMedMDA/status/1255203376813367296
jillfeldman4,2020-04-28 14:32,1,6,"In the use of ctDNA/liquid biopsy specificity is of paramount importance, especially with regard to patient anxiety. # StruggleIsReal # AACR20 # LCSM",,,# # #,"1255203276317917186",https://twitter.com/jillfeldman4/status/1255203276317917186
syinvesting,2020-04-28 14:30,0,1,"$ IOVA Detailed TIL data from # AACR20 update today. - 2 CR ongoing, 1 PR, 2 uPR and 1 uPR ongoing awaiting next CT - BORR 25% (33% if ongoing uPR is confirmed) https://twitter.com/jacobplieth/status/1255200711849230338?s=21 …https://twitter.com/JacobPlieth/status/1255200711849230338 …",,,#,"1255202762083581952",https://twitter.com/syinvesting/status/1255202762083581952
AACR,2020-04-28 14:30,11,28,"# AACR20 Virtual Annual Meeting I: Early Detection and ctDNA Session. Nickolas Papadopoulos presents: A first-of-its-kind prospective study of a multicancer blood test to screen and manage 10,000 women with no history of cancer. pic.twitter.com/KeMHhirfgU",,,#,"1255202650263556099",https://twitter.com/AACR/status/1255202650263556099
JCellBiol,2020-04-28 14:30,1,2,"A critical protease for metastasis uses a protein involved in intracellular transport to get to the cell surface. JCB’s new cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has short summaries of articles in this PDF: https://bit.ly/2XYckGS pic.twitter.com/m9c7lQmDPi",,,#,"1255202645565943810",https://twitter.com/JCellBiol/status/1255202645565943810
rosslevinemd,2020-04-28 14:27,0,1,"Would be good to post the data and your analyses as preprints before/at the time you present. Important timely work and we will all want to dig in! You're whetting our appetite by saying you've analyzed 1000 patients in a month...",,,,"1255202043209359365",https://twitter.com/rosslevinemd/status/1255202043209359365
krknrm,2020-04-28 14:26,0,2,"Thanks for a very engaging discussion, it was a great # AACR20 session! :) I appreciate we can have this platform at least, which is working great!",,,#,"1255201849805864963",https://twitter.com/krknrm/status/1255201849805864963
jillfeldman4,2020-04-28 14:26,6,17,"David Huntsman discusses role of ctDNA/liquid biopsies & interestingly the potential benefits of the uses are greatly increased due to # COVID19. # AACR20 # LCSMpic.twitter.com/VofP7CmZXH",,,# # #,"1255201709342765057",https://twitter.com/jillfeldman4/status/1255201709342765057
hilaryarobbins,2020-04-28 14:26,0,0,"I didn't watch this presentation - were there problems beyond this statement? (Asking so I can try to help prevent thoughtless statements by academics; examples are helpful...)",,,,"1255201674421043202",https://twitter.com/hilaryarobbins/status/1255201674421043202
ivybelkins,2020-04-28 14:23,6,10,"Technical challenges exist in using # liquidbiopsies to screen everyone for cancer, in addition to cost issues. # AACR20 # lcsm # lungcancer @ EGFRResisterspic.twitter.com/V3xu4uyIHW",,@,# # # #,"1255201090225741824",https://twitter.com/ivybelkins/status/1255201090225741824
MCT_AACR,2020-04-28 14:22,0,0,". @ SeattleGenetics # AACR20 https://mct.aacrjournals.org/content/19/4/976?utm_source=180873&utm_medium=twitter&utm_campaign=disclosures … (2 of 2))",,@,#,"1255200773245472768",https://twitter.com/MCT_AACR/status/1255200773245472768
JacobPlieth,2020-04-28 14:22,5,18,"$ IOVA at # AACR20. Ben Creelan says only subjects who had progressed on 4 cycles of Opdivo (+ 2 scans) were lymphodepleted and got TILs pic.twitter.com/aGD1kqxJwI",,,#,"1255200711849230338",https://twitter.com/JacobPlieth/status/1255200711849230338
LUNGevity,2020-04-28 14:21,2,2,"Interesting point made by Dr. David Huntsman @ BCCancer on the role of ctDNA/liquid biopsy-based approaches for monitoring patients during the time of # COVID19 # AACR2020 # AACR20 # LCSMpic.twitter.com/zgpsZ7WuPN",,@,# # # #,"1255200553170284546",https://twitter.com/LUNGevity/status/1255200553170284546
Dr_ZiMingZhao,2020-04-28 14:21,0,2,"Look forward to more applications in ctDNA in cancer, progress with epigenetics, after CancerSeek # AACR20 https://science.sciencemag.org/node/706205.full …https://twitter.com/aftimosp/status/1255198857845248000 …",,,#,"1255200523311030279",https://twitter.com/Dr_ZiMingZhao/status/1255200523311030279
CSpencerPhD,2020-04-28 14:20,0,1,"Thanks @ zaccoop! Fun for the whole family",,@,,"1255200323494436870",https://twitter.com/CSpencerPhD/status/1255200323494436870
Mojojammer,2020-04-28 14:19,0,0,"So if I am in remission for the last 5 years, and my counts have returned to normal, am I still at higher risk?",,,,"1255199937358368768",https://twitter.com/Mojojammer/status/1255199937358368768
Cait_Stewart,2020-04-28 14:19,0,3,"Going to start spamming with some # AACR20 tweets! Glad to be able to listen in because I wasn’t going to attend in person this year. Thanks for the virtual meeting @ AACR!",,@,#,"1255199915178889218",https://twitter.com/Cait_Stewart/status/1255199915178889218
HemOncToday,2020-04-28 14:18,1,0,"Mortality unexpectedly high among people with lung cancer, COVID-19 http://bit.ly/2KJINZn # AACR20 # coronaviruspic.twitter.com/BrklTvIAC5",,,# #,"1255199602002636800",https://twitter.com/HemOncToday/status/1255199602002636800
krknrm,2020-04-28 14:17,2,5,"Current session - # ctDNA and early detection. Thiel @ MayoClinic and Papadopoulos @ HopkinsMedicine talk about pan-cancer multi-analyte tests in prospective studies with or w/o prior history/knowledge of cancer - thanks @ Albert0Bardelli for a great chairing! # AACR20",,@ @ @,# #,"1255199531119054848",https://twitter.com/krknrm/status/1255199531119054848
StephenVLiu,2020-04-28 14:16,4,11,"# OncoAlert # AACR20 TAK-788 safety: At 160mg qd, G3+ AE in 40%, 25% dose reduction, 50% interruption. G3+ diarrhea 18%. Given the history of drugs here, does dose intensity correlate with DOR? I'm interested in G2 toxicities, which are very relevant here. Any QOL data? # LCSMpic.twitter.com/32yxkSYdLW",,,# # #,"1255199258715848711",https://twitter.com/StephenVLiu/status/1255199258715848711
DanBudwick,2020-04-28 14:15,1,5,"75% of cancers aren't picked up by current screening tests. Thrive conducted first-ever interventional study evaluating a liquid biopsy to detect cancer in healthy population. Results presented at # AACR20 and published today in @ ScienceMagazine: https://thrivedetect.com/press-release/the-first-prospective-interventional-study-of-a-blood-based-multicancer-test/ … # AACR20 pic.twitter.com/IN2vR9zQ6I",,@,# #,"1255199046064635905",https://twitter.com/DanBudwick/status/1255199046064635905
krknrm,2020-04-28 14:15,0,3,"ctDNA # AACR20 session: Thiel @ MayoClinic and Papadopoulos @ HopkinsMedicine talk about pan-cancer multi-analyte tests in prospective studies # AACR20 - thanks @ Albert0Bardelli for a great chairing!",,@ @ @,# #,"1255198848840085512",https://twitter.com/krknrm/status/1255198848840085512
Annals_Oncology,2020-04-28 14:14,25,46,"# AACR20 David Thiel from @ MayoClinic presents at the Early Detection and ctDNA session results from the study investigating the @ GrailBio cfDNA methylation signatures test. The manuscript can be found here in Annals of Oncology: https://www.sciencedirect.com/science/article/pii/S0923753420360580 …pic.twitter.com/cfEcY8pxVd",,@ @,#,"1255198644732649472",https://twitter.com/Annals_Oncology/status/1255198644732649472
Becky_ABC,2020-04-28 14:14,0,6,"Just in time for # AACR2020, our CEO Michele Cleary has joined twitter - follow her to keep up with how @ TheMarkFdn is moving cancer research forward during these crazy times.https://twitter.com/MicheleMFCR/status/1255189848715116544 …",,@,#,"1255198616228167681",https://twitter.com/Becky_ABC/status/1255198616228167681
MoffittNews,2020-04-28 14:13,4,9,"New hope for lung cancer patients. A Moffitt study shows personalized immunotherapy called TIL worked for at least 25% of patients in a clinical trial. Results were presented today at the American Association for Cancer Research Annual Meeting. # AACR20 http://bit.ly/3f1rmkY pic.twitter.com/3Ehc8JaZuw",,,#,"1255198559848325124",https://twitter.com/MoffittNews/status/1255198559848325124
AmgenOncology,2020-04-28 14:12,1,3,"What is the prevalence of # KRASG12C mutation in # NSCLC (non-small cell lung cancer) patients in the US? # AACR20",,,# # #,"1255198157165584384",https://twitter.com/AmgenOncology/status/1255198157165584384
cancerassassin1,2020-04-28 14:12,3,15,""~19% of cancer patients harbor RAS mutations" per recent study in # CancerResearch @ AACR journal. Not so much the 30% quoted historically. Wide variability across cancers.... # AACR20 https://twitter.com/cancerassassin1/status/1255197440489197569 …pic.twitter.com/nr0TfPFGR9",,@,# #,"1255198099980660739",https://twitter.com/cancerassassin1/status/1255198099980660739
StephenVLiu,2020-04-28 14:11,10,16,"# OncoAlert # AACR20 In patients with # EGFRex20 # NSCLC treated with TAK-788 at 160mg, RR was 43% (n=28) including ASV mutations and NPH insertions. mPFS 7.3 months. Responses independent of prior therapy. Certainly encouraging - need more numbers, longer f/u, full dataset. # LCSMpic.twitter.com/7TItSqO3W2",,,# # # # #,"1255198087875899392",https://twitter.com/StephenVLiu/status/1255198087875899392
DrChoueiri,2020-04-28 14:11,11,12,"Outstanding thread from @ ADesaiMD # COVID19 # AACR20 @ COVID19nCCChttps://twitter.com/ADesaiMD/status/1255154902504026113 …",,@ @,# #,"1255197936398462977",https://twitter.com/DrChoueiri/status/1255197936398462977
cancerassassin1,2020-04-28 14:09,3,1,"Recent study from @ LivUni @ FredNatLab "The Frequency of Ras Mutations in Cancers" found that ~19% of cancer patients harbor Ras mutations. Meaning everyone has to go back to their Intro Powerpoint slides and change from "30% of all cancers." # AACR20 https://pubmed.ncbi.nlm.nih.gov/32209560/",,@ @,#,"1255197440489197569",https://twitter.com/cancerassassin1/status/1255197440489197569
AstraZeneca,2020-04-28 14:08,4,18,"Why aren’t all medicines taken as pills? Teresa Klinowska, Global Project Leader in Oncology, explains some of the decisions that go into how medicines are developed. # SciencefromAtoZ # AACR20 pic.twitter.com/yuoe3QQtf1",,,# #,"1255197180324790272",https://twitter.com/AstraZeneca/status/1255197180324790272
Britt_Waters18,2020-04-28 14:07,0,0,"If you missed this # AACR2020 poster session, please find more information about this important # cancer study (10204) for patients with # autoimmune disorders...sponsored by the # NCICTEP # ETCTN. More: https://go.usa.gov/xvEua # CancerResearchhttps://twitter.com/NCICTEP_ClinRes/status/1254817591509557248 …",,,# # # # # #,"1255197007779696640",https://twitter.com/Britt_Waters18/status/1255197007779696640
mtmdphd,2020-04-28 14:06,0,3,"As you might imagine, it is in the works. Other updates will be shared at upcoming (virtual) conferences. We won't be shy when it comes out. Can follow at # CCC19 and @ COVID19nCCC",,@,#,"1255196812757139456",https://twitter.com/mtmdphd/status/1255196812757139456
allisoncarrbs,2020-04-28 14:06,1,11,"In biological science, cancer is considered especially heinous. The dedicated investigators who study these vicious malignancies are members of an elite squad known as the AACR. These Are My Disclosures ~ dun dun ~ # AACR20",,,#,"1255196787956162570",https://twitter.com/allisoncarrbs/status/1255196787956162570
OncoAlert,2020-04-28 14:06,9,20,"Our @ OncoAlert Colleague @ LeciaSequist of @ MassGeneralNews Live from # AACR20 Discussing The Geometry Study and Zenith20. # LCSM @ LungCancer Edited: @ weoncologistspic.twitter.com/U9ZPHynuZA",,@ @ @ @ @,# #,"1255196726446772224",https://twitter.com/OncoAlert/status/1255196726446772224
StephenVLiu,2020-04-28 14:06,0,1,"# OncoAlert # AACR20 Dose escalation of TAK-788 (mobocertinib) established MTD of 160mg qday. DLTs were 1 case each of grade 3 diarrhea, grade 3 mucositis, grade 3 pneumonitis, and grade 5 (fatal) pneumonitis. Study then enrolled into 7 different baskets to explore efficacy. # LCSMpic.twitter.com/RXexXZTKVB",,,# # #,"1255196694389706757",https://twitter.com/StephenVLiu/status/1255196694389706757
curePCTina,2020-04-28 14:05,0,1,"Day 2 of # AACR2020 and I have to say, I’m loving the 5 min video poster presentations! Able to “visit” multiple posters in a short period of time, can pause to re-view data, can connect with OL after...maybe something worth keeping for future # AACR conferences? Poster kiosks?",,,# #,"1255196574881366016",https://twitter.com/curePCTina/status/1255196574881366016
tmprowell,2020-04-28 14:05,0,4,"# AACR20 # WomenInMedicine # OslerPride # heforshehttps://twitter.com/guptaarjun90/status/1255192555773243394 …",,,# # # #,"1255196568980000769",https://twitter.com/tmprowell/status/1255196568980000769
METUPorg,2020-04-28 14:05,3,14,"Words matter and so does the amount of research focused on metastatic cancers. When treatments stop working the word we hear most is hospice. We need better treatments. We need you to make us a research priority. # AACR2020 # lcsm # bcsm # metastasticBC # advocacyhttps://twitter.com/tmprowell/status/1255138226085359617 …",,,# # # # #,"1255196564508811264",https://twitter.com/METUPorg/status/1255196564508811264
pashtoonkasi,2020-04-28 14:05,4,8,"# ctDNA # LiquidBiopsies # AACR20 https://twitter.com/NatureCancer/status/1255194959818502144 …",,,# # #,"1255196373680631810",https://twitter.com/pashtoonkasi/status/1255196373680631810
rosslevinemd,2020-04-28 14:04,0,2,"When will the analyses from the consortium be shared with us? would love to read them! the preprint is great in describing the effort, love to see the initial analyses and all subsequent!",,,,"1255196257745846272",https://twitter.com/rosslevinemd/status/1255196257745846272
pashtoonkasi,2020-04-28 14:02,1,3,"# ctDNA # LiquidBiopsies # AACR20 https://twitter.com/AACR/status/1255195115750076416 …",,,# # #,"1255195709432881152",https://twitter.com/pashtoonkasi/status/1255195709432881152
StephenVLiu,2020-04-28 14:02,15,30,"# OncoAlert # AACR20 Long awaited data from TAK-788 (now mobocertinib) in # EGFR exon 20 # NSCLC - this is clearly an unmet need with poor outcomes achieved using standard EGFR TKIs or immunotherapy. TAK-788 has some promising features to help in this setting # LCSMpic.twitter.com/43HKq137Sr",,,# # # # #,"1255195663589167105",https://twitter.com/StephenVLiu/status/1255195663589167105
pashtoonkasi,2020-04-28 14:01,0,2,"# PersonalizedMedicine fails when access to drugs is not possible without an approval & patients with rare cancers with rare aberrations tend to suffer the most since often # clinicaltrials in those situations aren’t always feasible or available. # AACR20 # BRCA",,,# # # #,"1255195379395702790",https://twitter.com/pashtoonkasi/status/1255195379395702790
tcellsrus,2020-04-28 14:00,0,0,"Congratulations on a most excellent discussion # AACR2020 ! pic.twitter.com/MRZWRfrJoG",,,#,"1255195273351102464",https://twitter.com/tcellsrus/status/1255195273351102464
JExpMed,2020-04-28 14:00,1,0,"New short summaries of articles (https://bit.ly/2XYhG4z ) are part of JEM’s new cancer collection for # AACR20 https://bit.ly/3avNaBK pic.twitter.com/zGEVuVD2Yj",,,#,"1255195157051441155",https://twitter.com/JExpMed/status/1255195157051441155
AACR,2020-04-28 14:00,7,20,"# AACR20 Virtual Annual Meeting I: Early Detection and ctDNA Session. David D. Thiel presents results from a study that tested a multicancer early detection liquid biopsy test designed to predict the presence or absence of cancer and the tissue of origin. pic.twitter.com/v8y6FZvGOS",,,#,"1255195115750076416",https://twitter.com/AACR/status/1255195115750076416
OncologyCentral,2020-04-28 14:00,0,2,"A global collaboration is investigating the impact of # COVID19 on # thoracicmalignancies. Find out the first results presented at # AACR20 today!",,,# # #,"1255195075161796608",https://twitter.com/OncologyCentral/status/1255195075161796608
JAMANetwork,2020-04-28 14:00,0,1,"Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer from @ JAMA_current, and other recent # oncology articles from the JAMA Network, are available free online during the # AACR20 virtual meeting https://ja.ma/3bDVFvS",,@,# #,"1255195072578170881",https://twitter.com/JAMANetwork/status/1255195072578170881
NatureCancer,2020-04-28 13:59,10,30,"Check recent content @ NatureCancer about # ctDNA and # LiquidBiopsy in cancer: - # Immunotherapy in SCLC and NSCLC, ITH, clinical implementation, and more! https://nature.com/articles/s43018-019-0011-0 … https://nature.com/articles/s43018-019-0022-x … https://nature.com/articles/s43018-019-0020-z … https://nature.com/articles/s43018-020-0043-5 … # AACR20 pic.twitter.com/agOl6k5Zfh",,@,# # # #,"1255194959818502144",https://twitter.com/NatureCancer/status/1255194959818502144
ivybelkins,2020-04-28 13:58,7,5,"Early detection at # AACR20: David Thiel @ MayoClinic speaks about test to predict cancer and organ of origin w/cfDNA. "Intention is to use in addition to testing based on screening guidelines (not on its own)" -- wondering why not for all patients? # lcsm @ lungcancer @ EGFRResisterspic.twitter.com/uzEWy6WNWR",,@ @ @,# #,"1255194814129324033",https://twitter.com/ivybelkins/status/1255194814129324033
pashtoonkasi,2020-04-28 13:58,1,2,"# AACR20 Interesting # Immunotherapy # COVID19pic.twitter.com/38uf7KAy1M",,,# # #,"1255194663105019904",https://twitter.com/pashtoonkasi/status/1255194663105019904
LUNGevity,2020-04-28 13:58,5,7,"Simple blood test based on methylation-based, circulating cell-free cancer DNA showing promise in catching cancer at different stages and identifying the tissue of origin of cancer. Cannot wait for it to be applied to early detection! Dr. David Thiel # AACR2020 # AACR20 # LCSMpic.twitter.com/C1Th37JSeA",,,# # #,"1255194628510400512",https://twitter.com/LUNGevity/status/1255194628510400512
GalMarkel,2020-04-28 13:57,0,8,"Just served as a discussant on the Adoptive Cell Transfer Session at the @ AACR Virtual Meeting. With 60,000+ participants, this puts @ lemelbaum and @ SHEBA_ on the map!",,@ @ @,,"1255194517646577667",https://twitter.com/GalMarkel/status/1255194517646577667
AriellaHanker,2020-04-28 13:57,5,15,"Happening now at # AACR20: early detection and # ctDNA, introduced by @ Albert0Bardelli. Very exciting area of research!pic.twitter.com/PUyQ3w3umO",,@,# #,"1255194433093619718",https://twitter.com/AriellaHanker/status/1255194433093619718
NatureCancer,2020-04-28 13:56,6,11,"Check recent content @ NatureCancer about # ctDNA and # LiquidBiopsy in cancer: - # Immunotherapy in SCLC and NSCLC, ITH, clinical implementation, and more! https://www.nature.com/articles/s43018-019-0011-0 … https://www.nature.com/articles/s43018-019-0022-x … https://www.nature.com/articles/s43018-019-0020-z … https://www.nature.com/articles/s43018-020-0043-5 … # AACR20 https://twitter.com/krknrm/status/1255192484923297792 …",,@,# # # #,"1255194301719556096",https://twitter.com/NatureCancer/status/1255194301719556096
HemOncToday,2020-04-28 13:56,2,0,"COVID-19 outcomes more severe among individuals with cancer according to data from # AACR20 and @ CD_AACR Read more: http://bit.ly/2VLx4jj # coronaviruspic.twitter.com/movThDL1od",,@,# #,"1255194274184024065",https://twitter.com/HemOncToday/status/1255194274184024065
adamfeuerstein,2020-04-28 13:56,3,23,"For the first time, a blood test helped doctors find and treat cancers in seemingly healthy people https://www.statnews.com/2020/04/28/thrive-aacr-results-blood-test-heathy-people/ … via @ sheridan_kate # AACR20",,@,#,"1255194263610155009",https://twitter.com/adamfeuerstein/status/1255194263610155009
A1exandra1193,2020-04-28 13:56,0,0,"I followed this page because it was founded by Governor Haley, who I had the utmost respect for. Anyone keeping up with the latest studies know American doctors and scientists are working with the Chinese. The @ AACR just published a joint study. Shame on you, Governor Haley.",,@,,"1255194215837040643",https://twitter.com/A1exandra1193/status/1255194215837040643
Martin_AngelMD,2020-04-28 13:56,2,2,"Agnostic indication or better called # PersonalizedMedicine approach... We need more # clinicaltrials like this! # AACR20 # OncoAlert # UroOncoIAF",,,# # # # #,"1255194187659706377",https://twitter.com/Martin_AngelMD/status/1255194187659706377
NicoleKuderer,2020-04-28 13:53,3,7,"@ Cihan_Ay_MD @ MarcCarrier1 @ AnnaFalanga19 @ ICTHIC @ icthicmagazine @ jzbos @ gary_lyman @ connors_md @ MaryCushmanMD @ KSanfilippoMD @ cczielinski @ MiddeldorpS @ ADesaiMD @ AggieLeeMD @ agrothey @ SimonNoble @ bwoodmd @ ASH_hematology @ ASCO @ SWOG @ fredhutch @ AACR @ VivekSubbiah @ PergamIChttps://twitter.com/NicoleKuderer/status/1255191905740001280 …",,@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @,,"1255193321724493824",https://twitter.com/NicoleKuderer/status/1255193321724493824
christeeny513,2020-04-28 13:52,0,9,"TNO155 is a SHP2 inhibitor in # ClinicalTrials for # metastatic # cancers incl breast & # NCSLC. Shows distinct differences from its predecessors incl fewer side effects & possible synergy w/ immunotherapy. # AACR20 # BCSM # LCSM # CrcSM # EsocSM # HncSM # GIST https://clinicaltrials.gov/ct2/show/NCT03114319 …https://twitter.com/HartungIngo/status/1255188319689940992 …",,,# # # # # # # # # # #,"1255193075732942850",https://twitter.com/christeeny513/status/1255193075732942850
tcellsrus,2020-04-28 13:50,1,0,"@ GalMarkel discussant for # AACR2020 virtual meeting Adoptive cell therapy section performed skillful dissection of NSCLC TIL study. All ACT trials should be subject to same rigor. I encourage you to view his discussion presentation.",,@,#,"1255192656386437120",https://twitter.com/tcellsrus/status/1255192656386437120
guptaarjun90,2020-04-28 13:50,4,42,"Baller co-fellow, physician-scientist, and desk neighbor @ JZimmermanMDPhD presents her work at # AACR20 virtually: ''miR-21 inhibition in mice models of pancreatic cancer'' She talks organoids, I talk OCM, @ jaffeejaffee/ @ laherda mentor both. Incredible to be at @ hopkinskimmel!pic.twitter.com/om7WtTTHj2",,@ @ @ @,#,"1255192555773243394",https://twitter.com/guptaarjun90/status/1255192555773243394
krknrm,2020-04-28 13:49,1,3,"Now, off to the # ctDNA and liquid biopsy # AACR20 !",,,# #,"1255192484923297792",https://twitter.com/krknrm/status/1255192484923297792
d2merino,2020-04-28 13:49,0,1,"Thank you, @ elfarukpath11 ! Hope you are doing well!!",,@,,"1255192390190747649",https://twitter.com/d2merino/status/1255192390190747649
krknrm,2020-04-28 13:48,1,1,"Adoptive Cell Transfer Therapy session # AACR2020 was fab -some ongoing phase I/II # clinicaltrials in DLBCL and NSCLC pipelines, challenges and finding novel targets or relevant cell types and resistance mechs using # CRISPR - whoa!",,,# # #,"1255192198884347905",https://twitter.com/krknrm/status/1255192198884347905
lymphomahub,2020-04-28 13:47,1,2,"CONGRESS | # AACR20 | Authors conclude GB226 has promising clinical activity, particularly in patients with PD-1 CPS >50%, and an acceptable safety profile # lymsmpic.twitter.com/vBJi5nbypz",,,# #,"1255192022895529985",https://twitter.com/lymphomahub/status/1255192022895529985
lymphomahub,2020-04-28 13:47,3,4,"CONGRESS | # AACR20 | Yuan-kai Shi presents results from a phase II trial of geptanolimab (GB226), an anti PD-1 humanized, monoclonal antibody, in patients with R/R PTCL # lymsmpic.twitter.com/WMsnNysH0Z",,,# #,"1255192013068263424",https://twitter.com/lymphomahub/status/1255192013068263424
RonPete88326415,2020-04-28 13:47,0,1,"Such as eating and breathing industrial pollutants. Always ready to blame 'lifestyle' never interested in study big polluters. Why is that?",,,,"1255191913717620737",https://twitter.com/RonPete88326415/status/1255191913717620737
acmoorephd,2020-04-28 13:42,0,3,"While watching # AACR20 talks, my kids: "Mom! There's a big fly in my room!" "Mom! Do we have a shoe horn?" "Mom! I need to print this form!"",,,#,"1255190653526409216",https://twitter.com/acmoorephd/status/1255190653526409216
BentheFidler,2020-04-28 13:42,2,5,"Latest for @ BioPharmaDive: Thrive, chasing Grail with a cancer blood test, finds tumors in seemingly healthy women https://www.biopharmadive.com/news/thrive-grail-liquid-biopsy-detect-cancer-aacr/576901/ … # AACR20 # liquidbiopsy @ GrailBio @ HopkinsMedicine",,@ @ @,# #,"1255190547322503168",https://twitter.com/BentheFidler/status/1255190547322503168
MicheleMFCR,2020-04-28 13:42,0,0,"Though I wish we could all meet in person, happy to be spending the day participating in @ AACR's 1st virtual annual meeting. Great to see all the breakthroughs that will change the game understanding the disease and discovering new biomarkers and treatment https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/ …",,@,,"1255190545238016000",https://twitter.com/MicheleMFCR/status/1255190545238016000
ADCReview,2020-04-28 13:41,2,1,"Netherlands-based @ Synthon Biopharmaceuticals, developing innovative the anti-HER2 antibody-drug conjugate [vic-] trastuzumab duocarmazine # SYD985 for breast cancer, has been relaunched as @ byondis https://adc.expert/Byondis # ADC # breastcancer @ World_ADC @ ASCO @ AACR @ CPhIWW # biotech",,@ @ @ @ @ @,# # # #,"1255190290719297544",https://twitter.com/ADCReview/status/1255190290719297544
tmprowell,2020-04-28 13:37,0,6,"Thanks Dr. @ LudaBazhenovaMD. I know the feeling. I just met my own Twitter-doctor-crush Dr. @ marklewismd at # ASCO19. The loss of the face-to-face connections at # AACR20, # ASCO20, & more is truly painful.",,@ @,# # #,"1255189375207575553",https://twitter.com/tmprowell/status/1255189375207575553
RousseauMC,2020-04-28 13:36,0,0,"Study from Wuhan presented at # AACR2020 today @ AACR https://twitter.com/washingtonpost/status/1255119702898155526 …",,@,#,"1255189176129146883",https://twitter.com/RousseauMC/status/1255189176129146883
GusTheChemist,2020-04-28 13:35,0,1,"Hohoooo ! This spiro-THF bearing 2 chiral centers is really nice ! Solving phototox but still exhibit a sulfur diaryl ? Is that prone to oxidation to the correspondung sulfone or sulfoxide ?",,,,"1255188901754527744",https://twitter.com/GusTheChemist/status/1255188901754527744
allisoncarrbs,2020-04-28 13:35,0,2,"Really enjoyed the Plenary Session on Adoptive Cell Transfer Therapy and particularly excited about the potential of multispecific CAR-T therapy and what the future holds. Thank you Dr's Chen and Shalabi for sharing with us! # AACR20",,,#,"1255188882393640960",https://twitter.com/allisoncarrbs/status/1255188882393640960
HartungIngo,2020-04-28 13:33,10,58,"This was the structural disclosure many were waiting for at # AACR20 @ AACR: Matthew LaMarche of @ NovartisScience raising the curtain for clinical SHP2 inhibitor # TNO155. Structurally quite distinct from previous tool SHP099 in order to address phototox & off-target liabilitiespic.twitter.com/iOeyie4nia",,@ @,# #,"1255188319689940992",https://twitter.com/HartungIngo/status/1255188319689940992
DrMirallas,2020-04-28 13:30,1,2,"Great talk about the usage of # TILs in # NSCLC by Dr. Creelan from @ MoffittNews # PhaseI Do not miss the remaining presentations from the I Virtual Meeting @ AACR Some slides # CancerResearchpic.twitter.com/J4pEMmkfmK",,@ @,# # # #,"1255187663025590275",https://twitter.com/DrMirallas/status/1255187663025590275
Kamacintosh,2020-04-28 13:30,0,1,"# AACR2020 has been very informative, awesome to have access to these plenary sessions, TY # LCSM",,,# #,"1255187608063356930",https://twitter.com/Kamacintosh/status/1255187608063356930
drsam,2020-04-28 13:30,0,4,"Sending the wonderful @ MaverickNY the three things that she'll be missing from # AACR20 this year. I will certainly miss seeing you in the front row! pic.twitter.com/Ed8QGtN5aa",,@,#,"1255187592200376321",https://twitter.com/drsam/status/1255187592200376321
LUNGevity,2020-04-28 13:30,2,5,"Excellent discussion on factors that determine tumor-infiltrating lymphocyte (TIL) anti-cancer therapy by @ GalMarkel @ SHEBA_ # AACR2020 # AACR20 # LCSMpic.twitter.com/AmxWgOuBeu",,@ @,# # #,"1255187568435609601",https://twitter.com/LUNGevity/status/1255187568435609601
CEBP_AACR,2020-04-28 13:30,1,1,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/2Ydstbt pic.twitter.com/HclH4Wazbh",,@,#,"1255187547120111618",https://twitter.com/CEBP_AACR/status/1255187547120111618
JCellBiol,2020-04-28 13:30,1,1,"Normal skin corrals cancer-causing mutations and reveals how tissue can subvert tumorigenesis. Read new short summaries of articles (https://bit.ly/2XYckGS ) that are part of JCB’s new cancer collection for # AACR20 https://bit.ly/2Vv9GXj pic.twitter.com/Afr4RVoSCS",,,#,"1255187544020574215",https://twitter.com/JCellBiol/status/1255187544020574215
OncologyCentral,2020-04-28 13:30,0,1,"Find out the breaking # cancer # earlydetection and # prevention news from # AACR20 in our summary piece below!",,,# # # #,"1255187524026339329",https://twitter.com/OncologyCentral/status/1255187524026339329
mponzsar,2020-04-28 13:29,1,1,"Congrats to @ evilarsan and team for the data presented at # AACR2020! https://twitter.com/evilarsan/status/1254866089865031681 …",,@,#,"1255187481185714177",https://twitter.com/mponzsar/status/1255187481185714177
RousseauMC,2020-04-28 13:28,1,6,"Patients with lung cancer, hematologic cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. https://twitter.com/aacr/status/1255143979265323010?s=21 … @ AACR # AACR2020 @ DoctorJSpicer @ BrendonStilesMDhttps://twitter.com/AACR/status/1255143979265323010 …",,@ @ @,#,"1255187241338576897",https://twitter.com/RousseauMC/status/1255187241338576897
Exon20Group,2020-04-28 13:26,0,2,"Takeda's Francois Gonzalvez, PhD delineated TAK-788's long-awaited structure today during # AACR20 New Drugs presentation. Great topic choices throughout the session by DFCI's Sara Buhrlage, PhD and the AACR Chemistry in Cancer Research Steering Committee. "mobo" for mobocertinib?",,,#,"1255186663782838273",https://twitter.com/Exon20Group/status/1255186663782838273
highwirepress,2020-04-28 13:26,0,1,". @ AACR has been a valued customer of HighWire for over a decade, and has continued to grow and scale its use of services over that time. We're very happy to see them renew once more!",,@,,"1255186594149040132",https://twitter.com/highwirepress/status/1255186594149040132
lymphomahub,2020-04-28 13:24,1,2,"ZUMA-6 study design available below # lymsm # AACR20 pic.twitter.com/Ta2nZVoGYR",,,# #,"1255186251138957312",https://twitter.com/lymphomahub/status/1255186251138957312
LUNGevity,2020-04-28 13:24,3,1,"Tumor-infiltrating lymphocytes (TILs)-based cell therapy looking promising in advanced-stage NSCLC patients who have progressed on immuno tx. Even in patients w/ driver mutations. Dr Ben Creelan @ MoffittNews # AACR2020 # AACR20 # LCSMpic.twitter.com/AqFJUzaYzK",,@,# # #,"1255186150815346690",https://twitter.com/LUNGevity/status/1255186150815346690
theresalygh,2020-04-28 13:23,0,1,"This online # AACR20 is pretty cool.",,,#,"1255186003460907009",https://twitter.com/theresalygh/status/1255186003460907009
allisoncarrbs,2020-04-28 13:23,0,0,"Watch Now button wasn't working for me. Had to right click and open in new window to get it to the livestream.",,,,"1255185826666905601",https://twitter.com/allisoncarrbs/status/1255185826666905601
MaverickNY,2020-04-28 13:22,0,5,"One of the cool things about # aacr20 virtual meeting is when a presenter has a motion in the slides to illustrate conformation, drug binding and dark tunnels as Dr LaMarche just showed for SHP2 - so much more fun!",,,#,"1255185580016709634",https://twitter.com/MaverickNY/status/1255185580016709634
highwirepress,2020-04-28 13:21,0,0,"American Association for Cancer Research @ AACR renews commitment to HighWire Hosting https://www.highwirepress.com/news/american-association-for-cancer-research-renews-commitment-to-highwire-hosting?utm_source=twitter&utm_medium=referral&utm_campaign=customer_news …",,@,,"1255185402757025794",https://twitter.com/highwirepress/status/1255185402757025794
DanaFarberNews,2020-04-28 13:20,1,5,"James Cleary, MD, PhD ( @ clearyonc), to present findings on binimetinib in patients NRAS mutation # tumors # AACR20 Abstract link: http://ms.spr.ly/6018Tgdlp pic.twitter.com/tE18CEZl7y",,@,# #,"1255185011021623297",https://twitter.com/DanaFarberNews/status/1255185011021623297
OncoAlert,2020-04-28 13:19,6,10,"Live # AACR20 Tweet by @ ivybelkins "Ben Creelan : Interesting Phase 1 trial shows durable CRs to adoptive cell transfer using TILs in # NSCLC. Many patients were low/no PDL1 and had oncogene drivers. Looking forward to seeing future work in this area" @ OncoAlert # LCSM # lungcancerhttps://twitter.com/ivybelkins/status/1255184180243320833 …",,@ @,# # # #,"1255184950514659328",https://twitter.com/OncoAlert/status/1255184950514659328
elfarukpath11,2020-04-28 13:17,0,1,"Congratulations Diana, I will watch this with my family today.",,,,"1255184456979283969",https://twitter.com/elfarukpath11/status/1255184456979283969
PDRennert,2020-04-28 13:17,2,7,"TIL for NSCLC at # AACR20 pic.twitter.com/Q0J79LXS7A",,,#,"1255184264435507200",https://twitter.com/PDRennert/status/1255184264435507200
ivybelkins,2020-04-28 13:16,21,42,"Ben Creelan, MD @ MoffittNews : Interesting Phase 1 trial shows durable CRs to adoptive cell transfer using TILs in # NSCLC. Many patients were low/no PDL1 and had oncogene drivers. Looking forward to seeing future work in this area. # AACR20 # lcsm # lungcancer @ EGFRResisterspic.twitter.com/16GBuyBez9",,@ @,# # # #,"1255184180243320833",https://twitter.com/ivybelkins/status/1255184180243320833
BiodesixInc,2020-04-28 13:15,1,2,"Tune in to the “Early Detection and ctDNA” plenary session at 2:45 PM ET today for our longitudinal # ddPCR data highlighted in @ AstraZeneca’s virtual podium presentation # AACR2020 https://www.abstractsonline.com/pp8/#!/9045/presentation/10736 …",,@,# # #,"1255183830702424064",https://twitter.com/BiodesixInc/status/1255183830702424064
DrHJHenderson,2020-04-28 13:15,0,1,"Just watched a good talk on this via the # AACR20 virtual meeting. Promising news for the 1-2% of NSCLC patients with EGFR exon 20 insertions. https://twitter.com/TakedaOncology/status/1254746508152442880 …",,,#,"1255183776088576002",https://twitter.com/DrHJHenderson/status/1255183776088576002
PDRennert,2020-04-28 13:14,0,0,"# AACR20",,,#,"1255183571754651650",https://twitter.com/PDRennert/status/1255183571754651650
MM_Oncology,2020-04-28 13:11,2,2,"# AACR20 news: Adding the novel innate immune activator Imprime PGG to # pembrolizumab may elicit a response in women with metastatic triple-negative # BreastCancer, study presented by @ ODayMD ( @ JohnWayneCI) # TNBC # immunotherapyhttps://bit.ly/2W5kbj3",,@ @,# # # # #,"1255182890717138944",https://twitter.com/MM_Oncology/status/1255182890717138944
RandiMHernandez,2020-04-28 13:09,0,1,"The # TERAVOLT trial was mentioned here, as was the upcoming # HERODOTUS trial # AACR20 -- Q&A with @ DrMLChuahttps://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/melvin-chua-interview-cancer-care-during-covid19-coronavirus-pandemic/ …",,@,# # #,"1255182401728364550",https://twitter.com/RandiMHernandez/status/1255182401728364550
NCICancerBio,2020-04-28 13:07,2,4,"# AACR20: Prospective grant applicants and current grantees can reach out to staff of the Division of Cancer Biology. Contact information for program directors is listed on our website at https://www.cancer.gov/about-nci/organization/dcb/about/contact ….pic.twitter.com/AkDLXp4Z9Q",,,#,"1255181743755313152",https://twitter.com/NCICancerBio/status/1255181743755313152
CBebernitz,2020-04-28 13:05,0,2,"I interned at @ Novartis in college on Dr. LaMarche's team and synthesized many analogues of the ones he is presenting at # AACR20. I miss working with small molecule inhibitors!",,@,#,"1255181415710367746",https://twitter.com/CBebernitz/status/1255181415710367746
celltrialsdata,2020-04-28 13:04,0,0,"# RT @ cells_nnm: RT @ JacobPlieth: Gracell scores a first for CD7-directed Car-T therapy in T-cell leukaemia. Via @ evaluatevantage http://bit.ly/2VJr8Y2 # AACR20",,@ @ @,# #,"1255181050357178371",https://twitter.com/celltrialsdata/status/1255181050357178371
jefburgin,2020-04-28 13:03,0,0,"I have myeloma and had a stem cell transplant in 2013. I’ve been fine since and at my check up in March my consultant said I no longer had “an underlying condition” as far as coronavirus was concerned. Then I got the letter from nhs saying I was on the vulnerable list. Confused!",,,,"1255180924628631553",https://twitter.com/jefburgin/status/1255180924628631553
lymphomahub,2020-04-28 13:03,15,20,"CONGRESS | # AACR20 | Caron A Jacobson, @ DanaFarber, presents results from ZUMA-6: axi-cel + atezolizumab for refractory DLBCL. ORR was 75% with a 46% CR rate and no significant increase in incidence of AEs # lymsmpic.twitter.com/nARISEHLLb",,@,# #,"1255180880320049152",https://twitter.com/lymphomahub/status/1255180880320049152
MDAndersonNews,2020-04-28 13:02,5,18,"Combining the immunotherapy drug durvalumab with chemotherapy achieved improved response in advanced # ovariancancer patients, according to a recent MD Anderson-led study, presented at # AACR20 by our @ ShannonWestin: https://bit.ly/2S8DaIf # CancerMoonshot # endcancer",,@,# # # #,"1255180482838499328",https://twitter.com/MDAndersonNews/status/1255180482838499328
PDRennert,2020-04-28 13:01,2,8,"atezolizumab does not notably improve axi-cel outcomes in DLBCL but -- a few noteworthy outcomes, n=2, late conversion of PR > CR, and CAR-T persistence might be a little bit better worth watching this $ GILD # KITE # AACR20",,,# #,"1255180472927297538",https://twitter.com/PDRennert/status/1255180472927297538
JExpMed,2020-04-28 13:00,8,18,". @ VirusesImmunity & Anna Marie Pyle: A stem loop RNA that stimulates RIG-I activation delays tumor growth, extends survival, and prevents tumor recurrence. JEM’s cancer collection for # AACR20 (https://bit.ly/3avNaBK ) has summaries of articles in this PDF: https://bit.ly/2XYhG4z pic.twitter.com/opwHDK5OAQ",,@,#,"1255180049063477250",https://twitter.com/JExpMed/status/1255180049063477250
AACR,2020-04-28 13:00,10,21,"# AACR20 Virtual Annual Meeting I: Adoptive Cell Transfer Therapy Session. Ben Creelan presents results from a phase I trial. Durable complete responses to adoptive cell transfer using tumor infiltrating lymphocytes (TIL) in non-small cell lung cancer (NSCLC). pic.twitter.com/CzRhFEQL6I",,,#,"1255180026275926016",https://twitter.com/AACR/status/1255180026275926016
MCT_AACR,2020-04-28 13:00,0,0,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/2KJdG00 pic.twitter.com/vmglimL5fn",,@,#,"1255180013017731075",https://twitter.com/MCT_AACR/status/1255180013017731075
CR_AACR,2020-04-28 13:00,0,0,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/3bL3OPv pic.twitter.com/T8TrvEFYqR",,@,#,"1255180012384391168",https://twitter.com/CR_AACR/status/1255180012384391168
MCR_AACR,2020-04-28 13:00,0,0,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/3bLkQwX pic.twitter.com/OU8SRZ8V5x",,@,#,"1255180012325658625",https://twitter.com/MCR_AACR/status/1255180012325658625
CIR_AACR,2020-04-28 13:00,2,2,"Read the Must Read article collection featuring the most-read pieces of content published in 2019. # AACR20 https://bit.ly/3bNAZ4H pic.twitter.com/U2ej6mdP0r",,,#,"1255180007573532674",https://twitter.com/CIR_AACR/status/1255180007573532674
JAMANetwork,2020-04-28 13:00,0,0,"Learn more about publishing your # AACR20 research, and other # oncology research, in @ JAMA_current and other JAMA Network journals https://ja.ma/2ytQmAP",,@,# #,"1255179973033328646",https://twitter.com/JAMANetwork/status/1255179973033328646
AmgenOncology,2020-04-28 13:00,11,81,". @ Amgen strives to address the unmet need for # prostatecancer patients. This includes investigating potential therapeutic targets such as STEAP1 which is over-expressed in more than 80 percent of prostate cancers. See data presented earlier today at # AACR20 pic.twitter.com/9eGGWlLpM6",,@,# #,"1255179972815122432",https://twitter.com/AmgenOncology/status/1255179972815122432
DrJNaidoo,2020-04-28 12:57,1,4,"Highlight 2 # LCSM # AACR2020 plenary. Tobacco is a risk factor for a proportion of lung cancers. Salient points: 1. Ecigs & vaping tobacco is on the rise in young individuals 2. Geospatial data identifies disparities in tobacco access, and in other factors relevant to lung cancer pic.twitter.com/C6uenbWKX7",,,# #,"1255179441900306433",https://twitter.com/DrJNaidoo/status/1255179441900306433
AriellaHanker,2020-04-28 12:57,0,8,"Promising new # SERD # GDC9545 for # ER+ # breastcancer. Optimized for ER degradation and PK. Also encouraging phase I results presented by @ jhaveri_komal at # SABCS19, including in pts with # ESR1 mutations. Wonder how this compares to other new SERDs. # AACR20 https://twitter.com/HartungIngo/status/1255174980213628929 …",,@,# # # # # # #,"1255179307221159938",https://twitter.com/AriellaHanker/status/1255179307221159938
ADCReview,2020-04-28 12:57,1,1,"ADC Review | Journal of Antibody-drug Conjugates likes to congratulate @ ImmunomedicsInc with the approval of sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with # mTNBC. https://adc.expert/Sacituzumab_Govitecan_Trodelvy … @ ASCO @ AACR @ World_ADC # ADC # breastcancer @ Trodelvy",,@ @ @ @ @,# # #,"1255179217538514944",https://twitter.com/ADCReview/status/1255179217538514944
SyedMAhmedMDPhD,2020-04-28 12:56,0,1,""low ECOG PS, hematologic malignancy, and receipt of chemotherapy in the last 3 mo (mostly for advanced disease) were associated with worse outcomes" # AACR20 https://twitter.com/Jbauml/status/1255130518418489344 …",,,#,"1255178999514488835",https://twitter.com/SyedMAhmedMDPhD/status/1255178999514488835
gerlach_d,2020-04-28 12:55,0,0,"Matthew J. LaMarche on "The discovery of TNO155: A first in class SHP2 inhibitor" at the # AACR20 meeting. # SHP2",,,# #,"1255178954706690048",https://twitter.com/gerlach_d/status/1255178954706690048
CBebernitz,2020-04-28 12:55,0,2,"Day 2 of # AACR20 and my coworker wanted to listen in with me, I’m not complaining. pic.twitter.com/pm3hZN14va",,,#,"1255178828231716865",https://twitter.com/CBebernitz/status/1255178828231716865
gerlach_d,2020-04-28 12:54,0,4,"Switching sessions/tracks has never been easier, thanks to the virtual format of the # AACR20 Annual Meeting compared to an in-person meeting - however missing the human interactions.",,,#,"1255178635222355968",https://twitter.com/gerlach_d/status/1255178635222355968
MaverickNY,2020-04-28 12:54,2,4,"Postcards from # AACR20 - some reflections and commentary on Day 1 of the virtual meeting - lots to think about and discuss here! https://pxlme.me/oQ37u728 pic.twitter.com/ugXgUJC58r",,,#,"1255178530423549952",https://twitter.com/MaverickNY/status/1255178530423549952
SyedMAhmedMDPhD,2020-04-28 12:53,0,0,"Thoracic cancer patients in Teravolt international registry for # COVID19 pts. # AACR20 https://twitter.com/Jbauml/status/1255127594141433856 …",,,# #,"1255178365939716100",https://twitter.com/SyedMAhmedMDPhD/status/1255178365939716100
GustaveRoussy,2020-04-28 12:53,13,30,"Pr Fabrice @ barlesi @ GustaveRoussy a présenté en plénière # Covid19etCancer du congrès # AACR20 une analyse précoce de la situation et la manière dont Gustave Roussy s’est adapté avec agilité pour gérer l’épidémie de # covid19. Lire le communiqué :https://www.gustaveroussy.fr/fr/congres-virtuel-aacr-pleniere-analyse-retour-experience-cancer-covid-19 …",,@ @,# # #,"1255178271995682818",https://twitter.com/GustaveRoussy/status/1255178271995682818
christeeny513,2020-04-28 12:52,3,8,"3/3 More research will lead to the development of improved preclinical animal models, more refined imaging & monitoring techniques, & the discovery of treatments for # patients w/ # brainmets. Overall MORE evidence-based data is needed! # BCSM # LCSM # MelSM # AACR20",,,# # # # # #,"1255178095956459525",https://twitter.com/christeeny513/status/1255178095956459525
christeeny513,2020-04-28 12:52,3,11,"2/3 Even when pre-clinical data show activity in the brain, patients with progressing, unstable, untreated # patients are often excluded. This is a MAJOR unmet need in the # cancer community. # BCSM # LCSM # MelSM # AACR20",,,# # # # # #,"1255178095184809985",https://twitter.com/christeeny513/status/1255178095184809985
christeeny513,2020-04-28 12:52,6,14,"1/3 Common among the many # ClinicalTrials I've posted testing drugs discussed at # # AACR20, is the exclusion of patients w/ unstable # BrainMets. Why?! # BCSM # LCSM # MelSM Cc @ itsnot_pink @ lianne_kraemer @ lyndaweatherby @ chawnte3 @ keylareece @ LizFrank18",,@ @ @ @ @ @,# # # # # # #,"1255178094379511813",https://twitter.com/christeeny513/status/1255178094379511813
StephenVLiu,2020-04-28 12:52,11,19,"# OncoAlert # AACR20 Dr. Carlos Gomez-Martin presents # COVID19 data from Hospital 12 de Octubre in Madrid, Spain. Data slides not posted at his request but of note: higher proportion of patients with lung cancer, mortality 25%, radiographic changes common, neutropenia a major risk.pic.twitter.com/s9JOTPgEur",,,# # #,"1255177971536707593",https://twitter.com/StephenVLiu/status/1255177971536707593
SyedMAhmedMDPhD,2020-04-28 12:51,0,0,"Cancer patients in Wuhan, China with # COVID19. # AACR20 https://twitter.com/Jbauml/status/1255122864359059462 …",,,# #,"1255177822626250754",https://twitter.com/SyedMAhmedMDPhD/status/1255177822626250754
AML_Hub,2020-04-28 12:51,6,12,"CONGRESS | # AACR20 | ABBV-184 is a survivin-specific TCR x CD3 bispecific therapeutic being investigated in patients with AML and lung cancer. The phase I trial is currently enrolling patients # leusmpic.twitter.com/lZKK15Qnmt",,,# #,"1255177815646969856",https://twitter.com/AML_Hub/status/1255177815646969856
Cancer_Cell,2020-04-28 12:50,1,2,"It's not too late to check the great content of the # CancerResearchWeek Hub from Cell Press # AACR20 https://twitter.com/CellPressNews/status/1252273045143719937 …",,,# #,"1255177607307571205",https://twitter.com/Cancer_Cell/status/1255177607307571205
rn_katie,2020-04-28 12:50,0,0,"I thought this was already a known risk factor?",,,,"1255177460435628038",https://twitter.com/rn_katie/status/1255177460435628038
OncoAlert,2020-04-28 12:49,3,3,"Live # AACR20 Tweet by @notthatjenesmith " # Cancer patients who received anti-tumor treatment within 14 days of # COVID19 diagnosis had an increased risk of severe events, according to data from 3 hospitals in Wuhan. Presentation by Li Zhang" @ OncoAlert https://twitter.com/notthatjensmith/status/1255167059937411072 …",,@notthatjenesmith @,# # #,"1255177278843224070",https://twitter.com/OncoAlert/status/1255177278843224070
theMMRF,2020-04-28 12:49,8,8,"We are monitoring reports from @ AACR this morning that # cancer patients may be more vulnerable to # COVID19. We are proactively gathering data from our # MMRC clinical sites to evaluate implications for # myeloma patients and will keep you updated.https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,@,# # # #,"1255177229740507136",https://twitter.com/theMMRF/status/1255177229740507136
OncoAlert,2020-04-28 12:47,3,5,"Live # AACR20 Tweet by @ ariellahanker "TAK-788 shows promise in # NSCLC patients with @ EGFR Exon 20 insertions. But, toxicity may be an issue. High rates of dose interruptions/reductions. GI toxicity and rash still a problem, suggesting it’s still blocking WT EGFR?" @ OncoAlert https://twitter.com/AriellaHanker/status/1255175759473397765 …",,@ @ @,# #,"1255176803997618176",https://twitter.com/OncoAlert/status/1255176803997618176
gerlach_d,2020-04-28 12:46,0,0,"No side effects under systemic miR-21 delivery in mice # AACR20",,,#,"1255176622250119168",https://twitter.com/gerlach_d/status/1255176622250119168
illumina,2020-04-28 12:46,1,4,"@ AlmacGroup # AACR20 4/ pic.twitter.com/u6ZojiLWGq",,@,#,"1255176487579222016",https://twitter.com/illumina/status/1255176487579222016
illumina,2020-04-28 12:46,0,5,"# AACR20 3/ pic.twitter.com/PHYeq3iymO",,,#,"1255176486513852417",https://twitter.com/illumina/status/1255176486513852417
illumina,2020-04-28 12:46,0,1,"@ OmniSeq # AACR20 2/ pic.twitter.com/mjAjq86TYG",,@,#,"1255176485356179456",https://twitter.com/illumina/status/1255176485356179456
AriellaHanker,2020-04-28 12:43,3,9,"TAK-788 shows promise in # NSCLC patients with @ EGFR Exon 20 insertions. But, toxicity may be an issue. High rates of dose interruptions/reductions. GI toxicity and rash still a problem, suggesting it’s still blocking WT EGFR? May also be a useful drug for # HER2 mutants. # AACR20 pic.twitter.com/mPY2RP4rJb",,@,# # #,"1255175759473397765",https://twitter.com/AriellaHanker/status/1255175759473397765
pashtoonkasi,2020-04-28 12:42,0,4,"# AACR20 agreed. Hopefully this would be another tumor-agnostic indication with better understanding of which aberrations & more potent but tolerable drugs. We have an agnostic trial open for the following. # PARP # PANCSM # BRCA https://clinicaltrials.gov/ct2/show/NCT04171700 …pic.twitter.com/jg012YKoC2",,,# # # #,"1255175469907021824",https://twitter.com/pashtoonkasi/status/1255175469907021824
JoWFSG,2020-04-28 12:40,1,4,"Great to see our Digital Editors still keeping their site members up to date with the latest research from # AACR20. Check out their coffee chat highlight from day 1 of the meeting https://twitter.com/TristanFreefsg/status/1255156646105546752 …",,,#,"1255175107984666626",https://twitter.com/JoWFSG/status/1255175107984666626
coffeemommy,2020-04-28 12:40,2,5,"Such a hot button for me too. People may have the ability to "reduce their risk" of cancer but true prevention is still not possible in most cases. To pretend otherwise is detrimental and creates stigma and shaming. # WordsMatter # lcsm # bcsm # AACR20 # AACR2020",,,# # # # #,"1255175000316710912",https://twitter.com/coffeemommy/status/1255175000316710912
HartungIngo,2020-04-28 12:40,5,20,"Great talk by Xiaojing Wang @ genentech today at # AACR20 @ AACR: the discovery path to 3rd gen. SERD GDC9545. An example for organizational perseverance & state-of-the-art structure-driven compound fine-tuning (with long ER off-rates potentially driving high degradation efficacy). pic.twitter.com/5wfX7IdgUq",,@ @,#,"1255174980213628929",https://twitter.com/HartungIngo/status/1255174980213628929
CellPressNews,2020-04-28 12:40,5,11,"The articles compiled in this free digital collection showcase current progress in # immunotherapy—from # immune checkpoint blockade to T cell therapy. # AACR20 - https://bit.ly/2ShjLVH",,,# # #,"1255174963306401800",https://twitter.com/CellPressNews/status/1255174963306401800
gerlach_d,2020-04-28 12:38,1,2,"Jacquelyn Zimmerman from @ JohnsHopkins on "miR-21 inhibition regulates mutant KRAS effector pathways and intercepts development of pancreatic ductal adenocarcinoma" # AACR20",,@,#,"1255174573139677196",https://twitter.com/gerlach_d/status/1255174573139677196
RiyueSunnyBao,2020-04-28 12:38,0,0,"# AACR2020 # virtual # meeting I day 2 ongoing! # COVID19 # Cancer # Adoptive # Cell # Transfer # ctDNA # Predictive # Biomarkers # Immunotherapeutics. Registration is free! https://bit.ly/3cZciCS pic.twitter.com/XAed4MnVlk",,,# # # # # # # # # # # #,"1255174550091857920",https://twitter.com/RiyueSunnyBao/status/1255174550091857920
OWise_uk,2020-04-28 12:37,0,3,"More research with a larger variety of people needs to be done so that we can better understand what factors drive certain demographics to be more prone to having specific breast cancer characteristics.",,,,"1255174244608217091",https://twitter.com/OWise_uk/status/1255174244608217091
NanomedZone,2020-04-28 12:37,3,8,"Editors @ racheljenkinsOC, @TristanFreeW1, @ aabisawyer and @ LChard_FSG sit down to discuss their highlights from day 1 of the first @ AACR Virtual Annual Meeting - take a look at what they had to say https://bit.ly/3aK3b7w # AACR2020",,@ @TristanFreeW1 @ @ @,#,"1255174190321135617",https://twitter.com/NanomedZone/status/1255174190321135617
OWise_uk,2020-04-28 12:36,0,3,"Yes, there is of course high heterogeneity. We understand breast cancer is a multifactoral disease where demographics are just one element. At one of our workshops we met identical twins who both have breast cancer - one was ER+, the other was triple negative.",,,,"1255174131068424200",https://twitter.com/OWise_uk/status/1255174131068424200
NP_Rudqvist,2020-04-28 12:33,0,0,"Yes!",,,,"1255173269390610432",https://twitter.com/NP_Rudqvist/status/1255173269390610432
PippaGledhill,2020-04-28 12:32,0,1,"First clinical data for Gracell's CAR-T against CD7, a niche target. Shanghai YaKe Biotech also listed a CD7 CAR-T in their pipeline in Dec 2017 but no news since # AACR20 https://twitter.com/JacobPlieth/status/1255167328947494913 …",,,#,"1255173154680573954",https://twitter.com/PippaGledhill/status/1255173154680573954
DrLen,2020-04-28 12:32,8,11,"We continue to learn about impact of # COVID19 on # cancer patients. A number of studies reported at @ AACR today continue to expand our knowledge. Now we need a coherent picture. What is clear: many patients with # cancer develop serious illness because of their disease/treatmenthttps://twitter.com/AACR/status/1255126347220951040 …",,@,# # #,"1255173051123142659",https://twitter.com/DrLen/status/1255173051123142659
deb_silverman,2020-04-28 12:32,2,12,"In addition to the results themselves at # AACR2020 online, I have genuinely enjoyed simply hearing the voices of several of my research mentors, clinical mentors, and docs, continuing to move the field forward. @ JenniferLitton @ lab_rezvani @ FilipJankuMD. @ MDAndersonNews",,@ @ @ @,#,"1255173046148743169",https://twitter.com/deb_silverman/status/1255173046148743169
fortint,2020-04-28 12:31,0,1,"Watch Now buttons on sessions page don't work. Have to use the opening page buttons # AACR20 @ AACR # poorusabilityhttps://twitter.com/fortint/status/1255166181796974594 …",,@,# #,"1255172750492291075",https://twitter.com/fortint/status/1255172750492291075
MM_Oncology,2020-04-28 12:30,2,2,"# AACR20 news: GEOMETRY mono-1 data point to the efficacy of # capmatinib in # MetExon14-mutated # NSCLC, inc in patients with brain mets. Click through to read more about this study presented by Edward Garon ( @ UofCalifornia) @ BeccaHeistMD @ MGHThoracicOnchttps://bit.ly/2yayriH",,@ @ @,# # # #,"1255172662122479617",https://twitter.com/MM_Oncology/status/1255172662122479617
AACR,2020-04-28 12:30,5,17,"# AACR20 Virtual Annual Meeting I: Adoptive Cell Transfer Therapy Session. Xinxin Wang presents: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR T therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL). pic.twitter.com/NMcFSXBDzG",,,#,"1255172466764386306",https://twitter.com/AACR/status/1255172466764386306
MyBioTechniques,2020-04-28 12:30,0,1,"The impact of # COVID19 on cancer patients can be devastating. This study presented at # AACR20 identifies the risk factors that could indicate poor outcomes for patients.",,,# #,"1255172422715785217",https://twitter.com/MyBioTechniques/status/1255172422715785217
Martin_AngelMD,2020-04-28 12:29,9,19,"Are all # PARP inhibitors the same?? hitting a PARP more potent can give better clinical outcomes. # NewDrugs session at # AACR20 . # OncoAlert # pcsm # bcsm # ovariancancer # DDR # BRCApic.twitter.com/mTUA5LkQsJ",,,# # # # # # # # #,"1255172329262518274",https://twitter.com/Martin_AngelMD/status/1255172329262518274
krknrm,2020-04-28 12:28,0,6,". @ DavideBernareg1 from the Kaufman just gave a great talk about a CRISPR screens to uncover genes that modulate response to NK immunotherapy - exciting! # AACR20 @ UCSD @ AACR",,@ @ @,#,"1255172070822105089",https://twitter.com/krknrm/status/1255172070822105089
FogacciJoao,2020-04-28 12:25,0,7,"Some signal of Anti-CXL12 therapy + IO in MSS PDA and CRC tumors. No objective responses but prolonged SD. Better outcome: "Immuno signature": IL2/ IL16 INFg Th1 Booster Different phenotype: Lymphoctytes near the tumor # AACR20 # PDA # Microenvironment # CXCL12pic.twitter.com/Q7dShAyIE7",,,# # # #,"1255171191129718784",https://twitter.com/FogacciJoao/status/1255171191129718784
christeeny513,2020-04-28 12:24,8,23,"Next "new drug on the horizon" is an oral SERD (Selective Estrogen Receptor Degrader), GDC-9545. Achieved same efficacy as other SERDs, but at a lower dose. Currently recruiting patients with # ER+ # MBC. # BCSM # AACR20 https://clinicaltrials.gov/ct2/show/NCT03332797 …",,,# # # #,"1255171050113040384",https://twitter.com/christeeny513/status/1255171050113040384
Aiims1742,2020-04-28 12:23,5,20,"The @ SU2C @ lustgartenfdn # PancreaticCancer Interception Dream Team is meeting remotely today (we were going to meet at @ AACR in person pre- # COVID19). @ SapnaSyngal is presenting an update on our @ GenerateStudy. Thank you to all exceptional team members!pic.twitter.com/BthPZ9KloH",,@ @ @ @ @,# #,"1255170742167179264",https://twitter.com/Aiims1742/status/1255170742167179264
NotThatBobJones,2020-04-28 12:22,0,4,"I’m going to have this on the big screen in my living room! Very excited to hear about some of the work being done by @ d2merino and @ md_stewart - both past chairs of # AACRAMC!",,@ @,#,"1255170446221119488",https://twitter.com/NotThatBobJones/status/1255170446221119488
LaurenFSG,2020-04-28 12:20,2,8,"Missing being at # AACR20 in person? Us too! But that doesn't mean that anyone need miss out: @ AACR have done a brilliant job of taking the talks virtual, and our Editors have discussed the key Day 1 takeaways in the first AACR Coffee Chat - take a look >> https://www.oncology-central.com/events-coverage/aacr-virtual-annual-meeting-i-editors-highlights-and-the-latest-news-from-day-1/ … https://twitter.com/OncologyCentral/status/1255167215663493124 …pic.twitter.com/ZvLfx9ZeYO",,@,#,"1255170050669129730",https://twitter.com/LaurenFSG/status/1255170050669129730
ASCOPost,2020-04-28 12:20,1,1,"ctDNA May Be a Prognostic Biomarker of Disease Recurrence in Patients With Lung Cancer https://www.ascopost.com/news/april-2020/ctdna-may-be-a-prognostic-biomarker-of-disease-recurrence-in-patients-with-lung-cancer/ … # LCSM # oncology # cancer # AACR20 # AACR2020 # biomarkers",,,# # # # # #,"1255169906288427009",https://twitter.com/ASCOPost/status/1255169906288427009
mtmdphd,2020-04-28 12:19,0,5,"We analyzed >1000 COVID19+ patients with cancer in less than a month from creating registry. I think people that treat cancer patients would be interested in that. If not they don't need to read it of course.",,,,"1255169904623435778",https://twitter.com/mtmdphd/status/1255169904623435778
mtmdphd,2020-04-28 12:19,0,1,"True. Better than anecdotes though.",,,,"1255169700222427137",https://twitter.com/mtmdphd/status/1255169700222427137
StavroulaSlk,2020-04-28 12:18,1,4,"Today we are moving on # ncRNAs in cancer and early detection & # ctDNA So excited for AACR Virtual Annual Meeting day 2 # AACR20 @ AACR",,@,# # #,"1255169627660922880",https://twitter.com/StavroulaSlk/status/1255169627660922880
DFBC_PedCare,2020-04-28 12:17,0,2,"Today at # AACR20, work on "Mechanisms and therapeutic implications of hypermutation in gliomas" by researchers including Pratiti Bandopadhayay, MBBS, PhD, will be presented at 4:40 p.m. EST. Learn more: http://ms.spr.ly/6017T5CmL pic.twitter.com/4QTmAXE8ek",,,#,"1255169156091195392",https://twitter.com/DFBC_PedCare/status/1255169156091195392
sanamloghavi,2020-04-28 12:16,0,2,"Ahh.. yes! @ ASH_hematology 2018... good times!pic.twitter.com/g2FRli9pXh",,@,,"1255168972594479105",https://twitter.com/sanamloghavi/status/1255168972594479105
RachelBurga,2020-04-28 12:15,0,0,"Agreed! Happy to have this on today’s WFH agenda",,,,"1255168791677480961",https://twitter.com/RachelBurga/status/1255168791677480961
myESMO,2020-04-28 12:15,3,15,"# Covid19 news: First Results from TERAVOLT Registry: mortality among # thoraciccancer pats w/ # COVID-19 is unexpectedly high. Mortality rates do not appear to be associated with any specific type of treatment or comorbidity http://ow.ly/EK5F50zqNQC # lcsm @ marinagarassino # AACR20 pic.twitter.com/bExMao0z9y",,@,# # # # #,"1255168695627890688",https://twitter.com/myESMO/status/1255168695627890688
gerlach_d,2020-04-28 12:14,0,0,"@ AACR, are the sessions from yesterday already available for online viewing? # AACR20",,@,#,"1255168510470356992",https://twitter.com/gerlach_d/status/1255168510470356992
pashtoonkasi,2020-04-28 12:13,3,6,"# AACR20 # COVID19 # COVID19nCancerhttps://twitter.com/notthatjensmith/status/1255167059937411072 …",,,# # #,"1255168313807773697",https://twitter.com/pashtoonkasi/status/1255168313807773697
pashtoonkasi,2020-04-28 12:12,0,1,"# AACR20 beyond this from a systems/process standpoint, as more of this becomes available for other solid tumor types, need to be comfortable understanding & managing toxicities from # CAR-T (and/or BIT-Es). # Immunotherapy # clinicaltrials",,,# # # #,"1255167952841838598",https://twitter.com/pashtoonkasi/status/1255167952841838598
NP_Rudqvist,2020-04-28 12:12,0,0,"This is such a great session!",,,,"1255167951226974211",https://twitter.com/NP_Rudqvist/status/1255167951226974211
tompowles1,2020-04-28 12:12,0,4,"30% mortality for COVID +ve lung cancer patients presented @ AACR. Mixed pateint group. This seems high. # AACR20 https://open.spotify.com/episode/0RIlwP0w4axcj1gvsCHQDo?si=DJSwuQHKSVOhb02B0k3eMg …",,@,#,"1255167903273492481",https://twitter.com/tompowles1/status/1255167903273492481
JacobPlieth,2020-04-28 12:11,1,3,"Did they? I understood that the TCR (and CD7) was separately knocked out by Crispr # AACR20",,,#,"1255167745123115010",https://twitter.com/JacobPlieth/status/1255167745123115010
lymphomahub,2020-04-28 12:10,2,2,"What was your lymphoma highlight from Day 1 of # AACR20? Vote below, or let us know in the comments! # lymsm",,,# #,"1255167475483906048",https://twitter.com/lymphomahub/status/1255167475483906048
StephenVLiu,2020-04-28 12:10,3,5,"# OncoAlert # AACR20 Mortality about 15% which is comparable to general population. Patients with poor performance status at particular risk as well as those who had recently received chemotherapy. Important to monitor characteristics, correlate to outcomes as the pandemic unfolds. pic.twitter.com/aXDadAzyQs",,,# #,"1255167460476686338",https://twitter.com/StephenVLiu/status/1255167460476686338
JacobPlieth,2020-04-28 12:09,10,17,"Gracell scores a first for CD7-directed Car-T therapy in T-cell leukaemia. Via @ evaluatevantage http://bit.ly/2VJr8Y2 # AACR20",,@,#,"1255167328947494913",https://twitter.com/JacobPlieth/status/1255167328947494913
evaluatevantage,2020-04-28 12:09,0,3,"Gracell validates a novel Car-T target https://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-gracell-validates-novel-car-t-target … # AACR20",,,#,"1255167218855415814",https://twitter.com/evaluatevantage/status/1255167218855415814
OncologyCentral,2020-04-28 12:09,5,10,"Check out our Editor's coffee chat, where we discuss our highlights from the first day of # AACR20! @ NanomedZone @ MyBioTechniques @ OncologyCentral",,@ @ @,#,"1255167215663493124",https://twitter.com/OncologyCentral/status/1255167215663493124
pashtoonkasi,2020-04-28 12:08,1,2,"Agreed. # COVID19 in # cancer patients. Not everyone will have the classic signs or symptoms or risk factors/exposure. The more we test, the more we find. # AACR20 # COVID19nCancer",,,# # # #,"1255167081034780674",https://twitter.com/pashtoonkasi/status/1255167081034780674
notthatjensmith,2020-04-28 12:08,9,13,"# Cancer patients who received anti-tumor treatment within 14 days of # COVID19 diagnosis had an increased risk of severe events, according to data from 3 hospitals in Wuhan. Presentation by Li Zhang. # AACR20 # AACR2020 pic.twitter.com/FmCGbWb6vS",,,# # # #,"1255167059937411072",https://twitter.com/notthatjensmith/status/1255167059937411072
AmeetRKini,2020-04-28 12:08,0,1,"This was during an ASH meeting,",,,,"1255166958972145664",https://twitter.com/AmeetRKini/status/1255166958972145664
adamfeuerstein,2020-04-28 12:07,5,18,"Off-the-shelf CAR-T therapy helps leukemia patients in a small, first-in-human trial https://www.statnews.com/2020/04/28/off-the-shelf-car-t-therapy-helps-leukemia-patients-in-a-small-first-in-human-trial/ … via @ sxbegle # AACR20",,@,#,"1255166883394990085",https://twitter.com/adamfeuerstein/status/1255166883394990085
CharuAggarwalMD,2020-04-28 12:07,10,20,"Excited to have @ BrendonStilesMD with us tmrw as we continue our discussions on management of # LungCancer during # COVID19, including updates from # AACR20 @ StephenVLiu @ JackWestMD @ n8pennell @ OncLive @ ginacolumbusonc # LCSM @ OncoAlerthttps://twitter.com/OncLive/status/1255166184976154627 …",,@ @ @ @ @ @ @,# # # #,"1255166762271813632",https://twitter.com/CharuAggarwalMD/status/1255166762271813632
AmeetRKini,2020-04-28 12:06,0,0,"Yes! I stayed at Little Italy in San Diego a few years ago, and it was the greatest experience!",,,,"1255166586715025409",https://twitter.com/AmeetRKini/status/1255166586715025409
oncologypharm,2020-04-28 12:06,9,21,"TAK-788 ph2 in pts with EGFR exon 20 insertions treated at 160mg. ORR 43%. Responses seen in pretreated TKI/IO pts as well. Most common AE is GI tox. Food instructions has been updated in this study to improve GI tox. # AACR20 pic.twitter.com/NJOR4A8xK5",,,#,"1255166549960220672",https://twitter.com/oncologypharm/status/1255166549960220672
StephenVLiu,2020-04-28 12:05,5,7,"# OncoAlert # AACR20 Chemotherapy within the past 3 months correlated with more severe clinical course. I suspect risk will vary by specific regimen though. Added risk not really seen with targeted therapy / TKI or immunotherapy though numbers are small. pic.twitter.com/TY93m1fU0r",,,# #,"1255166305642123264",https://twitter.com/StephenVLiu/status/1255166305642123264
fortint,2020-04-28 12:05,0,0,"# AACR20 # AACR2020 is anyone else having problems with the livestreams? I was dropped and can't get back in @ AACR",,@,# #,"1255166181796974594",https://twitter.com/fortint/status/1255166181796974594
tsellab,2020-04-28 12:05,0,1,"Nice lamp!!",,,,"1255166134334238721",https://twitter.com/tsellab/status/1255166134334238721
CharuAggarwalMD,2020-04-28 12:04,0,2,"# AACR20 # LCSMhttps://twitter.com/ajf324MD/status/1254903038977937409 …",,,# #,"1255165984723415040",https://twitter.com/CharuAggarwalMD/status/1255165984723415040
TaylorJ_MD,2020-04-28 12:04,0,1,"Problem with registry studies are the selection of those reported. Sounds like # CCC19 is trying to address that but there will still be bias towards sicker patients that are admitted or present to clinic.",,,#,"1255165934546964482",https://twitter.com/TaylorJ_MD/status/1255165934546964482
AML_Hub,2020-04-28 12:04,2,1,"Have your say What was your AML highlight from Day 1 at # AACR20? # leusm",,,# #,"1255165882671738884",https://twitter.com/AML_Hub/status/1255165882671738884
StephenVLiu,2020-04-28 12:02,4,6,"# OncoAlert # AACR20 Radiographic changes with # COVID19 fairly common. Will need to see how these evolve with time and recovery. Outcomes to date: 25% with clinical worsening, 11% required ICU, 15% mortality (16% still hospitalized).pic.twitter.com/7KrGpEvydx",,,# # #,"1255165485399891969",https://twitter.com/StephenVLiu/status/1255165485399891969
christeeny513,2020-04-28 12:02,0,1,"Catching up on the morning session "New Drugs on the Horizon" & learning about an oral PARP inhibitor (RBN-2397) actually already in phase 1 trials for any patient with # metastatic # cancer. Did not hear anything about efficacy for # BRCA+. # BCSM # AACR20 https://clinicaltrials.gov/ct2/show/NCT04053673 …",,,# # # # #,"1255165435080818696",https://twitter.com/christeeny513/status/1255165435080818696
CBebernitz,2020-04-28 12:00,0,1,"Interesting $ AMGN STEAP1 x CD3 bispecific data. Since mCRPC has a low mutational burden, I wonder if STEAP1 would better serve as a CAR T cell target than that of a bispecific antibody? # AACR20",,,#,"1255164926810783744",https://twitter.com/CBebernitz/status/1255164926810783744
CAPR_AACR,2020-04-28 12:00,1,2,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/2W8sDhw pic.twitter.com/IowOSopIwv",,@,#,"1255164925808390152",https://twitter.com/CAPR_AACR/status/1255164925808390152
BCD_AACR,2020-04-28 12:00,1,4,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/2yQYg7k pic.twitter.com/Tngbps5Bej",,@,#,"1255164925040787456",https://twitter.com/BCD_AACR/status/1255164925040787456
CIR_AACR,2020-04-28 12:00,1,2,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/2SgUv1V pic.twitter.com/aaBxbqzpYx",,@,#,"1255164924101263362",https://twitter.com/CIR_AACR/status/1255164924101263362
CD_AACR,2020-04-28 12:00,1,3,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/3bPYvy8 pic.twitter.com/kcOaXk4bDr",,@,#,"1255164924042641408",https://twitter.com/CD_AACR/status/1255164924042641408
CCR_AACR,2020-04-28 12:00,1,2,"ICYMI: All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Meeting I. https://bit.ly/2YpQ3C3 pic.twitter.com/5lm0QdUuJ0",,@,#,"1255164923593834497",https://twitter.com/CCR_AACR/status/1255164923593834497
JAMANetwork,2020-04-28 12:00,0,0,"Following the # AACR20 virtual meeting? Read Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types from @ JAMANetworkOpen free online https://ja.ma/2ytBS3U",,@,#,"1255164876055629835",https://twitter.com/JAMANetwork/status/1255164876055629835
ScienceCourtney,2020-04-28 11:58,0,0,"@ AACR Not sure if technical issues on your end or mine? has the EventPro site crashed?",,@,,"1255164601324503040",https://twitter.com/ScienceCourtney/status/1255164601324503040
StephenVLiu,2020-04-28 11:58,3,3,"# OncoAlert # AACR20 Most common symptoms were fever (47%), cough (46%), fatigue (34%), dyspnea (33%), anosmia (10%). Worth noting that only 20% had known contact exposure and 23% were asymptomatic. Also showing their testing rates - the more you test, the more you will find! pic.twitter.com/Mr6xDQSU4w",,,# #,"1255164562065756160",https://twitter.com/StephenVLiu/status/1255164562065756160
krknrm,2020-04-28 11:58,4,13,"Loving the talk by Yvonne Chen giving a bird's-eye view of the pipeline and challenges for CAR-T clinical implementation # AACR20 # cancer # therapypic.twitter.com/9IG5JtN5Er",,,# # #,"1255164406431956992",https://twitter.com/krknrm/status/1255164406431956992
StephenVLiu,2020-04-28 11:55,6,11,"# OncoAlert # AACR20 Overview of # COVID19 and cancer in patients @ GustaveRoussy presented by @ barlesi - 137 patients with COVID-19 also had a diagnosis of cancer. 20% breast, 15% GI, 10% lung. About 60% had active disease, 40% in follow-up / observation.pic.twitter.com/bGt4N84IDn",,@ @,# # #,"1255163722114519041",https://twitter.com/StephenVLiu/status/1255163722114519041
EuLozada1,2020-04-28 11:55,0,1,"Attending the virtual # AACR20 meeting today!!",,,#,"1255163651981443073",https://twitter.com/EuLozada1/status/1255163651981443073
krknrm,2020-04-28 11:53,4,6,"Fantastic thread about the # COVID19 and cancer # COVID19nCancer # AACR20 - thanks! https://twitter.com/ADesaiMD/status/1255154902504026113 …",,,# # #,"1255163328596512769",https://twitter.com/krknrm/status/1255163328596512769
krknrm,2020-04-28 11:52,1,2,"Exciting! # AACR20 # CART # leukemiahttps://twitter.com/SU2Cscience/status/1255161883889487875 …",,,# # #,"1255162953374019585",https://twitter.com/krknrm/status/1255162953374019585
Uromigos,2020-04-28 11:52,1,5,"High mortality presented for lung cancer patients with COVID (30%) from a large international collaboration. # COVID19. # AACR20 https://open.spotify.com/episode/0RIlwP0w4axcj1gvsCHQDo?si=DJSwuQHKSVOhb02B0k3eMg …",,,# #,"1255162866652655616",https://twitter.com/Uromigos/status/1255162866652655616
gerlach_d,2020-04-28 11:50,0,1,"The channel was out for a few minutes - I had to reload several times...",,,,"1255162406763986946",https://twitter.com/gerlach_d/status/1255162406763986946
pashtoonkasi,2020-04-28 11:48,0,0,"# AACR20 https://twitter.com/BeckiLee/status/1255153801276899328 …",,,#,"1255161987199315968",https://twitter.com/pashtoonkasi/status/1255161987199315968
SU2Cscience,2020-04-28 11:48,6,7,"Presentation at # AACR20: @ SU2C @ StBaldricks reports on Phase I trial for novel humanized bispecific CD19/CD22 CAR T cell construct in patients with relapsed/refractory B ALL, 4 of 6 patients respond. Next up is dosage and additional studies # leukemiahttps://standuptocancer.org/research/research-portfolio/dream-teams/intractable-pediatric-cancers-dream-team/ …",,@ @,# #,"1255161883889487875",https://twitter.com/SU2Cscience/status/1255161883889487875
FernandoOnco,2020-04-28 11:47,0,2,"Apesar de alguns estudos mostrarem uma pior evolução da infecção por coronavírus em pacientes com câncer. O melhor tratamento contra o câncer não pode ser negligenciado. Precisamos achatar a curva do câncer. # cancercare # AACR20 Great presentation @ sloan_ketteringpic.twitter.com/bPG46B7G4T",,@,# #,"1255161849814953989",https://twitter.com/FernandoOnco/status/1255161849814953989
ChristianRolfo,2020-04-28 11:47,4,10,"Promising results for EGFR and HER2 exon 20 insertions in phase 1/2. Currently in Trials ongoing. Excited we are close to open in our site the phase 3 for NSCLC first line in EGFR exon 20 insertions # AACR20 @ EGFRResisters @ UMmedschool @ UMGCCC @ OncoAlert @ lcsmchatpic.twitter.com/R2O2ozDqMT",,@ @ @ @ @,#,"1255161706436796417",https://twitter.com/ChristianRolfo/status/1255161706436796417
RachelBurga,2020-04-28 11:46,0,6,"Grateful to @ AACR for opening up their Annual Meeting and allowing everyone to virtually attend and learn from # AACR20 pic.twitter.com/kAvbQ9roTh",,@,#,"1255161507605815299",https://twitter.com/RachelBurga/status/1255161507605815299
RussellPetty19,2020-04-28 11:46,0,1,"Interesting updated data from Wuhan also in same session # AACR2020 with co-publication in @ CD_AACR .Suggests that all cancer patients at increased risk to a varying extent.https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,@,#,"1255161505827491850",https://twitter.com/RussellPetty19/status/1255161505827491850
FaizahAlotaibi_,2020-04-28 11:45,1,0,"Target hyperinflammation might be the fastest therapeutic approach for patients with sever symptoms of # COVID19 I Love this session of COVID-19 and cancer at the # AACR2020 pic.twitter.com/EecMJhAv0a",,,# #,"1255161263002456065",https://twitter.com/FaizahAlotaibi_/status/1255161263002456065
christeeny513,2020-04-28 11:45,5,7,"Great overview of the # COVID19 & # cancer session. # BCSM # LCSM # AACR20 https://twitter.com/notthatjensmith/status/1255159373556482050 …",,,# # # # #,"1255161246242033664",https://twitter.com/christeeny513/status/1255161246242033664
NCIEpiTraining,2020-04-28 11:45,7,13,"Tune in today at # AACR20 Virtual Annual Meeting. Olivia Lee will be presenting her work at 4:25 PM on the genomic characterization of brain metastases across four different types of cancer, breast, lung, renal cell carcinoma, and melanoma. https://buff.ly/2VKlPGB # NCI_ITEBpic.twitter.com/XLQCf7XKaf",,,# #,"1255161109331533825",https://twitter.com/NCIEpiTraining/status/1255161109331533825
HartungIngo,2020-04-28 11:44,4,24,"Interesting strategy to confuse your competitors exemplified today in the New Drugs on the Horizon Session Part 2. Just show different structures for your clinical asset on different slides... (The structure shown on the one pager for TAK-788 is actually osimertinib ) # AACR20 pic.twitter.com/9BzGbRQbhk",,,#,"1255161054998540288",https://twitter.com/HartungIngo/status/1255161054998540288
CharuAggarwalMD,2020-04-28 11:44,2,3,"# COVID19 and # Cancer Thread # AACR20 # LCSMhttps://twitter.com/ADesaiMD/status/1255154902504026113 …",,,# # # #,"1255161000925503488",https://twitter.com/CharuAggarwalMD/status/1255161000925503488
MPishvaian,2020-04-28 11:44,5,8,"PARP7 inhibition (NCT0405373) --> cytosolic nucleic acid signaling, and induces Type I IFN in tumors. By Dr. Vasbinder # AACR20. A more specific mech. for PARP inhibitors activating the STING pathway, as reported last year @ MDAndersonNews? https://www.ncbi.nlm.nih.gov/pubmed/30482774 . @ OncoAlert",,@ @,#,"1255160946563190790",https://twitter.com/MPishvaian/status/1255160946563190790
Cortellis,2020-04-28 11:43,3,1,"Bayer presents positive preclinical data for BAY-2416964, a small-molecule orally available AhR antagonist in phase I development for the treatment of advanced solid tumors. # AACR20",,,#,"1255160724067889154",https://twitter.com/Cortellis/status/1255160724067889154
gerlach_d,2020-04-28 11:43,0,2,"Great collaboration between @ Boehringer and the @ MDAndersonNews TRACTION platform with long-term partners including @ timheff5 and others - looking forward to more exiting science in the future. # AACR20",,@ @ @,#,"1255160705063489545",https://twitter.com/gerlach_d/status/1255160705063489545
TaylorJ_MD,2020-04-28 11:42,0,4,"Interesting session on # COVID19 and # Cancer today # AACR20 |conclusions from different parts of the world ranged from much worse to actually better outcomes vs the general population. Struck me that one difference was whether Stage 4 patients were considered for intubated or not.",,,# # #,"1255160375508717568",https://twitter.com/TaylorJ_MD/status/1255160375508717568
Cortellis,2020-04-28 11:41,0,2,"AstraZeneca presents positive preclinical data for AZD-9833, an orally available SERD that shows a desired half-life in humans and is currently in phase I for ER-positive metastatic breast cancer. # AACR20",,,#,"1255160293572972552",https://twitter.com/Cortellis/status/1255160293572972552
VaughtPhD,2020-04-28 11:41,0,1,"Watched the independent lens on Nobel laureate James Allison last night on @ PBS and follow that up with plenary session on immunotherapy clinical trials today at the @ AACR virtual annual meeting.",,@ @,,"1255160288766300161",https://twitter.com/VaughtPhD/status/1255160288766300161
OncoAlert,2020-04-28 11:41,2,4,"Live # AACR20 tweet by @ notthatjensmith “Patients with # COVID19 are more likely to have poor outcomes if they have # cancer, and # cancer type, stage, and treatment are associated with outcomes, according to a multicenter study presented by HongBing Cai. @ OncoAlert https://twitter.com/notthatjensmith/status/1255159373556482050 …",,@ @,# # # #,"1255160239382581248",https://twitter.com/OncoAlert/status/1255160239382581248
FernandoOnco,2020-04-28 11:40,0,1,"Data from France presented in # AACR20. Dr @ barlesi from @ GustaveRoussy show that target therapy and immune therapy is not associated with worse prognosis during covid19 infection. Great work @ barlesipic.twitter.com/FYZaThxht0",,@ @ @,#,"1255160084646289410",https://twitter.com/FernandoOnco/status/1255160084646289410
pashtoonkasi,2020-04-28 11:40,2,4,"# AACR20 TAK-788 Exon20 # LCSM - role in other HER2-driven cancers?https://www.jto.org/article/S1556-0864(18)32385-2/fulltext …",,,# #,"1255160050399789059",https://twitter.com/pashtoonkasi/status/1255160050399789059
BrittanyEHarvey,2020-04-28 11:39,2,6,"Important takeaways from Dr. Louis Voigt @ sloan_kettering on the widening of disparities during the # COVID19 pandemic & the obligation to protect the most vulnerable # COVID19nCancer # HealthEquity # AACR20 pic.twitter.com/YOKlXVHPXl",,@,# # # #,"1255159670173585411",https://twitter.com/BrittanyEHarvey/status/1255159670173585411
LUNGevity,2020-04-28 11:38,3,3,"TAK-788 (Mobocertinib), a "clean" (highly specific) EGFR Exon 20 inhibitor, is showing promise in Exon 20-mutant NSCLC. Dr Francois Gonzalvez frm Takeda # AACR2020 # AACR20 # LCSMpic.twitter.com/9G6rCiqsVg",,,# # #,"1255159412945227778",https://twitter.com/LUNGevity/status/1255159412945227778
gerlach_d,2020-04-28 11:38,0,1,"TAK-788 can also target HER2 exon20 mutations with a window against WT # AACR20",,,#,"1255159407916310528",https://twitter.com/gerlach_d/status/1255159407916310528
notthatjensmith,2020-04-28 11:38,7,5,"Patients with # COVID19 are more likely to have poor outcomes if they have # cancer, and cancer type, stage, and treatment are associated with outcomes, according to a multicenter study presented by HongBing Cai. # AACR20 # AACR2020 pic.twitter.com/LqmEqB0ge8",,,# # # #,"1255159373556482050",https://twitter.com/notthatjensmith/status/1255159373556482050
CancerAdvocacy,2020-04-28 11:37,2,2,"A new study on # COVID19nCancer was shared at # AACR20 meeting today - "Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak". Full Text @ CD_AACR:https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,@,# #,"1255159241184358402",https://twitter.com/CancerAdvocacy/status/1255159241184358402
PDRennert,2020-04-28 11:35,1,8,"the Gracell data at # AACR20 on UCART-CD7 is nice but very early. The knocked the CAR into the TCR which is good. CAR T cell persistence is limited < 3-4 weeks. Efficacy data is at 1 month only. (So risk of subsequent relapse not clear yet.)",,,#,"1255158783107567616",https://twitter.com/PDRennert/status/1255158783107567616
thecancergeek,2020-04-28 11:35,0,0,"What happened to the stream in the drug development session??? # AACR20",,,#,"1255158597937487874",https://twitter.com/thecancergeek/status/1255158597937487874
ivybelkins,2020-04-28 11:34,11,17,"TAK-788 ( # mobocertinib) in New Drugs on the Horizon at # AACR20. Just announced yesterday FDA Breakthrough designation for this drug for treating # exon20 # lungcancer patients, a subset of # NSCLC w/no approved treatment yet # AACR20 # lcsm @ EGFRResisters @ Exon20Group @ TakedaOncologypic.twitter.com/mgpGgUZPyd",,@ @ @,# # # # # # #,"1255158576441634816",https://twitter.com/ivybelkins/status/1255158576441634816
KristieBuckeye,2020-04-28 11:34,0,0,"I had to go back in and slide the progress bar to where I got dropped",,,,"1255158535220011009",https://twitter.com/KristieBuckeye/status/1255158535220011009
RazzaqMch,2020-04-28 11:34,0,4,"Looking forward to seeing plenty of abstracts from department of Surgery, CUH as always",,,,"1255158346958675968",https://twitter.com/RazzaqMch/status/1255158346958675968
jsoriamd,2020-04-28 11:33,32,81,"Targeting # EGFR exon 20 insertion with TAK788 leads to ORR of 43% # AACR20 pic.twitter.com/fYp5lEkShc",,,# #,"1255158135762776065",https://twitter.com/jsoriamd/status/1255158135762776065
emermsmyth,2020-04-28 11:32,0,1,"Today's session at # AACR20 was terrific!",,,#,"1255158067165085696",https://twitter.com/emermsmyth/status/1255158067165085696
NCRI_partners,2020-04-28 11:30,1,3,"New data from the @ CR_UK @ ucl # TRACERx study is being presented at the # AACR20 Virtual Annual Meeting today by @ AbboshChris, 19:30 UK time. # TRACERx is one of the NCRI # Lung_Group flagship studies.",,@ @ @,# # # #,"1255157518373969922",https://twitter.com/NCRI_partners/status/1255157518373969922
RussellPetty19,2020-04-28 11:30,1,6,"Fantastic and interesting presentation by @ barlesi at virtual # AACR2020 on @ GustaveRoussy COVID19 and cancer experience of 137 patients. Mortality rate 14.6%. Chemotherapy within<3 months but not IO or targettted therapies associated with more severe COVI19 outcomes. @ CRUKpic.twitter.com/YFEADMO22I",,@ @ @,#,"1255157482554396672",https://twitter.com/RussellPetty19/status/1255157482554396672
JulioPozueta,2020-04-28 11:30,0,2,"In a few hours at # AACR20 https://twitter.com/ntrkconnectinfo/status/1254693157184380929 …",,,#,"1255157451843928066",https://twitter.com/JulioPozueta/status/1255157451843928066
PacBio,2020-04-28 11:30,0,3,"Will the next # cancer breakthroughs be in # immunotherapy? Tumor microenvironment? # Microbiome? Or early detection &screening? Whatever the result, long-read sequencing can play a pivotal part in the discovery process, @ AshbyMere tells @ AmericanLab # AACR20 http://ow.ly/9IHa50zqEtk pic.twitter.com/0trbsAdy12",,@ @,# # # #,"1255157427781197825",https://twitter.com/PacBio/status/1255157427781197825
promega,2020-04-28 11:30,0,0,"Because we won’t be able to meet you in person at our booth this year, we’re bringing it to you. Explore our virtual booth for new products, instruments, posters, online presentation and resources. https://bit.ly/2VKfFHR # AACR2020 # AACR20 pic.twitter.com/WPzO21iwRn",,,# #,"1255157367173505024",https://twitter.com/promega/status/1255157367173505024
Jbauml,2020-04-28 11:30,2,2,"Seems the channel just went out... @ AACR any info?",,@,,"1255157361418874881",https://twitter.com/Jbauml/status/1255157361418874881
AACR,2020-04-28 11:30,5,12,"# AACR20 Virtual Annual Meeting I: Adoptive Cell Transfer Therapy Session. Haneen Shalabi presents findings on the safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL.",,,#,"1255157354909380608",https://twitter.com/AACR/status/1255157354909380608
Jbauml,2020-04-28 11:29,3,8,"Here we see the response data from the Ph1 trial of mobocertinib in EGFR Exon 20 and HER2 mutant NSCLC. Clearly this is a heterogeneous group of tumors - the waterfall plots in Exon 20 does not look very much like other EGFR TKI's in more classical mutations # LCSM # AACR20 pic.twitter.com/ukGZoFBFW3",,,# #,"1255157115422982146",https://twitter.com/Jbauml/status/1255157115422982146
gerlach_d,2020-04-28 11:29,3,1,"Clinical activity of TAK-788 - 160 mg qd recommended dose for Phase II # AACR20 pic.twitter.com/BbjUFD1vJD",,,#,"1255157071860940800",https://twitter.com/gerlach_d/status/1255157071860940800
TristanFreefsg,2020-04-28 11:27,11,18,"Check out our Editors coffee chat for day 1 of the @ AACR Virtual Annual Meeting. @ aabisawyer and I bring our highlights of the day alongside our colleagues @ racheljenkinsOC and @ LChard_FSG from @ OncologyCentral and @ NanomedZone - BioTechniqueshttps://www.biotechniques.com/cancer-research/aacr_vam-aacr-virtual-annual-meeting-i-day-1-editors-coffee-chat/ …",,@ @ @ @ @ @,,"1255156646105546752",https://twitter.com/TristanFreefsg/status/1255156646105546752
SU2Cscience,2020-04-28 11:26,0,3,"Immune response finding for squamous cell # lungcancer at # AACR20: the GSTP1 gene upregulated in progressing lesions + negatively correlated with immune activation pathways, may be target for immunotherapy @ SU2C @ LUNGevity @ LungAssociation Dream Teamhttps://standuptocancer.org/research/research-portfolio/dream-teams/lung-cancer-interception-intime-dream-team/ …",,@ @ @,# #,"1255156435043876864",https://twitter.com/SU2Cscience/status/1255156435043876864
DrJNaidoo,2020-04-28 11:24,0,0,"# AACR2020 # LCSM",,,# #,"1255155866170523648",https://twitter.com/DrJNaidoo/status/1255155866170523648
gerlach_d,2020-04-28 11:23,0,2,"Structure-based design of TAK-788 # EGFR # EXON20 # AACR20 pic.twitter.com/9S9KQkSeJD",,,# # #,"1255155779520192512",https://twitter.com/gerlach_d/status/1255155779520192512
mtmdphd,2020-04-28 11:23,0,1,"COVID-19 & Cancer Consortium ( # CCC19): a collaborative effort to understand the effects of # COVID19nCancer {Pre-print} [Apr 27, 2020] @ rubinstein_md @ steinharterjack @ hemoncwarner @ brian_rini @ peters_solange @ DrChoueiri @ CellCellPress http://ow.ly/mIk130qBnTL # COVID19pic.twitter.com/dUdPmJzJq1",,@ @ @ @ @ @ @,# # #,"1255155574154690561",https://twitter.com/mtmdphd/status/1255155574154690561
d2merino,2020-04-28 11:21,0,10,"Yeah!!! Proud to be a # AACRAMC alumna/past chair and be presenting our latest work on the @ CancerResrch # TMB harmonization initiative in this year's # AACR20 Virtual AM! It's my 9th @ AACR AM & although i miss being there in person, I'm excited to still be part of it! https://twitter.com/KKauffman131/status/1254965414632849408 …",,@ @,# # #,"1255155072989892608",https://twitter.com/d2merino/status/1255155072989892608
ADesaiMD,2020-04-28 11:20,35,62,"Missed # COVID19nCancer plenary in # AACR20 @ AACR? Here’s a thread to catch up on all the fascinating global research presented by: @ AACR @ AACRPres # AntoniRibas # LiZhang @ marinagarassino @ barlesi # CarlosGomez # LouisVoigt # HongbingCai cc: @ OncoAlert @ COVID19nCCC @ ASCO @ ASH_hematology",,@ @ @ @ @ @ @ @ @,# # # # # # #,"1255154902504026113",https://twitter.com/ADesaiMD/status/1255154902504026113
Jbauml,2020-04-28 11:17,10,16,"Critical to remember that Exon 20 insertions are not actually that rare - 2% is pretty similar incidence to ALK and ROS1, yet we have no approved therapies for these patients. We need to do better for our patients! # AACR20 # LCSM @ OncoAlertpic.twitter.com/LGclqdQ9CM",,@,# #,"1255154216349298688",https://twitter.com/Jbauml/status/1255154216349298688
kelseyrhampton,2020-04-28 11:17,1,0,"Fascinating morning of # AACR2020 talks on # COVID19 and cancer. My takeaways: cancer pts not more susceptible, but can have factors like recent chemo, surgery that can lead to severe outcomes. So far, unclear if immunotherapy is protective or a risk factor.",,,# #,"1255154204676698114",https://twitter.com/kelseyrhampton/status/1255154204676698114
gerlach_d,2020-04-28 11:17,2,3,"Upcoming talk by Francois Gonzalvez on "TAK-788: An EGFR inhibitor, currently in Phase II clinical trials, targeting lung cancers with Exon20 insertion mutations" - a review on EGFR exon 20 insertion in NSCLC to be prepared ;-) https://www.nature.com/articles/s41392-019-0038-9#Tab1 … # AACR20",,,#Tab1 #,"1255154075085074434",https://twitter.com/gerlach_d/status/1255154075085074434
FernandoOnco,2020-04-28 11:16,0,1,"Mais evidências que pacientes com câncer que desenvolvem infecção pelo coronavírus possuem mais risco de desenvolver quadros graves # AACR20 https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,,#,"1255153871044988931",https://twitter.com/FernandoOnco/status/1255153871044988931
Jbauml,2020-04-28 11:15,1,10,"Next up Dr Gonzalvez (employee of @ TakedaOncology) presents data on mobocertinib (nee TAK-788), which was recently granted Breakthrough Designation for the treatment of patients with NSCLC harboring an Exon 20 insertion in EGFR # AACR20 # LCSM @ Exon20Group https://www.thepharmaletter.com/in-brief/brief-takeda-gains-fda-breakthrough-status-for-mobocertinib …",,@ @,# #,"1255153798651301888",https://twitter.com/Jbauml/status/1255153798651301888
giusvisc,2020-04-28 11:15,5,10,"about the importance of sharing data within medical community and taking care of cancer patients during # COVID19 outbreak First data from a global registry on thoracic cancer and covid 19 # teravolt # AACR20 Here the website http://teravolt-consortium.org pic.twitter.com/z7DMXOZvE1",,,# # #,"1255153581683912706",https://twitter.com/giusvisc/status/1255153581683912706
pashtoonkasi,2020-04-28 11:13,0,1,"# AACR20 article collections @ AACR https://twitter.com/CAPR_AACR/status/1255149864842752003 …",,@,#,"1255153211045892098",https://twitter.com/pashtoonkasi/status/1255153211045892098
pashtoonkasi,2020-04-28 11:13,1,6,"# AACR20 # COVID19nCancer @ AACR worthwhile and timely. https://twitter.com/Aiims1742/status/1255151093501304832 …",,@,# #,"1255153057215569924",https://twitter.com/pashtoonkasi/status/1255153057215569924
LUNGevity,2020-04-28 11:12,0,1,"Nucleic acid sensing (essential part of innate immune system) a new target? RBN-2397 inhibits PARP7 to reactivate nucleic acid sensing and activates the anti-cancer immune response - Melissa Vasbinder @ RibonTx # AACR2020 # AACR20 # LCSMpic.twitter.com/M9v6GHZMFN",,@,# # #,"1255152976190042114",https://twitter.com/LUNGevity/status/1255152976190042114
RousseauMC,2020-04-28 11:11,0,0,"Early results of the global registry for COVID+ thoracic cancer patients TERAVOLT being presented @ AACR # AACR2020 livestream. Over 200 thoracic malignancies and COVID19 patients captured so far. pic.twitter.com/VsruuIrSQh",,@,#,"1255152653199306755",https://twitter.com/RousseauMC/status/1255152653199306755
aabisawyer,2020-04-28 11:11,0,1,". @ barlesi @ GustaveRoussy experience suggests it’s not # COVID19 on its own in # cancer patients representing higher risk of death @ AACR",,@ @ @,# #,"1255152612439031815",https://twitter.com/aabisawyer/status/1255152612439031815
CancerMedMDA,2020-04-28 11:11,0,1,"Join @ Lymphoma_Doc for # AACR20 Session CT055, "Phase 1/2 primary analysis of ZUMA-6: Axi-Cel in combo w/Atezo for pts with refractory DLBCL." Today at 11:45 AM (12:45 PM EDT). @ AACR https://bit.ly/2VSj5XS",,@ @,#,"1255152541698056192",https://twitter.com/CancerMedMDA/status/1255152541698056192
gerlach_d,2020-04-28 11:10,2,6,"Read along as you follow the presentation at the Virtual # AACR20 Meeting. Thanks for this compilation! https://twitter.com/CD_AACR/status/1255149843107856384 …",,,#,"1255152420650287104",https://twitter.com/gerlach_d/status/1255152420650287104
SprakerMDPhD,2020-04-28 11:09,1,7,"Catching some of the @ AACR virtual meeting today, super cool stuff. Makes me *very* excited for future virtual conferences! # AACR20 PS Fantastic discussion of social determinants of health during the # COVID19 session. Dont miss! PPS Virtual @ roecsg in <3 weeks what up!",,@ @,# #,"1255152262999150592",https://twitter.com/SprakerMDPhD/status/1255152262999150592
SamGallaher_,2020-04-28 11:09,0,2,"After saving the bird I can now tune into the virtual # AACR2020 https://twitter.com/SamGallaher_/status/1255151921972695040 …",,,#,"1255152207478919171",https://twitter.com/SamGallaher_/status/1255152207478919171
JanEhses,2020-04-28 11:09,0,1,"# AACR2020 Highly interesting data from Ribon Therapeutics on their selective PARP7i, which elicits type 1 interferon secretion from tumour cells to induce immune memory. Looking forward to their phase 1 data. pic.twitter.com/J5D1Dqm1GW",,,#,"1255152176092962823",https://twitter.com/JanEhses/status/1255152176092962823
marinagarassino,2020-04-28 11:08,9,20,"Please join us # TERAVOLT This is the website http://teravolt-consortium.org/ We need more data to help our patients and to tailor treatments Thank you # AACR2020 # dontgoonalone # OncoAlert @ myESMO @ IASLC @ HornLeora @ HwakeleeMD @ peters_solange",,@ @ @ @ @,# # # #,"1255151993317756928",https://twitter.com/marinagarassino/status/1255151993317756928
PfizerCongress,2020-04-28 11:08,0,3,"Learn about the latest in # oncology research through our abstract plain language summaries, where we provide an easy way to digest all of the data we are presenting at # AACR20:",,,# #,"1255151849486708739",https://twitter.com/PfizerCongress/status/1255151849486708739
gerlach_d,2020-04-28 11:07,0,0,"@ TakedaOncology will disclose the molecular structure of mobocertinib (TAK-788) in 10 minutes at the # AACR20 meeting - targeting lung cancers with exon 20 insertion mutations https://www.abstractsonline.com/pp8/#!/9045/presentation/6845 …",,@,# #,"1255151652920676355",https://twitter.com/gerlach_d/status/1255151652920676355
drzach,2020-04-28 11:07,0,0,"Very glad that @ AACR is meeting virtually, and especially that they held a special session this morning on the clinical experience of oncologists in treating oncology patients infected with COVID-19. Very encouraging to see international collaboration in the midst of all this.",,@,,"1255151549791133700",https://twitter.com/drzach/status/1255151549791133700
aabisawyer,2020-04-28 11:06,0,4,"Really insightful # COVID19 and # cancer session at @ AACR Virtual Meeting! Still a long way to go but some promising initial findings",,@,# #,"1255151402235473920",https://twitter.com/aabisawyer/status/1255151402235473920
aabisawyer,2020-04-28 11:05,0,1,"COVID-19 and cancer can’t be put into the same basket. Types of cancers should be key consideration, says @ marinagarassino @ AACR",,@ @,,"1255151111016595457",https://twitter.com/aabisawyer/status/1255151111016595457
Aiims1742,2020-04-28 11:05,12,28,"Toni Ribas just announced a dedicated symposium on # COVID19nCancer in July by @ AACR. # AACR20",,@,# #,"1255151093501304832",https://twitter.com/Aiims1742/status/1255151093501304832
OncLive,2020-04-28 11:05,1,3,"Novel Innate Immune Activator Boosts PD-1 Inhibition Responses in mTNBC @ JohnWayneCI @ SaintJohns2 @ AACR # bcsm # AACR20 http://ow.ly/rCJ950zqKnY",,@ @ @,# #,"1255151079198568448",https://twitter.com/OncLive/status/1255151079198568448
LChard_FSG,2020-04-28 11:03,0,0,"Great to hear all the experts at @ AACR Virtual Annual Meeting discussing the state of cancer and # COVID19, all the sessions are available here: https://bit.ly/35aN0ik # AACR2020",,@,# #,"1255150664423837698",https://twitter.com/LChard_FSG/status/1255150664423837698
gerlach_d,2020-04-28 11:03,0,1,"# AACR20 session "New Drugs on the Horizon: Part 2" in on featuring Melissa Vasbinder with "RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways"",,,#,"1255150656802811904",https://twitter.com/gerlach_d/status/1255150656802811904
chuynhMDCM,2020-04-28 11:03,0,1,"Dr. Cai, from Wuhan (China), presented a multicenter study of n=758 enrolled pts (105 w/ cancer). - COVID-19 pts at risks of severe outcomes. - Highest risks w/ hematologic Ca, lung mets or mets dz. - Pts undergoing surgery at risks compared to RT. # AACR20 # AACR2020 pic.twitter.com/vXfpkPLZd9",,,# #,"1255150646048817152",https://twitter.com/chuynhMDCM/status/1255150646048817152
tmprowell,2020-04-28 11:02,1,3,"# AACR20 # COVID19 Dr. Hongbing Cai w/ cohort study (N=105) from China: On multivariate analysis, ppl w/ # COVID19nCancer had OR=2.2 death, OR=2 severe sx, OR=3.1 ICU, & OR=2.7 for vent compared to w/ no cancer: http://bit.ly/2KKBbpq . Diff in results from EU ?due to comorbidities.",,,# # #,"1255150337029279744",https://twitter.com/tmprowell/status/1255150337029279744
IleanaLarios,2020-04-28 11:01,0,1,"The approach to treat adverse events like CRS seen in CAR T-cell patients can be used to treat hyperinflammation in SARS-CoV-2 patients. # AACR2020 # IL6 # covid19 @ PAsciertopic.twitter.com/FelbQb7DeY",,@,# # #,"1255150255307231232",https://twitter.com/IleanaLarios/status/1255150255307231232
jillfeldman4,2020-04-28 11:01,2,9,"Dr Voight @ sloan_kettering "We don't dive into the socioeconomic aspect of our pts lives (who struggles to eat, isolate, etc.), we need to dedicate time to identify those who are vulnerable & create pathways for care" # AACR20 # LCSM # disparities",,@,# # #,"1255150221656330240",https://twitter.com/jillfeldman4/status/1255150221656330240
OncoAlert,2020-04-28 11:01,4,2,"Live # AACR20 Tweet by @ LizCancerHealth "Hongbing Cai, Wuhan University: People with # cancer appear to have higher risk of severe # COVID19 outcomes" @ OncoAlert https://twitter.com/LizCancerHealth/status/1255146433029627904 …",,@ @,# # #,"1255150193239977987",https://twitter.com/OncoAlert/status/1255150193239977987
fiosgenomics,2020-04-28 11:01,0,0,"Back to AACR 2018, work on behalf of @ G1Therapeutics featured on two posters. The posters focused on two different therapies - lerociclib and trilaciclib. Both featured our work including on tumour growth inhibition and gene expression analysis. https://buff.ly/2FGauBi # AACR20 pic.twitter.com/t98ud79xgi",,@,#,"1255150118694612992",https://twitter.com/fiosgenomics/status/1255150118694612992
CAPR_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/35fhsYo pic.twitter.com/NYypqtTLmi",,,#,"1255149864842752003",https://twitter.com/CAPR_AACR/status/1255149864842752003
JExpMed,2020-04-28 11:00,2,3,"Non-small cell lung cancers can acquire resistance to immunotherapy by producing soluble versions of PD-L1 that can prevent immune checkpoint blockade. JEM’s collection for # AACR20 (https://bit.ly/3avNaBK ) has new short summaries of articles in this PDF: https://bit.ly/2XYhG4z pic.twitter.com/UCKI2AUIav",,,#,"1255149860648448014",https://twitter.com/JExpMed/status/1255149860648448014
AACRFoundation,2020-04-28 11:00,0,3,"More than 61,000 researchers, physician-scientists, patient advocates, and others registered to attend # AACR20. Show your support cutting-edge cancer science: https://bit.ly/2W9TGJt # ResearchSavesLives",,,# #,"1255149853845254145",https://twitter.com/AACRFoundation/status/1255149853845254145
CEBP_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/2yPWcww pic.twitter.com/jiIg3yhMYI",,,#,"1255149853371318272",https://twitter.com/CEBP_AACR/status/1255149853371318272
MCT_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/3bKsojf pic.twitter.com/sghxk4o4Bx",,,#,"1255149846270369792",https://twitter.com/MCT_AACR/status/1255149846270369792
MCR_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/3eYQ8ST pic.twitter.com/N8LpYVi6Hc",,,#,"1255149846010359808",https://twitter.com/MCR_AACR/status/1255149846010359808
CR_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/2YfC4i6 pic.twitter.com/cSDat3GCox",,,#,"1255149844986859520",https://twitter.com/CR_AACR/status/1255149844986859520
CIR_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/2YacH13 pic.twitter.com/oeumQT8Wfs",,,#,"1255149844311629827",https://twitter.com/CIR_AACR/status/1255149844311629827
CD_AACR,2020-04-28 11:00,1,2,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/3bMZGOX pic.twitter.com/tknWo0HrLd",,,#,"1255149843107856384",https://twitter.com/CD_AACR/status/1255149843107856384
CCR_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/2Se0Cnu pic.twitter.com/aOclHxUJcC",,,#,"1255149843032313860",https://twitter.com/CCR_AACR/status/1255149843032313860
BCD_AACR,2020-04-28 11:00,0,0,"Check out our resources related to # AACR20 Virtual Annual Meeting I, including collections curated by our editors to complement the latest presented research. https://bit.ly/3f2t59F pic.twitter.com/1KWiiZCfH2",,,#,"1255149842889756679",https://twitter.com/BCD_AACR/status/1255149842889756679
MCT_AACR,2020-04-28 11:00,0,1,"The @ US_FDA just approved # Tucatinib from @ SeattleGenetics. This # HER2+ metastatic # breastcancer drug made its publishing debut as a First Disclosure in MCT! Learn more about our new article type! # AACR20 https://bit.ly/2W8WPJg pic.twitter.com/dqVCuQN8KN",,@ @,# # # #,"1255149821263900690",https://twitter.com/MCT_AACR/status/1255149821263900690
JAMANetwork,2020-04-28 11:00,4,4,"Following the # AACR20 virtual meeting? Read Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial from @ JAMAOnc free online during the meeting https://ja.ma/2VpROwO",,@,#,"1255149774346481676",https://twitter.com/JAMANetwork/status/1255149774346481676
DrUshaSriram,2020-04-28 10:59,0,1,"Just when we thought we could focus on NCDs and deal with the usual actors and minor outbreaks! We are seeing something very similar with diabetes. Mortality is reported to be 50% higher than in people without diabetes. And new onset diabetes and more DKA.",,,,"1255149717022900225",https://twitter.com/DrUshaSriram/status/1255149717022900225
russo_cristina,2020-04-28 10:59,0,0,"Anyone able to access the "Translational Prevention Studies" session of # AACR20 ? Seems I get timed out every time I click. cc @ AACR",,@,#,"1255149608725999622",https://twitter.com/russo_cristina/status/1255149608725999622
meyersonlab,2020-04-28 10:58,2,6,"At 4:10 pm EDT today, Liam will speak at # AACR2020 on "Genomic correlates of PD-L1 expression are associated with response to immunotherapy in non-small cell lung cancer" in the session on Predictive Markers for Immunotherapeutics: https://aacr20.onlineeventpro.freeman.com/sessions/15335631/Predictive-Biomarkers-for-Immunotherapeutics … PS-great talk, Yvonne!https://twitter.com/lfspurr/status/1254841335024160768 …",,,#,"1255149372234293251",https://twitter.com/meyersonlab/status/1255149372234293251
LUNGevity,2020-04-28 10:58,2,2,"Immune cells present in pre-malignant lesions decide which lesions will progress to cancer and which ones will regress. Fantastic research from LUNGevity awardee Dr. Jen Beane @ BU_Tweets # AACR20 # AACR2020 # LCSMpic.twitter.com/FPVi6PI68i",,@,# # #,"1255149339132874754",https://twitter.com/LUNGevity/status/1255149339132874754
dapattmd,2020-04-28 10:58,0,2,"Final Overall Survival Results From the Phase III EMBRACA Trial - The ASCO Post https://ascopost.com/news/april-2020/final-overall-survival-results-from-the-phase-iii-embraca-trial/#.XqhD8UFdQe0.twitter … Great job Drs Litton Diab Blum and other investigators! @ TheUSONetwork @ TexasOncology @ AACR @ MDAndersonNews",,@ @ @ @,#,"1255149321269334019",https://twitter.com/dapattmd/status/1255149321269334019
Aiims1742,2020-04-28 10:58,4,16,"After six talks at the # COVID19nCancer session at # AACR20, one thing is clear - we need more clarity on the extent of risk for # COVID19 complications, whether certain cancers are truly at higher risk, and to separate causality from epiphenomena. As @ marinagarassino said, TEAM UP!https://twitter.com/rosslevinemd/status/1255142028653940737 …",,@,# # #,"1255149302449500168",https://twitter.com/Aiims1742/status/1255149302449500168
MDAndersonNews,2020-04-28 10:56,11,23,"Cancer patients like triple-negative # breastcancer survivor @ deb_silverman are among those most vulnerable to # COVID19: https://wapo.st/2Yau9T3 @ washingtonpost # AACR20 # endcancer",,@ @,# # # #,"1255148769496031235",https://twitter.com/MDAndersonNews/status/1255148769496031235
JulienMazieres,2020-04-28 10:55,5,20,"Capmatinib for Met Ex14 mut # NSCLC @ AACR n = 97. RR 40.6% and limited 5.4 m. PFS in pretreated pts; high RR 67% and PFS 9.7 m (in 1L pts) + interesting intra-cranial response. Tepotinib update awaited @ ASCO. Sounds like like MET is definitely druggable https://www.abstractsonline.com/pp8/#!/9045/presentation/10783 …",,@ @,# #,"1255148569792704513",https://twitter.com/JulienMazieres/status/1255148569792704513
StephenJWillia2,2020-04-28 10:54,1,1,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 28, 2020 Session on # COVID-19 and # Cancer # China # France # Italy 9:00 AM @ CureCancerNow # endcancer @ sloan_kettering @marinagarissino @ barlesi https://pharmaceuticalintelligence.com/2020/04/28/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-28-2020-session-on-covid-19-and-cancer-900-am/ … via @ Pharma_BI",,@ @ @ @marinagarissino @ @,# # # # # # #,"1255148507586981893",https://twitter.com/StephenJWillia2/status/1255148507586981893
jillfeldman4,2020-04-28 10:54,2,3,"Another presentation on the higher incidence of severe events in # cancerpatients with # COVID19 # AACR20 # LCSMhttps://twitter.com/LUNGevity/status/1255146720540758018 …",,,# # # #,"1255148373578878977",https://twitter.com/jillfeldman4/status/1255148373578878977
pashtoonkasi,2020-04-28 10:51,1,5,"# AACR20 current # COVID19 # COVIDnCancerhttps://twitter.com/CD_AACR/status/1255147168651829248 …",,,# # #,"1255147687881502720",https://twitter.com/pashtoonkasi/status/1255147687881502720
Dr_ZiMingZhao,2020-04-28 10:50,0,2,"More evidence from Dr. Hongbing Cai's talk # AACR20 https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …pic.twitter.com/fQmHeW7LeO",,,#,"1255147483916689412",https://twitter.com/Dr_ZiMingZhao/status/1255147483916689412
castro2355_mg,2020-04-28 10:50,0,1,"The key issue is how many will effectively participate.....looking forward to next year’s in person AACR meeting!",,,,"1255147444603482112",https://twitter.com/castro2355_mg/status/1255147444603482112
ivybelkins,2020-04-28 10:50,3,3,"People with hematological cancer and # lungcancer seem to have the highest risk of severe events # AACR20 # lcsm @ EGFRResistershttps://twitter.com/LizCancerHealth/status/1255146433029627904 …",,@,# # #,"1255147381303042051",https://twitter.com/ivybelkins/status/1255147381303042051
CellPressNews,2020-04-28 10:50,5,9,"Read @ TrendsinPharma "The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers" by Muranen ( @ tarumurmur) and colleagues - https://bit.ly/2VNpoxf - # CellPressOncology # AACR20",,@ @,# #,"1255147270913191936",https://twitter.com/CellPressNews/status/1255147270913191936
CD_AACR,2020-04-28 10:49,1,8,"Now being presented at # AACR20 Virtual Annual Meeting I- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …pic.twitter.com/hcDlIluhAj",,,#,"1255147168651829248",https://twitter.com/CD_AACR/status/1255147168651829248
pashtoonkasi,2020-04-28 10:49,0,2,"These are indeed challenging times for our # cancer patients. While for sure easier to defer chemotherapy for low risk situations, chemotherapy and/or surgery cannot be deferred indefinitely. Have been evaluating case by case on a weekly basis. # AACR20 # COVIDnCAncer # COVID19",,,# # # #,"1255147154357628928",https://twitter.com/pashtoonkasi/status/1255147154357628928
RousseauMC,2020-04-28 10:48,2,4,"@ AACR 2020 Outcome of cancer patients infected with COVID-19. Fabrice Barlesi from Gustave Roussy 137 COVID19 cancer patients 14.6% mortality Factors ass. with mortality: ECOG >1 Hematological cancer Cytotoxic chemo within 3mo. @ halletjulie @ DoctorJSpicerpic.twitter.com/d2dl6r0fwu",,@ @ @,,"1255146903194361856",https://twitter.com/RousseauMC/status/1255146903194361856
tmprowell,2020-04-28 10:48,0,7,"I believe our words not only reflect our attitudes, but shape them too. Dr. @ drdonsdizon & I spoke with @ Medscape about why # WordsMatter at # ASCO19: https://www.medscape.com/viewarticle/914359 …. # AACR20 # ASCO20",,@ @,# # # #,"1255146787066613768",https://twitter.com/tmprowell/status/1255146787066613768
LUNGevity,2020-04-28 10:47,3,4,"Another presentation on how vulnerable the cancer community is to # COVID19 and how these vulnerabilities are related to age, type, treatment, and stage of cancer - Dr. Hongbing Cai @ WuHanUniv # AACR20 # AACR2020 # LCSMpic.twitter.com/PI1qyBJ05e",,@,# # # #,"1255146720540758018",https://twitter.com/LUNGevity/status/1255146720540758018
IASLC,2020-04-28 10:47,4,8,"Proud to be a part of this extraordinary new initiative. Congratulations to all involved on its exciting rollout. # LCSM # AACR20 # COVID19 # Coronavirus Learn more about the TERAVOLT global consotium http://teravolt-consortium.org/ https://twitter.com/APassaroMD/status/1255144555663388675 …",,,# # # #,"1255146710252138497",https://twitter.com/IASLC/status/1255146710252138497
LizCancerHealth,2020-04-28 10:46,5,8,"Hongbing Cai, Wuhan University: People with # cancer appear to have higher risk of severe # COVID19 outcomes. # AACR20 # coronaviruspic.twitter.com/F0vVHsp1HC",,,# # # #,"1255146433029627904",https://twitter.com/LizCancerHealth/status/1255146433029627904
pashtoonkasi,2020-04-28 10:46,9,15,"# AACR20 # COVID19 # COVIDnCancer # OncoAlertpic.twitter.com/LrW5VXTgWP",,,# # # #,"1255146379736829952",https://twitter.com/pashtoonkasi/status/1255146379736829952
warriormegsie,2020-04-28 10:46,0,3,"Mine was # lobular ER+, HER2-. You must keep in mind some of us come from mixed race families. So many people think since I’m black I must have triple negative. When I correct them & say invasive lobular, they STILL question me because all they see is my skin color & demographic",,,#,"1255146286577184771",https://twitter.com/warriormegsie/status/1255146286577184771
ruthmparks,2020-04-28 10:45,0,2,"Thank you @ AACR for this really interesting session on # COVID19 and # Cancer, a chance to learn how our colleagues around the world are dealing with cancer patients during this time # AACR20 https://twitter.com/AACR/status/1255121099500720130 …",,@,# # #,"1255146199545339905",https://twitter.com/ruthmparks/status/1255146199545339905
NanomedZone,2020-04-28 10:44,3,3,"Watching some really interesting talks on # COVID19 and cancer at the @ AACR Virtual Annual Meeting - this presentation shows race and social disparities in patients during the pandemic # AACR2020 pic.twitter.com/sajIVSr7lS",,@,# #,"1255145862864359427",https://twitter.com/NanomedZone/status/1255145862864359427
msmelanoma,2020-04-28 10:43,2,2,"@ PAscierto on # COVID19 and # cancer at # AACR20: safety first, and prioritise patients. Multiple ongoing clinical trials, but too early to propose concrete actions. @ ASEICAnews @ krknrmpic.twitter.com/Etm2cx21Cc",,@ @ @,# # #,"1255145621448581120",https://twitter.com/msmelanoma/status/1255145621448581120
waynerlawrence,2020-04-28 10:42,1,11,"Amazing and timely presentation at @ AACR Virtual Annual Meeting by Dr. Louis Voigt from @ sloan_kettering on COVID-19 and cancer, with a focus on vulnerable populations. # AACR20 pic.twitter.com/6CzSJMr6Fa",,@ @,#,"1255145326916235266",https://twitter.com/waynerlawrence/status/1255145326916235266
OncoAlert,2020-04-28 10:41,6,7,"Live # AACR20 Tweet @ LizCancerHealth " Louis Voigt @ sloan_kettering: In NYC, African-Americans & Latinos more likely to die of # COVID19 than whites & Asians" @ OncoAlert https://twitter.com/LizCancerHealth/status/1255142434704461831 …",,@ @ @,# #,"1255145197614202881",https://twitter.com/OncoAlert/status/1255145197614202881
Aiims1742,2020-04-28 10:41,6,11,"Live from Wuhan China - Dr. Cai is discussing her @ CD_AACR paper released this morning in the # COVID19nCancer session at # AACR20 https://twitter.com/Aiims1742/status/1255130463150264320 …pic.twitter.com/jbv5qY2WT4",,@,# #,"1255145117486219265",https://twitter.com/Aiims1742/status/1255145117486219265
tmprowell,2020-04-28 10:40,16,41,"# AACR20 # COVID19 Dr. Louis Voigt w/ courageous talk "Flattening the Curve, but Widening the Disparities": # pandemic creates ideal conditions for emotion-driven decision-making & dev from std of care due to lack of evid & overwhelmed health system-> # healthinequalities # thatsbiaspic.twitter.com/hY3ZyUNF9x",,,# # # # #,"1255144970865963012",https://twitter.com/tmprowell/status/1255144970865963012
teamoncology,2020-04-28 10:40,1,3,"@ sloan_kettering experience in COVID-19 shared at @ AACR Virtual meeting. Very helpful to see the impact on the cancer patients in the New York Area. # AACR20 pic.twitter.com/V7AnTOiTam",,@ @,#,"1255144958559846402",https://twitter.com/teamoncology/status/1255144958559846402
OncoAlert,2020-04-28 10:40,1,4,"Live # AACR20 Tweet by @ ivybelkins " Louis Voigt, MD discusses # COVID19 and # cancer: flattening the curve but widening # disparities. "The most vulnerable among us can fall through the safety net if we're not careful" # lcsm @ OncoAlert # lungcancerhttps://twitter.com/ivybelkins/status/1255143646367637509 …",,@ @,# # # # # #,"1255144892008771584",https://twitter.com/OncoAlert/status/1255144892008771584
AndyBiotech,2020-04-28 10:40,14,52,"Menin-MLL1 antagonists -- the hottest new kids on the targeted therapy block arrive at # AACR20 $ SNDX +66% $ KURA +33%",,,#,"1255144745463996416",https://twitter.com/AndyBiotech/status/1255144745463996416
APassaroMD,2020-04-28 10:39,8,15,"Please join with us in the TERAVOLT consortium, lead by @ HornLeora @ marinagarassino @ peters_solange @ HwakeleeMD @ myESMO @ IASLC # AACR20 # OncoAlert http://teravolt-consortium.org",,@ @ @ @ @ @,# #,"1255144555663388675",https://twitter.com/APassaroMD/status/1255144555663388675
pashtoonkasi,2020-04-28 10:38,1,2,"# AACR20 # immunotherapy # COVID19https://twitter.com/teamoncology/status/1255143474506035201 …",,,# # #,"1255144385760514051",https://twitter.com/pashtoonkasi/status/1255144385760514051
chulkimMD,2020-04-28 10:38,7,13,"Thoughtful presentation on cancer and # COVID19 by Dr. Louis Voight from MSKCC. "Pandemic create perfect conditions for suboptimal care of deviation from standard care with major impact on the most vulnerable patients" # AACR20 @ OncoAlertpic.twitter.com/ceAeNmzrUx",,@,# #,"1255144341078601729",https://twitter.com/chulkimMD/status/1255144341078601729
imsmd,2020-04-28 10:38,2,5,"Louis Voigt just gave a great talk about # COVID19 and disparities at the # COVID19 # AACR20 session that brought to mind this @ DrSidMukherjee New Yorker piece:https://www.newyorker.com/magazine/2020/05/04/what-the-coronavirus-crisis-reveals-about-american-medicine …",,@,# # #,"1255144247822409730",https://twitter.com/imsmd/status/1255144247822409730
EnriqueSoto8,2020-04-28 10:37,1,7,"Nice presentation on racial/ethnic disparities and # covid19 by Dr Voigt However a huge disparity, age, was missing from the mix. A lot of ageism going on around # coronavirus # AACR2020",,,# # #,"1255144179136520197",https://twitter.com/EnriqueSoto8/status/1255144179136520197
JacobPlieth,2020-04-28 10:37,3,2,"What's a clinical response? Don't ask $ TROV # AACR20 Via @ evaluatevantage https://bit.ly/2KEtOjl $ MRTX $ VSTM",,@,#,"1255144167115599872",https://twitter.com/JacobPlieth/status/1255144167115599872
pashtoonkasi,2020-04-28 10:37,3,3,"# AACR20 @ CD_AACR paper on # COVID19 - supporting all the added efforts to realign care of # cancer patients. “Patients with cancer appear more vulnerable to SARS-COV-2”https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,@,# # #,"1255144066301300736",https://twitter.com/pashtoonkasi/status/1255144066301300736
jillfeldman4,2020-04-28 10:37,1,1,"@ PAscierto on treating # COVID19 inflammation, referred to as a "cytokine storm". Have to love medical lexicon # AACR20 # LCSMpic.twitter.com/f11cHx8pn8",,@,# # #,"1255144056587382786",https://twitter.com/jillfeldman4/status/1255144056587382786
ErikaHamilton9,2020-04-28 10:36,3,9,"# AACR20 @ JenniferLitton presented final # OS from # EMBRACA. Recall, 431 pts ~45% TN and 55%HR+, all gBRCAmut, PFS improves 5.6 vs. 8.6 mo with talazoparib over TPC chemo. no difference in OS HR0.84, 19.5 vs. 19.3 months however, large #subsequent PARP @ OncoAlert # bcsmpic.twitter.com/KRtw1tK0Bv",,@ @,# # # #subsequent #,"1255143981114994689",https://twitter.com/ErikaHamilton9/status/1255143981114994689
AACR,2020-04-28 10:36,29,35,"# AACR20 Hongbing Cai presents data showing cancer patients may be more vulnerable to SARS-COV-2 infection. Data were simultaneously published in Cancer Discovery. @ CD_AACR https://bit.ly/3bRoMMI pic.twitter.com/UDX54MAHdS",,@,#,"1255143979265323010",https://twitter.com/AACR/status/1255143979265323010
tcellsrus,2020-04-28 10:36,2,6,"# AACR2020 Louis Voigt among his disclosures: “and I hope my comments don’t upset anyone” for his talk on health disparities in ethnic minorities for COVID19.” I really like this guy but I hope his comments do upset enough people to do something about this. pic.twitter.com/FJhLhMPSjN",,,#,"1255143771571752965",https://twitter.com/tcellsrus/status/1255143771571752965
emermsmyth,2020-04-28 10:35,0,0,"Exceptional job # AACR20!",,,#,"1255143686389653506",https://twitter.com/emermsmyth/status/1255143686389653506
ivybelkins,2020-04-28 10:35,3,7,"@ sloan_kettering's Louis Voigt, MD discusses # COVID19 and cancer: flattening the curve but widening # disparities. "The most vulnerable among us can fall through the safety net if we're not careful" # AACR20 # lcsm @ EGFRResisterspic.twitter.com/sUYQtE3AFz",,@ @,# # # #,"1255143646367637509",https://twitter.com/ivybelkins/status/1255143646367637509
Aiims1742,2020-04-28 10:35,7,12,"# COVID19 and ethnic disparities in age-adjusted outcomes in NYC (note: the data is for all patients, not patients with cancer only). Presented at # COVID19nCancer session by Dr. Louis Voigt @ sloan_kettering at # AACR20 pic.twitter.com/YI9WjeQcCZ",,@,# # #,"1255143520202940416",https://twitter.com/Aiims1742/status/1255143520202940416
ElizSMcKenna,2020-04-28 10:35,7,22,"Being presented NOW at # AACR20 Virtual Annual Meeting Plenary Session on # COVID19 and Cancer!https://twitter.com/CD_AACR/status/1255120959385882632 …",,,# #,"1255143509968863232",https://twitter.com/ElizSMcKenna/status/1255143509968863232
teamoncology,2020-04-28 10:34,0,1,"The other two presentation did not show immunotherapy as a risk factor. But the data is limited.",,,,"1255143474506035201",https://twitter.com/teamoncology/status/1255143474506035201
VriesElisabeth,2020-04-28 10:34,6,20,"Important advice Marina Garassino @ marinagarassino #AACR2020#OncoAlert pic.twitter.com/jtQJrNFrXL",,@,#AACR2020 #OncoAlert,"1255143291558916097",https://twitter.com/VriesElisabeth/status/1255143291558916097
LUNGevity,2020-04-28 10:34,3,6,"# COVID19 serves as another reminder of the stark health disparities that exist in healthcare access. Lessons from New York City - Dr. Louis Voigt # healthdisparities @ MSKCC_OncoNotes # AACR2020 # AACR20 # LCSMpic.twitter.com/yDbKaBknjp",,@,# # # # #,"1255143269027049475",https://twitter.com/LUNGevity/status/1255143269027049475
loreleimucci,2020-04-28 10:34,0,9,"Thoughtful @ aacr virtual session on # cancer and # COVID19 - @ sloan_kettering dr. Louis Voigt highlights disparities in COVID incidence and mortality in black and hispanic populations and shared perspectives on effect of pandemic on carepic.twitter.com/vH49QHo1Ey",,@ @,# #,"1255143245572534273",https://twitter.com/loreleimucci/status/1255143245572534273
pashtoonkasi,2020-04-28 10:33,4,6,"# AACR20 thanks for sharing this slide. # immunotherapy usage # COVID19 # COVID19 @ jsoriamd @ GustaveRoussy @ barlesihttps://twitter.com/jsoriamd/status/1255131733608919043 …",,@ @ @,# # # #,"1255143190862000130",https://twitter.com/pashtoonkasi/status/1255143190862000130
OWise_uk,2020-04-28 10:31,4,6,"In the 90s/00s, oncologist Dr. Olufunmilayo Olopade discovered that women of African descent were more likely to get breast cancer younger and that the cancer would likely be ER-. Now, see her recent Q&A with @ AACR about genomics and # breastcancer: https://cancerdiscovery.aacrjournals.org/content/early/2020/02/12/2159-8290.CD-ND2020-003 …pic.twitter.com/Shl0umfBFI",,@,#,"1255142697179869188",https://twitter.com/OWise_uk/status/1255142697179869188
pashtoonkasi,2020-04-28 10:31,1,2,"# AACR20 # COVID19 # COVIDnCancerhttps://twitter.com/cancerassassin1/status/1255132458799886336 …",,,# # #,"1255142618301784069",https://twitter.com/pashtoonkasi/status/1255142618301784069
ZorawskiMD,2020-04-28 10:31,0,3,"One advantage of quarantine: having the opportunity to listen in on world leaders in cancer research through this *free* virtual conference! # AACR20 https://twitter.com/AACR/status/1255121099500720130 …",,,#,"1255142557190811649",https://twitter.com/ZorawskiMD/status/1255142557190811649
LizCancerHealth,2020-04-28 10:30,9,11,"Louis Voigt @ sloan_kettering: In NYC, African-Americans & Latinos more likely to die of # COVID19 than whites & Asians. # AACR20 # coronaviruspic.twitter.com/HKqWpaCrxN",,@,# # #,"1255142434704461831",https://twitter.com/LizCancerHealth/status/1255142434704461831
NCRI_partners,2020-04-28 10:30,2,6,"Are # cancer patients more vulnerable to # COVID19? A multi-centre study from Wuhan, # China concludes the # AACR20 Virtual Annual Meeting opening plenary on # COVID19 and # cancer.",,,# # # # # #,"1255142418455818250",https://twitter.com/NCRI_partners/status/1255142418455818250
lila4137,2020-04-28 10:30,0,0,"Katy is a hero and role model! I love her and am so excited for the adoptive cell therapy session. :)",,,,"1255142346527670273",https://twitter.com/lila4137/status/1255142346527670273
pashtoonkasi,2020-04-28 10:30,0,0,"How many patients they had on # immunotherapy and/or # targeted therapies? Any observations # AACR20 # COVID19",,,# # # #,"1255142267557261312",https://twitter.com/pashtoonkasi/status/1255142267557261312
JCellBiol,2020-04-28 10:30,2,4,". @ Nowak_Lab & @ trotmanlab: Identification of the phosphatase PHLPP2’s role in controlling MYC stability could have implications for many cancers. JCB’s cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has new short summaries of articles: https://bit.ly/2XYckGS pic.twitter.com/Go7IWLoJZY",,@ @,#,"1255142249018519553",https://twitter.com/JCellBiol/status/1255142249018519553
MM_Oncology,2020-04-28 10:29,5,2,"# AACR20 news: No improvement in metastatic # CRPC outcomes with addition of # atezolizumab to # enzalutamide - phase 3 IMbassador250 data reported by @ ChrisSweens1 (of @ DanaFarber) # immunotherapy @ PCF_Science @ DanaFarberNews @ uroupdatehttp://bit.ly/3aIcHaX",,@ @ @ @ @,# # # # #,"1255142112640724998",https://twitter.com/MM_Oncology/status/1255142112640724998
rosslevinemd,2020-04-28 10:29,1,7,"Challenge is how do we get aggregated data from all of our centers so we can amass numbers for each tumor type, treatment status/type, confounders? No one center, no matter how big, will have enough patients for clear conclusions. Need collaboration! @ AACR @ ASH_hematology",,@ @,,"1255142028653940737",https://twitter.com/rosslevinemd/status/1255142028653940737
pezaro_c,2020-04-28 10:28,0,3,"Gosh, also a reminder that enza is seldom active after abi. Radiographic progression within first few months suggests time would be better spent on a more active treatment. Maybe time to stop using this as a comparator arm? # AACR20 # pcsm",,,# #,"1255141853688524805",https://twitter.com/pezaro_c/status/1255141853688524805
pashtoonkasi,2020-04-28 10:28,1,2,"# AACR20 https://twitter.com/JAMANetwork/status/1255134674524925952 …",,,#,"1255141832591151105",https://twitter.com/pashtoonkasi/status/1255141832591151105
kelseyrhampton,2020-04-28 10:28,0,1,"I'm not used to attending # AACR2020 from the comfort of my own home, but I'm grateful that @ AACR is still able to share cutting edge research on their Virtual Meeting platform!",,@,#,"1255141828564627456",https://twitter.com/kelseyrhampton/status/1255141828564627456
tmprowell,2020-04-28 10:28,4,7,"# AACR20 # COVID19 Dr. Paolo Ascierto describes design of single arm ph 2 TOCIVID-19 study [hospitalized, O2<94% RA or ETT<24h (n=330)] + an observational cohort w/ ETT>24h (n=1781) in # COVID19. First analysis to happen soon. cc @ kizzyPhD @ EricTopol @ ScottGottliebMDpic.twitter.com/yNPpRvIDSy",,@ @ @,# # #,"1255141799082905600",https://twitter.com/tmprowell/status/1255141799082905600
RousseauMC,2020-04-28 10:28,1,7,"Immune checkpoint inhibitors not associated with worse outcome in COVID + cancer patients. Li Zhang from Wuhan sharing "The experience of treating patients with cancer during the COVID-19 pandemic in China" @ AACR # AACR2020 AACR Livestream pic.twitter.com/bAY59bMokN",,@,#,"1255141746784104448",https://twitter.com/RousseauMC/status/1255141746784104448
pashtoonkasi,2020-04-28 10:28,10,13,"# AACR20 # BRAF - one of my patients recently sent me this illustrating from a recent review the diversity of tumor types in which # BRAF mutations are seen as well as the spectrum of mutations (V600E non-V600E); classifications of # BRAF mutations. # precisionmedicinepic.twitter.com/Ls3p52ijEs",,,# # # # #,"1255141729025454082",https://twitter.com/pashtoonkasi/status/1255141729025454082
tehfem,2020-04-28 10:27,0,0,"35% death rate in # lungcancer patients with#COVID19# # TERAVOLT DATA # aacr2020 presented by @ marinagarassinohttps://twitter.com/Tony_Calles/status/1255139495315300356 …",,@,# #COVID19 # # #,"1255141562352189441",https://twitter.com/tehfem/status/1255141562352189441
JacobPlieth,2020-04-28 10:26,0,5,"Paolo Ascierto on treating Covid-19 hyperinflammation (AKA "cytokine storm") with cancer drugs # AACR20 $ SNY $ NVS $ INCY $ RHHBYpic.twitter.com/1wcC8o4VGT",,,#,"1255141456680898562",https://twitter.com/JacobPlieth/status/1255141456680898562
pashtoonkasi,2020-04-28 10:25,2,3,"# AACR20 any data presented on use of # immunotherapy in these # cancer patients with # COVID19 # OncoAlert - is immune checkpoint inhibitor prior usage was associated with worse or different outcomes?",,,# # # # #,"1255141074126770177",https://twitter.com/pashtoonkasi/status/1255141074126770177
OncoAlert,2020-04-28 10:24,3,7,"Dear Colleagues, Thank you for your use the # OncoAlert hashtag on your tweets during # AACR20 to keep colleagues worldwide informedPlease feel free to Tell a Friend about @ OncoAlert and help us make the oncology world even smallerWe Are ALL OncoAlertpic.twitter.com/umeMqU4rzj",,@,# #,"1255140885752238080",https://twitter.com/OncoAlert/status/1255140885752238080
LUNGevity,2020-04-28 10:23,0,1,"A multi-pronged anti-inflammatory treatment approach to treat the # COVID19 cytokine storm? @ PAscierto # AACR2020 # LCSM # AACR20 pic.twitter.com/a8TFXbf2mK",,@,# # # #,"1255140629832544257",https://twitter.com/LUNGevity/status/1255140629832544257
pashtoonkasi,2020-04-28 10:23,1,5,"# AACR20 Journals/simultaneous publications https://twitter.com/JExpMed/status/1255134932197797888 …",,,#,"1255140491189841921",https://twitter.com/pashtoonkasi/status/1255140491189841921
EnriqueSoto8,2020-04-28 10:22,6,21,"Over 2000 patients included in single arm studies of tocilizumab in # covid19 in Italy! # AACR2020 Another missed opportunity for a RCT @ VPrasadMDMPH # coronaviruspic.twitter.com/uTrgvbAJ3X",,@,# # #,"1255140447770435584",https://twitter.com/EnriqueSoto8/status/1255140447770435584
teamoncology,2020-04-28 10:22,5,16,"I heard this kind of stuff all the time and it is truly not the right impression. -Paitent failed the treatment or did not respond. -Patient is metastatic. There is a need for a plenary session at ASCO & AACR to re-educate some of the docs and researchers. # AACR20 https://twitter.com/tmprowell/status/1255138226085359617 …",,,#,"1255140402081853441",https://twitter.com/teamoncology/status/1255140402081853441
ivybelkins,2020-04-28 10:22,1,0,"@ PAscierto discusses experience using oncology drugs in patients w/ # COVID19. # AACR20 # lcsm @ EGFRResisterspic.twitter.com/7sk2dPjHEY",,@ @,# # #,"1255140385984143361",https://twitter.com/ivybelkins/status/1255140385984143361
PChavee,2020-04-28 10:22,1,0,"GSK: In today’s uncertain times, our scientists are steadfast in their commitment to progressing the R&D of novel therapies to address unmet medical needs. Learn more about our latest cancer research: https://gsk.to/3f1U0Cs # AACR20",,,#,"1255140215095623681",https://twitter.com/PChavee/status/1255140215095623681
CharuAggarwalMD,2020-04-28 10:21,6,12,"Use of Tocilizumab in # COVID19 at # AACR2020. As we gain better understanding of this disease, and use drugs effectively, we will have another steep learning curve ahead of us wrt late complications like fibrosis, characteristics of responder vs. non- @ PAscierto @ OncoAlertpic.twitter.com/GmQkzcgABc",,@ @,# #,"1255140169067323393",https://twitter.com/CharuAggarwalMD/status/1255140169067323393
pashtoonkasi,2020-04-28 10:21,1,3,"# AACR20 any data on # immunotherapy usage in any of the patients? # lcsm # COVID19",,,# # # #,"1255140138696364046",https://twitter.com/pashtoonkasi/status/1255140138696364046
pashtoonkasi,2020-04-28 10:20,11,8,"# AACR20 # TwitterPoll # COVID19 & # Cancer # COVIDnCancer. Thoughts on minimizing surveillance visits or deciding on who could be spared or prioritized for chemo using # ctDNA # liquidbiopsies for # MinimalResidualDisease # MRD. Access programs available for # cancer home-draw",,,# # # # # # # # # #,"1255139739671203840",https://twitter.com/pashtoonkasi/status/1255139739671203840
JulienMazieres,2020-04-28 10:20,1,5,"EGFR ex20 mutation in # NSCLC still a daunting task. Poziotinib phase 2 @ AACR 15% RR (albeit 65% tumor reduction). PFS 4.2 m. with some long lasting responses. We need to better define the optimal dosing (65% dose reduction) and the right molecular target https://www.abstractsonline.com/pp8/#!/9045/presentation/10782 …",,@,# #,"1255139738425552900",https://twitter.com/JulienMazieres/status/1255139738425552900
Tony_Calles,2020-04-28 10:19,2,5,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255124310521454593 …",,,# # # #,"1255139693903011843",https://twitter.com/Tony_Calles/status/1255139693903011843
Tony_Calles,2020-04-28 10:19,2,7,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255123438462787585 …",,,# # # #,"1255139652803026944",https://twitter.com/Tony_Calles/status/1255139652803026944
Tony_Calles,2020-04-28 10:19,4,2,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255123425670172672 …",,,# # # #,"1255139609480060937",https://twitter.com/Tony_Calles/status/1255139609480060937
Tony_Calles,2020-04-28 10:19,3,4,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255129529489616896 …",,,# # # #,"1255139567620902917",https://twitter.com/Tony_Calles/status/1255139567620902917
Tony_Calles,2020-04-28 10:19,4,2,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255129517988823041 …",,,# # # #,"1255139532363583489",https://twitter.com/Tony_Calles/status/1255139532363583489
Tony_Calles,2020-04-28 10:19,3,5,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255128976856461312 …",,,# # # #,"1255139495315300356",https://twitter.com/Tony_Calles/status/1255139495315300356
Tony_Calles,2020-04-28 10:18,4,3,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255133440845873152 …",,,# # # #,"1255139437236776969",https://twitter.com/Tony_Calles/status/1255139437236776969
Tony_Calles,2020-04-28 10:18,3,2,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255133431425449985 …",,,# # # #,"1255139397709606912",https://twitter.com/Tony_Calles/status/1255139397709606912
LizCancerHealth,2020-04-28 10:18,6,3,"Paolo Ascierto from Naples: Cancer pts on # immunotherapy showing pneumonits should be tested for # COVID19 before using steroids. Cancer docs well positioned to use tocilizumab - TOCIVID-19 data expected soon. # AACR20 # coronaviruspic.twitter.com/NwTvRo6kAi",,,# # # #,"1255139397323812864",https://twitter.com/LizCancerHealth/status/1255139397323812864
Tony_Calles,2020-04-28 10:18,4,5,"# AACR20 # COVID19 & # Cancer # OncoAlerthttps://twitter.com/Tony_Calles/status/1255133431425449985 …",,,# # # #,"1255139354445373440",https://twitter.com/Tony_Calles/status/1255139354445373440
weoncologists,2020-04-28 10:18,8,19,"First results from # TERAVOLT are out and presented today at # AACR20 by our @ myESMO @ OncoAlert colleague @ marinagarassino showing high mortality rate of # COVID19 in patients with thoracic malignancies.https://twitter.com/myESMO/status/1255138553517895683 …",,@ @ @,# # #,"1255139275886088192",https://twitter.com/weoncologists/status/1255139275886088192
GuiltFreeTips,2020-04-28 10:17,0,0,"Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak https://bit.ly/2W4RS4h via @ CD_AACR @ AACR # coronavirus",,@ @,#,"1255139180251734016",https://twitter.com/GuiltFreeTips/status/1255139180251734016
RousseauMC,2020-04-28 10:17,0,2,"Follow @ AACR 2020 livestream: High rate (14%) of DVT/PE in COVID-19 cancer patients (n = 63 pts) Carlos Gomez-Martin, Adapting oncologic practice to COVID19 outbreak: From outpatient triage to risk assessment for specific treatment in Madrid, Spain",,@,,"1255139155081785346",https://twitter.com/RousseauMC/status/1255139155081785346
teamoncology,2020-04-28 10:17,0,0,"Similar ideas floating around in breast cancer. Good to know this does not work in prostate cancer, maybe the same for # breastcancer. Need more preclinical study fo the role of AR pathway in Immune regulation. # AACR20 https://twitter.com/tompowles1/status/1254793493521805312 …",,,# #,"1255139083266883588",https://twitter.com/teamoncology/status/1255139083266883588
GSK,2020-04-28 10:16,7,21,"In today’s uncertain times, our scientists are steadfast in their commitment to progressing the R&D of novel therapies to address unmet medical needs. Learn more about our latest cancer research: https://gsk.to/3f1U0Cs # AACR20",,,#,"1255138721361301508",https://twitter.com/GSK/status/1255138721361301508
myESMO,2020-04-28 10:15,28,37,"# Covid19: First results from TERAVOLT registry for thoracic cancers show high mortality rate of COVID-19 in pats w/ thoracic malignancies. Mortality rate of COVID-19 in this group does not appear 2 b linked to specific treatmt/comorbidity. Video: https://youtu.be/-O1idXUntcQ # AACR20 pic.twitter.com/wPkHD6ouqF",,,# #,"1255138553517895683",https://twitter.com/myESMO/status/1255138553517895683
CRUKresearch,2020-04-28 10:15,2,7,". @ TheCrick’s @ TurajlicLab is chairing a Molecular and Cellular Biology/Genetics session at the # AACR20 Annual Meeting I. Join online tonight from 20:50 – 23:35 BST to hear about new research in this field. https://www.abstractsonline.com/pp8/#!/9045/session/838 …pic.twitter.com/Ya1R9IydPe",,@ @,# #,"1255138460215566336",https://twitter.com/CRUKresearch/status/1255138460215566336
ECMC_UK,2020-04-28 10:15,0,2,"Abstract on the differential prognosis of immune biomarkers in breast cancer will be presented today at # AACR20 Virtual Meeting I at 9:40-9:50pm. David Cameron, Edinburgh centre co-lead, is co-author on the study. Register for free access: https://www.abstractsonline.com/pp8/#!/9045/presentation/10534 … @ Edinburghunipic.twitter.com/vDYYTeR4R5",,@,# #,"1255138448865984512",https://twitter.com/ECMC_UK/status/1255138448865984512
tmprowell,2020-04-28 10:14,69,238,"# AACR20 Reminder that # WordsMatter. Just heard "Many of our pts are metastatic." Pts don't metastasize. Tumors do. Pts are not their disease so: "Many of our pts have metastatic dz." See our lang of respect guide for all speakers at # ASCO20: http://bit.ly/35axK55 # advocacypic.twitter.com/ZmDYDXNbIP",,,# # # #,"1255138226085359617",https://twitter.com/tmprowell/status/1255138226085359617
Annals_Oncology,2020-04-28 10:14,14,9,"# AACR20 Here is the link to the paper published in Annals of Oncology by Zhang et al on the clinical characteristics of patients with cancer infected by # COVID19 https://www.sciencedirect.com/science/article/pii/S0923753420363833 …https://twitter.com/AACR/status/1255121099500720130 …",,,# #,"1255138209261948937",https://twitter.com/Annals_Oncology/status/1255138209261948937
LUNGevity,2020-04-28 10:13,0,1,"Pts on immuno tx and showing pneumonitis, or pts on BRAF inhibitors and with persistent fever -- need to be tested for # COVID19. Lessons from melanoma. @ PAscierto # AACR20 # AACR2020 # LCSMpic.twitter.com/FdEA0kpH9U",,@,# # # #,"1255138105570422785",https://twitter.com/LUNGevity/status/1255138105570422785
BenWestphalen,2020-04-28 10:11,3,5,"Thanks to @ OncoAlert for sharing my thoughts on an excellent talk on # BRAF mutations presented during the @ AACR virtual meeting 2020! https://twitter.com/OncoAlert/status/1255134751695896579 …",,@ @,#,"1255137622793449473",https://twitter.com/BenWestphalen/status/1255137622793449473
LUNGevity,2020-04-28 10:10,0,0,"We need to protect cancer patients and healthcare workers during the # COVID19 pandemic - @ PAscierto # AACR2020 # AACR20 # LCSMpic.twitter.com/QJTCP539Ho",,@,# # # #,"1255137323206885376",https://twitter.com/LUNGevity/status/1255137323206885376
ASCOPost,2020-04-28 10:10,3,7,"Final Overall Survival Results From the Phase III EMBRACA Trial https://www.ascopost.com/news/april-2020/final-overall-survival-results-from-the-phase-iii-embraca-trial/ … # AACR2020 # AACR20 # bcsm # oncology # cancer",,,# # # # #,"1255137190818066432",https://twitter.com/ASCOPost/status/1255137190818066432
SKabrajiMD,2020-04-28 10:08,0,2,"Even if we go back to in-person # aacr annual meetings, please can we keep the live-stream? @ AACR",,@,#,"1255136855546163201",https://twitter.com/SKabrajiMD/status/1255136855546163201
sloan_kettering,2020-04-28 10:08,5,14,"Today's # AACR20's plenary session is # COVID19 and # Cancer. Tune in to hear from MSK's Dr. Louis Voigt, as he presents " # COVID19 and cancer: Flattening the curve but widening disparities." @ AACR https://bit.ly/3bJwhoE",,@,# # # #,"1255136704828026885",https://twitter.com/sloan_kettering/status/1255136704828026885
_SOLTI,2020-04-28 10:07,0,1,"@ AACR offers a very interesting and open access Plenary Session by Antoni Ribas. To learn more about this virtual meeting: https://www.aacr.org/professionals/blog/aacr-virtual-annual-meeting-i-a-users-guide/ …https://twitter.com/AACR/status/1255121099500720130 …",,@,,"1255136510099156993",https://twitter.com/_SOLTI/status/1255136510099156993
OncoAlert,2020-04-28 10:07,3,9,"Live # AACR20 Twet by @ docjavip : @ OncoAlert colleague @ barlesi of @ GustaveRoussy presents the experience with # COVID19 # cancer patients, death rate 14.8%, ICU admission 11%, worse evolution in frail patients and with chemo within the last 3 months"https://twitter.com/docjavip/status/1255134213877018626 …",,@ @ @ @,# # #,"1255136475454169088",https://twitter.com/OncoAlert/status/1255136475454169088
LizCancerHealth,2020-04-28 10:06,1,2,"Carlos Gomez-Martin from Madrid: 85% of # COVID19 patients with # cancer had metastatic disease, so not admitted to ICU due to short life expectancy. # AACR2020 # coronaviruspic.twitter.com/8J1wYz4asN",,,# # # #,"1255136389726789634",https://twitter.com/LizCancerHealth/status/1255136389726789634
Syndax,2020-04-28 10:06,0,1,"# DYK metastatic cancer occurs when cancer cells break away from a tumor and travel to other parts of the body via the bloodstream. Learn more about our data at # AACR20 here: https://bit.ly/2Sgymkj pic.twitter.com/a0YUdmUwKN",,,# #,"1255136376011423748",https://twitter.com/Syndax/status/1255136376011423748
msmelanoma,2020-04-28 10:06,1,3,"# COVID19 and # cancer at # AACR20. Carlos López Martín discussing findings on oncology @ hospital12Oct. Lung mets a complication. Standard clinical options still pending.pic.twitter.com/Spnz9JzeuL",,@,# # #,"1255136331425964032",https://twitter.com/msmelanoma/status/1255136331425964032
CancerMedMDA,2020-04-28 10:06,0,0,". @ lab_rezvani chairs # AACR20 Virtual Plenary Session VCTPL05 - Adoptive Cell Transfer Therapy, Today at 10 AM (11 AM EDT). @ AACR https://bit.ly/3bANSiD",,@ @,#,"1255136184063242240",https://twitter.com/CancerMedMDA/status/1255136184063242240
UCCancerCenter,2020-04-28 10:05,2,3,"Extra care must be taken to protect cancer patients from SARS-CoV-2 # AnswerCancer. Data reported at # AACR20 https://twitter.com/washingtonpost/status/1255119702898155526 …",,,# #,"1255136116937592835",https://twitter.com/UCCancerCenter/status/1255136116937592835
CellPressNews,2020-04-28 10:05,5,18,". @ LocasaleLab, @ WellenLab, and @ ThalesPapaG gather on Zoom to discuss the links between diet, extracellular nutrient availability, and cellular tumor metabolism. https://youtu.be/7u94a9ASmt4 # AACR20",,@ @ @,#,"1255136115935211524",https://twitter.com/CellPressNews/status/1255136115935211524
CellPressNews,2020-04-28 10:05,2,4,"Could # vaccines be used to treat # cancer? In this edition of Research Arc, we explore the rationale for developing vaccines against # tumors. # AACR20 -https://bit.ly/3bN3v6u",,,# # # #,"1255135948674707462",https://twitter.com/CellPressNews/status/1255135948674707462
APassaroMD,2020-04-28 10:04,44,63,"# COVID19 # AACR20 # LCSM TERAVOLT preliminary results by @ marinagarassino. An amazing international effort to improve knowledge about # lungcancer & COVID19. 198 pts evaluated with 34.6% of death rate. Not specific anti-cancer treatment was associated w/ higher mortality # OncoAlertpic.twitter.com/dWUKuoU1qi",,@,# # # # #,"1255135848699326465",https://twitter.com/APassaroMD/status/1255135848699326465
drleighellis,2020-04-28 10:03,0,2,"That was the trick",,,,"1255135678402138113",https://twitter.com/drleighellis/status/1255135678402138113
LuciaViola9,2020-04-28 10:03,0,1,"All hearts are in the same place # AACR2020",,,#,"1255135647611842561",https://twitter.com/LuciaViola9/status/1255135647611842561
susanmgalbraith,2020-04-28 10:02,0,1,"Patients with haematological malignancies have worse outcomes with COVID-19 vs patients with solid tumours in Gustave-Roussy series # AACR2020. https://twitter.com/jsoriamd/status/1255131390997225479 …",,,#,"1255135348364959754",https://twitter.com/susanmgalbraith/status/1255135348364959754
deLeeuwRenee,2020-04-28 10:02,0,2,"Have you tried clicking the session title link? The watch now button did not work for me.",,,,"1255135226600161282",https://twitter.com/deLeeuwRenee/status/1255135226600161282
Tony_Calles,2020-04-28 10:02,0,5,"We are all connected! # AACR20",,,#,"1255135193687445506",https://twitter.com/Tony_Calles/status/1255135193687445506
NCRI_partners,2020-04-28 10:01,0,1,"Experience of using oncology drugs in patients with # COVID19. Being presented by @ PAscierto at the # AACR20 Virtual Annual Meeting.",,@,# #,"1255135166445441029",https://twitter.com/NCRI_partners/status/1255135166445441029
tehfem,2020-04-28 10:01,5,5,"22% death rate in cancer patients with # COVID19 @ GustaveRoussy experience # AACR2020 AACR https://twitter.com/Tony_Calles/status/1255133422298599428 …",,@,# #,"1255134964774887425",https://twitter.com/tehfem/status/1255134964774887425
archerdxinc,2020-04-28 10:01,1,2,"We are aiming to expand # PrecisionOncology into early-stage cancer, when # cancer is typically easier to cure. # AACR20 # AACR2020 pic.twitter.com/dTrjwWZqge",,,# # # #,"1255134948169625600",https://twitter.com/archerdxinc/status/1255134948169625600
JExpMed,2020-04-28 10:01,1,1,"If you are interested in submitting work related to # AACR20 to JEM, we encourage you to contact JEM Scientific Editor Xin (Cindy) Sun @ Cindy_JExpMed",,@,#,"1255134932197797888",https://twitter.com/JExpMed/status/1255134932197797888
teamoncology,2020-04-28 10:00,21,45,"Oncologists are very used to see the Kaplan-Meier curve. For COVID-19, the curve shows statistically significant with Y-axis represented by days, not even months. It is a very sad outcome. Thanks, @ AACR for providing this opportunity to learn so that we can fight w/data. # AACR20 pic.twitter.com/VtVTqPxd3b",,@,#,"1255134869614522370",https://twitter.com/teamoncology/status/1255134869614522370
careyjans,2020-04-28 10:00,2,4,"A quick trip around the globe this morning to learn about # COVID19 in cancer patients: Wuhan —> Lombardy —> Paris —> Madrid (so far). Glad a virtual # AACR20 can facilitate sharing these important data!! # virtuallearning # StayAtHomehttps://twitter.com/AACR/status/1255121099500720130 …",,,# # # #,"1255134850396221442",https://twitter.com/careyjans/status/1255134850396221442
OncoAlert,2020-04-28 10:00,3,11,"Our @ OncoAlert colleague @ BenWestphalen from University of Munich on the # AACR20 GENIE project. Focus on Abstract 1092 on # BRAF mutations Edited: @ weoncologistspic.twitter.com/sB0bII8C8G",,@ @ @,# #,"1255134751695896579",https://twitter.com/OncoAlert/status/1255134751695896579
JAMANetwork,2020-04-28 10:00,0,0,"It's day 2 of # AACR20. Recent # oncology articles from @ JAMA_current, @ JAMAOnc, and @ JAMANetworkOpen are available free online during the meeting https://ja.ma/2yworjG",,@ @ @,# #,"1255134674524925952",https://twitter.com/JAMANetwork/status/1255134674524925952
tmprowell,2020-04-28 09:59,40,55,"# AACR20 # COVID19 Dr. Fabrice Barlesi on # COVID19nCancer at Gustave Roussy. Incidence # SARSCoV2 (12%), % asymptomatic (80%), ICU (11%), & death (15%) similar to non-oncology population. Risk factors for poor outcome: ECOG>1, heme malig, adv cancer w/ chemo (not other tx) in 3 mos.pic.twitter.com/st9GCjGirh",,,# # # #,"1255134574985674756",https://twitter.com/tmprowell/status/1255134574985674756
Tony_Calles,2020-04-28 09:59,0,3,"Great job! We were watching # AACR20",,,#,"1255134497252626440",https://twitter.com/Tony_Calles/status/1255134497252626440
NazliDizman,2020-04-28 09:58,17,37,"Kudos to @ barlesi of @ GustaveRoussy et al for this detailed analysis of cancer patients with # COVID19 @ AACR # AACR20 @ lalbiges @ jsoria @ FAndreMDpic.twitter.com/jHBGoQr5a6",,@ @ @ @ @ @,# #,"1255134375101870080",https://twitter.com/NazliDizman/status/1255134375101870080
ChristianRolfo,2020-04-28 09:58,3,11,"Important experience in cancer patients with # COVID19 in France presented by @ barlesi . Congrats! # AACR2020 @ OncoAlertpic.twitter.com/eXH3qJ2nFa",,@ @,# #,"1255134327987298304",https://twitter.com/ChristianRolfo/status/1255134327987298304
docjavip,2020-04-28 09:58,4,7,"@ barlesi at # AACR20 presented the experience with # COVID19 cancer patients, death rate 14.8%, ICU admission 11%, worse evolution in frail patients and with chemo within the last 3 monthspic.twitter.com/6Kjg4KUu9V",,@,# #,"1255134213877018626",https://twitter.com/docjavip/status/1255134213877018626
BeckiLee,2020-04-28 09:58,1,1,"# AACR20 # COVID19 experience in cancer patients - Performance status and haematological malignancy predictors of clinical worsening - Performance status most important predictor of survival -Importantly targeted and immune therapy don't appear to affect covid19 coursepic.twitter.com/ICyuvMiinO",,,# #,"1255134171514585090",https://twitter.com/BeckiLee/status/1255134171514585090
mitchiela,2020-04-28 09:57,1,4,"Today at 4:25 - Olivia Lee will present on the genomic characterization of brain metastases across different tumor types. # NCI_ITEB # AACR2020 @ AACR https://www.abstractsonline.com/pp8/#!/9045/presentation/10569 …https://twitter.com/NCIEpiTraining/status/1252600485686714369 …",,@,# # #,"1255134167051845633",https://twitter.com/mitchiela/status/1255134167051845633
krknrm,2020-04-28 09:57,5,5,"Fascinating talk by @ barlesi @ GustaveRoussy - Cancer patient outcomes with # COVID19, incl therapy, AEs and pediatric patients. Similar outcomes regardless of # COVID19 however need to pay attention to specific factors. "Participation in CTs is essential" # COVID19nCancer # AACR20 pic.twitter.com/ZRZMZ5nxGa",,@ @,# # # #,"1255134078061314049",https://twitter.com/krknrm/status/1255134078061314049
AnaBGGarcia,2020-04-28 09:57,0,3,"Nice to listen to his talk right now in # AACR2020 pic.twitter.com/FswfOyonWx",,,#,"1255133953624731658",https://twitter.com/AnaBGGarcia/status/1255133953624731658
CharuAggarwalMD,2020-04-28 09:56,5,14,"This finding, of patients with poor PS w/ worse outcomes is not entirely unexpected. Patients with ECOG PS of 2,3,4 are a highly vulnerable population, # COVID19 not withstanding. # AACR2020 @ OncoAlerthttps://twitter.com/Jbauml/status/1255131410874216448 …",,@,# #,"1255133881801433090",https://twitter.com/CharuAggarwalMD/status/1255133881801433090
LUNGevity,2020-04-28 09:55,2,3,"@ GustaveRoussy 's experience w/ # COVID19 - pts w/low-performance status (frail pts), pts w/ heme malignancies, &those who received chemo in past 3 months more likely to have severe complications frm COVID # AACR20 # AACR2020 # LCSMpic.twitter.com/yFkKd3vxWr",,@,# # # #,"1255133556919042051",https://twitter.com/LUNGevity/status/1255133556919042051
BiodesixInc,2020-04-28 09:55,1,3,"Excited for today's # AACR20 presentation on predictive biomarkers for immunotherapeutics: "Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project" https://qoo.ly/35qnjk # virtualconference # SocialDistancing",,,# # #,"1255133444390051845",https://twitter.com/BiodesixInc/status/1255133444390051845
Tony_Calles,2020-04-28 09:55,10,17,"Dr Fabrice Barlesi @ barlesi presents @ GustaveRoussy experience on # COVID19 & # Cancer # LCSM # AACR20 @ AACR # OncoAlert @ OncoAlertpic.twitter.com/Nd5EqAD8gq",,@ @ @ @,# # # # #,"1255133422298599428",https://twitter.com/Tony_Calles/status/1255133422298599428
ChristianRolfo,2020-04-28 09:54,4,8,"Nice results form TERAVOLT trial # COVID19 # AACR2020 presented by @ marinagarassino . Happy to participate in this registry in lung cancer patients @ UMGCCC @ UMmedschool @ lcsmchat @ OncoAlertpic.twitter.com/vyEzlm06w3",,@ @ @ @ @,# #,"1255133334574899200",https://twitter.com/ChristianRolfo/status/1255133334574899200
OncoAlert,2020-04-28 09:54,3,6,"Live # AACR20 tweet by @ jsoriamd “ Plenary session by @ barlesi of @ GustaveRoussy shows # COVID19 prevalence among cancer patients is a) 12% b) mortality is close to 15% (similar to general population c)Factors correlated with worst outcome: hemopathy, PS2+, recent chemotherapy”https://twitter.com/jsoriamd/status/1255131390997225479 …",,@ @ @,# #,"1255133330841858053",https://twitter.com/OncoAlert/status/1255133330841858053
Aiims1742,2020-04-28 09:53,0,5,"The @ GustaveRoussy # COVID19nCancer experience presented by @ barlesi at # AACR20 Similar to the Chinese experience above (caveat - small numbers!), the French too noted hematological cancers as having higher propensity for complications with # COVID19. @ rosslevinemd @ amitvermamdspic.twitter.com/RFsKy8I44k",,@ @ @ @,# # #,"1255133152692940800",https://twitter.com/Aiims1742/status/1255133152692940800
LizCancerHealth,2020-04-28 09:53,0,1,"They're screencaps. I've requested slides from @ AACR but haven't received them yet.",,@,,"1255133076260155394",https://twitter.com/LizCancerHealth/status/1255133076260155394
DMM_Journal,2020-04-28 09:53,0,0,"Fantastic and timely # AACR20 session on # COVID19 and cancer. When these two conditions collide, researchers and clinicians need to consider so many aspects, from patient care to drug repurposing.",,,# #,"1255133062091771907",https://twitter.com/DMM_Journal/status/1255133062091771907
CharuAggarwalMD,2020-04-28 09:53,6,13,"# TERAVOLT presented at # AACR20. Impact of # COVID19 on # LungCancer. Amongst other factors such as COPD, important to note that older age associated with worse outcomes - we must continue to prevent, and minimize exposure for this highly vulnerable population # LCSMhttps://twitter.com/StephenVLiu/status/1255130217078808576 …",,,# # # # #,"1255133024678629381",https://twitter.com/CharuAggarwalMD/status/1255133024678629381
teamoncology,2020-04-28 09:53,2,1,"French group, shows PS being the only risk factor for the poor outcome for COVID-19 cancer patients. However, hematological malignancy and chemo within the past 3M, we need to pay attention as high risk. # AACR20 pic.twitter.com/7ZkgSRQFct",,,#,"1255132997558300674",https://twitter.com/teamoncology/status/1255132997558300674
ivybelkins,2020-04-28 09:52,0,0,"@ barlesi from @ GustaveRoussy about # COVID19 and cancer. Found frail patients, patients with hematological diseases, and with advanced disease treated with chemo in last 3 months to be at higher risk of COVID-19 worsening # AACR20 # lcsm @ EGFRResisterspic.twitter.com/V023wxT4nA",,@ @ @,# # #,"1255132772101877774",https://twitter.com/ivybelkins/status/1255132772101877774
chulkimMD,2020-04-28 09:52,5,4,"Experience from @ GustaveRoussy by @ barlesi in various cancers and # COVIDー19. N=137. 23% asymptomatic. 14.6% mortality rate. ECOG PS, hematological disease, metastatic cancer on chemoTx were predictive of worse outcomes. No increase in AEs in 8 pediatric pts. # AACR20 @ OncoAlertpic.twitter.com/51BVmiufS0",,@ @ @,# #,"1255132687645343753",https://twitter.com/chulkimMD/status/1255132687645343753
NormandBlais,2020-04-28 09:52,0,0,"Mortalité des pts avec cancer poumon peu importe le type de traitement. Patients à protéger. # AACR20 pic.twitter.com/ezYhg9kPmv",,,#,"1255132665604235268",https://twitter.com/NormandBlais/status/1255132665604235268
cancerassassin1,2020-04-28 09:51,2,6,"# AACR20 @ GustaveRoussy # COVID report: Death rate 14.8%; 11% ICU admission; "Patients with advanced disease treated with cytotoxic chemotherapy" at particularly high risk. More data presented today supporting risk for specific cancer sub-populations that we had concerns about.",,@,# #,"1255132458799886336",https://twitter.com/cancerassassin1/status/1255132458799886336
Martin_AngelMD,2020-04-28 09:51,7,12,"# Covid19 and # Cancer lecture in # AACR20 . # OncoAlert No anti-cancer treatment associated with higher mortality Patients treateted with ICI wer NOT more succeptible to infection patchy consolidation risk factor for severe events don´t forget cancer tx.pic.twitter.com/zVXpumDKIv",,,# # # #,"1255132445059346433",https://twitter.com/Martin_AngelMD/status/1255132445059346433
mtmdphd,2020-04-28 09:50,4,3,"# COVID19nCancer # CCC19 # AACR20 https://twitter.com/jsoriamd/status/1255131390997225479 …",,,# # #,"1255132399010148353",https://twitter.com/mtmdphd/status/1255132399010148353
mtmdphd,2020-04-28 09:50,0,0,"# COVID19nCancer # CCC19 # AACR20 https://twitter.com/Jbauml/status/1255131410874216448 …",,,# # #,"1255132352826634245",https://twitter.com/mtmdphd/status/1255132352826634245
LizCancerHealth,2020-04-28 09:50,4,1,"Fabrice Barlesi @ barlesi ( @ GustaveRoussy): Incidence, outcomes & death rate of # # COVID19 patients with cancer appears similar to those without cancer. # AACR20 # coronaviruspic.twitter.com/SgTuhkNdAh",,@ @,# # # #,"1255132319578386440",https://twitter.com/LizCancerHealth/status/1255132319578386440
mtmdphd,2020-04-28 09:50,3,2,"# COVID19nCancer # CCC19 # AACR20 https://twitter.com/CharuAggarwalMD/status/1255132106922979328 …",,,# # #,"1255132274200244226",https://twitter.com/mtmdphd/status/1255132274200244226
DrGEcheverria,2020-04-28 09:49,3,12,"Just presented at # AACR2020: Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,,#,"1255132151248371718",https://twitter.com/DrGEcheverria/status/1255132151248371718
lgreco_ny,2020-04-28 09:49,1,4,"It didn't make me feel better. I'm still very upset about this. I'm trying awfully hard to stay alive and this is the best @ aacr can do? What does that mean for lung cancer? # lcsm",,@,#,"1255132116423069698",https://twitter.com/lgreco_ny/status/1255132116423069698
CharuAggarwalMD,2020-04-28 09:49,10,18,". @ barlesi presents on the French experience, N=137 pts w/ # Cancer. Important to note that 23% asymptomatic, only 20% w/ known contact. Following assoc w/ worse outcomes: > Poor PS (> ECOG 1) > Receipt of chemo in 3 months No relation to TKI/ IO use # LCSM # AACR20 @ OncoAlertpic.twitter.com/wcwcfNYal3",,@ @,# # #,"1255132106922979328",https://twitter.com/CharuAggarwalMD/status/1255132106922979328
nycdoc29,2020-04-28 09:49,1,1,"# EHA25 will be virtual June 11 to June 14 - https://ehaweb.org/congress/eha25/ @ EHA_Hematology # OncoAlert # AACR20",,@,# # #,"1255132064623493125",https://twitter.com/nycdoc29/status/1255132064623493125
OncoAlert,2020-04-28 09:49,1,1,"Live # AACR20 plenary session by our @ OncoAlert colleague @ barlesi of @ GustaveRoussy shows # COVID19 # cancer patients have a % mortality” tweet by our friend @ jsoriamd https://twitter.com/jsoriamd/status/1255130694302367746 …",,@ @ @ @,# # #,"1255131957891002369",https://twitter.com/OncoAlert/status/1255131957891002369
Jbauml,2020-04-28 09:48,2,4,"They found that receipt of IO or TKI in the last 3 mo was not associated with clinical worsening from COVID19. While chemotherapy in the adjuvant setting was associated with a higher risk of clinical worsening it was not associated with worse COVID19 mortality # AACR20",,,#,"1255131828857511936",https://twitter.com/Jbauml/status/1255131828857511936
jsoriamd,2020-04-28 09:48,40,77,"Data presented at plenary session # AACR20 from @ GustaveRoussy by @ barlesi shows that use of targeted agents or immunotherapy are not correlated with worst # COVID19 outcome among cancer patients in contrast with chemotherapypic.twitter.com/z0VqqIJrMJ",,@ @,# #,"1255131733608919043",https://twitter.com/jsoriamd/status/1255131733608919043
jsoriamd,2020-04-28 09:47,4,6,"Data presented at plenary session # AACR20 from @ GustaveRoussy by @ barlesi shows that prevalence of # COVID19 among cancer pediatric patients is almost 14% with a median age of 3 yearspic.twitter.com/IM1QHHcxJm",,@ @,# #,"1255131549546119168",https://twitter.com/jsoriamd/status/1255131549546119168
StephenVLiu,2020-04-28 09:47,1,7,"# OncoAlert # AACR20 This registry data is after only just month and reflects the global collaborative spirit that has emerged in the midst of the # COVIDー19 pandemic. Quickly endorsed by @ IASLC @ myESMO. We were proud to contribute from @ LombardiCancer and hope others join! # LCSMpic.twitter.com/uoZaKdGLvc",,@ @ @,# # # #,"1255131520924147714",https://twitter.com/StephenVLiu/status/1255131520924147714
NormandBlais,2020-04-28 09:47,7,6,"35% décès des patients avec cancer du poumon hospitalisés avec COVID. On se doit de tout faire pour protéger ces patients. # AACR20 https://twitter.com/Tony_Calles/status/1255128976856461312 …",,,#,"1255131466402422786",https://twitter.com/NormandBlais/status/1255131466402422786
Jbauml,2020-04-28 09:47,0,6,"This group found that low ECOG PS, hematologic malignancy, and receipt of chemotherapy in the last 3 mo (mostly for advanced disease) were associated with worse outcomes # AACR20 pic.twitter.com/yS7ufR4w04",,,#,"1255131410874216448",https://twitter.com/Jbauml/status/1255131410874216448
jsoriamd,2020-04-28 09:46,50,71,"Data at plenary session # AACR20 from @ GustaveRoussy by @ barlesi shows that # COVID19 prevalence among cancer patients is a) 12% b) mortality is close to 15% (similar to general population c)Factors correlated with worst outcome: hemopathy, PS2+, recent chemotherapypic.twitter.com/Ga25jTRfyz",,@ @,# #,"1255131390997225479",https://twitter.com/jsoriamd/status/1255131390997225479
MGriffin95,2020-04-28 09:46,0,2,"Benefit of isolation? I get to attend the # AACR2020 virtual meeting from the comfort of my home office. Currently catching up on yesterday’s talks, but very much looking forward to the Novel targets and therapies mini symposium later this evening. pic.twitter.com/FmaZvfG7Uy",,,#,"1255131345723875328",https://twitter.com/MGriffin95/status/1255131345723875328
jillfeldman4,2020-04-28 09:46,0,2,"@ marinagarassino discusses TERAVOLT, global collaboration on impact of # COVID19 in # lungcancer patients. Symptoms of COVID19 very similar to lung cancer w/pnuemonitis & ARDS most common. Mortality rate high at 35%. Limited data, but concerning for lc patients # LCSM # AACR20 pic.twitter.com/45nTu1kVtr",,@,# # # #,"1255131264492998656",https://twitter.com/jillfeldman4/status/1255131264492998656
cancerassassin1,2020-04-28 09:46,7,12,""Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematological cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events." # AACR20 @ CD_AACR @ AACR https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,@ @,#,"1255131161287954434",https://twitter.com/cancerassassin1/status/1255131161287954434
NCRI_partners,2020-04-28 09:45,0,0,"Next Carlos Gomez-Martin, Octubre University Hospital, Madrid, Spain is presenting data on adapting cancer treatment during # COVID19, including outpatient triage and treatment risk assessments. # AACR20",,,# #,"1255130958337990657",https://twitter.com/NCRI_partners/status/1255130958337990657
Jbauml,2020-04-28 09:45,1,1,"Here we see data on the management. They gave HCQ/Azithromycin in 40 patients - survival outcomes do not seem very different between those that received treatment or the overall population. # AACR20 pic.twitter.com/xrHMMkAoYg",,,#,"1255130946891808768",https://twitter.com/Jbauml/status/1255130946891808768
FayeJohnso,2020-04-28 09:45,0,1,"Thank you",,,,"1255130942210863111",https://twitter.com/FayeJohnso/status/1255130942210863111
stollm3,2020-04-28 09:44,0,0,"# CancerResearchSavesLives # AACR2020 https://twitter.com/AACRFoundation/status/1255119601945493504 …",,,# #,"1255130839957925889",https://twitter.com/stollm3/status/1255130839957925889
jsoriamd,2020-04-28 09:44,11,30,"Data presented at plenary session # AACR20 from @ GustaveRoussy by @ barlesi shows that # COVID19 cancer patients have a 15% mortality . Is this good outcome notably related to the almost 10% of patients who received compassionate # Tocilizumab ? https://www.aphp.fr/contenu/tocilizumab-improves-significantly-clinical-outcomes-patients-moderate-or-severe-covid-19 …pic.twitter.com/1kc0iD9VcV",,@ @,# # #,"1255130694302367746",https://twitter.com/jsoriamd/status/1255130694302367746
JFreemanDaily,2020-04-28 09:44,0,0,"Liz, This doesn't look like a screencap. Do you have access to a clean # AACR20 slide set?",,,#,"1255130663595896833",https://twitter.com/JFreemanDaily/status/1255130663595896833
VukovicPetra,2020-04-28 09:43,10,12,"# AACR20 # TERAVOLT High mortality among thoracic cancer pt with 34.6% death rate Pneumonitis (79%) and ARDS (26.8%) were the most frequent complications ICU admission in 8.8% and mechanical ventilation in 2.5% of pt # Oncoalertpic.twitter.com/9oKfNxZgD1",,,# # #,"1255130578350825472",https://twitter.com/VukovicPetra/status/1255130578350825472
chuynhMDCM,2020-04-28 09:43,1,1,"Interesting # TERAVOLT prelim findings: n=200 [81.1% smokers, 75.5% NSCLC, 73.5% stage IV, 73.9% on tx]. Main cx: pneumonitis/PNA (79.6%), ARDS (27%). No comorb or tx predictive of hospitalization or mortality. Mortality rate 34.6%, thought to be 2/2 COVID-19 infx. # AACR20 @ AACR pic.twitter.com/enebTBEtiz",,@,# #,"1255130573380648963",https://twitter.com/chuynhMDCM/status/1255130573380648963
Deborah91198441,2020-04-28 09:43,0,0,"TY..high volume was response. Guess I missed a good one!",,,,"1255130524806496256",https://twitter.com/Deborah91198441/status/1255130524806496256
Jbauml,2020-04-28 09:43,2,5,"@ barlesi reporting the experience of COVID19 in France. About 1/4 of patients were asymptomatic and most didnt know about contact with an infected patient. Largest proportion of patients did not have substantial imaging findings in this cohort (largely outpatient) # AACR20 pic.twitter.com/GUVBhAPfDK",,@,#,"1255130518418489344",https://twitter.com/Jbauml/status/1255130518418489344
SU2Cscience,2020-04-28 09:43,4,1,"Please tune in today for @ SU2C funded researchers presenting their work at the @ AACR annual meeting, being held now via the Web. Progress and results from five teams will be discussed, the first at 10:50 AM Eastern # AACR20 https://standuptocancer.org/press/stand-up-to-cancer-funded-research-to-be-presented-during-the-2020-aacr-virtual-meeting/ …",,@ @,#,"1255130489888755717",https://twitter.com/SU2Cscience/status/1255130489888755717
Aiims1742,2020-04-28 09:43,23,40,"Coinciding with the # COVID19nCancer session at # AACR20, @ CD_AACR has published the largest peer reviewed series (thus far) of # COVID19 in cancer patients (N=105 from China). Overall, a higher rate of complications is seen across the board. @ tmprowell https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …pic.twitter.com/32VGCKwx2u",,@ @,# # #,"1255130463150264320",https://twitter.com/Aiims1742/status/1255130463150264320
joshgoldstein1,2020-04-28 09:42,0,1,"# AACR20 Leading on cancer and # COVID the @ AACR Virtual Annual Meeting I highlights research on impact of the pandemic on cancer patients as cancer research labs utilize skills and technology to tackle # coronavirus. # ResearchSavesLiveshttps://twitter.com/AACR/status/1255126347220951040 …",,@,# # # #,"1255130266726813696",https://twitter.com/joshgoldstein1/status/1255130266726813696
StephenVLiu,2020-04-28 09:42,2,7,"# OncoAlert # AACR20 No specific treatment conferred greater risk. Factors associated with greater risk being sought - risk of greater risk in males also noted. Early data - this will continue to evolve as the registry grows. # LCSMpic.twitter.com/iSO3GiNp2O",,,# # #,"1255130217078808576",https://twitter.com/StephenVLiu/status/1255130217078808576
TakedaOncology,2020-04-28 09:42,3,6,"Join us today at 11:14AM EST for the # AACR20 virtual session, New Drugs on the Horizon, or review our abstract to learn more about mobocertinib (TAK-788) and its clinical development.",,,#,"1255130179904684032",https://twitter.com/TakedaOncology/status/1255130179904684032
HeManJespersen,2020-04-28 09:42,0,4,"# AACR20 the time of # COVID19pic.twitter.com/HD7ioSbuMY",,,# #,"1255130154289885185",https://twitter.com/HeManJespersen/status/1255130154289885185
Rick__Buck,2020-04-28 09:41,1,3,"Happy # AACR20 Virtual Annual Meeting Day 2 to you too Emil! Already lots of breaking news with our # COVID19 and # Cancer session, and up to more than 61,000 registered attendees!https://twitter.com/cancerassassin1/status/1255120276787990531 …",,,# # #,"1255129932491087872",https://twitter.com/Rick__Buck/status/1255129932491087872
GeneOnlineNews,2020-04-28 09:40,2,1,"The # lungcancer target therapy session at # AACR20 featured the recent advances in the field. Here we present the highlights including @ Novartis' TKI, Capmatinib, &yet another trial success for @ Merck's Keytruda in # NSCLC. # Cancer # immunotherapy # GeneOnlinehttps://wp.me/pb0TAP-1kH",,@ @,# # # # # #,"1255129731202199553",https://twitter.com/GeneOnlineNews/status/1255129731202199553
LungConsultant,2020-04-28 09:40,0,3,"@ marinagarassino shows high mortality rates in patients with lung cancer and # COVID19 in TERAVOLT registry. SARS-CoV2 infection (and not cancer) was cause of death in large majority. <10% patients were admitted to ICU @ AACR # COVID19 # lungcancer # lcsmpic.twitter.com/2c2H0oZaIl",,@ @,# # # #,"1255129719080579073",https://twitter.com/LungConsultant/status/1255129719080579073
ADesaiMD,2020-04-28 09:40,5,13,"Very excited to see our # metanalysis from @ ASCO_pubs # JCOGO presented at # AACR20 by @ marinagarassino @ HornLeora et al. # TERAVOLT team! @ tm_parekh @ ASCO @ AACR @ COVID19nCCCpic.twitter.com/iOFHphGBZj",,@ @ @ @ @ @ @,# # # #,"1255129712063586305",https://twitter.com/ADesaiMD/status/1255129712063586305
ErikaHamilton9,2020-04-28 09:40,5,9,"Catching up from # AACR20. @ bernmunster elegant discussion of # ISPY2. Great historical reference slides re: addition of # immunotherapy and addition of # PARP Contribution of PARP over immuno uncertain Need to pay attention to toxicity and financial toxicity. @ OncoAlertpic.twitter.com/24KasjzDlK",,@ @,# # # #,"1255129711719702528",https://twitter.com/ErikaHamilton9/status/1255129711719702528
StephenVLiu,2020-04-28 09:39,4,9,"# OncoAlert # AACR20 High mortality (35%) in patients with thoracic cancers and # COVIDー19 but note only 9% transferred to ICU and under 3% with mechanical ventilation. Some of the high mortality may be due to insufficient resources in areas hard hit by the pandemic. # LCSMpic.twitter.com/fteqnoDjlg",,,# # # #,"1255129547424641026",https://twitter.com/StephenVLiu/status/1255129547424641026
NazliDizman,2020-04-28 09:38,4,5,"A very important worldwide initiative of thoracic cancer patients with # COVID19 infection by @ marinagarassino of @ IstTumori @ AACR # AACR20 n=200, 73.9% are on active treatment, 34.6% mortality pic.twitter.com/dFaUJ6vA8S",,@ @ @,# #,"1255129341513494537",https://twitter.com/NazliDizman/status/1255129341513494537
pauldriscoll33,2020-04-28 09:37,0,0,"Day 2: Virtual Backstage! @ AACR # AACR20 Big # COVIDー19 and # cancer session going on right now!!pic.twitter.com/apBg7GUjUE",,@,# # #,"1255129115063201792",https://twitter.com/pauldriscoll33/status/1255129115063201792
Aiims1742,2020-04-28 09:37,2,2,"Very pertinent message from Dr. @ marinagarassino at the end of her presentation. Don't go on alone and join registries. # COVID19nCancer # AACR20 @ OncoAlertpic.twitter.com/4gmyYXEwTA",,@ @,# #,"1255129054845550593",https://twitter.com/Aiims1742/status/1255129054845550593
StephenVLiu,2020-04-28 09:37,3,10,"# OncoAlert # AACR20 Complications from # COVIDー19 in patients with thoracic cancers are striking. 80% with pneumonia and 27% with ARDS. 8% had multi-organ failure. 76% hospitalized. Mortality rate from this registry so far: 35% (66/191). Much higher than previous reports. # LCSMpic.twitter.com/3oMj774oxW",,,# # # #,"1255128978253320192",https://twitter.com/StephenVLiu/status/1255128978253320192
Tony_Calles,2020-04-28 09:37,13,33,"Dr Marina Garassino @ marinagarassino presenting data from # TERAVOLT evaluating # COVID19 and lung cancer # LCSM Results overlapping with our own institutional experience recently spread via # SoMe # AACR20 @ AACR @ OncoAlert # OncoAlert @ IASLC @ gecp_orgpic.twitter.com/zcglqIyYow",,@ @ @ @ @,# # # # # #,"1255128976856461312",https://twitter.com/Tony_Calles/status/1255128976856461312
CharuAggarwalMD,2020-04-28 09:36,8,15,"Humbling to see such high mortality rates in # NSCLC w/ # COVID19, No clear relation to therapy, Pneumonia seems to be the most common presentation. We must continue to # MinimizeExposure # Masking # ThermalScan # Restrict # LCSM @ OncoAlert # AACR20 https://twitter.com/LeciaSequist/status/1255128076431720451 …",,@,# # # # # # # #,"1255128690901635072",https://twitter.com/CharuAggarwalMD/status/1255128690901635072
OncoAlert,2020-04-28 09:35,1,6,"Live # AACR20 Tweet by @ lizca " Conclusions of presentation by our @ OncoAlert colleague @ marinagarassino : # COVID19 symptoms overlap with # lungcancer symptoms, so diagnosis can be very challenging "https://twitter.com/LizCancerHealth/status/1255127671295500288 …",,@ @ @,# # #,"1255128611431911426",https://twitter.com/OncoAlert/status/1255128611431911426
arosenzweig19,2020-04-28 09:35,1,3,"# AACR20 # COVIDnCancer - must work together and share experiencespic.twitter.com/kMuMN4f65s",,,# #,"1255128583623733250",https://twitter.com/arosenzweig19/status/1255128583623733250
teamoncology,2020-04-28 09:35,2,4,"The Italian Group reports the lung cancer & COVID-19 risk studies. Wow, 35% mortality. No particular treatment associated with worse outcomes. The risk factor is male, HTN, and age. # AACR2020 pic.twitter.com/9upPSHAqgi",,,#,"1255128521313259520",https://twitter.com/teamoncology/status/1255128521313259520
thubeena6,2020-04-28 09:35,0,0,"High mortality rate in thoracic cancer. Need to continue to collaborate to study this further. # AACR2020",,,#,"1255128512672890880",https://twitter.com/thubeena6/status/1255128512672890880
cancerassassin1,2020-04-28 09:35,3,7,"Dr. @ marinagarassino makes the important point: we need information on impact of COVID on cancer pts quickly, so joining established registry efforts will be more effective than many separate databases. Link to TERAVOLT collaboration via @ myESMO: https://www.esmo.org/covid-19-and-cancer/collaborating-on-registries-studies-and-surveys … # AACR20 https://twitter.com/cancerassassin1/status/1255126163774754818 …",,@ @,#,"1255128500069191680",https://twitter.com/cancerassassin1/status/1255128500069191680
krknrm,2020-04-28 09:35,6,14,"Incredible community efforts from the # TERAVOLT initiative presented by @ marinagarassino >200 # lungcancer patients with # COVIDー19 - record times at all stages! Such an exciting session # AACR2020 ! @ myESMO @ peters_solange @ barlesi @ EnriquetaFelip @ IASLC @ HwakeleeMDpic.twitter.com/knbOYy1e4R",,@ @ @ @ @ @ @,# # # #,"1255128468448260096",https://twitter.com/krknrm/status/1255128468448260096
mtmdphd,2020-04-28 09:35,3,2,"Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020] Liu et al. # AACR20 CT086 - VCTPL08 Session http://ow.ly/Oxpy30qB9U8 # lcsm # irAE # ImmunoOnc @ Syapse @ US_FDA @ Aurora_Cancer",,@ @ @,# # # #,"1255128421535014912",https://twitter.com/mtmdphd/status/1255128421535014912
JFreemanDaily,2020-04-28 09:34,7,19,"Conclusion for TERAVOLT registry presentation on # AACR20 pic.twitter.com/hR3R47wVNK",,,#,"1255128299312828416",https://twitter.com/JFreemanDaily/status/1255128299312828416
chulkimMD,2020-04-28 09:34,10,16,"First report of TERAVOLT by @ marinagarassino. N=200 (75% NSCLC, 81% smoker, age=68, 74% on active treatment). 80% with pneumonia/pneumonitis, 27% with ARDS. No spec Tx a/w higher mortality, but requires larger N. 35% death rate(!). Alarming rate of mortality. # AACR20 @ OncoAlertpic.twitter.com/2Z7l2DF6iN",,@ @,#,"1255128276114313216",https://twitter.com/chulkimMD/status/1255128276114313216
RamalingamMD,2020-04-28 09:34,35,70,"35% mortality for thoracic cancer patients infected with COVID19; @ marinagarassino reports from a global registry @ AACR virtual meeting. @ IASLC . @ WinshipAtEmory",,@ @ @ @,,"1255128212805423104",https://twitter.com/RamalingamMD/status/1255128212805423104
nifear,2020-04-28 09:34,0,0,"i cannot w/ the # AACR20 comments section... "did you test non-cancer patients?" "should I get my f/u imaging done next month?" what??",,,#,"1255128153606901761",https://twitter.com/nifear/status/1255128153606901761
StephenVLiu,2020-04-28 09:33,1,4,"# OncoAlert # AACR20 Most patients with # COVIDー19 were receiving treatment (74%), which may reflect the patients seen by participants, though patients in follow up also at risk. Most common symptoms: fever (64%), cough (52%), dyspnea (54%) and fatigue (27%). # LCSMpic.twitter.com/jMP9tx7hIY",,,# # # #,"1255128077937582080",https://twitter.com/StephenVLiu/status/1255128077937582080
LeciaSequist,2020-04-28 09:33,10,18,"@ marinagarassino Pneumonitis (80%) and ARDS (27%) look to be VERY common in # LungCancer pts with # COVID19. Death rate = 35%. No clear incr risk depending on type of cancer treatment. Awful news but need to know. Prevention of infection is CRITICAL! # LCSM # AACR2020",,@,# # # #,"1255128076431720451",https://twitter.com/LeciaSequist/status/1255128076431720451
ivybelkins,2020-04-28 09:33,7,10,"Dr. Garassino/TERAVOLT initial findings: unexpectedly high mortality among # lungcancer patients with # COVID19. 34.6% death rate in first dataset # AACR20 # lcsm @ EGFRResisterspic.twitter.com/YNVan2eZrQ",,@,# # # #,"1255128052952182784",https://twitter.com/ivybelkins/status/1255128052952182784
marcbjohnson74,2020-04-28 09:33,0,1,"The connection between certain types of cancer and COVID-19. The @ AACR has been investigating the connection. They just released a study on this issue at # AACR20. They are leading the charge. https://www.washingtonpost.com/health/2020/04/28/coronavirus-cancer-deathrates/ …",,@,#,"1255127931925532672",https://twitter.com/marcbjohnson74/status/1255127931925532672
LungConsultant,2020-04-28 09:33,0,3,"Fantastic work by @ marinagarassino and colleagues to present first 200 pts with # COVID19 and # lung cancer in TERAVOLT registry at @ AACR pic.twitter.com/NuuY0k6Vjq",,@ @,# #,"1255127913092878343",https://twitter.com/LungConsultant/status/1255127913092878343
CharuAggarwalMD,2020-04-28 09:32,10,21,". @ marinagarassino presenting on # TERAVOLT-Thoracic cancer registry w/ # COVID19-Rapid initiation of protocol, 70 cases/wk, international participation, n=200 cases, 75% w/ # NSCLC, frequently w/ overlapping s/s of cancer itself, High Mortality of 34.6% # LCSM @ OncoAlert # AACR20 pic.twitter.com/hPjS53f75Y",,@ @,# # # # #,"1255127814501814272",https://twitter.com/CharuAggarwalMD/status/1255127814501814272
OncologyCentral,2020-04-28 09:32,2,3,"The initial data from # TERAVOLT have been revealed at # AACR20. Find out more about the impact of # COVID19 in patients with # lungcancer # NSCLC on @ Oncology Central:",,@,# # # # #,"1255127760747393024",https://twitter.com/OncologyCentral/status/1255127760747393024
Rick__Buck,2020-04-28 09:32,4,6,"Breaking news from # AACR20>Cancer patients are nearly three times more likely to die of covid-19, study says - The Washington Post ⁦ @ lauriemcginley2⁩ https://www.washingtonpost.com/health/2020/04/28/coronavirus-cancer-deathrates/ …",,@,#,"1255127741294395392",https://twitter.com/Rick__Buck/status/1255127741294395392
YaleCancer,2020-04-28 09:32,0,7,"Attending # AACR20 virtually? Watch Dr. Patricia LoRusso as discussant for today’s # targetedtherapy session at 4:35pm. @ SmilowCancer @ YaleMed @ YNHH # oncoalert # cancerresearch https://www.abstractsonline.com/pp8/#!/9045/session/855 …pic.twitter.com/MpBDmcG5CV",,@ @ @,# # # # #,"1255127712894717952",https://twitter.com/YaleCancer/status/1255127712894717952
LizCancerHealth,2020-04-28 09:32,8,9,"Marina Chiara Garassino from Milan: # COVID19 symptoms overlap with # lungcancer symptoms, so diagnosis can be very challenging # AACR20 # coronaviruspic.twitter.com/yZgt88x7wU",,,# # # #,"1255127671295500288",https://twitter.com/LizCancerHealth/status/1255127671295500288
JCellBiol,2020-04-28 09:32,2,1,". @ slschmid_lab used a technique to follow fast recycling endosomes in p53 cancer cells. JCB’s new cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has short summaries of this and other articles here: https://bit.ly/2XYckGS pic.twitter.com/W4ge0ShGRB",,@,#,"1255127634410962944",https://twitter.com/JCellBiol/status/1255127634410962944
sloan_kettering,2020-04-28 09:31,2,7,"It's day 2 of # AACR20. For more info on the virtual meeting & what MSK experts will be featured please visit our website. @ AACR http://bit.ly/3cLMwSs",,@,#,"1255127595848552449",https://twitter.com/sloan_kettering/status/1255127595848552449
Jbauml,2020-04-28 09:31,8,10,"These are the very sobering outcomes. Very high death rate, and we can see here that some patients who would otherwise have received mechanical ventilation/ICU care were not because of resource limitations. This is why flattening the curve is so important. # AACR20 pic.twitter.com/Vi9GsbKhgx",,,#,"1255127594141433856",https://twitter.com/Jbauml/status/1255127594141433856
StephenVLiu,2020-04-28 09:30,1,4,"# OncoAlert # AACR20 This registry included patients with thoracic malignancy and # COVIDー19. Enrolling rapidly and this presentation describes the first 200 patients entered. Comorbidity rate is high, as previously reported. # LCSMpic.twitter.com/KSAIc833tM",,,# # # #,"1255127332672671744",https://twitter.com/StephenVLiu/status/1255127332672671744
NCRI_partners,2020-04-28 09:30,1,0,"As part of the # AACR20 opening plenary on # COVID19 and # cancer, @ barlesi is presenting the outcomes of cancer patients infected with # COVID19 in Villejuif, # France. Including toxicity of cancer treatments.",,@,# # # # #,"1255127311424389121",https://twitter.com/NCRI_partners/status/1255127311424389121
Aiims1742,2020-04-28 09:30,1,11,"# COVID19nCancer # AACR20 virtual session is ongoing - what a way to bring together the international oncology community together during a pandemic! @ OncoAlerthttps://twitter.com/Aiims1742/status/1250129896426418179 …",,@,# #,"1255127193962917889",https://twitter.com/Aiims1742/status/1255127193962917889
imsmd,2020-04-28 09:30,4,6,"Hot off the presses and will be presented piping warm at around 10:30 am (US EST) at the virtual # AACR20 today: https://twitter.com/CD_AACR/status/1255120959385882632 …",,,#,"1255127162857967616",https://twitter.com/imsmd/status/1255127162857967616
saidbahwal,2020-04-28 09:29,0,1,"Thanks @ AACR for arranging this event # AACR20. An opportunity to know more about recent advances in cancer treatment.",,@,#,"1255127058834841600",https://twitter.com/saidbahwal/status/1255127058834841600
JenSeligmann,2020-04-28 09:29,0,1,"I had to click directly on the session presentation rather than the ‘watch now’ option",,,,"1255127054485458945",https://twitter.com/JenSeligmann/status/1255127054485458945
ivybelkins,2020-04-28 09:29,4,10,"Marina Chiara Garassino, MD from Milan, Italy discusses a global collaboration (TERAVOLT) to address the impact of # COVID19 on # lungcancer patients. # lcsm # AACR20 @ EGFRResisterspic.twitter.com/Kqage3eRk3",,@,# # # #,"1255127033417535491",https://twitter.com/ivybelkins/status/1255127033417535491
Jbauml,2020-04-28 09:29,3,5,"This is a huge problem with diagnosing COVID19 in patients with lung cancer, as @ marinagarassino notes. Most of the symptoms of COVID19 overlap with the symptoms of lung cancer # LCSM # AACR20 pic.twitter.com/OxjsdLvybL",,@,# #,"1255126989129875456",https://twitter.com/Jbauml/status/1255126989129875456
blkstemhero,2020-04-28 09:29,0,1,"This session has pretty interesting interesting findings! # AACR20 https://twitter.com/AACR/status/1255121099500720130 …",,,#,"1255126879335415809",https://twitter.com/blkstemhero/status/1255126879335415809
JCampisano,2020-04-28 09:28,0,1,"# bcsm # AACR20 https://twitter.com/jillfeldman4/status/1255126547767472129 …",,,# #,"1255126863606759426",https://twitter.com/JCampisano/status/1255126863606759426
drleighellis,2020-04-28 09:28,0,1,"I have tried safari and chrome today and nothing thus far. Worked great yesterday - thanks for replying",,,,"1255126799882698752",https://twitter.com/drleighellis/status/1255126799882698752
FayeJohnso,2020-04-28 09:28,0,0,"I wish I could see this session but many of us cannot load it. :(",,,,"1255126694211575809",https://twitter.com/FayeJohnso/status/1255126694211575809
UCCancerCenter,2020-04-28 09:27,1,0,"@ UCCancerCenter is proud of our investigators and clinicians presenting at # AACR20 to # AnswerCancer. Excited to attend Session I Day 2 today. https://www.aacr.org/meeting/aacr-annual-meeting-2020/schedule-at-a-glance/ …pic.twitter.com/vvldXBEhoZ",,@,# #,"1255126618630225922",https://twitter.com/UCCancerCenter/status/1255126618630225922
jillfeldman4,2020-04-28 09:27,1,12,"Interesting that outcomes for cancer patients with # COVID19 seem to be associated with anti-tumor treatment within the past 14 days, but not necessarily specific to patients treated with ICI # AACR20 # LCSMpic.twitter.com/O0ZE7Ns32B",,,# # #,"1255126547767472129",https://twitter.com/jillfeldman4/status/1255126547767472129
AACR,2020-04-28 09:26,25,22,"The study was released at the # AACR20 Virtual Annual Meeting I and published in our peer-reviewed journal, @ CD_AACR. https://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …https://twitter.com/washingtonpost/status/1255119702898155526 …",,@,#,"1255126347220951040",https://twitter.com/AACR/status/1255126347220951040
JFreemanDaily,2020-04-28 09:26,0,1,"Try again--my colleague just got in",,,,"1255126331920023554",https://twitter.com/JFreemanDaily/status/1255126331920023554
StephenVLiu,2020-04-28 09:26,8,31,"# OncoAlert # AACR20 Global registry of # COVIDー19 in patients with lung cancer led by @ marinagarassino and @ HornLeora, the # TERAVOLT registry: Thoracic Cancers International COVID-19 Collaboration. An impressive and rapidly executed, global registry. # LCSMpic.twitter.com/UxjI9o6gcF",,@ @,# # # # #,"1255126313549148160",https://twitter.com/StephenVLiu/status/1255126313549148160
drleighellis,2020-04-28 09:26,0,2,"Only if I could get the @ AACR live stream to work today",,@,,"1255126294603288585",https://twitter.com/drleighellis/status/1255126294603288585
DrJNaidoo,2020-04-28 09:26,0,2,"And thank you to # AACR2020 for the privilege of serving as discussant",,,#,"1255126225938497536",https://twitter.com/DrJNaidoo/status/1255126225938497536
Jbauml,2020-04-28 09:26,0,3,"When designing a registry like this, it i critical to have inclusive inclusion criteria to ensure that you capture all of the relevant patient data. This is such important work! # AACR20 # LCSMpic.twitter.com/ow4c8FcBbt",,,# #,"1255126169453723649",https://twitter.com/Jbauml/status/1255126169453723649
cancerassassin1,2020-04-28 09:26,0,5,""We were prepared for a pandemic lasting for months, but not for years." That sums up the situation for all of us. Dr @ marinagarassino speaking on behalf of Thoracic Cancers International # COVID19 Collaboration. Kudos for this international collaboration - helping pts. # AACR20",,@,# #,"1255126163774754818",https://twitter.com/cancerassassin1/status/1255126163774754818
ShrutiPatelMD,2020-04-28 09:25,0,1,"THE BEST! Round 2 today to learn about residual disease monitoring on the molecular level with # ctDNA detection! @ NateraOncology",,@,#,"1255126079376891905",https://twitter.com/ShrutiPatelMD/status/1255126079376891905
JenSeligmann,2020-04-28 09:25,0,1,"@ AACR I’m impressed. Watching # covid19 and cancer live stream from my office post clinic. Registered today and free of charge. Really helping to share knowledge. Thanks! # AACR20 @ ACPUKpic.twitter.com/bYQbyTCASE – bei Bexley Wing",,@ @,# #,"1255126016688680961",https://twitter.com/JenSeligmann/status/1255126016688680961
weoncologists,2020-04-28 09:25,5,8,"Up next at # AACR20 our @ OncoAlert colleague @ marinagarassino to present # TERAVOLT A testament of how the # lungcancer come come@together and unite @ peters_solange @ barlesi @ EnriquetaFelip @ IASLC @ HwakeleeMDhttps://twitter.com/marinagarassino/status/1246118015634223110 …",,@ @ @together @ @ @ @ @,# # #,"1255125913177665536",https://twitter.com/weoncologists/status/1255125913177665536
Dr_ZiMingZhao,2020-04-28 09:24,2,3,"Lessons to learn for our cancer patients during covid-19: Data for severe conditions for cancer patients during covid-19 # AACR20 https://www.sciencedirect.com/science/article/pii/S0923753420363833 …pic.twitter.com/xbOYtNQcWc",,,#,"1255125796131389441",https://twitter.com/Dr_ZiMingZhao/status/1255125796131389441
LizCancerHealth,2020-04-28 09:24,0,1,"Marina Chiara Garassino from Milan: We were prepared for an epidemic lasting for days or weeks, but not a pandemic lasting for months # COVID19 # coronavirus # AACR20 pic.twitter.com/Br6e1DEbOU",,,# # #,"1255125760194404352",https://twitter.com/LizCancerHealth/status/1255125760194404352
LUNGevity,2020-04-28 09:24,0,0,"Framework to guide how cancer patients should be treated with radiotherapy and systemic therapy. @ marinagarassino # AACR2020 # AACR20 # LCSMpic.twitter.com/lxzJsPXPtv",,@,# # #,"1255125726266904577",https://twitter.com/LUNGevity/status/1255125726266904577
DrChoueiri,2020-04-28 09:24,1,5,"Congrats @ AlbigesL @ barlesi and all @ GustaveRoussy cc, @ jsoriamd # AACR20 https://twitter.com/AlbigesL/status/1255125107497930752 …",,@ @ @ @,#,"1255125709950869505",https://twitter.com/DrChoueiri/status/1255125709950869505
barlesi,2020-04-28 09:24,2,18,"Teravolt a huge international effort to understand how # Covid_19 impacted LCSM patients presented @ AACR meeting by @ marinagarassino @ peters_solange @ HornLeora @ HwakeleeMD",,@ @ @ @ @,#,"1255125678044913665",https://twitter.com/barlesi/status/1255125678044913665
NCIDirector,2020-04-28 09:24,27,45,"It’s day two of # AACR20. Today at 520 pm ET, @ theNCI’s Deputy Director for Scientific Strategy and Development, Dr. Dinah Singer will present a special session, “NCI Activities: # COVID-19 and # CancerResearch.” Be sure to tune in. https://www.abstractsonline.com/pp8/#!/9045/sessions/singer/1 …pic.twitter.com/zFQODE0ezB",,@,# # # #,"1255125631295090688",https://twitter.com/NCIDirector/status/1255125631295090688
benweinbergmd,2020-04-28 09:24,0,5,"The culmination of 5+ years of work, an idea that @ MPishvaian had in spring 2015! Mentored through @ AACR @ ASCO Vail workshop, supported by @ ConquerCancerFd YIA, excellent scientific collaborators @ RoswellPark, can’t thank you all enough!",,@ @ @ @ @,,"1255125629969842181",https://twitter.com/benweinbergmd/status/1255125629969842181
prgthees,2020-04-28 09:22,1,1,"https://youtu.be/XHA8FGuebvk Introduction to strength of materials-stress,strain and their types # BeatLockDownBlues # anxiety # AcademicTwitter # balance # AACR20 # application # ADHD # addiction # BBCBitesizeDaily # 3dmodeling # AcademicChatter # agile # 5G # ArtificialIntelligence # 3Dprinting",,,# # # # # # # # # # # # # # #,"1255125112124133380",https://twitter.com/prgthees/status/1255125112124133380
AlbigesL,2020-04-28 09:21,2,18,"COVID in patients with CANCER - The @ GustaveRoussy experience @ AACR highlight session - Does recent cancer treatment impact COVID outcome? @ barlesi @ jsoriamd @ marinagarassino @ FAndreMD @ DrChoueiri @ Uromigos @ montypalhttps://twitter.com/FAndreMD/status/1255118467361124357 …",,@ @ @ @ @ @ @ @ @,,"1255125107497930752",https://twitter.com/AlbigesL/status/1255125107497930752
LizCancerHealth,2020-04-28 09:21,2,0,"Li Zhang: Wuhan # cancer patients with # COVID19 appeared to have worse outcomes, associated with anti-tumor therapy, but not specifically w/checkpoint inhibitor # immunotherapy. # AACR20 pic.twitter.com/oUruq0fnfg",,,# # # #,"1255125107153887233",https://twitter.com/LizCancerHealth/status/1255125107153887233
ronny_drapkin,2020-04-28 09:21,0,2,"# AACR20 STRO-002 (phase I clinical trial of the folate receptor alpha antibody drug-conjugate) Shows Promise In Heavily Pre-Treated Patients With Ovarian Cancer Based On Updated Interim Data From Phase 1 Trial. https://www.cancernetwork.com/ovarian-cancer/updated-interim-data-phase-i-trial-stro-002-show-promise-ovarian-cancer …",,,#,"1255125065588506625",https://twitter.com/ronny_drapkin/status/1255125065588506625
RieWeb20,2020-04-28 09:21,0,2,"Anyone else having trouble watching @ AACR session this morning. I click on the "watch now" button, but nothing happens. I was able to watch the webinar all day yesterday. # AACR20",,@,#,"1255125062484733952",https://twitter.com/RieWeb20/status/1255125062484733952
Jbauml,2020-04-28 09:21,3,7,"Great summary slides of what we knew about COVID 19 and cancer prior to todays presentations. Sample sizes are limited, and we need to know so much more # AACR20 # COVID19 @ OncoAlertpic.twitter.com/tApQKNtbQo",,@,# #,"1255125027860733953",https://twitter.com/Jbauml/status/1255125027860733953
LeciaSequist,2020-04-28 09:20,4,23,"So excited to take 15 min out from clinic to watch @ marinagarassino present on TERAVOLT. Critical to learn about # LungCancer pts and # COVID19 # AACR2020 # LCSM",,@,# # # #,"1255124761987788802",https://twitter.com/LeciaSequist/status/1255124761987788802
OncoAlert,2020-04-28 09:20,3,4,"Live # AACR20 tweet by @ jillfeldman4 “Plenary session Day 2 Dr Zhang presents # Covid19 in patients in Wuhan China. # Lungcancer was most common at 25%” # LCSM @ OncoAlert https://twitter.com/jillfeldman4/status/1255122948253536257 …",,@ @,# # # #,"1255124756715585538",https://twitter.com/OncoAlert/status/1255124756715585538
teamoncology,2020-04-28 09:20,2,4,"Wuhan oncologist shared their experience of cancer management during the COVID-19. 2nd and 3rd conclusions are very interesting observations. # AACR2020 pic.twitter.com/7kDHvODArJ",,,#,"1255124745256869888",https://twitter.com/teamoncology/status/1255124745256869888
Maherjane,2020-04-28 09:20,0,0,"# AACR2020 - people with blood cancers, lung cancers & metastatic disease may have more severe events like admission to ITU with # COVID - UK oncologists are rightly cautious about risks but it does not mean all cancer treatment should stop # COVID # Cancerhttps://twitter.com/washingtonpost/status/1255119702898155526 …",,,# # # #,"1255124734968246273",https://twitter.com/Maherjane/status/1255124734968246273
FayeJohnso,2020-04-28 09:20,0,0,"Same",,,,"1255124700868628482",https://twitter.com/FayeJohnso/status/1255124700868628482
FayeJohnso,2020-04-28 09:20,0,1,"It will not start for me.",,,,"1255124646720143361",https://twitter.com/FayeJohnso/status/1255124646720143361
arosenzweig19,2020-04-28 09:19,0,10,"Up early for the # AACR20 # COVIDnCancer session. Grateful to @ AACR for organizing this important international session and phenomenal virtual meeting. pic.twitter.com/C4uoIdNEPG",,@,# #,"1255124553627348992",https://twitter.com/arosenzweig19/status/1255124553627348992
Jbauml,2020-04-28 09:19,4,9,"Now @ marinagarassino presents data from the TERAVOLT Registry, an impressive international collaboration of COVID19 in patients with lung cancer, led by oncology researchers around the world (also led b y @ HornLeora) # AACR20 # LCSMpic.twitter.com/f07FM0Nbip",,@ @,# #,"1255124462493749249",https://twitter.com/Jbauml/status/1255124462493749249
LUNGevity,2020-04-28 09:19,0,1,"Cancer case analysis from COVID-19 epicenter in Wuhan, China. Stage IV patients, those who received therapy within the past 14 days, and those who receive immune checkpoint inhibitors at higher risk of severe # COVID19. # AACR20 # AACR2020 # LCSMpic.twitter.com/sEVJhPkavZ",,,# # # #,"1255124445016055811",https://twitter.com/LUNGevity/status/1255124445016055811
CarmenBPhillips,2020-04-28 09:19,0,1,"Thank you!",,,,"1255124409536430081",https://twitter.com/CarmenBPhillips/status/1255124409536430081
FayeJohnso,2020-04-28 09:19,0,0,"Same here.",,,,"1255124389638615040",https://twitter.com/FayeJohnso/status/1255124389638615040
Deborah91198441,2020-04-28 09:18,0,1,"9am session today not loading",,,,"1255124215726051330",https://twitter.com/Deborah91198441/status/1255124215726051330
OncoAlert,2020-04-28 09:18,3,3,"Live # AACR20 :In Wuhan China the characteristics of # cancer patients with # covid19 % were # lungcancer patients tweet @ IreneMangues @ OncoAlert # lcsmhttps://twitter.com/IreneMangues/status/1255121970892595200 …",,@ @,# # # # #,"1255124141126103040",https://twitter.com/OncoAlert/status/1255124141126103040
DrJNaidoo,2020-04-28 09:18,15,45,"Highlights of the # LCSM # AACR2020 plenary: Pneumonitis incidence in pooled analysis of 8 trials + RW data(>8000pts) reassuringly shows: 1. overall incidence of IO or chemo-pneumonitis of 1-4.5% (chemo/IO/both) 2. higher incidence in those with PMHx pneumonitis from any cause. pic.twitter.com/2etbrCbpqR",,,# #,"1255124111036211201",https://twitter.com/DrJNaidoo/status/1255124111036211201
JFreemanDaily,2020-04-28 09:16,0,1,"Thanks, that worked for me on a PC, but not for my colleague on a Mac.",,,,"1255123850255187972",https://twitter.com/JFreemanDaily/status/1255123850255187972
Jbauml,2020-04-28 09:15,0,1,"They then looked at the rate of infection and outcomes for 124 patients with cancer being treated with immune checkpoint inhibitors (again most commonly in lung cancer). No difference in the prevalence of COVID 19 infection as a function of ICI receipt. # AACR20 # COVID19pic.twitter.com/FVz1fZzIT9",,,# #,"1255123545971134466",https://twitter.com/Jbauml/status/1255123545971134466
CarmenBPhillips,2020-04-28 09:15,0,0,"Anybody else having a problem with the # AACR20 live stream of the # covid19 plenary? Click on "watch now" and nothing happens.",,,# #,"1255123385622900736",https://twitter.com/CarmenBPhillips/status/1255123385622900736
Anna_LopezM,2020-04-28 09:13,0,0,"Day 2 at # AACR2020 begins! Its kind of nice to be on the sofa with a blanket and listen to some new science! pic.twitter.com/ui31qBjy8e",,,#,"1255123035499216898",https://twitter.com/Anna_LopezM/status/1255123035499216898
jillfeldman4,2020-04-28 09:13,5,8,"Plenary session Day 2 Dr Zhang presents # Covid19 in patients in Wuhan China. # Lungcancer was most common at 25% # AACR20 # LCSMpic.twitter.com/PX4l5el3jx",,,# # # #,"1255122948253536257",https://twitter.com/jillfeldman4/status/1255122948253536257
Jbauml,2020-04-28 09:13,0,2,"Interesting analysis trying to identify high risk features in this high risk group - likely limited by sample size. The only features associated with bad outcomes in this analysis was anti-tumor treatment in the last 14 days or consolidation on their first CT. # AACR20 # COVID19pic.twitter.com/1UlIpUYskJ",,,# #,"1255122864359059462",https://twitter.com/Jbauml/status/1255122864359059462
phenovista,2020-04-28 09:12,0,0,"In tribute to # AACR20 happening this week, we've expanded capabilities in our partnership with Champions Oncology around ex vivo PDX models, specifically quantifying proliferation (along with viability and live/dead cells) in more than 1200+ PDX models. pic.twitter.com/zYk8wWVREw",,,#,"1255122692782657537",https://twitter.com/phenovista/status/1255122692782657537
hashemalsaab,2020-04-28 09:12,2,4,"يحدث الان في مؤتمر # AACR2020 لقاء عن and cancer # COVIDー19pic.twitter.com/k4ltUE8Lxv",,,# #,"1255122672746467328",https://twitter.com/hashemalsaab/status/1255122672746467328
Jbauml,2020-04-28 09:10,1,0,"Here is the outcome data for reported patients. Tough to see from this slide the outcomes specific to those with severe events, but death rate among the overall population is quite concerning. This is a very serious disease for patients with cancer. # AACR20 pic.twitter.com/Z3PSJ1N1ze",,,#,"1255122299843489792",https://twitter.com/Jbauml/status/1255122299843489792
acmoorephd,2020-04-28 09:10,0,0,"Super disappointed that at least one more West Coast colleague and I can't get into the COVID session for # AACR20. What's the problem?",,,#,"1255122237474041856",https://twitter.com/acmoorephd/status/1255122237474041856
c0nc0rdance,2020-04-28 09:09,0,1,"I right clicked and "Open in New Window". Either that was the trick, or it got fixed at the same time.",,,,"1255122002651865088",https://twitter.com/c0nc0rdance/status/1255122002651865088
IreneMangues,2020-04-28 09:09,7,8,"COVID19 and Cancer: 25% Lung Cancer # AACR20 pic.twitter.com/rfpmaUQuUc",,,#,"1255121970892595200",https://twitter.com/IreneMangues/status/1255121970892595200
Jbauml,2020-04-28 09:09,0,0,"Here are some of the early ventilatory and systemic treatments given to these patients. Highlights the difficulty of treating this disease before we knew anything about efficacy of various therapies. We now know lopinavir/ritonavir is ineffective # AACR20 https://www.nejm.org/doi/full/10.1056/NEJMoa2001282 …pic.twitter.com/KEUO1LBpXe",,,#,"1255121840093179905",https://twitter.com/Jbauml/status/1255121840093179905
Tony_Calles,2020-04-28 09:08,2,13,"Ready for Day 2 exciting # AACR20 Virtual Annual Meeting with Clinical Plenary Session of # COVID19 & # Cancer # LCSM # OncoAlert @ OncoAlert Science available for everyone, everywhere. Proud @ AACR member and donor. pic.twitter.com/8NHr9o13wO",,@ @,# # # # #,"1255121650623950853",https://twitter.com/Tony_Calles/status/1255121650623950853
CRUKresearch,2020-04-28 09:07,2,10,". @ uclcancer’s @ squezadd will be chairing the Predictive Biomarkers for Immunotherapeutics session at the # AACR20 Virtual Annual Meeting I. Join online tonight from 20:20 – 23:35 BST to hear about emerging clinical research in immunology. https://www.abstractsonline.com/pp8/#!/9045/session/834 …pic.twitter.com/fv4PExKwi2",,@ @,# #,"1255121341403074561",https://twitter.com/CRUKresearch/status/1255121341403074561
nifear,2020-04-28 09:06,0,1,"https://aacr20.onlineeventpro.freeman.com/live-stream/15335630/COVID-19-and-Cancer …",,,,"1255121102579224576",https://twitter.com/nifear/status/1255121102579224576
AACR,2020-04-28 09:06,35,64,"# AACR20 Virtual Annual Meeting Program Chair Antoni Ribas opens the special Clinical Plenary Session on COVID-19 and Cancer. pic.twitter.com/2c42aOUazm",,,#,"1255121099500720130",https://twitter.com/AACR/status/1255121099500720130
Jbauml,2020-04-28 09:06,11,22,"First up, Dr Zhang presents the experience of taking care of patients with COVID in Wuhan, China. Lung cancer was the most common cancer seen in patients, but multiple other cancers were noted. # AACR20 pic.twitter.com/LKBTvEtg5w",,,#,"1255121093595144200",https://twitter.com/Jbauml/status/1255121093595144200
Fannyazimuts,2020-04-28 09:05,0,0,"Me neither",,,,"1255121040751157253",https://twitter.com/Fannyazimuts/status/1255121040751157253
JFreemanDaily,2020-04-28 09:05,0,2,"Is anyone able to access the Day 2 plenary of # AACR20? The "Watch" button isn't working for me--when I click, nothing happens. @ AACR",,@,#,"1255120980814356480",https://twitter.com/JFreemanDaily/status/1255120980814356480
CD_AACR,2020-04-28 09:05,0,0,"Watch the presentation @ # AACR20 Virtual Annual Meeting I at 10:30 EDT. https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/ …",,@,#,"1255120960648339456",https://twitter.com/CD_AACR/status/1255120960648339456
VivekSubbiah,2020-04-28 09:04,6,12,"First-in-human study of SC-004, an antibody-drug conjugate targeting CLDN6/9, in patients with epithelial ovarian cancers ⁦ @ ErikaHamilton9⁩ # AACR20 ⁦ @ AACR⁩ https://www.abstractsonline.com/pp8/#!/9045/presentation/10623 …",,@ @,# #,"1255120811708514305",https://twitter.com/VivekSubbiah/status/1255120811708514305
krknrm,2020-04-28 09:04,1,5,"Ready, set... go! On to another amazing day at # AACR20 :) https://twitter.com/AACR/status/1254762063416745985 …pic.twitter.com/mJDQlonUkE",,,#,"1255120686017908739",https://twitter.com/krknrm/status/1255120686017908739
ElizSMcKenna,2020-04-28 09:03,5,18,"Big news! Online now in @ CD_AACR concurrent with the # COVID19 and Cancer Plenary at # AACR20: Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak - by Cai et al from # Wuhan University and @ Harvardmedhttps://cancerdiscovery.aacrjournals.org/content/early/2020/04/24/2159-8290.CD-20-0422 …",,@ @,# # #,"1255120550617325569",https://twitter.com/ElizSMcKenna/status/1255120550617325569
NazliDizman,2020-04-28 09:03,3,8,"Day II of Virtual @ AACR # AACR20 starts with a two-hour-long plenary session on # Cancer and # COVID19 moderated by Antoni Ribas of @ UCLAJCCCpic.twitter.com/fHdV6ps39H",,@ @,# # #,"1255120400586928129",https://twitter.com/NazliDizman/status/1255120400586928129
cancerassassin1,2020-04-28 09:02,2,9,"Who's ready? Happy # AACR20 Virtual Meeting Day (2). Abstracts online: https://www.abstractsonline.com/pp8/#!/9045 Schedule for Day 2, Tuesday April 28: https://www.aacr.org/meeting/aacr-annual-meeting-2020/schedule-at-a-glance/ … 9:00 a.m.-11:00 a.m Eastern Time: Clinical Plenary is on Channel 1 Topic on all of our minds: # COVID19 and # Cancerpic.twitter.com/zU79RfJN6c",,,# # # #,"1255120276787990531",https://twitter.com/cancerassassin1/status/1255120276787990531
VivekSubbiah,2020-04-28 09:02,0,0,"Pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data # aacr20 https://www.abstractsonline.com/pp8/#!/9045/presentation/10787 …",,,# #,"1255120081325117440",https://twitter.com/VivekSubbiah/status/1255120081325117440
NCIBiospecimens,2020-04-28 09:00,0,0,"Day 2 of the virtual AACR meeting is underway! Don't forget to catch NCI's Dinah Singer's remarks on COVID-19 and cancer research, 5pm EDT https://aacr20.onlineeventpro.freeman.com/sessions/15336249/NCI-Activities-COVID-19-and-Cancer-Research … @ AACR # AACR2020 # CancerResearch",,@,# #,"1255119785836326912",https://twitter.com/NCIBiospecimens/status/1255119785836326912
NateraOncology,2020-04-28 09:00,1,7,"We are looking forward to day 2 of virtual # AACR20 and hearing about the latest data on applications of # ctDNA in molecular residual disease monitoring and predicting treatment efficacy from immunotherapies! # MRD",,,# # #,"1255119761354166273",https://twitter.com/NateraOncology/status/1255119761354166273
JExpMed,2020-04-28 09:00,2,3,"Cancer-associated proteins, miRNAs, and DNA sequences can all be detected in extracellular vesicles present in the lymph of metastatic melanoma patients. Read short summaries of articles (https://bit.ly/2XYhG4z ) & JEM’s new cancer collection for # AACR20 https://bit.ly/3avNaBK pic.twitter.com/SsIfutjunG",,,#,"1255119652100939780",https://twitter.com/JExpMed/status/1255119652100939780
CIR_AACR,2020-04-28 09:00,0,0,"This sequence analysis toolkit, called # pVACtools, allows users to identify # neoantigens for cancers of interest. # AACR20 @ obigriffith https://bit.ly/2VI4r6L pic.twitter.com/CPyaBBd0nn",,@,# # #,"1255119630756130816",https://twitter.com/CIR_AACR/status/1255119630756130816
nifear,2020-04-28 09:00,0,0,"Day 2! # AACR20",,,#,"1255119608249368577",https://twitter.com/nifear/status/1255119608249368577
AACRFoundation,2020-04-28 09:00,4,9,"Day 2 of # AACR20 Virtual Annual Meeting I features a session on cancer and COVID-19. # ResearchSavesLives. Show you support for lifesaving research with a donation to @ AACR now: https://bit.ly/2xfHuhT pic.twitter.com/Si7gyGblfd",,@,# #,"1255119601945493504",https://twitter.com/AACRFoundation/status/1255119601945493504
NCICTEP_ClinRes,2020-04-28 09:00,6,7,"Join # AACR20 presentation "A multicenter randomized phase 2 trial of atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers", at 2:25 - 2:35 PM April 28, 2020 @ AACR virtual annual meeting, # ETCTN @ hopkinskimmel Learn more: https://buff.ly/2W1eMts pic.twitter.com/H9jMSUDuRi",,@ @,# #,"1255119595389833221",https://twitter.com/NCICTEP_ClinRes/status/1255119595389833221
GRecondoMD,2020-04-28 09:00,4,10,"Check out today the virtual presentation # AACR2020 by Liam Spurr ( @ lfspurr) on Genomic Correlates of PD-L1 expression and response to IO in NSCLC. Teamwork led by @ GLambertiMD, Liam, Yvonne Li and mentor @ DrMarkAwad @ DanaFarber # LCSM @ BiagioMd @ OncoAlert https://www.abstractsonline.com/pp8/#!/9045/presentation/10533 …pic.twitter.com/sF96qIOj5w",,@ @ @ @ @ @,# # #,"1255119579044429824",https://twitter.com/GRecondoMD/status/1255119579044429824
MyBioTechniques,2020-04-28 09:00,2,4,"A prospective study evaluating the DETECT-A blood test finds it effective at detecting over 10 types of cancer in asymptomatic individuals # AACR20",,,#,"1255119575613661189",https://twitter.com/MyBioTechniques/status/1255119575613661189
VDapic,2020-04-28 08:58,0,1,"Day 2 of # AACR2020! Missing the energy of the live Congress but still learning so much! # TogetherAtHome",,,# #,"1255119160297865217",https://twitter.com/VDapic/status/1255119160297865217
Jbauml,2020-04-28 08:58,3,12,"Excited for day 2 of the @ AACR virtual meeting! Day one was full of very exciting data and I really enjoyed the social media engagement with people from all aspects of cancer care. First session I will be "attending" is an important one - COVID-19 and Cancer # AACR20",,@,#,"1255119160243220481",https://twitter.com/Jbauml/status/1255119160243220481
BenMedComm,2020-04-28 08:57,0,0,"Getting ready to start watching the virtual # AACR20 meeting. Very well done @ AACR. I really love this format.",,@,#,"1255119070082617347",https://twitter.com/BenMedComm/status/1255119070082617347
PTarantinoMD,2020-04-28 08:55,0,2,"Interesting trial, thanks for sharing. Unfortunately, it only includes advanced patients. It would be interesting to know if SERD could improve cure rates in the adjuvant setting for ESR1-mut pts",,,,"1255118533933125632",https://twitter.com/PTarantinoMD/status/1255118533933125632
FAndreMD,2020-04-28 08:55,12,59,"Live Digital @ AACR meeting ! New way of doing international conferences. Let see how it works and how to further improve it. soon the plenary session of @ barlesi @ AlbigesL from @ GustaveRoussy ; about covid and cancerpic.twitter.com/zN0D0PGh9K",,@ @ @ @,,"1255118467361124357",https://twitter.com/FAndreMD/status/1255118467361124357
MPishvaian,2020-04-28 08:55,4,11,"This poster was actually the one I was watching when it struck me how awesome the individual poster video format is . Nicely presented @ benweinbergmd # AACR20 # PancreaticCancerhttps://twitter.com/benweinbergmd/status/1255114625848422408 …",,@,# #,"1255118461099036672",https://twitter.com/MPishvaian/status/1255118461099036672
the__VAULT__,2020-04-28 08:54,1,0,"# COVID19 & Cancer begins today 9 am @ AACR # AACR20 Virtual Annual Mtg 1, day 2 # BREASTCANCER # CHEMOTHERAPY # BRCA",,@,# # # # #,"1255118310640934916",https://twitter.com/the__VAULT__/status/1255118310640934916
ESchattner,2020-04-28 08:52,3,22,"Yesterday I watched a few # AACR20 sessions and it was...convenient! I miss the speakers' highlighting of data on the slides, and seeing people, of course, but otherwise this free meeting is a great opportunity to learn what's up in # CancerResearch More today --https://twitter.com/AACR/status/1251193746298933252 …",,,# #,"1255117781659516928",https://twitter.com/ESchattner/status/1255117781659516928
OncoAlert,2020-04-28 08:52,5,17,"Coming up in minutes, part of # AACR20 And @ OncoAlert will be there # OncoAlert pic.twitter.com/DTt6Jjr0I7",,@,# #,"1255117643343958021",https://twitter.com/OncoAlert/status/1255117643343958021
IndependentSol4,2020-04-28 08:50,0,1,"A very important area.",,,,"1255117233359028225",https://twitter.com/IndependentSol4/status/1255117233359028225
StoverLab,2020-04-28 08:49,1,3,"Lasofoxefine vs Fulvestrant for ESR1 mutated is open @ OSUCCC_James and many other sites. -Lasofoxefine has promising preclinical activity vs ESR1 mutated cell lines & xenograft models. Several other trials open or in development for this population.https://clinicaltrials.gov/ct2/show/NCT03781063 …",,@,,"1255116961052266496",https://twitter.com/StoverLab/status/1255116961052266496
ErikaHamilton9,2020-04-28 08:46,0,0,"Found it!",,,,"1255116079732609025",https://twitter.com/ErikaHamilton9/status/1255116079732609025
TrevanLocke,2020-04-28 08:43,0,3,"Excited for day 2 of the virtual # AACR20, which starts with a session focused on COVID-19 and Cancer. https://twitter.com/AACR/status/1251193746298933252 …",,,#,"1255115414079778818",https://twitter.com/TrevanLocke/status/1255115414079778818
ErikaHamilton9,2020-04-28 08:42,0,3,"Are the presentations from yesterday archived? I was trying to find a couple but when I go to yesterday’s schedule, it’s just abstracts, can’t find videos. Am I looking in the wrong place?",,,,"1255115241727418368",https://twitter.com/ErikaHamilton9/status/1255115241727418368
Bf3R_centre,2020-04-28 08:41,0,1,"# AACR20 ( @ AACR): If you need more information: Rethinking the incentive system in science: animal study registries: EMBO reports: Vol 21, No 1 https://www.embopress.org/doi/full/10.15252/embr.201949709#.Xqghr-VfKwo.twitter …pic.twitter.com/UkgEpPAgDp",,@,# #,"1255114973157654529",https://twitter.com/Bf3R_centre/status/1255114973157654529
benweinbergmd,2020-04-28 08:40,5,23,"Come "see" our video poster with results of our phase I study of # ribociclib + # everolimus in patients with refractory metastatic # pancreaticcancer # aacr2020 # pancsm @ RueschCenter @ LombardiCancer @ MPishvaian @ marshalj23 @ RuthHe12 @ AACR @ ConquerCancerFdhttps://aacr20.onlineeventpro.freeman.com/posters/24211255/A-phase-I-study-of-ribociclib-plus-everolimus-in-patients-with-metastatic-pancreatic-adenocarcinoma-refractory-to-chemotherapy …",,@ @ @ @ @ @ @,# # # # #,"1255114625848422408",https://twitter.com/benweinbergmd/status/1255114625848422408
JacobPlieth,2020-04-28 08:38,0,1,"BTW that $ TROV onvansertib study was an # AACR20 placeholder abstract with no clinical data, so totally off my radar https://bit.ly/2yQhMAS",,,#,"1255114189913288704",https://twitter.com/JacobPlieth/status/1255114189913288704
MDAndersonNews,2020-04-28 08:34,1,8,"“These variations highlight the need for continued study of # brainmetastases in order to better understand them and potentially find therapeutic targets,” says our Dr. Andy Futreal: https://bit.ly/2YdHutV # AACR20 # endcancer",,,# # #,"1255113274611433472",https://twitter.com/MDAndersonNews/status/1255113274611433472
MPishvaian,2020-04-28 08:30,3,57,"I am watching the abstracts for # AACR20 and I gotta say - I LOVE this format of short presentations by the presenter that we get to watch on our schedule. This should be how all abstracts are presented for all meetings from now on. Thank you @ AACR for setting a new standard.",,@,#,"1255112038109655041",https://twitter.com/MPishvaian/status/1255112038109655041
1stOncology,2020-04-28 08:30,0,0,"# TarvedaTherapeutics Presents Pharmacokinetic and # TumorBiopsy Data from First in Human Study of # PEN866 at # AACR20 https://www.1stoncology.com/blog/tarveda-therapeutics-presents-pharmacokinetictumor-biopsy-data-from-first-in-human-study-of-pen-866-at-the-2020-aacr-virtual-annual-meeting1234556654 …",,,# # # #,"1255112033600598017",https://twitter.com/1stOncology/status/1255112033600598017
1stOncology,2020-04-28 08:29,1,2,"# NOXXON Presents Latest Clinical Data From the Phase 1/2 # NOXA12 / # Keytruda® Combination Trial in # ColorectalCancer and # PancreaticCancer at the # AACR20 $ ALNOX https://www.1stoncology.com/blog/noxxon-presents-latest-clinical-data-from-the-phase-12-nox-a12-keytruda-combination-trial-in-colorectalpancreatic-cancer-at-the-aacr-virtual-annual-meeting-20201234556652 …",,,# # # # # #,"1255111820462813184",https://twitter.com/1stOncology/status/1255111820462813184
Amira_etc,2020-04-28 08:29,0,15,"Today's office # AACR2020 pic.twitter.com/hsa4G7hkX5",,,#,"1255111816931356672",https://twitter.com/Amira_etc/status/1255111816931356672
lisaksheldon,2020-04-28 08:28,0,1,"Include full perspectives on the impact of # COVID19 on cancer care and delivery and outcomes @ OncologyNursing @ AACR @ AACR_CEO AACRhttps://twitter.com/AACR/status/1254766640178307072 …",,@ @ @,#,"1255111633732599808",https://twitter.com/lisaksheldon/status/1255111633732599808
1stOncology,2020-04-28 08:28,0,0,"# RGENIX Presents Initial Results of Combination Trial of # RGX104 at # AACR20 https://www.1stoncology.com/blog/rgenix-presents-initial-results-of-combination-trial-of-rgx-104-at-the-2020-aacr-annual-meeting1234556651 …",,,# # #,"1255111606662393866",https://twitter.com/1stOncology/status/1255111606662393866
DanaFarberNews,2020-04-28 08:28,5,23,"Today at 12:45 PM, hear from Caron Jacobson, MD, on # CART cell therapy for the treatment of adult relapsed/refractory diffuse large B cell lymphoma # DLBCL # AACR20 Abstract link: http://ms.spr.ly/6014TgdzA pic.twitter.com/RXNEQp29k1",,,# # #,"1255111525876072448",https://twitter.com/DanaFarberNews/status/1255111525876072448
1stOncology,2020-04-28 08:27,0,0,"# AIVITABiomedical Presents Updates from Ongoing # OvarianCancer and # Glioblastoma Clinical Studies at # AACR20 https://www.1stoncology.com/blog/aivita-biomedical-presents-updates-from-ongoing-ovarian-cancerglioblastoma-clinical-studies-at-2020-aacr-virtual-annual-meeting1234556649 …",,,# # # #,"1255111404534693889",https://twitter.com/1stOncology/status/1255111404534693889
jesusanampa,2020-04-28 08:25,1,1,"Do not miss # AACR20 Clinical Plenary today at 9AM EST: # COVID19 and Cancer @ AACR",,@,# #,"1255110962111295489",https://twitter.com/jesusanampa/status/1255110962111295489
LizCancerHealth,2020-04-28 08:24,4,2,"Coming up in less than an hour... # AACR20 https://twitter.com/AACR/status/1251193746298933252 …",,,#,"1255110705730031617",https://twitter.com/LizCancerHealth/status/1255110705730031617
JacobPlieth,2020-04-28 08:24,0,8,"$ TROV "clinical response" # AACR20 pic.twitter.com/KErfdWV575",,,#,"1255110587689979908",https://twitter.com/JacobPlieth/status/1255110587689979908
1stOncology,2020-04-28 08:24,0,0,"# Novocure Announces Presentation of EF-19 Post-approval Registry Trial Data Studying # Optune as a Monotherapy for the Treatment of Recurrent # GBM at the # AACR20 $ NVCR https://www.1stoncology.com/blog/novocure-announces-presentation-of-ef-19-post-approval-registry-trial-data-studying-optune-as-a-monotherapy-for-the-treatment-of-recurrent-gbm-at-the-american-association-for-cancer-research-2020-vir1234556647 …",,,# # # #,"1255110547080536064",https://twitter.com/1stOncology/status/1255110547080536064
PrecursorCell,2020-04-28 08:20,0,1,"Let me just put this out there. This season of free access all-virtual scientific meetings has been one of the most liberating times I've experienced. Sent links to my friends and mentees and WE DISCUSSED. Shoutout for the successful first day, @ AACR. I hope others follow.",,@,,"1255109569602150400",https://twitter.com/PrecursorCell/status/1255109569602150400
CRUKresearch,2020-04-28 08:20,0,1,"Abstract on Targeting chromatin remodeling-associated genetic vulnerabilities in cancer, co-authored by @ ICR_London's @ IcrLordLab is being presented this evening at the # AACR20 Virtual Meeting I. Join from 19:35 – 19:45 BST: https://www.abstractsonline.com/pp8/#!/9045/presentation/10550 …pic.twitter.com/ZL9dYlNKNt",,@ @,# #,"1255109515177013249",https://twitter.com/CRUKresearch/status/1255109515177013249
1stOncology,2020-04-28 08:19,0,0,"# RibonTherapeutics Presents Preclinical Data from its # PARP7 and # PARP14 Programs at # AACR20 https://www.1stoncology.com/blog/ribon-therapeutics-presents-preclinical-data-from-its-parp7parp14-programs-at-aacr-virtual-meeting-i1234556633 …",,,# # # #,"1255109265104048132",https://twitter.com/1stOncology/status/1255109265104048132
CDMRP,2020-04-28 08:16,0,1,"If you plan to submit a research proposal to the Lung Cancer Research Program for the # CDMRP Idea Development Award or Investigator Initiated Translational Research Award they are due May 6, 2020. Details available here https://cdmrp.army.mil/funding/lcrp . @ AACR20 # AACR20 pic.twitter.com/WipLt3VFtW",,@,# #,"1255108656498200576",https://twitter.com/CDMRP/status/1255108656498200576
1stOncology,2020-04-28 08:15,0,0,"Stand Up To # Cancer Funded Research To Be Presented During The # AACR20 https://www.1stoncology.com/blog/stand-up-to-cancer-funded-research-to-be-presented-during-the-aacr-virtual-meeting-1-april-27-28-20201234556629 …",,,# #,"1255108459453837312",https://twitter.com/1stOncology/status/1255108459453837312
1stOncology,2020-04-28 08:13,0,0,"# BioPathHoldings Presents at # AACR20 $ BPTH https://www.1stoncology.com/blog/bio-path-holdings-presents-at-2020-american-association-for-cancer-research-annual-meeting1234556624 …",,,# #,"1255107774179995650",https://twitter.com/1stOncology/status/1255107774179995650
1stOncology,2020-04-28 08:12,0,0,"# Aptose Presents Preliminary Clinical Data on # CG806 at # AACR2020 $ APTO https://www.1stoncology.com/blog/aptose-presents-preliminary-clinical-data-on-cg-806-at-aacr-virtual-annual-meeting-20201234556623 …",,,# # #,"1255107620257427457",https://twitter.com/1stOncology/status/1255107620257427457
1stOncology,2020-04-28 08:11,0,0,"# AlpineImmuneSciences Presents Design of the # ALPN202 Phase 1 Study ( # NEON1) at # AACR20 https://www.1stoncology.com/blog/alpine-immune-sciences-presents-design-of-the-alpn-202-phase-1-study-neon-1-at-aacr-virtual-annual-meeting-i1234556622 …",,,# # # #,"1255107472915697664",https://twitter.com/1stOncology/status/1255107472915697664
JaniceTNBCmets,2020-04-28 08:09,2,12,"Discussion by # GRASPtweet co-founder and @ OncoAlert colleague @ itsnot_pink on # AACR20 session presented by @ MDAndersonNews, Dr. Jennifer Litton, on results from EMBRACA trial of Talazoparib for BRCA+ Advanced # BreastCancer. QOL improved, but not OS. # MBC # bcsmhttps://twitter.com/OncoAlert/status/1255090061697257472 …",,@ @ @,# # # # #,"1255106841954181120",https://twitter.com/JaniceTNBCmets/status/1255106841954181120
1stOncology,2020-04-28 08:09,0,0,"# Compugen Presents Data Update from Ongoing Phase 1 Trial of # COM701 at the # AACR20 $ CGEN https://www.1stoncology.com/blog/compugen-presents-data-update-from-ongoing-phase-1-trial-of-com701-at-the-2020-aacr-virtual-annual-meeting1234556615 …",,,# # #,"1255106760257400838",https://twitter.com/1stOncology/status/1255106760257400838
1stOncology,2020-04-28 08:05,0,0,"# MacroGenics Announces Presentation of # Flotetuzumab Translational Data at the # AACR20 $ MGNX https://www.1stoncology.com/blog/macrogenics-announces-presentation-of-flotetuzumab-translational-data-at-the-2020-aacr-annual-meeting1234556612 …",,,# # #,"1255105911821004801",https://twitter.com/1stOncology/status/1255105911821004801
1stOncology,2020-04-28 08:04,0,0,"First Clinical Outcomes Evaluating Six-Week Dosing Schedule for # Merck’s # KEYTRUDA® ( # Pembrolizumab) Presented at # AACR20 $ MRK https://www.1stoncology.com/blog/first-clinical-outcomes-evaluating-six-week-dosing-schedule-for-merck-s-keytruda-pembrolizumab-presented-at-aacr-virtual-annual-meeting-i1234556610 …",,,# # # #,"1255105490163359744",https://twitter.com/1stOncology/status/1255105490163359744
FoundationATCG,2020-04-28 08:01,4,12,"Today at # AACR20: @ CancerResrch will present phase 2 data showing it’s possible to align standards for # TMB, a genomic signature that can help identify treatments for patients. Proud to partner on this. Watch live at 4:55pm ET or access afterward: http://ow.ly/NNVu50zq1XJ pic.twitter.com/33ZFIrnBcQ",,@,# #,"1255104867821117440",https://twitter.com/FoundationATCG/status/1255104867821117440
CD_AACR,2020-04-28 08:00,2,7,"Looking forward to the # AACR20 Virtual Annual Meeting I sessions today! Reach out to our editors if you’d like to talk about publishing in the journal! @ ElizSMcKenna @ TaliLev123 @ imsmd https://bit.ly/2W6Xpat pic.twitter.com/nWWAnnqi5h",,@ @ @,#,"1255104511682793474",https://twitter.com/CD_AACR/status/1255104511682793474
petitprez_f,2020-04-28 08:00,0,4,"Yesterday was a great start of # AACR20. Looking forward to seeing some more fantastic science today! Congrats to @ AACR for organizing this and making it free! It's not that bad to be able to attend from my couch this year. pic.twitter.com/yuFKsu9AVz",,@,#,"1255104487200604161",https://twitter.com/petitprez_f/status/1255104487200604161
BayerPharma,2020-04-28 08:00,4,7,"Join us virtually at # AACR20, where we will be presenting new analyses on genomic alterations in cancer: http://spr.ly/601914Qz1 pic.twitter.com/gEqrivb5Im",,,#,"1255104481567571969",https://twitter.com/BayerPharma/status/1255104481567571969
joshgoldstein1,2020-04-28 07:58,0,1,"Check out this study from @ AACR member @ LFejerman examining factors that may explain # breastcancer # disparities for Latinas.https://twitter.com/AACRFoundation/status/1254862908233674753 …",,@ @,# #,"1255104042231050245",https://twitter.com/joshgoldstein1/status/1255104042231050245
teamoncology,2020-04-28 07:57,0,1,". @ AACR virtual conference day 2 will have the plenary session of COVID-19 and Cancer from 9 am EST. https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …",,@,,"1255103778849726464",https://twitter.com/teamoncology/status/1255103778849726464
abcam,2020-04-28 07:53,0,2,"Tune in today for Maria Paola Serra’s presentation on IHC as a part of our # AACR20 virtual week! Learn more here: https://bit.ly/3aoLx8V pic.twitter.com/QBL6AFcGyj",,,#,"1255102718840102914",https://twitter.com/abcam/status/1255102718840102914
MKnoll_MD,2020-04-28 07:46,0,4,"yes!! Twitter handle and hashtag!",,,,"1255101114808258560",https://twitter.com/MKnoll_MD/status/1255101114808258560
OncoAlert,2020-04-28 07:46,1,6,"Thank you for a GREAT first day @ AACR !! Ready for day two of # AACR20 Best from our Global @ OncoAlert familyhttps://twitter.com/AACR/status/1254943770921099270 …",,@ @,#,"1255100965356736514",https://twitter.com/OncoAlert/status/1255100965356736514
ErinGillespieMD,2020-04-28 07:45,1,5,"Great! Yesterday, @ AACR provided within conf website: 1) a link to video presentation (can use # QuickTime + # PowerPoint to create), and 2) presenter’s email address. Suspect 3) a twitter handle and 4) a conf hashtag would engagement. Anything else? @ MKnoll_MD @ subatomicdoc",,@ @ @,# #,"1255100765468798976",https://twitter.com/ErinGillespieMD/status/1255100765468798976
ACIR_org,2020-04-28 07:45,0,0,"Day 2 for # AACR2020 ! Clinical plenary starts at 9am, EDT. http://ow.ly/BaXH50zoU1Q pic.twitter.com/gWkKU9zSU8",,,#,"1255100723265765378",https://twitter.com/ACIR_org/status/1255100723265765378
BreastDocUK,2020-04-28 07:31,0,2,"Context: This was 1 presentation (from 7) on tobacco and vaping in teens partic. Hispanic groups. With tobacco control we massively reduce lung cancer and have more resource for those *not* caused by tobacco. # AACR20",,,#,"1255097299530891264",https://twitter.com/BreastDocUK/status/1255097299530891264
dhjutsw1,2020-04-28 07:16,0,0,"Missed it! Couldn't load @ AACR website. https://twitter.com/HornLeora/status/1254870571202068480 …",,@,,"1255093594869948420",https://twitter.com/dhjutsw1/status/1255093594869948420
pashtoonkasi,2020-04-28 07:16,0,1,"# AACR20 https://twitter.com/ShaalanBeg/status/1255089686504226818 …",,,#,"1255093519758364672",https://twitter.com/pashtoonkasi/status/1255093519758364672
CRUKresearch,2020-04-28 07:13,2,6,"Join @ uclcancer’s @ AbboshChris tonight from 19:15 – 19:25 BST as he presents the latest data from the # CRUKFunded, @ ucl-sponsored # TRACERx study at the # AACR20 Annual Meeting I. Join the session here: https://www.abstractsonline.com/pp8/#!/9045/presentation/10734 …pic.twitter.com/pD6Vxmr44w",,@ @ @,# # # #,"1255092651847757825",https://twitter.com/CRUKresearch/status/1255092651847757825
RobinTranchant,2020-04-28 07:04,0,0,"After this post, I'm waiting for TAK-788 presentation now!https://www.takeda.com/newsroom/newsreleases/2020/takeda-announces-u.s.-fda-breakthrough-therapy-designation-for-mobocertinib-tak-788-for-the-treatment-of-nsclc-patients-with-egfr-exon-20-insertion-mutations/ …",,,,"1255090626447790082",https://twitter.com/RobinTranchant/status/1255090626447790082
OncoAlert,2020-04-28 07:02,10,24,"Our @ OncoAlert colleague @ itsnot_pink live from # AACR20 discussing EMBRACA trial led by @ MDAndersonNews .Advanced # breastcancer patients w/ # BRCA mutation, talazoparib did not see improved OS compared to # chemotherapy However did see improved QOL # BCSM edited: @ weoncologistspic.twitter.com/9aMaP9tnXK",,@ @ @ @,# # # # #,"1255090061697257472",https://twitter.com/OncoAlert/status/1255090061697257472
ShaalanBeg,2020-04-28 07:01,4,24,"Observations: - Science is still cool - Personal interactions are still happening, but their nature/intimacy is different. - industry/ commercial entities dont get it, hope they start to use platforms to deliver valuable content/insights instead of promotion # asco20 # aacr20 pic.twitter.com/NPBeXrW3LV",,,# #,"1255089686504226818",https://twitter.com/ShaalanBeg/status/1255089686504226818
cancer_navi,2020-04-28 06:57,2,2,"METエクソン14スキッピング変異陽性進行NSCLCで脳転移を有する患者にcapmatinibは有効【AACR2020】：がんナビ 日本では先日テポチニブが承認されていますが、どう使って行くのかが気になります。 # 肺がん # MET変異 # capmatinib # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565343.html …",,,# # # #,"1255088777485152259",https://twitter.com/cancer_navi/status/1255088777485152259
cancer_navi,2020-04-28 06:54,1,0,"poziotinibはEGFRエクソン20挿入変異を持つ既治療の進行NSCLC患者の65％で腫瘍を縮小【AACR2020】：がんナビ 新たな分子標的薬の登場に期待しています。 # 肺がん # EGFRエクソン20挿入変異 # poziotinib # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565342.html …",,,# # # #,"1255087965732171777",https://twitter.com/cancer_navi/status/1255087965732171777
ShaalanBeg,2020-04-28 06:52,0,8,"Enjoying # AACR20 on twitter and amazed by how # COVID19 has impacted the medical world. Will medIcal conferences return to baseline? Or do you think we will have a new baseline post # COVID19? # ASCO20https://twitter.com/AACR/status/1254943770921099270 …",,,# # # #,"1255087518317494273",https://twitter.com/ShaalanBeg/status/1255087518317494273
cancer_navi,2020-04-28 06:51,1,1,"BRAFv600変異陽性で未治療の進行悪性黒色腫にベムラフェニブ・cobimetinib・アテゾリズマブの併用が有効【AACR2020】：がんナビ 日本が参加していないのが残念です。 # 悪性黒色腫 # メラノーマ # BRAFv600変異 # 免疫療法 # アテゾリズマブ # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565341.html …",,,# # # # # #,"1255087320891486208",https://twitter.com/cancer_navi/status/1255087320891486208
OncoAlert,2020-04-28 06:50,10,25,"Our @ OncoAlert colleague @ ErikaHamilton9 of @ SarahCannonDocs Live from # AACR20 discussing the I-SPY2 trial by @ YaleCancer .Addition of durvalumab & olaparib to neoadjuvant paclitaxel improved pCR in high-risk, HER2- stage II/III # breastcancer # BCSM Edit: @ weoncologistspic.twitter.com/OWj0UnnxIh",,@ @ @ @ @,# # #,"1255087078657986560",https://twitter.com/OncoAlert/status/1255087078657986560
cancer_navi,2020-04-28 06:48,1,1,"原発性乳癌で診断時のESR1遺伝子変異は術後内分泌療法の選択に役立つ可能性【AACR2020】：がんナビ 興味深い発表です。 # 乳がん # ホルモン受容体陽性 # ESR1遺伝子変異 # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565340.html …",,,# # # #,"1255086570232676356",https://twitter.com/cancer_navi/status/1255086570232676356
tompowles1,2020-04-28 06:47,1,5,"A discussion about the atezolizumab randomised phase 3 study in prostate cancer. What’s the future of immune therapy in this disease? # AACR20 # prostatecancerhttps://open.spotify.com/episode/6MXVKND5wxZD2FDJtNkDmD?si=xI6UgpYDTjCy34AMS_r1tQ …",,,# #,"1255086173145518081",https://twitter.com/tompowles1/status/1255086173145518081
cancer_navi,2020-04-28 06:46,1,0,"転移のあるトリプルネガティブ乳癌の2次治療以降でImprime PGGとペムブロリズマブの併用が有望【AACR2020】：がんナビ 乳がんでの免疫療法の更なる進展に、期待したいです。 # 乳がん # トリプルネガティブ # ペムブロリズマブ # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565339.html …",,,# # # #,"1255086044703100930",https://twitter.com/cancer_navi/status/1255086044703100930
cancer_navi,2020-04-28 06:44,1,2,"アビラテロン投与歴があるmCRPCにエンザルタミドとアテゾリズマブの併用投与はOSを延長できず【AACR2020】：がんナビ 残念な結果になりました。 # 前立腺がん # mCRPC # エンザルタミド # アテゾリズマブ # 免疫療法 # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565337.html …",,,# # # # # #,"1255085548672126976",https://twitter.com/cancer_navi/status/1255085548672126976
cancer_navi,2020-04-28 06:42,1,1,"BRCA1/2遺伝子変異のあるHER2陰性進行乳癌にPARP阻害薬talazoparibはOSを延長せず【AACR2020】：がんナビ 残念な結果でした。 # 乳がん # BRCA # PARP阻害薬 # talazoparib # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565338.html …",,,# # # # #,"1255084948618268673",https://twitter.com/cancer_navi/status/1255084948618268673
cancer_navi,2020-04-28 06:40,1,0,"PIK3CA変異陽性HR陽性HER2陰性進行乳癌で閉経後の患者にp110α選択的阻害薬GDC-0077とフルベストラントの併用が有望【AACR2020】：がんナビ 今後に期待します。 # 乳がん # AACR20 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202004/565336.html …",,,# #,"1255084382424985600",https://twitter.com/cancer_navi/status/1255084382424985600
pashtoonkasi,2020-04-28 06:39,1,6,"Agreed. The figure is intriguing. I liked the statement “lightning bolts indicate subclonal driver mutations”. Data being presented # AACR20 highlighting some of these aspects. Easier to do now with all the technological advancements as well as non-invasive tests ( # ctDNA).pic.twitter.com/1uXgzEbfYo",,,# #,"1255084112404234240",https://twitter.com/pashtoonkasi/status/1255084112404234240
Jbauml,2020-04-28 06:34,0,2,"All the presentations are available for free through the @ AACR website. You have to register (but that’s free too).",,@,,"1255083049630474240",https://twitter.com/Jbauml/status/1255083049630474240
syinvesting,2020-04-28 06:30,2,9,"# AACR20 $ CGEN Compugen's COM701 targets PVRIG, which is expressed on immune cells and when engaged by its ligand PVRL2, it signals to suppress immune responses. PVRIG is a part of the DNAM axis, along with TIGIT. @ CIR_AACR Feb '19 background paper: https://cancerimmunolres.aacrjournals.org/content/7/2/257 pic.twitter.com/DNn7cdFhxq",,@,#,"1255081826877505536",https://twitter.com/syinvesting/status/1255081826877505536
pashtoonkasi,2020-04-28 06:28,0,1,"# AACR20 interesting to note that the drug also ERBB2 https://www.cell.com/cancer-cell/pdfExtended/S1535-6108(19)30384-8 …",,,#,"1255081405282955264",https://twitter.com/pashtoonkasi/status/1255081405282955264
ednacukierman,2020-04-28 06:25,1,3,"# Ispy a talk by @ FraleyLab at # AACR20 # AACR2020 today (April 28; 445pm) https://aacr20.onlineeventpro.freeman.com/sessions/15335388/subsession/24211423/Identifying-regulators-of-cancer-heterogeneity-with-phenotypic-sorting-and-single-cell-sequencing …",,@,# # #,"1255080583526592514",https://twitter.com/ednacukierman/status/1255080583526592514
pashtoonkasi,2020-04-28 06:22,0,3,"Furthermore, I’ve been pleasantly surprised at the “mutual exclusivity” statements. While for sure applicable at baseline, once you expose these tumors to targeted therapies, all kinds of evolution & clones emerge. # AACR20 # ctDNA # LiquidBiopsiespic.twitter.com/leqhkFvwpT",,,# # #,"1255079846050508800",https://twitter.com/pashtoonkasi/status/1255079846050508800
pashtoonkasi,2020-04-28 06:18,0,1,". Agreed One of my patients sent me this. Important that some # BRAF mutations retain sensitivity to EGFR. Wasn’t aware of how many tumors it plays a role in. # CRCSM # AACR20 # Cholangiocarcinoma Some make the BRAF low kinase or kinase dead. https://www.nature.com/articles/s41388-018-0171-x …pic.twitter.com/7vfpfA50Bm",,,# # # #,"1255079040895123457",https://twitter.com/pashtoonkasi/status/1255079040895123457
ECMC_UK,2020-04-28 06:12,0,0,"Today is Day 2 of # AACR20 Virtual Meeting I. Register today for free to access today's sessions and presentations: https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/?utm_medium=twitter_ecmc&utm_source=ecmcsocialmedia&utm_campaign=annualmeeting&utm_content=2020vam1&sf121161878=1 …",,,#,"1255077296068636673",https://twitter.com/ECMC_UK/status/1255077296068636673
healthhashtags,2020-04-28 06:10,0,2,"Top Influencers of # aacr2020: @ OncoAlert @ HornLeora @ marinagarassino @ barlesi @ ChristianRolfo @ myESMO More https://hcsm.io/2zBgTg1",,@ @ @ @ @ @,#,"1255076906006917120",https://twitter.com/healthhashtags/status/1255076906006917120
pashtoonkasi,2020-04-28 06:09,0,1,"The MSS-CRC ( # ColorectalCancer) reported in these # Immunotherapy trials need to have more genomic characterization especially the # ExceptionalResponders. Need to understand if it’s indeed the novel drug or just PD1 itself. E.g. POL-E subset are MSS but TMB-High. # AACR20",,,# # # #,"1255076712309817344",https://twitter.com/pashtoonkasi/status/1255076712309817344
pashtoonkasi,2020-04-28 06:05,0,1,"In metastatic setting # ctDNA # liquidbiopsies may aid. “ESR1 mutations are rarely acquired during adjuvant AI, and frequently during metastatic AI therapy.” # AACR20 https://stm.sciencemag.org/content/7/313/313ra182 …",,,# # #,"1255075711683104768",https://twitter.com/pashtoonkasi/status/1255075711683104768
CRUKresearch,2020-04-28 06:05,0,3,"Abstract on MicroRNA deregulation, co-authored by @ icr_london’s Nicola Valeri is being presented this evening at the # AACR20 Virtual Meeting I. Join from 18:35 – 18:45 BST: https://www.abstractsonline.com/pp8/#!/9045/presentation/10833 …pic.twitter.com/2GNIt0qUvi",,@,# #,"1255075538953273346",https://twitter.com/CRUKresearch/status/1255075538953273346
pashtoonkasi,2020-04-28 06:01,0,4,"Biggest drawback IMHO is inability to meet colleagues ( # networking) & lack of between sessions. Also prioritize which sessions. Multitasking sessions with more than 1 window not the best of ideas. @ cancerassassin1 @ Aiims1742 had great ideas for @ zoom_us in parallel? # AACR20",,@ @ @,# #,"1255074659181178880",https://twitter.com/pashtoonkasi/status/1255074659181178880
healthhashtags,2020-04-28 06:00,2,3,"Top Influencers of # AACR20: @ AACR @ OncoAlert @ weoncologists @ Jbauml @ ErikaHamilton9 @ pashtoonkasi More https://hcsm.io/2TPswt7",,@ @ @ @ @ @,#,"1255074471410532352",https://twitter.com/healthhashtags/status/1255074471410532352
sanguinebiomab,2020-04-28 05:55,0,0,"Very important annual @ AACR meeting with > 40.000 attendants. # virtualmeetings . It's a new and intriguing # scientific and # Medical world.pic.twitter.com/hUV8sLMLQJ",,@,# # #,"1255073188062560256",https://twitter.com/sanguinebiomab/status/1255073188062560256
pashtoonkasi,2020-04-28 05:55,0,0,"I’ve seen STK11 often for my upper GI cancer patients. Does it have the same significance in other tumor types as it is showing here for # lcsm. Also is KEAP1 reported on NGS testing? # AACR20",,,# #,"1255073144244764673",https://twitter.com/pashtoonkasi/status/1255073144244764673
pashtoonkasi,2020-04-28 05:53,0,3,"Very true. Same stigma surrounds a lot of GI malignancies & not sure about the preventable aspect for all patients. # AACR20",,,#,"1255072657952911362",https://twitter.com/pashtoonkasi/status/1255072657952911362
pashtoonkasi,2020-04-28 05:51,0,1,"Agreed @ AlanBryce9. As the discussant during # AACR20 pointed out as well, lack of anti-PD1 activity doesn’t mean no role for # Immunotherapy.",,@,# #,"1255072125888663552",https://twitter.com/pashtoonkasi/status/1255072125888663552
pashtoonkasi,2020-04-28 05:32,0,1,"Yes. They did report on subset analysis for # BRCA and # PDL1 @ AACR # AACR20. In practice for sure # BRCA testing. My colleagues from # bcsm can chime in if they routinely do # PDL1.",,@,# # # # # #,"1255067349092352000",https://twitter.com/pashtoonkasi/status/1255067349092352000
GustaveRoussy,2020-04-28 05:32,8,21,"L'expérience de @ GustaveRoussy dans le traitement des patients atteints de # cancer & # covid19 sera présentée en séance plénière de l' # AACR20 ce 28/04 à 15h30 (heure ) par le Pr Fabrice @ barlesi. Accès gratuit aux conférences virtuelles de l' @ AACR : https://cloud.aacr-outbound.com/virtual-am20?j=47626&sfmc_sub=35349323&l=2450_HTML&u=1236369&mid=110005635&jb=233&utm_source=Salesforce%20Marketing%20Cloud&utm_medium=Email&utm_campaign=&sfmc_s=eileen.loftus@aacr.org …pic.twitter.com/lkIhIUXHIG",,@ @ @ @aacr,# # #,"1255067254611480577",https://twitter.com/GustaveRoussy/status/1255067254611480577
ChiaraCATANIA4,2020-04-28 05:25,1,2,"Interesting. But the curve drops for 6 months and then curves significantly separate. Would A cytotossic drug be needed?",,,,"1255065665918115842",https://twitter.com/ChiaraCATANIA4/status/1255065665918115842
OncologyCentral,2020-04-28 05:06,0,2,"A really interesting first day at # AACR20 learning all about # lungcancer, # breastcancer, # melanoma and so much more! Ready for day 2 of the virtual event",,,# # # #,"1255060732976205827",https://twitter.com/OncologyCentral/status/1255060732976205827
giusvisc,2020-04-28 05:01,1,2,"Heterogeneity of EGFR mutant NSCLC described through concurrent mutations in tumor suppressors genes # EGFR # AACR2020 pic.twitter.com/1V0xWmV0c3",,,# #,"1255059662241759238",https://twitter.com/giusvisc/status/1255059662241759238
giusvisc,2020-04-28 04:59,0,0,"Tailored treatment for LKB1 deficient NSCLC is still an unmet need. Explore the role of co-ocurring mutations and metabolic pathways to improve therapies. # LKB1 # AACR2020 pic.twitter.com/tmuKEpGE7T",,,# #,"1255058974413553664",https://twitter.com/giusvisc/status/1255058974413553664
weoncologists,2020-04-28 04:19,0,7,"MonarcHER Results suggest chemo free regimen might potentially be an alternative in HR+ HER2+ advanced # breastcancer # AACR20",,,# #,"1255049056046456833",https://twitter.com/weoncologists/status/1255049056046456833
weoncologists,2020-04-28 04:19,14,30,"Just outat @ TheLancetOncol by @ OncoAlert colleague @ FAndreMD &team. MonarcHER sees combo abemaciclib,fulvestrant, &trastuzumab improved PFS Vs. SOC # chemotherapy +trastuzumab, w/a tolerable safety # breastcancer # aacr20 # bcsm https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30112-1/fulltext?rss=yes …pic.twitter.com/gi8FMoJcrv",,@ @ @,# # # #,"1255049047641075713",https://twitter.com/weoncologists/status/1255049047641075713
SurgeryNUIG,2020-04-28 04:10,0,0,"Fantastic Shree, we look forward to receiving your abstracts .",,,,"1255046635463282689",https://twitter.com/SurgeryNUIG/status/1255046635463282689
iam_shri_,2020-04-28 04:00,0,1,"Thanks. Will send in the abstracts! It’s always great to drive research forward even during these testing times. @ SurgeryNUIG",,@,,"1255044252624715776",https://twitter.com/iam_shri_/status/1255044252624715776
CrMazars,2020-04-28 03:59,1,0,"# AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://endpts.com/aacr20-early-data-suggest-novartis-incyte-discovered-met-inhibitor-helps-lung-cancer-patients-with-brain-lesions/ …",,,#,"1255043961221263366",https://twitter.com/CrMazars/status/1255043961221263366
CrMazars,2020-04-28 03:59,0,0,"# AACR20: Iovance revels in promising lung cancer data out of Moffitt as TIL therapy triggers 2 complete responses - https://endpts.com/aacr20-iovance-revels-in-promising-lung-cancer-data-out-of-moffitt-as-til-therapy-triggers-2-complete-responses/ …",,,#,"1255043886281613312",https://twitter.com/CrMazars/status/1255043886281613312
SurgeryNUIG,2020-04-28 03:55,0,1,"Yes Shree, oral & poster presentations including a plenary session. It’s a new exciting challenge for # Freyer2020!",,,#,"1255043027208482816",https://twitter.com/SurgeryNUIG/status/1255043027208482816
iam_shri_,2020-04-28 03:41,0,0,"Virtually, of course",,,,"1255039521906982913",https://twitter.com/iam_shri_/status/1255039521906982913
iam_shri_,2020-04-28 03:41,0,0,"@ SurgeryNUIG will there be oral presentations as well?",,@,,"1255039407859609600",https://twitter.com/iam_shri_/status/1255039407859609600
NicoleKuderer,2020-04-28 03:27,2,8,"Yes @ PTarantinoMD. Need to start RCTs for patients with ESR1 mutant # bcsm. The data of poor prognosis has been very consistent and its time to find better solution for these pts. @ AACR # AACR20 @ ErikaHamilton9 @ StoverLab @ Nikhilwagle @ corrie_painter @ jesusanampa @ itsnot_pinkhttps://twitter.com/PTarantinoMD/status/1255013267308785664 …",,@ @ @ @ @ @ @ @,# #,"1255036016764698626",https://twitter.com/NicoleKuderer/status/1255036016764698626
g_mountzios,2020-04-28 02:49,6,18,"A personal slide mix on # STK11- # KEAP mutations in # NSCLC from # AACR20 . My interpretation: Co-occurrence with # KRAS shows resistance to IO BUT STK11/KEAP1 mut in KN42 benefit from pembro STK11/KEAP1 mut- KRAS wt- PDL1+ may respond to IO! # LCSM @ lcsmchat # OncoAlert @ myESMOpic.twitter.com/UZw2e4aDOA",,@ @,# # # # # # #,"1255026289393782784",https://twitter.com/g_mountzios/status/1255026289393782784
endpts,2020-04-28 02:19,1,1,"# AACR20 roundup: Tecentriq/Xtandi combo fails to show OS benefit, halting Roche's PD-L1 push into prostate cancer https://endpts.com/aacr20-roundup-tecentriq-xtandi-combo-fails-to-show-os-benefit-halting-roches-pd-l1-push-into-prostate-cancer/ … $ RHHBY",,,#,"1255018663540862976",https://twitter.com/endpts/status/1255018663540862976
ErikaHlavacek,2020-04-28 02:10,0,1,"# aacr you should be ashamed! # lungcancer is preventable? I have several non smoking friends that died from it. LC advocates work so hard to erase this fallacy how does # AACR20 let this happen on a slide. # LCSMhttps://twitter.com/LungCancerFaces/status/1254884790035087360 …",,,# # # #,"1255016559623446529",https://twitter.com/ErikaHlavacek/status/1255016559623446529
leslie_ardron,2020-04-28 02:07,0,5,"Feel like somebody just kicked me in the gut!!! Untruth like this at such a prestigious event # AACR20 will continue the nearly always late diagnosis in young, never smokers. And as for the blame, shaming element, DON’T GET ME STARTED!!!",,,#,"1255015867634647040",https://twitter.com/leslie_ardron/status/1255015867634647040
healthhashtags,2020-04-28 02:00,1,0,"Today's Health Conferences: # AACR20 # AATS2020 # depression # aacr2020 http://hcsm.io/healthconfs # hcsm",,,# # # # #,"1255014082153009152",https://twitter.com/healthhashtags/status/1255014082153009152
DrJatinNagpal1,2020-04-28 01:55,0,0,"Suggest me an International Scientific Judicial Forum to file a complaint of Professional harassment and sabotage of career and fundamental human rights against mentors @ AACR @ narendramodi @ PMOIndia @ republic @ Republic_Bharat @ NIH @ NCIDirector",,@ @ @ @ @ @ @,,"1255012737849208834",https://twitter.com/DrJatinNagpal1/status/1255012737849208834
NicoleKuderer,2020-04-28 01:48,3,7,"# OncoAlert Agree. Only preliminary results so far, but very intriguing suggestion of benefits of a fasting-mimicking diet for people with # breastcancer. # AACR20 # AACR2020 # bcsmhttps://twitter.com/LizCancerHealth/status/1254861649602686977 …",,,# # # # #,"1255010977956786176",https://twitter.com/NicoleKuderer/status/1255010977956786176
PharmaLeader1,2020-04-28 01:42,0,0,"# AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://endpts.com/aacr20-early-data-suggest-novartis-incyte-discovered-met-inhibitor-helps-lung-cancer-patients-with-brain-lesions/ … @ Novartis # AACR2020 # oncology # CancerResearch # lungcancer",,@,# # # # #,"1255009422755143681",https://twitter.com/PharmaLeader1/status/1255009422755143681
PharmaLeader1,2020-04-28 01:38,0,0,"# AACR20 roundup: Tecentriq/Xtandi combo fails to show OS benefit, halting Roche's PD-L1 push into prostate cancer - https://endpts.com/aacr20-roundup-tecentriq-xtandi-combo-fails-to-show-os-benefit-halting-roches-pd-l1-push-into-prostate-cancer/ … # oncology # Immunotherapy",,,# # #,"1255008508677951489",https://twitter.com/PharmaLeader1/status/1255008508677951489
Le13916628,2020-04-28 01:10,0,0,"Admire Wei for high production! # AACR20 pic.twitter.com/Lum3p5QmNS",,,#,"1255001457855795200",https://twitter.com/Le13916628/status/1255001457855795200
OncLive,2020-04-28 01:10,0,0,"WATCH: Dr. Thirman on the Rationale for Using SNDX-5613 in Acute Leukemias @ UChicagoMed @ AACR # AACR20 # leusmhttp://ow.ly/3bSz50zqbJK",,@ @,# #,"1255001305854234624",https://twitter.com/OncLive/status/1255001305854234624
GeneOnlineNews,2020-04-28 01:04,2,0,"# AACR20 Four presentations were featured in the opening clinical plenary session on day 1 of the AACR Virtual Annual Meeting I. I-SPY2, IMspire150 trials succeed, IMbassador250 trial folds. # Cancer # melanoma # breastcancer # prostatecancer # GeneOnlinehttps://wp.me/pb0TAP-1kq",,,# # # # # #,"1254999925185708032",https://twitter.com/GeneOnlineNews/status/1254999925185708032
nivoipicombo,2020-04-28 01:03,0,0,"No control cohort. What the the historical DCR data with blockers alone?",,,,"1254999711439745028",https://twitter.com/nivoipicombo/status/1254999711439745028
SilasInman,2020-04-28 00:30,1,0,"Adding Durvalumab/Olaparib to Neoadjuvant Chemo Improves pCR in High-Risk HER2-Negative Breast Cancer https://www.onclive.com/conference-coverage/aacr-2020/adding-durvalumab-olaparib-to-neoadjuvant-chemo-improves-pcr-in-high-risk-her2-negative-breast-cancer … # bcsm # AACR20",,,# #,"1254991404901728257",https://twitter.com/SilasInman/status/1254991404901728257
ChenLabUofL,2020-04-28 00:11,0,1,"pic.twitter.com/a6l7GbdfC9",,,,"1254986691640778753",https://twitter.com/ChenLabUofL/status/1254986691640778753
EIPGeu,2020-04-27 23:50,0,0,"# AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://endpts.com/aacr20-early-data-suggest-novartis-incyte-discovered-met-inhibitor-helps-lung-cancer-patients-with-brain-lesions/ …",,,#,"1254981401260240901",https://twitter.com/EIPGeu/status/1254981401260240901
EIPGeu,2020-04-27 23:50,0,0,"# AACR20 roundup: Tecentriq/Xtandi combo fails to show OS benefit, halting Roche's PD-L1 push into prostate cancer - https://endpts.com/aacr20-roundup-tecentriq-xtandi-combo-fails-to-show-os-benefit-halting-roches-pd-l1-push-into-prostate-cancer/ …",,,#,"1254981293642784774",https://twitter.com/EIPGeu/status/1254981293642784774
sanamloghavi,2020-04-27 23:44,4,21,". @ AACR managing to impeccably execute virtual # AACR20 in the midst of this pandemic is nothing short of remarkable... but a walk along the # Pacific followed by a glass of at # LittleItaly would’ve been nice tonight.. just sayin! # COVIDConfessions San Diego Harbor, 10/2019pic.twitter.com/bouO1r7CE7",,@,# # # #,"1254979890874585088",https://twitter.com/sanamloghavi/status/1254979890874585088
Rajesh42763366,2020-04-27 23:26,0,0,"Thanks @ AACR for giving opportunity to attend virtual meeting, Had good information :)",,@,,"1254975218914750465",https://twitter.com/Rajesh42763366/status/1254975218914750465
JaimeMerchan10,2020-04-27 23:24,0,1,"Glad to be part of this exciting study!",,,,"1254974858817044481",https://twitter.com/JaimeMerchan10/status/1254974858817044481
Rajesh42763366,2020-04-27 23:23,0,0,"Thanks a lot @ AACRPres",,@,,"1254974566419451908",https://twitter.com/Rajesh42763366/status/1254974566419451908
GiorgiaFoggetti,2020-04-27 23:14,2,27,"Today was really exciting! Thanks to @ PolitiKaterina, my labmates at @ Yalemed and amazing collaborators from Winslow and @ PetrovADmitri Labs at @ StanfordMed, @ lichuan_Bio, Hongchen Cai and many more! # AACR20 # AACRProjectGENIEhttps://twitter.com/YaleCancer/status/1254877638449127424 …",,@ @ @ @ @,# #,"1254972185648791552",https://twitter.com/GiorgiaFoggetti/status/1254972185648791552
angelinatjokdoc,2020-04-27 23:10,0,7,"A new normal...working from home, having lunch on the balcony and joining 45,000 other registrants to virtually attend the @ AACR annual meeting from Sydney. Could get used to this - no jet lag! pic.twitter.com/14pqL5uQCL",,@,,"1254971317939388416",https://twitter.com/angelinatjokdoc/status/1254971317939388416
OncLive,2020-04-27 23:10,8,17,"Adding Durvalumab/Olaparib to Neoadjuvant Chemo Improves pCR in High-Risk HER2-Negative Breast Cancer @ YaleCancer @ AACR # bcsm # AACR20 http://ow.ly/JNzx50zqbF1",,@ @,# #,"1254971107112824832",https://twitter.com/OncLive/status/1254971107112824832
c0nc0rdance,2020-04-27 23:02,0,0,"Great job on a very successful day. Smooth and professional, all day.",,,,"1254969132879163392",https://twitter.com/c0nc0rdance/status/1254969132879163392
KKauffman131,2020-04-27 22:52,2,6,"Looking forward to tomorrow's # AACR20 # VirtualConference Symposium w/ @ theNCI highlighting # COVID19 & # CancerResearch activities as well as all the other fantastic # cancer # science # research being presented throughout the day!https://twitter.com/NCIDirector/status/1254764237034938369 …",,@,# # # # # # #,"1254966815261949953",https://twitter.com/KKauffman131/status/1254966815261949953
Latinamd,2020-04-27 22:50,4,9,"I can’t remember when was the last time I saw a HR of 12.33. # precisionmedicine is all about the right drug for the right patient. # poziotinib for # egfrins20 # lcsm # AACR20 https://twitter.com/Jbauml/status/1254836825371414535 …",,,# # # # #,"1254966271042564096",https://twitter.com/Latinamd/status/1254966271042564096
antgiorda,2020-04-27 22:47,6,10,"In a large Swedish cohort (>3,000), 1.1% of early ER+ breast cancer presented de novo ESR1 mutations (E380Q most frequent), before any treatment. Patients had 4-fold higher relapse risk, 2-fold worse OS. Thanks Dr. Malin Dahlgren # AACR20 # bcsm Should we screen for this mut?",,,# #,"1254965467053199361",https://twitter.com/antgiorda/status/1254965467053199361
KKauffman131,2020-04-27 22:47,4,10,"Ok, maybe just kinda, potentially/possibly biased, but...seriously, tune in & support former # AACRAMC alumna/past chair @ d2merino during the @ AACR # AACR20 Virtual Mtg I at 4:55pm Eastern tomorrow (part of the Virtual MiniSymp: Predictive Biomarkers for Immunotherapeutics)! https://twitter.com/d2merino/status/1254906697463803905 …",,@ @,# #,"1254965414632849408",https://twitter.com/KKauffman131/status/1254965414632849408
ratupayachi,2020-04-27 22:43,0,0,"Nanoparticulas en Tratamiento del Cáncer .... # AACR20 https://twitter.com/Jbauml/status/1254804729500258304 …",,,#,"1254964306439032833",https://twitter.com/ratupayachi/status/1254964306439032833
pashtoonkasi,2020-04-27 22:41,3,11,"# AACR20 for hosting the meeting virtually. Amidst # COVID19 chaos, good to see some great science presented & discussed. Interactive format of great value.https://twitter.com/AACR/status/1254943770921099270 …",,,# #,"1254963834864926721",https://twitter.com/pashtoonkasi/status/1254963834864926721
vmariotti_,2020-04-27 22:33,0,4,"Exciting presentation today by @ GiorgiaFoggetti at # AACR2020 @ AACR on co-occurring alterations in # EGFR-driven # lungcancer. @ YaleCancer @ YaleMed @ politikaterina @ StanfordMed https://www.biorxiv.org/content/10.1101/2020.04.13.036921v1 …pic.twitter.com/jqhXUis4mH",,@ @ @ @ @ @,# # #,"1254961953887285248",https://twitter.com/vmariotti_/status/1254961953887285248
pashtoonkasi,2020-04-27 22:32,14,40,"# AACR20 delighted to share that my small observation/formulais now published.Small but novel finding. What if you could calculate the CA-19-9/CEA ratio & it could identify BRAFV600E MSS MSI-High Others. Simple, rapid, & cheap. # CRCSM http://jgo.amegroups.com/article/view/35165/html …pic.twitter.com/t359VmAK1n",,,# #,"1254961621333610497",https://twitter.com/pashtoonkasi/status/1254961621333610497
antgiorda,2020-04-27 22:22,8,12,"Dr. Pusztai # AACR20 showed constant (2x) improvement of pCR rate in HER2-negative breast cancer with addition of olaparib and durvalumab to paclitaxel in the I-SPY2, BRCA-independently. Ultra-high MammaPrint can be a biomarker for higher benefit in the ER+/HER2- subtype. # bcsm",,,# #,"1254959262188609536",https://twitter.com/antgiorda/status/1254959262188609536
kabeer_suhail,2020-04-27 22:15,1,6,"Benefits of lockdown! Enjoying the # AACR Annual meeting virtually from my living room!!! Kudos to the organisers for making it free for all! Science goes on! # virtualconference # AACR20 https://lnkd.in/g6GEdef",,,# # #,"1254957440266690560",https://twitter.com/kabeer_suhail/status/1254957440266690560
OncLive,2020-04-27 22:10,0,3,"WATCH: Dr. Wang-Gillam on Results of a Phase 1 Study With Defactinib in Pancreatic Ductal Adenocarcinoma @ WUSTLmed @ AACR http://ow.ly/4t5r50zqbGI",,@ @,,"1254956010571251715",https://twitter.com/OncLive/status/1254956010571251715
MDAndersonNews,2020-04-27 22:08,9,28,"The Phase III EMBRACA clinical trial led by our @ JenniferLitton showed advanced # breastcancer patients taking talazoparib had better overall health for longer than those on chemotherapy: https://bit.ly/2xUOO2V # AACR20 # bcsm # endcancer",,@,# # # #,"1254955495594524675",https://twitter.com/MDAndersonNews/status/1254955495594524675
SiwenONC,2020-04-27 22:02,3,7,"Important special plenary session on COVID19 and Cancer tomorrow @ AACR virtual meeting. Speakers from hot spot countries sharing experience helping COVID19 infected cancer patients. Get up early and join the session. # AACR2020 https://twitter.com/SWOG/status/1254892159007776768 …pic.twitter.com/QhhDMTXFlL",,@,#,"1254954005408518149",https://twitter.com/SiwenONC/status/1254954005408518149
aparna1024,2020-04-27 22:00,0,2,"We published a small paper in ccr this year on response prediction but clinically does early switching make a different in outcomes? Unclear . Certain tox sparing",,,,"1254953572027990016",https://twitter.com/aparna1024/status/1254953572027990016
pashtoonkasi,2020-04-27 21:59,1,4,"@ JenSaam I believe this is from all the patients who consented for their tumor/samples for the screening phase. The actual trial my understanding was only for # BRCA. Correct me Dr. @ EileenMOReilly @ Aiims1742. That’s why no response data for other . # PANCSM # AACR20",,@ @ @,# # #,"1254953366238769154",https://twitter.com/pashtoonkasi/status/1254953366238769154
SiwenONC,2020-04-27 21:57,2,13,"Join us tomorrow in the AACR virtual clinical plenary. I will discuss two important abstracts. Is there concern of anti-PD1 in unleashing tumor cells in T Cell Malignancy? Should we switch to Pembrolizumab 400mg q6wk? Stay tuned! @ AACR pic.twitter.com/69NyruO5ce",,@,,"1254952758081273856",https://twitter.com/SiwenONC/status/1254952758081273856
laraparenter,2020-04-27 21:54,0,0,"Today the day was dedicated to the virtual annual meeting I of the @ AACR , important topics addressed as Novel Drugs on the Horizon Part 1-3 and on first disclosure of new small molecules and biologics that recently entered phase I clinical trials. pic.twitter.com/jMGjZaCkeM",,@,,"1254952021897220099",https://twitter.com/laraparenter/status/1254952021897220099
pashtoonkasi,2020-04-27 21:53,0,1,"Given it’s short half-life, I do think it has the potential & has been shown to predate progression or response. # ctDNA # LiquidBiopsies. For example in the one of the # LCSM, it mirrored & anticipated/predated RECIST response or progression. # AACR20",,,# # # #,"1254951800861573125",https://twitter.com/pashtoonkasi/status/1254951800861573125
KKauffman131,2020-04-27 21:52,2,4,"So incredibly proud to be a part of this amazing association as we make history during unprecedented times. # VirtualConference # VirtualScience & # VirtualLearning are all a go for # AACR20!!!! Can't wait to see you all join @ AACR for more # Science tomorrow!https://twitter.com/AACR/status/1254943770921099270 …",,@,# # # # #,"1254951476801286145",https://twitter.com/KKauffman131/status/1254951476801286145
pashtoonkasi,2020-04-27 21:50,0,2,"# AACR20 I don’t think it was covered in depth. The discussants did ask about how the # diet # fasting would impact other targeted therapies or # immunotherapy and/or its effects on # microbiome; but there wasn’t enough time.",,,# # # # #,"1254951171615264774",https://twitter.com/pashtoonkasi/status/1254951171615264774
KKauffman131,2020-04-27 21:39,2,5,"Wow, what a record-breaking, historic 1st day of # AACR20 Virtual Mtg I - did you join us? Any guesses on the overall total attendance numbers by the end of day 2 when things get even more exciting w/ both a clin plenary & a NCI symposium on # COVID19 & # cancer? Don't suffer # FOMO!https://twitter.com/AACRPres/status/1254893122204696576 …",,,# # # #,"1254948265000415232",https://twitter.com/KKauffman131/status/1254948265000415232
TheodoreKee,2020-04-27 21:38,2,6,"Congrats to @ AgataBlasiak for the clinical trial abstract at # AACR20. Great virtual presentation and narration on using CURATEAI to help patients with multiple myeloma. # WeAreN1https://twitter.com/thedeanh/status/1254922247375958017 …",,@,# #,"1254948175070105600",https://twitter.com/TheodoreKee/status/1254948175070105600
taeh00nha,2020-04-27 21:38,0,0,"First day of # AACR2020 https://aacr20.onlineeventpro.freeman.com/live-stream/15335379/Opening-Session …",,,#,"1254948154610507778",https://twitter.com/taeh00nha/status/1254948154610507778
coristarlit,2020-04-27 21:34,0,2,"This slide was presented in the Lung Cancer Targeted Therapies session at # AACR20 today. As a healthy THIRTY TWO year old when dx with # lungcancer completely out of the blue, with no known risk factors, I would like to know how I could have PREVENTED my LC # lcsm @ AACRFoundationhttps://twitter.com/ivybelkins/status/1254917359707578368 …",,@,# # #,"1254947043308519430",https://twitter.com/coristarlit/status/1254947043308519430
Rick__Buck,2020-04-27 21:33,3,3,"Today’s # AACR20 Twitter highlights, thanks to all who tweeted about day one of @ AACR Virtual Annual Meeting I! https://twitter.com/AACR/status/1254943770921099270 …",,@,#,"1254946855865155585",https://twitter.com/Rick__Buck/status/1254946855865155585
Mesmer21,2020-04-27 21:32,0,5,"$ VSTM was a bit hype upto # AACR20 data readout (SP ws 2x in a mo) For KRASG12V $ VSTM: VS-6766 showed 1/10 pts PR + Resale of Up To 46.5 M shares of Comm stock Now, comparatively For KRASG12C $ AMGN: AMG 510 @ ASCO19 - 5/10 pts showed PR $ MRTX: MRTX849 @ AACR19 – 3/5 pts showed PR",,@ @,#,"1254946556068929536",https://twitter.com/Mesmer21/status/1254946556068929536
OncLive,2020-04-27 21:25,3,2,"Poziotinib Shows Mixed Findings in Exon 20-Mutant NSCLC @ MDAndersonNews @ AACR # lcsm # AACR20 http://ow.ly/b0cY50zqbBx",,@ @,# #,"1254944684646039552",https://twitter.com/OncLive/status/1254944684646039552
endpts,2020-04-27 21:22,3,4,"# AACR20: Early data suggest # Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesionshttps://endpts.com/aacr20-early-data-suggest-novartis-incyte-discovered-met-inhibitor-helps-lung-cancer-patients-with-brain-lesions/ …",,,# #,"1254943919072251904",https://twitter.com/endpts/status/1254943919072251904
AACR,2020-04-27 21:21,19,98,"Thank you to everyone who participated in day one of # AACR20 Virtual Meeting I. We loved reading all of your tweets throughout the day, here are the highlights: pic.twitter.com/7yW5Nen5Yl",,,#,"1254943770921099270",https://twitter.com/AACR/status/1254943770921099270
NicoleKuderer,2020-04-27 21:18,0,2,"Thank you Dr. Gil Morgan @ OncoAlert !!",,@,,"1254943049114767361",https://twitter.com/NicoleKuderer/status/1254943049114767361
shelly_et,2020-04-27 21:05,1,4,"Unbelievable!!! # AACR20 https://twitter.com/lgreco_ny/status/1254873486180352000 …",,,#,"1254939745391607809",https://twitter.com/shelly_et/status/1254939745391607809
SilasInman,2020-04-27 21:00,1,3,"Capmatinib Shows Clinical Meaningful Activity and Intracranial Responses in MET Exon 14+ NSCLC https://www.onclive.com/conference-coverage/aacr-2020/clinical-meaningful-activity-and-intracranial-responses-observed-for-capmatinib-in-met-exon-14mutant-nsclc … # LCSM # AACR20",,,# #,"1254938610090094592",https://twitter.com/SilasInman/status/1254938610090094592
StephenJWillia2,2020-04-27 20:58,1,3,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 27, 2020 Minisymposium on Signaling in # Cancer 11:45am-1:30 pm https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-minisymposium-on-signaling-in-cancer-1145am-130-pm/ … via @ Pharma_BI @ GenomeInstitute @ CureCancerNow @ UCLAJCCC # endcancer",,@ @ @ @ @,# # #,"1254937931338432512",https://twitter.com/StephenJWillia2/status/1254937931338432512
StephenJWillia2,2020-04-27 20:55,1,1,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 27, 2020 Opening Remarks and Clinical Session 11:45am-1:15pm Advances in # Cancer Drug Discovery https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-opening-remarks-and-clinical-session-1145am-115pm-advances-in-cancer-drug-discovery/ … via @ Pharma_BI # endcancer @ CureCancerNow",,@ @ @,# # #,"1254937262279835649",https://twitter.com/StephenJWillia2/status/1254937262279835649
StephenJWillia2,2020-04-27 20:53,1,1,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 27, 2020 Minisymposium on Drugging Undrugged#Cancer Targets 1:30 pm - 5:00 pm https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-minisymposium-on-drugging-undrugged-cancer-targets-130-pm-500-pm/ … via @ Pharma_BI @ CureCancerNow @ pharmanews @ BiotechWorld # endcancer",,@ @ @ @ @,# #Cancer #,"1254936808770744321",https://twitter.com/StephenJWillia2/status/1254936808770744321
StephenJWillia2,2020-04-27 20:47,1,1,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 27, 2020 Symposium New Drugs on the Horizon Part 1 4:50- 6:00 pm https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-symposium-new-drugs-on-the-horizon-part-1-450-600-pm/ … via @ Pharma_BI @ CureCancerNow @ pharmanews @ BiotechWorld @ BiotechWkBoston @ MDAndersonNews @ pharmalot",,@ @ @ @ @ @ @ @,#,"1254935129375617025",https://twitter.com/StephenJWillia2/status/1254935129375617025
AshaniTW,2020-04-27 20:43,0,11,"So happy to hear this. I have been inundated all day with Covid Chaos as I have come to call life as we now know it, and am delighted to hear that @ AACR and the presenters knocked it out of the park! https://twitter.com/cancerassassin1/status/1254913249960574976 …",,@,,"1254934243668606981",https://twitter.com/AshaniTW/status/1254934243668606981
barrosonco,2020-04-27 20:43,2,3,"@ AACR for all! New era! # COVIDー19https://twitter.com/CD_AACR/status/1243591380305313794 …",,@,#,"1254934103260102659",https://twitter.com/barrosonco/status/1254934103260102659
AmyABaran,2020-04-27 20:41,1,13,"Odd feeling to not be at my 10th Annual Meeting (in-person) as an @ AACR scientist/employee this time of year. But I am SO inspired by the research being presenting to keep us moving forward and my colleagues who are making this happen! Our “plenary hall” was full! # AACR20 pic.twitter.com/GthnoIdRkq",,@,#,"1254933805900668933",https://twitter.com/AmyABaran/status/1254933805900668933
DevikaDasMD,2020-04-27 20:40,1,19,"It’s Day 4/14 on inpatient Hemonc consults Having serious FOMO while # AACR20 is ongoing but spent the last couple of hours browsing twitter to catch up on all relevant # lcsm presentations ! One of the many reasons I love twitter",,,# #,"1254933430355275777",https://twitter.com/DevikaDasMD/status/1254933430355275777
ValsamoA,2020-04-27 20:39,3,7,"Stay tuned for next steps including linking Ras genotypes to disease stage and therapeutic outcomes. # RobScharpf @ christine_lovly @ RielyMD @ DrMarkAwad # JocelynLee # PrecisionMedicine # RAS # AACR20 #4/4",,@ @ @,# # # # # #4,"1254933187639169024",https://twitter.com/ValsamoA/status/1254933187639169024
christeeny513,2020-04-27 20:39,22,92,"STOP patient shaming! If you must say “prevention”, consider using the more accurate phrase of “risk reduction.” As a vegetarian for 20 yrs, avid half marathoner, no history of # breastcancer, & diagnosed # metastatic at 34- my cancer was not preventable. # BCSM # LCSM # AACR20 https://twitter.com/ivybelkins/status/1254917359707578368 …",,,# # # # #,"1254933139899781127",https://twitter.com/christeeny513/status/1254933139899781127
AVIVA1950,2020-04-27 20:38,0,0,"Live Notes, Real Time Conference Coverage 2020 # AACR # Virtual Meeting April 27, 2020 Opening # Remarks 9 am https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-opening-remarks-9-am/ … via @ Pharma_BI 2StephenJWillia2 @ pharma_BI @ AACR @ GenomeInstitute @ CureCancerNow @ UCLAJCCC # AACR20 # AACR2020 # curecancernow # pharmanews",,@ @ @ @ @ @,# # # # # # #,"1254933018336206848",https://twitter.com/AVIVA1950/status/1254933018336206848
Pharma_BI,2020-04-27 20:37,0,1,"Outstanding coverage by Dr. Williams @ pharma_BI @ AACR @ GenomeInstitute @ CureCancerNow @ UCLAJCCC # AACR20 # AACR2020 # curecancernow # pharmanewshttps://lnkd.in/dzipnt6",,@ @ @ @ @,# # # #,"1254932726282584064",https://twitter.com/Pharma_BI/status/1254932726282584064
StephenJWillia2,2020-04-27 20:34,0,1,"Live Notes, Real Time Conference Coverage @ AACR # AACR20 Virtual Meeting April 27, 2020 Minisymposium on AACR Project Genie & Bioinformatics 4:00 PM - 6:00 PM https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-minisymposium-on-aacr-project-genie-bioinformatics-400-pm-600-pm/ … via @ Pharma_BI @ CureCancerNow @ pharmanews @ BiotechWorld @ HopkinsMedicine",,@ @ @ @ @ @,#,"1254931913892126720",https://twitter.com/StephenJWillia2/status/1254931913892126720
Pharma_BI,2020-04-27 20:30,0,1,"Outstanding coverage in REAL TIME by Dr. Williams @ AACR @ GenomeInstitute @ CureCancerNow @ UCLAJCCC # AACR20 # AACR2020 # curecancernow # pharmanews https://lnkd.in/ddhUK2v",,@ @ @ @,# # # #,"1254930836316729345",https://twitter.com/Pharma_BI/status/1254930836316729345
ValsamoA,2020-04-27 20:29,10,28,"Thanks @ RielyMD for chairing an awesome session on cutting edge analyses leveraging # AACRGENIE data at # AACR20. Our # AACR_GENIE_KRAS team reported tumor-dependent Ras prevalence estimates and co-mutation patterns based on Bayesian modeling by # RobScharpf @ hopkinskimmel #1/4pic.twitter.com/sBu9fLa3Bv",,@ @,# # # # #1,"1254930713071108097",https://twitter.com/ValsamoA/status/1254930713071108097
AVIVA1950,2020-04-27 20:28,0,0,"2020 # AACR # Virtual Meeting April 27, 2020 # Symposium # New # Drugs on the # Horizon Part 1 4:50- 6:00 pm https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-symposium-new-drugs-on-the-horizon-part-1-450-600-pm/ … via @ Pharma_BI @ StephenJWillia2 @ AACR @ GenomeInstitute @ CureCancerNow @ UCLAJCCC # AACR20 # AACR2020 # curecancernow # pharmanews",,@ @ @ @ @ @,# # # # # # # # # #,"1254930407268782080",https://twitter.com/AVIVA1950/status/1254930407268782080
OncLive,2020-04-27 20:19,4,14,"Capmatinib Shows Clinical Meaningful Activity and Intracranial Responses in MET Exon 14+ NSCLC @ dgsomucla @ AACR # lcsm # AACR20 http://ow.ly/fJ4E50zqbzS",,@ @,# #,"1254928243108589570",https://twitter.com/OncLive/status/1254928243108589570
Kamacintosh,2020-04-27 20:12,5,23,"How was this PREVENTABLE ?....Plenary session at # LungCancer # TargetedTherapy # AACR20 today. I was a healthy 49 yr old medical professional with no apparent Hx or risk factors when dx with stage IV # lungcancer # lcsm # endthestigma # AACR2020 @ cityofhopepic.twitter.com/Eo7clr182L",,@,# # # # # # #,"1254926512266117120",https://twitter.com/Kamacintosh/status/1254926512266117120
DrSGraff,2020-04-27 20:11,0,1,"Looking forward to your continued work & publication!",,,,"1254926240613621760",https://twitter.com/DrSGraff/status/1254926240613621760
mdmanishshah,2020-04-27 20:10,1,2,"Definitely would endorse this! # AACR20 https://twitter.com/cancerassassin1/status/1254803439600746503 …",,,#,"1254926005057343489",https://twitter.com/mdmanishshah/status/1254926005057343489
BLLPHD,2020-04-27 20:09,0,4,"Really engaging interview of @ Nfcanavan by @ bradloncar Wish we were all live in person having a beer together # AACR20 https://twitter.com/bradloncar/status/1254847847427645445 …",,@ @,#,"1254925635069370368",https://twitter.com/BLLPHD/status/1254925635069370368
Pharma_BI,2020-04-27 20:04,0,0,"Outstanding Real Time Coverage by Dr. Williams @ pharma_BI @ AACR @ CureCancerNow @ pharmanews @ BiotechWorld @ HopkinsMedicine # AACR20 # AACR2020 # curecancernow # pharmanews https://lnkd.in/djMUCBA",,@ @ @ @ @ @,# # # #,"1254924494877179905",https://twitter.com/Pharma_BI/status/1254924494877179905
wljohntus,2020-04-27 19:57,0,1,"Uncanny!",,,,"1254922573458137089",https://twitter.com/wljohntus/status/1254922573458137089
Rick__Buck,2020-04-27 19:56,3,9,"Thanks for the great summary of # AACR20 Day 1 @ cancerassassin1 and all your tweets today. We are up to 54,000 registered attendees and will share final numbers on all, including demographics, in a press release on Wednesday.https://twitter.com/cancerassassin1/status/1254913249960574976 …",,@,#,"1254922462460067840",https://twitter.com/Rick__Buck/status/1254922462460067840
tmprowell,2020-04-27 19:56,6,22,"Looking forward to this # AACR20 Plenary session Tues 4/28/20 9am EDT on # COVID19nCancer. cc @ COVID19nCCChttps://twitter.com/jsoriamd/status/1254804182902673408 …",,@,# #,"1254922325008568320",https://twitter.com/tmprowell/status/1254922325008568320
thedeanh,2020-04-27 19:55,1,18,"Our team @ TheN1Institute is privileged to present our clinical trial abstract at # AACR20. We’re harnessing # CURATE.AI for novel trial designs to help patients with multiple myeloma. Proud to be part of an amazing team! # WeAreN1pic.twitter.com/qbKSsHOq7k",,@,# # #,"1254922247375958017",https://twitter.com/thedeanh/status/1254922247375958017
oalhalabimd,2020-04-27 19:54,1,14,"I am watching the # AACR20 recorded live stream (1.5x speed) and frankly my retention is higher than 2 years ago when I was their in person (jogging from one hall to the other)",,,#,"1254921846140665856",https://twitter.com/oalhalabimd/status/1254921846140665856
RossMarklein,2020-04-27 19:49,0,2,"Looks like AACR took some inspiration from @ US_FDA for their logo pic.twitter.com/8lJDmgJrjU",,@,,"1254920616429400066",https://twitter.com/RossMarklein/status/1254920616429400066
evilarsan,2020-04-27 19:47,0,2,"This was just a Phase Ib to discovery new biomarkers of activity of Naproxen. The molecular biomarker assessment was designed to address only the colorectal mucosa. Hopefully this will be the first step to design a larger study that can look at other organs/tumors (many thanks!)",,,,"1254920049506344961",https://twitter.com/evilarsan/status/1254920049506344961
PersimmonTI,2020-04-27 19:46,2,18,"$ VSTM PTI will follow up with more about the interesting case of Verastem's # AACR20 abstract later... For now, suffice it to say - added significantly at or near today's lows... Will add more if dip persists. /conviction.",,,#,"1254919982984683520",https://twitter.com/PersimmonTI/status/1254919982984683520
MalhotraNidhiK,2020-04-27 19:43,1,1,"# AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://endpts.com/aacr20-early-data-suggest-novartis-incyte-discovered-met-inhibitor-helps-lung-cancer-patients-with-brain-lesions/ …",,,#,"1254919253049905157",https://twitter.com/MalhotraNidhiK/status/1254919253049905157
sepideh_gholami,2020-04-27 19:41,1,5,"We are all waiting to drug Ras!",,,,"1254918510284697600",https://twitter.com/sepideh_gholami/status/1254918510284697600
ivybelkins,2020-04-27 19:36,14,92,"This slide was presented in the Lung Cancer Targeted Therapies session at # AACR20 today. As a healthy 47 year old when dx with stage IV # lungcancer completely out of the blue, with no known risk factors, I would like to know how I could have PREVENTED my LC # lcsm @ AACRFoundationpic.twitter.com/VIGVdFoHtB",,@,# # #,"1254917359707578368",https://twitter.com/ivybelkins/status/1254917359707578368
saxotomy,2020-04-27 19:24,0,1,"It’s great to be able to have s’thing to shift the attention at this time! Thank you @ AACR ! https://twitter.com/OncoAlert/status/1254871556909662212 …",,@,,"1254914445995765760",https://twitter.com/saxotomy/status/1254914445995765760
cancerassassin1,2020-04-27 19:20,25,161,"What we learned at # AACR20 Day 1: 1. You CAN get 48,000+ participants to register for the world’s largest webinar (can’t wait to see demographic data); 2. KRAS is Undrugged (*yet*), not Undruggable; 3. BRAF is the ultimate Hydra; 4. @ AACR really came through",,@,#,"1254913249960574976",https://twitter.com/cancerassassin1/status/1254913249960574976
umayrsufi,2020-04-27 19:18,1,1,"I'd love to see @ accrf_org hit at least 500 by this week! Let's work to shed light on # RareDisease during this challenging time! @ UCDavisHealth @ StanfordMed @ SU2C @ AACR @ AmericanCancer @ JoeBiden @ mehdirhasan!",,@ @ @ @ @ @ @ @,#,"1254912713689448448",https://twitter.com/umayrsufi/status/1254912713689448448
sarahannbest,2020-04-27 19:16,0,8,"Thank you @ AACR for hosting a brilliant virtual meeting with free registration. It's been a whirlwind of a morning (AUS time zone!) # AACR2020",,@,#,"1254912392108011521",https://twitter.com/sarahannbest/status/1254912392108011521
AACRFoundation,2020-04-27 19:09,0,2,"Don’t miss @ NobelPrize winner and @ AACR Fellow Jim Allison’s documentary tonight. https://twitter.com/CancerCureDoc/status/1254899171733233667 …",,@ @,,"1254910507334721536",https://twitter.com/AACRFoundation/status/1254910507334721536
ReneFromMd,2020-04-27 19:08,0,0,"# AACR2020 One suggestion is to make searching the posters a bit easier. Would be nice to search on CRC or solid tumor to make it user friendly.",,,#,"1254910209891368961",https://twitter.com/ReneFromMd/status/1254910209891368961
TischCancer,2020-04-27 19:02,1,5,".@MdKrystal and colleagues @ IcahnMountSinai report on combination of endocrine therapy, palbociclib, and dual HER2 therapy with pertuzumab and trastuzumab in women with metastatic HR+, HER2+ # BreastCancer. @ AACR https://bit.ly/2Sf635J pic.twitter.com/hVmgypV5Qu",,@MdKrystal @ @,#,"1254908692031569922",https://twitter.com/TischCancer/status/1254908692031569922
Lampgen_CR,2020-04-27 19:00,0,0,"# AACR20: Early data suggest Novartis’ Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions – Endpoints News http://ow.ly/CAA030qBdmp",,,#,"1254908274291421192",https://twitter.com/Lampgen_CR/status/1254908274291421192
SystemsOncology,2020-04-27 18:57,0,0,"Today is the @ AACR Virtual Annual Meeting I. We are excited to attend, check this link out to see today’s schedule: https://bit.ly/2KAdxvU # cancerresearch # ai # bigdatapic.twitter.com/odE24haHM0",,@,# # #,"1254907447916900352",https://twitter.com/SystemsOncology/status/1254907447916900352
Kamacintosh,2020-04-27 18:55,5,7,"Pneumonitis A/E in pts with # NSCLC treated with immunotherapy or chemotherapy in clinical trials and RWD Hope they expand this data... # LCSM # AACR20 # Lungcancer presented by Qi Luipic.twitter.com/MU75kofHkX",,,# # # #,"1254906971196723200",https://twitter.com/Kamacintosh/status/1254906971196723200
timheff5,2020-04-27 18:48,5,43,"Great day for the @ MDAndersonNews TRACTION Platform. First time disclosure of our GLS1 inh, IPN60090 by Jeff Kovacs and updated data from our partners at @ Boehringer @ MarcoHHofmann and @ gerlach_d on their SOS1::KRAS inh program. Great to see the science advance # AACR20",,@ @ @ @,#,"1254905351373312007",https://twitter.com/timheff5/status/1254905351373312007
illumina,2020-04-27 18:45,6,38,"We believe in the advancement of personalized medicine guided by comprehensive genomic profiling to improve patient outcomes. We’re one step closer to helping make this the standard of care in oncology. Now shipping TSO 500 ctDNA & TSO 500 HT. # AACR20 https://www.illumina.com/company/news-center/feature-articles/trusight-oncology-family-grows-with-liquid-biopsy-and-high-throu.html?SCID=2020-271SMO2571 …",,,#,"1254904424427933698",https://twitter.com/illumina/status/1254904424427933698
ajf324MD,2020-04-27 18:39,1,6,"@ Jbauml @ CharuAggarwalMD @ JFreemanDaily thanks for promoting a much needed and very educational distraction from COVID mortality graphs and Lysol ingestion memes!! # LCSM",,@ @ @,#,"1254903038977937409",https://twitter.com/ajf324MD/status/1254903038977937409
SilviaJim_Mor,2020-04-27 18:39,0,1,"It was a great day! Thank you to all the people who organized this exciting meeting.",,,,"1254902922145488899",https://twitter.com/SilviaJim_Mor/status/1254902922145488899
OncLive,2020-04-27 18:38,8,24,"Talazoparib Improves QOL, But Not OS in Advanced BRCA1/2+ Breast Cancer @ JenniferLitton @ MDAndersonNews @ AACR # AACR20 # bcsm http://ow.ly/G5ev50zq7I8",,@ @ @,# #,"1254902750510559232",https://twitter.com/OncLive/status/1254902750510559232
CWickerPhD,2020-04-27 18:24,0,1,"Indeed and it also helps those with disabilities that make traveling to conferences difficult. I hope some hybrid on remote and in person meetings continues.",,,,"1254899159322316800",https://twitter.com/CWickerPhD/status/1254899159322316800
AACR_CEO,2020-04-27 18:23,9,35,"Thank you to all the registrants attending our first @ AACR Virtual Annual Meeting. We are thrilled to bring this cutting-edge science to the cancer research community. # AACR20 https://twitter.com/AACRPres/status/1254893122204696576 …",,@,#,"1254899020943831041",https://twitter.com/AACR_CEO/status/1254899020943831041
drcbsteer,2020-04-27 18:22,0,2,"Atezolizumab Plus Vemurafenib/Cobimetinib Impresses in BRAF V600+ # Melanoma # nonCOVID19 news @ AACR @ PeterMacCC @ VicCompCancerCr @ McArthurGrant https://www.onclive.com/conference-coverage/aacr-2020/atezolizumab-plus-vemurafenib-cobimetinib-impresses-in-braf-v600-melanoma … via @ onclive",,@ @ @ @ @,# #,"1254898793457184768",https://twitter.com/drcbsteer/status/1254898793457184768
krknrm,2020-04-27 18:22,5,20,"Ha! I spy with my little eye... that I am on the list of # AACR20 influencers! Just did a profile pic change right in time , so look out for my former me https://twitter.com/OncoAlert/status/1254898022074519552 …",,,#,"1254898709059510272",https://twitter.com/krknrm/status/1254898709059510272
RenoHemonc,2020-04-27 18:19,0,0,"Difficult trial, had a patient on it, could never stay on schedule",,,,"1254898081507602432",https://twitter.com/RenoHemonc/status/1254898081507602432
OncoAlert,2020-04-27 18:19,19,34,"Thank you @ AACR for a great first day of this Amazing # AACR20 , very very well done & we are grateful for all your hard workHere are some of the logistics from our friends at @ symplur for today Best, @ OncoAlert https://www.symplur.com/healthcare-hashtags/AACR20/analytics/?hashtag=AACR20&fdate=4%2F27%2F2020&shour=4&smin=0&tdate=4%2F27%2F2020&thour=15&tmin=0 …pic.twitter.com/XZqjgjkCGv",,@ @ @,#,"1254898022074519552",https://twitter.com/OncoAlert/status/1254898022074519552
endpts,2020-04-27 18:19,0,4,"# AACR20: # Iovance revels in promising lung cancer data out of # Moffitt as TIL therapy triggers 2 complete responseshttps://endpts.com/aacr20-iovance-revels-in-promising-lung-cancer-data-out-of-moffitt-as-til-therapy-triggers-2-complete-responses/ …",,,# # #,"1254897867828985863",https://twitter.com/endpts/status/1254897867828985863
krknrm,2020-04-27 18:18,2,3,"Being able to view some of the talks later on is actually really cool, I also hope we can do here a bit of networking - send us a message if you want to discuss your research, happy to do a formal/informal chat if you are interested in @ NatureCancer! # AACR20",,@,#,"1254897709590478849",https://twitter.com/krknrm/status/1254897709590478849
krknrm,2020-04-27 18:18,1,4,"I also miss post-talks # cancer research banter and catching up with some colleagues (looking at you @ dow_lab @ LoweLabMSKCC @ NatureComms @ NatureMedicine @ Nature @ NatureCancer and many others!) but doing conferences in my slippers + good coffee is def a plus! :P # AACR20",,@ @ @ @ @ @,# #,"1254897708751519747",https://twitter.com/krknrm/status/1254897708751519747
MasonIsraelPhD,2020-04-27 18:15,8,11,"MET exon 14 skipping alterations are an emerging biomarker in # NSCLC. The GEOMETRY mono-1 study previously found # capmatinib can successfully target this alteration. Today results were presented by Dr. Garon at # AACR20 further highlighting efficacy in brain mets. $ NVS @ UCLAJCCChttps://twitter.com/LUNGevity/status/1254843299917168640 …",,@,# # #,"1254897033405587456",https://twitter.com/MasonIsraelPhD/status/1254897033405587456
jamesking00,2020-04-27 18:15,0,5,"atezo+cabozantinib showing promising activity in mCRPC (COSMIC021). Sponsors planning for AA by early 2021",,,,"1254896861690892288",https://twitter.com/jamesking00/status/1254896861690892288
ppisters,2020-04-27 18:14,4,12,". @ MDAndersonnews' Therapeutics Discovery division is seeing success from the unique approach we have implemented for drug discovery. At # AACR20, Dr. Jeffrey Kovacs presents another new medicine that has entered clinical trials for patients in need. https://twitter.com/MDAndersonNews/status/1254888056328523782 …",,@,#,"1254896671647051778",https://twitter.com/ppisters/status/1254896671647051778
ProfDanielKim,2020-04-27 18:10,5,9,"More exciting work highlighting importance of RAS @ AACR Project GENIE virtual session, presented by Elsa Anagnostou @ ValsamoA @ hopkinskimmel using 644,757 mutations from 64,217 tumors in 97 cancer types! # AACR20 pic.twitter.com/9ve8Nfafhc",,@ @ @,#,"1254895837399793664",https://twitter.com/ProfDanielKim/status/1254895837399793664
krh020,2020-04-27 18:08,0,1,"# AACR2020 setting the standard for how to host a virtual meeting. High stream quality, pre-recorded content ensures key points are delivered, Q&A via chat brilliant to keep everything on track. We’re learning a LOT about how to host effective meetings, say nothing of the science!",,,#,"1254895177883439110",https://twitter.com/krh020/status/1254895177883439110
krknrm,2020-04-27 18:04,3,43,"Thank you so much to the # AACR20 organizers for making this possible: kudos for organizing a seamless event even in the face of # COVID19 . Very thoughtful discussion, tons of participation from the audience and some very cool # cancer tweep connections. See y'all tomorrow!pic.twitter.com/tUxR4msXCN",,,# # #,"1254894221271711744",https://twitter.com/krknrm/status/1254894221271711744
emilysmithmeded,2020-04-27 18:04,1,5,"Day 1 of # AACR20 done Looking forward to tomorrow’s sessions! Of course it’s not quite the same as being onsite, but the virtual meeting format works very well and the presentation quality is excellent",,,#,"1254894193421541376",https://twitter.com/emilysmithmeded/status/1254894193421541376
zaccoop,2020-04-27 18:01,1,5,"@ CSpencerPhD great job co-chairing # AACR20 @ AACR minisymposium on Therapeutic modification of the # tumor # microenvironment or # microbiome. Great work by @ ProfRScolyerMIA @ ProfGLongMIA @ BertrandRouty and others.",,@ @ @ @ @,# # # #,"1254893553928585216",https://twitter.com/zaccoop/status/1254893553928585216
HartungIngo,2020-04-27 18:01,12,22,"First time disclosures from tonight's New Drugs on the Horizon Session (Part 1) at # AACR20 @ AACR: # AhR antagonist BAY 2416964 @ BayerPharma, glutaminase inhibitor IPN60090 @ MDAndersonNews & Menin inhibitor SNDX-5613 @ Syndaxpic.twitter.com/C9UP5V3y03",,@ @ @ @,# #,"1254893336244228104",https://twitter.com/HartungIngo/status/1254893336244228104
AACRPres,2020-04-27 18:00,22,158,"What an amazing day! Thanks to everyone who joined us for Day 1 of the @ AACR Virtual Annual Meeting I. Please join us at 9:00 a.m. EDT tomorrow, Tuesday, April 28 for a special Virtual Plenary Session on # COVID19 and Cancer.pic.twitter.com/KtX2XympEq",,@,#,"1254893122204696576",https://twitter.com/AACRPres/status/1254893122204696576
OncologyCentral,2020-04-27 18:00,0,3,"Does intermittent or continuous dosing of # dabrafenib and # trametinib impact # melanoma patient quality of life? Find out in the latest # AACR20 news on @ OncologyCentral",,@,# # # #,"1254893084120244224",https://twitter.com/OncologyCentral/status/1254893084120244224
OncLive,2020-04-27 17:58,7,9,"Atezolizumab Plus Vemurafenib/Cobimetinib Impresses in BRAF V600+ Melanoma @ VicCompCancerCr @ unimelb @ PeterMacCC @ AACR # AACR20 # melsmhttp://ow.ly/cJan50zq6af",,@ @ @ @,# #,"1254892781451042816",https://twitter.com/OncLive/status/1254892781451042816
HemOncToday,2020-04-27 17:58,1,0,"Addition of GX-188E to pembrolizumab improves response rate in advanced cervical cancer http://bit.ly/35bQ8dM # AACR20 # HPV",,,# #,"1254892619848650753",https://twitter.com/HemOncToday/status/1254892619848650753
SWOG,2020-04-27 17:56,4,12,"Great idea and a great leader. Congrats to new @ AACR president Dr. Antoni Ribas - the former @ SWOG melanoma chair - on helping to pull together a terrific virtual annual meeting in less than a month! # AACR20 https://twitter.com/AACR/status/1254766640178307072 …",,@ @,#,"1254892159007776768",https://twitter.com/SWOG/status/1254892159007776768
krknrm,2020-04-27 17:55,0,7,"Thanks for a great session # AACR20 on "Therapeutic Modification of the Tumor Microenvironment or Microbiome" @ adrianaalbini1 and Christine Spencer @ parkerici - very nice discussion!",,@ @,#,"1254891908524113920",https://twitter.com/krknrm/status/1254891908524113920
JaniceM10,2020-04-27 17:54,0,0,"Simply outstanding!",,,,"1254891688608268288",https://twitter.com/JaniceM10/status/1254891688608268288
krknrm,2020-04-27 17:50,2,4,"Very nice talk! # AACR20 https://twitter.com/LizCancerHealth/status/1254881543815696384 …",,,#,"1254890811709423617",https://twitter.com/krknrm/status/1254890811709423617
itsnot_pink,2020-04-27 17:49,1,4,"I disagree, @ Martha__Carlson. As long as it's emphasized as a risk reduction and not a prevention, the data presented today needs to be shared. Plus, at least one of the studies looked at progression of metastatic disease, not risk of cancer # aacr20 @ OncoAlert # bcsm",,@ @,# #,"1254890370510598146",https://twitter.com/itsnot_pink/status/1254890370510598146
krknrm,2020-04-27 17:48,1,1,". Food for thought (and for shaping the microbiome-induced immunotherapy responses!) @marcelbatten lab discusses connections btw microbiome diversity, intestinal barrier and # immunotherapy responses + # AEs via butyrate production - very cool stuff! # AACR20 @ AACR",,@marcelbatten @,# # #,"1254890110119751682",https://twitter.com/krknrm/status/1254890110119751682
KhannousOlfat,2020-04-27 17:46,0,1,"Low microbial diversity is associated with poor clinical outcomes. Some microbiome biomarkers are reported but it's difficult to establish a consensus because of the gut microbiome functional redundancy. # AACR20",,,#,"1254889666882473986",https://twitter.com/KhannousOlfat/status/1254889666882473986
LizCancerHealth,2020-04-27 17:40,3,5,". @ marcel_batten: Microbial butyrate production, which plays a role in maintaining intestinal barrier function, may help explain association between gut # microbiome & checkpoint # immunotherapy response & AEs. # AACR20 pic.twitter.com/JXdqMKbI2U",,@,# # #,"1254888076087705600",https://twitter.com/LizCancerHealth/status/1254888076087705600
MDAndersonNews,2020-04-27 17:40,4,12,"Because of the GLS1 enzyme’s role in metabolic processes, it makes an attractive target for cancer therapy, according to our Dr. Jeffrey Kovacs. Learn how our experts are looking into its use to treat # lungcancer and # ovariancancer: https://bit.ly/2YbTFrc # AACR20 # endcancer",,,# # # #,"1254888056328523782",https://twitter.com/MDAndersonNews/status/1254888056328523782
LUNGevity,2020-04-27 17:39,1,9,"Great discussion by @ handlerwagner on how we can overcome the "interpretation bottleneck" of genomic sequencing data. Applaud the efforts of the Variant Interpretation for Cancer Consortium ( @ cancervariants). # AACR2020 # AACR20 # LCSMpic.twitter.com/QWNDQir2DE",,@ @,# # #,"1254887865584058368",https://twitter.com/LUNGevity/status/1254887865584058368
ChenLabUofL,2020-04-27 17:36,0,4,"Enjoying the @ AACR virtual meeting today! S/O to all the organizers and speakers for making this possible # AACR2020 pic.twitter.com/JvcuGTEqpn",,@,#,"1254887057224318976",https://twitter.com/ChenLabUofL/status/1254887057224318976
Dr_ZiMingZhao,2020-04-27 17:34,6,8,"Appreciate such consortium level efforts for clinical knowledgebases that will benefit Molecular Tumor Board and Precision Medicine by Dr. Alex Wagner # AACR20 https://www.nature.com/articles/s41588-020-0603-8 …pic.twitter.com/ozsIs0K9AE",,,#,"1254886785311793154",https://twitter.com/Dr_ZiMingZhao/status/1254886785311793154
krknrm,2020-04-27 17:33,0,1,"100% agree, sigh! But good to catch up with some research and see exciting talks! # AACR20",,,#,"1254886456973295618",https://twitter.com/krknrm/status/1254886456973295618
OncoAlert,2020-04-27 17:33,4,17,"Live # AACR20 Tweet @ AriellaHanker " I’m loving the emphasis on # cooccurring mutations in the # projectGENIE session! Nice analysis of mutations that co occur with # Ras mutations" from @ ValsamoA & our @ OncoAlert colleague @ christine_lovlyhttps://twitter.com/AriellaHanker/status/1254884543632416771 …",,@ @ @ @,# # # #,"1254886304392896512",https://twitter.com/OncoAlert/status/1254886304392896512
rgenix,2020-04-27 17:32,0,4,"Our abstract, “RGX-104, a first-in-class immunotherapy targeting the liver-X receptor (LXR)” reporting initial phase 1b results, will be presented at # AACR20 by lead author Dr. Emerson Lim of Columbia University. Learn more: https://bit.ly/2yLYL2w @ AACR pic.twitter.com/SDMKLYvClX",,@,#,"1254886251729244167",https://twitter.com/rgenix/status/1254886251729244167
christeeny513,2020-04-27 17:31,0,3,"# bcsm # aacr20 https://twitter.com/Martha__Carlson/status/1254875917714960384 …",,,# #,"1254885881825112065",https://twitter.com/christeeny513/status/1254885881825112065
MaverickNY,2020-04-27 17:31,0,6,"No sound, no sound! I hear the wails of 10,000 lost souls # AACR20 must be the effects of tryptophan...",,,#,"1254885813864869888",https://twitter.com/MaverickNY/status/1254885813864869888
TaylorJ_MD,2020-04-27 17:30,9,44,"New drugs on the horizon # AACR2020 # AACR20 MLL1-Menin inhibitor Syndax-5613 shows activity as monotherapy for R/R # AML | trial ongoing with plan for Phase 2 in MLL-r and NPM1c mutant AML # leusm",,,# # # #,"1254885699519733761",https://twitter.com/TaylorJ_MD/status/1254885699519733761
ProfAllieG,2020-04-27 17:29,1,8,"So completed my second # TwoPointSixChallenge this eve - walked 2.6miles around my garden whilst attending the virtual @ AACR virtual meeting!! @ BCRT # teambones # untiltheresacurepic.twitter.com/ldgDWhZcqv",,@ @,# # #,"1254885496582537216",https://twitter.com/ProfAllieG/status/1254885496582537216
AML_Hub,2020-04-27 17:29,2,4,"CONGRESS | # AACR20 | The second part of the presentation focused on the phase I/II AUGMENT-101 study. Patient responses to date were shown according to whether patients were receiving a CYP3A4 inhibitor concurrently # leusmpic.twitter.com/kJhjkmPzzK",,,# #,"1254885428601257989",https://twitter.com/AML_Hub/status/1254885428601257989
AML_Hub,2020-04-27 17:29,5,6,"CONGRESS | # AACR20 | Jerry MacGeehan presents SNDX-5613, an menin-MLL1 antagonist for MLL-r and NPM1 mutated acute leukemias such as # AML and ALL. The first part of this presentation focused on the development, efficacy in xenografts models and target PK profile # leusmpic.twitter.com/jFXP0K8KPn",,,# # #,"1254885417972895744",https://twitter.com/AML_Hub/status/1254885417972895744
CampKatiee,2020-04-27 17:29,3,14,"Great hearing from @ HandlerWagner on the incredible efforts by the @ cancervariants consortium to harmonize somatic variant interpretation. For more information, check out http://www.cancervariants.org # AACR20 pic.twitter.com/Gqz45iljMK",,@ @,#,"1254885282790338562",https://twitter.com/CampKatiee/status/1254885282790338562
silke4senate,2020-04-27 17:28,0,1,"@ MarcusDGon thank you for your review of dietary strategies for breast cancer at # AACR20 today. I saw a planned study for diet and Alpelisib - are you going forward with it in the times of COVID-19? And is there somebody on the West Coast or in CA you work with? # bcsm",,@,# #,"1254885230713827330",https://twitter.com/silke4senate/status/1254885230713827330
MaverickNY,2020-04-27 17:28,0,0,"Sound has gone again in New Drugs session!",,,,"1254885053890539521",https://twitter.com/MaverickNY/status/1254885053890539521
oncologypharm,2020-04-27 17:27,7,18,"KRAS/RAS co-occurrence and mutual exclusivity by tumor types. STK11, ATM, KEAP1 have high co-occurrence patterns with KRAS mutated NSCLC # AACR20 pic.twitter.com/2II78VFUwc",,,#,"1254884907702079488",https://twitter.com/oncologypharm/status/1254884907702079488
LungCancerFaces,2020-04-27 17:27,12,49,"WTF @ cityofhope and # AACR20?! LUNG CANCER IS NOT A PREVENTABLE DISEASE. How can you present this garbage at a major scientific meeting? I am appalled. # lcsmhttps://twitter.com/lgreco_ny/status/1254873486180352000 …",,@,# #,"1254884790035087360",https://twitter.com/LungCancerFaces/status/1254884790035087360
AriellaHanker,2020-04-27 17:26,9,26,"I’m loving the emphasis on # cooccurring mutations in the # AACR20 # projectGENIE session! Nice analysis of mutations that co occur with # Ras mutations from @ ValsamoA and @ christine_lovlypic.twitter.com/8CIFjtUn4f",,@ @,# # # #,"1254884543632416771",https://twitter.com/AriellaHanker/status/1254884543632416771
acmoorephd,2020-04-27 17:24,1,6,"Looking forward to this presentation tomorrow # AACR20 # lcsm # COVID19https://twitter.com/HornLeora/status/1254870571202068480 …",,,# # #,"1254884038935932928",https://twitter.com/acmoorephd/status/1254884038935932928
NCICCR_VB,2020-04-27 17:22,6,9,"Not too late! You can still enjoy remaing 1 day virtual # AACR20 meeting! Free registration Hop on tomorrow! On demand viewing will be available later. # CancerResearch # CancerImmunotherapyhttps://twitter.com/AACR/status/1252650827233341440 …",,,# # #,"1254883723184660485",https://twitter.com/NCICCR_VB/status/1254883723184660485
OncoAlert,2020-04-27 17:20,6,5,"Dear friends, Quick Poll on which part of the worldour Colleagues (Doctors, Nurses, Scientists & Patient Advocates) attending # AACR20 are coming from, care to share? best, @ weoncologists & @ OncoAlert",,@ @,#,"1254883219712946182",https://twitter.com/OncoAlert/status/1254883219712946182
LUNGevity,2020-04-27 17:20,8,13,"LUNGevity Awarde @ ValsamoA 's prez demonstrates that co-occurring mutations in KRAS-mutant lung cancer may predict treatment context. Important to keep in mind when treating KRAS-mutant cancers @ JohnsHopkins # AACR2020 # AACR20 # LCSMpic.twitter.com/VCRbnpq63G",,@ @,# # #,"1254883158379692037",https://twitter.com/LUNGevity/status/1254883158379692037
PapaemmanuilLab,2020-04-27 17:19,3,33,"Awesome presentations at @ AACR project genie session. Not all mutations in cancer genes are equal. Amazing data, statistical & functional approaches. Data driven precision oncology that extends beyond the single biomarker. Thank you to everyone involved in making # AACR2020",,@,#,"1254882782876184580",https://twitter.com/PapaemmanuilLab/status/1254882782876184580
lgreco_ny,2020-04-27 17:18,0,0,"@ AACR @ AACRPreshttps://twitter.com/lgreco_ny/status/1254873486180352000 …",,@ @,,"1254882606228877312",https://twitter.com/lgreco_ny/status/1254882606228877312
pashtoonkasi,2020-04-27 17:18,14,32,"# AACR20 Important to know the spectrum of # KRAS and now the specific codons. # Clinicaltrials for the # KRASG12C # AMG510 and other . # CRCSM # PANCSM # LCSM # PrecisionMedicine Importance of co-occurring mutations. Interesting co-mutation patterns & dependencies. Type-specific.pic.twitter.com/lZvYQjr0Aw",,,# # # # # # # # #,"1254882525475897351",https://twitter.com/pashtoonkasi/status/1254882525475897351
Martha__Carlson,2020-04-27 17:18,0,1,"That's interesting",,,,"1254882522405748738",https://twitter.com/Martha__Carlson/status/1254882522405748738
jillfeldman4,2020-04-27 17:16,3,19,"2/ that creates barriers to dx, treatment & acceptance. Stigma also prevents research into all the other risks of lc, leaving the public w/ a false sense that if they don’t smoke they won’t get lc. ANYONE can get lung cancer and NO ONE deserves it. @ AACR # LCSM # AACR20",,@,# #,"1254882218926800897",https://twitter.com/jillfeldman4/status/1254882218926800897
Martha__Carlson,2020-04-27 17:16,0,1,"lol that was what put me off initially.",,,,"1254882218817830914",https://twitter.com/Martha__Carlson/status/1254882218817830914
jillfeldman4,2020-04-27 17:16,10,33,"1/The sociological context of tobacco/vape shops is impt for disparities in ALL cancers. Cancer is complicated, no simple cause/effect & not preventable - one can only reduce risk. The message ‘lung cancer is preventable’ is a DEADLY problem & perpetuates a stigma # LCSM # AACR20 pic.twitter.com/rGIghH2Ny5",,,# #,"1254882217102376963",https://twitter.com/jillfeldman4/status/1254882217102376963
DrMmajeed,2020-04-27 17:16,0,0,"@ RazzaqMch",,@,,"1254882046087962631",https://twitter.com/DrMmajeed/status/1254882046087962631
greisha_ortiz,2020-04-27 17:15,0,0,"OMG! Any takers? # AACR20 https://twitter.com/cancerassassin1/status/1254869294007177217 …",,,#,"1254881878634459136",https://twitter.com/greisha_ortiz/status/1254881878634459136
changermindset,2020-04-27 17:15,0,1,"Prior to my diagnosis both times, I couldn’t do anything to lose weight but as soon as the cancer was debulked by surgery & treatment I lost weight with no effort. It was crazy weird to me.",,,,"1254881821738876928",https://twitter.com/changermindset/status/1254881821738876928
CharuAggarwalMD,2020-04-27 17:14,4,48,"Kudos to @ AACR @ AACRPres for organizing a seamless # AACR20. While I get used to this new # virtual format, I am reminded of *how* much I miss the vibe of the plenary halls, the palpable energy and chatter, the audience applause and connecting with my friends + colleagues.",,@ @,# #,"1254881732676861952",https://twitter.com/CharuAggarwalMD/status/1254881732676861952
DrSGraff,2020-04-27 17:14,1,3,"Did you see any impact on other lynch associated cancers? Or only CRC? # AACR20 (and congrats—interesting work!)",,,#,"1254881583116562432",https://twitter.com/DrSGraff/status/1254881583116562432
LizCancerHealth,2020-04-27 17:14,4,6,"Nice -- albeit complex -- illustration from Athanasios Papadas # AACR20 pic.twitter.com/hr5DBAKhyA",,,#,"1254881543815696384",https://twitter.com/LizCancerHealth/status/1254881543815696384
changermindset,2020-04-27 17:13,0,1,"Well, the opening slide said “obesity & breast cancer”. So not really. As for me, I started doing intermittent fasting because I have a Pik3ca mutation that my oncologist thinks causes higher glucose uptake. I also think some cancers put off chemicals that alter metabolism..",,,,"1254881406767022081",https://twitter.com/changermindset/status/1254881406767022081
DrSGraff,2020-04-27 17:12,1,3,"# genetics # RiskReduction # AACR20 https://twitter.com/MDAndersonNews/status/1254865152442130432 …",,,# # #,"1254881154316095488",https://twitter.com/DrSGraff/status/1254881154316095488
KhannousOlfat,2020-04-27 17:11,0,4,"Gut microbiome in # oncology oncology as a novel prognostic marker @ AACR",,@,#,"1254880999961477120",https://twitter.com/KhannousOlfat/status/1254880999961477120
krknrm,2020-04-27 17:11,2,6,"Exciting audience discussion with Dr Messaoudene @ Meriem_M_ at the "Therapeutic Modification of the Tumor Microenvironment or Microbiome" session # AACR20 - polyphenol prebiotics shapes the gut microbiota and enhances a-PD1 therapy in mice",,@,#,"1254880864787484672",https://twitter.com/krknrm/status/1254880864787484672
MeganRShowalter,2020-04-27 17:11,0,0,"Enjoying attending @ AACR online, thank you # AACR2020 organizers for making this happen. Great session so far on # tumor microenvironment and # microbiome!!",,@,# # #,"1254880846428827648",https://twitter.com/MeganRShowalter/status/1254880846428827648
caitthornton,2020-04-27 17:10,3,34,"Authenticate your 2020 virtual conference experience by having an unnecessary number of pens and a large canvas bag handy # AACR2020 pic.twitter.com/I53Z5RwwSi",,,#,"1254880737880428544",https://twitter.com/caitthornton/status/1254880737880428544
DrSGraff,2020-04-27 17:10,1,4,"# WordMatter # AACR20 https://twitter.com/JenniferCKing/status/1254870518118912000 …",,,# #,"1254880648571031557",https://twitter.com/DrSGraff/status/1254880648571031557
ErikaHamilton9,2020-04-27 17:10,8,17,"Love that they rigorously conducted # QOL analyses. Even with = efficacy, our patients would take improved QOL any day. This is a very important endpoint! # bcsm @ OncoAlert # AACR20 https://twitter.com/christeeny513/status/1254836500098932739 …",,@,# # #,"1254880637334573056",https://twitter.com/ErikaHamilton9/status/1254880637334573056
ArielleElkrief,2020-04-27 17:10,0,2,"Listening to Dr Messaoudene give a fantastic presentation on potential of a prebiotic to improve anti PD-1 efficacy. So many questions from the audience! @ BertrandRouty @ AACR # microbiome",,@ @,#,"1254880618435031044",https://twitter.com/ArielleElkrief/status/1254880618435031044
cancerassassin1,2020-04-27 17:10,2,4,"I'm pleased to see that Day 1 of # AACR20 Virtual Meeting is RAS-centric. And why shouldn't it be? Traditionally said to drive 30% of all cancers (more recently likely 19% https://cancerres.aacrjournals.org/content/early/2020/03/24/0008-5472.CAN-19-3682 …), it was referred to by a session chair as "Undrugged" rather than "Undruggable"pic.twitter.com/y0pr3DgOih",,,#,"1254880545810591747",https://twitter.com/cancerassassin1/status/1254880545810591747
DrSGraff,2020-04-27 17:09,2,4,"Great update for # bcsm as well # AACR20 https://twitter.com/Jbauml/status/1254866452110127106 …",,,# #,"1254880287118557185",https://twitter.com/DrSGraff/status/1254880287118557185
AriellaHanker,2020-04-27 17:08,1,4,"Co occurring mutations are important! # AACR20 https://twitter.com/Jbauml/status/1254877859157553153 …",,,#,"1254880196869730305",https://twitter.com/AriellaHanker/status/1254880196869730305
NateraOncology,2020-04-27 17:06,1,3,"What do you miss most about an in-person annual # AACR20 meeting?",,,#,"1254879530910486528",https://twitter.com/NateraOncology/status/1254879530910486528
ivybelkins,2020-04-27 17:05,2,6,"@ GiorgiaFoggetti @ YaleCancer presents on genetic determinants of # EGFR driven # lungcancer & therapeutic response. Decreased response to TKI therapy due to alterations in tumor suppressor genes such as Keap1 # AACR20 # lcsm @ EGFRResisterspic.twitter.com/dnxEFvNTlw",,@ @ @,# # # #,"1254879419304480771",https://twitter.com/ivybelkins/status/1254879419304480771
LUNGevity,2020-04-27 17:05,8,14,"Fantastic presentation discussing how co-occurring mutations in mouse models of EGFR-mutant lung cancer affect response to treatment. Such a great example of "bench to bedside". @ GiorgiaFoggetti @ politikaterina @ Yale # AACR2020 # AACR20 # LCSMpic.twitter.com/A888kgFUmZ",,@ @ @,# # #,"1254879410882252802",https://twitter.com/LUNGevity/status/1254879410882252802
Martha__Carlson,2020-04-27 17:05,0,1,"100% the framing is everything. Do you think they did a good job avoiding that trap? (I'm not ER+ and I haven't seen it applied to HER2+ but I just feel better when I restrict eating hours.)",,,,"1254879401206046721",https://twitter.com/Martha__Carlson/status/1254879401206046721
LizCancerHealth,2020-04-27 17:05,2,3,"Meriem Messaoudene asks us not to post slides, but it looks like a polyphenol prebiotic may improve gut # microbiome diversity & improve checkpoint inhibitor response -- at least in mice. # AACR20",,,# #,"1254879314664804352",https://twitter.com/LizCancerHealth/status/1254879314664804352
SandraOrtizCua,2020-04-27 17:05,1,11,"Beautiful work from @ GiorgiaFoggetti ( @ politikaterina Lab) on the impact on co-occuring mutations in TSG in EGFR-mutant lung adenocarcinoma. KEAP1 inactivation limits response to osimertinib @ AACR # AACR2020 # LCSMpic.twitter.com/N0kzS2dODp",,@ @ @,# #,"1254879307702337537",https://twitter.com/SandraOrtizCua/status/1254879307702337537
cancerassassin1,2020-04-27 17:03,1,1,"# AACR20 # ImmunoOnchttps://twitter.com/cancerassassin1/status/1254878825730715660 …",,,# #,"1254878980840337412",https://twitter.com/cancerassassin1/status/1254878980840337412
marinagarassino,2020-04-27 17:03,0,0,"Thanks @ smartshavit",,@,,"1254878752649158657",https://twitter.com/marinagarassino/status/1254878752649158657
FellowsHsl,2020-04-27 17:02,2,16,"Facing previous data suggesting imunorresistance, this small exploratory analysis of KN042 exhibits IO monotherapy benefit for PDL1 > 1% patients regardless of STK11/KEAP1 status. Nevertheless it seems insufficient to encourage mono IO as 1L for STK11/KEAP1 mut NSCLC. # AACR20 pic.twitter.com/QviVJqAId1",,,#,"1254878651646119938",https://twitter.com/FellowsHsl/status/1254878651646119938
APassaroMD,2020-04-27 17:02,16,43,"# AACR20 # LCSM # EGFR Disappointing results of # Poziotinib in 2L+ EGFR Exon20ins (n=115) by @ LeXiuning ORR: 15% | mPFS: 4.2 m TRAEs ≥ 3: 63% (72/114) w/ 68% dose-reduction! Toxic profile w/ limited activity for being a good TKI. What to expect from Ph3? Not much else # OncoAlertpic.twitter.com/ihvbaL7gZU",,@,# # # # #,"1254878641340776448",https://twitter.com/APassaroMD/status/1254878641340776448
Jbauml,2020-04-27 17:01,10,18,"The authors found that the genes with differential impact on EGFR and KRAS also had a differential incidence as a comutated gene # LCSM # AACR20 pic.twitter.com/1X5y39eXHu",,,# #,"1254878258224644096",https://twitter.com/Jbauml/status/1254878258224644096
LauraSipe3,2020-04-27 17:00,0,10,"Attending # AACR2020 from a hammock this year. pic.twitter.com/8SLCSJKVJb",,,#,"1254878215983767554",https://twitter.com/LauraSipe3/status/1254878215983767554
ErikaHamilton9,2020-04-27 17:00,7,22,"Find the data regarding the 12/44 TNBC that we’re previous ER+ particularly fascinating. Small #, but 50% ORR and 6 mo DCR 50%. What is it about these “converters” that make them immunologically receptive when ER+ pts are normally less responsive to immuno? # AACR20 @ OncoAlerthttps://twitter.com/jesusanampa/status/1254850529517281281 …",,@,# #,"1254878183779950595",https://twitter.com/ErikaHamilton9/status/1254878183779950595
ChristianRolfo,2020-04-27 17:00,4,8,"Congrats to @ marinagarassino and @ HornLeora for leading this great registry open worldwide. Data presented tomorrow at clinical plenary # AACR2020 . @ lcsmchat @ OncoAlertpic.twitter.com/23omL3E9Jj",,@ @ @ @,#,"1254878061536915460",https://twitter.com/ChristianRolfo/status/1254878061536915460
HemOncToday,2020-04-27 17:00,2,1,"Addition of atezolizumab to cobimetinib and vemurafenib extends PFS in BRAF V600-mutant advanced melanoma http://bit.ly/3aFBqwz # AACR20 @ genentech",,@,#,"1254877983199973376",https://twitter.com/HemOncToday/status/1254877983199973376
OncologyCentral,2020-04-27 17:00,0,1,"The addition of the # immunotherapy, # atezolizumab, to a combination of targeted therapies has suggested improved progression-free survival for # melanoma patients. Keep up-to-date with the latest # AACR20 news on @ OncologyCentral",,@,# # # #,"1254877982578978820",https://twitter.com/OncologyCentral/status/1254877982578978820
Jbauml,2020-04-27 16:59,2,5,"In a mouse model, this group found that co-mutation was associated with differential tumor growth rate. The effect of these genes on growth seemed to differ a bit between KRAS and EGFR # LCSM # AACR20 pic.twitter.com/NoWNKaJQ69",,,# #,"1254877859157553153",https://twitter.com/Jbauml/status/1254877859157553153
YaleCancer,2020-04-27 16:58,5,22,". @ GiorgiaFoggetti presented research results with @ PolitiKaterina at # AACR20 showing tumor suppressor gene inactivation can influence growth and treatment response in # EGFR-driven # lungcancer. @ SmilowCancer @ YalePathology @ YaleMed @ YNHH # oncoalert https://www.abstractsonline.com/pp8/#!/9045/presentation/10576 …pic.twitter.com/oYTH9aAzkd",,@ @ @ @ @ @,# # # # #,"1254877638449127424",https://twitter.com/YaleCancer/status/1254877638449127424
CharuAggarwalMD,2020-04-27 16:58,5,12,"# Targeted # Immunotherapy In addition, we present data on a DNA therapeutic vaccine for # HPV6 associated lesions @ AACR # AACR20 CT126 - A synthetic DNA plasmid encoding HPV6 E6 and E7 proteins in patients with HPV6-associated aerodigestive lesions https://bit.ly/2yRqO0I https://twitter.com/CharuAggarwalMD/status/1254820241215021056 …",,@,# # # #,"1254877548510474240",https://twitter.com/CharuAggarwalMD/status/1254877548510474240
Brnda27,2020-04-27 16:57,0,4,"First of many # AACR20.",,,#,"1254877456957407234",https://twitter.com/Brnda27/status/1254877456957407234
changermindset,2020-04-27 16:57,0,1,"Yeah. I am planning on it. I was listening to that last segment -you were mentioning- as well -and it made me grimace too. Tho, I use intermittent fasting, low carb nutrition & I notice that it reduces my bone pain dramatically. Still, I hate the framing of “obesity” & cancer.",,,,"1254877451114725377",https://twitter.com/changermindset/status/1254877451114725377
Lin_ling_88,2020-04-27 16:56,0,11,"$ APTO: as I “hinted” last night when it’s # AACR20 Abstract first hit the ground, investors may have expcted some mention of “reduction of tumor load” by GC’806 in the highly elaborated dose escalation studies...but no, APTO is saving it for another day. Thus the 10% haircut today",,,#,"1254877142812430337",https://twitter.com/Lin_ling_88/status/1254877142812430337
oncologypharm,2020-04-27 16:56,2,7,"Capmatinib intracranial activity in MET exon14 skipping NSCLC shows 54% intracranial response # AACR20 # LCSMpic.twitter.com/xDdxato65N",,,# #,"1254876992882663424",https://twitter.com/oncologypharm/status/1254876992882663424
Jbauml,2020-04-27 16:55,4,6,"We know that comutations can occur with EGFR mutation in NSCLC, but the effect of these mutations on outcomes has been inconsistent in retrospective series # AACR20 # LCSMpic.twitter.com/10D8EdyJQq",,,# #,"1254876931587178504",https://twitter.com/Jbauml/status/1254876931587178504
lgreco_ny,2020-04-27 16:54,2,12,"We are in DESPERATE need of better treatments. I've known personally three lung cancer patients who have died in the past couple of weeks. And the # AACR20 thinks THIS presentation merits highlighting in LUNG cancer. # lcsm",,,# #,"1254876640619921408",https://twitter.com/lgreco_ny/status/1254876640619921408
TristanFreefsg,2020-04-27 16:53,1,1,"Check out the session currently streaming on the @ AACR Project GENIE: An International pan-cancer registry with over 79000 tumour samples! go to AACR Virtual Anual Meeting now to watch:https://aacr20.onlineeventpro.freeman.com/",,@,,"1254876426790154244",https://twitter.com/TristanFreefsg/status/1254876426790154244
LUNGevity,2020-04-27 16:53,3,13,"Surprised to see that we still consider lung cancer "preventable". This perpetuates the bias and stigma associated with lung cancer. # AACR2020 # AACR20 # LCSMhttps://twitter.com/lgreco_ny/status/1254873486180352000 …",,,# # #,"1254876381802004487",https://twitter.com/LUNGevity/status/1254876381802004487
Jbauml,2020-04-27 16:53,2,8,"In the @ AACR GENIE session at # AACR20, @ GiorgiaFoggetti is giving a presentation about a critical question - what genetic factors affect outcomes for patients with EGFR mutant NSCLC. We thought this was a homogenous disease, but we know outcomes can be disparate. # LCSM",,@ @,# #,"1254876280262144007",https://twitter.com/Jbauml/status/1254876280262144007
Martha__Carlson,2020-04-27 16:52,0,1,"It's tomorrow, as well though I haven't looked at schedule. Glad you were able to listen",,,,"1254876074774855685",https://twitter.com/Martha__Carlson/status/1254876074774855685
Martha__Carlson,2020-04-27 16:51,0,9,"2. However, they did a good job of avoiding words that blame. People with breast cancer want to do what they can to get rid of it (see mastectomies, loss of sex drive, joint pain), so saying diet could support treatment outcomes is better than using words like "prevent". # AACR20",,,#,"1254875918612475904",https://twitter.com/Martha__Carlson/status/1254875918612475904
Martha__Carlson,2020-04-27 16:51,0,20,"1. If you live with # cancer, but especially breast cancer imo, is can seem as though you are to blame for this cancer if you are judged to be obese or even overweight (like a significant cancer-free % of the US population) so seeing diet promoted at # AACR2020 had me grimacing",,,# #,"1254875917714960384",https://twitter.com/Martha__Carlson/status/1254875917714960384
ChristianRolfo,2020-04-27 16:50,13,23,"Check the trial in progress we present today at # AACR2020 CT267 - A phase 1b/2, open-label study of bintrafusp alfa with chemotherapy in patients with stage IV NSCLC. A new dual inhibitor TGF-B/PDL1 @ barlesi @ HornLeora # LCSM @ OncoAlert @ AACR pic.twitter.com/7lnMcHkyji",,@ @ @ @,# #,"1254875514059268097",https://twitter.com/ChristianRolfo/status/1254875514059268097
AACR,2020-04-27 16:50,11,43,"# AACR20 Don’t miss the three sessions today and tomorrow: Novel Drugs on the Horizon Part 1-3. These sessions will feature the first disclosure of new small molecules and biologics that recently entered phase I clinical trials. https://bit.ly/2yNdE4M",,,#,"1254875482845327363",https://twitter.com/AACR/status/1254875482845327363
christeeny513,2020-04-27 16:49,3,12,"I completely agree! And as a # patient- we can’t always travel, we can’t always afford it. Is this the wave of the future? # covidmusings # bcsm # aacr20 https://twitter.com/DrXinliLiu/status/1254873633450790914 …",,,# # # #,"1254875306395082752",https://twitter.com/christeeny513/status/1254875306395082752
Alfdoc2,2020-04-27 16:48,0,0,"Very disappointing",,,,"1254875125985562625",https://twitter.com/Alfdoc2/status/1254875125985562625
Tony_Calles,2020-04-27 16:47,4,5,"@ DrJNaidoo discussing immune-related pneumonitis in NSCLC # AACR20 @ AACR @ OncoAlert # OncoAlert # LCSMpic.twitter.com/EbqDG9UAZh",,@ @ @,# # #,"1254874803112161284",https://twitter.com/Tony_Calles/status/1254874803112161284
kurzsolutions,2020-04-27 16:46,0,0,"AACR 2020 preview – no Tigit, but plenty of novel mechanisms https://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-preview-no-tigit-plenty-novel-mechanisms … # aacr20",,,#,"1254874647700688897",https://twitter.com/kurzsolutions/status/1254874647700688897
ErikaHamilton9,2020-04-27 16:45,3,10,"This is very important information clinically for our patients with a history of # pneumonitis. 16% recurrence rate. # AACR20 # immunotherapyhttps://twitter.com/Jbauml/status/1254866452110127106 …",,,# # #,"1254874366862655496",https://twitter.com/ErikaHamilton9/status/1254874366862655496
lgreco_ny,2020-04-27 16:45,5,27,"There is NO place for this tobacco presentation in the LUNG cancer plenary session. Tobacco use raises cancer risk for more than 12 cancers. Once again, # stigma # AACR20 # aacr # lcsm",,,# # # #,"1254874210582908930",https://twitter.com/lgreco_ny/status/1254874210582908930
AriellaHanker,2020-04-27 16:43,0,2,"Cool high throughput approach presented by Gabi Tarcic to determine the functionality of non hotspot mutations in # oncogenes and response of each mutant to inhibitors, here applied to # BRAF. Would love to see the results on # HER2 mutations! # AACR20 pic.twitter.com/u0hz5a9Gcf",,,# # # #,"1254873950884171777",https://twitter.com/AriellaHanker/status/1254873950884171777
changermindset,2020-04-27 16:43,0,1,"This was great @ Martha__Carlson ! Thank you again for alerting me to it. I listened to 5hrs worth but there were no breaks-so I had to sign off... I am hoping the @ AACR will make the recordings available for awhile.",,@ @,,"1254873846806700032",https://twitter.com/changermindset/status/1254873846806700032
Syndax,2020-04-27 16:43,2,2,"Via @ FierceBiotech, CEO Briggs Morrison's interview with @ amirahalidrus on the SNDX-5316 data presented today during the New Drugs on the Horizon session at # AACR20 https://www.fiercebiotech.com/biotech/aacr-early-syndax-data-broach-undruggable-leukemia-mutation …",,@ @,#,"1254873794226933761",https://twitter.com/Syndax/status/1254873794226933761
EnvRhet,2020-04-27 16:43,1,3,"Is there any basis for using LB to anticipate disease progression and restart/change treatment in metastatic pts who are NED?",,,,"1254873780226154496",https://twitter.com/EnvRhet/status/1254873780226154496
DrXinliLiu,2020-04-27 16:42,0,8,"Really appreciate @ AACR has converted 2020 annual cancer meeting to the virtual meeting format! Great programming and exciting new discovery # AACR2020! Enjoying the day 1 meeting and having my 5 year old as companion https://twitter.com/AACR/status/1254862918878769152 …pic.twitter.com/3FEjKGLkpZ",,@,#,"1254873633450790914",https://twitter.com/DrXinliLiu/status/1254873633450790914
graymattersorg,2020-04-27 16:42,0,0,"Thinking of you today listening to # AACR20",,,#,"1254873614559490052",https://twitter.com/graymattersorg/status/1254873614559490052
lgreco_ny,2020-04-27 16:42,15,79,"Unbelievably unacceptable presentation going on by @ cityofhope. Lung cancer is preventable? Tell that to @ VirginiaMByrne (dead- no risk factors). Or tell it to me (neversmoker) # aacr20, you can do better. # lcsmpic.twitter.com/13lloILxmU",,@ @,# #,"1254873486180352000",https://twitter.com/lgreco_ny/status/1254873486180352000
CellPressNews,2020-04-27 16:40,1,1,"Read @ TrendsinPharma "Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy" by Liu and Zheng - https://bit.ly/3eVCsbk - # CellPressOncology # AACR20",,@,# #,"1254872966015463431",https://twitter.com/CellPressNews/status/1254872966015463431
curePCTina,2020-04-27 16:39,0,6,"It’s been awhile Twitter world, but I’m back! Had some kids, focused on the career and now I’m back to share science Really enjoyed the virtual # AACR2020 today! First time my feet didn’t hurt at the end of day 1 https://twitter.com/AACR/status/1254762685423587328 …",,,#,"1254872891168108546",https://twitter.com/curePCTina/status/1254872891168108546
HartungIngo,2020-04-27 16:39,1,10,"Looking forward to the highlight of day 1 of virtual # AACR20: New Drugs on the Horizon Part 1! Featuring many former colleagues & collaborators @ BayerPharma & @ broadinstitute: https://aacr20.onlineeventpro.freeman.com/sessions/15335384/New-Drugs-on-the-Horizon-Part-1 …pic.twitter.com/ufokmnfovt",,@ @,#,"1254872791914033157",https://twitter.com/HartungIngo/status/1254872791914033157
HemOncToday,2020-04-27 16:39,1,0,"COM701 shows antitumor activity in advanced solid tumors http://bit.ly/3cTfdNk # AACR20 @ CompugenIncpic.twitter.com/UCdViRiBAV",,@,#,"1254872697735016448",https://twitter.com/HemOncToday/status/1254872697735016448
graymattersorg,2020-04-27 16:38,0,2,"Participating Virtually # AACR20 Good Iinformation being talked about # lungcancer",,,# #,"1254872461146943488",https://twitter.com/graymattersorg/status/1254872461146943488
KhannousOlfat,2020-04-27 16:35,0,0,"One of the take-home messages of # AACR Project GENIE's talk: "Phenomic data such as tumor type, histology and demographics can augment the value of genomic data" @ AACR",,@,#,"1254871720168689667",https://twitter.com/KhannousOlfat/status/1254871720168689667
OncoAlert,2020-04-27 16:34,19,35,"Thank you @ AACR , an Amazing Part of # AACR20 and thank you for making registration freeSuch details eliminates the economic issues many colleagues face in their countries & makes it available to ALL, VERY well done https://twitter.com/weoncologists/status/1254865440628600832 …",,@,#,"1254871556909662212",https://twitter.com/OncoAlert/status/1254871556909662212
LUNGevity,2020-04-27 16:33,2,7,"Identifying new drugs that block non-V600E/K BRAF mutations in different cancers - Gabi Taric from NovellusDx # AACR2020 # LCSMpic.twitter.com/49spfW55lY",,,# #,"1254871399279341568",https://twitter.com/LUNGevity/status/1254871399279341568
thenasheffect,2020-04-27 16:32,1,4,"getting a bit tough concentrating on the presentations now ;)",,,,"1254870941437440001",https://twitter.com/thenasheffect/status/1254870941437440001
DrR_DUNNE,2020-04-27 16:31,1,3,"LOVE to see this study in action but Let me fix the tweet you quoted : RR of 2nd line FOLFIRI/Bev is 26% and 1 of 8 in this study had partial response at 8 weeks, 3 of 8 at 24 weeks. # AACR20 https://www.ncbi.nlm.nih.gov/books/NBK164635/ …",,,#,"1254870860680355843",https://twitter.com/DrR_DUNNE/status/1254870860680355843
JenniferCKing,2020-04-27 16:30,39,213,"Kind of upset that a talk in the # AACR20 # lungcancer plenary started with “lung cancer is deadly, yet preventable.” I know many never-smokers with lung cancer (and no one deserves this disease!) # EndtheStigma",,,# # #,"1254870518118912000",https://twitter.com/JenniferCKing/status/1254870518118912000
ChilesResearch,2020-04-27 16:30,0,1,"Abstracts are live at the @ AACR Virtual Annual Meeting, including one co-authored by @ RachelSanbornMD. "Interim results from CLASSICAL-Lung, phase 1b/2 study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC." http://ow.ly/xCxK50zpYxL # AACR20 pic.twitter.com/sBURQQZLIn",,@ @,#,"1254870492571488258",https://twitter.com/ChilesResearch/status/1254870492571488258
CD_AACR,2020-04-27 16:30,5,6,"ICYMI: New! Read the Precision Oncology article collection just released for # AACR20 Virtual Annual Meeting I! https://bit.ly/2W3bEx9 pic.twitter.com/BOzU8lTdeP",,,#,"1254870465530736641",https://twitter.com/CD_AACR/status/1254870465530736641
KyleighMrf,2020-04-27 16:28,3,13,"Two # melanoma sessions presented at virtual @ AACR on BRAF mutant melanoma and # targetedtherapy # immunotherapy. Learn more about current approved # treatment optionshttps://melanoma.org/patients-caregivers/cutaneous-melanoma/treatment-cutaneous/ …",,@,# # # #,"1254870007974178817",https://twitter.com/KyleighMrf/status/1254870007974178817
nima_genome,2020-04-27 16:27,0,4,"Interesting talk from @ FDAOncology Dr. Qi Liu @ Qi61685034, using # RWD from @ Syapse RWD comparably (under)estimates drug pneumonitis incidence in NSCLC patients receiving ICI and chemo Prior medical history of pneumonitis increases incidence by roughly 4-fold # AACR20 # AACR2020 pic.twitter.com/6xt38nRxf5",,@ @ @,# # #,"1254869895780511746",https://twitter.com/nima_genome/status/1254869895780511746
cancerassassin1,2020-04-27 16:25,8,30,"The # AACR20 "WHAT??!!" Fact of the Day: "There are over 500 unique mutations in BRAF, most of which have not been studied." And no drugs targeting non-V600E variants. Learning a lot during the @ AACR Project Genie portion of today's program (Channel 3) https://www.aacr.org/professionals/research/aacr-project-genie/ …pic.twitter.com/OgPkPWSpS4",,@,#,"1254869294007177217",https://twitter.com/cancerassassin1/status/1254869294007177217
jillfeldman4,2020-04-27 16:23,3,5,"@ FDAOncology Dr Liu presents data on pneumonitis in clinical trials & real world data # RWD. While incidence is comparable, there were limitations such as small #in RWD cohort & data from 1 health system. Next steps include continued studies # LCSM # AACR20 pic.twitter.com/OSMnTahK7P",,@,# #in # #,"1254868768020475911",https://twitter.com/jillfeldman4/status/1254868768020475911
weoncologists,2020-04-27 16:23,7,19,"Live # AACR20 Study from @ MDAndersonNews Shows how Taking Naproxendaily may reduce the risk of developing # Colorectalcancer in people with # lynchSyndrome @ OncoAlert # CRChttps://twitter.com/MDAndersonNews/status/1254865152442130432 …",,@ @,# # # #,"1254868720150892549",https://twitter.com/weoncologists/status/1254868720150892549
pashtoonkasi,2020-04-27 16:20,0,11,"Who else is # fasting today? # AACR20 # Cancer # Dietpic.twitter.com/KySztQd3H4",,,# # # #,"1254868044704292867",https://twitter.com/pashtoonkasi/status/1254868044704292867
UCCancerCenter,2020-04-27 16:19,1,2,"Encouraging phase I dose-escalation with novel therapy targeting FR overexpression in chemo-resistant Ovarian Cancer shows clinical benefit # AACR20 @ UCCancerCenter led by Dr. John Moroney # OCSM # AnswerCancer Abstract CT125 https://www.abstractsonline.com/pp8/#!/9045/presentation/10624 …pic.twitter.com/oNV7tSfuxs",,@,# # # #,"1254867908976455680",https://twitter.com/UCCancerCenter/status/1254867908976455680
LUNGevity,2020-04-27 16:18,9,12,"Analysis of real-world lung cancer data demonstrates feasibility of Project GENIE. However, we need to be cautious when using real-world data. Data quality & analysis models determinant of success. @ RielyMD @ MSKCC_OncoNotes # AACR20 # LCSM.pic.twitter.com/mVCws9ak9A",,@ @,# #,"1254867563260948482",https://twitter.com/LUNGevity/status/1254867563260948482
BrasilOncologia,2020-04-27 16:18,1,2,"Os resultados foram apresentados em uma das primeiras plenárias do @ AACR 2020 e demonstraram que o tratamento combinado foi seguro e bem tolerado, apresentando taxa de resposta global de 42,3%. Saiba mais: https://bit.ly/2Yb6qCj # AACR2020 # cancer # cervicalcancerpic.twitter.com/RErEhfa4md",,@,# # #,"1254867546555195397",https://twitter.com/BrasilOncologia/status/1254867546555195397
LizCancerHealth,2020-04-27 16:17,1,3,". @ MarcusDGon: fast-like diets may stress tumors & make them more susceptible to therapy; can tailor diet to deprive tumors of what they rely on most. # AACR20 # AACR2020",,@,# #,"1254867294057934851",https://twitter.com/LizCancerHealth/status/1254867294057934851
NateraOncology,2020-04-27 16:17,1,12,"Natera is excited to tune in to the first ever # AACR20 virtual meeting! Although we are not together in person, we are united by our commitment to improving cancer care through research and innovation. http://natera.com/oncology pic.twitter.com/QxYvZXxokc",,,#,"1254867293923729408",https://twitter.com/NateraOncology/status/1254867293923729408
HemOncToday,2020-04-27 16:17,2,3,"Addition of atezolizumab to enzalutamide fails to extend OS in metastatic castration-resistant prostate cancer http://bit.ly/2SeUawF # AACR20 # Tecentriq @ genentechpic.twitter.com/n6qSe9AamP",,@,# #,"1254867161446785031",https://twitter.com/HemOncToday/status/1254867161446785031
pashtoonkasi,2020-04-27 16:15,2,2,"# AACR20 # CRCSM # LynchSyndromehttps://twitter.com/evilarsan/status/1254866089865031681 …",,,# # #,"1254866737113133057",https://twitter.com/pashtoonkasi/status/1254866737113133057
Lampgen_CR,2020-04-27 16:15,1,2,"# AACR20 roundup: Tecentriq/Xtandi combo fails to show OS benefit, halting Roche’s PD-L1 push into prostate cancer – Endpoints News http://ow.ly/3DpH30qBdmH",,,#,"1254866693383286784",https://twitter.com/Lampgen_CR/status/1254866693383286784
DMSLung,2020-04-27 16:15,5,12,"# AACR20 # LCSM @ Oncoalert Pneumonitis incidence in patients with NSCLC treated with IO or CT in clinical trials and RWD.pic.twitter.com/qBcK2zL5aD",,@,# #,"1254866681391800321",https://twitter.com/DMSLung/status/1254866681391800321
Jbauml,2020-04-27 16:14,6,20,"I find this slide reassuring as well. Only 14-17% of patients with a prior history of pneumonitis developed recurrent pneumonitis while on checkpoint inhibitors. # LCSM # AACR20 pic.twitter.com/eS9qiSsTsG",,,# #,"1254866452110127106",https://twitter.com/Jbauml/status/1254866452110127106
pashtoonkasi,2020-04-27 16:13,1,5,"# AACR20 very interesting classification of # diets # fasting regimens. # Cancer # Dietpic.twitter.com/T422NCFRGC",,,# # # # #,"1254866395202027520",https://twitter.com/pashtoonkasi/status/1254866395202027520
LUNGevity,2020-04-27 16:13,5,6,"AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) creating comprehensive repository of real-world pancancer patient data. @ RielyMD @ MSKCC_OncoNotes # AACR2020 # LCSMpic.twitter.com/hxd3rjrzDY",,@ @,# #,"1254866340256477184",https://twitter.com/LUNGevity/status/1254866340256477184
RDavis_PhD,2020-04-27 16:13,2,4,"The first of three # AACR20 "New Drugs on the Horizon" panels begins soon at 4:50 (Eastern) on myAACR. While you enjoy the panel, check out our first two First Disclosure articles in the April edition! https://mct.aacrjournals.org/disclosures pic.twitter.com/mbQMED00sq",,,#,"1254866154604105730",https://twitter.com/RDavis_PhD/status/1254866154604105730
evilarsan,2020-04-27 16:12,8,38,"The results of our Naproxen in # LynchSyndrome Phase I clinical trial presented today at # AACR20 @ AACR Naproxen induced activation of resident immune cells in the normal colorectal mucosa # immuneinterception https://twitter.com/MDAndersonNews/status/1254865152442130432 …",,@,# # #,"1254866089865031681",https://twitter.com/evilarsan/status/1254866089865031681
Jbauml,2020-04-27 16:12,3,9,"Similar incidence of pneumonitis in clinical trials and in real world data. This is reassuring - the tox profiles seen in the trials can sometimes not be representative of the real world given a lower incidence of medical comorbidity. # LCSM # AACR20 pic.twitter.com/DSsGmQdljt",,,# #,"1254865931181764614",https://twitter.com/Jbauml/status/1254865931181764614
LizCancerHealth,2020-04-27 16:11,1,5,". @ MarcusDGon: "Fasting" isn't just one thing. # AACR20 # AACR2020 pic.twitter.com/HACGAvG5Br",,@,# #,"1254865886214668288",https://twitter.com/LizCancerHealth/status/1254865886214668288
DrSarcoma,2020-04-27 16:11,0,7,"Bravo!!! # AACR20 pic.twitter.com/GpM5AMfbdu",,,#,"1254865782858592259",https://twitter.com/DrSarcoma/status/1254865782858592259
asmaakenawy,2020-04-27 16:11,0,15,"While fasting # Ramadan .. it is always cool to attend a virtual talk about the Benefits of fasting # AACR20 :) pic.twitter.com/DiChoMoPAl",,,# #,"1254865676474265604",https://twitter.com/asmaakenawy/status/1254865676474265604
weoncologists,2020-04-27 16:10,20,62,"An amazing job with this Virtual # AACR20 , Kudos Thank you very much to all the hard working people at @ AACR for making this possibleWay to set the bar Best from @ weoncologists & all of us at @ OncoAlert pic.twitter.com/R5MDUSCIQ9",,@ @ @,#,"1254865440628600832",https://twitter.com/weoncologists/status/1254865440628600832
Syndax,2020-04-27 16:10,3,6,"Syndax announces positive preclinical profile and initial phase 1 data for the Menin inhibitor SNDX-5613 in adults with relapsed or refractory acute leukemias. # leukemia # AACR20 https://bit.ly/2W38BoH pic.twitter.com/g51o4AXVUq",,,# #,"1254865438598508544",https://twitter.com/Syndax/status/1254865438598508544
OncLive,2020-04-27 16:09,2,2,"Continuous Dabrafenib/Trametinib Dosing Improves PFS in BRAF+ Melanoma @ UCSF # AACR20 # melsmhttp://ow.ly/tM6w50zpZTg",,@,# #,"1254865168514727936",https://twitter.com/OncLive/status/1254865168514727936
MDAndersonNews,2020-04-27 16:09,23,45,"People with # LynchSyndrome are more likely to develop # colorectalcancer. But, a study led by our @ evilarsan shows taking naproxen daily may reduce that risk: https://bit.ly/2zy8Xfn # AACR20 # endcancer",,@,# # # #,"1254865152442130432",https://twitter.com/MDAndersonNews/status/1254865152442130432
UmutDisel,2020-04-27 16:08,2,6,"Upfront NGS should standard for all NSCLC patients - we need discuss further- Big Q Tissue only, Tissue + ctDNa or liquid only? @ AACR # AACR2020 # AACR20 @ christine_lovly @ JackWestMD @ AACRPres @ peters_solange @ TonyMok9 @ StephenVLiu",,@ @ @ @ @ @ @,# #,"1254865122515775488",https://twitter.com/UmutDisel/status/1254865122515775488
Jbauml,2020-04-27 16:06,3,7,"Dr Liu from the @ FDAOncology now presents data on IO induced pneumonitis, derived clinical trial and real world evidence # AACR20 # LCSM",,@,# #,"1254864527423713283",https://twitter.com/Jbauml/status/1254864527423713283
ajf324MD,2020-04-27 16:05,0,3,"Living-room tumor board: interested in opinions of thoracic gurus ‘at’ # AACR2020: treatment naïve adenoCa w/ nonnoncanonical activating EGFR R776H (exon 20 mt) and BRAF G469A MT (cont below) @ LeciaSequist @ StephenVLiu @ n8pennell @ JackWestMD @ HornLeora",,@ @ @ @ @,#,"1254864246510424065",https://twitter.com/ajf324MD/status/1254864246510424065
jillfeldman4,2020-04-27 16:05,3,17,"Dr Skoulidis discusses need for more studies on STK11-KEAP1 in # NSCLC. “Preferred choice for this patient population with an unmet need is science-driven 1st-line # clinicaltrials # LCSM # AACR20 pic.twitter.com/jAn1nAjE5J",,,# # # #,"1254864181968334848",https://twitter.com/jillfeldman4/status/1254864181968334848
LizCancerHealth,2020-04-27 16:03,4,7,". @ MarcusDGon on precision nutrition for # breastcancer. Dietary fats & sugars can both directly feed tumors & cause obesity, which leads to inflammation & enhances tumor growth. # AACR20 # AACR2020 # bcsmpic.twitter.com/uOORyYCehR",,@,# # # #,"1254863833723580417",https://twitter.com/LizCancerHealth/status/1254863833723580417
UCCancerCenter,2020-04-27 16:03,1,2,"Results of novel therapy for chemo-resistant ovarian and endometrial cancers presentented # AACR20. Dr. Gini Fleming led the @ UCCancerCenter trial of the multi-institutional effort. Abstract CT124 # AnswerCancer https://www.abstractsonline.com/pp8/#!/9045/presentation/10623 …",,@,# # #,"1254863762894532608",https://twitter.com/UCCancerCenter/status/1254863762894532608
pashtoonkasi,2020-04-27 16:01,2,7,"# AACR20 This metaanalysis @ BioMedCentral looked at previously published studies on # fasting and/or # diet restrictions augment tumor growth/metabolism. Many patients are doing this/asking about this.https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5931-7 …",,@,# # #,"1254863314036940800",https://twitter.com/pashtoonkasi/status/1254863314036940800
healthhashtags,2020-04-27 16:00,0,0,"New Health Hashtag # aacr2020 https://hcsm.io/2zBgTg1 @ AACR "AACR Annual Meeting 2020"",,@,#,"1254863022813622272",https://twitter.com/healthhashtags/status/1254863022813622272
JAMANetwork,2020-04-27 16:00,0,1,"Following the # AACR20 virtual meeting? Read Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma from @ JAMAOnc free online during the meeting https://ja.ma/2VsDDHv",,@,#,"1254862884384972801",https://twitter.com/JAMANetwork/status/1254862884384972801
AACR,2020-04-27 15:59,10,37,"We appreciate all the tweets! As a reminder, the official hashtag for the AACR Virtual Annual Meeting is # AACR20.",,,#,"1254862822183297025",https://twitter.com/AACR/status/1254862822183297025
tmprowell,2020-04-27 15:59,1,19,"# AACR20 If Dr. @ benhopark came back home to us at @ hopkinskimmel, he could make jokes like "I'm Dr. Ben Park, not Ben Park, Maryland." Just sayin'. We at @ JHbreastgyn miss you 'round these parts, friend. # bcsmhttps://twitter.com/JaniceTNBCmets/status/1254855638036828160 …",,@ @ @,# #,"1254862721780035587",https://twitter.com/tmprowell/status/1254862721780035587
UmutDisel,2020-04-27 15:59,0,3,"This case Adeno NSCLC FMIcdx report already came. Timing :) ARID1A plus KEAP1 co-mutation TMB 14 PDL-1 20%- any suggestions? @ AACR @ StephenVLiu @ christine_lovly @ JackWestMD @ TonyMok9 @ Dr_R_Kurzrock @ DrYukselUrunpic.twitter.com/jOsNIBAgxC",,@ @ @ @ @ @ @,,"1254862721616457730",https://twitter.com/UmutDisel/status/1254862721616457730
drteplinsky,2020-04-27 15:59,0,3,"Really fascinating data about fasting mimicking diet and endocrine therapy. Most data in mice and we need more research into this but I’m intrigued! # aacr20",,,#,"1254862640402202624",https://twitter.com/drteplinsky/status/1254862640402202624
WarOnCancer,2020-04-27 15:58,1,2,"Continuing good news for ICAN's exon 20 lung cancer pts today--Xiuning Le, MD, PhD, and Taofeek Owonikoko, MD, PhD gave excellent presentations on # poziotinib at # AACR20. Great session led by NSCLC expert @ RamalingamMD Proud that Suresh is an hon chair of ICAN's Exon 20 Group.",,@,# #,"1254862532046544896",https://twitter.com/WarOnCancer/status/1254862532046544896
RobertoFerrara_,2020-04-27 15:58,6,19,"Definitively different from what observed in clinical practice and previous studies. LkB1 mut alone probably not the best biomarker. . The immunometabolism beyond is the way. # AACR2020 pic.twitter.com/MiBZsx7alq",,,#,"1254862438446571520",https://twitter.com/RobertoFerrara_/status/1254862438446571520
jillfeldman4,2020-04-27 15:57,5,13,"Retrospective analysis of Keynote 189 combo of Pem + Plat Chemo + Pembro versus Pem + Plat Chemo in patients with # NSCLC showed increased survival with comparable & manageable side effects with minimal increased toxicity in the maintenance of Pembro. # LCSM # AACR20 pic.twitter.com/4gaKqt1SnU",,,# # #,"1254862210301480960",https://twitter.com/jillfeldman4/status/1254862210301480960
pauldriscoll33,2020-04-27 15:56,0,1,"And with us, backstage!!! # AACR20",,,#,"1254862048749477890",https://twitter.com/pauldriscoll33/status/1254862048749477890
LUNGevity,2020-04-27 15:56,1,6,"Science-driven clinical trials are a good option for 1st-line therapy for STK11-mutant or KEAP1-mutant metastatic NSCLC? Dr. Skoulidis @ MDAndersonNews # AACR2020 # LCSMpic.twitter.com/auhJu4pOYf",,@,# #,"1254861922651918336",https://twitter.com/LUNGevity/status/1254861922651918336
pashtoonkasi,2020-04-27 15:55,19,26,"# AACR20 interesting data being presented on a # fasting mimicking diet in # cancer animal models & patients. A questionthat often comes up in care of our cancer patients. effects on many aspects of metabolism. anti-cancer effects - interesting - hypotheses. # OncoAlertpic.twitter.com/6szW87WhsA",,,# # # #,"1254861873410985988",https://twitter.com/pashtoonkasi/status/1254861873410985988
BiodesixInc,2020-04-27 15:55,0,1,"# AACR20 kicks off this week. We're looking forward to a packed session with lots of great discussions. Especially excited for talks on targeted therapies. # precisiontherapy # personalizedmedicine # socialdistancing @ AACR",,@,# # # #,"1254861840930070528",https://twitter.com/BiodesixInc/status/1254861840930070528
LizCancerHealth,2020-04-27 15:55,7,12,"Only preliminary results so far, but interesting suggestion of benefits using a fasting-mimicking diet for people with # breastcancer. # AACR20 # AACR2020 # bcsmpic.twitter.com/nuMzDsSwA1",,,# # # #,"1254861649602686977",https://twitter.com/LizCancerHealth/status/1254861649602686977
HemOncToday,2020-04-27 15:54,3,1,"Durvalumab regimen improves pathologic complete response in HER2-negative breast cancer http://bit.ly/2xUvx1y @ AstraZenecaUS # AACR20 pic.twitter.com/tN2iqYDEGi",,@,#,"1254861506816045056",https://twitter.com/HemOncToday/status/1254861506816045056
Exon20Group,2020-04-27 15:53,4,9,"Continuing good news for EGFR exon 20 patients--two of our favorites, Xiuning Le, MD, PhD, and Taofeek Owonikoko, MD, PhD discussed insights on # poziotinib at # AACR20. Great session led by EGFR expert @ RamalingamMD Proud that Suresh is one of the honorary chairs at @ Exon20Group",,@ @,# #,"1254861314091958272",https://twitter.com/Exon20Group/status/1254861314091958272
LeciaSequist,2020-04-27 15:52,3,22,"Dr. Skoulidis w/nice discussion of Cho abstract: data on STK11 and KEAP1 is still early. Need many further studies to learn how to interpret these 2 in setting of co-mutations, IO biomarkers, etc. His preferred 1L choice: Chemo/IO or science-driven clinical trials # LCSM # AACR2020",,,# #,"1254861012437569536",https://twitter.com/LeciaSequist/status/1254861012437569536
krknrm,2020-04-27 15:52,1,9,"Great session # AACR20: "Drugging Undrugged Cancer Targets". BCAT1, PP2A, PTPN22, BCL10-MALT1 and many others - interesting connections with immunotherapies, intriguing non-cat functions and great discussion by @ johnslazo and Peter C. Lucas @ UPMC",,@ @,#,"1254860953633427457",https://twitter.com/krknrm/status/1254860953633427457
drleemachado,2020-04-27 15:50,0,2,"# AACR20 A focus on ABC # DLBCL targeting the CARMA1-BCL10- MALT-1 (CBM) signallasome. 3 million compounds screened to i.d two inhibitors of bcl10/MALT1 intxn. Tumour inhibition in xenograft model",,,# #,"1254860554549620737",https://twitter.com/drleemachado/status/1254860554549620737
YMAbdelhalim,2020-04-27 15:49,0,2,"Another interesting part of the talk!! Area of interest 2 (Cancer Metabolism) @ AACR # Metabolicreprogramming # FastingMimickingDiet # BreastCancerTherapy # AACR20 pic.twitter.com/LCguaeWX0P",,@,# # # #,"1254860282989391874",https://twitter.com/YMAbdelhalim/status/1254860282989391874
OncoAlert,2020-04-27 15:44,2,3,"Live # AACR20 Tweet by @ ryangentzler "New prospective data on outcomes with IO for # NSCLC based on STK11 and KEAP1 status. Certainly limitations with only subset with available NGS results. Some of my best IO responders have been 2 STK11-mut patients" # Lungcancer @ LCSM @ OncoAlerthttps://twitter.com/ryangentzler/status/1254854304873103363 …",,@ @ @,# # #,"1254859103840559104",https://twitter.com/OncoAlert/status/1254859103840559104
MarieWislez,2020-04-27 15:44,0,1,"ORR 15% little disappointing? Enjoy San Diego Denis ! # AACR2020 https://twitter.com/DMSLung/status/1254838218966605824 …",,,#,"1254859078561484800",https://twitter.com/MarieWislez/status/1254859078561484800
UmutDisel,2020-04-27 15:44,3,8,"Dr.Cho summarized Keynote42-Pembro still work regardless of STK11 and KEAP1 mut. So imp. Q answered. Need approval. How ARID1 A co-mutations? All STK11 and Keap1 mut tend higher TMB @ LeciaSequist @ AACR @ christine_lovly @ TonyMok9 @ JackWestMD @ peters_solange @ StephenVLiupic.twitter.com/D4x0VCUonX",,@ @ @ @ @ @ @,,"1254858930703876096",https://twitter.com/UmutDisel/status/1254858930703876096
chulkimMD,2020-04-27 15:43,5,10,"A post-hoc analysis of KEYNOTE-189. Most Gr 3 or higher AEs occurred during first 4 cycles. Limited tx discontinuation for AEs during maintenance. How much does pemetrexed maintenance contribute during maintenance? We need a randomized trial to answer this. # AACR20 @ OncoAlertpic.twitter.com/YwfLBCJ28Y",,@,#,"1254858804535021569",https://twitter.com/chulkimMD/status/1254858804535021569
Kamacintosh,2020-04-27 15:43,0,1,"# AACR2020",,,#,"1254858771370659840",https://twitter.com/Kamacintosh/status/1254858771370659840
JFreemanDaily,2020-04-27 15:42,5,11,"Is there an official definition of "durable" for # cancer # clinicaltrials? Heard one presentor claim 6 months respresents a durable response. # AACR20 # LCSM # AACR2020",,,# # # # #,"1254858553447165953",https://twitter.com/JFreemanDaily/status/1254858553447165953
LUNGevity,2020-04-27 15:42,7,8,"Great discussion by LUNGevity Dr. Eddie Garon @ UCLAJCCC on safety profile of KEYNOTE-189 combo (pembro-pem-platinum chemo) in retrospective analysis. Combo's toxicity profile comparable to chemo alone and manageable. # AACR20 # LCSMpic.twitter.com/ex7pqoMiBD",,@,# #,"1254858547403173892",https://twitter.com/LUNGevity/status/1254858547403173892
PTarantinoMD,2020-04-27 15:42,5,20,"Side note: it’s such a good feeling to see that any scientist with a PC, some free time and some curiosity can join a great Congress as # AACR20 regardless of geographical and financial issues Great job @ AACR !",,@,#,"1254858370323902465",https://twitter.com/PTarantinoMD/status/1254858370323902465
krknrm,2020-04-27 15:41,2,7,"Will be there (virtually, of course! :) ) - excited to see these results, don't miss them! # AACR20 # TERAVOLT # Covid19https://twitter.com/marinagarassino/status/1254857687415705601 …",,,# # #,"1254858281627062272",https://twitter.com/krknrm/status/1254858281627062272
LizCancerHealth,2020-04-27 15:41,3,4,"Meanwhile over at # AACR2020... (I've been following # AACR20 so far) https://twitter.com/udai_banerji/status/1254812370901307393 …",,,# #,"1254858186047098881",https://twitter.com/LizCancerHealth/status/1254858186047098881
NatureCancer,2020-04-27 15:39,12,25,"Check the recent publication @ NatureCancer by @ corsellos @ toddgolub1 on discovering the anticancer potential of non-oncology drugs - it's a must read! https://www.nature.com/articles/s43018-019-0018-6 … https://rdcu.be/b3OOs # AACR20 https://twitter.com/ronny_drapkin/status/1254856049598672896 …pic.twitter.com/y87gdeLIet",,@ @ @,#,"1254857745695518721",https://twitter.com/NatureCancer/status/1254857745695518721
drteplinsky,2020-04-27 15:39,0,5,"A good summary of the two presentations on ESR1 mutations and Imprime PGG in TNBC. # aacr20 pic.twitter.com/JXAzi4HAz6",,,#,"1254857740372963328",https://twitter.com/drteplinsky/status/1254857740372963328
marinagarassino,2020-04-27 15:39,15,36,"Tomorrow at # AACR2020 there will be the first release of # TERAVOLT on 200 patients with thoracic malignancies and COVID-19 @ OncoAlert @ myESMO @ HornLeora @ peters_solange @ HwakeleeMD @ barlesipic.twitter.com/34gOgBcIzM",,@ @ @ @ @ @,# #,"1254857687415705601",https://twitter.com/marinagarassino/status/1254857687415705601
Jasoncology,2020-04-27 15:38,0,1,"Continuous Dabrafenib/Trametinib Dosing Improves PFS in BRAF + Melanoma https://www.onclive.com/conference-coverage/aacr-2020/continuous-dabrafenibtrametinib-dosing-improves-pfs-in-braf-melanoma … # AACR20 # melsm",,,# #,"1254857405428412427",https://twitter.com/Jasoncology/status/1254857405428412427
DMSLung,2020-04-27 15:37,5,13,"# AACR2020 # OncoAlert Safety of Pem +Plat with Pembro post hoc analysis of KEYNOTE-189pic.twitter.com/Y7UlQdDdZu",,,# #,"1254857263329603584",https://twitter.com/DMSLung/status/1254857263329603584
marta_msalido,2020-04-27 15:36,0,7,"Virtual AACR meeting now. Nice!! # AACR2020 # breastcancerpic.twitter.com/JOsMoX1vKw",,,# #,"1254856902632189955",https://twitter.com/marta_msalido/status/1254856902632189955
joshgoldstein1,2020-04-27 15:35,1,4,"The official hashtag is # AACR20",,,#,"1254856639179485185",https://twitter.com/joshgoldstein1/status/1254856639179485185
YMAbdelhalim,2020-04-27 15:33,0,4,"Area (disease) of interest "TNBC" !! # AACR20 # BreastCancerTherapy # PrecisionMedicine # TranslationalResearchpic.twitter.com/izlufiaFhM",,,# # # #,"1254856333746036736",https://twitter.com/YMAbdelhalim/status/1254856333746036736
OncologyCentral,2020-04-27 15:33,0,0,"The data suggests that most adverse events occur within the first three months after treatment administration, and are resolved within two weeks after onset. Overall, this suggests that the toxicity caused by the above drug combination is manageable for long-term use # AACR20",,,#,"1254856323834904578",https://twitter.com/OncologyCentral/status/1254856323834904578
lymphomahub,2020-04-27 15:33,3,8,"CONGRESS | # AACR20 | Heejae Kang, @ PittTweet, talks about the discovery of small molecule inhibitors of BCL10-MALT1 interaction and the significance of these agents as a potential treatment for DLBCL # lymsmpic.twitter.com/Kc1EDYg3F1",,@,# #,"1254856225629454336",https://twitter.com/lymphomahub/status/1254856225629454336
Cortellis,2020-04-27 15:33,1,2,"Alligator Bioscience’s ATOR-1015 bispecific antibody targeting CTLA-4 and OX40 was well tolerated up to a dose of 400 mg in patients with advanced and/or refractory solid malignancies # AACR20",,,#,"1254856132805287936",https://twitter.com/Cortellis/status/1254856132805287936
StephenVLiu,2020-04-27 15:33,5,12,"# OncoAlert # AACR20 Adverse events included # VEGF-related tox. How does this apply in IMp133/CASPIAN world where IO is delivered with 1L therapy? I would welcome more novel agents for # SCLC, but hoping to see biomarker work from this trial and a follow up randomized effort. # LCSMpic.twitter.com/L0akfOuxBK",,,# # # # #,"1254856090820292611",https://twitter.com/StephenVLiu/status/1254856090820292611
weoncologists,2020-04-27 15:32,5,9,"Tomorrow Tuesday at # AACR20 phase 1 clinical trial of Iovance’s highly anticipated tumor-infiltrating lymphocyte product in # NSCLC # lungcancer will be discussed: “durable complete responses.” But just how durable?? # lcsm # oncoalert https://www.fiercebiotech.com/research/aacr-iovance-details-early-responses-to-til-cell-therapy-lung-cancer …",,,# # # # #,"1254856056729026560",https://twitter.com/weoncologists/status/1254856056729026560
ronny_drapkin,2020-04-27 15:32,3,12,"# AACR20 Great talk by @ corsellos from @ broadinstitute describing the Repurposing Hub - screening drugs already approved or in clinical development. 53% are not in the oncology space but many hits are emerging from within this subset for cancer treatment!",,@ @,#,"1254856049598672896",https://twitter.com/ronny_drapkin/status/1254856049598672896
JustinKlein1,2020-04-27 15:32,0,0,"Personal Genome Diagnostics Receives FDA Clearance for PGDx elio™ tissue complete, the First Comprehensive Genomic Profiling Diagnostic Kit for Oncology | @ PGDx_ @ johnshopkins # AACR2020 https://www.businesswire.com/news/home/20200427005738/en/Personal-Genome-Diagnostics-Receives-FDA-Clearance-PGDx#.XqcwNq2BBws.twitter …",,@ @,# #,"1254855995962134528",https://twitter.com/JustinKlein1/status/1254855995962134528
Alfdoc2,2020-04-27 15:32,0,2,"And mut groups are very small",,,,"1254855940257361929",https://twitter.com/Alfdoc2/status/1254855940257361929
JFreemanDaily,2020-04-27 15:31,1,9,"I see both # AACR20 and # AACR2020 in use for the @ AACR 2020 Annual Virtual Meeting. Would help to have the correct hashtag on the @ AACR cover slides and website for clarity. Guess we'll have to use both.",,@ @,# #,"1254855715224563716",https://twitter.com/JFreemanDaily/status/1254855715224563716
Ran_Barayan,2020-04-27 15:31,0,0,"Really interesting talk!",,,,"1254855617639878656",https://twitter.com/Ran_Barayan/status/1254855617639878656
AstraZeneca,2020-04-27 15:31,5,32,"Are all viruses bad? @ Mark_Cobbold, a scientist & VP Oncology Early Discovery, breaks down one of the most exciting areas of cancer research: viruses that are designed to infect and kill cancer cells. # SciencefromAtoZ # AACR20 pic.twitter.com/Q2Iix6vk6y",,@,# #,"1254855601244434432",https://twitter.com/AstraZeneca/status/1254855601244434432
FernandoOnco,2020-04-27 15:30,0,1,"Great # AACR20",,,#,"1254855508046962689",https://twitter.com/FernandoOnco/status/1254855508046962689
LeciaSequist,2020-04-27 15:30,0,3,"Good question about carbo/pem/pembro, but not able to be addressed b/c this was a subgroup analysis of only KN042 (no triplet included) # AACR2020",,,#,"1254855495786983424",https://twitter.com/LeciaSequist/status/1254855495786983424
StephenVLiu,2020-04-27 15:30,3,10,"# OncoAlert # AACR20 RR encouraging but hard to interpret single arm phase II. What is the contribution of apatinib? VEGFR2 + PD1 is an exciting combination but would we have seen the same results (but less tox) with camrelizumab alone? Need a comparator arm. # LCSM",,,# # #,"1254855494788771840",https://twitter.com/StephenVLiu/status/1254855494788771840
CCR_AACR,2020-04-27 15:30,0,0,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/3bKrjb8 pic.twitter.com/oOltIdzyaT",,@ @,#,"1254855364392054785",https://twitter.com/CCR_AACR/status/1254855364392054785
CellPressNews,2020-04-27 15:30,3,2,"Improve your understanding of the mechanisms underlying resistance to # Immunotherapy with the free Cell Press Selection. # CancerCell # AACR20 - https://bit.ly/2y3Rzii",,,# # #,"1254855350630543365",https://twitter.com/CellPressNews/status/1254855350630543365
smitha42,2020-04-27 15:30,2,7,"Kudos to AACR for virtual # AACR20. I enjoyed the # Immunotherapy # clinicaltrials session featuring studies targeting PVRIG and an HPV vaccine. Providing hope for increased immunotherapy trials for # Colorectalcancer and # Analcancer",,,# # # # #,"1254855336646684672",https://twitter.com/smitha42/status/1254855336646684672
RenoHemonc,2020-04-27 15:29,0,2,"KRAs co-mutation status important..",,,,"1254855301007720448",https://twitter.com/RenoHemonc/status/1254855301007720448
chulkimMD,2020-04-27 15:27,25,48,"STK11 and KEAP1 mutations in KEYNOTE-042. STK11 mutation a/w lower PD-L1 expression. Pembro a/w better outcomes compared with chemo, regardless of STK11 or KEAP1 mutation status. Very low ORR with chemo in STK11 mutation+ NSCLC. # AACR20 @ OncoAlertpic.twitter.com/Nqe7NetuCO",,@,#,"1254854697749368832",https://twitter.com/chulkimMD/status/1254854697749368832
LUNGevity,2020-04-27 15:27,2,5,"Pembro monotherapy better than chemo irrespective of STK11 and KEAP1 mutation status in exploratory KEYNOTE-042 data analysis. Interestingly, STK11 or KEAP1 mutant cancers respond poorly to chemo as compared to wild-type STK11 or KEAP1 cancers. # AACR20 # LCSMpic.twitter.com/8anTii6zYM",,,# #,"1254854688102428673",https://twitter.com/LUNGevity/status/1254854688102428673
StephenVLiu,2020-04-27 15:26,6,8,"# OncoAlert # AACR20 Camrelizumab plus apatinib qday had a RR of 34% including a 32.3% RR in chemo-resistant # SCLC. Encouraging activity. Median duration of response 6.2 months with many ongoing responses. Recall 3L nivo RR 11.9%, 3L pembro RR 19.3%. Is this notably better? # LCSMpic.twitter.com/E4tQTHYVAE",,,# # # #,"1254854499782537216",https://twitter.com/StephenVLiu/status/1254854499782537216
CharuAggarwalMD,2020-04-27 15:26,12,35,"STK11 & KEAP1 MT in # NSCLC pts receiving # Pembro on # KN42. Authors conclude that IO was superior to chemo in these subsets. Imp' to note: 1. # KRASMT not reported 2. How do these pts do with chemo+IO? 3. Overall prevalence of these MT seem low # AACR20 @ AACR # LCSM @ OncoAlertpic.twitter.com/FRCZqybOP8",,@ @,# # # # # #,"1254854430899318784",https://twitter.com/CharuAggarwalMD/status/1254854430899318784
JFreemanDaily,2020-04-27 15:26,5,13,"# AACR20 Preliminary analysis suggests PD-L1 positive NSCLC patients who have germline STK11 mutation should receive pembro instead of chemo first line # LCSMpic.twitter.com/r6N17AzBCo",,,# #,"1254854358400774148",https://twitter.com/JFreemanDaily/status/1254854358400774148
ryangentzler,2020-04-27 15:25,38,115,"New prospective data on outcomes with IO for NSCLC based on STK11 and KEAP1 status. Certainly limitations with only subset with available NGS results. Some of my best IO responders have been 2 STK11-mut patients. Not ready to skip IO for these patients yet. # AACR20 # LCSMpic.twitter.com/1T8Mwt9hTu",,,# #,"1254854304873103363",https://twitter.com/ryangentzler/status/1254854304873103363
DeepOnCar,2020-04-27 15:25,3,3,"Interesting strategy for activating # PP2A tumor suppressor in cancers by using SMAPS by @ NarlaLabUMich at # AACR20. I guess the enemy of my enemy really is my friend. Screening efforts by our neighbor, @ westermarcklab at @ BioscienceTurku, were important contributions.pic.twitter.com/CUQyPvHpTD",,@ @ @,# #,"1254854145397440517",https://twitter.com/DeepOnCar/status/1254854145397440517
MasonIsraelPhD,2020-04-27 15:23,2,3,"Imprime PGG is a molecule that aims to recruit immune cells to tumors. Today at # AACR20 Dr. Steven O'Day presented on the phase 2 IMPRIME1 trial which looks at # pembro + PGG in # TNBC. Promising results compared to historic data. @ JohnWayneCIpic.twitter.com/ljqHxhcCMN",,@,# # #,"1254853699022643200",https://twitter.com/MasonIsraelPhD/status/1254853699022643200
LeciaSequist,2020-04-27 15:23,11,38,"Cho: subgroup analysis of KN042 shows pembro better than chemo regardless of STK11 or KEAP1 mutation status in PDL1>1% pts (same as overall study results). Impt missing data: how did 3% with BOTH STK11/KEAP do? In my experience, this is v. poor marker. # LCSM # AACR2020",,,# #,"1254853603614789632",https://twitter.com/LeciaSequist/status/1254853603614789632
DMSLung,2020-04-27 15:23,6,20,"# AACR2020 # OncoAlert Relationship btwn STK11 and KEAP1 mutnl status and efficacy in KEYNOTE-042 (429 pts) STK11 a biomarker for …… chemotherapy pic.twitter.com/U2RCZl2YHm",,,# #,"1254853588330975238",https://twitter.com/DMSLung/status/1254853588330975238
Martin_AngelMD,2020-04-27 15:23,4,8,"drugging the # undruggable......repositioning of drugs!!!! many new possible targets. Elegant presentation of Dr. Gouthan Narla. # OncoAlert # AACR20 pic.twitter.com/mqaelAd7RT",,,# # #,"1254853578134564866",https://twitter.com/Martin_AngelMD/status/1254853578134564866
ScripMandy,2020-04-27 15:22,0,0,"Same # AACR20",,,#,"1254853505593950208",https://twitter.com/ScripMandy/status/1254853505593950208
drteplinsky,2020-04-27 15:22,17,35,"Pre existing ESR1 mutations in early stage primary breast cancer predict failure of endocrine therapy and poor OS. This is important and should guide how we think about ER+ breast cancer. # aacr20 pic.twitter.com/DC3ROEJt4l",,,#,"1254853428171268096",https://twitter.com/drteplinsky/status/1254853428171268096
Jbauml,2020-04-27 15:22,15,19,"Data argue against choosing chemo alone in STK11/KEAP1 patients. The HR in STK11 mutant patients is particularly impressive. The work done by @ MMarmarelis and @ erin_bange indicated that STK11 co-mutation status was critical to outcomes # LCSM # AACR20 https://ascopubs.org/doi/full/10.1200/PO.18.00326 …pic.twitter.com/0brGEgUeC4",,@ @,# #,"1254853374622740480",https://twitter.com/Jbauml/status/1254853374622740480
quirogad,2020-04-27 15:21,1,2,"Very interesting study showing how innate immune response can be utilized to produce a more robust downstream adaptive immune response # AACR20 https://twitter.com/jesusanampa/status/1254850529517281281 …",,,#,"1254853295392174081",https://twitter.com/quirogad/status/1254853295392174081
jillfeldman4,2020-04-27 15:21,4,9,"Results from phase II PASSION trial of Camrelizumab and apatinib looks promising in ES # SCLC. Good news for a subset of # lungcancer patients who desperately need new & better treatment options # LCSM # AACR20 https://twitter.com/StephenVLiu/status/1254851153902415872 …",,,# # # #,"1254853223023812615",https://twitter.com/jillfeldman4/status/1254853223023812615
StephenVLiu,2020-04-27 15:21,5,7,"# OncoAlert # AACR20 Patient characteristics reveal a slightly higher proportion of never-smokers (10/47, 21%). # SCLC strongly linked to smoking but can be seen in never smokers (4.5% in IMpower 133). Spontaneous transformation from # EGFR? Different outcomes in this group? # LCSMpic.twitter.com/zDyvqZXOw5",,,# # # # #,"1254853155843706882",https://twitter.com/StephenVLiu/status/1254853155843706882
drleemachado,2020-04-27 15:20,0,0,"# AACR20 The amino acid transaminase (BCAT-1) inhibited with ERG245 drug potentiates with anti-PD1 Tx (5/6 mice) in CT26 colon cancer model. A boost to Bioenergetic rather than transaminase activity in CD8 T cells.",,,#,"1254853048016437251",https://twitter.com/drleemachado/status/1254853048016437251
christeeny513,2020-04-27 15:20,1,3,"# BCSM # OncoAlert # AACR20 https://twitter.com/OncoAlert/status/1254852120513327107 …",,,# # #,"1254852914411188226",https://twitter.com/christeeny513/status/1254852914411188226
MM_Oncology,2020-04-27 15:20,2,1,"We kick off our # AACR20 coverage with this report from the I-SPY2 trial: Neoadjuvant durvalumab, olaparib addition promising in HER2-negative # breastcancer. Presented by Lajos Pusztai (of @ YaleCancer) @ YaleMed # Immunotherapy # PARPinhibitors @ Dr_RShatskyhttp://bit.ly/3bKkMxf",,@ @ @,# # # #,"1254852905976377346",https://twitter.com/MM_Oncology/status/1254852905976377346
christeeny513,2020-04-27 15:19,9,29,"This is very interesting - patients who originally had ER+ # breastcancer but lost this receptor & became # TNBC showed a pronounced clinical benefit in a study testing IMPRIME in combo with pembrolizumab (Keytruda). Other cancers still recruiting! # BCSM # LCSM # CRCSM # AACR20 https://twitter.com/CarlosHBarcenas/status/1254849795866451968 …",,,# # # # # #,"1254852681027313664",https://twitter.com/christeeny513/status/1254852681027313664
StephenVLiu,2020-04-27 15:19,5,9,"# OncoAlert # AACR20 Stage I included three different schedules of apatinib delivery (camrelizumab is given IV q2w). The apatinib 375mg qday schedule was chosen for stage 2. Included chemo-sensitive and resistant # SCLC, using a 90-day platinum-free interval cutoff. # LCSMpic.twitter.com/PBpjHc8sPa",,,# # # #,"1254852595287576576",https://twitter.com/StephenVLiu/status/1254852595287576576
Jbauml,2020-04-27 15:18,11,13,"PD-L1 expression seems to be lowing among those with STK11 mutations, but similar in KEAP1. There is a slightly higher amount of TMB in both mutated groups. All of these differences seem rather small to me # LCSM # AACR20 @ OncoAlertpic.twitter.com/CMGRTm78vN",,@,# #,"1254852542024101889",https://twitter.com/Jbauml/status/1254852542024101889
AML_Hub,2020-04-27 15:18,2,6,"CONGRESS | # AACR20 | Rafael Bejar presents early clinical results of CG-806, an orally available cluster-selective kinase inhibitor in patients with R/R CLL/SLL or NHL. Based on the results, a phase I study in patients with R/R AML with FLT3-mut and wt is planned # leusmpic.twitter.com/0Vo3gaeTau",,,# #,"1254852414189920256",https://twitter.com/AML_Hub/status/1254852414189920256
OncoAlert,2020-04-27 15:17,5,7,"Live # AACR20 by @ OncoAlert colleague @ StoverLab "Overview of HRD/BRCAness biomarkers" by Susan Domchek @ PennCancer .Important highlight that tumors may CHANGE and that even at a single timepoint different lesions may have different BRCAness features.https://twitter.com/StoverLab/status/1254849410644746243 …",,@ @ @,#,"1254852120513327107",https://twitter.com/OncoAlert/status/1254852120513327107
MCR_AACR,2020-04-27 15:15,0,0,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/2W75HPX pic.twitter.com/yfpLqMFAqa",,@ @,#,"1254851596275658753",https://twitter.com/MCR_AACR/status/1254851596275658753
CEBP_AACR,2020-04-27 15:15,0,0,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/2KGqcNP pic.twitter.com/wWO5kEilLh",,@ @,#,"1254851584355438599",https://twitter.com/CEBP_AACR/status/1254851584355438599
lymphomahub,2020-04-27 15:14,2,2,"CONGRESS | # AACR20 | Rafael Bejar presents early clinical results of CG-806 in R/R CLL/SLL or NHL. CG-806 is an orally available cluster-selective kinase inhibitor that has been dosed at three levels with no DLTs. The phase I trial is ongoing. # lymsmpic.twitter.com/QKnUPqPUvF",,,# #,"1254851513253597187",https://twitter.com/lymphomahub/status/1254851513253597187
ivybelkins,2020-04-27 15:14,6,10,"Targeted therapy for # SCLC? Jie Wang, MD presents on # camrelizumab and # apatinib in a Chinese multi-center phase 2 trial. # AACR20 # lungcancer # lcsm @ EGFRResisterspic.twitter.com/FUCLDxhlDC",,@,# # # # # #,"1254851430680342534",https://twitter.com/ivybelkins/status/1254851430680342534
OncoAlert,2020-04-27 15:13,2,2,"Live # AACR20 by our @ OncoAlert Colleague @ jesusanampa "Steven O'day IMPRIME1 trial: Imprime PGG (immune activator) + pembro in mTNBC: ORR 16%, OS 16.4m, PFS 2.7m( better than historical data for ICI monotherapy KEYNOTE086)"https://twitter.com/jesusanampa/status/1254850529517281281 …",,@ @,#,"1254851274316668930",https://twitter.com/OncoAlert/status/1254851274316668930
StephenVLiu,2020-04-27 15:13,11,28,"# OncoAlert # AACR20 Results from phase II study of camrelizumab (SHR-1210, anti-PD-1) plus apatinib in # SCLC presented by Dr. Jie Wang. Camrelizumab is approved in China for Hodgkin lymphoma and has shown promise in HCC. Here, results from single arm phase II. # LCSMpic.twitter.com/a6as8M61lp",,,# # # #,"1254851153902415872",https://twitter.com/StephenVLiu/status/1254851153902415872
MaverickNY,2020-04-27 15:12,0,3,"Gah have waited an hour for a talk I really wanted to hear - now have slides and no sound in # aacr20 lung cancer session :(",,,#,"1254850952022110209",https://twitter.com/MaverickNY/status/1254850952022110209
UmutDisel,2020-04-27 15:12,0,0,"Agreed sound problem @ AACRPres @ AACR",,@ @,,"1254850854949183488",https://twitter.com/UmutDisel/status/1254850854949183488
LeciaSequist,2020-04-27 15:11,1,7,"@ AACR there may be a problem w/ audio in the lung oral session!",,@,,"1254850634731466753",https://twitter.com/LeciaSequist/status/1254850634731466753
Jbauml,2020-04-27 15:10,8,23,"Next up Dr Cho presents data from KEYNOTE 042 (pembro vs chemo in PD-L1≥1%) among patients with NSCLC harboring a STK11 or KEAP1 mutation. Prior series (including @ MMarmarelis) have shown this to indicate a group of patients relatively unlikely to respond to IO # AACR20 # LCSM",,@,# #,"1254850547720601600",https://twitter.com/Jbauml/status/1254850547720601600
jesusanampa,2020-04-27 15:10,6,11,"Steven O'day IMPRIME1 trial: Imprime PGG (immune activator) + pembro in mTNBC: ORR 16%, OS 16.4m, PFS 2.7m( better than historical data for ICI monotherapy KEYNOTE086) If originally ER+, better response. if monocyte/T-cell activation improved OS # AACR20 # BCSMpic.twitter.com/XDY8SX0qU4",,,# #,"1254850529517281281",https://twitter.com/jesusanampa/status/1254850529517281281
chulkimMD,2020-04-27 15:10,8,16,"Camrelizumab in combination with apatinib in ES-SCLC after 1st line platinum chemo. N=59. ORR=34%. Similar survival outcomes between chemo-sensitive and resistant pts. It would be of interest to know the status of biomarkers in study pts(e.g. PD-L1, TMB). # AACR20 @ OncoAlertpic.twitter.com/XR7n8SOmlA",,@,#,"1254850423711768577",https://twitter.com/chulkimMD/status/1254850423711768577
Martha__Carlson,2020-04-27 15:09,1,8,"Steven O'Day showing pronounced clinical benefit in TNBC "converters"--those who were ER+, progressed and subsequently tested TNBC--in phase 2 study of the combination of the immune checkpoint inhibitor pembrolizumab with the novel innate immune activator, Imprime PGG. # AACR20",,,#,"1254850078675738624",https://twitter.com/Martha__Carlson/status/1254850078675738624
ManuelDomine,2020-04-27 15:08,5,10,"PASSION phase II trial of Camrelizumab (Anti PD-1 + apatinib (TKI VEGFR2) showed promising potent activity in chemo-sensitive and chemo-resistant ES- SCLC ORR @ OncoAlert @ gecp_org # LCSM # AACR20 # SCLC",,@ @,# # #,"1254850008727388161",https://twitter.com/ManuelDomine/status/1254850008727388161
weoncologists,2020-04-27 15:08,3,8,"Thank you @ NicoleKuderer , I still remember your awesome tweets at # AACR19 !! Can’t believe # AACR20 is already here and virtual so everyone can attend!!",,@,# #,"1254849940754399233",https://twitter.com/weoncologists/status/1254849940754399233
CarlosHBarcenas,2020-04-27 15:07,0,5,"Interesting that this treatment approach had a pronounced clinical benefit in TNBC “converters” # AACR20 pic.twitter.com/xW4WBQfJXJ",,,#,"1254849795866451968",https://twitter.com/CarlosHBarcenas/status/1254849795866451968
jillfeldman4,2020-04-27 15:07,3,19,"Toxicity profile matters! We/patients don't only want to survive -- We want to LIVE! QOL is also a meaningful endpoint for patients. # AACR20 # LCSM # targetedtherapy # MetExon14https://twitter.com/Jbauml/status/1254842263655587841 …",,,# # # #,"1254849741416026119",https://twitter.com/jillfeldman4/status/1254849741416026119
DMSLung,2020-04-27 15:07,7,11,"# AACR2020 # OncoAlert Camrelizumab plus apatinib in ES-SCLC (PASSION ph 2 trial)pic.twitter.com/tuxFpX0ykR",,,# #,"1254849622687842305",https://twitter.com/DMSLung/status/1254849622687842305
StoverLab,2020-04-27 15:06,10,31,"Fantastic overview of HRD/BRCAness biomarkers by Susan Domchek @ PennCancer - so many biomarkers, so little clarity! Important highlight that tumors may CHANGE and that even at a single timepoint different lesions may have different BRCAness features. # AACR2020 pic.twitter.com/3Hlmle2UpY",,@,#,"1254849410644746243",https://twitter.com/StoverLab/status/1254849410644746243
Jbauml,2020-04-27 15:06,5,10,"Impressive ORR in this setting - higher than was seen with other PD-1 inhibitors in SCLC after plat. Long term survival is intriguing. Critical to remember, tho, that so many Ph2 trials in ES-SCLC look exciting only to be disproven in the Ph3. # AACR20 # LCSMpic.twitter.com/WwnltIzGmp",,,# #,"1254849362259304450",https://twitter.com/Jbauml/status/1254849362259304450
Somaang06,2020-04-27 15:06,0,0,"The Science must go on! @ AACR # AACR20 # inthetimesofcoronapic.twitter.com/5JBQAEGWAO",,@,# #,"1254849359096606728",https://twitter.com/Somaang06/status/1254849359096606728
YaleCancer,2020-04-27 15:05,1,7,"Interested in new treatments for # braincancer # coloncancer? @ amritasule presents study findings at # AACR20 with @ RanjitBindra showing how # DNA repair inhibitors target these diseases. Watch at 2:50pm tomorrow! @ SmilowCancer @ YaleMed @ YNHH # btsm # CRCSM https://www.abstractsonline.com/pp8/#!/9045/presentation/10551 …pic.twitter.com/SdewNqlVn9",,@ @ @ @ @,# # # # # # #,"1254849244420284422",https://twitter.com/YaleCancer/status/1254849244420284422
tmfiesta,2020-04-27 15:05,0,3,"# AACR20 attending a session on breast cancer treatment. While this is not my primary area of expertise, I'm excited to learn about the current therapeutic strategies under investigation by clinicians.",,,#,"1254849069081456641",https://twitter.com/tmfiesta/status/1254849069081456641
LizCancerHealth,2020-04-27 15:04,2,1,"More evidence for combo # immunotherapy for solid tumors. Keytruda (pembrolizumab) + immune activator Imprime PGG works better than Keytruda alone for TNBC. # AACR20 # breastcancer # bcsmpic.twitter.com/JYAyliXwEv",,,# # # #,"1254848889150210048",https://twitter.com/LizCancerHealth/status/1254848889150210048
lymphomahub,2020-04-27 15:04,2,4,"CONGRESS | # AACR20 | Ana Tari Ashizawa presents the design of a phase I study to investigate BP1002, an antisense oligonucleotide, for advanced lymphoid malignancies # lymsmpic.twitter.com/ZXRfF8crQh",,,# #,"1254848873648082944",https://twitter.com/lymphomahub/status/1254848873648082944
Jbauml,2020-04-27 15:04,0,2,"Interesting distribution of patients - most got daily dosing of capmatinib. Also note the p value for significance in this study was set at 0.1. Notable that there were a lot of never smokers for a study of ES-SCLC.... # LCSM # AACR20 pic.twitter.com/6xzFWKLGIV",,,# #,"1254848835693789187",https://twitter.com/Jbauml/status/1254848835693789187
UMRogelCancer,2020-04-27 15:03,0,11,". @ gouthamnarla presenting now at # AACR20! pic.twitter.com/7eSBXSmw8e",,@,#,"1254848768467283969",https://twitter.com/UMRogelCancer/status/1254848768467283969
Cortellis,2020-04-27 15:02,2,0,"The combination of Genexine’s GX-188E vaccine and pembrolizumab was safe and effective in patients with HPV 16-/18-caused recurrent or metastatic cervical cancer # AACR20",,,#,"1254848468432158720",https://twitter.com/Cortellis/status/1254848468432158720
LifeSciComms,2020-04-27 15:02,0,0,"This @ FierceBiotech article details data from a study presented by Compugen at # AACR2020 today. Its novel # CheckpointInhibitor shows early promise for patients with advanced solid tumors who have exhausted all other treatment options. Read more:https://bit.ly/3eVoAOi",,@,# #,"1254848411012038658",https://twitter.com/LifeSciComms/status/1254848411012038658
MDAndersonNews,2020-04-27 15:02,7,20,"A combination therapy targeting the WNT pathway resulted in 67% decrease in tumor activity for some patients with # solidtumors, according to a recent clinical trial led by our @ FilipJankuMD: https://bit.ly/3cWDjqt # AACR20 # endcancer",,@,# # #,"1254848293760380928",https://twitter.com/MDAndersonNews/status/1254848293760380928
Jbauml,2020-04-27 15:01,0,7,"Here is the trial schema - multiple dosing options for the apatinib. Notably, patients could not have received CPI and could not have active brain metastases. This is a major limitation of applicability of these data to modern management # LCSM # AACR20 pic.twitter.com/TVIUNqvYzk",,,# #,"1254848222432038912",https://twitter.com/Jbauml/status/1254848222432038912
MasonIsraelPhD,2020-04-27 15:01,4,4,"# LOH (Loss of heterozygosity) is an emerging biomarker that can be helpful with PARPi decision-making in # BRCA wild type patients with # ovariancancer. Today at # AACR20 Dr. Susan Domchek gave a great summary of LOH data in # breastcancer patients with germline BRCA alterations.pic.twitter.com/1onClnxhc7",,,# # # # #,"1254848045604171777",https://twitter.com/MasonIsraelPhD/status/1254848045604171777
Kamacintosh,2020-04-27 15:00,3,8,"Poziotinib / Exon 20 insertion PFS 7.4 modest and meaningful efficacy.... Safety profile is a challenge. # AACR20 # targetdtherapy # LCSM # TKIpic.twitter.com/6bboh2fnY6",,,# # # #,"1254848029175267328",https://twitter.com/Kamacintosh/status/1254848029175267328
AGreenMonster,2020-04-27 15:00,0,1,"It’s pretty good but not scheduling any breaks is pretty intense. In person you usually can’t attend them all but you can at least eat lunch. There’s something about being there live that I think may not translate as well if only watching the taped versions- though nice option.",,,,"1254848012817498115",https://twitter.com/AGreenMonster/status/1254848012817498115
Aurora_Cancer,2020-04-27 15:00,0,1,"Pneumonitis incidence in Pts w/ NSCLC Tx'd w/ immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020 4:00- 4:10p EDT] Liu et al. # AACR20 CT086 - VCTPL08 Session http://ow.ly/Oxpy30qB9U8 # lcsm # irAE # ImmunoOnc @ Syapse @ US_FDA @ Aurora_Cancer",,@ @ @,# # # #,"1254847925072662528",https://twitter.com/Aurora_Cancer/status/1254847925072662528
bradloncar,2020-04-27 15:00,8,22,"LIVE: talking “Jim Allison:Breakthrough” and # AACR20 with @ SoleburyTrout’s @ Nfcanavan.https://www.pscp.tv/w/cXXRuzg4NDI5fDF5cEpkUUJPYXdReFesdhz9cXTTj_6oim-Cg4xeJ6U4acFJqOl7njaPG4ofeA== …",,@ @,#,"1254847847427645445",https://twitter.com/bradloncar/status/1254847847427645445
CCR_AACR,2020-04-27 15:00,0,0,"Read the April 15 issue -all articles are freely available during # AACR20 Virtual Annual Meeting I! https://bit.ly/2SeDF3F pic.twitter.com/0Ny3lpDRFb",,,#,"1254847842159595522",https://twitter.com/CCR_AACR/status/1254847842159595522
CAPR_AACR,2020-04-27 15:00,0,0,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/35buM06 pic.twitter.com/v1B4d54fiU",,@ @,#,"1254847840221908992",https://twitter.com/CAPR_AACR/status/1254847840221908992
BCD_AACR,2020-04-27 15:00,0,1,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/3aJBlbt pic.twitter.com/7p14yUmhNc",,@ @,#,"1254847837277425674",https://twitter.com/BCD_AACR/status/1254847837277425674
CD_AACR,2020-04-27 15:00,2,3,"Contact our editors with questions about submissions to Cancer Discovery! # AACR20 Virtual Annual Meeting I @ ElizSMcKenna @ TaliLev123 @ imsmd https://bit.ly/2W2iymh pic.twitter.com/RX9iQ6TMZr",,@ @ @,#,"1254847827131412481",https://twitter.com/CD_AACR/status/1254847827131412481
AACR,2020-04-27 15:00,1,8,"# AACR20 Virtual Annual Meeting I: Lung Cancer Targeted Therapy Session. Kimlin T. Ashing presents CT087: A geospatial approach to explore the socioecological context of tobacco and vape shop locations.",,,#,"1254847821326569472",https://twitter.com/AACR/status/1254847821326569472
JAMANetwork,2020-04-27 15:00,0,0,"Following the # AACR20 virtual meeting? Read Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial from @ JAMA_current free online during the meeting https://ja.ma/3cA4CXm",,@,#,"1254847784311717891",https://twitter.com/JAMANetwork/status/1254847784311717891
Jbauml,2020-04-27 14:59,10,24,"Next at the lung cancer session at # AACR20: a study of camrelizumab (PD-1 inhibitor)with apatinib (VEGFR2 TKI) in ES-SCLC, presented by Dr Wang # LCSM @ OncoAlert",,@,# #,"1254847753139740674",https://twitter.com/Jbauml/status/1254847753139740674
drteplinsky,2020-04-27 14:59,1,3,"Results from single arm study of Imprime PGG + pembro compared to historical control of pembro alone. # aacr20 pic.twitter.com/MyuZHYP03q",,,#,"1254847628677873671",https://twitter.com/drteplinsky/status/1254847628677873671
YMAbdelhalim,2020-04-27 14:59,0,1,"Although there was many technical errors at the beginning and still struggling with my internet connection @ AACR # AACR20 first time to attend their events, this virtual meeting is highly informative!! Please reach out to @ ElizSMcKenna for more info about @ CD_AACR https://twitter.com/ElizSMcKenna/status/1254760072779042817 …",,@ @ @,#,"1254847564932923399",https://twitter.com/YMAbdelhalim/status/1254847564932923399
OncologyCentral,2020-04-27 14:59,0,0,"# AACR20 Ji Wang presents data from the Phase II trial investigating a novel # combinationtherapy for # NSCLC",,,# # #,"1254847560008818697",https://twitter.com/OncologyCentral/status/1254847560008818697
OncoAlert,2020-04-27 14:56,1,2,"Live # AACR20 Tweet by @ drteplinsky "Great summary on PARP inhibitors and breast cancer and potential biomarkers" @ OncoAlert https://twitter.com/drteplinsky/status/1254845771842760710 …",,@ @,#,"1254847019140689921",https://twitter.com/OncoAlert/status/1254847019140689921
ivybelkins,2020-04-27 14:56,2,4,"@ teekayowo provides interesting discussant perspectives on # poziotinib and # capmatinib # lungcancer # targetedtherapy trial results presented today at # AACR20. # lcsm @ EGFRResisters @ Exon20Group # METpic.twitter.com/jGwXBLOTzZ",,@ @ @,# # # # # # #,"1254846912253104130",https://twitter.com/ivybelkins/status/1254846912253104130
acmoorephd,2020-04-27 14:55,1,14,"Proud to see @ ga_res_alliance Distinguished Cancer Scientists, Drs. @ RamalingamMD and @ teekayowo, presenting on # lungcancer at # AACR20. Georgia's long-standing investments in # research continue to pay off.",,@ @ @,# # #,"1254846632006279169",https://twitter.com/acmoorephd/status/1254846632006279169
drteplinsky,2020-04-27 14:55,0,1,"Now listening to a study presented on pembrolizumab and Imprime PGG (novel beta glucan binds to endogenous anti B glucan Ab—> immune complex) in metastatic TNBC. # aacr20",,,#,"1254846565719605250",https://twitter.com/drteplinsky/status/1254846565719605250
pashtoonkasi,2020-04-27 14:54,0,0,"Important to see the barrier penetration of the drug. # AACR20",,,#,"1254846520085614592",https://twitter.com/pashtoonkasi/status/1254846520085614592
MdC_UQAM,2020-04-27 14:54,0,4,"Félicitations au prof Borhane Annabi du Département de # chimie @ UQAM pour l'implication de son laboratoire dans le développement de 2 médicaments ciblant le cancer des ovaires dont les résultats seront présentés au Congrès de l’American Association of Cancer Research. @ AACR https://twitter.com/Theratech_/status/1254734812189020160 …",,@ @,#,"1254846349734010881",https://twitter.com/MdC_UQAM/status/1254846349734010881
drleemachado,2020-04-27 14:53,0,1,"# AACR20 Poziotinib targets EGFR exon 20 insertions. Effective in this lung cancer patient sub group? Some efficacy but challenging safety profile...",,,#,"1254846104845328384",https://twitter.com/drleemachado/status/1254846104845328384
ARosen380,2020-04-27 14:53,2,9,"As a patient advocate I am excited to be attending @ AACR as a # virtualmeeting today! Some of most innovative research projects presented today online! Spending time this afternoon learning about # clinicaltrials # cancerresearch # advocate # AACR20 pic.twitter.com/7jv7qNCH1d",,@,# # # # #,"1254846102039339008",https://twitter.com/ARosen380/status/1254846102039339008
pashtoonkasi,2020-04-27 14:53,0,0,"# AACR20 journal resources https://twitter.com/CR_AACR/status/1254844029637922816 …",,,#,"1254846093822701568",https://twitter.com/pashtoonkasi/status/1254846093822701568
drteplinsky,2020-04-27 14:52,10,11,"Great summary on PARP inhibitors and breast cancer and potential biomarkers. # aacr20 pic.twitter.com/eIk2iimdHy",,,#,"1254845771842760710",https://twitter.com/drteplinsky/status/1254845771842760710
eduhor82,2020-04-27 14:51,1,4,"No BENEFIT adding Atezo to Enza in # mCRPC # AACR20 OS or rPFS https://twitter.com/tompowles1/status/1254793493521805312 …",,,# #,"1254845638585565184",https://twitter.com/eduhor82/status/1254845638585565184
CarlosHBarcenas,2020-04-27 14:51,1,3,"PARP inhibitors in breast cancer # AACR20 Great discussion! # endcancerpic.twitter.com/zw19UZng83",,,# #,"1254845543194529792",https://twitter.com/CarlosHBarcenas/status/1254845543194529792
lymphomahub,2020-04-27 14:49,9,17,"CONGRESS | # AACR20 | Results from a randomized study comparing DDGP regimen to SMILE in patients with newly diagnosed extranodal NK/T-cell lymphoma show no significant difference in CR and ORR rate between regimens # lymsmpic.twitter.com/8Gn8C11Xdv",,,# #,"1254845172212477954",https://twitter.com/lymphomahub/status/1254845172212477954
YVR_Trader,2020-04-27 14:48,1,10,"My take is some investors thought $ APTO would be presenting new CG’806 data at # AACR20 This was never the case as AACR is a pre-clinical meeting. New data should be presented at # EHA2020 in June.",,,# #,"1254844884827037696",https://twitter.com/YVR_Trader/status/1254844884827037696
gerlach_d,2020-04-27 14:46,1,0,"Xiuning Le: Poziotinib activity and durability of responses in previously treated EGFR exon 20 NSCLC patients - a Phase 2 study # AACR20 pic.twitter.com/AXz3uwdHIA",,,#,"1254844325244162048",https://twitter.com/gerlach_d/status/1254844325244162048
TimWitney,2020-04-27 14:45,0,1,"So in this case it’s at least being true to it’s normal self!",,,,"1254844069920026632",https://twitter.com/TimWitney/status/1254844069920026632
CR_AACR,2020-04-27 14:45,1,4,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/2W5yx2O pic.twitter.com/9IM7rj17K3",,@ @,#,"1254844029637922816",https://twitter.com/CR_AACR/status/1254844029637922816
MCT_AACR,2020-04-27 14:45,1,1,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/2VFdnd6 pic.twitter.com/78wEk1z0pu",,@ @,#,"1254844029013032961",https://twitter.com/MCT_AACR/status/1254844029013032961
CD_AACR,2020-04-27 14:45,1,5,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/2VHPS3d pic.twitter.com/PqJWk9ddG5",,@ @,#,"1254844028887224321",https://twitter.com/CD_AACR/status/1254844028887224321
CIR_AACR,2020-04-27 14:45,1,1,"RT @ AACR: Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/2ScvLb6 pic.twitter.com/WE7xoKipEI",,@ @,#,"1254844028778172421",https://twitter.com/CIR_AACR/status/1254844028778172421
YMAbdelhalim,2020-04-27 14:44,0,1,"Me It's quite overwhelming that you wanna attend all the sessions but can't I never attended before, but it truly provides such interesting topics!!",,,,"1254843897051832321",https://twitter.com/YMAbdelhalim/status/1254843897051832321
Kamacintosh,2020-04-27 14:44,4,12,"Capmatinib for MET Exon 14 Skipping Mutation # AACR20 # TargetedTheraoypic.twitter.com/ODo97BjHCC",,,# #,"1254843893767692289",https://twitter.com/Kamacintosh/status/1254843893767692289
OncoAlert,2020-04-27 14:44,2,5,"Live # AACR20 Tweet by our @ oncoalert colleague @ Jbauml "Critical slide - capmatinib has clear efficacy in the brain. We knew it got in, but the fact that we are seeing IC responses is very important"https://twitter.com/Jbauml/status/1254841708262588416 …",,@ @,#,"1254843853343010816",https://twitter.com/OncoAlert/status/1254843853343010816
ManuelDomine,2020-04-27 14:43,7,27,"GEOMETRY trial Capmatinib in advanced NSCLC harboring MET ex14 mutations obtained a 67.9%, mDOR of 11.14 m in 1 line and 40.6% DOR 9.72 m in 2/3 line, with good activity in Brain Metastasis (54%) with manageable safety profile @ AlertOnco # AACR20 # LCSMpic.twitter.com/WKfuAGFpU8",,@,# #,"1254843642075926530",https://twitter.com/ManuelDomine/status/1254843642075926530
ppisters,2020-04-27 14:43,1,13,"Translational research is key to improving care for our patients. Proud of @ JenniferLitton leading important efforts to evaluate new treatment options for BRCA+ breast cancer, presented today at # AACR20. https://twitter.com/MDAndersonNews/status/1254832730367557635 …",,@,#,"1254843558282104838",https://twitter.com/ppisters/status/1254843558282104838
OncoAlert,2020-04-27 14:42,3,13,"Live # AACR20 Tweet @ ivybelkins " Capmatinib in # MET # exon14 skipping mutation. Two cohorts -- treatment naive and pre-treated. Looks promising with respect to brain penetration" @ OncoAlert # LungCancer # LCSMhttps://twitter.com/ivybelkins/status/1254842970362257408 …",,@ @,# # # # #,"1254843494813794305",https://twitter.com/OncoAlert/status/1254843494813794305
CathyEngMD,2020-04-27 14:42,0,8,"Thank you @ AACR for finally addressing my # IT issues for the # AACR20 # VirtualMeeting I"m up and running! @ twitter for getting my message across! @ VUMC_Cancer # academictwitter",,@ @ @,# # # #,"1254843418737545216",https://twitter.com/CathyEngMD/status/1254843418737545216
LUNGevity,2020-04-27 14:42,12,27,"Capmatinib continues to show promise fr Met Exon 14 skipping NSCLC, including brain mets. Reinforces need for comprehensive biomarker testing to catch these rare mutations so our patients can benefit from these new drugs - LUNGevity SAB Dr. Eddie Garron @ UCLAJCCC # AACR20 # LCSMpic.twitter.com/s5GBmIMq3x",,@,# #,"1254843299917168640",https://twitter.com/LUNGevity/status/1254843299917168640
BairdAM,2020-04-27 14:42,5,17,"Edward Garon: GEOMETRY study - Capmatinib (MET inhibitor) shows clinically meaningful efficacy in people with advanced NSCLC with METex14 mutations # LCSM # AACR20",,,# #,"1254843293311143936",https://twitter.com/BairdAM/status/1254843293311143936
Boehringer,2020-04-27 14:41,3,12,"# AACR20: @ MarcoHHofmann, a member of our cancer research team presents preclinical data on how our pan-KRAS and MEK inhibitor combinations work across a broad range of mutations leading to tumor stasis or regression:",,@,#,"1254843125669015553",https://twitter.com/Boehringer/status/1254843125669015553
DeepOnCar,2020-04-27 14:41,6,12,"Live from # AACR20 Interesting results from # GEOMETRY_MONO1 trial for the highly selective # MET inhibitor, # capmatinib, reporting 40% ORR and a duration of response > 9mos. CNS metastasis also show encouraging results. # OncoAlert Major Caveat: cohort size.",,,# # # # #,"1254843092982738947",https://twitter.com/DeepOnCar/status/1254843092982738947
ivybelkins,2020-04-27 14:40,10,19,"Edward Garon @ UCLA presents on # capmatinib in # MET # exon14 skipping mutation. Two cohorts -- treatment naive and pre-treated. Looks promising with respect to brain penetration. # AACR20 # lungcancer # lcsm @ EGFRResisterspic.twitter.com/KOdFxOhXFC",,@ @,# # # # # #,"1254842970362257408",https://twitter.com/ivybelkins/status/1254842970362257408
TimWitney,2020-04-27 14:39,0,6,"Who’s viewing @ AACR’s first virtual meeting # AACR2020? What’s your thoughts? The way forward or has it lost some of the crazy madness that we all love?",,@,#,"1254842681722880003",https://twitter.com/TimWitney/status/1254842681722880003
DrSanjayPopat,2020-04-27 14:38,5,12,"Agree. An active drug but ORR disappointing. Likely due to tolerability and DRs. Perhaps BID dosing (being pursued further) may yield different outcomes # AACR20 https://twitter.com/Jbauml/status/1254838319483162630 …",,,#,"1254842372460105732",https://twitter.com/DrSanjayPopat/status/1254842372460105732
Jbauml,2020-04-27 14:38,6,18,"Toxicity of capmatinib is generally pretty mild, and not dissimilar from with crizotinib. We gain CNS efficacy without cost in the form of toxicity. Hopefully patients will have access to this agent soon. It is currently under priority review at the FDA # AACR20 # LCSMpic.twitter.com/s4f8Gble9o",,,# #,"1254842263655587841",https://twitter.com/Jbauml/status/1254842263655587841
DMSLung,2020-04-27 14:37,2,5,"Results from the phase II GEOMETRY mono-1 study impressive results with capmatinib # AACR2020 pic.twitter.com/gW5QTsXNK5",,,#,"1254842189361930248",https://twitter.com/DMSLung/status/1254842189361930248
pashtoonkasi,2020-04-27 14:36,0,4,"Thoroughly enjoying the # AACR20 virtual session on “Drugging Undrugged Cancer Targets”. # hydroxychloroquine # itraconazole being discussed - repurposing.",,,# # #,"1254841934868348935",https://twitter.com/pashtoonkasi/status/1254841934868348935
marinagarassino,2020-04-27 14:36,10,28,"Met ex 14 with # capmatinib Median age 71, also in smokers. RR 67% DOR 9.72 peripheral edema the most common AE Brain penetration @ OncoAlert # AACR2020 pic.twitter.com/5IK7UkwYdK",,@,# #,"1254841842891448321",https://twitter.com/marinagarassino/status/1254841842891448321
Jbauml,2020-04-27 14:35,13,23,"This is a critical slide - capmatinib has clear efficacy in the brain. We knew it got in, but the fact that we are seeing IC responses is very important. As I mentioned above, this draws an important distinction from crizotinib where CNS efficacy is rare. # AACR20 # LCSMpic.twitter.com/QFd0uHSgU3",,,# #,"1254841708262588416",https://twitter.com/Jbauml/status/1254841708262588416
LeciaSequist,2020-04-27 14:35,12,47,"Garon: capmatinib in GEOMETRY study # MetExon14 pts. Impressive ORR 41% in 69 pre-treated pts and 68% in 28 rx-naive pts. Early data on CNS responses promising. AE's very tolerable, mostly LE swelling, nausea. This is exciting data! # AACR2020 # LCSM # OncoAlert",,,# # # #,"1254841661311660032",https://twitter.com/LeciaSequist/status/1254841661311660032
LizCancerHealth,2020-04-27 14:35,3,0,"One of several cancer vaccine studies being presented at # AACR20 virtual meeting. For background, see recent @ cancerhealthmag overview: https://www.cancerhealth.com/article/shot-cure-therapeutic-vaccine …https://twitter.com/NazliDizman/status/1254838015622410241 …",,@,#,"1254841616453365760",https://twitter.com/LizCancerHealth/status/1254841616453365760
lgreco_ny,2020-04-27 14:35,2,8,"Love that intercranial disease control seen in all but one patients. # lcsm # AACR20 pic.twitter.com/tS5dqZM7Jf",,,# #,"1254841609067339776",https://twitter.com/lgreco_ny/status/1254841609067339776
OncoAlert,2020-04-27 14:35,2,4,"Live # AACR20 Tweet from our @ OncoAlert colleague @ marinagarassino "The toxicity of # poziotinib is higher than second generation TKI" # LCSM # LungCancerhttps://twitter.com/marinagarassino/status/1254838965066182658 …",,@ @,# # # #,"1254841606420590595",https://twitter.com/OncoAlert/status/1254841606420590595
DeepOnCar,2020-04-27 14:34,5,6,"Live from # AACR20: Underwhelming data for # Poziotinib in # EGFR # exon20 insertions in NSCLC from the # ZENITH20 trial. ORR of 14.8% and a median PFS of 4.2 months (IRC review) for the 115 patients. Let's await the 3 arms of the trial to mature (incl. # HER2 exon20ins) # OncoAlert",,,# # # # # # #,"1254841461914374144",https://twitter.com/DeepOnCar/status/1254841461914374144
lfspurr,2020-04-27 14:34,1,4,"Come check out an exciting talk at # AACR20 today at 5:35pm EDT from one of my close colleagues, Yvonne Li, on our work with @ clearyonc @ meyersonlab & many others describing FGFR2 in-frame insertions: a novel targetable alteration in biliary tract cancer https://www.abstractsonline.com/pp8/#!/9045/presentation/10579 …",,@ @,# #,"1254841335024160768",https://twitter.com/lfspurr/status/1254841335024160768
Jbauml,2020-04-27 14:33,5,10,"Efficacy was quite impressive for capmatinib. Seen again is the higher ORR in the first line management. This is a surprising feature of MET skipping NSCLC (but has been seen in multiple studies). Perhaps different biology of MET modification vs EGFR? # LCSM # AACR20 pic.twitter.com/jgNHQmRclp",,,# #,"1254841154287394817",https://twitter.com/Jbauml/status/1254841154287394817
CharuAggarwalMD,2020-04-27 14:32,10,13,"Relatively large data set (N=115) in patients with # EGFR # Exon20 of # poziotinib use, results from # ZENITH20-1 @ AACR AM RR ~ 15% DCR ~ 68.7% med PFS ~ 4.2 months (2L+) significant AEs # LCSM # AACR20 https://twitter.com/LeciaSequist/status/1254837931157659649 …",,@,# # # # # #,"1254840967749726209",https://twitter.com/CharuAggarwalMD/status/1254840967749726209
OncoAlert,2020-04-27 14:32,2,2,"Live # AACR20 Tweet by @ LizCancerHealth "Poziotinib for selected # NSCLC patients shows 65% have some tumor shrinkage -- but 68% had to reduce doses due to side effects" @ OncoAlert # lungcancer # LCSMhttps://twitter.com/LizCancerHealth/status/1254839951931215873 …",,@ @,# # # #,"1254840770084904963",https://twitter.com/OncoAlert/status/1254840770084904963
SeanSachdevMD,2020-04-27 14:32,14,92,"# AACR20 starts as a virtual meeting with 54,000 ppl An important meeting held in this format: Should others follow? No facility/flight expenses Reduced environment impact Reduce $ to register More can participate globally More important information disseminated pic.twitter.com/OPSjKPNWsG",,,#,"1254840766519803907",https://twitter.com/SeanSachdevMD/status/1254840766519803907
inigo_landa,2020-04-27 14:31,0,0,"I’d consider trading your East river views for my homemade chicken tikka masala. Deal? # AACR2020 pic.twitter.com/WAluoJdVLL",,,#,"1254840730591379456",https://twitter.com/inigo_landa/status/1254840730591379456
Jbauml,2020-04-27 14:31,1,0,"Here is the description of enrolled patients, consistent with prior series on this cancer type. Over 10% of the patients in both cohorts had brain mets at the time of enrollment # LCSM # AACR20 pic.twitter.com/jkHYZZr5Qy",,,# #,"1254840720676003840",https://twitter.com/Jbauml/status/1254840720676003840
drteplinsky,2020-04-27 14:31,0,0,"Up now: Susan Domchek discussing who benefits from PARP inhibitors. # aacr20",,,#,"1254840538559381505",https://twitter.com/drteplinsky/status/1254840538559381505
HartungIngo,2020-04-27 14:31,5,20,"Great talk by @ corsellos of @ broadinstitute @ DanaFarber about a systematic repurposing campaign of annotated drugs leading to the surprising finding that certain A2A receptor antagonists selectively kill FoxA1-expressing cancer cells by off-target agonism of # AhR # AACR20 pic.twitter.com/PeKCkbivmG",,@ @ @,# #,"1254840521614405634",https://twitter.com/HartungIngo/status/1254840521614405634
MGiajLevraMD,2020-04-27 14:30,0,18,"# lungcancer # aacrplenary # AACR20 session at home with my family, while our baby is sleeping. Thank you for this opportunity @ AACR !! Hope to see soon the # lcsm community. See you (virtually) at # asco. Don't stop # CancerResearch , we'll be stronger.pic.twitter.com/IXmvKwBatj",,@,# # # # # #,"1254840468585746433",https://twitter.com/MGiajLevraMD/status/1254840468585746433
Jbauml,2020-04-27 14:30,4,10,"Here is the trial schema, which highlights the difficulty in measuring "MET Positive" NSCLC. Is it only Exon 14? Amplification? Overexpression? This has been an issue of substantial research in the past # LCSM # AACR20 pic.twitter.com/mAj21ieD0G",,,# #,"1254840354970443776",https://twitter.com/Jbauml/status/1254840354970443776
AACR,2020-04-27 14:30,4,6,"Don't forget to check out the journal resources related to # AACR20! Read the collections, learn about our newest journal, @ BCD_AACR, and discover where to submit your manuscripts. https://bit.ly/2W6ZfZf pic.twitter.com/dBwWRywkIc",,@,#,"1254840272002973703",https://twitter.com/AACR/status/1254840272002973703
ReneFromMd,2020-04-27 14:30,0,1,"I was looking at the poster CT129 on this phase one trial. Was the colorectal cancer patient that had PFS of 102 weeks MSS or MSI-H? # AACR20",,,#,"1254840263563976706",https://twitter.com/ReneFromMd/status/1254840263563976706
JCellBiol,2020-04-27 14:30,0,0,"If you are interested in submitting work related to # AACR20 to JCB, we encourage you to contact JCB Senior Scientific Editor Melina Casadio https://bit.ly/2VLW9cE",,,#,"1254840251924840449",https://twitter.com/JCellBiol/status/1254840251924840449
ProfDanielKim,2020-04-27 14:30,6,17,"Fantastic RAS-centric virtual session @ AACR with exciting work from Jillian Silva (McCormick Lab) @ UCSFCancer on NF1 & @ MarcoHHofmann @ Boehringer on SOS1::KRAS inhibitors! Thank you to session chairs @ SilvioGutkind @ UCSDMedSchool & Adrienne Cox @ UNC_Lineberger! # AACR20 pic.twitter.com/GCGwxGk4is",,@ @ @ @ @ @ @,#,"1254840246987943938",https://twitter.com/ProfDanielKim/status/1254840246987943938
MM_Hub,2020-04-27 14:29,0,1,"The trial will evaluate the feasibility of incorporating this approach into clinical practice in order to maximize efficacy and reduce toxicity in # myeloma # mmsm # AACR20 pic.twitter.com/q3k7Ji0VEx",,,# # #,"1254840211135246336",https://twitter.com/MM_Hub/status/1254840211135246336
MM_Hub,2020-04-27 14:29,1,0,"CONGRESS | # AACR20 | @ AgataBlasiak, @ NUSingapore, presents CURATE-AI - a clinical decision support system to optimize dosing. The prospective pilot trial has two arms - one with physician dosing and one with N-of-1 CURATE-AI dosing. # mmsmpic.twitter.com/QlxN6Cm0hx",,@ @,# #,"1254840199898714112",https://twitter.com/MM_Hub/status/1254840199898714112
msmelanoma,2020-04-27 14:29,0,3,"Hi, sorry if this is obvious. Do you mean there is an access to an e-chat with you at @ NatureCancer through the # AACR20 website?",,@,#,"1254840136283631618",https://twitter.com/msmelanoma/status/1254840136283631618
OncoAlert,2020-04-27 14:29,3,3,"Live # AACR20 Tweet by @ NazliDizman "Oncolytic/immunotherapeutic vaccinia virus + anti-PD-1 (cemiplimab) in IO-naive clear-cell # mRCC is tolerable wo IRAEs and promising w a DCR of 75% (6.2% CR, 31.3% PR, 37.5% SD, 25% PD)" @ OncoAlert https://twitter.com/NazliDizman/status/1254838015622410241 …",,@ @,# #,"1254840110065074177",https://twitter.com/OncoAlert/status/1254840110065074177
lgreco_ny,2020-04-27 14:29,0,11,"Capmatinib...one of my drugs... # AACR20 METExon14 # lcsmpic.twitter.com/dqWBSahcCP",,,# #,"1254840099440902144",https://twitter.com/lgreco_ny/status/1254840099440902144
LizCancerHealth,2020-04-27 14:28,3,5,"Poziotinib for selected NSCLC patients shows 65% have some tumor shrinkage -- but 68% had to reduce doses due to side effects. # AACR20 pic.twitter.com/upEOqdpGh5",,,#,"1254839951931215873",https://twitter.com/LizCancerHealth/status/1254839951931215873
cancerassassin1,2020-04-27 14:28,0,1,"# AACR20 # ImmunOnchttps://twitter.com/cancerassassin1/status/1254839214602096641 …",,,# #,"1254839930112663552",https://twitter.com/cancerassassin1/status/1254839930112663552
AileenIlianaPhD,2020-04-27 14:28,0,2,"Taking the opportunity to learn more about # cMet and # NSCLC and the results of phase II GEOMETRY mono-1 study! # AACR20 @ AACR pic.twitter.com/U1dlTRQ8WB",,@,# # #,"1254839860759654400",https://twitter.com/AileenIlianaPhD/status/1254839860759654400
OncoAlert,2020-04-27 14:27,3,5,"Live # AACR20 Tweet by @ ivybelkins " @ LeXiuning presents about phase 2 trial of # poziotinib on previously treated # EGFR # exon20 # NSCLC. " # lcsm # lungcancer @ OncoAlert https://twitter.com/ivybelkins/status/1254838018688659459 …",,@ @ @,# # # # # # #,"1254839703829917702",https://twitter.com/OncoAlert/status/1254839703829917702
CBebernitz,2020-04-27 14:27,0,0,"Really enjoyed Dr. Corsello's talk. I think drug repurposing is extremely valuable but rather underutilized in drug discovery. Another reason to love the @ broadinstitute. # AACR20",,@,#,"1254839682799669249",https://twitter.com/CBebernitz/status/1254839682799669249
OncologyCentral,2020-04-27 14:27,0,1,"Next up, researchers report the results from the Phase II GEOMETRY mono-1 study investigating the use of # capmatinib in # NSCLC.. # AACR20",,,# # #,"1254839527341948928",https://twitter.com/OncologyCentral/status/1254839527341948928
Jbauml,2020-04-27 14:27,3,6,"Next up data on capmatinib in MET Exon 14 skipping NSCLC, presented by Dr Garon. This presentation specifically will describe efficacy in the CNS - this is a major limitation of crizotinib, which is the current SOC for these patients in USA # AACR20 # LCSM",,,# #,"1254839489073201161",https://twitter.com/Jbauml/status/1254839489073201161
OncoAlert,2020-04-27 14:26,1,3,"Live # AACR20 Tweet by @ DMSLung "Poziotinib a promising agent in NSCLC with exon 20 insertion"https://twitter.com/DMSLung/status/1254838218966605824 …",,@,#,"1254839341911859201",https://twitter.com/OncoAlert/status/1254839341911859201
ManuelDomine,2020-04-27 14:25,6,13,"Phase II of Poziotinib in NSCLC with EGFR EXON 20 insertions. Cohort 1 previously treated patients obtained a poor RR of 14.8% @ OncoAlert # LCS # AACR20 pic.twitter.com/Q5m5EsGbH9",,@,# #,"1254839222999158785",https://twitter.com/ManuelDomine/status/1254839222999158785
LeciaSequist,2020-04-27 14:25,2,7,"In discussion, @ LeXiuning says reasons for multi-center results being less impressive could be: a) broader types of mutations allowed, b) less experience managing AE's, c) selection bias of those traveling to MDACC. Great presentation and responses! Congrats! # LCSM # AACR2020",,@,# #,"1254839066593501187",https://twitter.com/LeciaSequist/status/1254839066593501187
LUNGevity,2020-04-27 14:24,3,5,"Poziotinib for EGFR Exon 20 insertions in NSCLC. It's exciting to see progress for Exon 20 insertions... How will pozio line up against mobocertinib? - Dr Xiuning Le @ MDAndersonNews # AACR20 # LCSMpic.twitter.com/18YhoLsYx2",,@,# #,"1254838900662702080",https://twitter.com/LUNGevity/status/1254838900662702080
Jbauml,2020-04-27 14:24,11,20,"This drug is quite toxic - 68% needed to have a dose reduction due to toxicity and 10% permanent treatment cessation because of AE's. Difficult to imagine this dosing level being a feasible approach. Dr Le notes they are looking at BID dosing. # LCSM # AACR20 pic.twitter.com/y5piw7S8Cx",,,# #,"1254838838519832576",https://twitter.com/Jbauml/status/1254838838519832576
manisit_das,2020-04-27 14:23,0,4,"From San Diego to living room # AACR20 @ AACR pic.twitter.com/SgQfqcsQ0L",,@,#,"1254838662900019200",https://twitter.com/manisit_das/status/1254838662900019200
SWOG,2020-04-27 14:23,1,2,"Thanks for the shout-out, @ AACR. If you missed Dr. Algazi's # AACR20 presentation, check out the press release at https://bit.ly/3eY9mYC @ SWOG @ UCSFCancer @ theNCI # PublicPoweredCancerResearchhttps://twitter.com/AACR/status/1254787460413841412 …",,@ @ @ @,# #,"1254838585846411264",https://twitter.com/SWOG/status/1254838585846411264
SatejaParadkar,2020-04-27 14:23,0,3,"And for free!",,,,"1254838496784769033",https://twitter.com/SatejaParadkar/status/1254838496784769033
greisha_ortiz,2020-04-27 14:22,0,0,"Looking forward this sessions!",,,,"1254838425380745222",https://twitter.com/greisha_ortiz/status/1254838425380745222
Jbauml,2020-04-27 14:22,6,10,"This is the surprising data (which had previously b een reported by press release. A much lower ORR was seen here than seen in the Ph1 trial. I suspect this was driven by toxicity and the need for dose reductions, as Dr Le notes had to happen frequently on trial # AACR20 # LCSMpic.twitter.com/olKD5fT8mX",,,# #,"1254838319483162630",https://twitter.com/Jbauml/status/1254838319483162630
DMSLung,2020-04-27 14:21,17,31,"# AACR20 Poziotinib a promising agent in NSCLC with exon 20 insertion pic.twitter.com/Phd6sZe5dG",,,#,"1254838218966605824",https://twitter.com/DMSLung/status/1254838218966605824
lgreco_ny,2020-04-27 14:21,0,5,"Conclusion.. poziotinib. Interesting variation in ORR. Good option for Exon20 patients! # lcsm # AACR20 pic.twitter.com/TrRIHHrudI",,,# #,"1254838114998267905",https://twitter.com/lgreco_ny/status/1254838114998267905
ivybelkins,2020-04-27 14:21,3,11,"@ LeXiuning presents about phase 2 trial of # poziotinib on previously treated # EGFR # exon20 NSCLC. # AACR20 # lcsm @ EGFRResisters @ Exon20Grouppic.twitter.com/VzacRRyjPf",,@ @ @,# # # # #,"1254838018688659459",https://twitter.com/ivybelkins/status/1254838018688659459
NazliDizman,2020-04-27 14:21,19,41,"Ph1 study presented by Dr. Sun Young Rha et al @ AACR # AACR20 @ yonsei_u @ UnivMiami Oncolytic/immunotherapeutic vaccinia virus + anti-PD-1 (cemiplimab) in IO-naive clear-cell # mRCC is tolerable wo IRAEs and promising w a DCR of 75% (6.2% CR, 31.3% PR, 37.5% SD, 25% PD)pic.twitter.com/tEJDBb8kos",,@ @ @,# #,"1254838015622410241",https://twitter.com/NazliDizman/status/1254838015622410241
KarenWehling,2020-04-27 14:20,1,2,"I am also excited to be listening in for the first time!",,,,"1254837935121170432",https://twitter.com/KarenWehling/status/1254837935121170432
Jbauml,2020-04-27 14:20,2,5,"Here are the enrolled patient characteristics. Note that only 25% had received a prior EGFR TKI. Unclear from this table what TKI's were used (exon 20 targeting or not). Varied Exon 20 insertions were noted in the trial # LCSM # AACR20 pic.twitter.com/SIfTEWOoeM",,,# #,"1254837871359545352",https://twitter.com/Jbauml/status/1254837871359545352
CDMRP,2020-04-27 14:20,0,0,"Lung cancer preproposals for the Idea Development Award & the Investigator Initiated Translational Research Award are due May 6, 2020. Details available here https://cdmrp.army.mil/funding/lcrp . @ AACR20 # AACR20 pic.twitter.com/spOrbhPamd",,@,#,"1254837822432968705",https://twitter.com/CDMRP/status/1254837822432968705
lgreco_ny,2020-04-27 14:19,0,2,"# aacr20 dose reductions and AE are concerning, but responses still found at lower dose. # lcsmpic.twitter.com/LgJKPSfspT",,,# #,"1254837501505781760",https://twitter.com/lgreco_ny/status/1254837501505781760
Jbauml,2020-04-27 14:18,4,3,"The trial presented here is a multicenter Phase 2 trial, after impressive ORR seen in the Phase 1. Of note, toxicity was an issue in Ph1 so I will be looking for these data here. # LCSM # AACR20 pic.twitter.com/n4Vd6oz154",,,# #,"1254837354826784770",https://twitter.com/Jbauml/status/1254837354826784770
Jbauml,2020-04-27 14:16,15,45,"Next up at # AACR20 a study of poziotinib in patients with EGFR Exon 20 insertions presented by Dr Le. This variant of EGFR mutated NSCLC tends to be nonresponsive to traditional EGFR TKI's, as is shown dramatically in this KM survival curve. # LCSMpic.twitter.com/fiKlplLPBM",,,# #,"1254836825371414535",https://twitter.com/Jbauml/status/1254836825371414535
christeeny513,2020-04-27 14:15,5,11,"The EMBRACA trial tested talazoparib in BRCA+ HER2-neg locally adv & # metastatic BC. @ JenniferLitton discusses results which did NOT produce overall survival benefit, but DID improve patient-reported # QOL over available chemotherapies. # BCSM # AACR20 https://www.ascopost.com/news/april-2020/final-overall-survival-results-from-the-phase-iii-embraca-trial/ …",,@,# # # #,"1254836500098932739",https://twitter.com/christeeny513/status/1254836500098932739
Dr_ZiMingZhao,2020-04-27 14:15,0,3,"Progress in using cancer genomics to stratify patients in immunotherapy # AACR20 - glad to see increasing WNT/β-catenin translational roles after years of my catenin gene family evolutionary studies https://link.springer.com/article/10.1186/1471-2148-11-198 …https://twitter.com/jitcancer/status/1254831318799712259 …",,,#,"1254836497477402624",https://twitter.com/Dr_ZiMingZhao/status/1254836497477402624
abcam,2020-04-27 14:14,0,3,"Don’t forget to stop by tomorrow to learn about Epigenetic targets in cancer & advances in multiplex immunohistochemistry from Maria Paola Serra. Join us daily as we stream our # AACR20 cancer research talks and information, April 27- May 1. Learn more: https://bit.ly/3aoLx8V pic.twitter.com/Em6oDdz4wN",,,#,"1254836215209177093",https://twitter.com/abcam/status/1254836215209177093
francescocay,2020-04-27 14:12,0,6,"The virtual # AACR20 annual meeting is underway. Love being able to switch between sessions in seconds without running between opposite sides of the conference center! Missing the San Diego weather and all my friends and colleagues though. https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …",,,#,"1254835820755693568",https://twitter.com/francescocay/status/1254835820755693568
drleemachado,2020-04-27 14:11,0,0,"# AACR20 Disappointing results for PARPi Talazoparib vs Chemo final overall survival results from phase 3 EMBRACA Breast cancer trial...",,,#,"1254835598625517570",https://twitter.com/drleemachado/status/1254835598625517570
IreneMangues,2020-04-27 14:11,3,8,"Comienza ahora en # AACR20 Lung Cancer Targeted Therapy Clinical Plenary Session pic.twitter.com/pumWKrkW8k",,,#,"1254835541272657920",https://twitter.com/IreneMangues/status/1254835541272657920
cancerassassin1,2020-04-27 14:11,2,4,"# AACR20 - an emerging theme of Adaptive Therapy @ ara_anderson @ mathoncoblog @ mathonco @ dbasanta @ theheikmanhttps://twitter.com/ara_anderson/status/1254829456528637953 …",,@ @ @ @ @,#,"1254835514227785729",https://twitter.com/cancerassassin1/status/1254835514227785729
OncologyCentral,2020-04-27 14:10,0,0,"The first # lungcancer presentation looks at the durability of # poziotinib in Phase II clinical trial involving # NSCLC patients # AACR20",,,# # # #,"1254835303048765440",https://twitter.com/OncologyCentral/status/1254835303048765440
StoneEL2,2020-04-27 14:10,0,0,"use a different email address and make a new log-in for AACR.",,,,"1254835263148158977",https://twitter.com/StoneEL2/status/1254835263148158977
_antjeschaefer,2020-04-27 14:09,0,1,"1st day of the # AACR Virtual Annual Meeting I: interesting talks and Q&As. # AACR2020 # CancerResearch @ AACR pic.twitter.com/E2ozkArPww",,@,# # #,"1254835197519986688",https://twitter.com/_antjeschaefer/status/1254835197519986688
CathyEngMD,2020-04-27 14:09,1,2,"Major # FOMO re: @ AACR # virtualmeeting! Tried all AM but my password reset won't work (I have tried 7x's...It just sends me and my AA in circles) # AACR2020 IT I have filled out the form. CALL me back pls so I can enjoy the meeting @ AACR_CEO! @ VUMC_Cancer # CancerResearch # Cancers",,@ @ @,# # # # #,"1254834979101646854",https://twitter.com/CathyEngMD/status/1254834979101646854
Vaccinex,2020-04-27 14:09,0,1,"Updated interim results from CLASSICAL-Lung, our Ph. 1b/2 study of pepinemab in # NSCLC will be presented in a virtual poster session today at the @ AACR Virtual Annual Meeting. See here for more information about how to access the presentation: https://bddy.me/3bKhj1A # AACR20 pic.twitter.com/h0WIXlhQU2",,@,# #,"1254834966363504645",https://twitter.com/Vaccinex/status/1254834966363504645
nycdoc29,2020-04-27 14:08,0,0,"# AACR20 - virtual # lungcancer session # lcsmpic.twitter.com/WD8efofHYn",,,# # #,"1254834910667460610",https://twitter.com/nycdoc29/status/1254834910667460610
pashtoonkasi,2020-04-27 14:08,0,3,"# TwitterPoll in parallel to # AACR20. Taking a stab at scenarios: # CRCSM - hopefully not getting them wrong. Assuming no # clinicaltrials option.pic.twitter.com/I9Dz15e66X",,,# # # #,"1254834818971549697",https://twitter.com/pashtoonkasi/status/1254834818971549697
LeciaSequist,2020-04-27 14:08,4,40,"So great to be "at" the lung cancer session # AACR2020, starting now. Exciting to be thinking about # LungCancer again # LCSM",,,# # #,"1254834701740789760",https://twitter.com/LeciaSequist/status/1254834701740789760
tmprowell,2020-04-27 14:08,9,22,"Hey # advocacy colleagues, here's your chance to access all @ AACR journal content w/ no paywall during # AACR20 Virtual Annual Mtg 1 (which is also free). cc @ GRASPtweets @ ros1cancer @ EGFRResisters @ PanCAN @ MelanomaReAlli @ KidneyCancer @ NBTStweets @ SusanGKomen @ SU2C @ LLSusahttps://twitter.com/CIR_AACR/status/1254832737753739265 …",,@ @ @ @ @ @ @ @ @ @ @,# #,"1254834696783122443",https://twitter.com/tmprowell/status/1254834696783122443
OncologyCentral,2020-04-27 14:07,0,1,"The # lungcancer targeted therapy session at # AACR20 has began! Excited to find out how the results from clinical trials can be applied to the field.",,,# #,"1254834632853458946",https://twitter.com/OncologyCentral/status/1254834632853458946
drteplinsky,2020-04-27 14:07,0,4,"Final OS data from EMBRACA: no OS difference between talazoparib and chemo but many patients went on to get PARP inhibitor or platinum later on. # aacr20",,,#,"1254834535277174786",https://twitter.com/drteplinsky/status/1254834535277174786
PolakPaz,2020-04-27 14:07,0,0,"Since the normal endometrial paper of Sanger, I wonder if PIK3CA is important for cancer beyond the early stages. (",,,,"1254834529879183360",https://twitter.com/PolakPaz/status/1254834529879183360
LwoodCUAnschutz,2020-04-27 14:07,0,7,"The bright side of going virtual: I can attend AACR with my mom and make her explain all the clinical data to me. she doesn’t kill me by day 2 # generationsofcancerresearchers @ AACR pic.twitter.com/yrN8E0WNl2",,@,#,"1254834523671494656",https://twitter.com/LwoodCUAnschutz/status/1254834523671494656
ErikaHamilton9,2020-04-27 14:07,2,10,"# AACR20 abstract CT107 by Dr. Silva, @ kalinskykevin et al: ricolinostat (HDAC6 inhibitor) + nab-pac in ph I # bcsm. 16 pts with no MTD, of 15 with measurable disease, 2PRs, 11SD. CBR at 6 mo, 31.3% pts with HDAC6 score imp PFS (6.6 vs. 2.0 months) @ OncoAlert",,@ @,# #,"1254834489387356160",https://twitter.com/ErikaHamilton9/status/1254834489387356160
RoswellPark,2020-04-27 14:06,31,60,"Dr. Grace Dy is presenting new data today from Roswell Park's CIMAvax/nivolumab study. The combination’s activation of B and T cells is encouraging compared to checkpoint blockade # immunotherapy alone. # AACR20 https://www.abstractsonline.com/pp8/#!/9045/presentation/10629 …pic.twitter.com/NtjKeAxZfu",,,# # #,"1254834375511990274",https://twitter.com/RoswellPark/status/1254834375511990274
LizCancerHealth,2020-04-27 14:05,1,0,"Final survival data from EMBRACA study of Talzenna for BRCA-mutation # breastcancer just reported at # AACR20 https://twitter.com/MDAndersonNews/status/1254832730367557635 …",,,# #,"1254834122897240065",https://twitter.com/LizCancerHealth/status/1254834122897240065
johnmckenneyiii,2020-04-27 14:05,0,1,"Despite a few early morning hiccups caused by an unprecedented volume of attendees, our # AACR20 Virtual Annual Meeting I meeting is a huge success! So proud of my team of @ SalesforceOrg Trailblazers!",,@,#,"1254834041788018692",https://twitter.com/johnmckenneyiii/status/1254834041788018692
YMAbdelhalim,2020-04-27 14:00,0,1,"Will that be available afterwards? As I'm currently attending the Immunotherapy CT session and I can't watch both at the same time. Thank you!",,,,"1254832811426676736",https://twitter.com/YMAbdelhalim/status/1254832811426676736
alantanmd,2020-04-27 14:00,0,2,"Given the lack of options in ocular # melanoma I’d consider this a small victory with stable disease # AACR20 pic.twitter.com/zfMPRo76lV",,,# #,"1254832754488782848",https://twitter.com/alantanmd/status/1254832754488782848
JExpMed,2020-04-27 14:00,2,0,"Philippe Bousso lab: Single-cell intravital imaging reveals that genetically engineered T cells can induce tumor regression by direct killing of cancer cells. JEM’s collection for # AACR20 (https://bit.ly/3avNaBK ) has new short summaries of articles: https://bit.ly/2XYhG4z pic.twitter.com/br5lVjKeNp",,,#,"1254832744124821504",https://twitter.com/JExpMed/status/1254832744124821504
CIR_AACR,2020-04-27 14:00,3,5,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2ScptIw pic.twitter.com/pchjkXlnA0",,@,#,"1254832737753739265",https://twitter.com/CIR_AACR/status/1254832737753739265
MCT_AACR,2020-04-27 14:00,0,0,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/3bDtWvv pic.twitter.com/nquFEvujhd",,@,#,"1254832730547896328",https://twitter.com/MCT_AACR/status/1254832730547896328
MDAndersonNews,2020-04-27 14:00,8,18,"“Talazoparib remains an option for patients with advanced # breastcancer and a germline BRCA mutation due to its improvements in progression free survival,” says our @ JenniferLitton of the findings of the Phase III EMBRACA clinical trial: https://bit.ly/2xUOO2V # AACR20 # endcancer",,@,# # #,"1254832730367557635",https://twitter.com/MDAndersonNews/status/1254832730367557635
CR_AACR,2020-04-27 14:00,0,1,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2W6ofQf pic.twitter.com/BN6osykNer",,@,#,"1254832729390297090",https://twitter.com/CR_AACR/status/1254832729390297090
MCR_AACR,2020-04-27 14:00,0,2,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2S76Ohh pic.twitter.com/2cVfn8DBiG",,@,#,"1254832728769527810",https://twitter.com/MCR_AACR/status/1254832728769527810
CEBP_AACR,2020-04-27 14:00,4,13,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2Ym9v2z pic.twitter.com/cJbKZFX2xO",,@,#,"1254832728119410689",https://twitter.com/CEBP_AACR/status/1254832728119410689
JAMANetwork,2020-04-27 14:00,0,0,"Learn more about publishing your # AACR20 research, and other # oncology research, in @ JAMAOnc and other JAMA Network journals https://ja.ma/3eDqBOV",,@,# #,"1254832685371047939",https://twitter.com/JAMANetwork/status/1254832685371047939
Chapiscience,2020-04-27 13:59,0,0,"Attending # AACR20 virtual meeting, great way to keep researchers in touch with latest advances in cancer research despite beeing stuck home. Hoping for more of these broadly accessible international meetings in the future pic.twitter.com/5klg2rL9Xh",,,#,"1254832592353976321",https://twitter.com/Chapiscience/status/1254832592353976321
YMAbdelhalim,2020-04-27 13:57,0,0,"Now attending @ AACR # AARC20 Virtual Meeting Ihttps://twitter.com/AACR/status/1254824558017875968 …",,@,#,"1254832156947472386",https://twitter.com/YMAbdelhalim/status/1254832156947472386
IreneMangues,2020-04-27 13:56,3,3,"COVID-19 and Cancer. Clinical Plenary. American Association for Cancer Research # AACR20. Tuesday, April 28. 15:00pm - 17:00 pm (GMT+2)",,,#,"1254831884082782210",https://twitter.com/IreneMangues/status/1254831884082782210
JeremyWaight,2020-04-27 13:56,0,1,"A slight wave of depression with the fist session of the # AACR2020 Virtual Annual - realizing that no matter how well this is organized, nothing can replace the F2F meeting...",,,#,"1254831856568209410",https://twitter.com/JeremyWaight/status/1254831856568209410
sarahhwangg_,2020-04-27 13:54,0,6,"So cool that # AACR20 was able to hold their annual meeting virtually! Learning a lot of cutting edge research from home and in comfy sweats",,,#,"1254831375233908736",https://twitter.com/sarahhwangg_/status/1254831375233908736
jitcancer,2020-04-27 13:54,9,22,"Great discussion by Dr @ jasonlukemd @ UPMCHillmanCC on mech of immune-exclusion, T cell-inflamed tumors & # immunotherapy # AACR20 @ AACR Referenced paper for genomic changes & immune infiltration @ biorxivpreprint https://www.biorxiv.org/content/10.1101/773127v1 …pic.twitter.com/dbnDk7AoqO",,@ @ @ @,# #,"1254831318799712259",https://twitter.com/jitcancer/status/1254831318799712259
OncoAlert,2020-04-27 13:54,3,4,"Live # AACR20 Tweet by @ gerlach_d "Adrienne Cox providing a summary on the session "Emerging Signaling Vulnerabilities in Cancer" " @ OncoAlert https://twitter.com/gerlach_d/status/1254826846086184960 …",,@ @,#,"1254831173274083328",https://twitter.com/OncoAlert/status/1254831173274083328
CancerMedMDA,2020-04-27 13:53,0,0,"Dr. Ferdinandos Skoulidis discusses Lung Cancer Targeted Therapy, # AACR20 Session VCTPL08. Today at 2:40 PM (3:40 PM EDT). @ AACR https://bit.ly/2KzOYz2",,@,#,"1254830922500673538",https://twitter.com/CancerMedMDA/status/1254830922500673538
LUNGevity,2020-04-27 13:52,1,3,"# COVID19 isn't stopping scientists from presenting at # AACR20. Cannot wait for the next session to start at 2 PM Eastern and learn about advances in targeted therapies. # lcsmpic.twitter.com/jQV7saDf1q",,,# # #,"1254830820239519746",https://twitter.com/LUNGevity/status/1254830820239519746
_Ktktktktk,2020-04-27 13:49,4,8,"Wading through # AACR20 AACR content? Here's a rundown of how biology and technology trends we've covered at @ BioCentury in the last year are showing up in Part 1 of the meeting.https://www.biocentury.com/article/305010",,@,#,"1254830140279808000",https://twitter.com/_Ktktktktk/status/1254830140279808000
DrMariFragoso,2020-04-27 13:47,0,5,"Day will be divided in work meetings, talks from the # AACR2020 Virtual Meeting and # coffee. # StayHomepic.twitter.com/QY4SkYOGEM",,,# # #,"1254829601534197762",https://twitter.com/DrMariFragoso/status/1254829601534197762
Rick__Buck,2020-04-27 13:46,2,4,"Here is coverage of the # AACR2020 Opening Session this morning on our ⁦ @ AACR⁩ blog.https://www.aacr.org/professionals/blog/virtual-annual-meeting-i-the-opening-session/ …",,@,#,"1254829180870692867",https://twitter.com/Rick__Buck/status/1254829180870692867
AML_Hub,2020-04-27 13:45,1,3,"In a small sample of patients with TP53-mutated # AML the overall response rate to flotetuzumab was encouraging and the authors conclude this immunotherapeutic approach warrants further study # leusm # AACR20 pic.twitter.com/XysFrjRI90",,,# # #,"1254828992210907138",https://twitter.com/AML_Hub/status/1254828992210907138
AML_Hub,2020-04-27 13:45,8,12,"CONGRESS | # AACR20 | Sergio Rutella, @ TrentUni, discusses how TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab in AML # leusmpic.twitter.com/Ym63LNPHI2",,@,# #,"1254828982744297472",https://twitter.com/AML_Hub/status/1254828982744297472
AndySchmeltz,2020-04-27 13:44,0,8,"Excited for # AACR20 to kick-off today! This meeting gives us a chance to learn from early stage data on novel approaches, including this one from our pipeline. # PfizerProud # Cancerhttps://twitter.com/PfizerCongress/status/1254776104109215745 …",,,# # #,"1254828816444395525",https://twitter.com/AndySchmeltz/status/1254828816444395525
SU2Cscience,2020-04-27 13:44,3,8,"Please tune in tomorrow (TUESDAY April 28) for @ SU2C funded researchers presenting their work at the @ AACR annual meeting, being held now via the Web. Progress and results from five teams will be discussed, the first at 10:50 AM Eastern # AACR20 https://standuptocancer.org/press/stand-up-to-cancer-funded-research-to-be-presented-during-the-2020-aacr-virtual-meeting/ …",,@ @,#,"1254828665826873344",https://twitter.com/SU2Cscience/status/1254828665826873344
hemato,2020-04-27 13:43,0,2,"Very excited attending # AACR2020. Seeing the highest level science from my own living-room, in my slippers :-) ! Muy interesado asitiendo # AACR2020 desde la sala de casa. No habria pensado en oir en vivo ciencia de este nivel, usando pantunflas("pantunflos" para El Quijote ;-) pic.twitter.com/ssXwX4OGUY",,,# #,"1254828610189484033",https://twitter.com/hemato/status/1254828610189484033
ourbrainbank,2020-04-27 13:41,0,2,"If so, please share to @ ourbrainbank, a nonprofit founded by @ jessicamorris, living with # GBM. We have an IRB-approved study using a free smartphone app. More: http://OurBrainBank.org # AACR20 # AACR2020 # glioblastoma",,@ @,# # # #,"1254828087004606470",https://twitter.com/ourbrainbank/status/1254828087004606470
OncoAlert,2020-04-27 13:41,6,14,"Throwback to # AACR19 , Where @ OncoAlert Got its official Start, our KICK OFF CongressGreat Job with # AACR20 @ AACR https://twitter.com/OncoAlert/status/1111943994014085122 …",,@ @,# #,"1254827936395517952",https://twitter.com/OncoAlert/status/1254827936395517952
ADCReview,2020-04-27 13:41,1,0,"Netherlands-based @ Synthon Biopharmaceuticals, developing innovative the anti-HER2 antibody-drug conjugate [vic-] trastuzumab duocarmazine # SYD985 for breast cancer, has been relaunched as @ byondis https://adc.expert/Byondis # ADC # breastcancer @ World_ADC @ ASCO @ AACR @ CPhIWW # biotech",,@ @ @ @ @ @,# # # #,"1254827902715064322",https://twitter.com/ADCReview/status/1254827902715064322
AriellaHanker,2020-04-27 13:40,2,17,"Exciting session on signaling vulnerabilities with implications for targeting # KRAS and # PI3K. So much pathway complexity! Nice summary by Dr. Adrienne Cox @ UNC_Lineberger # AACR20 pic.twitter.com/KpQ20dEvCK",,@,# # #,"1254827807026425864",https://twitter.com/AriellaHanker/status/1254827807026425864
christeeny513,2020-04-27 13:40,1,3,". @ FilipJankuMD of @ MDAndersonNews discusses the small molecule inhibitor WNT974 (LGK974) in combo with immunotherapy spartalizumab (PDR001) Trial currently recruiting for # TNBC & others! # BCSM # PancSM # CRCSM # MelSM # GyncSM # LCSM # HNCSM # EsocSM # AACR2020 https://clinicaltrials.gov/ct2/show/NCT01351103 …",,@ @,# # # # # # # # # #,"1254827801724760065",https://twitter.com/christeeny513/status/1254827801724760065
FaizahAlotaibi_,2020-04-27 13:39,1,1,"The trend in # cancer research nowadays is drugs combination! Do you agree? # AACR2020",,,# #,"1254827470550859778",https://twitter.com/FaizahAlotaibi_/status/1254827470550859778
teamTME_UHN,2020-04-27 13:38,2,11,"HAPPENING NOW: Tune in to @ AACR’s “drugging undrugged cancer target” session to hear more about our very own # teamTME member, Dr. Stefano Marastoni’s research!pic.twitter.com/nDTumyA7PU",,@,#,"1254827275318710274",https://twitter.com/teamTME_UHN/status/1254827275318710274
jitcancer,2020-04-27 13:38,3,6,"Great talk on TP53 mutation & T cell-inflamed acute myeloid leukemia by Dr. Rutella @ vanGeestCancer @ TrentUni # AACR20 @ AACR Full manuscript for this work in the @ biorxivpreprint https://www.biorxiv.org/content/10.1101/702001v1 …pic.twitter.com/1xQFNAqPkk",,@ @ @ @,#,"1254827223116328962",https://twitter.com/jitcancer/status/1254827223116328962
SachitaGanesa,2020-04-27 13:37,1,4,"So excited to attend @ AACR's virtual annual meeting online today and tomorrow. Thank you for making science so much more accessible!",,@,,"1254826969184731136",https://twitter.com/SachitaGanesa/status/1254826969184731136
DFBC_PedCare,2020-04-27 13:36,0,4,"As part of the # AACR20 virtual meeting trials in progress session, David Shulman, MD, will present on "A phase 2 clinical trial of palbociclib and ganitumab for relapsed/refractory Ewing sarcoma" today, available from 9:00 a.m. to 6:00 pm EST. Learn more: http://ms.spr.ly/6016Tgjvq pic.twitter.com/JtBLBlTlcd",,,#,"1254826860153917447",https://twitter.com/DFBC_PedCare/status/1254826860153917447
gerlach_d,2020-04-27 13:36,5,5,"Adrienne Cox providing a summary on the session "Emerging Signaling Vulnerabilities in Cancer" # AACR20 pic.twitter.com/iWCzVGIAaa",,,#,"1254826846086184960",https://twitter.com/gerlach_d/status/1254826846086184960
levinemd,2020-04-27 13:35,12,47,"Rosen Lab @ sloan_kettering presents fascinating mTOR-regulated homeostatic interactions between PIK3CA and PTEN @ AACR # AACR2020 online today; https://www.abstractsonline.com/pp8/#!/9045/presentation/10562 …pic.twitter.com/MkMEhjQFF6",,@ @,# #,"1254826625834811392",https://twitter.com/levinemd/status/1254826625834811392
DeepOnCar,2020-04-27 13:35,2,3,"Promising preclinical in-vitro data from Marco Hoffman of @ Boehringer for their # SOS1 inhibitor BI-1701963 in targeting # KRAS mutant # Pancreatic and # Colorectal cancer in combination with # MEKi, and # irinotecan. # AACR2020 # OncoAlert",,@,# # # # # # # #,"1254826492636381189",https://twitter.com/DeepOnCar/status/1254826492636381189
boehringerus,2020-04-27 13:35,3,11,"# AACR20: Marco Hofmann, a member of our # CancerResearch team presents preclinical data on how our pan # KRAS and # MEKInhibitor combinations work across a broad range of mutations leading to tumor stasis or regression: https://bit.ly/2SaPCHN pic.twitter.com/TZcYx1PZDc",,,# # # #,"1254826412462268416",https://twitter.com/boehringerus/status/1254826412462268416
SWOG,2020-04-27 13:32,0,1,"Thanks for the shout-out @ RutgersCancer Check out our press release on the # AACR20 presentation at https://bit.ly/3eY9mYC https://twitter.com/RutgersCancer/status/1254783721925795841 …",,@,#,"1254825776899227649",https://twitter.com/SWOG/status/1254825776899227649
CancerConnector,2020-04-27 13:32,1,5,"Eager to see these adaptive therapy trials with a stronger basic science foundation - our first attempts at this here in @ NatureEcoEvo : https://www.nature.com/articles/s41559-018-0768-z … # AACR2020",,@,#,"1254825644522864642",https://twitter.com/CancerConnector/status/1254825644522864642
ScripMandy,2020-04-27 13:31,1,10,"I’ll be watching # AACR20 presentations in a bit, but had to take a break from job no. 2 for some important team-building exercises in job no. 1. pic.twitter.com/nkTUh7teU2",,,#,"1254825561236533252",https://twitter.com/ScripMandy/status/1254825561236533252
Instinctif_HLS,2020-04-27 13:31,1,1,". @ KarusTx announces new data from Phase I # clinicaltrial in advanced # cancer at @ AACR annual meeting. # AACR20 https://karustherapeutics.com/karus-therapeutics-announces-new-data-from-phase-i-cancer-trial-at-aacr/ …",,@ @,# # #,"1254825408836579330",https://twitter.com/Instinctif_HLS/status/1254825408836579330
ReeseFCRC,2020-04-27 13:31,4,9,"Even though # AACR2020 isn’t happening in person, there is still a virtual option! Excited to listen in to latest # Colorectalcancer # research updates. @ FightCRC @ AACR https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …",,@ @,# # #,"1254825394869592065",https://twitter.com/ReeseFCRC/status/1254825394869592065
AACR,2020-04-27 13:30,11,28,"# AACR20 Today’s minisymposia will cover the topics: Advances in Cancer Drug Design and Discovery, Emerging Signaling Vulnerabilities in Cancer, Drugging Undrugged Cancer Targets (1 of 2)",,,#,"1254825181832531970",https://twitter.com/AACR/status/1254825181832531970
JCellBiol,2020-04-27 13:30,1,1,"Duplicated chromosome sets is common in cancer but the extra chromosomes act as a barrier to typical “bipolar” cell division. Read new short summaries of articles (https://bit.ly/2XYckGS ) that are part of JCB’s new cancer collection for # AACR20 https://bit.ly/2Vv9GXj pic.twitter.com/rs6h6PRP3Z",,,#,"1254825162559688707",https://twitter.com/JCellBiol/status/1254825162559688707
pauldriscoll33,2020-04-27 13:29,0,0,"In the virtual house!!",,,,"1254825070243053570",https://twitter.com/pauldriscoll33/status/1254825070243053570
AACR,2020-04-27 13:27,2,8,"# AACR20 Virtual Annual Meeting I: Immunotherapy Clinical Trials 1. Presenter Ryan Sullivan shares results from a phase I trial testing COM701:",,,#,"1254824558017875968",https://twitter.com/AACR/status/1254824558017875968
elan662,2020-04-27 13:26,0,2,"According to Jacob Plieth, there will be a second # AACR20 in June. Abstracts for this conference drop 15 May. So EHA be taking place around the same time? $ apto",,,#,"1254824369429327878",https://twitter.com/elan662/status/1254824369429327878
OncoAlert,2020-04-27 13:26,1,1,"Live # AACR20 Tweet by @ AriRosenbergMD "Promising # HPV DNA # vaccine + anti-PD1 therapy may have efficacy in # HPV associated cancer. Need further characterization of non responders with evidence of antigen specific T-cell responses" # hncsm @ OncoAlert https://twitter.com/AriRosenbergMD/status/1254823403128852480 …",,@ @,# # # # #,"1254824302358286337",https://twitter.com/OncoAlert/status/1254824302358286337
Rick__Buck,2020-04-27 13:26,0,6,"Agree Emil. We will need to have a virtual # SSP gathering after # AACR2020. @ Carefree411",,@,# #,"1254824280824651777",https://twitter.com/Rick__Buck/status/1254824280824651777
webofmeetings,2020-04-27 13:25,0,0,"# AACR20 Are you attending the world-class conference "American Association for Cancer Research Annual Meeting 2020"? Leave your review of 2020 edition @ webofmeetings and share your opinion https://webofmeetings.com/2019/biomedicine/cancer/american-association-for-cancer-research-annual-meeting-2020 … @ AACR",,@ @,#,"1254824112427618307",https://twitter.com/webofmeetings/status/1254824112427618307
DanChenMDPhD,2020-04-27 13:25,1,5,"Great to see the outcome of # cancer # immunotherapy in combination with # oncogene targeted therapy here. The results of combinations where the individual components are are all known to be active in a given disease have been quite positive. # atezolizumab # melanoma",,,# # # # #,"1254823885381328896",https://twitter.com/DanChenMDPhD/status/1254823885381328896
lymphomahub,2020-04-27 13:23,7,15,"CONGRESS | # AACR20 | @ DrNathanFowler, @ MDAndersonNews, presents the design of the phase III PERSPECTIVE study: ibrutinib + rituximab versus placebo + rituximab for frontline FL. Study is based on promising phase II results published in British Journal of Haematology # lymsmpic.twitter.com/EOq3JwOrXz",,@ @,# #,"1254823539040976897",https://twitter.com/lymphomahub/status/1254823539040976897
AriRosenbergMD,2020-04-27 13:23,0,7,"Promising HPV DNA vaccine + anti-PD1 therapy may have efficacy in # HPV associated cancer. Need further characterization of non responders with evidence of antigen specific T-cell responses. # AACR20 # hncsmpic.twitter.com/dCtkPTND2j",,,# # #,"1254823403128852480",https://twitter.com/AriRosenbergMD/status/1254823403128852480
CancerMedMDA,2020-04-27 13:23,0,0,"Don't miss @ LeXiuning for # AACR20 Session CT081, "Poziotinib activity & durability of responses in previously treated EGFR exon 20 NSCLC pts-a Phase 2 study." Today at 1:05 PM (2:05 PM EDT). @ AACR https://bit.ly/3bCqvVP",,@ @,#,"1254823372879511554",https://twitter.com/CancerMedMDA/status/1254823372879511554
JocelynnPearl,2020-04-27 13:22,0,0,"@ AACR is free and open and can be streamed! woohoo",,@,,"1254823205119782912",https://twitter.com/JocelynnPearl/status/1254823205119782912
MABaghdadi,2020-04-27 13:19,0,4,"The program of the # AACR20 Virtual Annual Meeting I (Apr 27-28) will include a session on # COVID19 and Cancer. Learn more and register for free access: http://bit.ly/3ektp3i",,,# #,"1254822558282788866",https://twitter.com/MABaghdadi/status/1254822558282788866
MABaghdadi,2020-04-27 13:19,0,5,"For the first time, you can register for the # AACR20 virtual annual meeting for free! It will include a session on # COVID19 and # cancer",,,# # #,"1254822462207991809",https://twitter.com/MABaghdadi/status/1254822462207991809
icrpartners1,2020-04-27 13:19,1,3,"Follow # AACR2020 for the latest news from the virtual # cancerresearch meeting. Visit https://www.aacr.org/meeting/aacr-annual-meeting-2020/ … to participate onlinepic.twitter.com/P390ysAIBj",,,# #,"1254822424639651840",https://twitter.com/icrpartners1/status/1254822424639651840
gerlach_d,2020-04-27 13:18,5,16,"Potent and selective SOS1::KRAS inhibitors from @ Boehringer - new data presented now at # AACR20 by @ MarcoHHofmann https://www.abstractsonline.com/pp8/#!/9045/presentation/10563 … # KRAS # PANKRASpic.twitter.com/GBatw69pmk",,@ @,# # # #,"1254822338501185537",https://twitter.com/gerlach_d/status/1254822338501185537
ErikaHamilton9,2020-04-27 13:18,7,21,"# AACR20 abstract CT108 by @ hoperugo et al: ph IB of AI + abema + pembro in HR+ HER2neg # bcsm. Of 26 pts, 2 fatal pneumonitis, 31% LFT G3, and unsurprising 31% G3 neutropenia. 58% d/c’3ed due to AEs. 19% ORR, CBR at 6 mo 27%. Surprising toxicity, no? @ OncoAlert",,@ @,# #,"1254822293316009984",https://twitter.com/ErikaHamilton9/status/1254822293316009984
cancerassassin1,2020-04-27 13:18,0,1,"I had an opportunity to come up with fun titles for my team's videos for this Cancer Killers @ CellPressNews. I called this one: 'Road to Perdition' - intercellular transfer of GFP-expressing oncolytic herpes simplex virus https://www.youtube.com/watch?time_continue=20&v=GzhdZaDl4sI&feature=emb_logo … https://www.cell.com/pictureshow/cancer-killers … # AACR20 https://twitter.com/cancerassassin1/status/1254770453912010753 …",,@,#,"1254822264635359239",https://twitter.com/cancerassassin1/status/1254822264635359239
DanaFarberNews,2020-04-27 13:18,5,10,"Today at 2:05 PM EST, Dana-Farber’s Steven Corsello, MD ( @ corsellos), will present research on how adenosine receptor antagonists exhibit potent and selective off-target killing of FOXA1-high # cancers # AACR20 Abstract link: http://ms.spr.ly/6016TgjS6 pic.twitter.com/ECswuP6oLM",,@,# #,"1254822247405178880",https://twitter.com/DanaFarberNews/status/1254822247405178880
NanomedZone,2020-04-27 13:18,3,5,"The @ AACR Virtual Annual Meeting has kicked off to a great start today with some interesting sessions including a presentation on the PEANUT trial on chemotherapeutics for urothelial carcinoma, read more on @ NanomedZone https://bit.ly/2Y9qtB1 # nanomedicine # AACR2020",,@ @,# #,"1254822192711434242",https://twitter.com/NanomedZone/status/1254822192711434242
MegVoda,2020-04-27 13:18,0,1,"Gracias por la informacion! Un buen opportunidad por ellos quien estudiar cancer, pero no son parte de AACR. Disculpe mi Espanol pobre.",,,,"1254822138231566339",https://twitter.com/MegVoda/status/1254822138231566339
OncoAlert,2020-04-27 13:16,0,0,"Live # AACR20 Tweet by our dear friend @ ednacukierman "Interested in downstream Kras signaling? don't miss https://abstractsonline.com/pp8/#!/9045/presentation/10558 …… "Downstream kinase signaling is dictated by specific KRAS mutations" @ OncoAlert https://twitter.com/ednacukierman/status/1254746856237797376 …",,@ @,# #,"1254821764414267392",https://twitter.com/OncoAlert/status/1254821764414267392
YuanPan3,2020-04-27 13:15,0,4,"Time for # AACR20! pic.twitter.com/UMuS64Uy2D",,,#,"1254821530015420416",https://twitter.com/YuanPan3/status/1254821530015420416
MasonIsraelPhD,2020-04-27 13:12,0,0,"Disappointing # immunotherapy results in metastatic # ProstateCancer today at # AACR20. Hopefully additional biomarker and research will help in future. $ RHHBYhttps://twitter.com/tompowles1/status/1254793493521805312 …",,,# # #,"1254820724864253960",https://twitter.com/MasonIsraelPhD/status/1254820724864253960
cancerassassin1,2020-04-27 13:12,0,15,"One thing that is hard to replace, and what I really miss about # AACR20: not seeing attendees of the # AACRSSP ScientistSurvivor Program this year - Thinking of friends and alums of # SSP @ chemobrainfog @ jleePSOC @ AnnaBarker20 @ amos18 and *everyone* I can't fit here # AACR20",,@ @ @ @,# # # #,"1254820648943263745",https://twitter.com/cancerassassin1/status/1254820648943263745
manjuggm,2020-04-27 13:11,0,0,"# AACR2020 If the full poster titles would show, then scrolling through the posters to find ones of interest would be easier.",,,#,"1254820454193389569",https://twitter.com/manjuggm/status/1254820454193389569
Instinctif_HLS,2020-04-27 13:10,1,1,"Dr. Apostolia Maria Tsimberidou on behalf of @ MDAndersonNews is presenting @ KarusTx's latest # clinicaldata from Phase I study of # KA2507, a selective # HDAC6 inhibitor, in patients with relapsed or refractory solid # tumors. @ AACR https://bit.ly/2VIVNVzaa pic.twitter.com/7PVFUVrOXE",,@ @ @,# # # #,"1254820273825726464",https://twitter.com/Instinctif_HLS/status/1254820273825726464
cannon_alexa,2020-04-27 13:10,0,4,"Great presentation, @ KonstantinBuda2! # AACR20 https://twitter.com/ednacukierman/status/1254746856237797376 …",,@,#,"1254820263952343040",https://twitter.com/cannon_alexa/status/1254820263952343040
CharuAggarwalMD,2020-04-27 13:10,2,12,"# Targeted # Immunotherapy using antigen specific vaccine + anti PD(L)-1 is possible in select cancers, such as # HPV associated malignancies. We have an ongoing trial of HPV16/18 # DNA vaccine + Durvalumab in pts with HNCa @ PennCancer. Early data of GX-188E + Pembro # AACR20 https://twitter.com/Jbauml/status/1254813031281963008 …",,@,# # # # #,"1254820241215021056",https://twitter.com/CharuAggarwalMD/status/1254820241215021056
lymphomahub,2020-04-27 13:07,1,1,"Enrica Marchi and colleagues concluded that adding an immune checkpoint inhibitor to an epigenegic backbone is well-tolerated and leads to encouraging responses in T-cell lymphoma # lymsm # AACR20 pic.twitter.com/H4DxSmZ2gw",,,# #,"1254819481194565632",https://twitter.com/lymphomahub/status/1254819481194565632
lymphomahub,2020-04-27 13:07,2,1,"The DURABILITY study enrolled patients with PTCL, both de novo and R/R. All responders were in Arm A - durvalumab + 5-azacitidine + romidepsin. # lymsm # AACR20 pic.twitter.com/qQXwJ4Dw81",,,# #,"1254819473355350016",https://twitter.com/lymphomahub/status/1254819473355350016
christeeny513,2020-04-27 13:07,0,1,"Dr. Eric Gangl of @ AstraZenecaUS discusses the next gen oral SERD (selective estrogen receptor degrader) - AZD9833. Currently recruiting for the phase 1 SERENA-1 trial for ER+/HER2-neg # MBC patients. NCT04214288 is not yet recruiting. # BCSM # AACR20 https://clinicaltrials.gov/ct2/show/NCT03616587 …",,@,# # #,"1254819468137635847",https://twitter.com/christeeny513/status/1254819468137635847
lymphomahub,2020-04-27 13:07,2,2,"The EMBOLDEN study was conducted in patients with PTCL or CTCL. All responders were in Arm B: pembrolizumab + pralatrexate + decitabine with one partial response ongoing at 18 months # lymsm # AACR20 pic.twitter.com/QTgivyp8qp",,,# #,"1254819464589312001",https://twitter.com/lymphomahub/status/1254819464589312001
lymphomahub,2020-04-27 13:07,1,3,"CONGRESS | # AACR20 | Enrica Marchi, @ ColumbiaMed, presents results from two studies, EMBOLDEN and DURABILITY, which are investigating the addition of a PD1 inhibitor to an epigenetic backbone in T-cell lymphoma # lymsmpic.twitter.com/hkmOvtpOte",,@,# #,"1254819456141967361",https://twitter.com/lymphomahub/status/1254819456141967361
drleemachado,2020-04-27 13:06,0,0,"# AACR20 # AZD9833 degrades ERalpha and may surpass other SERDS (selective estrogen receptor degrader)",,,# #,"1254819293130301440",https://twitter.com/drleemachado/status/1254819293130301440
FerchoHdz88,2020-04-27 13:06,0,1,"Nada como estar de congreso...Aunque sea virtual @ AACR # AACR2020",,@,#,"1254819223857172480",https://twitter.com/FerchoHdz88/status/1254819223857172480
Franklinmejiafr,2020-04-27 13:06,0,2,"For all you cancer folks! ICYMI: @ AACR 's (virtual) annual meeting part 1 is ongoing today and tomorrow and is completely free. That's 100% cheaper than it has ever been. It's a huge, insightful and (typically) expensive one, stop by! This is a fantastic oppotunity/gift.",,@,,"1254819168156876800",https://twitter.com/Franklinmejiafr/status/1254819168156876800
KendallLabNCH,2020-04-27 13:05,0,5,"To all of the trainees presenting at the # AACR20 virtual meeting - congratulations, that’s a big deal! I am so impressed with all of your presentations and poise.",,,#,"1254819031363784708",https://twitter.com/KendallLabNCH/status/1254819031363784708
manjuggm,2020-04-27 13:04,1,4,"# AACR2020.. Excited to be part of it.. One suggn for the next part of the meeting.. Pts struggling to make the best use of info. Posters & abstracts don't seem very searchable.. If there was any way to make it more searchable/ have tumor groups, it would be more useful, thank yo",,,#,"1254818788865949698",https://twitter.com/manjuggm/status/1254818788865949698
ivybelkins,2020-04-27 13:04,1,9,"Exciting news for patients living with # EGFR # exon20 # lungcancer. Will be a session about # mobocertinib at # AACR20 tomorrow. @ EGFRResisters @ Exon20Grouphttps://twitter.com/weoncologists/status/1254810176722546691 …",,@ @,# # # # #,"1254818754380300288",https://twitter.com/ivybelkins/status/1254818754380300288
jitcancer,2020-04-27 13:04,4,5,"Nice presentation on HPV DNA vaccine GX-188E + PD1 by Dr. Woo & excellent discussion by @ sitcancer leader Dr. Bhardwaj @ SinaiImmunol # AACR20 @ AACR. For reference, Ph 2 results for another HPV vaccine + PD1 from @ JAMAOnchttps://jamanetwork.com/journals/jamaoncology/fullarticle/2703886 …",,@ @ @ @,#,"1254818615309807617",https://twitter.com/jitcancer/status/1254818615309807617
cityofhope,2020-04-27 13:02,3,8,"# AACR20 is now LIVE. Watch research presentations by City of Hope's Yuman Fong, M.D., the chief of the Department of Surgery; Kimlin Tam Ashing, Ph.D., the founding director of the Center of Community Alliance for Research & Education, and medical oncologist Mihaela Cristea, M.D. https://twitter.com/AACR/status/1254810066743627776 …",,,#,"1254818210584522752",https://twitter.com/cityofhope/status/1254818210584522752
SWOG,2020-04-27 13:01,2,4,"At # AACR20 opening clinical plenary @ SWOG investigator Dr. Alain Algazi of @ UCSF @ UCSFCancer presented results of S1320 showing continuous dosing of two targeted melanoma drugs leads to longer progression-free survival. Read the press release here: https://bit.ly/3eY9mYC pic.twitter.com/eFggk6huti",,@ @ @,#,"1254817962202038275",https://twitter.com/SWOG/status/1254817962202038275
LizCancerHealth,2020-04-27 13:00,2,2,"For those new to virtual meetings. (I feel like an old pro after # CROI2020 ). # AACR20 https://twitter.com/AACR/status/1254442634267017217 …",,,# #,"1254817783667294210",https://twitter.com/LizCancerHealth/status/1254817783667294210
JExpMed,2020-04-27 13:00,1,6,"If you are interested in submitting work related to # AACR20 to JEM, we encourage you to contact JEM Scientific Editor Xin (Cindy) Sun @ Cindy_JExpMed",,@,#,"1254817672237383682",https://twitter.com/JExpMed/status/1254817672237383682
CCR_AACR,2020-04-27 13:00,0,0,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2YerJmj pic.twitter.com/UffoSbXkgs",,@,#,"1254817633851052034",https://twitter.com/CCR_AACR/status/1254817633851052034
CAPR_AACR,2020-04-27 13:00,0,0,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2KG7m9L pic.twitter.com/K3nAVdOFyR",,@,#,"1254817632865472517",https://twitter.com/CAPR_AACR/status/1254817632865472517
CD_AACR,2020-04-27 13:00,2,5,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2Y7W99I pic.twitter.com/BNtzt4KF87",,@,#,"1254817632831901701",https://twitter.com/CD_AACR/status/1254817632831901701
FredNatLab,2020-04-27 13:00,0,2,"One of many translational research abstracts on # RAScancer # oncogene at # AACR20. https://twitter.com/oncologypharm/status/1254809073339400192 …",,,# # #,"1254817599763841033",https://twitter.com/FredNatLab/status/1254817599763841033
NCICTEP_ClinRes,2020-04-27 13:00,4,5,"Check out # AACR20 poster “A phase 1b study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO)” today April 27, 2020 @ AACR virtual annual meeting. See abstract: https://buff.ly/3eVlOIR pic.twitter.com/JZXnGhlg0x",,@,#,"1254817591509557248",https://twitter.com/NCICTEP_ClinRes/status/1254817591509557248
OncologyCentral,2020-04-27 13:00,2,1,"Intermittent dosing of # targetedtherapy for # melanoma could reduce acquired resistance, but what effect does it have on survival? Research presented at # AACR20 reports the latest findings:",,,# # #,"1254817589563232257",https://twitter.com/OncologyCentral/status/1254817589563232257
JAMANetwork,2020-04-27 13:00,0,1,"Association Between Breastfeeding and Ovarian Cancer Risk from @ JAMAOnc, and other recent # oncology articles from the JAMA Network, are available free online during the # AACR20 virtual meeting https://ja.ma/2xOAGI7",,@,# #,"1254817585880760321",https://twitter.com/JAMANetwork/status/1254817585880760321
IreneMangues,2020-04-27 12:58,1,8,"Conectada al Congreso de @ AACR. Este año virtual por COVID19. Sesiones y pósters hoy y mañana. Acceso gratuito. En Junio segunda parte. Thanks # AACR20 pic.twitter.com/5ibk6vfv43",,@,#,"1254817303167975426",https://twitter.com/IreneMangues/status/1254817303167975426
JFreemanDaily,2020-04-27 12:58,0,2,"Would work better than having multiple text chats with different groups! # AACR20",,,#,"1254817200415768578",https://twitter.com/JFreemanDaily/status/1254817200415768578
DrMhidalgo,2020-04-27 12:57,4,35,"I just finished to chair the clinical plenary with Dr. Azad. Went very well. So glad # AACR2020 is happening. Some good news for patients presented! https://twitter.com/Aiims1742/status/1254808404205412354 …",,,#,"1254816955510460417",https://twitter.com/DrMhidalgo/status/1254816955510460417
Daniel_Rabe,2020-04-27 12:57,0,4,"Enjoying watching # AACR2020 from the comfort of my bed.",,,#,"1254816845242171395",https://twitter.com/Daniel_Rabe/status/1254816845242171395
RdgzSonsoles,2020-04-27 12:56,0,1,"I am glad to be able to hear such a good Cancer Science in # AACR20 Virtual Annual Meeting. Thank u to the organizers.",,,#,"1254816648600715269",https://twitter.com/RdgzSonsoles/status/1254816648600715269
xrtGenomics,2020-04-27 12:56,3,13,"DNA HPV Vaccine (GX-188E) +anti-PD1 showing ~ 40% RR in phase II study from S. Korea in met cervical scc. # hncsm # gynsm # aacr20 pic.twitter.com/QxmRLi4dil",,,# # #,"1254816619009912833",https://twitter.com/xrtGenomics/status/1254816619009912833
Amanda_trng,2020-04-27 12:56,2,9,"Congrats to @ kaliphornya815 on her virtual @ AACR talk! # teammclabpic.twitter.com/JeAkbW8jtJ",,@ @,#,"1254816613108379648",https://twitter.com/Amanda_trng/status/1254816613108379648
bjork5,2020-04-27 12:55,2,9,""In a phase 2 study to be presented virtually at the American Association for Cancer Research annual meeting, capmatinib controlled disease in the brain in 12 of 13 evaluable patients with brain metastases, and it shrunk tumors in seven of those 13 patients" # AACR20 # btsmhttps://twitter.com/KKurbs/status/1254800502208036865 …",,,# #,"1254816329460264960",https://twitter.com/bjork5/status/1254816329460264960
pashtoonkasi,2020-04-27 12:54,0,3,"Would be of value to study and applicable for our # analcancer patients where # Immunotherapy single-agent has not been as promising/durable. # AACR20",,,# # #,"1254816100791078915",https://twitter.com/pashtoonkasi/status/1254816100791078915
gautamkollu,2020-04-27 12:53,0,1,"Even getting to a diagnosis of cancer can be a long, expensive journey. Our latest results show that @ GrailBio's blood test can simplify it. If you are tuning into # AACR20, see our data on Tuesday: https://grail.com/press-releases/grail-to-present-new-data-at-the-american-association-for-cancer-research-aacr-annual-meeting/ …",,@,#,"1254815958805315588",https://twitter.com/gautamkollu/status/1254815958805315588
ArasanzMd,2020-04-27 12:53,0,1,"Unimpressive results so far, aren't they? Let's see what happens with OS...",,,,"1254815953822666755",https://twitter.com/ArasanzMd/status/1254815953822666755
drleemachado,2020-04-27 12:53,0,0,"# AACR20 GX-188E + Pembro combo trial. rr= 42.3% and T cell responses in 78.3% of patients. Applicability to other HPV16/18 tumours?",,,#,"1254815832972185600",https://twitter.com/drleemachado/status/1254815832972185600
cancerassassin1,2020-04-27 12:52,1,6,"You know what would really work well (perhaps something for @ AACR to consider for # AACR20 Virtual Meeting II in June): a Slack-style online messaging board with numerous chat rooms based on specific symposia or areas of interest. Participants can actively interact that way (?)",,@,#,"1254815723907620867",https://twitter.com/cancerassassin1/status/1254815723907620867
Holz_lab,2020-04-27 12:52,0,2,"At # AACR20 virtual meeting. Kudos to organizers and presenters for making it happen!",,,#,"1254815602365128704",https://twitter.com/Holz_lab/status/1254815602365128704
pashtoonkasi,2020-04-27 12:51,7,10,"# AACR20 # Immunotherapy # clinicaltrials - while studied in HPV - high-risk 16/18 # cervicalcancer - should be applicable and worth studying in our # analcancer patients. # CRCSM # OncoAlertpic.twitter.com/xlCOjiw7n8",,,# # # # # # #,"1254815458647330824",https://twitter.com/pashtoonkasi/status/1254815458647330824
bjork5,2020-04-27 12:51,0,1,"# lcsm # AACR20 https://twitter.com/endpts/status/1254731391566299136 …",,,# #,"1254815345744982019",https://twitter.com/bjork5/status/1254815345744982019
aroimpact,2020-04-27 12:51,0,9,"Very comfortable and great to learn Current updates on cancer research while maintaining social distancing in # AACR2020. These live moderated sessions definetly needs to be an option for all the conferences. Great job, team @ AACR pic.twitter.com/xNG6AxZW7m",,@,#,"1254815340300812289",https://twitter.com/aroimpact/status/1254815340300812289
ADCReview,2020-04-27 12:51,0,0,"ADC Review | Journal of Antibody-drug Conjugates likes to congratulate @ ImmunomedicsInc with the approval of sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with # mTNBC. https://adc.expert/Sacituzumab_Govitecan_Trodelvy … @ ASCO @ AACR @ World_ADC # ADC # breastcancer @ Trodelvy",,@ @ @ @ @,# # #,"1254815319761158157",https://twitter.com/ADCReview/status/1254815319761158157
Jbauml,2020-04-27 12:50,2,3,"In this waterfall plot, PD-L1 + tumors had a higher ORR, but responses were seen in PD-L1- tumors as well. Numbers are limited by the fact that so many tumors are PD-L1+. Similarly hard to interpret difference in outcome for HPV16 and HPV18 - small numbers. # AACR20 @ OncoAlertpic.twitter.com/8JnsqCAoFL",,@,#,"1254815149820608514",https://twitter.com/Jbauml/status/1254815149820608514
msmelanoma,2020-04-27 12:49,4,17,"Nacho Melero from @ CIMA_unav: kudos to use Quijote and Sancho to illustrate the pros and cons of new immunotherapeutic agents. Even greater to be able to access # AACR20 virtual meeting for free! Setting an example for other conferences. @ ASEICAnews @ _SEOM @ SaludISCIII @ AACR pic.twitter.com/wlgneh4YDX",,@ @ @ @ @,#,"1254814969109057536",https://twitter.com/msmelanoma/status/1254814969109057536
STouhida,2020-04-27 12:49,0,1,"Hi, looking for # logo # Branding # Corporate # Identy ? contact me: fiverr : https://cutt.ly/ZrBvsG0 # Hope_Hicks # Maythe4th Ghost of Tsushima Coretta Scott King # killing # CupOfJoe # LockdownEnd # AACR20 # AllAmericans # Black Hippy # FAKE # PRESIDENT # JusticeForEMC2pic.twitter.com/gf8gPnESWF",,,# # # # # # # # # # # # # # #,"1254814936741617664",https://twitter.com/STouhida/status/1254814936741617664
drleemachado,2020-04-27 12:48,0,1,"# AACR20 Christopher Johnson is discussing a fragment-based drug screen to identify small molecule allosteric inhibitors of SHP2.",,,#,"1254814763323965440",https://twitter.com/drleemachado/status/1254814763323965440
AriellaHanker,2020-04-27 12:48,0,9,"Trying to simulate running to the other end of the convention center to catch the next talk. Except I’m wearing sneakers. # AACR20 pic.twitter.com/JOcjWTAa4Y",,,#,"1254814724430204929",https://twitter.com/AriellaHanker/status/1254814724430204929
pogowatts,2020-04-27 12:47,0,1,"That’s amazing. Love that you’re looking at CRC. Would like it even better if you included Q61 mutations!!",,,,"1254814543282348037",https://twitter.com/pogowatts/status/1254814543282348037
Jbauml,2020-04-27 12:47,1,1,"The combination was well tolerated, and was associated with an impressive ORR. The ORR to pembrolizumab monotherapy for PD-L1+ cervical cancer was 17% in prior trials https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.74.5471 … # AACR20 pic.twitter.com/ooFF7iSXhn",,,#,"1254814483026935810",https://twitter.com/Jbauml/status/1254814483026935810
CharuAggarwalMD,2020-04-27 12:47,3,10,"# COVID19 can’t squash enthusiasm for # CancerResearch. Exciting data being presented @ AACR Annual Meeting # AACR20 (and we are all celebrating the successes virtually) Congratulations to @ AACR and @ AACRPres for organizing a terrific # virtual meeting! # LCSM @ OncoAlerthttps://twitter.com/CharuAggarwalMD/status/1254812369823379456 …",,@ @ @ @,# # # # #,"1254814373685735426",https://twitter.com/CharuAggarwalMD/status/1254814373685735426
cancerassassin1,2020-04-27 12:46,0,4,"I will say also it's much easier to juggle watching (on iPad) while Tweeting and also looking up references mentioned during talks (on office desktop) at the same time (as compared to balancing devices on my lap). Trying to be optimistic that we're not on site at # AACR20 !",,,#,"1254814296405655553",https://twitter.com/cancerassassin1/status/1254814296405655553
davidjeinstein,2020-04-27 12:46,0,1,"Also under investigation in combo with abiraterone in mCRPC https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2018-01398&r=1 … # AACR20 https://twitter.com/pashtoonkasi/status/1254811597442371584 …",,,#,"1254814182458961921",https://twitter.com/davidjeinstein/status/1254814182458961921
OncoAlert,2020-04-27 12:46,2,3,"Live # AACR20 Tweet by our @ OncoAlert "Dr Woo presents data on pembro + GX-188E, a therapeutic DNA # vaccine for HPV 16/18+ cervical CA. Data are from # gyncsm, but also has obvious implications for # hncsm. Targeting # HPV with therapeutic vaccines is an appealing strategy "https://twitter.com/Jbauml/status/1254813031281963008 …",,@,# # # # #,"1254814169356021767",https://twitter.com/OncoAlert/status/1254814169356021767
drstuwilliamson,2020-04-27 12:46,0,9,"Liking the # AACR2020 virtual format. Can listen in and watch while exercising! Doubt that would have been approved of in San Diego!",,,#,"1254814121066971138",https://twitter.com/drstuwilliamson/status/1254814121066971138
FredNatLab,2020-04-27 12:46,1,5,"# FredNatLab # Molecular Characterization Laboratory proud to collaborate with @ CancerResearch, @ theNCI & partners on this important project! # AACR20 https://twitter.com/CancerResrch/status/1254774827249831936 …",,@ @,# # #,"1254814105883430913",https://twitter.com/FredNatLab/status/1254814105883430913
AnnikHSpencer,2020-04-27 12:44,1,1,"It may not be sunny San Diego, but tuning into # AACR20 meeting virtually from my couch listening to MSK healthcare experts ain't bad! https://twitter.com/sloan_kettering/status/1254723065201786881 …",,,#,"1254813673710895105",https://twitter.com/AnnikHSpencer/status/1254813673710895105
lymphomahub,2020-04-27 12:43,0,4,"Results from a study investigating another triplet, Pola-G-Len, was previously reported in R/R follicular lymphoma. Read more on the @ lymphomahub: https://lymphomahub.com/medical-information/full-efficacy-and-safety-analysis-from-go29834-or-polatuzumab-vedotin-obinutuzumab-and-lenalidomide-for-rr-fl … # lymsm # AACR20",,@,# #,"1254813475748163586",https://twitter.com/lymphomahub/status/1254813475748163586
lymphomahub,2020-04-27 12:43,9,17,"CONGRESS | # AACR20 | Can targeting BCL-2 and MCL-1 overcome resistance in R/R NHL? Elisabeth Lasater presents preclinical data supporting this dual-targeting approach and presents results of a phase Ib study of Pola-G-Ven for R/R follicular lymphoma with an ORR of 76% # lymsmpic.twitter.com/MFUMnW8f0i",,,# #,"1254813472111636488",https://twitter.com/lymphomahub/status/1254813472111636488
UCCancerCenter,2020-04-27 12:42,1,4,"Genetic profiling of pancreatic cancer tumors from the POLO study by Dr. Hedy Kindler @ UCCancerCenter and colleagues reveals rates of BRCA1/2 and ATM mutations. # AACR20 Abstract CT217, https://www.abstractsonline.com/pp8/#!/9045/presentation/10720 … # AnswerCancer",,@,# # #,"1254813245396975616",https://twitter.com/UCCancerCenter/status/1254813245396975616
vshar15,2020-04-27 12:42,0,4,""Unfortunately due to the lockdown..." is my fave # AACR2020 Q&A period catchphrase, be will using during honours thesis defense tomorrow",,,#,"1254813058691731457",https://twitter.com/vshar15/status/1254813058691731457
Jbauml,2020-04-27 12:41,6,13,"Next up, Dr Woo presents data on pembro + GX-188E, a therapeutic DNA vaccine for HPV 16/18+ cervical CA. Data are from # gyncsm, but also has obvious implications for # hncsm. Targeting HPV with therapeutic vaccines is an appealing strategy # AACR20 pic.twitter.com/doXOKklWDO",,,# # #,"1254813031281963008",https://twitter.com/Jbauml/status/1254813031281963008
drleemachado,2020-04-27 12:41,0,0,"# AACR20 "Unfortunately due to the lockdown"...",,,#,"1254812931394621441",https://twitter.com/drleemachado/status/1254812931394621441
tcellsrus,2020-04-27 12:41,0,4,"@ AACR # AACR2020 brought to you by @ Tesla, MOBILE virtual AACR meeting. Kudos to Toni Ribas for organizing! Ignacio Melero now describing how to make the impossible dream, possiblepic.twitter.com/biIYolhWGK",,@ @,#,"1254812861756563458",https://twitter.com/tcellsrus/status/1254812861756563458
OncoAlert,2020-04-27 12:41,2,4,"Live # AACR20 Tweet by @ NazliDizman "Exciting Ph1 data by @ DrScottTagawa of @ weillcornell @ nyphospital PSMA-targeted alpha emitter 225Ac-J591 in # mCRPC is safe and promising with 63.6% (14/22) PSA decline and 2 with response >1 yr" @ OncoAlert https://twitter.com/NazliDizman/status/1254805146451636225 …",,@ @ @ @ @,# #,"1254812828122394624",https://twitter.com/OncoAlert/status/1254812828122394624
claunch_cheryl,2020-04-27 12:40,0,6,"Who is attending the # AACR20 Virtual Annual Meeting today? I know I am! While you’re there, check out my poster in the Clinical Trials session. # OHSU # clinicaltrials # immunotherapy # CancerResearch # MedTwitterpic.twitter.com/X5qlfjnf4u",,,# # # # # #,"1254812730755710979",https://twitter.com/claunch_cheryl/status/1254812730755710979
udai_banerji,2020-04-27 12:39,11,36,"Clinical responses in non-G12C KRAS cancers, Virtual Poster at AACR today. Thank you to patients for participating in the trial and the amazing teams behind this study. @ ICR_London @ royalmarsdenNHS @ cancerBRC @ ICR_DDU_IIT @ CR_UK @ ECMC_UK # AACR2020 # RASpic.twitter.com/qVf81hBu1L",,@ @ @ @ @ @,# #,"1254812370901307393",https://twitter.com/udai_banerji/status/1254812370901307393
CharuAggarwalMD,2020-04-27 12:39,12,29,"Exciting news for patients with # EGFR # exon20mutation. Historically a poor cousin of activating EGFRMT- now with an effective therapy. Data from 2L+ trial of # Mobocertinib, RR 43% and mPFS 7.3 mo Important to test with NGS! @ AACR # AACR20 # LCSM @ EGFRResisters @ OncoAlerthttps://twitter.com/weoncologists/status/1254810176722546691 …",,@ @ @,# # # # #,"1254812369823379456",https://twitter.com/CharuAggarwalMD/status/1254812369823379456
drleemachado,2020-04-27 12:39,0,0,"# AACR20 phenocopying of NF1 by loss of SPRED1/2.",,,#,"1254812320922054656",https://twitter.com/drleemachado/status/1254812320922054656
FranExpositoR,2020-04-27 12:38,0,3,"I thought I wouldn’t be able to attend # AACR2020 but since it become # virtual here we are! Willing to learn what’s going on and new science stuff! pic.twitter.com/Qb77wia86l",,,# #,"1254812195843706880",https://twitter.com/FranExpositoR/status/1254812195843706880
Aiims1742,2020-04-27 12:38,0,8,"I think Dr. Melero deserves a Don Quixote gif for working in a perfectly placed Sancho Panza reference into his discussion. # AACR20 pic.twitter.com/1GLpk1T0R3",,,#,"1254812069238636546",https://twitter.com/Aiims1742/status/1254812069238636546
Fstar_Biotech,2020-04-27 12:38,2,6,"Great to see the @ AACR annual meeting being held as a virtual event this week – a key date for the scientific community and an important forum for innovative cancer research. We look forward to 'attending' this week with our fellow scientists from around the world. # AACR20 pic.twitter.com/diw4qsEqBw",,@,#,"1254812048367792132",https://twitter.com/Fstar_Biotech/status/1254812048367792132
melodytantx,2020-04-27 12:37,0,1,"Just started watching the @ AACR virtual annual meeting and this Don Quixote reference has my attention! pic.twitter.com/FknXR5jOm6",,@,,"1254812023180988417",https://twitter.com/melodytantx/status/1254812023180988417
jillfeldman4,2020-04-27 12:36,34,58,"Good news for # EGFR # exon20 patients! FDA granted Breakthrough Therapy Designation for @ TakedaOncology mobocertinib (TAK-788) for patients w/ # EGFR # exon20 after platinum-based chemotherapy. Will be discussed tomorrow at # AACR20 # LCSM @ EGFRResisters @ Exon20Grouphttps://twitter.com/TakedaOncology/status/1254757186745466884 …",,@ @ @,# # # # # #,"1254811792963969026",https://twitter.com/jillfeldman4/status/1254811792963969026
pashtoonkasi,2020-04-27 12:36,2,5,"# CRCSM # AACR20 Onvansertib # ctDNAhttps://twitter.com/oncologypharm/status/1254809073339400192 …",,,# # #,"1254811597442371584",https://twitter.com/pashtoonkasi/status/1254811597442371584
krknrm,2020-04-27 12:35,2,8,"Drug Design & Discovery session # AACR20: very exciting talk from Xiaohui Du -a novel cpd targeting CD73/adenosine product. - curious to see how it remodels the immune TME and if it can be eventually used in glioma as in the recent paper @ NatureMedicine https://twitter.com/DrSTANtheMAN/status/1209321410369331200?s=20 …pic.twitter.com/YG3ooKEvyl",,@,#,"1254811531528810497",https://twitter.com/krknrm/status/1254811531528810497
drleemachado,2020-04-27 12:35,0,2,"# AACR20 Laurie Schenkel showing that PARP14 inhibition (RBN012759) decreases tumoural macrophage function.",,,#,"1254811475543195649",https://twitter.com/drleemachado/status/1254811475543195649
EvanHallMD,2020-04-27 12:35,0,4,"My thoughts re: @ SWOG S1320 study examining continuous vs intermittent rx of dabrafenib/trametinib in metastatic BRAF mut melanoma. Study presented by Dr. Alain Algazi @ UCSFCancer. Study Q: Is PFS is improved with intermittent tx vs continuous tx? # melsm # melanoma # AACR20 1/5",,@ @,# # #,"1254811445927149570",https://twitter.com/EvanHallMD/status/1254811445927149570
Marta_Sans_,2020-04-27 12:34,0,6,"Excited to attend my first @ AACR Annual Meeting, even if it is in virtual mode . Fantastic opening session this morning. # AACR2020 pic.twitter.com/ltJkIBeW0C",,@,#,"1254811116863197184",https://twitter.com/Marta_Sans_/status/1254811116863197184
HeikoEnderling,2020-04-27 12:33,1,6,"I wonder if @ ReneeBradyPhD's latest work could provide a template of how to use mathematical modeling in real time to personalize intermittent dosing # AACR20 https://rdcu.be/b3ubf https://twitter.com/luddyka/status/1254790099763523585 …",,@,#,"1254811001926582272",https://twitter.com/HeikoEnderling/status/1254811001926582272
HartungIngo,2020-04-27 12:33,0,11,"The benefits of a virtual # AACR20 meeting... pic.twitter.com/E8eG2xrlrp",,,#,"1254810981290725380",https://twitter.com/HartungIngo/status/1254810981290725380
Jorge_GarciaRod,2020-04-27 12:33,1,1,"# AACR20 # mCRPChttps://twitter.com/NazliDizman/status/1254805146451636225 …",,,# #,"1254810966681944064",https://twitter.com/Jorge_GarciaRod/status/1254810966681944064
cancerassassin1,2020-04-27 12:33,0,0,"via myAACR - also follow this link via @ AACR: https://twitter.com/AACR/status/1254762063416745985?s=20 …",,@,,"1254810858779291648",https://twitter.com/cancerassassin1/status/1254810858779291648
oncologypharm,2020-04-27 12:32,2,1,"Safety and treatment response/duration for onvansertib # AACR20 pic.twitter.com/D1UPHKDblm",,,#,"1254810734459936769",https://twitter.com/oncologypharm/status/1254810734459936769
cancerassassin1,2020-04-27 12:32,0,8,"Bravo @ AACR - I echo @ Aiims1742's message & like his recommendation for Zooming and texting with colleagues to discuss results and presentations in real time throughout # AACR20 (Part I). I'm also becoming partial to GIFs for displaying the reactions that we can't show in person. https://twitter.com/Aiims1742/status/1254808404205412354 …pic.twitter.com/bbXZ5evIO4",,@ @,#,"1254810565974863873",https://twitter.com/cancerassassin1/status/1254810565974863873
AgataBlasiak,2020-04-27 12:31,3,14,"# AACR20 started today and we are very excited to be there... virtually! A poster presentation has turned into a 5 min video. Privileged to be presenting our oncology clinical trial - # CURATE.AI for treatment of Multiple Myeloma. # WeAreN1 # TeamWork pic.twitter.com/dZEFxDxdC7",,,# # # #,"1254810347963203584",https://twitter.com/AgataBlasiak/status/1254810347963203584
weoncologists,2020-04-27 12:30,14,32,"Just Out @ US_FDA grants Breakthrough Therapy Designation for mobocertinib in the treatment of metastatic # NSCLC # lungcancer w/EGFR exon 20 insertion mutationswhose disease has progressed on or after platinum-based # chemotherapy # AACR20 @ OncoAlert https://www.biospace.com/article/releases/takeda-announces-u-s-fda-breakthrough-therapy-designation-for-mobocertinib-tak-788-for-the-treatment-of-nsclc-patients-with-egfr-exon-20-insertion-mutations/ …pic.twitter.com/U409gQn2dm",,@ @,# # # #,"1254810176722546691",https://twitter.com/weoncologists/status/1254810176722546691
boehringerus,2020-04-27 12:30,4,12,"At today’s # AACR20 Virtual Annual Meeting, we will present new preclinical data on our SOS1::KRAS inhibitor combinations with # MEKInhibitors and # irinotecan. Learn more about our # KRAS combination approach here:pic.twitter.com/8GxzUqhkeO",,,# # # #,"1254810134083141632",https://twitter.com/boehringerus/status/1254810134083141632
MCT_AACR,2020-04-27 12:30,0,0,"In this # FirstDisclosure, Kotanides et al describe fully human IgG1 Fc effector null monoclonal antibody 7A5, a CD137 agonist that inhibits # TumorGrowth and whose activity is enhanced in combination with a PD-L1. # antagonist # antibody @ LillyPad # AACR20 https://bit.ly/2zAoVWs pic.twitter.com/ehqCqg5CgF",,@,# # # # #,"1254810076185014272",https://twitter.com/MCT_AACR/status/1254810076185014272
AACR,2020-04-27 12:30,15,34,"# AACR20 Virtual Annual Meeting program covers the latest discoveries across the spectrum of cancer research and highlights the work of the best minds in research and medicine from institutions all over the world. https://bit.ly/3cVjtvQ",,,#,"1254810066743627776",https://twitter.com/AACR/status/1254810066743627776
lymphomahub,2020-04-27 12:29,2,2,"CONGRESS | # AACR20 | Bin Zhang presents a poster on orelabrutinib - a potent and selective Bruton's tyrosine kinase inhibitor - for B-cell malignancies. Phase I study in healthy subjects found the drug was well-tolerated with no DLTs & MTD was not reached. # lymsmpic.twitter.com/qyjsmLeVvS",,,# #,"1254809896165441536",https://twitter.com/lymphomahub/status/1254809896165441536
ohaganr,2020-04-27 12:27,12,27,"A good reminder at # AACR20 from Dr. Sharma about the differences between fundamental immune targets in cancer - different opportunities for benefit from different mechanisms pic.twitter.com/gu7BbOPi24",,,#,"1254809520196509696",https://twitter.com/ohaganr/status/1254809520196509696
Ludwig_Cancer,2020-04-27 12:27,0,0,"Ludwig @ StanfordMed’s Ash Alizadeh will present his research during the Predictive Biomarkers for Immunotherapeutics Virtual Minisymposium from 3:40 to 3:50 PM ET. # AACR20 https://bit.ly/2xOvfJw pic.twitter.com/pIC7cBUgY7",,@,#,"1254809511036178432",https://twitter.com/Ludwig_Cancer/status/1254809511036178432
JFreemanDaily,2020-04-27 12:26,3,34,"Cancer conferences in the age of # COVID19: "The compound <MOM! She's touching my stuff!> has shown bioavailability in <I did not! He's lying!> and suppresses <Stop it, both of you!> ..." # AACR20 # LCSM",,,# # #,"1254809232655843334",https://twitter.com/JFreemanDaily/status/1254809232655843334
oncologypharm,2020-04-27 12:26,4,9,"Updated ph1b onvansertib results in pretreated KRASm mCRC. Historically 2L therapies have 5% RR in mCRC # AACR20 $ trovpic.twitter.com/9rg8FSiH3z",,,#,"1254809073339400192",https://twitter.com/oncologypharm/status/1254809073339400192
Novocure,2020-04-27 12:25,1,2,"Novocure announces presentation of EF-19 post-approval registry trial data studying Novocure’s cancer treatment as a monotherapy for the treatment of recurrent GBM at the @ AACR 2020 Virtual Annual Meeting I # AACR2020 https://bit.ly/2W8DOae",,@,#,"1254808952543551493",https://twitter.com/Novocure/status/1254808952543551493
Ludwig_Cancer,2020-04-27 12:25,1,1,"Ludwig @ sloan_kettering’s Margaret Callahan will present during the Immunotherapy Clinical Trails 2 Virtual Plenary Session from 3:30 to 3:45 PM ET. # AACR20 https://bit.ly/3aBu5hI",,@,#,"1254808823753310211",https://twitter.com/Ludwig_Cancer/status/1254808823753310211
Ludwig_Cancer,2020-04-27 12:24,0,0,"Ludwig @ HopkinsMedicine’s Nickolas Papadopoulos presents his research on a multi-cancer blood test used to screen and manage 10,000 women with no history of cancer during the Early Detection & ctDNA Virtual Plenary Session from 1:40 to 1:50 PM ET. # AACR20 https://bit.ly/2KCeq73 pic.twitter.com/WhUiVpm5Yt",,@,#,"1254808746687152129",https://twitter.com/Ludwig_Cancer/status/1254808746687152129
Natale_CA,2020-04-27 12:24,0,12,"I'm pretty into virtual # AACR2020, it's so much easier to listen to all the talks I want to hear since I am not lost in a convention center.",,,#,"1254808734863368194",https://twitter.com/Natale_CA/status/1254808734863368194
DeepOnCar,2020-04-27 12:23,0,0,"Thanks for the interesting talk on differential sensitivity of KRAS G12D vs G12V to CDKi @ KonstantinBuda2. Really stupid question, (couldn't get through to you at # AACR20), What was the % of the BFP → GFP (you said 1.1% turnover) recombinants also had the desired KRAS mutation.",,@,#,"1254808452913926144",https://twitter.com/DeepOnCar/status/1254808452913926144
NCIBiospecimens,2020-04-27 12:23,0,2,"AACR is live streaming now! Poster videos are also available for viewing on demand. Take a look here! https://aacr20.onlineeventpro.freeman.com/ # AACR20",,,#,"1254808421934612480",https://twitter.com/NCIBiospecimens/status/1254808421934612480
Aiims1742,2020-04-27 12:23,3,48,"I am loving the virtual # AACR20 meeting so far. Thanks @ AACRPres @ AACR_CEO for pulling this off in the midst of a pandemic. Missing the personal touch? Text or zoom with your co-listeners on the side :) (like @ DrMhidalgo and I just did) Any other tips @ cancerassassin1?",,@ @ @ @,#,"1254808404205412354",https://twitter.com/Aiims1742/status/1254808404205412354
drleemachado,2020-04-27 12:22,0,1,"# AACR20 Konstantin Budagyan discussing how downstream kinase signalling is dictated by specific KRAS mutations... Use of G12V lines indicates different responses to putative CDK4 inhibitors",,,#,"1254808249133662210",https://twitter.com/drleemachado/status/1254808249133662210
pashtoonkasi,2020-04-27 12:21,0,0,"# AACR20 https://twitter.com/jitcancer/status/1254806900362883074 …",,,#,"1254807993201418240",https://twitter.com/pashtoonkasi/status/1254807993201418240
Nfcanavan,2020-04-27 12:20,0,6,"Currently covering # AACR2020 by myself while ensconced in a walk-in closet. Sadly, this is not the overflow room.",,,#,"1254807698748604422",https://twitter.com/Nfcanavan/status/1254807698748604422
Ludwig_Cancer,2020-04-27 12:20,1,6,"@ AACR's Virtual Annual Meeting I kicks off on Monday, April 27 and will feature a number of plenary sessions with more than 30 oral presentations. Tune in to learn more about the work some of our Ludwig scientists are doing! # AACR20 https://bit.ly/2KyazYU",,@,#,"1254807688426504192",https://twitter.com/Ludwig_Cancer/status/1254807688426504192
StavroulaSlk,2020-04-27 12:20,1,5,"# AACR2020 Virtual Annual Meeting! This year from my own laptop Thank you @ AACR for this opportunity!! # aacr # livestreamingpic.twitter.com/CJSUOLND1G",,@,# # #,"1254807683531751424",https://twitter.com/StavroulaSlk/status/1254807683531751424
christeeny513,2020-04-27 12:20,4,14,"All # metastatic patients are eligible for this phase 1 trial testing mRNA-2416 alone & in combo with durvalumab; Only ovarian cancer patients are eligible for phase 2 # BCSM # GyncSM # AACR20 https://clinicaltrials.gov/ct2/show/NCT03323398 …https://twitter.com/Jbauml/status/1254804729500258304 …",,,# # # #,"1254807670747541507",https://twitter.com/christeeny513/status/1254807670747541507
OncoAlert,2020-04-27 12:20,0,0,"Check out this collection of recent articles by @ CD_AACR prepared precisely for # AACR20 https://twitter.com/ElizSMcKenna/status/1254806395372912642 …",,@,#,"1254807625897783296",https://twitter.com/OncoAlert/status/1254807625897783296
JaniceTNBCmets,2020-04-27 12:20,0,0,"# TNBC # AACR20 https://twitter.com/christeeny513/status/1254804345134166025 …",,,# #,"1254807621242060800",https://twitter.com/JaniceTNBCmets/status/1254807621242060800
Jbauml,2020-04-27 12:19,0,1,"One of the questions just asked highlights a major barrier forward in the development of this and similar compounds - risk of tumor injection can be quite a big hurdle to clear. I think for an agent to be successful, outcomes would need to be very very impressive # AACR20",,,#,"1254807297576091648",https://twitter.com/Jbauml/status/1254807297576091648
pashtoonkasi,2020-04-27 12:18,0,0,"# AACR20 # PrecisionMedicine # Oncology Collection of articles @ AACR https://twitter.com/ElizSMcKenna/status/1254806395372912642 …",,@,# # #,"1254807038724538374",https://twitter.com/pashtoonkasi/status/1254807038724538374
jitcancer,2020-04-27 12:17,2,3,"Interesting IO targets in PVRIG:PVRL2 - TIGIT pathway mediators. Great talk from Dr Sullivan @ MGHCancerCenter # AACR20 @ AACR on combo w PD1! Nice paper on this pathway @ HopkinsMedicine @ CIR_AACRhttps://cancerimmunolres.aacrjournals.org/content/7/2/257.long …",,@ @ @ @,#,"1254806900362883074",https://twitter.com/jitcancer/status/1254806900362883074
OncoAlert,2020-04-27 12:16,1,5,"Live # AACR20 tweet by our @ OncoAlert colleague @ Jbauml “ Dr Jimeno presents data on mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding OX40L, made for tumor injection, given alone or with the PD-L1 inhibitor durvalumab”https://twitter.com/Jbauml/status/1254804729500258304 …",,@ @,#,"1254806545394794499",https://twitter.com/OncoAlert/status/1254806545394794499
pashtoonkasi,2020-04-27 12:15,0,0,"# AACR20 https://twitter.com/jitcancer/status/1254805334172094467 …",,,#,"1254806467917512706",https://twitter.com/pashtoonkasi/status/1254806467917512706
ElizSMcKenna,2020-04-27 12:15,5,19,"Check out this collection of recent @ CD_AACR articles we prepared for # AACR20! https://twitter.com/CD_AACR/status/1254802564752838657 …",,@,#,"1254806395372912642",https://twitter.com/ElizSMcKenna/status/1254806395372912642
MM_Hub,2020-04-27 12:15,0,1,"Read the full results from the DREAMM-2 study on the @ MM_Hub: https://multiplemyelomahub.com/medical-information/dreamm-2-belantamab-mafodotin-for-relapsed-or-refractory-multiple-myeloma … # mmsm # AACR20",,@,# #,"1254806343162253312",https://twitter.com/MM_Hub/status/1254806343162253312
MM_Hub,2020-04-27 12:15,0,1,"It was previously announced that the DREAMM-2 study of belantamab mafodotin in RRMM met the primary endpoint of a clinically significant improvement in ORR: https://multiplemyelomahub.com/medical-information/primary-objective-met-in-the-dreamm-2-trial-of-belantamab-mafodotin-in-relapsed-refractory-multiple-myeloma … # mmsm # AACR20",,,# #,"1254806337902575618",https://twitter.com/MM_Hub/status/1254806337902575618
ChristianRolfo,2020-04-27 12:15,6,8,"Thanks @ haloupek form @ CD_AACR for the interview about the great paper of @ max_diehn on liquid biopsy in early NSCLC Machine Learning Yields Lung Cancer Test https://cancerdiscovery.aacrjournals.org/content/early/2020/04/27/2159-8290.CD-NB2020-033 … @ OncoAlert @ UMGCCC @ UMmedschool @ AACR @ isliquidbiopsy @ ElizSMcKenna",,@ @ @ @ @ @ @ @ @,,"1254806337646743552",https://twitter.com/ChristianRolfo/status/1254806337646743552
MM_Hub,2020-04-27 12:15,1,2,"CONGRESS | # AACR20 | Study using population pharmacokinetics and exposure-response analyses supports 2.5mg/kg IV Q3W dose of single-agent belantamab mafodotin for patients with heavily pretreated R/R multiple # myeloma, consistent with phase II DREAMM-2 trial # mmsm",,,# # #,"1254806333368532993",https://twitter.com/MM_Hub/status/1254806333368532993
EvanHallMD,2020-04-27 12:15,0,0,"My thoughts re: IMspire-150 study presented by @ McArthurGrant at @ AACR, comparing 1L atezolizumab/vemurafenib/cobimetinib vs vem/cobi for pts with BRAFV600 mut metastic melanoma. To me, OS is pivotal here and curves overlap thus far (immature f/u). # melsm # Melanoma # AACR20 1/4",,@ @,# # #,"1254806327055888384",https://twitter.com/EvanHallMD/status/1254806327055888384
OncoAlert,2020-04-27 12:14,1,4,"Live # AACR20 tweet by @ chulkimMD “Phase I study of COM701 (PVRIG targeting Ab) monoTx (Arm A) or in combo with nivolumab (Arm B). N=28. No DLTs in both arms. PR seen in primary peritoneal cancer (n=1) and MSS-CRC (n=1)” @ OncoAlert https://twitter.com/chulkimMD/status/1254805319059935232 …",,@ @,#,"1254806090891526151",https://twitter.com/OncoAlert/status/1254806090891526151
Jorge_GarciaRod,2020-04-27 12:12,0,0,"# AACR20 # mCRPChttps://twitter.com/duemed/status/1254792429418536967 …",,,# #,"1254805692881436672",https://twitter.com/Jorge_GarciaRod/status/1254805692881436672
jitcancer,2020-04-27 12:11,5,19,"mRNA based OX40-L # immunotherapy appears preliminarily interesting with intra-tumoral immune changes # AACR20 @ AACR. More info on this type of approach @ ScienceTMhttps://stm.sciencemag.org/content/11/477/eaat9143 …",,@ @,# #,"1254805334172094467",https://twitter.com/jitcancer/status/1254805334172094467
chulkimMD,2020-04-27 12:11,16,19,"Phase I study of COM701 (PVRIG targeting Ab) monoTx (Arm A) or in combo with nivolumab (Arm B). N=28. No DLTs in both arms. PR seen in primary peritoneal cancer (n=1) and MSS-CRC (n=1). Interesting target deserving further evaluation. # AACR20 pic.twitter.com/zqPjjEVsQF",,,#,"1254805319059935232",https://twitter.com/chulkimMD/status/1254805319059935232
Jbauml,2020-04-27 12:11,1,1,"Patients with a wide range of tumors were enrolled. The drug was relatively well tolerated, but no RECIST responses were seen with this regimen. There were clinical responses seen, but none reached RECIST cutoff # AACR20 pic.twitter.com/SPWgqfvcGo",,,#,"1254805303406866442",https://twitter.com/Jbauml/status/1254805303406866442
UCCancerCenter,2020-04-27 12:11,1,1,"Promising clinical data is being presented by @ UCCancerCenter researchers at the # AACR20 poster session # AnswerCancerhttps://twitter.com/AACR/status/1254802560973713409 …",,@,# #,"1254805269239992321",https://twitter.com/UCCancerCenter/status/1254805269239992321
OncoAlert,2020-04-27 12:10,11,15,"Not to be missed, our @ OncoAlert colleague @ barlesi of @ GustaveRoussy tomorrow at # AACR20 : The Clinical Plenary: # COVID19 and # Cancer https://twitter.com/jsoriamd/status/1254804182902673408 …",,@ @ @,# # #,"1254805243445084167",https://twitter.com/OncoAlert/status/1254805243445084167
gerlach_d,2020-04-27 12:10,0,1,"Follow the session Emerging Signaling Vulnerabilities in Cancer at # AACR20, to learn more about RAS biology and MAPK signaling.",,,#,"1254805224256086025",https://twitter.com/gerlach_d/status/1254805224256086025
NazliDizman,2020-04-27 12:10,20,33,"Exciting Ph1 data by @ DrScottTagawa of @ weillcornell @ nyphospital at # AACR20 @ AACR PSMA-targeted alpha emitter 225Ac-J591 in # mCRPC is safe and promising with 63.6% (14/22) PSA decline and 2 with response >1 yr @ Panos_Vlach @ nhbander @ cnsternberg @ DrDavidNanuspic.twitter.com/MrGYk9MPIP",,@ @ @ @ @ @ @ @,# #,"1254805146451636225",https://twitter.com/NazliDizman/status/1254805146451636225
c0nc0rdance,2020-04-27 12:10,0,5,"Really enjoying Virtual # AACR2020. Lots of more junior faculty, postdocs and even students presenting. Everyone seems well prepared, relaxed, and the organizers did a good job with the technology: everything running smoothly.",,,#,"1254805110787637250",https://twitter.com/c0nc0rdance/status/1254805110787637250
lgreco_ny,2020-04-27 12:10,3,39,"Blood test. Because cancer doesn't quit. # lcsm # aacr20 pic.twitter.com/ZhrfDvVWs7",,,# #,"1254805077866565638",https://twitter.com/lgreco_ny/status/1254805077866565638
noxxon_pharma,2020-04-27 12:10,3,8,"Dr. Niels Halama, from the National Center for Tumor Diseases (NCT) in Heidelberg presented the latest # clinicaldata from the Ph 1/2 study testing # NOXA12 & Keytruda in patients w/ # colorectal or # pancreaticcancer @ AACR Virtual Annual Meeting 2020. https://bit.ly/2yt7bvz pic.twitter.com/heLGEKv7UB",,@,# # # #,"1254805056236511234",https://twitter.com/noxxon_pharma/status/1254805056236511234
duemed,2020-04-27 12:10,0,2,"# AACR20 @ TonyMok9 @ delvysra @ barlesi @ finleypic.twitter.com/YRRqB7Wvo6",,@ @ @ @,#,"1254805032660336642",https://twitter.com/duemed/status/1254805032660336642
greisha_ortiz,2020-04-27 12:09,0,0,"For people having issues with the @ AACR website! https://twitter.com/AACR/status/1254762063416745985 …",,@,,"1254804977496633344",https://twitter.com/greisha_ortiz/status/1254804977496633344
Jbauml,2020-04-27 12:08,7,15,"At # AACR20, Dr Jimeno presents data on mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding OX40L, made for tumor injection, given alone or with the PD-L1 inhibitor durvalumab. pic.twitter.com/JPXn4wjlrT",,,#,"1254804729500258304",https://twitter.com/Jbauml/status/1254804729500258304
OncoAlert,2020-04-27 12:08,1,2,"Live # AACR20 tweet by @ AdrianaHepner “IMspire150 just presented at # AACR20 in metastatic # melanoma. Important PFS data up to 12m which may help individualize selection of initial therapies for BRAFmut pts. “ @ OncoAlert https://twitter.com/AdrianaHepner/status/1254802975157112834 …",,@ @,# # #,"1254804519726321673",https://twitter.com/OncoAlert/status/1254804519726321673
jdflaysakier,2020-04-27 12:07,0,5,"Le monde merveilleux de la Bourse ! Au cours du congrés virtuel # AACR20 une étude très preliminaire sur 20 patients atteints de cancer du poumon. Nouvelle approche par utilisation de lymphocytes. 3 réponses radiologiques. Titre: +4%",,,#,"1254804429594939395",https://twitter.com/jdflaysakier/status/1254804429594939395
ShrutiPatelMD,2020-04-27 12:07,0,13,"THANK YOU @ AACR for making # AACR20 virtual (and free!) allowing me to attend and discuss with my pops from across the country # gotitfrommypapa # AACR20 # Cancer # distancelearning # MedTwitter # MedEd # Immunotherapy # clinicaltrialspic.twitter.com/kOycNrJOug",,@,# # # # # # # # #,"1254804368370663426",https://twitter.com/ShrutiPatelMD/status/1254804368370663426
duemed,2020-04-27 12:07,0,3,"IMpower150 final analysis # AACR20 ABCP vs ACP vs BCP in stage IV non-sqNSCLC ChT-naive pic.twitter.com/jbmnu0MWlN",,,#,"1254804350339252225",https://twitter.com/duemed/status/1254804350339252225
christeeny513,2020-04-27 12:07,2,10,"COM701 is a immunotherapeutic antibody that is well tolerated & currently recruiting for a phase 1 trial testing COM701 as monotherapy & in combo with nivolumab. # AACR20 Several cancers are eligible incl # TNBC. # BCSM # LCSM # GyncSM # CRCSM https://clinicaltrials.gov/ct2/show/NCT03667716 …https://twitter.com/UCCancerCenter/status/1254798186746728448 …",,,# # # # # #,"1254804345134166025",https://twitter.com/christeeny513/status/1254804345134166025
MartialSonia,2020-04-27 12:07,0,2,"Now attending the 1st virtual # AACR20 meeting. Very interesting clinical trials session! pic.twitter.com/d1HHg1iFpK",,,#,"1254804307511312390",https://twitter.com/MartialSonia/status/1254804307511312390
jsoriamd,2020-04-27 12:06,28,70,"Do not miss during # AACR20 tomorrow April 28th 9:00 11:00 a.m. EST the Clinical Plenary: # COVID19 and Cancer where @ barlesi will present the outcome of all COVID19 cancer patients treated @ GustaveRoussy http://bit.ly/2Y4UUbu pic.twitter.com/AaAikxXUBs",,@ @,# #,"1254804182902673408",https://twitter.com/jsoriamd/status/1254804182902673408
jennifer_klomp,2020-04-27 12:06,0,11,"Watching AACR virtual meeting with my dog Story. Makes sense he has been my study/work partner for awhile. # AACR20 pic.twitter.com/Hr9olW9H19",,,#,"1254804135339266057",https://twitter.com/jennifer_klomp/status/1254804135339266057
Lampgen_CR,2020-04-27 12:05,0,0,"# AACR20: # Iovance revels in promising # lungcancer data out of Moffitt as TIL therapy triggers 2 complete responses – Endpoints News http://ow.ly/6lZK30qB756 # oncology # drugdevelopment # cancer # clinicaltrials",,,# # # # # # #,"1254803801669881857",https://twitter.com/Lampgen_CR/status/1254803801669881857
cancerassassin1,2020-04-27 12:03,2,26,"It's weird not hearing standard applause from the audience as we would have otherwise in person at # AACR20. Maybe after each Virtual Presentation, we should post GIFs instead.",,,#,"1254803439600746503",https://twitter.com/cancerassassin1/status/1254803439600746503
pashtoonkasi,2020-04-27 12:03,5,8,"# AACR20 COM701 # Immunotherapy data - always intriguing to see the tumors respond to therapy when they theoretically won’t. Data on an MSS KRAS-mutant # CRCSM with sustained PR. Also saw a pancreas cancer # PANCSM patient listed on ongoing treatment(?MSI). # OncoAlertpic.twitter.com/4J10DvZDzJ",,,# # # # #,"1254803327155605509",https://twitter.com/pashtoonkasi/status/1254803327155605509
BCD_AACR,2020-04-27 12:03,0,0,"Did you know? All @ AACR journal content, including the most recent scientific research, is now freely available throughout the duration of # AACR20 Virtual Annual Meeting I. https://bit.ly/2yP73GK pic.twitter.com/gCgX22sH87",,@,#,"1254803301314560000",https://twitter.com/BCD_AACR/status/1254803301314560000
drleemachado,2020-04-27 12:02,0,0,"# AACR20 EFR3A enhances RAS oncogenesis by modulating plasmid membrane lipid content at the plasma membrane",,,#,"1254803158389469184",https://twitter.com/drleemachado/status/1254803158389469184
AdrianaHepner,2020-04-27 12:01,16,34,"IMspire150 just presented at # AACR20 in metastatic # melanoma. Important PFS data up to 12m which may help individualize selection of initial therapies for BRAFmut pts. Longer FU to access who are the long responders (PD1 driven only? or synergistic effect?) is needed.pic.twitter.com/I5gJ5C0BVr",,,# #,"1254802975157112834",https://twitter.com/AdrianaHepner/status/1254802975157112834
ACGTFoundation,2020-04-27 12:01,0,0,"# AACR20: A look at next-gen CAR-T therapies for blood cancers https://www.fiercebiotech.com/biotech/aacr-a-look-at-next-gen-car-t-therapies-for-blood-cancers …",,,#,"1254802875147935744",https://twitter.com/ACGTFoundation/status/1254802875147935744
stir_bar,2020-04-27 12:00,0,0,"There is q and a, no?",,,,"1254802664002592768",https://twitter.com/stir_bar/status/1254802664002592768
CD_AACR,2020-04-27 12:00,1,2,"New! Read the Precision Oncology article collection! # AACR20 Virtual Annual Meeting I! https://bit.ly/2KJbhlX pic.twitter.com/8HnxxEfreH",,,#,"1254802564752838657",https://twitter.com/CD_AACR/status/1254802564752838657
AACR,2020-04-27 12:00,3,9,"The # AACR20 will feature eight poster sessions on Phase I, II, and III Clinical Trials and Trials in Progress. https://bit.ly/3cSX6Hm",,,#,"1254802560973713409",https://twitter.com/AACR/status/1254802560973713409
PDRennert,2020-04-27 12:00,0,2,"what is up with the pulmonary/cardiac events in the Compugen COM701 trial? # AACR20 and thoughts on this efficacy? pic.twitter.com/gnnmewNgMq",,,#,"1254802545136074752",https://twitter.com/PDRennert/status/1254802545136074752
JanssenGlobal,2020-04-27 12:00,1,7,"As we prepare to participate in @ AACR’s virtual annual meeting, we share our support and well wishes for the entire # cancer community. # AACR20 pic.twitter.com/BL6plfETEb",,@,# #,"1254802514874155011",https://twitter.com/JanssenGlobal/status/1254802514874155011
syinvesting,2020-04-27 12:00,0,0,"$ CGEN Compugen provided its # AACR20 data update. The Company stated that it had two confirmed PRs across both mono and combo treatment cohorts in microsatellite stable colorectal cancer and primary peritoneal cancer. Official PR: https://www.cgen.com/wp-content/uploads/COM701-data-AACR-2020-Final-27-04-2020.pdf …https://www.fiercebiotech.com/biotech/aacr-compugen-s-checkpoint-inhibitor-keeps-cancer-check …",,,#,"1254802490639278081",https://twitter.com/syinvesting/status/1254802490639278081
CancerMedMDA,2020-04-27 12:00,1,2,"Don't miss @ FilipJankuMD "Phase I study of WNT974 + spartalizumab in pts w/advanced solid tumors" Session VCTPL03, # AACR20 Today at 12:10 PM (1:10 PM EDT) @ AACR https://bit.ly/2W0ZV2i",,@ @,#,"1254802488269643777",https://twitter.com/CancerMedMDA/status/1254802488269643777
JAMANetwork,2020-04-27 12:00,0,0,"Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial from @ JAMAOnc is free online during the # AACR20 virtual meeting https://ja.ma/2KmyH0D",,@,#,"1254802487766331392",https://twitter.com/JAMANetwork/status/1254802487766331392
OncoAlert,2020-04-27 11:59,0,0,"Live # AACR20 by @ NazliDizman “Great presentation by Dr. Padmanee Sharma of @ MDAndersonNews @ AACR # AACR20 on why PD-1 and PD-L1 inhibitors performed poorly in # mCRPC to date and what the next steps should be” @ OncoAlert https://twitter.com/NazliDizman/status/1254798724422725633 …",,@ @ @ @,# # #,"1254802425963253761",https://twitter.com/OncoAlert/status/1254802425963253761
Ancora_AI,2020-04-27 11:58,0,2,"Promising # clinicaltrial results regarding adding immune checkpoint inhibitor # durvalumab & PARP inhibitor # olaparib to standard of care neoadjuvant chemo improved outcomes for women w/ stage II/III, high-risk, # HER2 negative # breastcancer. # AACR20 Link: https://bit.ly/2W8zJmq https://twitter.com/ErikaHamilton9/status/1254772007004016643 …",,,# # # # # #,"1254802173956890629",https://twitter.com/Ancora_AI/status/1254802173956890629
Lauren_Langbein,2020-04-27 11:58,0,5,"Switching between the 3 concurrent # AACR20 sessions and, of course, Twitter. pic.twitter.com/lIl78JRRf1",,,#,"1254802051294539776",https://twitter.com/Lauren_Langbein/status/1254802051294539776
ksrcristianchen,2020-04-27 11:58,0,0,"try https://aacr20.onlineeventpro.freeman.com/",,,,"1254802017303687168",https://twitter.com/ksrcristianchen/status/1254802017303687168
ksrcristianchen,2020-04-27 11:56,1,3,"# AACR20 So what is the real role of CTLA4 pic.twitter.com/faZw0nWoFZ",,,#,"1254801519444217862",https://twitter.com/ksrcristianchen/status/1254801519444217862
HartungIngo,2020-04-27 11:54,2,7,"Now online the Drug Design & Discovery session at # AACR20 chaired by @ ChrisNasveschuk: From EED inhibition via CD73 inhibitors to fragment-based drugging of SHP2 and oral ER degraders: Unfortunately no virtual Q&A option, something to add for June! @ AACR https://aacr20.onlineeventpro.freeman.com/live-stream/15335375/Advances-in-Cancer-Drug-Design-and-Discovery …pic.twitter.com/34Wko4uRtn",,@ @,#,"1254801020661780481",https://twitter.com/HartungIngo/status/1254801020661780481
mtmdphd,2020-04-27 11:53,3,3,"Pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy in clinical trials and real-world data [Apr 27, 2020 4:00- 4:10p EDT] Liu et al. # AACR20 CT086 - VCTPL08 - Lung Cancer Targeted Therapy http://ow.ly/Oxpy30qB9U8 # lcsm # irAE",,,# # #,"1254800966005788674",https://twitter.com/mtmdphd/status/1254800966005788674
drteplinsky,2020-04-27 11:53,0,0,"So what is the contribution of olaparib to durvalumab?? We need a larger trial to answer this question and different study arms to break out whether there is a contribution. # aacr20",,,#,"1254800802977402880",https://twitter.com/drteplinsky/status/1254800802977402880
TheYCluster,2020-04-27 11:52,0,2,"i think it is awesome that @ AACR has moved their meeting online and made it free--going great so far! # AACR # WorkFromHome # sciencetwitter",,@,# # #,"1254800497720123396",https://twitter.com/TheYCluster/status/1254800497720123396
bilenma,2020-04-27 11:51,0,1,"May be way to go is mHSPC?",,,,"1254800435568947201",https://twitter.com/bilenma/status/1254800435568947201
bermesproject,2020-04-27 11:51,0,1,"@ aromicsbiotech asiste en estos momentos a la Reunión Virtual @ AACR. Esta reunión virtual contará con documentos de alto impacto en investigación básica, trasnacional y clínica e incluirá una sesión plenaria sobre # COVID19 y # Cancer.pic.twitter.com/JqqGk2DyBK",,@ @,# #,"1254800421039849476",https://twitter.com/bermesproject/status/1254800421039849476
LamaTesh,2020-04-27 11:51,1,2,"I am glad AACR annual meeting didn’t cancel and went virtual during the COVID-19 crisis # aacr2020 # StayHome # COVID19pic.twitter.com/S7zUeCQYmJ",,,# # #,"1254800251225100288",https://twitter.com/LamaTesh/status/1254800251225100288
MosheOrnsteinMD,2020-04-27 11:50,0,5,"Just amazing to see the lack of IO efficacy in CRPC # PCSM",,,#,"1254800014695694337",https://twitter.com/MosheOrnsteinMD/status/1254800014695694337
OncoAlert,2020-04-27 11:50,7,13,"Dear Colleagues, Thank you for your use the # OncoAlert hashtag on your tweets during # AACR20 to keep colleagues worldwide informedPlease feel free to Tell a Friend about @ OncoAlert and help us make the oncology world even smallerWe Are ALL OncoAlertpic.twitter.com/PXhpCrUdmZ",,@,# #,"1254799979492921347",https://twitter.com/OncoAlert/status/1254799979492921347
sara_musetti,2020-04-27 11:49,0,1,"I'm also SO THANKFUL that @ AACR decided to make the meeting virtual and easily accessible, I'm so looking forward to learning over the next few days.",,@,,"1254799773514829825",https://twitter.com/sara_musetti/status/1254799773514829825
CAPR_AACR,2020-04-27 11:48,0,0,"# AACR20 https://twitter.com/CAPR_AACR/status/1245788116935467009 …",,,#,"1254799603888766979",https://twitter.com/CAPR_AACR/status/1254799603888766979
xrtGenomics,2020-04-27 11:48,3,20,"Padmanee Sharma ending clinical trial plenary at # aacr20 with an important plea for more studies investigating biologic effects of (novel) immunotherapies in human --given significant differences in immune system between humans and pre-clinical models.",,,#,"1254799582506123264",https://twitter.com/xrtGenomics/status/1254799582506123264
sara_musetti,2020-04-27 11:47,0,7,"Look, I know virtual meetings are not ideal, but there is something so delicious about getting to experience the @ AACR meeting wrapped in a shawl with a massaging pad instead of in business attire on folding chairs.",,@,,"1254799399999492097",https://twitter.com/sara_musetti/status/1254799399999492097
gselvaggiMD,2020-04-27 11:47,0,2,"It started ... our NEW normal ! The virtual @ AACR # AACR20 pic.twitter.com/BuD6BKoQoO",,@,#,"1254799375571828739",https://twitter.com/gselvaggiMD/status/1254799375571828739
alantanmd,2020-04-27 11:46,0,3,"Weird not hearing applause after these sessions that usually have rooms filled with thousands, but i imagine we will save a lot of time cumulatively and have more efficient meetings # AACR20",,,#,"1254799085405564928",https://twitter.com/alantanmd/status/1254799085405564928
nycdoc29,2020-04-27 11:45,0,1,"# AACR20 while I miss attending # IRL plenary what I’m thrilled about virtual meeting - no worries about WiFi & no worries about charging",,,# #,"1254798864495845377",https://twitter.com/nycdoc29/status/1254798864495845377
StephanieHilz,2020-04-27 11:45,0,3,"Excited to tune into some of these talks, which are available for free to anyone # AACR20 https://twitter.com/AACR/status/1254442634267017217 …",,,#,"1254798862423715840",https://twitter.com/StephanieHilz/status/1254798862423715840
NazliDizman,2020-04-27 11:45,43,106,"Great presentation by Dr. Padmanee Sharma of @ MDAndersonNews @ AACR # AACR20 on why PD-1 and PD-L1 inhibitors performed poorly in # mCRPC to date and what the next steps should bepic.twitter.com/0vT59YkLKy",,@ @,# #,"1254798724422725633",https://twitter.com/NazliDizman/status/1254798724422725633
StephenJWillia2,2020-04-27 11:44,3,3,""Cold" immune tumors like prostate which don't have lots of infiltrating T cells versus "hot" tumors like melanoma where checkpoint inhibitors work because of infiltrating T cells. How can we drive t cells into cold tumors # AACR20 @ Pharma_BI",,@,#,"1254798476434640896",https://twitter.com/StephenJWillia2/status/1254798476434640896
UCCancerCenter,2020-04-27 11:42,2,2,"Stay tuned at # AACR20 to learn about a novel checkpoint inhibitor # immunotherapy COM701. This multi-institutional study was led at @ UCCancerCenter by Dr. Gini Fleming. Abstract CT031 # AnswerCancer Coming up now!",,@,# # #,"1254798186746728448",https://twitter.com/UCCancerCenter/status/1254798186746728448
CarlosHBarcenas,2020-04-27 11:42,3,12,"Today during the virtual meeting # AACR20 at 1:55PM EDT starts the Breast Cancer Therapy session with two presentations by @ JenniferLitton from @ MDAndersonNews",,@ @,#,"1254798118329159680",https://twitter.com/CarlosHBarcenas/status/1254798118329159680
Digital_Way_930,2020-04-27 11:41,0,1,"Spotify Gift Card Giveaway! # AACR20 # spotifygiftcardtrade # spotifygiftcardsfortrade http://bxcode.justsharedthis.info/qudAwa",,,# # #,"1254797943464439812",https://twitter.com/Digital_Way_930/status/1254797943464439812
drteplinsky,2020-04-27 11:41,0,1,"Exploratory analysis suggests potential predictive markers of durvalumab/olaparib over chemo alone: mammaprint ultra high in HR+/HER2-; in TNBC: low CD3/CD8 ratio, Hugh macrophage/Tcell MHC class II ratio and high proliferation. # aacr20",,,#,"1254797928251695104",https://twitter.com/drteplinsky/status/1254797928251695104
jitcancer,2020-04-27 11:41,0,4,"Great discussion from Dr. Sharma @ MDAndersonNews on # immunotherapy in # prostatecancer # AACR @ AACR Definitely a sub-set of # PCSM that is immune-infiltrated & can be targeted w IO. Great @ ScienceTM study by @ sumit_subudhi & Dr Sharma belowhttps://twitter.com/jitcancer/status/1246768326803632129 …",,@ @ @ @,# # # #,"1254797840917938176",https://twitter.com/jitcancer/status/1254797840917938176
pashtoonkasi,2020-04-27 11:41,1,2,"Agreed. I think the challenges that were eluded to funding another arm in these # clinicaltrials for intermittent dosing question. Also like the idea of “pulsatile” dosing that was presented # AACR20 @ AACR. # OncoAlert # PrecisionMedicine",,@,# # # #,"1254797790108139520",https://twitter.com/pashtoonkasi/status/1254797790108139520
drteplinsky,2020-04-27 11:40,1,5,"Immune rich cancers had higher pCR in all HER2- subtypes and in both treatment arms. # aacr20",,,#,"1254797553247367169",https://twitter.com/drteplinsky/status/1254797553247367169
NCRI_partners,2020-04-27 11:40,1,4,"On channel 1 at the # AACR20 Virtual Annual Meeting the results of a number of # immunotherapy clinical trials are being presented.pic.twitter.com/DbX4vkBr1D",,,# #,"1254797498595659776",https://twitter.com/NCRI_partners/status/1254797498595659776
drteplinsky,2020-04-27 11:38,0,0,"Most frequent Grade 3/4 AEs in durvalumab/olaparib subgroup: febrile neutropenia, colitis, adrenal insufficiency, increased ALT, dehydration and vaginal infection. # aacr20",,,#,"1254797183511134211",https://twitter.com/drteplinsky/status/1254797183511134211
sommioney,2020-04-27 11:37,0,1,"Enjoy this # AACR20 pic.twitter.com/SjeQlGfe8X",,,#,"1254796837103349766",https://twitter.com/sommioney/status/1254796837103349766
drteplinsky,2020-04-27 11:37,0,0,"Interestingly, durvalumab and olaparib shifted residual cancer burden to lower values across all categories except for RCBIII in TNBC. # aacr20",,,#,"1254796791557521410",https://twitter.com/drteplinsky/status/1254796791557521410
sommioney,2020-04-27 11:36,0,0,"Enjoy this # AACR20 pic.twitter.com/uHfVMRBVDe",,,#,"1254796672263053312",https://twitter.com/sommioney/status/1254796672263053312
cancerassassin1,2020-04-27 11:36,9,16,"Discussant Dr. Sawyers mentioned and showed a schematic of a model of drug resistance from Dr. Gatenby and team @ mathonco @ MoffittNews - Adaptive therapy and clinical trial design including intermittent (rather than continuous) therapy has merit. https://clincancerres.aacrjournals.org/content/25/14/4413.figures-only … # AACR20 https://twitter.com/cancerassassin1/status/1254785651251179522 …pic.twitter.com/lfdNPIAG9J",,@ @,#,"1254796667674603522",https://twitter.com/cancerassassin1/status/1254796667674603522
duemed,2020-04-27 11:36,0,2,"Towards the future; final slide from Dr Sharma # AACR20 pic.twitter.com/mIChs4HEZi",,,#,"1254796647458115585",https://twitter.com/duemed/status/1254796647458115585
FellowsHsl,2020-04-27 11:34,3,14,"Elegant proof-of-concept study at # AACR20! Ipatasertib modulated TME regardless of PI3K pathway mutation status & its combination w/ Atezo switched from a desert to an inflamed phenotype w/ clinical benefit. Congrats @ marianascarant1 & team! @ AACR @ royalmarsdenNHSpic.twitter.com/G5kzHOGqKB",,@ @ @,#,"1254796097337384960",https://twitter.com/FellowsHsl/status/1254796097337384960
joselgutierrez5,2020-04-27 11:34,0,1,""Del cáncer al amor" libro gratuito para compartir y aprender de la experiencia del autor, Pablo, y de muchos colaboradores, sobre el cáncer. No tengas miedo, pasa: https://drive.google.com/file/d/1JtoWC3tMy0N7p4vETNpYy0dd2OEzPext/view?usp=sharing … @ somos_pacientes @ AACR @ CDC_Cancer @ JovenesCancer @ apetp_ @ GEPAC_ @ aecc_granada",,@ @ @ @ @ @ @,,"1254796016336977927",https://twitter.com/joselgutierrez5/status/1254796016336977927
pashtoonkasi,2020-04-27 11:34,1,9,"# AACR20 # Immunotherapy 101 Anti-PD-1/PD-L1 = Anti-CTLA-4",,,# #,"1254796007226908674",https://twitter.com/pashtoonkasi/status/1254796007226908674
DMSLung,2020-04-27 11:34,0,3,"# AACR2020 very well organized website. Nice access to the poster sessions. Unfortunately we can't discuss F2F but during the outbreak it' not so bad https://twitter.com/Tony_Calles/status/1254782345921441803 …",,,#,"1254795989933871104",https://twitter.com/DMSLung/status/1254795989933871104
AndresC27622123,2020-04-27 11:33,2,2,"Recent news presented in # AACR20 https://twitter.com/DrSuneil_PCa/status/1254792974606782464 …",,,#,"1254795707506208770",https://twitter.com/AndresC27622123/status/1254795707506208770
vitoriamaiams,2020-04-27 11:31,0,0,"Currently attending # AACR annual meeting, thank you @ AACR for promoting this amazing event! # MedTwitter # oncologypic.twitter.com/g37KRHdRrl",,@,# # #,"1254795423946063872",https://twitter.com/vitoriamaiams/status/1254795423946063872
Dr_ZiMingZhao,2020-04-27 11:31,0,2,"Mechanisms that adding immunotherapy - not improving OS # AACR20 https://twitter.com/eiger_daniel/status/1254794005256306689 …pic.twitter.com/5lDg4Uo9Bw",,,#,"1254795334368342017",https://twitter.com/Dr_ZiMingZhao/status/1254795334368342017
ParticleDoc,2020-04-27 11:31,0,1,"# AACR20 See how our MESF & QSC kits support quantitative # flowcytometry in # cancer # research & # immunotherapy development. http://spok.al/697t pic.twitter.com/Qww2zbqvnq",,,# # # # #,"1254795202599976960",https://twitter.com/ParticleDoc/status/1254795202599976960
MDAndersonNews,2020-04-27 11:30,5,31,"Starting today, our # cancer researchers will be presenting their practice-changing findings virtually at # AACR20. Discover the latest: http://www.mdanderson.org/AACR # endcancer",,,# # #,"1254795113739571203",https://twitter.com/MDAndersonNews/status/1254795113739571203
JCellBiol,2020-04-27 11:30,1,2,"Targeting importin-11 may block the growth of colorectal cancers caused by mutations in APC. JCB’s new cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has short summaries of articles in this PDF: https://bit.ly/2XYckGS pic.twitter.com/lRu29zMxWH",,,#,"1254794959540150272",https://twitter.com/JCellBiol/status/1254794959540150272
acmoorephd,2020-04-27 11:30,1,2,"Missing seeing so many of my current and former colleagues in sunny San Diego! Have a good virtual meeting! @ AACR # research # lcsm",,@,# #,"1254794937805070336",https://twitter.com/acmoorephd/status/1254794937805070336
MyBioTechniques,2020-04-27 11:30,1,1,"Study estimates over one-third of US high schoolers have ever used an # ecigarette and indicates that # tobacco and vape shops are more concentrated in areas with a higher percentage of ethnic minorities or lower-income inhabitants. # AACR20",,,# # #,"1254794936890748930",https://twitter.com/MyBioTechniques/status/1254794936890748930
ResearchAtJeff,2020-04-27 11:29,0,15,"Congratulations to our very own Alison Shupp ( @ AlisonShupp), a graduate student in The Bussard Lab ( @ KMBussard), for being selected for @ AACR's Women in Cancer Research Scholar Award 2020 for her work on # breastcancer! # JeffersonResearchhttps://www.aacr.org/professionals/meetings/aacr-travel-grants/women-in-cancer-research-scholar-awards/%E2%80%8B2020-women-in-cancer-research-scholar-awards/ …",,@ @ @,# #,"1254794912043851776",https://twitter.com/ResearchAtJeff/status/1254794912043851776
HassanSheikh_MD,2020-04-27 11:29,0,3,"Happy Virtual Annual # AACR20 . It’s exhilarating to be able join in the Clinical Plenary. pic.twitter.com/lZ5gesmcii",,,#,"1254794745622257665",https://twitter.com/HassanSheikh_MD/status/1254794745622257665
DrOmarMian,2020-04-27 11:28,2,19,"IMbassador250 Ph3 RCT comparing Atezo+Enzalutamide vs Enzalutamide for mCRPC presented at # AACR2020 Unfortunately no benefit with IO combo therapy and more toxicity with combo. Important negative results presented by @ ChrisSweens1. @ AACR # pcsm # prostatecancerpic.twitter.com/YVst0pQNAH",,@ @,# # #,"1254794636784263169",https://twitter.com/DrOmarMian/status/1254794636784263169
duemed,2020-04-27 11:28,1,3,"Possible causes of failure for this combination # AACR20 from the discussant Dr Padmanee Sharma pic.twitter.com/nw5nJSeMeV",,,#,"1254794468588507137",https://twitter.com/duemed/status/1254794468588507137
drteplinsky,2020-04-27 11:27,0,3,"Results from I-SPY2 trial: durvalumab and olaparib have highest pCR in TNBC subset. # aacr20 pic.twitter.com/s2K0P41msV",,,#,"1254794282520756224",https://twitter.com/drteplinsky/status/1254794282520756224
OncoAlert,2020-04-27 11:27,3,9,"Live # AACR20 tweet @ alantanmd “No benefit of addition of atezo to enzalutamide in mCRPC” # pcsm # prostatecancer @ OncoAlert https://twitter.com/alantanmd/status/1254793165984239616 …",,@ @,# # #,"1254794280545202176",https://twitter.com/OncoAlert/status/1254794280545202176
ASGCTherapy,2020-04-27 11:26,1,1,"Tumors shrank in one quarter of advanced # LungCancer patients who received a # CellTherapy made by doctors at @ MoffittNews, according to study results released during @ AACR's virtual meeting. # AACR20 https://bit.ly/2VGuJpR",,@ @,# # #,"1254794051007676416",https://twitter.com/ASGCTherapy/status/1254794051007676416
vitoriamaiams,2020-04-27 11:26,0,0,"I tried to log in but couldn’t as well",,,,"1254794033819418627",https://twitter.com/vitoriamaiams/status/1254794033819418627
eiger_daniel,2020-04-27 11:26,12,19,"Just out: adding atezo to enza in mCRPC pts failing abi not eligible to taxanes didn’t improve OS, nor secondary endpoints. No signs of efficacy in PDL1+ subgroups in exploratory analysis # AACR20 # oncoalertpic.twitter.com/E4cFKyhiAS",,,# #,"1254794005256306689",https://twitter.com/eiger_daniel/status/1254794005256306689
EladSharonMD,2020-04-27 11:25,0,0,"It's always good to look at the biomarkers and figure out how to learn more going forward. Monotherapy data with # PD1/ # PDL1 inhibitors was never encouraging in the overall prostate cancer population, however.",,,# #,"1254793740637499392",https://twitter.com/EladSharonMD/status/1254793740637499392
jdflaysakier,2020-04-27 11:25,2,9,"# Cancer : la combinaison Atezoluzimab-enzalutamide n’apporte aucun benefice par rapport à l’enzalutamide seul dans le traitement du cancer de la prostate résistant après castration # IMbassador250 # AACR20",,,# # #,"1254793706516996096",https://twitter.com/jdflaysakier/status/1254793706516996096
TischCancer,2020-04-27 11:25,1,7,"Dr. Nina Bhardwaj, @ IcahnMountSinai, is discussant at 12:50 pm today, # immunotherapy clinical trials. @ AACR https://www.abstractsonline.com/pp8/#!/9045/session/852 …pic.twitter.com/CglDi42oQf",,@ @,# #,"1254793694277963778",https://twitter.com/TischCancer/status/1254793694277963778
OncoAlert,2020-04-27 11:24,3,6,"Live # AACR20tweey @ DrSuneil_PCa : IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in mCRPC # AACR20 # pcsm. A negative study with higher tox for combo (IO side-effects as per prev studies) @ OncoAlert # pcsm # prostatecancerhttps://twitter.com/DrSuneil_PCa/status/1254792974606782464 …",,@ @,# # # # #,"1254793614217089026",https://twitter.com/OncoAlert/status/1254793614217089026
tompowles1,2020-04-27 11:24,154,273,"Atezolizumab + enzalutamide not increasing OS or PFS (vs Enza alone) in prostate cancer (CRPC) - HR1.12. No subgroup appears to benefit and no long-term progressors. This seriously questions any role for ICIs in prostate cancer # AACR20 # prostatecancerpic.twitter.com/VBx5PDu0bO",,,# #,"1254793493521805312",https://twitter.com/tompowles1/status/1254793493521805312
duemed,2020-04-27 11:24,0,1,"# AACR20 A negative trial. pic.twitter.com/IFNjIEcZeZ",,,#,"1254793449682935809",https://twitter.com/duemed/status/1254793449682935809
malignantheme,2020-04-27 11:23,0,0,"No improvement in OS. Intermittent therapy could likely be a proof of concept in other targetable cancers? # AACR2020",,,#,"1254793292820160515",https://twitter.com/malignantheme/status/1254793292820160515
jitcancer,2020-04-27 11:23,2,10,"Tough to see negative trial of anti-androgen (enzalutamide) with anti-PDL1 for # prostatecancer # AACR @ AACR. Wonder what this regimen would look like in CDK12 mut or hi CD8 T cell density / IFN-γ gene signature? Certainly more to do for # immunotherapy in this dz! @ PCFnews # PCSM",,@ @,# # # #,"1254793183655079936",https://twitter.com/jitcancer/status/1254793183655079936
alantanmd,2020-04-27 11:22,0,1,"no benefit of addition of atezo to enzalutamide in mCRPC in phase III # AACR20 pic.twitter.com/IjS9WiiwA3",,,#,"1254793165984239616",https://twitter.com/alantanmd/status/1254793165984239616
OncoAlert,2020-04-27 11:22,2,6,"Live # AACR20 tweet by @ drteplinsky Schema for I-SPY2 trial of olaparib+ durvalumab + taxol. @ OncoAlert https://twitter.com/drteplinsky/status/1254792165018021888 …",,@ @,#,"1254793076910043137",https://twitter.com/OncoAlert/status/1254793076910043137
DrSuneil_PCa,2020-04-27 11:22,8,17,"@ ChrisSweens1 presents IMbassador250: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in mCRPC # AACR20 # pcsm. A negative study with higher tox for combo (IO side-effects as per prev studies).pic.twitter.com/JxcFbxrQAc",,@,# #,"1254792974606782464",https://twitter.com/DrSuneil_PCa/status/1254792974606782464
DeepOnCar,2020-04-27 11:22,3,7,"# IMbassador250 trial demonstrates that addition of # atezolizumab to androgen receptor antagonist # enzalutamide doesn't provide any benefit in metastatic CRPC compared to monotherapy with AR antagoinist alone. # AACR20 # oncoalertpic.twitter.com/1rLIhdV0o3",,,# # # # #,"1254792938330210304",https://twitter.com/DeepOnCar/status/1254792938330210304
Dr_JJ_Berenguer,2020-04-27 11:20,0,0,"A really interesting your clinical plenary Manuel",,,,"1254792524641828867",https://twitter.com/Dr_JJ_Berenguer/status/1254792524641828867
duemed,2020-04-27 11:20,2,6,"Results from IMbassador250 trial (enza vs enza + atezolizumab in mCRPC) presented at # AACR20 by @ ChrisSweens1pic.twitter.com/viIn3NBmI1",,@,#,"1254792429418536967",https://twitter.com/duemed/status/1254792429418536967
FaizahAlotaibi_,2020-04-27 11:19,1,3,"# AACR20 which was supposed to be in San Diego is now streaming online and everyone can register for free Check out the schedule https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/ …pic.twitter.com/NPj4fBNrIz",,,#,"1254792362448105474",https://twitter.com/FaizahAlotaibi_/status/1254792362448105474
drteplinsky,2020-04-27 11:18,3,7,"Schema for I-SPY2 trial of olaparib+ durvalumab + taxol. # aacr20 pic.twitter.com/KxjKs1V04A",,,#,"1254792165018021888",https://twitter.com/drteplinsky/status/1254792165018021888
SKabrajiMD,2020-04-27 11:18,0,0,"@ ChrisSweens1 providing a master-class in clear and transparent presentation at # AACR2020 plenary @ DanaFarber",,@ @,#,"1254792037372760066",https://twitter.com/SKabrajiMD/status/1254792037372760066
YaleCancer,2020-04-27 11:17,2,7,"Watch at 4:50 pm today . @ GiorgiaFoggetti presents research results with @ PolitiKaterina at # AACR20 concerning gene editing and # EGFR-driven # lungcancer. @ SmilowCancer @ YalePathology @ YaleMed @ YNHH # oncoalert https://www.abstractsonline.com/pp8/#!/9045/session/839 …pic.twitter.com/sL35nTsobw",,@ @ @ @ @ @,# # # # #,"1254791864995082240",https://twitter.com/YaleCancer/status/1254791864995082240
DrMarkKiel,2020-04-27 11:17,1,3,"Tuning in from home for the @ AACR Virtual Event today # AACR20 # AACR2020pic.twitter.com/GBAoUEEQa6",,@,# #,"1254791861035839490",https://twitter.com/DrMarkKiel/status/1254791861035839490
AminaZoubeidi,2020-04-27 11:15,0,19,"Live @ aacr ⁦ @ ChrisSweens1⁩ # CRPC # ENZpic.twitter.com/tE2m3x6izn",,@ @,# #,"1254791372822810626",https://twitter.com/AminaZoubeidi/status/1254791372822810626
bnserer,2020-04-27 11:15,0,7,"attending my first @ AACR annual meeting!! very excited for a couple days of talks, presentations, and inspiring research! # AACR20 pic.twitter.com/dztXCiObx5",,@,#,"1254791197714939905",https://twitter.com/bnserer/status/1254791197714939905
drteplinsky,2020-04-27 11:14,1,2,"Biological and clinical rationale exists to combine PARPi and immunotherapy. One of the reasons is that PARP inhibitor upregulates PD-L1 expression in breast cell lines. # aacr20",,,#,"1254791130975285248",https://twitter.com/drteplinsky/status/1254791130975285248
politikaterina,2020-04-27 11:13,0,6,"Looking forward to Chairing the VCTPL03 - Immunotherapy Clinical Trials 1 session at # AACR20 at 11:40am today. @ YaleCancer https://www.abstractsonline.com/pp8/#!/9045/session/852 …",,@,# #,"1254790679101759492",https://twitter.com/politikaterina/status/1254790679101759492
chadinabhan,2020-04-27 11:12,0,6,"Very interesting # AACR20 https://endpts.com/aacr20-early-data-suggest-novartis-incyte-discovered-met-inhibitor-helps-lung-cancer-patients-with-brain-lesions/ …",,,#,"1254790581357735936",https://twitter.com/chadinabhan/status/1254790581357735936
luddyka,2020-04-27 11:12,0,0,"Session 1: Intermittent dosing with IO drugs would be difficult because half-life of antibodies is a large hindrance. # AACR20",,,#,"1254790547912392705",https://twitter.com/luddyka/status/1254790547912392705
archerdxinc,2020-04-27 11:11,0,2,"Multiple challenges exist with current, standard of care # cancer screening. We believe monitoring early-stage cancer in patients may have several applications. # AACR20 # AACR2020 # MRD https://hubs.ly/H0pTlZv0 pic.twitter.com/wNSfI8903l",,,# # # #,"1254790200363905031",https://twitter.com/archerdxinc/status/1254790200363905031
drteplinsky,2020-04-27 11:11,0,0,"Listening to Dr. Lajos Pusztai discuss durvalumab in combination with olaparib and paclitaxel from I-SPY2 trial. # aacr20",,,#,"1254790171955879936",https://twitter.com/drteplinsky/status/1254790171955879936
CancerMedMDA,2020-04-27 11:11,1,3,"Join @ JenniferLitton for # AACR20 Session VCTPL07 "Talazoparib in germline BRCA1/2-mutated HER2- advanced breast cancer (ABC): Final overall survival (OS) results from randomized Phase 3 EMBRACA trial." Today at 1PM (2PM EDT) @ AACR https://bit.ly/2KycxbA",,@ @,#,"1254790154125885445",https://twitter.com/CancerMedMDA/status/1254790154125885445
luddyka,2020-04-27 11:10,0,5,"Following failure of an intermittent dosing trial with a static schedule the speaker was asked about adding modeling to help personalize intermittent therapy to prevent acquired resistance. The speaker replies... logistics are hard. # AACR20",,,#,"1254790099763523585",https://twitter.com/luddyka/status/1254790099763523585
drteplinsky,2020-04-27 11:09,0,0,"Finally got it!",,,,"1254789698997809157",https://twitter.com/drteplinsky/status/1254789698997809157
MarioParreno,2020-04-27 11:08,0,2,"Attending from home my first AACR Annual Meeting :)) # AACR20 pic.twitter.com/g9IP1LSxJL",,,#,"1254789419455791104",https://twitter.com/MarioParreno/status/1254789419455791104
cathy_ileana_md,2020-04-27 11:06,5,14,"Multidisciplinary collaboration to evaluate nivolumab in patients with cancer and autoimmune diseases (AIM-Nivo) @ EladSharonMD @ NCICTEP_ClinRes @ NCICancerTrials @ HTawbi_MD @ MDAndersonNews @ PainterJeane Check our virtual poster at @ AACR # AACR20 https://www.abstractsonline.com/pp8/#!/9045/presentation/10677 …",,@ @ @ @ @ @ @,# #,"1254789083135524865",https://twitter.com/cathy_ileana_md/status/1254789083135524865
AileenIlianaPhD,2020-04-27 11:06,1,12,"Kudos to # AACR20 - love the accessibility, plus I’m not too upset about attending from my couch pic.twitter.com/bKOenAMEjv",,,#,"1254789008762134531",https://twitter.com/AileenIlianaPhD/status/1254789008762134531
SKabrajiMD,2020-04-27 11:05,0,0,"Exactly how many drugs will be tested in a combination to get better # pCR in # bcsm ? Aren't we done with this approach without better # biomarkers? # AACR20",,,# # # #,"1254788875563659271",https://twitter.com/SKabrajiMD/status/1254788875563659271
sillysalz,2020-04-27 11:05,0,1,"Attending today's opening sessions of # AACR20 # VirtualMeeting and so glad we all have this unique opportunity to hear exciting and important new data.",,,# #,"1254788711931211777",https://twitter.com/sillysalz/status/1254788711931211777
alantanmd,2020-04-27 11:05,0,0,"unprecedented times - attending # AACR20 from home, let’s see how effective this is @ COVID19nCCCpic.twitter.com/y55CTpAjPB",,@,#,"1254788676434812929",https://twitter.com/alantanmd/status/1254788676434812929
Alfdoc2,2020-04-27 11:04,0,0,"Yes me",,,,"1254788597279936512",https://twitter.com/Alfdoc2/status/1254788597279936512
Alfdoc2,2020-04-27 11:04,0,0,"Toxicity data?",,,,"1254788540598153216",https://twitter.com/Alfdoc2/status/1254788540598153216
SKabrajiMD,2020-04-27 11:03,0,0,"Nice work to order questions by popular interest at # AACR20 Virtual Meeting @ AACR Same @ ASCO ?",,@ @,#,"1254788358342991873",https://twitter.com/SKabrajiMD/status/1254788358342991873
brendanweiss,2020-04-27 11:03,1,8,"My # AACR20 virtual set up. Jumping between sessions and work will be easy. Coffee lines are very short here. Will miss colleagues and collaborators. Stay safe everyone! pic.twitter.com/8VcqLOaN25",,,#,"1254788350789087235",https://twitter.com/brendanweiss/status/1254788350789087235
DrPatyJuarez,2020-04-27 11:03,0,0,"Acceso gratuito al meeting anual virtual de la Asociación Americana para la Investigación en Cancer (AACR), excelente oportunidad! @ AACR https://twitter.com/AACR/status/1254078991524397056 …",,@,,"1254788166847836165",https://twitter.com/DrPatyJuarez/status/1254788166847836165
pashtoonkasi,2020-04-27 11:01,2,5,"# AACR20 very intriguing data indeed. pic.twitter.com/6URbLkpn3m",,,#,"1254787828858318850",https://twitter.com/pashtoonkasi/status/1254787828858318850
pratt_ed,2020-04-27 11:00,0,1,"I'm really enjoying the integration of discussant formal presentations into the # AACR20 schedule. Taking the time to zoom out and put the prior scientific presentations in context of the field is helpful & informative!",,,#,"1254787560888389633",https://twitter.com/pratt_ed/status/1254787560888389633
VivekSubbiah,2020-04-27 11:00,0,0,"# AACR20 : Roche's Tecentriq, added to Cotellic and Zelboraf, stalls melanoma progression https://www.fiercepharma.com/pharma/embargoed-roche-s-tecentriq-added-to-cotellic-and-zelboraf-stalls-melanoma-progression …",,,#,"1254787541967925248",https://twitter.com/VivekSubbiah/status/1254787541967925248
OncoGerard,2020-04-27 11:00,1,1,"Comienza el primer gran congreso internacional en oncología totalmente virtual, # AACR20. Le seguirán ASCO y WCGIC. Será este el principio de un cambio de paradigma? https://twitter.com/AACR/status/1254762685423587328 …",,,#,"1254787526532796416",https://twitter.com/OncoGerard/status/1254787526532796416
JExpMed,2020-04-27 11:00,2,1,"Huntly lab: The histone methyltransferase EZH2 can delay the development of AML but then maintains tumor growth once the disease is established. New short summaries of articles (https://bit.ly/2XYhG4z ) that are part of JEM’s cancer collection for # AACR20 https://bit.ly/3avNaBK pic.twitter.com/5Bd9zi6eiI",,,#,"1254787492848349191",https://twitter.com/JExpMed/status/1254787492848349191
AACR,2020-04-27 11:00,8,18,"# AACR20 Virtual Annual Meeting I: Alain Algazi shares results from SWOG S1320. Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma. pic.twitter.com/FMAQDNjdHB",,,#,"1254787460413841412",https://twitter.com/AACR/status/1254787460413841412
MCT_AACR,2020-04-27 11:00,1,2,"Our new First Disclosures article type presents drugs for the first time in the published literature. Read our inaugural First Disclosures articles and submit yours today! # AACR20 https://bit.ly/2KFrXuE pic.twitter.com/YV17NQCRIm",,,#,"1254787459814064135",https://twitter.com/MCT_AACR/status/1254787459814064135
BayerPharma,2020-04-27 11:00,3,14,"We invite you to join us virtually at this year’s # AACR20, where we will be presenting on a new approach to immunotherapy (IO). # cancer http://spr.ly/601614QKO pic.twitter.com/GJP7ZgNn1c",,,# #,"1254787414666604547",https://twitter.com/BayerPharma/status/1254787414666604547
lymphomahub,2020-04-27 11:00,0,4,"Don’t miss the @ lymphomahub coverage of the # AACR20 Annual Meeting starting today! We will be covering the sessions virtually through social media! Stay tuned for all the latest information on # lymphoma and CLL! # lymsmpic.twitter.com/Fb25QhHUYy",,@,# # #,"1254787397239226368",https://twitter.com/lymphomahub/status/1254787397239226368
JAMANetwork,2020-04-27 11:00,6,4,"Following the # AACR20 virtual meeting? Read Oncology Practice During the COVID-19 Pandemic from @ JAMA_current free online during the meeting https://ja.ma/3auw1bE",,@,#,"1254787385973280774",https://twitter.com/JAMANetwork/status/1254787385973280774
FredNatLab,2020-04-27 10:59,1,5,"Hats off to @ AACR for hosting virtual # AACR20, complete with plenary, symposia & poster sessions. No badge required! Register & attend for free. https://buff.ly/2VVAGOw # CancerResearch # RAScancer # translationalresearchpic.twitter.com/JOsYMaRsiF",,@,# # # #,"1254787201537150977",https://twitter.com/FredNatLab/status/1254787201537150977
pashtoonkasi,2020-04-27 10:58,4,4,"Indeed. While not everything can be deciphered, point mutations in RAFRAS pathway can easily be detected in # ctDNA # LiquidBiopsies. Worthwhile integrating this into identifying molecular resistance earlier. # AACR20 # oncoalert # clinicaltrialspic.twitter.com/ARpi3r8KUQ",,,# # # # #,"1254786955381891079",https://twitter.com/pashtoonkasi/status/1254786955381891079
FellowsHsl,2020-04-27 10:55,0,7,"Adding Atezo to Vemutafenib & Cobimetinib in advanced Melanoma BRAFmut leads to meaningful improvement in PFS & clinically improvement in mDOR (21 vs 12.6m) - as expected with the use of checkpoint blockade in this scenario. ORR similar & OS data not mature. @ AACR # AACR20 https://twitter.com/AACR/status/1254782373008248833 …",,@,#,"1254786347736301568",https://twitter.com/FellowsHsl/status/1254786347736301568
PrimaAnggara99,2020-04-27 10:55,0,0,"Check out this awesome 'Coding Design For Programmers' design on @ TeePublic! http://tee.pub/lic/3ux4TI5cF1I # programer # programming # coding # RespectBTSV # LockdownEnd # Killing # MayThe4th # AllAmericans # MondayMood # AACR20 # Covid19 # LiebyJimin100M",,@,# # # # # # # # # # # #,"1254786311715647490",https://twitter.com/PrimaAnggara99/status/1254786311715647490
NaagKPrasad,2020-04-27 10:54,0,0,"Thx. I tried that multiple times + closing browser, clearing the cache, restarting the computer - it keeps redirecting to myAACR login.",,,,"1254786069515522049",https://twitter.com/NaagKPrasad/status/1254786069515522049
eiger_daniel,2020-04-27 10:54,0,5,"Despite the good pre clinical rationale (selective pressure for the emergence of resistant clones) and promising toxicities, intermittent dosing of dabra/trametinib couldn’t prove super to continuous dosing in BRAFmut melanoma. Numerically similar OS though # AACR20 pic.twitter.com/SypmgcmVP0",,,#,"1254786007892779013",https://twitter.com/eiger_daniel/status/1254786007892779013
YaleCancer,2020-04-27 10:54,2,18,"Dr. Lajos Pusztai presented new research at # AACR20 showing # Immunotherapy prior to surgery may help destroy high-risk # breastcancer. @ SmilowCancer @ YaleMed @ YNHH # bcsm # oncoalert https://www.yalecancercenter.org/news-article/24238/ …pic.twitter.com/2oCa5CUcXh",,@ @ @,# # # # #,"1254785883586179074",https://twitter.com/YaleCancer/status/1254785883586179074
OncoAlert,2020-04-27 10:53,1,2,"Live # AACR20 @ OncoAlert https://twitter.com/AACR/status/1254782618156929027 …",,@,#,"1254785786408402945",https://twitter.com/OncoAlert/status/1254785786408402945
StephenJWillia2,2020-04-27 10:53,0,1,"80% of braf mek inhibitor acquired resistance due to restored erk signaling; rest due to either braf amplification or braf splice variants # AACR20 @ Pharma_BI",,@,#,"1254785705701564416",https://twitter.com/StephenJWillia2/status/1254785705701564416
cancerassassin1,2020-04-27 10:53,3,19,"Listening to @ CharlesSawyers discussing BRAF on the # AACR20 Virtual Meeting reminds us just how much it is a Master of Resistance - in # melanoma & colorectal cancer. CS: "80% of acquired resistance is associated with restored ERK signaling" - BRAF mutation, amplification, NRAS mt",,@,# #,"1254785651251179522",https://twitter.com/cancerassassin1/status/1254785651251179522
c0nc0rdance,2020-04-27 10:52,1,12,"Interesting question from # AACR2020 Why do combinations of cancer therapies work better? Hypothesis A: Synergy They work together to product effect better than either one alone. Hypothesis B: Kitchen sink Patients are diverse, and cocktails multiply chance *something* works. pic.twitter.com/z3Q8qp7sPr",,,#,"1254785452747321346",https://twitter.com/c0nc0rdance/status/1254785452747321346
JacobPlieth,2020-04-27 10:52,3,6,"Tomorrow it's $ IOVA's big day at # AACR20 https://www.evaluate.com/vantage/articles/news/snippets/aacr-2020-iovance-doesnt-disappoint …",,,#,"1254785432224542720",https://twitter.com/JacobPlieth/status/1254785432224542720
DrAbhiPal,2020-04-27 10:50,3,16,"Fantastic to see results of 3 @ royalmarsdenNHS @ ICR_London investigator initiated trials ( @ ICR_DDU_IIT) presented at # AACR20 today - really enjoyed working on these trials with the fellows at DDU - @ DrABiondo @ DrRajivNShinde @ DrSachinkhurana @ JuliaLaiKwon @ crescensdtiu @ thubeena6https://twitter.com/ICR_DDU_IIT/status/1254779300223397888 …",,@ @ @ @ @ @ @ @ @,#,"1254784911535267840",https://twitter.com/DrAbhiPal/status/1254784911535267840
cafepharma,2020-04-27 10:50,1,1,"# AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions http://dlvr.it/RVXyn9",,,#,"1254784882426822659",https://twitter.com/cafepharma/status/1254784882426822659
JacobPlieth,2020-04-27 10:50,10,23,"$ VSTM shows promise in Kras-mutated cancers at # AACR20, so why is it off 40%? Via @ evaluatevantagehttps://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-verastem-reveals-logic-behind-its-kras-deal …",,@,#,"1254784880770117634",https://twitter.com/JacobPlieth/status/1254784880770117634
SmartMarketNews,2020-04-27 10:45,0,0,"@ AlligatorBio Presents Promising Interim Phase I Data for its # Bispecific Drug Candidate ATOR-1015 at AACR # COVID19 # pandemic # clinicaltrials # patients # ATOR1015 # MetastaticCancer # AACR20 # Drughttps://www.smartmarketnews.com/news/2020-04-27/alligator-bioscience-presents-promising-interim-phase-i-data-for-its-bispecific-drug-candidate-ator-1015-at-aacr …",,@,# # # # # # # # #,"1254783775109599233",https://twitter.com/SmartMarketNews/status/1254783775109599233
RutgersCancer,2020-04-27 10:45,4,11,". @ RutgersCancer’s Dr. Janice Mehnert @ JaniceM10, colleagues find continuous targeted therapy in BRAF-mutated # melanoma = superior progression-free survival vs. intermittent dosing. @ SWOG @ EAONC Ph2 # clinicaltrial data presented @ AACR virtual mtg # AACR20. https://www.cinj.org/superior-progression-free-survival-associated-continuous-targeted-therapy-combination-braf-mutated …pic.twitter.com/PdixAEnoEi",,@ @ @ @ @,# # #,"1254783721925795841",https://twitter.com/RutgersCancer/status/1254783721925795841
Leglesszebra,2020-04-27 10:45,0,1,"I’ve gone healthy - almost ;)pic.twitter.com/XKFqokD2zb",,,,"1254783649947344898",https://twitter.com/Leglesszebra/status/1254783649947344898
maria_petraki_,2020-04-27 10:44,2,12,"Melbourne-based research on melanoma clinical trials presented @ AACR @ PeterMacCC @ PeterMacRespic.twitter.com/EynUh2pafu",,@ @ @,,"1254783571333545986",https://twitter.com/maria_petraki_/status/1254783571333545986
pashtoonkasi,2020-04-27 10:43,1,5,"# AACR20 very intriguing data on prolonged duration of responses noted. pic.twitter.com/VvK5QLLu1I",,,#,"1254783204520652802",https://twitter.com/pashtoonkasi/status/1254783204520652802
KidneyCancerJ,2020-04-27 10:42,0,0,"Ready for some science ? LIVE NOW! Get best out of @ AACR Virtual Conference. FREE to attend (Regd required). # AACR20. Try this new link if you experience issue with AACR website. https://aacr20.onlineeventpro.freeman.com/ pic.twitter.com/XTdeDIcVWu",,@,#,"1254783071225647111",https://twitter.com/KidneyCancerJ/status/1254783071225647111
FellowsHsl,2020-04-27 10:42,2,6,"Adding Durvalumab + Olaparib to chemo in preoperative setting of early stage breast cancer leads to higher pCR rates irrespective of molecular subset! Adverse events in PARP inhibitor group lower than previous data. Patients not yet stratified by PDL1 & BRCAmut status. # AACR20 https://twitter.com/AACR/status/1254770396085149696 …",,,#,"1254783024819875842",https://twitter.com/FellowsHsl/status/1254783024819875842
LumicellSurg,2020-04-27 10:42,1,3,"Join us at the AACR Virtual Annual Meeting to hear about our Pivotal Study in Breast Cancer! Free registration: https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/ … Lumicell Presentation Session: https://www.abstractsonline.com/pp8/#!/9045/session/847 … # AACR20 # CancerResearch # clinicaltrials # lumicell # breastcancerawareness",,,# # # # # #,"1254782902979592194",https://twitter.com/LumicellSurg/status/1254782902979592194
dr_turk,2020-04-27 10:42,1,10,"Looking forward to catching up on some on some non-COVID research for the day job Well done to @ AACR for providing free registration # cancerresearchpic.twitter.com/vVxecumHNJ",,@,#,"1254782889532649475",https://twitter.com/dr_turk/status/1254782889532649475
AACR,2020-04-27 10:41,3,16,"The study tested whether adding the immune checkpoint inhibitor atezolizumab to the targeted therapies vemurafenib and cobimetinib could improve the durability of treatment responses in patients with advanced melamoma. # AACR20",,,#,"1254782618156929027",https://twitter.com/AACR/status/1254782618156929027
Syapse,2020-04-27 10:40,6,9,"Syapse, FDA, and Advocate Aurora Health present plenary session at AACR today on lung safety (treatment-associated pneumonitis) in NSCLC patients treated with immunotherapy or chemotherapy. PR: https://www.syapse.com/news/press-releases/aacr-2020-pneumonitis … Blog: https://www.syapse.com/company/blog/syapse-and-safety … # AACR20 # RealWorldEvidence",,,# #,"1254782377412317184",https://twitter.com/Syapse/status/1254782377412317184
AACR,2020-04-27 10:40,5,14,"# AACR20 Virtual Annual Meeting I: Grant A. McArthur presents primary results from the phase 3 IMspire150 trial. pic.twitter.com/PkhvG3aZ7a",,,#,"1254782373008248833",https://twitter.com/AACR/status/1254782373008248833
jasonlukemd,2020-04-27 10:39,7,14,"Great effort & import sci concept Algazi et al @ SWOG S1320; intermittent BRAF-MEK vs continuous # melanoma. Not sure fully answers Q tho due to crazy schedule (5 on/3 off wks) for trametinib washout (long t1/2). A smaller study of BRAF-MEK w better PK still relevant # AACR20 @ AACR",,@ @,# #,"1254782244670984198",https://twitter.com/jasonlukemd/status/1254782244670984198
OncoAlert,2020-04-27 10:39,2,5,"Live # AACR20 tweet from @ DeepOnCar “Combination of # atezolizumab with # vemurafenib and # cobimetinib showed improvement in PFS as compared to the combo of the BRAFi/MEKi in the # IMspire150 trial” @ OncoAlert https://twitter.com/DeepOnCar/status/1254780067625889794 …",,@ @,# # # # #,"1254782170616328197",https://twitter.com/OncoAlert/status/1254782170616328197
HaoZengPhD,2020-04-27 10:39,0,2,"Excited to be at # AACR virtual meeting! Looking forward to all exciting scientific presentations as well as clinical trial updates. @ AACR pic.twitter.com/ayORETdAOv",,@,#,"1254782170033295360",https://twitter.com/HaoZengPhD/status/1254782170033295360
pashtoonkasi,2020-04-27 10:39,4,7,"# AACR20 5 week on 3 weeks off is an interesting schedule for the BRAFMEK. PFS 9m 5.5m. Not sure why the intermittent wasn’t superior. Wonder if they got less drug exposure. 3 week is a long interval. Also ?rebound growth. # OncoAlert maybe use # ctDNA to guide decisions.pic.twitter.com/ME2nnnuxbO",,,# # #,"1254782116232966145",https://twitter.com/pashtoonkasi/status/1254782116232966145
RibonTx,2020-04-27 10:39,0,3,"We're presenting new preclinical data this week from our PARP7 and PARP14 programs at # AACR20. Check out our press release here: https://bit.ly/2Sb9fPE pic.twitter.com/3aVScSMEPZ",,,#,"1254782112688832512",https://twitter.com/RibonTx/status/1254782112688832512
MelinaMunozb,2020-04-27 10:38,0,2,"Una lucha campal contra internet, pero ya conectada a la virtual annual meeting de la @ AACR, ciencia en tiempos de cuarentena pic.twitter.com/QvFvcrDjoV",,@,,"1254782011765473283",https://twitter.com/MelinaMunozb/status/1254782011765473283
StephenJWillia2,2020-04-27 10:37,0,0,"Live Notes, Real Time Conference Coverage 2020 @ AACR Virtual Meeting April 27, 2020 Opening Remarks 9 am # AACR20 talks by @ GenomeInstitute @ UCLAJCCC https://pharmaceuticalintelligence.com/2020/04/27/live-notes-real-time-conference-coverage-2020-aacr-virtual-meeting-april-27-2020-opening-remarks-9-am/ … via @ Pharma_BI # curecancernow # pharmanews",,@ @ @ @,# # #,"1254781660421173250",https://twitter.com/StephenJWillia2/status/1254781660421173250
drsarahsam,2020-04-27 10:37,0,1,"Durvalumab/olaparib added to chemotherapy increases pCR in TNBC and high risk ER+. Phase III would need to compare neoadjuvant olaparib to platinum and focus on biomarkers. Keynote-522 pCR rates are better... # AACR20 https://twitter.com/PTarantinoMD/status/1254775248391557121 …",,,#,"1254781597124947976",https://twitter.com/drsarahsam/status/1254781597124947976
tmprowell,2020-04-27 10:36,2,12,"# AACR20 For all you parents also on non-consensual home school day #infinity (thanks # COVID19), I say watching this # JimAllisonPBS special Mon 4/27 at 10p EDT ( @ PBS, who chose that time?) counts as your lesson plan & their science credit for the whole wk. # MedEd # cancer # STEMedhttps://twitter.com/PBS/status/1253368033432809485 …",,@,# #infinity # # # # #,"1254781488362471427",https://twitter.com/tmprowell/status/1254781488362471427
kuraoncology,2020-04-27 10:36,1,11,"In these trying times, we remain hopeful as a wealth of studies evaluating treatment candidates in a range of hard-to-treat cancers were unveiled at this year’s American Association for Cancer Research. # AACR20 pic.twitter.com/02yKQkEYpJ",,,#,"1254781465109262339",https://twitter.com/kuraoncology/status/1254781465109262339
Inivata,2020-04-27 10:36,0,1,"The @ AACR virtual meeting is here! In case you can't connect... https://twitter.com/AACR/status/1254762063416745985 …",,@,,"1254781456414412800",https://twitter.com/Inivata/status/1254781456414412800
endpts,2020-04-27 10:36,4,3,"# AACR20 roundup: Tecentriq/Xtandi combo fails to show OS benefit, halting Roche's PD-L1 push into prostate cancer https://endpts.com/aacr20-roundup-tecentriq-xtandi-combo-fails-to-show-os-benefit-halting-roches-pd-l1-push-into-prostate-cancer/ …",,,#,"1254781412634324996",https://twitter.com/endpts/status/1254781412634324996
CellPressNews,2020-04-27 10:35,1,3,"Don't miss Research Arc: Immunotherapy, Vol. 3: # CancerVaccines. Download your free digital edition today! # AACR20 - https://bit.ly/2VJVMkl",,,# #,"1254781108752801795",https://twitter.com/CellPressNews/status/1254781108752801795
MaggieChasse,2020-04-27 10:33,0,10,"Not quite the same as being in San Diego but I’ll take it! # phdlife # QuarantineLife # aacr2020 pic.twitter.com/k6UT2uQKfi",,,# # #,"1254780736252461059",https://twitter.com/MaggieChasse/status/1254780736252461059
OncoAlert,2020-04-27 10:33,4,4,"Live from # AACR20 from @ OncoAlert colleague @ Tony_Calles “results on IMspire 150 in # melanoma patients. Atezolizumab + vemurafenib + cobimetinib better PFS and DOR than V+C, pending on OS mature results.” # cancerhttps://twitter.com/Tony_Calles/status/1254779982494105601 …",,@ @,# # #,"1254780623706714118",https://twitter.com/OncoAlert/status/1254780623706714118
TristanFreefsg,2020-04-27 10:33,1,3,"Good to hear from @ AACRPres Elaine Mardis and Antoni Ribas at the Opening session of the first @ AACR Virtual Annual Meeting. It is fantastic how well AACR has adjusted to this crisis, pivoting to an online format. I look forward to covering this year's meeting on @ MyBioTechniques",,@ @ @,,"1254780598821875720",https://twitter.com/TristanFreefsg/status/1254780598821875720
weldeiry,2020-04-27 10:32,5,13,"Continuous Dosing Improves Progression-Free Survival for Melanoma Patients with Common BRAF Mutations, according to @ SWOG results presented at @ AACR virtual annual meeting # AACR20 by Dr. Alain Algazi @ UCSFCancer https://eurekalert.org/e/9wpW via @ SWOG @ EurekAlert",,@ @ @ @ @,#,"1254780397323354115",https://twitter.com/weldeiry/status/1254780397323354115
StephenJWillia2,2020-04-27 10:32,0,0,"PDL1 inhibitors in SWOG trials and SPY trials for melanoma, breast and others are showing more incidence of hepatic failure and liver tox. Is these checkpoint inhibitors showing an IDILI? Was this ever seen in preclinical tox? # AACR20 @ Pharma_BI",,@,#,"1254780377089978370",https://twitter.com/StephenJWillia2/status/1254780377089978370
syinvesting,2020-04-27 10:32,7,9,"$ VSTM (-43% intraday) Here is more detail on Verastem's # AACR20 data - LGSOC PRs in KRAS G12V/G12A/G12D mutations - 1 more KRAS G12V # NSCLC patient had a PR after Nov '19 cutoff date (total of 2) - VS-6766 3.2mg + defactinib 200mg selected as RP2D Deck: https://investor.verastem.com/static-files/93835009-c4b6-4818-9075-16cb64237930 …pic.twitter.com/7k1XNrlqyo",,,# #,"1254780350045147136",https://twitter.com/syinvesting/status/1254780350045147136
phase1oncomd,2020-04-27 10:31,0,3,"# AACR20 virtual AACR is ongoing now! Join! @ HemOncWomenDocs",,@,#,"1254780190959431683",https://twitter.com/phase1oncomd/status/1254780190959431683
DeepOnCar,2020-04-27 10:30,8,11,"Combination of # atezolizumab with # vemurafenib and # cobimetinib showed improvement in PFS as compared to the combo of the BRAFi/MEKi in the # IMspire150 trial. # AACR20 # oncoalertpic.twitter.com/LWjjW7iMHE",,,# # # # # #,"1254780067625889794",https://twitter.com/DeepOnCar/status/1254780067625889794
Tony_Calles,2020-04-27 10:30,23,63,"This is amazing. Attending live @ AACR Anual Meeting at my place! Now results on IMspire 150 in melanoma patients. Atezolizumab + vemurafenib + cobimetinib better PFS and DOR than V+C, pending on OS mature results. I can imagine this combination for BRAF mutant lung cancer # LCSMpic.twitter.com/exmtzIia5Z",,@,#,"1254779982494105601",https://twitter.com/Tony_Calles/status/1254779982494105601
michael_biotech,2020-04-27 10:30,0,0,"Where was the data on cross over in the doublet arm?",,,,"1254779936847495179",https://twitter.com/michael_biotech/status/1254779936847495179
JCellBiol,2020-04-27 10:30,5,9,". @ jimjaxn100: Senescent cancer cells can engulf and digest their neighbors, allowing them to stay alive and initiate tumor relapse. Read new short summaries of articles (https://bit.ly/2XYckGS ) that are part of JCB’s new cancer collection for # AACR20 https://bit.ly/2Vv9GXj pic.twitter.com/pgXwYqrmg9",,@,#,"1254779867704389633",https://twitter.com/JCellBiol/status/1254779867704389633
OncologyCentral,2020-04-27 10:29,0,1,"In the latest work presented at # AACR20, researchers have investigated the effects of intermittent dosing compared to continuous dosing of # dabrafenib and # trametinib on progression-free survival in # melanoma patients. Read the latest updates now:",,,# # # #,"1254779794819911681",https://twitter.com/OncologyCentral/status/1254779794819911681
jasonlukemd,2020-04-27 10:29,5,22,"BRAF-MEK-PDL1 could be better. Placebo group has more M1C, vem dose is low for 3x, ORR is same, 7 deaths & absolute PFS benefit real but not amazing. Long term data going to be super important here for OS & durability of response beyond 1 yr FU. # AACR20 @ AACR # Melanoma",,@,# #,"1254779764285427722",https://twitter.com/jasonlukemd/status/1254779764285427722
UcianeScarlett,2020-04-27 10:29,0,3,"Loving that # AACR20 went virtual - bonus that registration is free! Streaming the opening clinical plenary between zoom calls pic.twitter.com/B5J7zrZ7W3",,,#,"1254779721998462978",https://twitter.com/UcianeScarlett/status/1254779721998462978
pashtoonkasi,2020-04-27 10:29,3,4,"# AACR20 # OncoAlertpic.twitter.com/b1n90sY30y",,,# #,"1254779652507234305",https://twitter.com/pashtoonkasi/status/1254779652507234305
KidneyCancer,2020-04-27 10:28,1,4,"# AACR20 virtual meeting happening today and tomorrow. # CancerResearch # kidneycancerhttps://twitter.com/AACR/status/1254442634267017217 …",,,# # #,"1254779451327434759",https://twitter.com/KidneyCancer/status/1254779451327434759
Lauren_Langbein,2020-04-27 10:27,0,7,"Attending # AACR20 wrapped in a blanket on my couch... Not a bad start to the week",,,#,"1254779331093475333",https://twitter.com/Lauren_Langbein/status/1254779331093475333
HTawbi_MD,2020-04-27 10:27,2,19,"Triplet therapy for melanoma (PD-L1+BRAFi+MEKi)- shape of PFS curves and Duration of Response are compelling! OR rate about same but prolonged responses! Immunotherapy does modulate response quality favorably @ AACR @ McArthurGrantpic.twitter.com/8Gb1cGI70s",,@ @,,"1254779321790590976",https://twitter.com/HTawbi_MD/status/1254779321790590976
ICR_DDU_IIT,2020-04-27 10:27,0,11,"Three of our studies are today being presented at the virtual # AACR20 conference. HyPeR (CT129), IceCAP (CT140) and FRAME (CT143) are available through the VPO.CT01-Phase I Clinical Trials Poster Session: https://www.abstractsonline.com/pp8/#!/9045/session/842 … @ udai_banerji @ JLoWalker @ DionysisPastos",,@ @ @,# #,"1254779300223397888",https://twitter.com/ICR_DDU_IIT/status/1254779300223397888
tmprowell,2020-04-27 10:27,5,12,"# AACR20 Dr. Pam Munster, I-SPY2 discussant, cautions about # financialtoxicity of regimens w/ mult targeted therapies in neoadjuvant setting given lrg #of pts w/ early-stage cancers. Need high-quality correlative science effort to identify more robust prog/pred biomarkers # bcsm",,,# # #of #,"1254779140328222720",https://twitter.com/tmprowell/status/1254779140328222720
ShannonWestin,2020-04-27 10:26,11,39,"Our phase II study of combination of durvalumab and standard chemotherapy in # ovariancancer will be presented today at the virtual # AACR20 meeting! # gyncsm # CancerMoonshot # endcancerhttps://twitter.com/MDAndersonNews/status/1254753501965582336 …",,,# # # # #,"1254778919980433411",https://twitter.com/ShannonWestin/status/1254778919980433411
eiger_daniel,2020-04-27 10:26,5,12,"Just out at the plenary session of AACR virtual meeting: I-SPY2 trial (bayesian multi-arms) shows that q1w Pacli + Durva + Olaparib have graduated for efficacy as NAST for HER2- stage II-III BC, with pCR rate of 37% compared to 20% in control arm. Phase 3 to come? # AACR20 pic.twitter.com/NcKfU66ePE",,,#,"1254778875441115137",https://twitter.com/eiger_daniel/status/1254778875441115137
Carefree411,2020-04-27 10:25,0,0,"@ AACR Patient Advocates are important participants in the AACR Virtual Meeting l. Thank you for tuning in! # AACR20 # AACRSSP",,@,# #,"1254778811314343943",https://twitter.com/Carefree411/status/1254778811314343943
pauldriscoll33,2020-04-27 10:24,0,1,"# AACR20 @ AACR Opening Session video. https://youtu.be/XfrJYT76Sjg",,@,#,"1254778390973841410",https://twitter.com/pauldriscoll33/status/1254778390973841410
pashtoonkasi,2020-04-27 10:24,2,7,"# AACR20 # OncoAlert plenary right now - duration of response data is very intriguing.https://twitter.com/pashtoonkasi/status/1254757094374375425 …",,,# #,"1254778355846533120",https://twitter.com/pashtoonkasi/status/1254778355846533120
pauldriscoll33,2020-04-27 10:23,0,0,"We had a little hiccup with the website this morning.",,,,"1254778144273256449",https://twitter.com/pauldriscoll33/status/1254778144273256449
jitcancer,2020-04-27 10:22,0,4,"BRAF-MEK-PD1/L1 triplet exciting as a next step in # melanoma. # AACR20 @ AACR One wonders how this regimen would compare against PD1-CTLA4 # immunotherapy combo - is BRAF-MEK the best control arm?",,@,# # #,"1254777972176773127",https://twitter.com/jitcancer/status/1254777972176773127
pauldriscoll33,2020-04-27 10:22,0,1,"On the VAM home page, click on the red box that says posterspic.twitter.com/RMrE73OXxx",,,,"1254777914878394369",https://twitter.com/pauldriscoll33/status/1254777914878394369
OncologyCentral,2020-04-27 10:22,3,4,"The addition of # immunotherapy to a combination of # targetedtherapy shows potential for improving survival in # melanoma, the latest # AACR20 results suggest. Read the full story on @ OncologyCentral!",,@,# # # #,"1254777865079451656",https://twitter.com/OncologyCentral/status/1254777865079451656
krknrm,2020-04-27 10:22,1,0,"Excited to hear Dr. Puzstai and Dr. Munster @ bernmunster about the neoAdj therapy in breast cancer and the # ISPY trials - results from randomized studies still pending to confirm a role for PARPis in immunotherapy for early stage breast cancer # AACR20 pic.twitter.com/xj5VpUrVzE",,@,# #,"1254777831147462657",https://twitter.com/krknrm/status/1254777831147462657
NaagKPrasad,2020-04-27 10:22,0,0,"The link doesn’t work. It keeps redirecting to myAACR login page. Very frustrating",,,,"1254777823253807105",https://twitter.com/NaagKPrasad/status/1254777823253807105
pashtoonkasi,2020-04-27 10:21,7,12,"# AACR20 & # Liquidbiopsies # ctDNA # circulatingtumorDNA - many facets of expanding use & indications where this would be of value. # OncoAlert @ AACR # cancer. Minimal residual disease # MRD is ominous regardless of what tumor type. Fusions helpful whenbut can be missed.pic.twitter.com/As0CR2lF5p",,@,# # # # # # #,"1254777757113802760",https://twitter.com/pashtoonkasi/status/1254777757113802760
UroDocAsh,2020-04-27 10:21,2,5,"Nicely written piece on protecting cancer patients & healthcare workers; # SARSCoV2 vaccine strategies - specific and non-specific both - to be tested asap. One such trial is at http://bcgbadas.org",,,#,"1254777603371618310",https://twitter.com/UroDocAsh/status/1254777603371618310
BernabeCarolina,2020-04-27 10:19,0,0,"Yes I was trying to log in from my iPhone and unable to do it",,,,"1254777198927462406",https://twitter.com/BernabeCarolina/status/1254777198927462406
DamarisIntriago,2020-04-27 10:19,2,9,"Attending my first @ AACR Annual Meeting. This time, virtual mode. # AACR20 pic.twitter.com/mkKHfnPeFP",,@,#,"1254777137518620674",https://twitter.com/DamarisIntriago/status/1254777137518620674
emilysmithmeded,2020-04-27 10:18,1,4,"Today & tomorrow I will be live-tweeting and virtually covering the # AACR20 meeting on behalf of the @ lymphomahub, @ AML_Hub and @ MM_Hub. Make sure you're following these accounts for the latest updates from the meeting! # lymsm # mmsm # leusmpic.twitter.com/N74V6Fb55S",,@ @ @,# # # #,"1254776956546977792",https://twitter.com/emilysmithmeded/status/1254776956546977792
OncoAlert,2020-04-27 10:16,6,10,"LIve # AACR20 Tweet from @ OncoAlert colleague @ jesusanampa "Durvalumab added to Pacli-AC in locally advanced HER2 # breastcancerhttps://twitter.com/jesusanampa/status/1254773333888884736 …",,@ @,# #,"1254776538014203904",https://twitter.com/OncoAlert/status/1254776538014203904
tmprowell,2020-04-27 10:16,0,6,"# AACR20 Dr. Puzstai answering audience Q on I-SPY2 says that # BRCA, TMB, & HRD are being analyzed in study tissue samples & will be reported at a future time. # bcsm",,,# # #,"1254776340231815169",https://twitter.com/tmprowell/status/1254776340231815169
StephenJWillia2,2020-04-27 10:16,0,0,"BRAF and MEK inhibitors yield objective responses in the majority of BRAFV600E/K mutant melanoma patients, but acquired resistance limits response durations. SWOG trial # AACR20 Note to # TUBiol3373 an example of kinome plasticity leading to resistance",,,# #,"1254776338482753538",https://twitter.com/StephenJWillia2/status/1254776338482753538
weldeiry,2020-04-27 10:15,1,2,"On-off dosing of cancer drugs does not help melanoma patients # AACR20 https://www.sciencemag.org/news/2020/04/dosing-cancer-drugs-does-not-help-melanoma-patients …",,,#,"1254776135218393088",https://twitter.com/weldeiry/status/1254776135218393088
PfizerCongress,2020-04-27 10:15,0,4,"Our daily lives are different than what we’re used to, but our commitment to the # cancer community & scientific advancement hasn’t changed. Join us for a virtual presentation of new data on our investigational subcutaneous checkpoint inhibitor. # AACR20 https://bit.ly/2Y7vmKG pic.twitter.com/9nQUZ20c3y",,,# #,"1254776104109215745",https://twitter.com/PfizerCongress/status/1254776104109215745
ECMC_UK,2020-04-27 10:15,1,5,". @ kingshealth centre co-lead Professor James Spicer is presenting today on the Phase I MOv18 study at # AACR20 Virtual Meeting I. Dr Udai Banerji ( @ udai_banerji) from @ icr_london is also co-author on the study. Register for free access: https://www.abstractsonline.com/pp8/#!/9045/presentation/10640 … @ AACR pic.twitter.com/6XZpm2gr04",,@ @ @ @,# #,"1254776061297975296",https://twitter.com/ECMC_UK/status/1254776061297975296
VivekSubbiah,2020-04-27 10:13,15,29,"Managing Cancer Care during the # COVID19 # Pandemic and Beyond https://www.sciencedirect.com/science/article/pii/S2405803320301357 … @ trendscancer @ CellCellPress @ CellPressNews @ AACR # coronavirus # AACR20 @ AACR pic.twitter.com/ouvTLkZIPp",,@ @ @ @ @,# # # #,"1254775778752880642",https://twitter.com/VivekSubbiah/status/1254775778752880642
LabWidget,2020-04-27 10:12,0,0,"Hey # AACR20 We built an online database to help wet labs organize cell lines, mouse strains, antibodies, and more. Customizable. Web based. Built by scientists for scientists. Free trial. http://labwidget.com",,,#,"1254775535172870144",https://twitter.com/LabWidget/status/1254775535172870144
KyleighMrf,2020-04-27 10:12,0,0,"# researchers DON’T MISS THIS @ AACR Tuesday 4/28 at 5PM ET learn how # COVID19 is impacting # cancer # research and # fundingpic.twitter.com/s1oIwztk1t",,@,# # # # #,"1254775491556282369",https://twitter.com/KyleighMrf/status/1254775491556282369
PTarantinoMD,2020-04-27 10:11,10,37,"Brilliant opening of # AACR20 virtual meeting with results from the Durvalumab/Olaparib arm of # ISPY trial - Durva/ola added to standard NACT (T->AC) in early BC pCR rates in both TNBC & HR+\HER2- patients - non-negligible 19% rate of G3 immune-related AEs, @ OncoAlert # bcsmpic.twitter.com/jLP6zJZYJF",,@,# # #,"1254775248391557121",https://twitter.com/PTarantinoMD/status/1254775248391557121
GraneOShady,2020-04-27 10:11,1,30,"It may not be San Diego but there is something to be said for attending a conference from the comfort of your back garden # AACR20 pic.twitter.com/tMID8kHZil",,,#,"1254775090941583360",https://twitter.com/GraneOShady/status/1254775090941583360
AmgenOncology,2020-04-27 10:10,0,10,"Good morning # AACR20! We would love to see how many people are joining the first virtual annual meeting. Please give us a “Like” if you are participating and let us know what session you are most excited about.",,,#,"1254774966408499201",https://twitter.com/AmgenOncology/status/1254774966408499201
CBebernitz,2020-04-27 10:10,0,2,"Tuning into # AACR20 from my parent's dining room table. Who needs sunny San Diego, I have slippers and a fuzzy blanket!",,,#,"1254774917700005889",https://twitter.com/CBebernitz/status/1254774917700005889
CancerResrch,2020-04-27 10:10,0,1,"Tomorrow: the Phase 2 results of our TMB Harmonization Project will be presented at # AACR20 starting at 4:55pm in the session "Predictive Biomarkers for Immunotherapeutics." Make sure you don't miss out by registering here https://bit.ly/2VmQtH4 !pic.twitter.com/TtwwuTZNol",,,#,"1254774827249831936",https://twitter.com/CancerResrch/status/1254774827249831936
VivekSubbiah,2020-04-27 10:08,6,12,"Just in time for # AACR20 @ AACR Hot off the press @ CellPressNews @ trendscancer Restoring the balance for # cancer care & # cancer # research in the # COVID19 era and beyond. @ oalhalabimd https://bit.ly/3cLu6B4 pic.twitter.com/2UGiIYV2xW",,@ @ @ @,# # # # #,"1254774359316525059",https://twitter.com/VivekSubbiah/status/1254774359316525059
tmprowell,2020-04-27 10:08,1,10,"# AACR20 Dr. Lajos Puzstai reporting on I-SPY2 trial notes that immune-rich cancers had higher pCR rates in all # breastcancer subtypes & both treatment arms. # bcsm",,,# # #,"1254774311803473920",https://twitter.com/tmprowell/status/1254774311803473920
VerastemOncolog,2020-04-27 10:07,0,8,"Today at # AACR20, Dr. Banerji will be virtually presenting Phase 1 RAF/MEK + FAK combination data in # KRAS mutant advanced solid # tumors. Join us at Poster #CT143.pic.twitter.com/pA6rm7FMJk",,,# # # #CT143,"1254774194824335361",https://twitter.com/VerastemOncolog/status/1254774194824335361
Cindy_JExpMed,2020-04-27 10:07,5,9,"Check out this @ JExpMed special collection of cancer research articles, timed to coincide with @ AACR's Virtual # AACR20. It celebrates the progress made in understanding the biology of cancer and its interplay with immune system, and the development of highly innovative therapies. https://twitter.com/JExpMed/status/1252976327323537408 …",,@ @,#,"1254774119742070787",https://twitter.com/Cindy_JExpMed/status/1254774119742070787
KDRichardson924,2020-04-27 10:07,4,9,"Virtual AACR Annual Meeting happening today and tomorrow is free and allows more patient advocates to learn about the current science of cancer research. Thank you @ AACR_CEO! # AACR20 # bcsm # gynscm # btsm # cancersurvivor # crcsm # lcsm # ayacsm # survonc # pancsm",,@,# # # # # # # # # #,"1254774066772246531",https://twitter.com/KDRichardson924/status/1254774066772246531
weldeiry,2020-04-27 10:06,0,0,"Third clinical plenary abstract shows results from SWOG S1320 a PFS (but not OS) benefit from continuous (105 patients; PFS 9 mo) vs intermittent (101 patients; PFS 5.5 mo) dosing of dabrafenib + trametinib in BRAF-mutated melanoma # AACR20 https://www.abstractsonline.com/pp8/#!/9045/presentation/10595 …",,,# #,"1254773850295791627",https://twitter.com/weldeiry/status/1254773850295791627
bottleby,2020-04-27 10:05,0,0,"I would prefer not to read the April issue- all articles are freely available during # AACR20 Virtual Annual Meeting I! https://www.twitter.com/CD_AACR/status/1254772335665537027 …",,,#,"1254773704292093952",https://twitter.com/bottleby/status/1254773704292093952
pashtoonkasi,2020-04-27 10:05,0,1,"How much role is the concurrent chemotherapy (in this case taxol) is playing as opposed to sole PARP& # immunotherapy synergy # AACR20",,,# #,"1254773547060215810",https://twitter.com/pashtoonkasi/status/1254773547060215810
DrRoyHerbstYale,2020-04-27 10:04,4,30,"The AACR @ AACR virtual meeting has begun. Great to see our own Yale Medical Oncology Breast cancer leader Lajos Pusztai presenting the opening plenary talk from the I-SPY trial. @ YaleCancer @ SmilowCancer @ SWOG. Great results with Durvalumab and Olaparib! @ YaleMedicine @ Yalepic.twitter.com/7V5KQ9mFM3",,@ @ @ @ @ @,,"1254773379724238848",https://twitter.com/DrRoyHerbstYale/status/1254773379724238848
jesusanampa,2020-04-27 10:04,7,19,"Durvalumab added to paclitaxel-AC in locally-advanced HER2- # breastCancer -Increased pCR: from 20 to 37% -19% immune AEs -Fewer RCB II/III -High immune markers associated with pCR -In ER+, mammaprint ultrahigh derived most benefit - Also some markers in ER- # AACR20 pic.twitter.com/y3JDp3ULz1",,,# #,"1254773333888884736",https://twitter.com/jesusanampa/status/1254773333888884736
CancerMedMDA,2020-04-27 10:03,0,0,"Join @ cathy_ileana_md for # AACR20 Session VCTPL03 "COM701 demonstrates preliminary antitumor activity as monotherapy & in combo w/nivolumab in patients w/advanced solid tumors." Today at 10:45AM (11:45 EDT) @ AACR https://bit.ly/2S4EpbL",,@ @,#,"1254773041856253952",https://twitter.com/CancerMedMDA/status/1254773041856253952
ajchgt,2020-04-27 10:02,0,0,"For me is working",,,,"1254772938634522631",https://twitter.com/ajchgt/status/1254772938634522631
ErikaHamilton9,2020-04-27 10:02,2,7,"Analysis post-hoc. # ISPY # bcsm @ OncoAlert # AACR20 pic.twitter.com/GVoK5c0IP7",,@,# # #,"1254772913472823297",https://twitter.com/ErikaHamilton9/status/1254772913472823297
AstraZeneca,2020-04-27 10:02,3,14,"Today kicks off the first # AACR20 virtual annual meeting. We’re showcasing what the future holds for # cancer treatment – from # ImmunoOncology to DNA damage response.https://bit.ly/3aABeyQ",,,# # #,"1254772793339600897",https://twitter.com/AstraZeneca/status/1254772793339600897
Leglesszebra,2020-04-27 10:01,0,2,"Excited to be following the online # AACR20 plenary sessions for @ medwireNews and @ MM_Oncology - check out our news this week",,@ @,#,"1254772733805649921",https://twitter.com/Leglesszebra/status/1254772733805649921
ilanaSchlam,2020-04-27 10:01,8,27,"Olaparib + durvalumab increased pCR in all subsets # bcsm # oncoalert # AACR20 https://twitter.com/ErikaHamilton9/status/1254772007004016643 …",,,# # #,"1254772704047067137",https://twitter.com/ilanaSchlam/status/1254772704047067137
StephenJWillia2,2020-04-27 10:00,1,1,"I-SPY2 demonstrated a significant improvement in pCR with durvalumab and olaparib included with paclitaxel compared to chemotherapy alone in women with stage II/III high-risk, HER2-negative breast cancer, improvement was seen in both the HR+ and TNBC subsets. # AACR20",,,#,"1254772441722675202",https://twitter.com/StephenJWillia2/status/1254772441722675202
JExpMed,2020-04-27 10:00,1,1,"Lélia Delamarre lab: Mutation position proves to be an important determinant of immunogenic neoantigens, which play a role in individualized cancer treatment. JEM’s collection for # AACR20 (https://bit.ly/3avNaBK ) has new summaries of articles in this PDF: https://bit.ly/2XYhG4z pic.twitter.com/eBTWYeqhCk",,,#,"1254772388262080512",https://twitter.com/JExpMed/status/1254772388262080512
pashtoonkasi,2020-04-27 10:00,18,31,"# AACR20 plenary on # PARP # immunotherapy resulted in not only pathCR (pCR) but also another important measure: residual cancer burden (RCB). HER220%37% HRHER227%47% HRHER214%28% # OncoAlertpic.twitter.com/DraYXx4vwL",,,# # # #,"1254772366351032320",https://twitter.com/pashtoonkasi/status/1254772366351032320
CD_AACR,2020-04-27 10:00,1,0,"Read the April issue- all articles are freely available during # AACR20 Virtual Annual Meeting I! https://bit.ly/3cLui3g pic.twitter.com/anKhYSbi2j",,,#,"1254772335665537027",https://twitter.com/CD_AACR/status/1254772335665537027
CCR_AACR,2020-04-27 10:00,0,1,"Attending # AACR20 Virtual Annual Meeting I? Be sure to read the articles in the Clinical Trials collection! https://bit.ly/2y4fHBd pic.twitter.com/D1RVtTAZGi",,,#,"1254772331039223810",https://twitter.com/CCR_AACR/status/1254772331039223810
JAMANetwork,2020-04-27 10:00,0,0,"During the # AACR20 virtual meeting, read recent articles from @ JAMA_current, @ JAMAOnc, and @ JAMANetworkOpen free online https://ja.ma/2XTFEhn",,@ @ @,#,"1254772288496340996",https://twitter.com/JAMANetwork/status/1254772288496340996
ErikaHamilton9,2020-04-27 09:59,5,10,"# bcsm # ISPY # AACR20 @ OncoAlertpic.twitter.com/OVkKpoX5WL",,@,# # #,"1254772284503425027",https://twitter.com/ErikaHamilton9/status/1254772284503425027
weldeiry,2020-04-27 09:59,1,3,"Second clinical plenary abstr shows exciting results from 514 patient phase 3 IMspire150 trial that addition of atezolizumab (A) to cobimetinib (C) & vemurafenib (V) improves PFS (15.1 mo vs 10.6) & median DOR (21 mo vs 12.6) vs placebo + C+V in BRAFV600 advanced melanoma # AACR20",,,#,"1254772175627677699",https://twitter.com/weldeiry/status/1254772175627677699
UCCancerCenter,2020-04-27 09:59,0,3,"Dr. Rita Nanda led the @ UCCancerCenter clinical trial in this multi-institutional study # AACR20 # AnswerCancerhttps://twitter.com/AACR/status/1254770396085149696 …",,@,# #,"1254772145550274562",https://twitter.com/UCCancerCenter/status/1254772145550274562
ErikaHamilton9,2020-04-27 09:58,13,31,"Dr. Pusztai presents # ISPY at # AACR20. # bcsm @ OncoAlertpic.twitter.com/eGwPFnvfDy",,@,# # #,"1254772007004016643",https://twitter.com/ErikaHamilton9/status/1254772007004016643
cora_esparza,2020-04-27 09:58,0,3,"Hoping for some clinical trials that have improved GBM patient survival at the # AACR20 Virtual Annual meeting!",,,#,"1254771854356541444",https://twitter.com/cora_esparza/status/1254771854356541444
jitcancer,2020-04-27 09:57,1,8,"For comparison of PDL1+PARPi from I-SPY2, follow up pCR rates 44%v17%, 30%vs13%, and 60%v22% for pembro vs control in HER2-, HER2+ & TNBC, respectively. # TNBC # breastcancer # AACR20 @ AACR @ JAMAOnchttps://jamanetwork.com/journals/jamaoncology/article-abstract/2761193 …",,@ @,# # #,"1254771747817046017",https://twitter.com/jitcancer/status/1254771747817046017
AltafMoledina,2020-04-27 09:57,0,2,"Attending # AACR20, the first virtual annual meeting thanks to # COVID19. So far, so good!",,,# #,"1254771683140886531",https://twitter.com/AltafMoledina/status/1254771683140886531
DMSLung,2020-04-27 09:57,0,10,"# AACR20 virtual session from my office pic.twitter.com/bOvYnkCGeO",,,#,"1254771587393261569",https://twitter.com/DMSLung/status/1254771587393261569
imbehzadqureshi,2020-04-27 09:56,0,0,"# AACR20 pic.twitter.com/9BLkmSFI4A",,,#,"1254771493612875782",https://twitter.com/imbehzadqureshi/status/1254771493612875782
UCSFCancer,2020-04-27 09:56,0,1,"Login complete. First scientific session # AACR20 on I-SPY2 Trial. If having trouble logging in, try the link below. https://twitter.com/AACR/status/1254762063416745985 …",,,#,"1254771458355544067",https://twitter.com/UCSFCancer/status/1254771458355544067
TheNeoantigen,2020-04-27 09:55,0,3,"Excited to attend this first virtual @ AACR. Thanks @ AACRPres for your leadership. # CancerResearch # immunotherapypic.twitter.com/Z8rLBeYpR0",,@ @,# #,"1254771210056945664",https://twitter.com/TheNeoantigen/status/1254771210056945664
kirsiketola,2020-04-27 09:54,1,4,"@ LabKetola attending # AACR20 at the @ UniEastFinland # CancerResearch # etäsuomenyliopistopic.twitter.com/OApR5JymGn",,@ @,# # #,"1254770784859353102",https://twitter.com/kirsiketola/status/1254770784859353102
TihaLong,2020-04-27 09:53,0,0,"Advancements using immunotherapy to treat aggressive breast cancer reported now at # AACR20 clinical leaders include Dr. Rita Nanda from @ UCCancerCenterhttps://twitter.com/UCCancerCenter/status/1254769639411732482 …",,@,#,"1254770753297240071",https://twitter.com/TihaLong/status/1254770753297240071
Isra_canadas,2020-04-27 09:52,0,8,"Ready for the Virtual Annual Meeting I # AACR20 # CancerResearch # science # StayHome pic.twitter.com/cIYhljipGL",,,# # # #,"1254770519078887426",https://twitter.com/Isra_canadas/status/1254770519078887426
cancerassassin1,2020-04-27 09:52,2,5,"Just in time for # AACR20: the @ CellPressNews Picture Show focused on Cancer Killers includes work on oncolytic viral therapy from my team with longtime collaborator @ SoCalYuman @ COH_SurgOnc (3 videos + last 2 images) https://www.cell.com/pictureshow/cancer-killers … # ImmunoOncpic.twitter.com/dB8sSQOxDs",,@ @ @,# #,"1254770453912010753",https://twitter.com/cancerassassin1/status/1254770453912010753
MacroGenics,2020-04-27 09:52,0,2,"Read more here: http://bit.ly/3cUSwbE # AACR20 pic.twitter.com/zDFwcJnaxq",,,#,"1254770405551665155",https://twitter.com/MacroGenics/status/1254770405551665155
sushscfaiims,2020-04-27 09:52,0,0,"Very excited to be able to attend @ AACR 2020 virtually.",,@,,"1254770400476622848",https://twitter.com/sushscfaiims/status/1254770400476622848
AACR,2020-04-27 09:52,4,31,"# AACR20 Virtual Annual Meeting I, Opening Clinical Plenary: Lajos Pusztai presents results from the I-SPY 2 TRIAL. pic.twitter.com/gGXHsRu4TY",,,#,"1254770396085149696",https://twitter.com/AACR/status/1254770396085149696
columbiacancer,2020-04-27 09:51,0,1,"Don't forget to join the # AACR2020 virtual meeting today! Here is a look at some of the # HICCC member research that will be featured at this first virtual session of the @ AACR annual meeting: http://ow.ly/6ESY50zpvA6 https://twitter.com/AACR/status/1254762685423587328 …",,@,# #,"1254770196180430851",https://twitter.com/columbiacancer/status/1254770196180430851
jitcancer,2020-04-27 09:51,1,4,"Is PARP inhibitor + anti-PD1/L1 augmentation dependent on HRD/DDR? Rehashing this tweet with some relevant paper links # TNBC # breastcancer # AACR20 @ AACR https://twitter.com/jitcancer/status/1247478003862568967 …",,@,# # #,"1254770048201183237",https://twitter.com/jitcancer/status/1254770048201183237
UCCancerCenter,2020-04-27 09:49,0,2,"Tune in now to # AACR20 to hear Results from the I-SPY 2 TRIAL reporting progress in treatment of advanced breast cancer. Inter-institutional trial led at @ UCCancerCenter by Dr. Rita Nanda.",,@,#,"1254769639411732482",https://twitter.com/UCCancerCenter/status/1254769639411732482
pashtoonkasi,2020-04-27 09:49,3,3,"# AACR20 happening now # PARP+ # Immunotherapy # oncoalert @ AACR pic.twitter.com/a0JVxi6wXm",,@,# # # #,"1254769589038256128",https://twitter.com/pashtoonkasi/status/1254769589038256128
Becky_Shreeve,2020-04-27 09:49,1,2,"Sat with a cup of coffee listening to the start of the virtual # AACR20 meeting. COVID-19 has introduced many barriers but this is one way in which the community can continue to communicate # CancerResearch, excited to see how this goes!",,,# #,"1254769542053543938",https://twitter.com/Becky_Shreeve/status/1254769542053543938
DrSGraff,2020-04-27 09:47,3,12,"So excited to have something other than # COVID19 to tweet about. # AACR20 https://twitter.com/AACR/status/1254762685423587328 …",,,# #,"1254769260376645633",https://twitter.com/DrSGraff/status/1254769260376645633
weldeiry,2020-04-27 09:47,0,1,"Opening plenary abstract # AACR20 features I-SPY2 trial in breast cancer with important results that immunotherapy (durvalumab) plus olaparib (PARP inhibitor) combined with chemo (paclitaxel --> AC) in neoadjuvant setting improved pCR for HR+ Her2- and TNBC https://www.abstractsonline.com/pp8/#!/9045/presentation/10593 …",,,# #,"1254769259823001601",https://twitter.com/weldeiry/status/1254769259823001601
NCIBehaviors,2020-04-27 09:47,1,1,"# AACR20 attendees, Dr. Singer will present on NCI’s efforts to contribute to the # COVID19 crisis. Tune in tomorrow at 5:20pm ET.https://twitter.com/theNCI/status/1253736181994524672 …",,,# #,"1254769235114352642",https://twitter.com/NCIBehaviors/status/1254769235114352642
rfhb,2020-04-27 09:47,0,0,"Following @ AACR online: thank you for this opportunity to learn about latest research for patients with a cancer https://twitter.com/AACR/status/1254762685423587328 …",,@,,"1254769226461532168",https://twitter.com/rfhb/status/1254769226461532168
TotalHealthConf,2020-04-27 09:47,0,0,"Are they thinking to organize a live conference?",,,,"1254769200372912131",https://twitter.com/TotalHealthConf/status/1254769200372912131
SynBioJamesH,2020-04-27 09:47,0,0,"Great to be attending # AACR20 online - especially looking forward to the latest on advanced therapies. Can't log in to the networking tab though - anyone else having trouble? @ AACR",,@,#,"1254769175865651201",https://twitter.com/SynBioJamesH/status/1254769175865651201
AshwiniRonghe,2020-04-27 09:47,0,0,"It's back on!",,,,"1254769171960741891",https://twitter.com/AshwiniRonghe/status/1254769171960741891
sesiegler,2020-04-27 09:47,0,0,"Do I care about # AACR20? Nope. Right now my focus is on the programs of SES, aka our programs. # cellbasedgenetherapy # CARTcells",,,# # #,"1254769138872041472",https://twitter.com/sesiegler/status/1254769138872041472
StephenJWillia2,2020-04-27 09:46,0,0,"Live Conference Coverage of @ AACR 2020 Annual Virtual Meeting; April 27-28, 2020 # AACR20 https://pharmaceuticalintelligence.com/2020/04/26/live-conference-coverage-of-aacr-2020-annual-virtual-meeting-april-27-28-2020/ … via @ Pharma_BI",,@ @,#,"1254768986429915136",https://twitter.com/StephenJWillia2/status/1254768986429915136
BZavaletaMD,2020-04-27 09:46,0,2,"Important info : opportunity for FREE meeting content @ AACR. I’ll be working Hospitalist shifts so not possible for me, but others might attend? # bcsm # lcsm # crcsmhttps://twitter.com/Martha__Carlson/status/1254521524448628736 …",,@,# # #,"1254768880943161344",https://twitter.com/BZavaletaMD/status/1254768880943161344
tmprowell,2020-04-27 09:46,0,2,"# AACR20 Dr. Elaine Mardis, @ AACRPres, notes that part 2 of AACR virtual Annual Mtg on 6/22-6/24/20 will include full content usually found in @ AACR Annual Mtg, both scientific program & # MedEd.",,@ @,# #,"1254768862475587584",https://twitter.com/tmprowell/status/1254768862475587584
Syndax,2020-04-27 09:46,0,2,"We’re looking forward to joining the virtual # AACR20 meeting and are grateful to the organizers for enabling the research community to continue important work in sharing the latest advances for # cancer patients despite these challenging times.pic.twitter.com/VOCPL9ThDY",,,# #,"1254768786441416704",https://twitter.com/Syndax/status/1254768786441416704
vickyyyf,2020-04-27 09:45,0,7,"Impressed # AACR20 all very positive - not about what has been lost, but entirely about what the meeting can still do in difficult circumstances. Also can't underestimate impact on investigators who wouldn't have been able to afford the trip to the in-person conference.",,,#,"1254768744733110281",https://twitter.com/vickyyyf/status/1254768744733110281
msmelanoma,2020-04-27 09:45,2,15,"New times for science: virtual annual meeting of @ AACR, with welcome by Committee Chair, Toni Ribas, emphasising the need to keep supporting cancer research, with measures presented to @ theNCI, particularly for young investigators. @ ASEICAnewspic.twitter.com/ORQdlLl0Mn",,@ @ @,,"1254768529481424901",https://twitter.com/msmelanoma/status/1254768529481424901
ECMC_UK,2020-04-27 09:45,2,2,"The HyPeR phase 1 study, co-authored by @ icr_london’s Professor Johann de Bono and Dr Udai Benerji ( @ udai_banerji), is being presented today at # AACR Virtual Meeting I. Register for free access: https://www.abstractsonline.com/pp8/#!/9045/presentation/10628 … @ royalmarsdenNHS @ AACR pic.twitter.com/0dI7dp1GIt",,@ @ @ @,# #,"1254768512045690881",https://twitter.com/ECMC_UK/status/1254768512045690881
kirsiketola,2020-04-27 09:44,0,0,"University of Eastern Finland attending # AACR20 @ UniEastFinland # etäsuomenyliopistopic.twitter.com/MGNiEOofpy",,@,# #,"1254768468013969409",https://twitter.com/kirsiketola/status/1254768468013969409
allisonoconn,2020-04-27 09:44,3,34,"Wow! 45,000 attendees at # AACR20! While I know we’re all disappointed to miss out on the in-person experience, perhaps a silver lining is increased accessibility of the most cutting edge research. Particularly for this who can’t afford to travel.",,,#,"1254768336384253952",https://twitter.com/allisonoconn/status/1254768336384253952
Boehringer,2020-04-27 09:44,4,20,"At today’s # AACR20 Virtual Annual Meeting, we will present new preclinical data on our SOS1::KRAS inhibitor combinations with # MEKInhibitors and # irinotecan. Learn more about our # KRAS combination approach here:pic.twitter.com/p1X9CttSqA",,,# # # #,"1254768266876080131",https://twitter.com/Boehringer/status/1254768266876080131
RongFan8,2020-04-27 09:43,0,3,"AACR annual meeting live online now! Toni Ribas opening remark. @ AACR https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …pic.twitter.com/8V9iDk1quh",,@,,"1254768123619602434",https://twitter.com/RongFan8/status/1254768123619602434
FergusPoynton,2020-04-27 09:43,1,1,"For anyone interested in attending the American Association for Cancer Research @ AACR Conference, it has just started screening online for FREE. Registration at https://aacr20.onlineeventpro.freeman.com/ # CancerResearch # Cancer # Conference",,@,# # #,"1254768050395471872",https://twitter.com/FergusPoynton/status/1254768050395471872
PCF_Science,2020-04-27 09:41,3,6,"The @ PCFnews team is logged into # AACR20 Virtual Meeting 1! We are very excited to see the high-impact new cancer research data being presented & how a virtual format will work for global dissemination & dialogue on these advancements! @ AACR pic.twitter.com/ca9Vx2H3Ix",,@ @,#,"1254767691828572160",https://twitter.com/PCF_Science/status/1254767691828572160
StephenJWillia2,2020-04-27 09:41,0,0,"Dr. Ribas @ UCLAJCCC at @ AACR # AACR20 meeting: @ AACR have created an AACR COVID task force. The AACR has just asked Congress and NIH to extend the grants due to the COVID induced shutdown of many labs.",,@ @ @,#,"1254767563143340032",https://twitter.com/StephenJWillia2/status/1254767563143340032
morris_juliaa,2020-04-27 09:41,0,4,"I'm definitely looking forward to hearing about cutting edge research, however, I'm especially looking forward to hearing about how cancer researchers are adapting to join the fight against # COVID19. There's plenty to learn over the next couple of days! # AACR20 # virtualconference",,,# # #,"1254767508420059137",https://twitter.com/morris_juliaa/status/1254767508420059137
Rick__Buck,2020-04-27 09:40,5,17,"The Virtual # AACR20 Annual Meeting I is underway, with more than 48,000 registered attendees tuning in during the next two days. pic.twitter.com/eoALDhvZpe",,,#,"1254767495065620481",https://twitter.com/Rick__Buck/status/1254767495065620481
alexia_zz,2020-04-27 09:40,5,32,"Delighted that # AACR20 is *finally* here! Can't wait to be virtually transported to the conference hall and hear all the exciting new research over the next two days! https://twitter.com/NatureCancer/status/1254765146972606464 …",,,#,"1254767349481254913",https://twitter.com/alexia_zz/status/1254767349481254913
CellPressNews,2020-04-27 09:40,0,0,"You’re not in San Diego, but you can still get the @ CellPressNews # AACR2020 experience. Today our # CancerResearch hub focuses on # FoundationalCancer, check out the latest inspiring research and more from @ CellPressNews.",,@ @,# # #,"1254767253196730369",https://twitter.com/CellPressNews/status/1254767253196730369
russo_cristina,2020-04-27 09:39,0,1,"Can you provide a downloadable / PDF schedule? It's unwieldy to use the website for consulting it due to traffic",,,,"1254767179859402752",https://twitter.com/russo_cristina/status/1254767179859402752
tmprowell,2020-04-27 09:39,6,12,"# AACR20 Dr. Ribas highlights a special session on # COVID19nCancer taking place Tues 4/28/20 at 9a EDT, notes that @ AACR is organizing a special conference on # COVID19 & # cancer in 07/2020. cc @ COVID19nCCC # MedEd # MedStudentTwitter",,@ @,# # # # # #,"1254767050796474368",https://twitter.com/tmprowell/status/1254767050796474368
followdeba,2020-04-27 09:38,1,1,"# AACR20 is now live, the first large # oncology virtual meeting adapting to the # COVID19 # pandemic. Congratulations to # AACR for ensuring the dissemination of key scientific information is maintained even in these trying times! https://myaacr.aacr.org",,,# # # # #,"1254766991656828928",https://twitter.com/followdeba/status/1254766991656828928
krknrm,2020-04-27 09:37,1,2,"This link works in Chrome if you are having trouble logging in! # AACR20 https://twitter.com/AACR/status/1254762063416745985 …",,,#,"1254766744146755584",https://twitter.com/krknrm/status/1254766744146755584
ilanaSchlam,2020-04-27 09:37,1,6,"# AACR20 virtual annual meeting. Looking forward to posters and presentations from home @ AACR pic.twitter.com/sJhda6sXoM",,@,#,"1254766677964787712",https://twitter.com/ilanaSchlam/status/1254766677964787712
AACR,2020-04-27 09:37,13,35,"# AACR20 Virtual Annual Meeting I: Dr. Ribas announces the formation of an AACR COVID-19 and Cancer Task Force. The Task Force will provide leadership and insight to the AACR on issues surrounding the COVID-19 pandemic, focusing on high-impact initiatives. pic.twitter.com/Pb1hMrgnGx",,,#,"1254766640178307072",https://twitter.com/AACR/status/1254766640178307072
Gkbioinfo,2020-04-27 09:37,0,0,"@ AACR virtual meeting opening session in progress.. pic.twitter.com/WmIOfALO2F",,@,,"1254766518359003136",https://twitter.com/Gkbioinfo/status/1254766518359003136
BellKingKal,2020-04-27 09:36,0,1,"Agree, that report should be interesting.",,,,"1254766474624892929",https://twitter.com/BellKingKal/status/1254766474624892929
KyleighMrf,2020-04-27 09:36,1,7,"Happening now! @ CureMelanoma is proud to support @ AACR annual virtual meeting and the vital information that will be shared to help our # cancer community. # research will lead the way to helping the 1.8 million people diagnosed this yearpic.twitter.com/Ev0YPzb7mw",,@ @,# #,"1254766369654157312",https://twitter.com/KyleighMrf/status/1254766369654157312
theLundLab,2020-04-27 09:36,0,30,"definitely some advantages of this virtual meeting format - ready for some science # AACR20 pic.twitter.com/18886X5kej",,,#,"1254766299017875456",https://twitter.com/theLundLab/status/1254766299017875456
maria_petraki_,2020-04-27 09:36,0,4,"# AACR20 virtual meeting has begun # virtualconferencing # americanassociationforcancerresearchpic.twitter.com/kCBYS6Ow1O",,,# # #,"1254766277526081540",https://twitter.com/maria_petraki_/status/1254766277526081540
hannah_reed8,2020-04-27 09:35,2,8,"Looking forward to 2 days of engaging talks from world leading cancer researchers at the first virtual @ AACR annual meeting! pic.twitter.com/NNnsU1JO61",,@,,"1254766118184443909",https://twitter.com/hannah_reed8/status/1254766118184443909
Covid_19_focus,2020-04-27 09:34,0,1,"Couldn't get it to work on safari - but link works on chrome!",,,,"1254765989574533121",https://twitter.com/Covid_19_focus/status/1254765989574533121
bradloncar,2020-04-27 09:34,2,8,"The only real # AACR20 mover at the open is $ VSTM -27% to the downside.",,,#,"1254765897614610434",https://twitter.com/bradloncar/status/1254765897614610434
DeepOnCar,2020-04-27 09:34,0,3,"Attending the # AACR20 from the comfort of my home this year. Although we're missing out on the networking, the constant neck proning isn't required for note-taking anymore. Advancing # CancerResearch and continuing # OurFightAgainstCancerpic.twitter.com/E2obTR03Lm",,,# # #,"1254765893814325266",https://twitter.com/DeepOnCar/status/1254765893814325266
DMM_Journal,2020-04-27 09:33,0,0,"So good to see our own Elaine Mardis opening the inaugural virtual # AACR20. @ AACR @ AACRPres # StayAtHome",,@ @,# #,"1254765553907949572",https://twitter.com/DMM_Journal/status/1254765553907949572
StephenJWillia2,2020-04-27 09:32,0,0,"@ AACR AACR is being vigilant as also an advocacy platform and public policy platform in Congress and Washington. The @ AACR AACR has been at the front of public policy on electronic cigarettes. # AACR20 @ Pharma_BI Opening Remarks from Dr. Mardis",,@ @ @,#,"1254765376216465408",https://twitter.com/StephenJWillia2/status/1254765376216465408
Aiims1742,2020-04-27 09:32,8,45,"A couple of # PancreaticCancer studies coinciding with virtual # AACR20. First, @ RonDePinho & Pingping Hou demonstrate how HDAC5 orchestrates bypass of KRAS dependency through remodeling of the tumor microenvironment & macrophage mediated trophic support. https://cancerdiscovery.aacrjournals.org/content/early/2020/04/25/2159-8290.CD-19-0597 …pic.twitter.com/rDUnkt60zP",,@,# #,"1254765349536501761",https://twitter.com/Aiims1742/status/1254765349536501761
NatureCancer,2020-04-27 09:31,3,11,"It's # AACR20 day today! Our Chief Editor @ alexia_zz, Senior Editor Julia Simundza and Associate Editor @ krknrm are attending, so please reach out to discuss your research and learn more about @ NatureCancer!https://twitter.com/AACR/status/1254442634267017217 …",,@ @ @,#,"1254765146972606464",https://twitter.com/NatureCancer/status/1254765146972606464
cancerassassin1,2020-04-27 09:31,3,9,"If you're having trouble logging in to the # AACR20 Virtual Meeting, try this link via @ AACR instead. Additional tip: check your browser (including cache) and consider trying using a mobile device instead of desktop if you're still having trouble. https://twitter.com/AACR/status/1254762063416745985 …",,@,#,"1254765071533834240",https://twitter.com/cancerassassin1/status/1254765071533834240
StephenJWillia2,2020-04-27 09:31,0,0,"606,000 lives will be lost in US this year from cancer. @ AACR # AACR20 # endcancer @ Pharma_BI",,@ @,# #,"1254765006257827841",https://twitter.com/StephenJWillia2/status/1254765006257827841
AWallacePovirk,2020-04-27 09:30,0,2,"Ready for a day of great talks! # AACR20",,,#,"1254764886728552448",https://twitter.com/AWallacePovirk/status/1254764886728552448
JCellBiol,2020-04-27 09:30,2,1,"Interaction between DLC1 and tumor promoting kinase SRC reveals a possible new treatment route for DLC1-positive tumors. JCB’s new cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has short summaries of articles in this PDF: https://bit.ly/2XYckGS pic.twitter.com/8dZMJ8vcW6",,,#,"1254764756726136833",https://twitter.com/JCellBiol/status/1254764756726136833
BioClavis,2020-04-27 09:29,0,1,"Although it's not quite the same as being at the # AACR2020 in person, we really appreciate that @ AACR have put on an online meeting to enable researchers to share their latest results. Looks like a fantastic programme - we'll be joining online. https://twitter.com/AACR/status/1254762685423587328 …",,@,#,"1254764604187570178",https://twitter.com/BioClavis/status/1254764604187570178
pratt_ed,2020-04-27 09:29,1,4,"Exciting to hear about new opportunities for researchers in the physical sciences and oncology to collaborate and disseminate exciting new avenues of translational research! # AACR20 pic.twitter.com/rQQ5N0ZAmr",,,#,"1254764580384825345",https://twitter.com/pratt_ed/status/1254764580384825345
drleemachado,2020-04-27 09:28,0,0,"# AACR20 Elaine R Mardis highlighting the importance of promoting training, education and career advancement for minorities in # CancerResearch",,,# #,"1254764401271255041",https://twitter.com/drleemachado/status/1254764401271255041
JayMoltzau,2020-04-27 09:28,0,2,"Excited to be attending the # AACR Virtual Annual Meeting I on April 27-28th, 2020! # Cancer # CancerResearch # publichealth # cancerclinicaltrials # tumormicrobiome # AACR20 #https://www.aacr.org/meeting/aacr-annual-meeting-2020/ pic.twitter.com/CQn74Ye7DP",,,# # # # # # # #https,"1254764362331566081",https://twitter.com/JayMoltzau/status/1254764362331566081
NCIDirector,2020-04-27 09:28,14,22,"Today and tomorrow, the # AACR20 agenda includes presentations and poster sessions from @ theNCI scientists representing @ NCItreatment, @ NCIprevention, @ NCIEpiTraining, @ NCIDataSci and @ NCIResearchCtr. More information on http://cancer.gov :https://www.cancer.gov/news-events/events/conferences/aacr-2020 …",,@ @ @ @ @ @,#,"1254764238238650369",https://twitter.com/NCIDirector/status/1254764238238650369
SMImmunology,2020-04-27 09:28,1,5,"Excited to attend this first virtual @ AACR meeting because of # COVID19. Hopefully this will be a new tradition for attending conferences. Thanks @ AACRPres for your leadership. # CancerResearch # immunotherapypic.twitter.com/7eQmqpt0Zc",,@ @,# # #,"1254764237718765570",https://twitter.com/SMImmunology/status/1254764237718765570
NCIDirector,2020-04-27 09:28,11,56,"# CancerResearch is @ theNCI’s vital mission and we remain committed to it. At this critical time, we're highly focused and working diligently to meet needs of the cancer research community. Looking forward to # AACR20 presentations and connecting virtually w/ colleagues worldwide.",,@,# #,"1254764237034938369",https://twitter.com/NCIDirector/status/1254764237034938369
talli1199,2020-04-27 09:27,0,0,"Not working",,,,"1254764204185325573",https://twitter.com/talli1199/status/1254764204185325573
Wenjun39194334,2020-04-27 09:27,0,0,"pic.twitter.com/gBs0jjA3UR",,,,"1254764137562935297",https://twitter.com/Wenjun39194334/status/1254764137562935297
Dr_LuisBorrero,2020-04-27 09:27,0,3,"Attending the # AACR20 today! # CancerResearchhttps://twitter.com/AACR/status/1254762685423587328 …",,,# #,"1254764072358330369",https://twitter.com/Dr_LuisBorrero/status/1254764072358330369
BairdAM,2020-04-27 09:27,0,2,"Great that @ AACR is doing so much in the area of health care disparities # AACR20",,@,#,"1254764037889499136",https://twitter.com/BairdAM/status/1254764037889499136
asmaakenawy,2020-04-27 09:26,0,0,"The Link just directs me to myaacr and not to the meeting.",,,,"1254763851477893120",https://twitter.com/asmaakenawy/status/1254763851477893120
caseccc,2020-04-27 09:25,0,0,"Part I of the @ AACR Virtual Annual Meeting begins today! We've compiled a list of virtual plenary sessions, minisymposia, and posters from Cleveland-based institutions and wish best of luck to all presenters! # AACR20 https://case.edu/cancer/about-us/news/american-association-cancer-research-annual-meeting-2020-highlights-case-ccc …pic.twitter.com/k2E4dPdRA4",,@,#,"1254763568391696385",https://twitter.com/caseccc/status/1254763568391696385
ivybelkins,2020-04-27 09:24,0,2,"@ AACRPres Elaine Mardis opens # AACR20. Presentations broadcast today will also be available for on-demand viewing starting tomorrow and going through the end of the @ AACR Virtual Annual Meeting II (June 22-24). Registration is free and open to all! # lcsm @ EGFRResisterspic.twitter.com/VTbrnR0Zs4",,@ @ @,# #,"1254763427257556992",https://twitter.com/ivybelkins/status/1254763427257556992
hemepa_c,2020-04-27 09:24,0,1,"Excited to be tuning in to the @ AACR annual meeting in their virtual format - cost of registration has always prohibited my attendance as a PA, and I am grateful for the opportunity to participate this year. # CancerResearch",,@,#,"1254763420752248837",https://twitter.com/hemepa_c/status/1254763420752248837
gowenj,2020-04-27 09:24,0,2,"Still cannot enter. I am redirected to my login page , then nothing",,,,"1254763261355950081",https://twitter.com/gowenj/status/1254763261355950081
NatConte,2020-04-27 09:23,0,0,"It's on! Pr Elaine Mardis, President of AACR, giving the opening lecture # AACR20 https://twitter.com/AACR/status/1254762063416745985 …",,,#,"1254763163503005696",https://twitter.com/NatConte/status/1254763163503005696
SarahE_PhD,2020-04-27 09:23,0,1,"# AACR20 website is already having issues and it’s only 9:30am... pic.twitter.com/zcW640jBE2",,,#,"1254763132913934346",https://twitter.com/SarahE_PhD/status/1254763132913934346
MyelomaTeacher,2020-04-27 09:23,0,1,"I’m enjoying my morning coffee too",,,,"1254763108087857152",https://twitter.com/MyelomaTeacher/status/1254763108087857152
jillfeldman4,2020-04-27 09:22,0,5,"Starting soon... # AACR20 # LCSM @ EGFRResistershttps://twitter.com/ivybelkins/status/1254747214687227904 …",,@,# #,"1254762964483260416",https://twitter.com/jillfeldman4/status/1254762964483260416
ChaiWaiYeeng,2020-04-27 09:22,0,0,"At the first AACR virtual meeting now :D # AACR2020 pic.twitter.com/374v6o5XUN",,,#,"1254762928449806337",https://twitter.com/ChaiWaiYeeng/status/1254762928449806337
itsthebunk,2020-04-27 09:22,0,2,"Hi Cindy! Same here! # aacr20",,,#,"1254762926172286981",https://twitter.com/itsthebunk/status/1254762926172286981
HenningWillers,2020-04-27 09:22,0,3,"Ha !! So glad you are saying this Sooo, may this be a good time to start a discussion as to why oh why we give 60 Gy to the GTV AND CTV for locally advanced # lungcancer?? @ SBRT_CR maybe some other time - yield to # AACR20 this week",,@,# #,"1254762890281836545",https://twitter.com/HenningWillers/status/1254762890281836545
HunterBRogers,2020-04-27 09:22,0,2,"link isn’t working, still unable to access",,,,"1254762766008832000",https://twitter.com/HunterBRogers/status/1254762766008832000
MyelomaTeacher,2020-04-27 09:22,0,11,"This year I’m attending the @ AACR Annual Meeting in my PJ’s # mmsm # AACR20 # AACRSSPpic.twitter.com/Ck7h0EhnWQ",,@,# # #,"1254762747977437186",https://twitter.com/MyelomaTeacher/status/1254762747977437186
drteplinsky,2020-04-27 09:22,0,5,"Anyone else having trouble accessing @ aacr meeting website?",,@,,"1254762737982472192",https://twitter.com/drteplinsky/status/1254762737982472192
Rndubois,2020-04-27 09:21,0,0,"# AACR20 virtual meeting up now: https://aacr20.onlineeventpro.freeman.com/live-stream/15335379/Opening-Session …",,,#,"1254762707816984576",https://twitter.com/Rndubois/status/1254762707816984576
AnaRoblesPhD,2020-04-27 09:21,0,0,"47,000 registrants from 103 countries registered for # AACR20, the first all virtual @ AACR meeting. # CancerResearch",,@,# #,"1254762695464751106",https://twitter.com/AnaRoblesPhD/status/1254762695464751106
AACR,2020-04-27 09:21,23,115,"AACR President Dr. Elaine R. Mardis welcomes virtual attendees to the # AACR20 Virtual Annual Meeting I and thanks everyone for joining the meeting from their homes across the country. pic.twitter.com/akyzjMwQnh",,,#,"1254762685423587328",https://twitter.com/AACR/status/1254762685423587328
morris_juliaa,2020-04-27 09:21,0,0,"I’m excited to attend the # AACR20 today. # cancerresearch # COVID19",,,# # #,"1254762634966114304",https://twitter.com/morris_juliaa/status/1254762634966114304
lavrodi,2020-04-27 09:20,0,2,"At # AACR2020 Virtual Merting, Opening session with Elaine Mardis @ AACRPrespic.twitter.com/EWF6mESlGY",,@,#,"1254762469693759488",https://twitter.com/lavrodi/status/1254762469693759488
DrSarcoma,2020-04-27 09:20,1,3,"It works now. Dr. Mardis introducing the meeting. 47,000 registrants WORLDWIDE. Let’s all learn together, and then move forward together like next before # AACR20",,,#,"1254762448722198528",https://twitter.com/DrSarcoma/status/1254762448722198528
pashtoonkasi,2020-04-27 09:20,1,7,"# AACR20 47000 registrants-103 countries @ AACR pic.twitter.com/RTEOfa1xOH",,@,#,"1254762445370994688",https://twitter.com/pashtoonkasi/status/1254762445370994688
beijindollar,2020-04-27 09:20,0,1,"Its on! American Association of Cancer Researchers (AACR) Annual Meeting I (Virtual). Life goes on # COVID19 @ AACR pic.twitter.com/s2oUJZeaB9",,@,#,"1254762324096888835",https://twitter.com/beijindollar/status/1254762324096888835
AnaRoblesPhD,2020-04-27 09:20,0,1,"Success!",,,,"1254762252751732739",https://twitter.com/AnaRoblesPhD/status/1254762252751732739
GeorginaBinnie,2020-04-27 09:20,0,4,"Sorry not to be meeting attendees in San Diego but pleased to still be able to attend @ AACR's first virtual, annual meeting. Here's to meeting in-person in the future @ MCRCnews # AACR2020 pic.twitter.com/9d0eSSrCtH",,@ @,#,"1254762239934038018",https://twitter.com/GeorginaBinnie/status/1254762239934038018
AACR,2020-04-27 09:19,22,37,"The AACR website is temporarily unavailable, but you can access the # AACR20 Virtual Meeting through this link: https://aacr20.onlineeventpro.freeman.com/",,,#,"1254762063416745985",https://twitter.com/AACR/status/1254762063416745985
CancerSurvSM,2020-04-27 09:19,5,2,"This @ AACR meeting is free for all to attend and has many sessions that may be of interest for # cancersurvivors. You can register for this session and all of the others at the link below! # AACR20 https://twitter.com/AACR/status/1253375604512026624 …",,@,# #,"1254762020232212482",https://twitter.com/CancerSurvSM/status/1254762020232212482
jamimmunology,2020-04-27 09:18,3,16,"Sitting down at home to start the virtual # AACR20 meeting with a nice cuppa, having traveled only from the next room. I can't help but feel (hope?) that even after the pandemic is contained that virtual meetings become far more common in future.",,,#,"1254761743668174850",https://twitter.com/jamimmunology/status/1254761743668174850
hi_stem_lab,2020-04-27 09:18,1,5,"Looking forward to join world-wide # fightcancer community the first virtual # AACR20 congress kicking-off NOW! pic.twitter.com/HZbzC6s7lu",,,# #,"1254761741940076545",https://twitter.com/hi_stem_lab/status/1254761741940076545
EnricBarba,2020-04-27 09:17,0,1,"Conectado al congreso anual ( virtual este año) de la American Assoc. for Cancer Research. @ AACR Dura 2 días. Habra presentaciones sobre ensayos clínicos para pacientes melanoma con BRAF. Tambien del impacto del # COVID19. Responsable del programa: Dr Antoni Ribas de la UCLA.",,@,#,"1254761636969226240",https://twitter.com/EnricBarba/status/1254761636969226240
canceropole,2020-04-27 09:17,7,4,"Le congrès # AACR20 a lieu aujourd'hui et demain de manière virtuelle et est accessible gratuitement sur leur site web. Et ça commence... Maintenant ! https://twitter.com/AACR/status/1254442634267017217 …",,,#,"1254761569902264324",https://twitter.com/canceropole/status/1254761569902264324
AnaRoblesPhD,2020-04-27 09:17,0,2,"Missing seeing all my peeps in San Diego for # AACR20 but happy to attend the virtual session starting now!",,,#,"1254761558057590785",https://twitter.com/AnaRoblesPhD/status/1254761558057590785
c0nc0rdance,2020-04-27 09:17,6,58,"I'm attending the Annual Meeting of the American Association for Cancer Research in my underwear. They're making it easier to do than they did last year, when security was all like "sir, where are your pants?" and "sir, we have a no-alcohol policy in the auditorium." # AACR2020",,,#,"1254761526441005056",https://twitter.com/c0nc0rdance/status/1254761526441005056
waynerlawrence,2020-04-27 09:16,0,3,"So excited for Opening Session of @ AACR Virtual Annual Meeting to begin. Looking forward to hearing from @ AACRPres # AACR20 pic.twitter.com/59YwlWXrSO",,@ @,#,"1254761434313043969",https://twitter.com/waynerlawrence/status/1254761434313043969
pashtoonkasi,2020-04-27 09:16,1,4,"Interesting hypothesis generating observation on durable activity of MEK in 61-NRAS-mutated cancers. Not all # NRAS-mutations are alike. # AACR20 # OncoAlert # PrecisionMedicine More data from the @ theNCI # Match # ClinicalTrials # CRCSMpic.twitter.com/SdXMwRF7eC",,@,# # # # # # #,"1254761415849717761",https://twitter.com/pashtoonkasi/status/1254761415849717761
HartungIngo,2020-04-27 09:15,4,9,"Though it's going to be late in the evening in Europe, it's worthwhile staying up for # AACR20 tonight: My former colleague @ gutcherina @ BayerPharma disclosing the first # AhR antagonist in clinical testing: Looking forward to an exciting update! https://aacr20.onlineeventpro.freeman.com/sessions/15335384/New-Drugs-on-the-Horizon-Part-1 …pic.twitter.com/uPVFqdhaIQ",,@ @,# #,"1254761185754390528",https://twitter.com/HartungIngo/status/1254761185754390528
megwoodworth,2020-04-27 09:15,0,0,"How do we access the poster presentations?",,,,"1254761123817062400",https://twitter.com/megwoodworth/status/1254761123817062400
AriellaHanker,2020-04-27 09:15,0,2,"I’m ready! # AACR20 pic.twitter.com/u4S4SHw7Uw",,,#,"1254761108684050433",https://twitter.com/AriellaHanker/status/1254761108684050433
ECMC_UK,2020-04-27 09:15,1,0,"IMbassador250 phase III clinical trial is being presented at today’s # AACR20 Virtual Meeting I. Professor Thomas Powles from CRUK Barts Centre is a co-author on the study. Mon 27 Apr, 4:00-4:15pm. Make sure to register to access the presentation: https://www.abstractsonline.com/pp8/#!/9045/presentation/10596 … @ QMBCIpic.twitter.com/9F59Dlj0hn",,@,# #,"1254760961690370051",https://twitter.com/ECMC_UK/status/1254760961690370051
PippaGledhill,2020-04-27 09:14,0,2,"Tuning into AACR's opening session. Not quite the entertaining chaos of a convention centre filled with 25,000 people in sunny San Diego but at least there's some cheery waiting room music # aacr20",,,#,"1254760832442994696",https://twitter.com/PippaGledhill/status/1254760832442994696
cinar_ozcan,2020-04-27 09:14,0,5,"It's starting! Dear @ AACR , thank you so much for organizing this and making it available to all of us around the globe. # AACR20 pic.twitter.com/v38q6Gywm5",,@,#,"1254760825400803330",https://twitter.com/cinar_ozcan/status/1254760825400803330
followdeba,2020-04-27 09:14,0,0,"still on music...",,,,"1254760806253834242",https://twitter.com/followdeba/status/1254760806253834242
joshua_miller,2020-04-27 09:13,0,1,":) Excited that they were able to get this off the ground. Virtual sessions should be interesting, I think conferences will learn alot this year.",,,,"1254760586266771459",https://twitter.com/joshua_miller/status/1254760586266771459
vm1689,2020-04-27 09:13,0,0,"It is working now. Thanks.",,,,"1254760550048780288",https://twitter.com/vm1689/status/1254760550048780288
ProfAllieG,2020-04-27 09:12,0,4,"You have to log in to your @ Aacr account and then go to "my content" and access via there...",,@,,"1254760316874960896",https://twitter.com/ProfAllieG/status/1254760316874960896
ElizSMcKenna,2020-04-27 09:11,7,46,"Ready for # AACR20!! Looking forward to a day of talks and posters! Please reach out if you’d like to talk about publishing in @ CD_AACR!pic.twitter.com/4rc9v83B0n",,@,#,"1254760072779042817",https://twitter.com/ElizSMcKenna/status/1254760072779042817
AnaRoblesPhD,2020-04-27 09:11,0,0,"Not working for me :-( just taking forever to load",,,,"1254760024091525126",https://twitter.com/AnaRoblesPhD/status/1254760024091525126
endpts,2020-04-27 09:11,0,9,"# AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions https://endpts.com/aacr20-early-data-suggest-novartis-incyte-discovered-met-inhibitor-helps-lung-cancer-patients-with-brain-lesions/ …",,,#,"1254760018219589632",https://twitter.com/endpts/status/1254760018219589632
drleighellis,2020-04-27 09:11,0,1,"Thanks - yes safari isn’t cutting for me",,,,"1254759970756755458",https://twitter.com/drleighellis/status/1254759970756755458
DrOdedina,2020-04-27 09:10,0,0,"Not resolved at my end",,,,"1254759938481704961",https://twitter.com/DrOdedina/status/1254759938481704961
antonionakasato,2020-04-27 09:10,0,0,"it worked. listening to music while presentation doesnt start. thanks!",,,,"1254759904100913152",https://twitter.com/antonionakasato/status/1254759904100913152
samsuresh94,2020-04-27 09:10,0,3,"Excited to virtually attend one of the biggest conferences in cancer research # AACR20 pic.twitter.com/11tJm64WHq",,,#,"1254759871360237571",https://twitter.com/samsuresh94/status/1254759871360237571
lgreco_ny,2020-04-27 09:10,0,20,"All set for # AACR20 virtual conference. Registration is free! # lcsmpic.twitter.com/XoZcjxTEB0",,,# #,"1254759850304831488",https://twitter.com/lgreco_ny/status/1254759850304831488
SandraOrtizCua,2020-04-27 09:10,0,1,"Yes, using Chrome. Tried with Safari but it didn't work very well. The opening ceremony starts in 5 mins.",,,,"1254759759338786818",https://twitter.com/SandraOrtizCua/status/1254759759338786818
UCCancerCenter,2020-04-27 09:09,0,0,"@ UCCancerCenter researchers are presenting at # AACR20 today! The virtual meeting starts now. https://twitter.com/AACR/status/1254442634267017217 …",,@,#,"1254759684663361543",https://twitter.com/UCCancerCenter/status/1254759684663361543
HartungIngo,2020-04-27 09:09,0,4,"Network found BBQ ready Beer in the fridge Beautiful sunny "San-Diego-like" sunshine in Darmstadt... Ready for # AACR20 https://twitter.com/gerlach_d/status/1254667747876909056 …",,,#,"1254759669471510531",https://twitter.com/HartungIngo/status/1254759669471510531
meissner_t,2020-04-27 09:09,0,3,"First time attending AACR in my pyjamas. Virtual meeting starting now. Excited! # AACR20",,,#,"1254759590597726210",https://twitter.com/meissner_t/status/1254759590597726210
JacobPlieth,2020-04-27 09:09,0,2,"One additional NSCLC G12V partial remission after Nov 2019 # AACR20 cutoff, says $ VSTM",,,#,"1254759581223399424",https://twitter.com/JacobPlieth/status/1254759581223399424
CN_Bio,2020-04-27 09:09,0,1,"Really interesting presentations on Day 1 of the @ AACR Virtual Annual meeting, including the latest developments in new therapies and clinical trials. Find full event details at: https://bit.ly/3arR3aR # AACR20 # cancerresearch",,@,# #,"1254759492773990400",https://twitter.com/CN_Bio/status/1254759492773990400
neha_nehapant,2020-04-27 09:09,1,2,"Ready for # aacr2020!! Go virtual!!!",,,#,"1254759463418056704",https://twitter.com/neha_nehapant/status/1254759463418056704
Aiims1742,2020-04-27 09:08,12,41,"TONIGHT on @ PBS - the premiere of MUST WATCH @ CancerCureDoc! The most amazing thing about Jim Allison - he’s won the @ NobelPrize, has a PBS documentary where he’s the protagonist, yet here he is, still presenting # Immunotherapy research at # AACR20 https://www.abstractsonline.com/pp8/#!/9045/presentation/10969 … https://twitter.com/PBS/status/1253368033432809485 …",,@ @ @,# # #,"1254759301572411392",https://twitter.com/Aiims1742/status/1254759301572411392
CallumM85193322,2020-04-27 09:08,0,0,"Definitely not resolved. I’m still being redirected to profile log in details",,,,"1254759245272231936",https://twitter.com/CallumM85193322/status/1254759245272231936
OncoAlert,2020-04-27 09:08,2,9,"Dear # AACR20 WE are @ OncoAlert @ UmbertoMalapel1 @ BenWestphalen @ kevinpunie @ MPishvaian @ curijoey @Tincho_Angel @ DrYukselUrun @ Aiims1742",,@ @ @ @ @ @ @Tincho_Angel @ @,#,"1254759237797974016",https://twitter.com/OncoAlert/status/1254759237797974016
OncoAlert,2020-04-27 09:08,1,13,"Dear # AACR20 WE are @ OncoAlert @ AndresC27622123 @ s_couraud @ double_whammied @ Dr_R_Kurzrock @ drcbsteer @ helitropen @ stage4kelly @ Jdmunter1 @ BrendonStilesMD @ PercyLeeMD @ BairdAM @ _ShankarSiva @ Jbauml @ Piuchagarrido @ JFreemanDaily @ cczielinski @ BettinaRyll @ HenningWillers",,@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @,#,"1254759235419766784",https://twitter.com/OncoAlert/status/1254759235419766784
OncoAlert,2020-04-27 09:08,1,11,"Dear # AACR20 We are @ OncoAlert @ E_de_Azambuja @ PauloBergerot @ crisbergerot @ g_mountzios @ sarahaboualaiwi @ ZiadBakouny @ NarjustDumaMD @ RobertoFerrara_ @ APassaroMD @ tsemiglazovaMD @RosaJeeves @ agz_eriksson @ WilliamDale_MD @ DarcyBurbage @ alexshoushtari @ IshwariaMD @ yzafar @ Jbauml",,@ @ @ @ @ @ @ @ @ @ @ @RosaJeeves @ @ @ @ @ @ @,#,"1254759233041633285",https://twitter.com/OncoAlert/status/1254759233041633285
OncoAlert,2020-04-27 09:08,10,17,"Dear # AACR20 We're # OncoAlert : @ CharuAggarwalMD @ Alfdoc2 @ Tony_Calles @ agrothey @ JTrentMDPhD @ ChristianRolfo @ TiansterZhang @ StephenVLiu @ guiperini @ prat_aleix @ marklewismd @ FAndreMD @ weldeiry @ BK_radiation @ sharp_lena @ DrSGraff @ DrDanielHeng @ MKnoll_MD @ marinagarassino",,@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @,# #,"1254759230738960384",https://twitter.com/OncoAlert/status/1254759230738960384
OncoAlert,2020-04-27 09:08,3,15,"Dear # AACR20 We are @ OncoAlert : @ chadinabhan @ bozovicspa @ DrRaulCordoba @ rcarvalhoonco @ PGrivasMDPhD @ CharlesSwanton @ apolo_andrea @ AndreasC466 @ herbloong @ PatelOncology @ pashtoonkasi @AminNassar92 @ barlesi @ curijoey @ teamoncology @ bmassutis @ ErikaHamilton9 @ fumikochino",,@ @ @ @ @ @ @ @ @ @ @ @ @AminNassar92 @ @ @ @ @ @,#,"1254759228461498368",https://twitter.com/OncoAlert/status/1254759228461498368
OncoAlert,2020-04-27 09:08,14,23,"Lets Get it Started Global @ OncoAlert Colleagues # AACR20 # OncoAlert : @ weoncologists @ GlopesMd @ peters_solange @ JackWestMD @ matteolambe @ DrChoueiri @ NicoleKuderer @ drdonsdizon @ MKnoll_MD @ OphiraG @ DrBetofMDPhD @ StoverLab @ DrMarkham @ ErikaHamilton9 @ BK_radiation @ jesusanampapic.twitter.com/BjGzVsMfEe",,@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @,# #,"1254759225022177282",https://twitter.com/OncoAlert/status/1254759225022177282
pauldriscoll33,2020-04-27 09:08,0,0,"We are streaming!!! # aacr20 @ AACR pic.twitter.com/fnwW7aEQsc",,@,#,"1254759212103675904",https://twitter.com/pauldriscoll33/status/1254759212103675904
nifear,2020-04-27 09:07,0,1,"here we go! # AACR2020",,,#,"1254759193405349895",https://twitter.com/nifear/status/1254759193405349895
drleighellis,2020-04-27 09:07,0,0,"Is it working for you?",,,,"1254759163273633798",https://twitter.com/drleighellis/status/1254759163273633798
quirogad,2020-04-27 09:07,0,3,"Home work station all set up for AACR virtual meeting! # AACR20 # AACRpic.twitter.com/tG6xEjij8F",,,# #,"1254759102879879168",https://twitter.com/quirogad/status/1254759102879879168
thenasheffect,2020-04-27 09:07,0,0,"Yea still having issues @ AACR",,@,,"1254758972776726530",https://twitter.com/thenasheffect/status/1254758972776726530
_rjw,2020-04-27 09:07,0,1,"The issues are still happening.",,,,"1254758963926704130",https://twitter.com/_rjw/status/1254758963926704130
SoliloqVish,2020-04-27 09:06,0,0,"Just logged into # AACRVirtualAnnualMeeting # AACR20",,,# #,"1254758940652580865",https://twitter.com/SoliloqVish/status/1254758940652580865
antonionakasato,2020-04-27 09:06,0,2,"I am still facing same problems. It is redirecting me to my profile page.",,,,"1254758732023697408",https://twitter.com/antonionakasato/status/1254758732023697408
SandraOrtizCua,2020-04-27 09:05,0,7,"The @ AACR Annual Meeting is, by far, my favorite scientific meeting. Excited to experience the first virtual # AACR20 today and tomorrow, despite the current # COVID19 situationpic.twitter.com/7xvLGOTMSx",,@,# #,"1254758491111202817",https://twitter.com/SandraOrtizCua/status/1254758491111202817
tmprowell,2020-04-27 09:04,16,33,"# AACR20 Virtual Annual Meeting Part 1 starting now! Streaming on 3 channels 9a-5p Eastern 4/27-4/28/20. Registration required but provided free of charge to all by @ AACR. Abstracts online now. Day 1 schedule at a glance below. https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i-access/ …pic.twitter.com/Y3aRpaOCyW",,@,#,"1254758308155666432",https://twitter.com/tmprowell/status/1254758308155666432
bindesh1,2020-04-27 09:04,0,0,"Online now # AACR20 with @ smagbapic.twitter.com/kUY9VNAsBN",,@,#,"1254758219592990722",https://twitter.com/bindesh1/status/1254758219592990722
erikrpeterson92,2020-04-27 09:03,0,3,"Very excited to be “attending” my first @ AACR this week! # AACR20",,@,#,"1254758042517876737",https://twitter.com/erikrpeterson92/status/1254758042517876737
ValsamoA,2020-04-27 09:03,0,12,"so excited for # AACR20 starting in few minutes! All virtual!",,,#,"1254758041334890496",https://twitter.com/ValsamoA/status/1254758041334890496
AlpineImmuneSci,2020-04-27 09:03,0,3,"Alpine Immune Sciences Presents Design of the ALPN-202 Phase 1 Study (NEON-1) at # AACR20 Virtual Annual Meeting I. NEON-1 is now open for enrollment for patients with advanced malignancies. https://ir.alpineimmunesciences.com/news-releases/news-release-details/alpine-immune-sciences-presents-design-alpn-202-phase-1-study …pic.twitter.com/VeZEwrM9Ry",,,#,"1254758034318020608",https://twitter.com/AlpineImmuneSci/status/1254758034318020608
VerastemOncolog,2020-04-27 09:02,0,2,"Join us today for a virtual presentation at # AACR20 of data from a multicenter Phase 1 study in advanced pancreatic ductal adenocarcinoma (PDAC). pic.twitter.com/MlCZaCFus5",,,#,"1254757920820125696",https://twitter.com/VerastemOncolog/status/1254757920820125696
Rick__Buck,2020-04-27 09:02,0,1,"Thank you @ cancerassassin1! Happy Virtual # AACR20 Day to you too. https://twitter.com/cancerassassin1/status/1254755320938803201 …",,@,#,"1254757786468126722",https://twitter.com/Rick__Buck/status/1254757786468126722
storr_sarah,2020-04-27 09:01,0,8,"Virtual AACR annual meeting - I’m so pleased it’s still going ahead! # AACR2020 # AACRpic.twitter.com/H8J3jsmKhk",,,# #,"1254757647846453248",https://twitter.com/storr_sarah/status/1254757647846453248
Palleon_Pharma,2020-04-27 09:01,0,3,"The first session of the virtual @ AACR Annual Meeting begins today, and our Palleon team is looking forward to reconnecting with far-flung colleagues to discuss the progress and opportunities in cancer therapeutics. Hope to see you there! # AACR20 https://bddy.me/3eUu0Jo pic.twitter.com/KO1OB0WRm0",,@,#,"1254757575658295297",https://twitter.com/Palleon_Pharma/status/1254757575658295297
AACR,2020-04-27 09:01,4,17,"The # AACR20 login issues have been resolved. The Opening Session will begin at 9:10 AM EDT.",,,#,"1254757557111001094",https://twitter.com/AACR/status/1254757557111001094
pratt_ed,2020-04-27 09:00,0,0,"Great, thank you so much!",,,,"1254757259004919808",https://twitter.com/pratt_ed/status/1254757259004919808
JExpMed,2020-04-27 09:00,1,0,"Approach from Ping-Hsien Lee and Nick Restifo could expand use of adoptive cell therapy for epithelial cancers. JEM’s cancer collection for # AACR20 (https://bit.ly/3avNaBK ) has new short summaries of articles in this PDF: https://bit.ly/2XYhG4z pic.twitter.com/DZKwLyXDiR",,,#,"1254757255297339398",https://twitter.com/JExpMed/status/1254757255297339398
CIR_AACR,2020-04-27 09:00,0,1,"Using this pipeline, # OvarianCancer-specific antigens were found that would not have been picked up through more traditional methods. https://bit.ly/3bHlknN # MassSpec # Proteogenomics # MHC # AACR20 @ IRIC_umontrealpic.twitter.com/JCvvBaoSoL",,@,# # # # #,"1254757238914285577",https://twitter.com/CIR_AACR/status/1254757238914285577
SygnatureDiscov,2020-04-27 09:00,1,3,"We should be in San Diego today for the annual @ AACR meeting. However we are pleased to say we will be at the Virtual Annual Meeting II in June 2020 with some new posters. For now, you can view previous posters here: https://hubs.ly/H0pF_VR0 # AACR20 pic.twitter.com/Dg84e7w89m",,@,#,"1254757228801929216",https://twitter.com/SygnatureDiscov/status/1254757228801929216
NCICTEP_ClinRes,2020-04-27 09:00,6,7,"Join # AACR20 presentation "Binimetinib in patients with tumors with NRAS mutations: NCI-MATCH ECOG-ACRIN Cancer Research Group subprotocol EAY131-Z1A", at 4:05 - 4:15 pm on April 28, 2020 @ AACR virtual annual meeting, # NCIMATCH # NCICTEP @ eaonc Learn more: https://buff.ly/2SdPWW5 pic.twitter.com/cAglzS2qTQ",,@ @,# # #,"1254757224213331969",https://twitter.com/NCICTEP_ClinRes/status/1254757224213331969
TakedaOncology,2020-04-27 09:00,5,16,"For the first time, we’re disclosing the molecular structure of mobocertinib (TAK-788)! Join us tomorrow during # AACR20’s virtual annual meeting at 11:14AM EST to learn more.",,,#,"1254757186745466884",https://twitter.com/TakedaOncology/status/1254757186745466884
eileen_parkes,2020-04-27 08:59,0,58,"Settling in for a virtual # AACR20 - while keeping my hands busy sewing science-themed face masks: Conferencing in a Pandemic. pic.twitter.com/fDB5N37n5l",,,#,"1254757184363204608",https://twitter.com/eileen_parkes/status/1254757184363204608
pashtoonkasi,2020-04-27 08:59,3,12,"# AACR20 looking forward to the plenary session. # Immunotherapy alongside with BRAFMEK a strategy potentially useful to explore outside of # melanoma for other # BRAFV600Emutated cancers e.g. # CRCSM. # OncoAlert # PrecisionMedicinepic.twitter.com/c3CgOurNXb",,,# # # # # # #,"1254757094374375425",https://twitter.com/pashtoonkasi/status/1254757094374375425
ohmiyajohn,2020-04-27 08:59,0,0,"オンライン学会なう。無料なのは良いけど日本だと夜中開催というのが辛い # AACR20",,,#,"1254757061851676672",https://twitter.com/ohmiyajohn/status/1254757061851676672
Anna_LopezM,2020-04-27 08:59,0,1,"All set for # AACR20! Excited, first virtual conference pic.twitter.com/nqVmSfXXaQ",,,#,"1254756968503312385",https://twitter.com/Anna_LopezM/status/1254756968503312385
bindesh1,2020-04-27 08:57,0,0,"Getting ready to watch the # AACR20 conference at home with @ smagba # AACRpic.twitter.com/jzfqR7IoEs",,@,# #,"1254756629284823040",https://twitter.com/bindesh1/status/1254756629284823040
Jbauml,2020-04-27 08:56,0,1,"Yes I am finding it quite speedy now! I wanted to test my system so I can keep those tweets flying...",,,,"1254756331959042048",https://twitter.com/Jbauml/status/1254756331959042048
TrevanLocke,2020-04-27 08:56,1,5,"It's virtual # AACR20 day! Tune in to the virtual meeting for free today and tomorrow! https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …",,,#,"1254756179651244033",https://twitter.com/TrevanLocke/status/1254756179651244033
cancerassassin1,2020-04-27 08:55,4,14,"Happy Virtual # AACR20 Day! The @ AACR Virtual Annual Meeting I/Day 1 begins in a few minutes (9:00 am EST) Abstracts are searchable online and can be found here (HT @ Aiims1742): https://www.abstractsonline.com/pp8/#!/9045 Program includes: clinical trial plenary sessions & poster sessionshttps://twitter.com/adamfeuerstein/status/1254714097205153793 …",,@ @,# #,"1254756020632633345",https://twitter.com/cancerassassin1/status/1254756020632633345
SaheliSadanand,2020-04-27 08:55,3,14,"Excited to be at # AACR20 today and tomorrow! Please reach out if you'd like to discuss your research and learn more about @ NatureMedicine!https://twitter.com/AACR/status/1254442634267017217 …",,@,#,"1254755981478825985",https://twitter.com/SaheliSadanand/status/1254755981478825985
EnricBarba,2020-04-27 08:55,0,0,"@ AACR Virtual Annual Meeting will start in 10 min with the Opening Session. Program Chair: Antoni Ribas. https://twitter.com/AACR/status/1254442634267017217 …",,@,,"1254755973715148811",https://twitter.com/EnricBarba/status/1254755973715148811
CellPressNews,2020-04-27 08:55,2,6,"Read the latest advances in the rapidly evolving field of # immunotherapy in this free Cell Press Selection. # AACR20 https://bit.ly/3aCbLox",,,# #,"1254755946062139392",https://twitter.com/CellPressNews/status/1254755946062139392
bethneilsen,2020-04-27 08:54,0,2,"Excited to learn about cancer at the @ AACR virtual meeting!",,@,,"1254755902659461125",https://twitter.com/bethneilsen/status/1254755902659461125
vm1689,2020-04-27 08:54,0,1,". @ AACR virtual conference channel is redirecting to my profile page. Anyone facing similar issue? # AACR20",,@,#,"1254755697033490433",https://twitter.com/vm1689/status/1254755697033490433
DevonLCarter,2020-04-27 08:53,0,15,"# COVID19 is forcing conferences to go virtual. # AACR20 is helping forge the way. You can keep up with the exciting things coming out of the meeting from @ MDAndersonNews here. # endcancerhttps://twitter.com/MDAndersonNews/status/1254588577532579841 …",,@,# # #,"1254755468695789569",https://twitter.com/DevonLCarter/status/1254755468695789569
cancerassassin1,2020-04-27 08:52,0,1,"I like this - Happy Virtual # AACR20 Day! Ready to enjoy Day 1 starting in just a few short minutes! Phenomenal work @ Rick__Buck @ AACR @ AACR_CEO @ AACRPres engaging 48,000 scientists to register using this online platform!",,@ @ @ @,#,"1254755320938803201",https://twitter.com/cancerassassin1/status/1254755320938803201
russopartners,2020-04-27 08:50,0,0,"Today @ AACR hosts their Virtual Annual Meeting Preview! The virtual meeting program will include exciting clinical trial data from submitted abstracts as well as basic and translational science selected by the Annual Meeting Scientific Program Committee. https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/ …pic.twitter.com/KpKxPv5h5D",,@,,"1254754875793162240",https://twitter.com/russopartners/status/1254754875793162240
G1Therapeutics,2020-04-27 08:50,0,2,"Research is critical for the development of innovative therapies to improve the lives of people affected by # cancer. Great to see @ AACR providing free access to the latest research and news from this year’s meeting. Register for # AACR20 here: http://bit.ly/2S9bfbu pic.twitter.com/ZcIrwIaawb",,@,# #,"1254754690530770944",https://twitter.com/G1Therapeutics/status/1254754690530770944
krknrm,2020-04-27 08:48,0,14,"Sad that it cannot happen in-person this year, but happy to see # AACR20 going virtual! Me and my colleague Julia Simundza will e-attend to represent @ NatureCancer, hit us up to discuss your cancer research! So exciting!https://twitter.com/AACR/status/1254442634267017217 …",,@,#,"1254754379837644802",https://twitter.com/krknrm/status/1254754379837644802
medwireNews,2020-04-27 08:48,2,8,"Attempting to recreate the press room experience with coffee and snacks at the ready as we prepare to report on the # AACR20 virtual meeting for @ MM_Oncology. Looking forward to bringing you news and expert interviews - keep an eye on http://bit.ly/2zyNNu3 ! @ AACR @ jcplopic.twitter.com/eITIV58V3f",,@ @ @,#,"1254754330529447937",https://twitter.com/medwireNews/status/1254754330529447937
drleemachado,2020-04-27 08:46,0,0,"It's back!!!",,,,"1254753908787945472",https://twitter.com/drleemachado/status/1254753908787945472
MDAndersonNews,2020-04-27 08:45,2,16,"“The goal of this study was to understand what’s happening to the tumor before and after treatment and gather translational data to recognize which patients may see survival benefits,” says our @ ShannonWestin: https://bit.ly/2S8DaIf # AACR20 # CancerMoonshot # endcancer",,@,# # #,"1254753501965582336",https://twitter.com/MDAndersonNews/status/1254753501965582336
drleemachado,2020-04-27 08:41,0,1,"yes- they are aware of the issue and trying to fix it I think",,,,"1254752545773424646",https://twitter.com/drleemachado/status/1254752545773424646
drscoop,2020-04-27 08:40,0,1,"Many of us, apparently. @ aacr are aware.",,@,,"1254752305720823809",https://twitter.com/drscoop/status/1254752305720823809
pauldriscoll33,2020-04-27 08:40,0,1,"Stay on. It is being resolved.",,,,"1254752259432493057",https://twitter.com/pauldriscoll33/status/1254752259432493057
CureMelanoma,2020-04-27 08:40,1,3,"The @ AACR Annual Meeting begins today ...virtually! We are looking forward to many fascinating presentations over the next two days, including two # melanoma studies to start things off this morning. Learn more:https://buff.ly/39IgR2R",,@,#,"1254752161789104128",https://twitter.com/CureMelanoma/status/1254752161789104128
Jbauml,2020-04-27 08:39,0,13,"Anyone else having a problem loading the # AACR20 virtual meeting? @ AACR pic.twitter.com/0Ww4Xxjv2D",,@,#,"1254751942997348352",https://twitter.com/Jbauml/status/1254751942997348352
pauldriscoll33,2020-04-27 08:36,0,2,"Virtual backstage at # AACR20 @ AACR. Wrapping up some loose ends! pic.twitter.com/7VY7a4L6OP",,@,#,"1254751256880570368",https://twitter.com/pauldriscoll33/status/1254751256880570368
Martin_AngelMD,2020-04-27 08:35,0,3,"About to start @ AACR! Virtual time! @ OncoAlert # UroOncoIAFpic.twitter.com/txs4lMrROA",,@ @,#,"1254751074650652672",https://twitter.com/Martin_AngelMD/status/1254751074650652672
JacobPlieth,2020-04-27 08:34,2,10,"$ VSTM remissions in LGSOC, via Udai Banerji. Two G12D, one G12V and one G12A # AACR20 pic.twitter.com/JcvRrZDehF",,,#,"1254750690141966336",https://twitter.com/JacobPlieth/status/1254750690141966336
ProfValS,2020-04-27 08:33,1,19,"All set to experience first virtual # AACR20 from my home office aka living room. At least I won’t be arriving jet lagged! # cancer # CancerResearch @ CR_UK @ BreastCancerNow @ BreastCancer_UK @ FriendsofANCHOR",,@ @ @ @,# # #,"1254750577558421505",https://twitter.com/ProfValS/status/1254750577558421505
fiosgenomics,2020-04-27 08:30,0,1,"2019 was a busy year at AACR. As part of @ CellCentric's poster - “p300/CBP inhibitor CCS1477 targets 22Rv1 prostate tumor AR and c-myc gene expression in vivo” - we conducted quality control, statistical analysis and pathway analysis. More info: https://buff.ly/2TNOesC # AACR20 pic.twitter.com/UQzIc9PxNu",,@,#,"1254749733366759429",https://twitter.com/fiosgenomics/status/1254749733366759429
MyBioTechniques,2020-04-27 08:30,4,5,"It's business as usual for BioTechiques. We are excited to be covering the @ AACR Virtual Annual Meeting today and tomorrow. Watch out for key updates in cancer research news and be sure to follow Digital Editors @ aabisawyer and @TristanFreeW1 for live updates from # AACR20",,@ @ @TristanFreeW1,#,"1254749637799366656",https://twitter.com/MyBioTechniques/status/1254749637799366656
JacobPlieth,2020-04-27 08:28,0,0,"Exactly. It doesn't seem to. $ VSTM # AACR20",,,#,"1254749351437651971",https://twitter.com/JacobPlieth/status/1254749351437651971
BayerPharma,2020-04-27 08:28,3,14,"Join us virtually at # AACR20, where we will be presenting new analyses for patients with TRK fusion # cancer: http://spr.ly/601914QKH pic.twitter.com/oS2uO9ryAT",,,# #,"1254749136026570753",https://twitter.com/BayerPharma/status/1254749136026570753
JacobPlieth,2020-04-27 08:24,0,6,"# AACR20 portal working for anyone?",,,#,"1254748299434889217",https://twitter.com/JacobPlieth/status/1254748299434889217
vickyyyf,2020-04-27 08:22,0,14,"Have to say, the conference coffee is better than normal... # AACR20 pic.twitter.com/kIJXiRIJ5k",,,#,"1254747703910764545",https://twitter.com/vickyyyf/status/1254747703910764545
ivybelkins,2020-04-27 08:20,1,31,"Looking forward to attending the # AACR20 virtual annual meeting, starting soon. I will be representing the @ EGFRResisters along with @ jillfeldman4. Follow us for live tweets from the meeting! # lcsm # lungcancerhttps://twitter.com/AACR/status/1254442634267017217 …",,@ @,# # #,"1254747214687227904",https://twitter.com/ivybelkins/status/1254747214687227904
CancerMedMDA,2020-04-27 08:19,0,4,"Check out # AACR20 virtual poster session with John Heymach, "1st-in-human Phase I study of OX40 agonist GSK998 +/- pembro in pts w/selected advanced solid tumors (ENGAGE-1)," Session VPO.CT01-CT150. Starting today at 8 am (9 AM EDT). @ AACR https://bit.ly/2S2uXFA",,@,#,"1254746868816285698",https://twitter.com/CancerMedMDA/status/1254746868816285698
ednacukierman,2020-04-27 08:18,4,34,"# AACR20 @ AACR Interested in downstream Kras signaling? don't miss https://www.abstractsonline.com/pp8/#!/9045/presentation/10558 … "Downstream kinase signaling is dictated by specific KRAS mutations" by our own @ KonstantinBuda2, from @ scidir1 lab. @ FoxChaseCancer and @ DrexelMedicine at 12:10",,@ @ @ @ @,# #,"1254746856237797376",https://twitter.com/ednacukierman/status/1254746856237797376
AmberTongPW,2020-04-27 08:15,3,6,"From virtual # AACR20: Iovance revels in promising lung cancer data out of Moffitt as TIL therapy triggers 2 complete responses - https://endpts.com/aacr20-iovance-revels-in-promising-lung-cancer-data-out-of-moffitt-as-til-therapy-triggers-2-complete-responses/ …",,,#,"1254745989434359808",https://twitter.com/AmberTongPW/status/1254745989434359808
ECMC_UK,2020-04-27 08:15,4,16,"Dr Udai Banerji ( @ udai_banerji) from @ icr_london will be presenting a Phase I study at today’s # AACR20 Virtual Meeting I. Professor Johann de Bono, @ icr_london and @ royalmarsdenNHS, is co-author on the study also. Register for free access: https://www.abstractsonline.com/pp8/#!/9045/presentation/10642 …pic.twitter.com/ZZhGeczkJM",,@ @ @ @,# #,"1254745862086901762",https://twitter.com/ECMC_UK/status/1254745862086901762
JacobPlieth,2020-04-27 08:14,0,3,"Sorry, not NSCLC. I meant the LGSOC remissions: two in G12D, one in G12V and one in G12A $ VSTM # AACR20",,,#,"1254745804876718081",https://twitter.com/JacobPlieth/status/1254745804876718081
LizCancerHealth,2020-04-27 08:09,0,1,"It just doesn't seem right that # AACR20 was scheduled for San Diego but the virtual annual meeting is on East Coast time! # notamorningperson",,,# #,"1254744453618610181",https://twitter.com/LizCancerHealth/status/1254744453618610181
JacobPlieth,2020-04-27 08:09,1,4,"But it does: of the 4 NSCLC remissions only one is in G12V. Two in G12D, one in G12A $ VSTM # AACR20",,,#,"1254744374283550721",https://twitter.com/JacobPlieth/status/1254744374283550721
maxdieterich,2020-04-27 08:06,0,0,"Looking forward to # AACR20 # virtualmeeting Good luck with the new concept. Oncologic Science does not rest! Keep up!",,,# #,"1254743645124726784",https://twitter.com/maxdieterich/status/1254743645124726784
abcam,2020-04-27 08:06,0,1,"Have you tuned into our # AACR20 virtual week? Today, Abcam’s own Anthony Couvillon is presenting “Investigating the Tumor Microenvironment via # Multiplex Imaging”. Learn more here: https://bit.ly/3aoLx8V pic.twitter.com/vh6Satm0wQ",,,# #,"1254743605341753344",https://twitter.com/abcam/status/1254743605341753344
ElizSMcKenna,2020-04-27 08:04,6,81,"Bittersweet day - really sad we're not all in San Diego, but excited for the Virtual Annual Meeting # AACR20 to start and proud of my @ AACR colleagues for making it happen! https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …",,@,#,"1254743245726285824",https://twitter.com/ElizSMcKenna/status/1254743245726285824
VerastemOncolog,2020-04-27 08:04,0,2,"# Clinical data in # KRAS mutant advanced solid # tumors presented today at # AACR20. More details on data being presented here: https://bit.ly/3aKLvZg pic.twitter.com/4PD2T4xHuT",,,# # # #,"1254743167360028672",https://twitter.com/VerastemOncolog/status/1254743167360028672
JacobPlieth,2020-04-27 08:03,2,3,"$ VSTM crapping out, off 30% in the premarket # AACR20 pic.twitter.com/4EtgMPoAUS",,,#,"1254742997771735042",https://twitter.com/JacobPlieth/status/1254742997771735042
DrSarcoma,2020-04-27 08:02,0,2,"But as convenient as virtual # AACR20 is, I still miss jostling through the crowds of 25,000 of my closest friends and colleagues. pic.twitter.com/pfcjxevuLX",,,#,"1254742773435117569",https://twitter.com/DrSarcoma/status/1254742773435117569
MM_Hub,2020-04-27 08:00,2,7,"The countdown begins! The @ MM_Hub can’t wait to share the latest developments on multiple # myeloma from the # AACR20 Annual Meeting today! Stay tuned for live virtual session coverage! # mmsmpic.twitter.com/v3EbTaP0Po",,@,# # #,"1254742172076834816",https://twitter.com/MM_Hub/status/1254742172076834816
DrSarcoma,2020-04-27 07:58,0,6,"Happy virtual # AACR20 Day to you, too, Adam! It is refreshing to get back to cancer science (which can teach us a lot about COVID-science, given how much cancer research=immunology these days). Look forward to a busy v-Day! https://twitter.com/adamfeuerstein/status/1254714097205153793 …",,,#,"1254741770694467584",https://twitter.com/DrSarcoma/status/1254741770694467584
ChristinaLeahK1,2020-04-27 07:56,0,0,"As a cancer researcher, super thanks to AACR for providing free access to # AACR20! https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/ …",,,#,"1254741304149409792",https://twitter.com/ChristinaLeahK1/status/1254741304149409792
duemed,2020-04-27 07:56,0,2,"Sorry, I am lost in the time zones. # AACR20 starts at 15:00 in Spain.",,,#,"1254741128986984449",https://twitter.com/duemed/status/1254741128986984449
GSTTresearch,2020-04-27 07:47,3,13,"Early # clinicaltrials have shown promise for a new type of # cancer # immunotherapy developed by our researchers with support from our @ NIHRresearch BRC. Our researchers will present the # research today at the virtual conference # AACR20. Read more: https://www.kcl.ac.uk/news/new-class-immunotherapy-drug-promise-early-clinical-trial …pic.twitter.com/Bib1sUzzrw",,@,# # # # #,"1254738952378028033",https://twitter.com/GSTTresearch/status/1254738952378028033
OncologyCentral,2020-04-27 07:42,5,5,"Looking forward to the # AACR20 virtual preview over the next couple of days. Make sure to keep up with @ OncologyCentral as we cover the conference live!",,@,#,"1254737709198966785",https://twitter.com/OncologyCentral/status/1254737709198966785
UMRogelCancer,2020-04-27 07:41,2,2,"Happening today! Several # RogelCancer research efforts will be presented at the # AACR20 Virtual Meeting. Here's the schedule of Rogel Cancer Center research presentations: http://michmed.org/AACR2020 pic.twitter.com/c75VvLSTXT",,,# #,"1254737521990303744",https://twitter.com/UMRogelCancer/status/1254737521990303744
Theratech_,2020-04-27 07:31,0,0,"Theratechnologies annonce des résultats positifs pour deux conjugués peptide-médicament expérimentaux ciblant le cancer des ovaires exprimant la sortiline $ THTX $ TH.TO # AACR20 https://www.theratech.com/theratechnologies-annonce-des-resultats-positifs-pour-deux-conjugues-peptide-medicament-experimentaux-ciblant-le-cancer-des-ovaires-exprimant-la-sortiline/ …",,,#,"1254734812189020160",https://twitter.com/Theratech_/status/1254734812189020160
FoundationATCG,2020-04-27 07:30,2,18,"Adaptability and continued commitment to cancer care give us hope during uncertain times. We’ll be tuning into the first-ever # AACR20 virtual meeting for insights on # TMB and other developments. Follow along with us here: http://ow.ly/olc450zoP7Q pic.twitter.com/ebc40Sn4uS",,,# #,"1254734600808562688",https://twitter.com/FoundationATCG/status/1254734600808562688
ACIR_org,2020-04-27 07:30,0,0,"Today is the day! # AACR2020 starts at 9am, EDT. http://ow.ly/BaXH50zoU1Q pic.twitter.com/HdGoEfkmKi",,,#,"1254734600200429571",https://twitter.com/ACIR_org/status/1254734600200429571
Theratech_,2020-04-27 07:30,0,0,"Theratechnologies Announces New Positive Results For Two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer $ THTX $ TH.TO # AACR20 https://www.theratech.com/en/theratechnologies-announces-new-positive-results-for-two-investigational-peptide-drug-conjugates-targeting-sortilin-positive-ovarian-cancer/ …",,,#,"1254734599525208065",https://twitter.com/Theratech_/status/1254734599525208065
endpts,2020-04-27 07:17,3,7,"# AACR20: Iovance revels in promising lung cancer data out of Moffitt as TIL therapy triggers 2 complete responses https://endpts.com/aacr20-iovance-revels-in-promising-lung-cancer-data-out-of-moffitt-as-til-therapy-triggers-2-complete-responses/ …",,,#,"1254731391566299136",https://twitter.com/endpts/status/1254731391566299136
ECMC_UK,2020-04-27 07:15,1,1,"Day 1 of # AACR20 Virtual Meeting I starts today. Registration is free and is open to the community. Sign-up for access here: https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/?utm_medium=twitter_ecmc&utm_source=ecmcsocialmedia&utm_campaign=annualmeeting&utm_content=2020vam1&sf121161878=1 …",,,#,"1254730762714300425",https://twitter.com/ECMC_UK/status/1254730762714300425
LaoSaal,2020-04-27 07:14,3,9,"Super proud that one of my PhD students, @ malinnd Malin Dahlgren, will give a selected oral presentation *TODAY* at the @ AACR Annual Conference (virtual) !!! 21:05 CEST (3:05pm EDT). Free registration https://cloud.aacr-outbound.com/virtual-am20 # bcsm # esr1 # breastcancer # breastcancerawarenesspic.twitter.com/IEhG61eS5d",,@ @,# # # #,"1254730732045586433",https://twitter.com/LaoSaal/status/1254730732045586433
seigomaeda,2020-04-27 07:11,0,0,"# AACR20: Iovance revels in promising lung cancer data out of Moffitt as TIL therapy triggers 2 complete responses http://dlvr.it/RVXMhm",,,#,"1254729777291816961",https://twitter.com/seigomaeda/status/1254729777291816961
fwpharma,2020-04-27 07:10,0,1,"Compugen's anti-PVRIG antibody COM701 shows "encouraging signals" of antitumour activity in early study https://beta.firstwordpharma.com/story/5001583 $ CGEN # AACR20",,,#,"1254729587017351168",https://twitter.com/fwpharma/status/1254729587017351168
NCRI_partners,2020-04-27 07:10,1,6,"It is day one of the # AACR20 Virtual Annual Meeting. Congratulations to all of the NCRI Group members who have had abstracts accepted for presentation pic.twitter.com/6EvsPXXHpF",,,#,"1254729539621728256",https://twitter.com/NCRI_partners/status/1254729539621728256
Pota_Yuru,2020-04-27 07:09,0,2,"半額も返してくれるのか イベント中止で色々大変だろうに なんか申し訳ない そのお金は松本か大北で消費をしよう # AACR2020 https://twitter.com/AACR_official/status/1254697317594132480?s=19 …",,,#,"1254729281059516416",https://twitter.com/Pota_Yuru/status/1254729281059516416
weldeiry,2020-04-27 07:01,2,10,"Looking forward to virtually learning the latest developments about cancer coming from the world's premiere # AACR20 cancer research meeting; amazing record 48K attendees this year. I've been attending since the 1990 meeting in DC & this year # eldeirylab has quite a few abstracts.https://twitter.com/Rick__Buck/status/1254716908395540482 …",,,# #,"1254727465815212033",https://twitter.com/weldeiry/status/1254727465815212033
iTeosTx,2020-04-27 07:01,1,5,"We’re presenting the latest updates on the Phase 1/2a study of EOS-850 today in a virtual poster presentation at # AACR20. You can read more here: https://bit.ly/3d1VHyj # immunotherapy # cancer # clinicaltrialpic.twitter.com/vO3ESaJ2nl",,,# # # #,"1254727464288468994",https://twitter.com/iTeosTx/status/1254727464288468994
VerastemOncolog,2020-04-27 07:00,0,3,"Reminder: call today on clinical data from RAF/MEK + FAK combination study in # KRAS mutant advanced solid # tumors being presented at # AACR20. pic.twitter.com/GAlaBHeO7H",,,# # #,"1254727048737800192",https://twitter.com/VerastemOncolog/status/1254727048737800192
IacovosMichael,2020-04-27 06:53,0,0,"Access to Virtual Annual Meeting I is free. @ AACR # CancerResearch # AACR20 https://twitter.com/AACR/status/1254442634267017217 …",,@,# #,"1254725333426810880",https://twitter.com/IacovosMichael/status/1254725333426810880
vs_lim,2020-04-27 06:50,1,2,"Virtual @ AACR Annual Meeting I today and tomorrow. Free registration. Lung Cancer Targeted Therapy today, COVID-19 and Cancer tomorrow http://tiny.cc/1p1unz # AACR20 # lcsm # CancerResearchpic.twitter.com/VC5eWNdiJ9",,@,# # #,"1254724714309664768",https://twitter.com/vs_lim/status/1254724714309664768
sloan_kettering,2020-04-27 06:44,3,17,"We're excited for the virtual # AACR20 meeting to begin. Be sure to check out this helpful user guide from @ AACR. https://twitter.com/AACR/status/1254442634267017217 …",,@,#,"1254723065201786881",https://twitter.com/sloan_kettering/status/1254723065201786881
Ahdab_Als,2020-04-27 06:24,0,0,"The @ AACR 1st virtual annual meeting 2020 should be interesting! # CancerResearch # sciencefromhome # AACR20 https://www.aacr.org/meeting/aacr-annual-meeting-2020/ …",,@,# # #,"1254718014139793410",https://twitter.com/Ahdab_Als/status/1254718014139793410
pashtoonkasi,2020-04-27 06:20,3,6,"Implications for other tumors e.g. # PANCSM # clinicaltrials with # BRCA DNA-repair universal testing now adopted. @ Aiims1742 @ EileenMOReilly @ MPishvaian @ ShaalanBeg # AACR20 @ letswinpc",,@ @ @ @ @,# # # #,"1254717063119212546",https://twitter.com/pashtoonkasi/status/1254717063119212546
Rick__Buck,2020-04-27 06:19,5,9,"Happy Virtual # AACR20 Annual Meeting Day to you too Adam. We have more than 48,000 registered attendees joining the party the next two days!",,,#,"1254716908395540482",https://twitter.com/Rick__Buck/status/1254716908395540482
adamfeuerstein,2020-04-27 06:18,3,16,"New type of checkpoint inhibitor offers early promise against tumors, but will it last? https://www.statnews.com/2020/04/27/new-checkpoint-inhibitor-offers-early-promise-against-tumors-will-it-last/ … Another early # AACR20 story, this one centers on $ CGEN and its anti-PVRIG antibody.",,,#,"1254716585811591173",https://twitter.com/adamfeuerstein/status/1254716585811591173
BertrandBio,2020-04-27 06:17,1,0,"3 # AACR20 for EU bios $ ATORX ATOR-1015 (CTLA-4 x OX40) ph1 dose-esc: nothing special, safe/tol OK at reported doses, current dose 600mg https://www.abstractsonline.com/pp8/#!/9045/presentation/10644 … $ ALNOX NOX-A12 + pembro ph1/2: add. biopsy data https://www.abstractsonline.com/pp8/#!/9045/presentation/10616 …",,,# # #,"1254716254549610497",https://twitter.com/BertrandBio/status/1254716254549610497
crownbioscience,2020-04-27 06:15,0,0,"# AACR20: A look at next-gen # CARTcell therapies for # bloodcancers https://buff.ly/2ScR0cL pic.twitter.com/sqipMveq3N",,,# # #,"1254715690323410944",https://twitter.com/crownbioscience/status/1254715690323410944
pashtoonkasi,2020-04-27 06:12,0,0,"Decisions end up being case by case. With the # COVID19, issues regarding accommodation at hope lodges an issue alongside timing of surgery. Leaning more towards TNT. # CRCSM Will see if there’s more data & # clinicaltrials at # AACR20 # ASCO20. A lot of these incorporating # ctDNA.",,,# # # # # #,"1254715064403333120",https://twitter.com/pashtoonkasi/status/1254715064403333120
adamfeuerstein,2020-04-27 06:08,4,21,"Good morning. It’s “why bother?” weather in Cambridge, MA today. Happy virtual # AACR20 Day. Here’s my story on the Moffitt TIL lung cancer data, w/ repercussions for $ IOVA. More details in here than the abstract.https://www.statnews.com/2020/04/27/custom-cell-therapy-shrinks-lung-tumors/ …",,,#,"1254714097205153793",https://twitter.com/adamfeuerstein/status/1254714097205153793
pashtoonkasi,2020-04-27 06:01,6,16,"Our # clinicaltrial is studying the classic # HRR # BRCA 1/2, # PALB2 in 1 cohort & still worth studying in an exploratory cohort. Need strategies for ATM. Thoughts on CHEKNot sure if I’ve seen data. # AACR20 # PANCSM # CRCSM https://clinicaltrials.gov/ct2/show/NCT04171700 … # OncoAlert # clinicaltrialspic.twitter.com/R7UsT8l29U",,,# # # # # # # # #,"1254712146438639616",https://twitter.com/pashtoonkasi/status/1254712146438639616
healthhashtags,2020-04-27 06:00,0,1,"Top Influencers of # AACR20: @ AACR @ OncoAlert @ JackWestMD @ oncologician @ tmprowell @ VivekSubbiah @ UmutDisel More https://hcsm.io/2TPswt7",,@ @ @ @ @ @ @,#,"1254712102775898112",https://twitter.com/healthhashtags/status/1254712102775898112
CRUKresearch,2020-04-27 06:00,1,4,"The phase I Mov18 study, developed by @ KingsCollegeLon, and sponsored by our Centre for Drug Development, is being presented at the # AACR20 Virtual Annual Meeting I today. Register for free now to access the poster here: https://www.abstractsonline.com/pp8/#!/9045/presentation/10640 …pic.twitter.com/FC7OrM31ul",,@,# #,"1254712093049323520",https://twitter.com/CRUKresearch/status/1254712093049323520
OncologyCentral,2020-04-27 06:00,1,3,"Are you attending the # AACR20 Virtual Annual Meeting I today? Register with @ OncologyCentral for the latest updates straight to your inbox!",,@,#,"1254711889864454144",https://twitter.com/OncologyCentral/status/1254711889864454144
JacobPlieth,2020-04-27 05:47,4,15,"$ VSTM CKI27 + defactinib in Kras mutant cancers, via Udai Banerji. Note responses in subjects on prior Mek inhibitor treatment # AACR20 pic.twitter.com/agkGzF2ZWb",,,#,"1254708695235211264",https://twitter.com/JacobPlieth/status/1254708695235211264
drleemachado,2020-04-27 05:29,0,2,"Looking forward to the @ AACR virtual cancer meeting https://twitter.com/AACR/status/1254442634267017217 …",,@,,"1254704323377889280",https://twitter.com/drleemachado/status/1254704323377889280
BursatilBiotech,2020-04-27 05:25,1,1,"# AACR20 $ GSK Ph1 study ENGAGE-1 N:138 (Part 1: 45, Part 2: 96) 3 crossed over from Part 1. DLTs: 2 in part 2 only Part 1: 1 PR, 1 SD Part 2: 2 CR, 7 PR, 9 SD peripheral and tumor expression of OX40: <2% total cells in tumor were OX40 +ve Clinical responses & SD ≥24 weeks",,,#,"1254703308796723200",https://twitter.com/BursatilBiotech/status/1254703308796723200
iaeapact,2020-04-27 05:14,3,6,"Register now for @ AACR's open and cost-free # virtual Annual Meeting, with a dedicated session on ' # Cancer and # COVID_19'. Today and tomorrow at 9am EST/ 3pm CET! # CancerCare4All More info: https://bit.ly/2SbLQhd pic.twitter.com/2QP8gSniI3",,@,# # # #,"1254700375770349569",https://twitter.com/iaeapact/status/1254700375770349569
iTeosTx,2020-04-27 05:11,0,2,"Joanne Lager comments on the significance of the EOS-850 data being presented at # AACR20 Virtual Annual Meeting. The full press release can be found here: http://bit.ly/3d1VHyj # immunotherapy # cancer # clinicaltrialpic.twitter.com/XbzeFNbcut",,,# # # #,"1254699589329960961",https://twitter.com/iTeosTx/status/1254699589329960961
AACR_official,2020-04-27 05:02,58,52,"先般ご案内させていただきました通り、新型コロナウイルス感染防止のため、今年のアルプスあづみの センチュリーライドは桜・緑ともに中止とさせていただきました。 大会中止にともなう今後の対応についてお知らせしますので以下ご確認ください。 https://aacr.jp/wp-content/uploads/2020/04/info200427.pdf … # AACR2020",,,#,"1254697317594132480",https://twitter.com/AACR_official/status/1254697317594132480
ntrkconnectinfo,2020-04-27 04:53,4,6,"# AACR20 starts today as # virtuallearning ! A second topic will cover # NTRK gene fusions. @ alexdrilon will present that # larotrectinib benefited patients across varying degrees of pretreatment or ECOG performance status. https://www.abstractsonline.com/pp8/#!/9045/presentation/10700 … # MedEd # oncology # precisionmedicine",,@,# # # # # # # #,"1254695193607102464",https://twitter.com/ntrkconnectinfo/status/1254695193607102464
MatthewHSimmons,2020-04-27 04:51,0,0,"News from @ AACR Virtual Annual Meeting 2020... https://twitter.com/iTeosTx/status/1254638101227614208 …",,@,,"1254694608489058305",https://twitter.com/MatthewHSimmons/status/1254694608489058305
ntrkconnectinfo,2020-04-27 04:45,3,5,"# AACR20 starts today virtually! @ DavidHongMD will present tomorrow on # larotrectinib # efficacy and # safety comparing patients with # NTRK gene fusions vs other # NTRK alterations confirming the efficacy in gene fusions! https://www.abstractsonline.com/pp8/#!/9045/presentation/10962 … # oncology # MedEd # PrecisionMedicine",,@,# # # # # # # # # #,"1254693157184380929",https://twitter.com/ntrkconnectinfo/status/1254693157184380929
gerlach_d,2020-04-27 04:45,0,4,"Posters are already online - RAF/MEK + FAK inhibition leads to reduction in tumor sizes in non G12C KRAS mutant cancers by @ udai_banerji: https://aacr20.onlineeventpro.freeman.com/posters/24211288/Phase-I-study-of-the-combination-of-a-RAF-MEK-inhibitor-CH5126766-and-FAK-inhibitor-defactinib-in-an-intermittent-dosing-schedule-with-expansions-in-KRAS-mutant-cancers … # AACR20",,@,#,"1254693046236655617",https://twitter.com/gerlach_d/status/1254693046236655617
AML_Hub,2020-04-27 04:09,4,6,"The # AACR20 Annual Meeting begins today! Look out for our live virtual session coverage! Stay tuned for all the latest news and updates on # AML! # leusmpic.twitter.com/UuGMW06LIT",,,# # #,"1254684102181126144",https://twitter.com/AML_Hub/status/1254684102181126144
BayerPharma,2020-04-27 04:00,4,21,"We look forward to sharing the latest study progress of our cancer research with the scientific community at the virtual # AACR20. # OncologyInspired https://bit.ly/2KyCwjk pic.twitter.com/CyigGJBGcw",,,# #,"1254681709083271168",https://twitter.com/BayerPharma/status/1254681709083271168
CRUKresearch,2020-04-27 04:00,5,13,"Today is day 1 of # AACR20 Virtual Meeting I. Make sure you've registered for free access and look out for the # CRUKFunded researchers who are presenting. Sign-up for free here: https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/?utm_medium=twitter_crukresearch&utm_source=cruksocialmedia&utm_campaign=annualmeeting&utm_content=2020vam1&sf121161878=1 …",,,# #,"1254681698375282688",https://twitter.com/CRUKresearch/status/1254681698375282688
gerlach_d,2020-04-27 03:49,2,13,"Great team effort @ Boehringer on hitting KRAS-driven cancers beyond KRAS G12C with our SOS1::KRAS inhibitors. @ MarcoHHofmann will present data on our SOS1 inhibitors and their combination partners today at 1:10PM EDT (7:10PM CEST) in the # AACR20 meeting: https://www.abstractsonline.com/pp8/#!/9045/presentation/10563 …",,@ @,# #,"1254679011847962624",https://twitter.com/gerlach_d/status/1254679011847962624
syinvesting,2020-04-27 03:22,2,2,"# AACR20 abstracts can be searched for here: https://www.abstractsonline.com/pp8/#!/9045 For the few I pulled out, I searched up the abstract numbers from the far right columns of the images below.https://twitter.com/syinvesting/status/1253032069766230026 …",,,# #,"1254672261665001473",https://twitter.com/syinvesting/status/1254672261665001473
crownbioscience,2020-04-27 03:11,0,0,"# AACR20 : Early @trovagene data offers hope for # KRASmutant # coloncancer https://buff.ly/2y4xCYx pic.twitter.com/nFh1EQAZOB",,@trovagene,# # #,"1254669514568015872",https://twitter.com/crownbioscience/status/1254669514568015872
gerlach_d,2020-04-27 03:04,1,13,"Dressing up for the # AACR20 Virtual Annual Meeting in my home office. The meeting will start today, April 27 at 9AM EDT (3PM CEST) online at https://www.aacr.org/meeting/aacr-annual-meeting-2020 … - 6 hours to go.",,,#,"1254667747876909056",https://twitter.com/gerlach_d/status/1254667747876909056
bio_jkb,2020-04-27 02:51,0,0,"Bispecifics @ # AACR20 | Bispecific abstract (CT145) for ATOR-1015 CTLA-4 x OX40 BiAb. pic.twitter.com/WztlVm381J",,@,#,"1254664520846446598",https://twitter.com/bio_jkb/status/1254664520846446598
1stOncology,2020-04-27 02:47,0,0,"# AlligatorBioscience Presents Promising Interim Phase I Data for its # BispecificDrugCandidate # ATOR1015 at # AACR20 $ ATORX https://www.1stoncology.com/blog/alligator-bioscience-presents-promising-interim-phase-i-data-for-its-bispecific-drug-candidate-ator-1015-at-aacr1234556607 …",,,# # # #,"1254663496404316160",https://twitter.com/1stOncology/status/1254663496404316160
bio_jkb,2020-04-27 02:46,2,2,"Bispecifics @ # AACR20 | Bispecific abstract (5672) for ABBV-428 mesothelin (MSLN) x CD40 BiAb pic.twitter.com/2gdFvO2akk",,@,#,"1254663126370443264",https://twitter.com/bio_jkb/status/1254663126370443264
bio_jkb,2020-04-27 02:43,0,0,"Bispecifics @ # AACR20 | Bispecific abstract (DDT03-01) for ABBV-184 survivin specific T cell receptor x CD3 BiAb pic.twitter.com/zispa7RVUb",,@,#,"1254662506318086145",https://twitter.com/bio_jkb/status/1254662506318086145
1stOncology,2020-04-27 02:42,0,0,"# GRAIL to Present New Data at the # AACR20 https://www.1stoncology.com/blog/grail-to-present-new-data-at-the-american-association-for-cancer-research-aacr-annual-meeting1234556604 …",,,# #,"1254662081434882054",https://twitter.com/1stOncology/status/1254662081434882054
1stOncology,2020-04-27 02:41,1,0,"# VerastemOncology Announces Preliminary Data from Investigator-initiated Study Highlighting Clinical Activity of # RAF/ # MEK and # FAK Combination in # KRASMutantTumors Presented at # AACR20 Virtual Annual Meeting I $ VSTM https://www.1stoncology.com/blog/verastem-oncology-announces-preliminary-data-from-investigator-initiated-study-highlighting-clinical-activity-of-rafmekfak-combination-in-kras-mutant-tumors-presented-at-the-american-association-for1234556603 …",,,# # # # # #,"1254661881760845824",https://twitter.com/1stOncology/status/1254661881760845824
bio_jkb,2020-04-27 02:40,0,0,"Bispecifics @ # AACR20 | Bispecific abstract (DDT02-04) for AMG 509 STEAP1 x CD3 TCE BiAb pic.twitter.com/4qDdqROGux",,@,#,"1254661634079035392",https://twitter.com/bio_jkb/status/1254661634079035392
bio_jkb,2020-04-27 02:37,0,0,"Bispecifics @ # AACR20 | Bispecific abstract (CT145) for ATOR-1015 CTLA-4 x OX40 BiAb pic.twitter.com/6HbjTRcGP5",,@,#,"1254660880807211010",https://twitter.com/bio_jkb/status/1254660880807211010
bio_jkb,2020-04-27 02:34,0,0,"Bispecifics @ # AACR20 | Bispecific abstract (CT120) for AK104 PD-1 x CTLA-4 BiAb pic.twitter.com/D568UNI3Mq",,@,#,"1254660243453337600",https://twitter.com/bio_jkb/status/1254660243453337600
jagasquet,2020-04-27 02:11,0,0,"Verastem Oncology Announces Preliminary Data from Investigator-initiated Study Highlighting Clinical Activity of RAF/MEK and FAK Combination in KRAS Mutant Tumors # AACR20 https://finance.yahoo.com/news/verastem-oncology-announces-preliminary-data-041100029.html …",,,#,"1254654500775825408",https://twitter.com/jagasquet/status/1254654500775825408
healthhashtags,2020-04-27 02:00,1,0,"Today's Health Conferences: # AACR20 http://hcsm.io/healthconfs # hcsm",,,# #,"1254651650750496770",https://twitter.com/healthhashtags/status/1254651650750496770
Aiims1742,2020-04-27 01:56,2,21,"Pooled data on NTRK alterations across 3 clinical trials (>150 patients)- tag team by @ MDAndersonNews @ DavidHongMD & @ alexdrilon @ sloan_kettering https://www.abstractsonline.com/pp8/#!/9045/presentation/10962 … -Responses limited to fusions -16% CR -Median Duration of response ~36mo -Median OS 44.4mo # AACR20",,@ @ @ @,# #,"1254650733900763137",https://twitter.com/Aiims1742/status/1254650733900763137
JacobPlieth,2020-04-27 01:49,4,7,"Interesting $ VSTM data in Kras. Other preclinical # AACR20 Kras data from $ NVS (SHP2 inhib) & Boehringer (Kras & SOS1). $ MRTX",,,#,"1254648873030737920",https://twitter.com/JacobPlieth/status/1254648873030737920
JacobPlieth,2020-04-27 01:44,4,8,"$ IOVA 2 CRs of long duration (1yr out). More key detail in presentation # AACR20 https://twitter.com/msollender/status/1254621806394109952?s=21 …https://twitter.com/MSollender/status/1254621806394109952 …",,,#,"1254647588659363841",https://twitter.com/JacobPlieth/status/1254647588659363841
Dr_RShatsky,2020-04-27 01:40,5,32,"Be sure to get up early tomorrow for our ISPY-2 abstract on our durvalumab/olaparib arm! # AACR20 Clinical plenary presentation by Lajos Pusztai. Great study and great arm!",,,#,"1254646589529796608",https://twitter.com/Dr_RShatsky/status/1254646589529796608
JacobPlieth,2020-04-27 01:37,2,13,"Cd7 knockout (Crispr) to avoid fratricide. But the Car is virally tranduced so this is q complex manufacturing, like $ CLLS $ ALLO https://twitter.com/bradloncar/status/1254635977764753409?s=21 … # AACR20 https://twitter.com/bradloncar/status/1254635977764753409 …",,,#,"1254645776963289093",https://twitter.com/JacobPlieth/status/1254645776963289093
syinvesting,2020-04-27 01:21,2,7,"# AACR20 iTeos' EOS100850 (A2A receptor antagonist) first-in-human Phase 1 data (n=21). As of the data cut off (1/15/20), stable disease was observed in 6 participants who remain on therapy. @ iTeosTx Recent financing: https://twitter.com/syinvesting/status/1245508747319029760 … Abstract: https://www.abstractsonline.com/pp8/#!/9045/presentation/10651 …pic.twitter.com/LWny4wkeen",,@,# #,"1254641736560730113",https://twitter.com/syinvesting/status/1254641736560730113
syinvesting,2020-04-27 01:10,3,9,"# AACR20 Gracell's TruUCAR™ GC027 (off-the-shelf CD7 CAR-T) FIH data in r/r T-cell # ALL (n=5). 4 pts achieved minimal residual disease (MRD) negative complete responses at D28 evaluations. 3 of these remained MRD- at follow-up re-evaluations. Abstract: https://www.abstractsonline.com/pp8/#!/9045/presentation/10760 …pic.twitter.com/i4yJdsRdcr",,,# # #,"1254638918248488961",https://twitter.com/syinvesting/status/1254638918248488961
NicoleKuderer,2020-04-27 01:09,1,2,"Sincerely hope I will find time, despite # COVID19, to tweet about the always amazing @ AACR conference also with amazing female leaderhsip @ AACR_CEO @ AACRPres !!!",,@ @ @,#,"1254638769572962304",https://twitter.com/NicoleKuderer/status/1254638769572962304
iTeosTx,2020-04-27 01:06,2,7,"We’re presenting the latest updates on the Phase 1/2a study of EOS-850 today in a virtual poster presentation at # AACR20. You can read more here: https://bit.ly/3d1VHyj # immunotherapy # cancer # clinicaltrial",,,# # # #,"1254638101227614208",https://twitter.com/iTeosTx/status/1254638101227614208
PersimmonTI,2020-04-27 01:04,4,7,"$ IOVA # AACR20 2/13 durable Complete Responses in r/r mNSCLC. - CRs nearly one year & counting - 1 CR from patient with only 1% PD-L1 expression. 5/13 Overall Response Rate - 3/13 maintained clinical remission after ablative Tx. pic.twitter.com/YapXjqMx2X",,,#,"1254637583432331264",https://twitter.com/PersimmonTI/status/1254637583432331264
syinvesting,2020-04-27 01:01,2,6,"# AACR20 $ CGEN Compugen's COM701 (anti-PVRIG mAb) Ph 1 data of mono & combo therapy with nivolumab in patients with advanced solid tumors (n=28). $ BMY - Peritoneal cancer: 1 PR w/ mono - MSS-CRC: 1 unconfirmed PR w/ combo - 11 pts still on study Abstract: https://www.abstractsonline.com/pp8/#!/9045/presentation/10741 …pic.twitter.com/ELXG9J600F",,,# #,"1254636693681958913",https://twitter.com/syinvesting/status/1254636693681958913
syinvesting,2020-04-27 00:49,2,3,"# AACR20 $ STRO Sutro announced interim Phase 1 clinical data of STRO-002 (FolRα ADC) in # OvarianCancer (n=20). In pts treated at dose levels of ≥2.9 mpk: - 1 pt with ongoing PR (36 weeks) - 5 pts with confirmed SD - 7 ongoing pts with unconfirmed SDhttps://ir.sutrobio.com/news-releases/news-release-details/sutro-biopharma-announces-encouraging-interim-phase-1-clinical …",,,# #,"1254633769085972481",https://twitter.com/syinvesting/status/1254633769085972481
syinvesting,2020-04-27 00:31,4,4,"# AACR20 $ IOVA Iovance's TIL therapy demonstrated *two* durable CRs, which are still ongoing almost 1 year post-TIL, in metastatic # NSCLC. @ statnews @ adamfeuerstein article: https://www.statnews.com/2020/04/27/custom-cell-therapy-shrinks-lung-tumors/ …pic.twitter.com/LN0JJH34Xe",,@ @,# #,"1254629105506508802",https://twitter.com/syinvesting/status/1254629105506508802
Aiims1742,2020-04-27 00:27,9,29,"Assessment of BRCA & non-BRCA homologous recombination repair gene mutations in # PancreaticCancer - by @ AstraZeneca POLO team. # AACR20 https://www.abstractsonline.com/pp8/#!/9045/presentation/10720 … Including additional non-BRCA HRR mutations could double “actionable cohort”. Need ATM targeting strategies.pic.twitter.com/pomxlr3FSQ",,@,# # #,"1254628217283117062",https://twitter.com/Aiims1742/status/1254628217283117062
syinvesting,2020-04-27 00:22,15,26,"# AACR20 $ VSTM Verastem announced preliminary data of VS-6766 (RAF/MEKi) + defactinib (FAKi) combo - KRAS mutant LGSOC: 67% ORR (4/6) - KRASG12V # NSCLC: 57% ORR (4/7) [combined analysis] - KRASG12V gynecologic cancers: 60% ORR (3/5) [combined analysis]https://www.businesswire.com/news/home/20200426005068/en/Verastem-Oncology-Announces-Preliminary-Data-Investigator-initiated-Study …",,,# #,"1254627029493792768",https://twitter.com/syinvesting/status/1254627029493792768
maryam_lustberg,2020-04-27 00:11,1,11,"Looking forward to following @ OncoAlert updates during # AACR20 https://twitter.com/NicoleKuderer/status/1254621489329893377 …",,@,#,"1254624258002731010",https://twitter.com/maryam_lustberg/status/1254624258002731010
Aiims1742,2020-04-27 00:10,2,30,"# AACR20 full text abstracts are now online. Looking forward to the 1st of two virtual meetings tomorrow @ AACR @ cancerassassin1",,@ @,#,"1254624014653362178",https://twitter.com/Aiims1742/status/1254624014653362178
msmoneymoves,2020-04-27 00:05,0,0,"$ VSTM clears the LGSOC bar...tune in in the morning for CRC and NSCLC # stocks # money # AACR20 https://msmoneymoves.com/2020/04/26/all-eyes-on-verastem/ …",,,# # #,"1254622781012090883",https://twitter.com/msmoneymoves/status/1254622781012090883
GrailBio,2020-04-27 00:05,7,29,"GRAIL announces new data demonstrating strong performance of our multi-cancer early detection blood test in patients with suspicion of cancer presented at @ AACR https://bit.ly/2VFqACD # DetectCancerEarly # AACR2020 pic.twitter.com/Czj0gnrJc6",,@,# #,"1254622660224376832",https://twitter.com/GrailBio/status/1254622660224376832
NicoleKuderer,2020-04-27 00:00,11,25,"@ OncoAlert 1. Conference @ AACR # AACR19 Much has happened since and # OncoAlert has become among the most important # cancer Twitter Accounts! So honored to be an early founding member. Kudos to @ weoncologists & all of @ OncoAlert! @ ErikaHamilton9 @ maryam_lustberg @ TiansterZhanghttps://twitter.com/OncoAlert/status/1254405917174620162 …",,@ @ @ @ @ @ @,# # #,"1254621489329893377",https://twitter.com/NicoleKuderer/status/1254621489329893377
bradloncar,2020-04-26 23:30,0,19,"# AACR20 Midnight Madness starts in 30...",,,#,"1254613943471013893",https://twitter.com/bradloncar/status/1254613943471013893
NCIBiospecimens,2020-04-26 22:48,0,1,"Did you know AACR will hold a virtual meeting this year on April 26th and 27th? Registration is free and simple! Sign up today! https://cloud.aacr-outbound.com/virtual-am20 # AACR # AACR20 # cancerresearch",,,# # #,"1254603309144592384",https://twitter.com/NCIBiospecimens/status/1254603309144592384
AVIVA1950,2020-04-26 22:27,0,0,"Live # Conference Coverage of # AACR2020 # Annual # Virtual Meeting; April 27-28, 2020 https://pharmaceuticalintelligence.com/2020/04/26/live-conference-coverage-of-aacr-2020-annual-virtual-meeting-april-27-28-2020/ … via @ Pharma_BI @ StephenJWillia2",,@ @,# # # #,"1254598079778623488",https://twitter.com/AVIVA1950/status/1254598079778623488
StephenJWillia2,2020-04-26 22:05,1,2,"Live # Conference Coverage of @ AACR 2020 Annual Virtual Meeting; April 27-28, 2020 # AACR20 # endcancer https://pharmaceuticalintelligence.com/2020/04/26/live-conference-coverage-of-aacr-2020-annual-virtual-meeting-april-27-28-2020/ … via @ Pharma_BI @ AVIVA1950",,@ @ @,# # #,"1254592492651065344",https://twitter.com/StephenJWillia2/status/1254592492651065344
MDAndersonNews,2020-04-26 21:50,10,38,"Starting tomorrow, our experts will be presenting key clinical trial findings virtually at # AACR20. Follow along with meeting highlights, including our presentation schedule, news releases and articles on data being presented: http://www.mdanderson.org/aacr . # endcancer",,,# #,"1254588577532579841",https://twitter.com/MDAndersonNews/status/1254588577532579841
MuhammetOzerMD,2020-04-26 21:49,1,2,"# AACR20 Virtual Meeting begins tomorrow morning - Free registration continues for all virtual sessions @ AACR https://twitter.com/AACR/status/1254442634267017217 …",,@,#,"1254588482099519488",https://twitter.com/MuhammetOzerMD/status/1254588482099519488
Mesmer21,2020-04-26 21:47,2,9,"As AACR abstracts going live after midnight today, @ @ JacobPlieth did a great job in summarizing key highlights for various targets and trials readouts # AACR20 # AACRhttps://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-preview-no-tigit-plenty-novel-mechanisms …",,@ @,# #,"1254587851599118337",https://twitter.com/Mesmer21/status/1254587851599118337
MNakada,2020-04-26 20:32,0,3,"PARP what?! Not PARP1! Check out @ RibonTx Ribon at # AACR20 New Drugs on the Horizon Session reporting about exciting novel targets: PARP 7 in the clinic and PARP14 preclinical program # JJDC portfolio company @ JNJInnovationhttps://twitter.com/RibonTx/status/1253757528896409600 …",,@ @,# #,"1254569053722730496",https://twitter.com/MNakada/status/1254569053722730496
duemed,2020-04-26 19:14,3,6,"Amidst all COVID-19 news, cancer researchers must remember that today starts # AACR20 @ AACR At 09:00 EDT (13:00 in Spain +6) will start the opening session. These are the trials that will be presented at the plenary session starting at 09:30 (13:30 Spain) pic.twitter.com/zocKNCVlwc",,@,#,"1254549356700672001",https://twitter.com/duemed/status/1254549356700672001
Dr_RShatsky,2020-04-26 19:04,0,35,"As a working mom with an exceedingly busy clinic, I am really excited that both # AACR20 and # ASCO20 are virtual. I will miss seeing my friends, but I won’t need to shut down my clinic stressing out all my patients and partners or break the bank with conference fees and travel.",,,# #,"1254546989234049026",https://twitter.com/Dr_RShatsky/status/1254546989234049026
bio_jkb,2020-04-26 18:43,4,6,"Bispecifics @ # AACR20 | Bispecific antibody line up for this year’s AACR20 virtual meeting. pic.twitter.com/UKiFVH2U77",,@,#,"1254541549406429184",https://twitter.com/bio_jkb/status/1254541549406429184
hashemalsaab,2020-04-26 17:58,2,4,"All my plan was to attend # AACR20 and I couldn’t arrange for that because this semester load And suddenly we have # COVID19 and I registered for this spectacular meeting and I could arrange to attend Thanks @ AACR for the opportunity to attend this year virtual meeting pic.twitter.com/tOacMaCFR3",,@,# #,"1254530243873984514",https://twitter.com/hashemalsaab/status/1254530243873984514
BioStocks,2020-04-26 17:36,10,17,"The Week Ahead In # Biotech # AACR20 $ NBIX $ UTHR $ IOVA $ OVID $ GILD $ ITRM $ IDRA $ MRNAhttps://www.benzinga.com/general/biotech/20/04/15877610/the-week-ahead-in-biotech-april-26-may-2-cancer-conference-earnings-news-flow-in-the-spotlight …",,,# #,"1254524694767828995",https://twitter.com/BioStocks/status/1254524694767828995
JacobPlieth,2020-04-26 17:30,4,14,"Reminder that # AACR20 I abstracts drop at 12:01am ET tonight. Here's my earlier chat with @ bradloncarhttps://twitter.com/bradloncar/status/1253322895260033025 …",,@,#,"1254523144410292224",https://twitter.com/JacobPlieth/status/1254523144410292224
changermindset,2020-04-26 17:25,0,2,"Thank you!!!",,,,"1254522033532211202",https://twitter.com/changermindset/status/1254522033532211202
Martha__Carlson,2020-04-26 17:23,3,8,"Attend 2 days of the @ AACR annual meeting for free online starting Monday 4/27. Registration info here @ changermindsethttps://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/?utm_source=Salesforce%20Marketing%20Cloud&utm_medium=Email&utm_campaign=&sfmc_s=0031I000017TGeZQAW …",,@ @,,"1254521524448628736",https://twitter.com/Martha__Carlson/status/1254521524448628736
the_funkydr,2020-04-26 17:14,0,0,"Yeah that would have been an awesome experience, I’m know it won’t be long before they’ll be knocking on your door again!",,,,"1254519216226607104",https://twitter.com/the_funkydr/status/1254519216226607104
adamfeuerstein,2020-04-26 17:10,10,44,"A reminder: # AACR20 full-text abstracts will drop 12:01 am ET, just ahead of virtual meeting at 9 am ET. If you’re interested in $ IOVA, check STAT’s site for my story on the Moffitt TIL lung data. It will post when abstract does, but I have more details!",,,#,"1254518248646881284",https://twitter.com/adamfeuerstein/status/1254518248646881284
cityofhope,2020-04-26 17:00,0,1,"City of Hope's Mihaela Cristea, M.D., will present her phase 1 safety study results of gene-edited autologous NeoTCR-T cells given to patients with locally advanced or metastatic solid tumors at # AACR20. Dr. Cristea’s presentation will be available 4/27. https://bddy.me/2SaNkbr pic.twitter.com/HRmAtgG8hG",,,#,"1254515668902445056",https://twitter.com/cityofhope/status/1254515668902445056
JacobPlieth,2020-04-26 17:00,12,33,"Reminder that # AACR20 I abstracts drop at 12:01am ET tonight. Here's my preview, from earlier https://bit.ly/3bFOinY",,,#,"1254515595279626240",https://twitter.com/JacobPlieth/status/1254515595279626240
JExpMed,2020-04-26 16:47,2,6,"Study from Lili Yang lab suggests that creatine supplementation can improve T cell–based cancer immunotherapies. New short summaries of articles (https://bit.ly/2XYhG4z ) that are part of JEM’s new cancer collection for # AACR20 https://bit.ly/3avNaBK pic.twitter.com/eTHaSdWJlf",,,#,"1254512326797074432",https://twitter.com/JExpMed/status/1254512326797074432
saksappeal,2020-04-26 16:17,0,1,"All signed up, can't wait",,,,"1254504902614749185",https://twitter.com/saksappeal/status/1254504902614749185
Barzin_,2020-04-26 16:16,5,7,"Don't forget to register for @ AACR # AACR20 and hear about our work with @ mohamshah @ max_diehn @ AshAlizadeh https://www.aacr.org/meeting/aacr-annual-meeting-2020/ … Session: https://www.abstractsonline.com/pp8/#!/9045/session/834 … Talk: https://www.abstractsonline.com/pp8/#!/9045/presentation/10531 … All times ET (I originally had the wrong time in my )https://twitter.com/Barzin_/status/1250064945926078465 …",,@ @ @ @,# # #,"1254504661219864576",https://twitter.com/Barzin_/status/1254504661219864576
YaleCancer,2020-04-26 15:19,1,6,". @ PolitiKaterina chairs the # Immunotherapy # clinicaltrials session tomorrow at # AACR20. Watch at 11:40am! @ SmilowCancer @ YalePathology @ YaleMed @ YNHH # oncoalert https://www.abstractsonline.com/pp8/#!/9045/session/852 …pic.twitter.com/GBRGW1vKNe",,@ @ @ @ @,# # # # #,"1254490228447903745",https://twitter.com/YaleCancer/status/1254490228447903745
cancerassassin1,2020-04-26 14:28,8,51,"Just a thought for # academicmedicine to ponder: now that the whole world has transitioned to teleconferences including research seminars, now would be a great time to invite early-career investigators to discuss their research - not just the most senior of investigators. # AACR20",,,# #,"1254477349762064384",https://twitter.com/cancerassassin1/status/1254477349762064384
Rick__Buck,2020-04-26 14:06,1,3,"Thank you @ cancerassassin1. Appreciate your support and tweets! It has been a massive collaborative effort by the entire @ AACR team under the leadership of @ AACR_CEO, @ AACRPres and # AACR20 Program Chair Dr. Ribas. Looking forward to Virtual Meeting I beginning April 27, 9am ET! https://twitter.com/cancerassassin1/status/1254469711972184064 …",,@ @ @ @,#,"1254471868440027136",https://twitter.com/Rick__Buck/status/1254471868440027136
cancerassassin1,2020-04-26 13:57,0,8,"# AACR20 Virtual Meeting begins tomorrow morning, with 47,000 attendees registered (!) - nice work @ AACR @ AACRPres and special HT to @ Rick__Buck and entire media team for making this happen under trying circumstances (let’s all note that the schedule follows Eastern Standard Time)https://twitter.com/cancerassassin1/status/1254435799669538822 …",,@ @ @,#,"1254469711972184064",https://twitter.com/cancerassassin1/status/1254469711972184064
cancerassassin1,2020-04-26 13:48,0,2,"Likewise, @ Rick__Buck - I was going to reach out to state the same sentiment! Looking forward to the # AACR20 Virtual Meeting, and hoping we can all resume meeting in person for # AACR21!",,@,# #,"1254467517357142018",https://twitter.com/cancerassassin1/status/1254467517357142018
AshaniTW,2020-04-26 13:48,0,14,"I am retweeting this on the appropriate day. Hope you all get a chance to virtually log into the @ AACR annual meeting tomorrow! Check it out for free at https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/ …https://twitter.com/AshaniTW/status/1251876195970560005 …",,@,,"1254467291468742662",https://twitter.com/AshaniTW/status/1254467291468742662
JCellBiol,2020-04-26 13:45,6,6,"Modulating cell stress pathways that regulate levels of the pro-apoptotic protein BIK could help treat deadly triple-negative breast cancer. JCB’s cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has new short summaries of articles: https://bit.ly/2XYckGS pic.twitter.com/fS2W1ZYxWP",,,#,"1254466531825770501",https://twitter.com/JCellBiol/status/1254466531825770501
Rick__Buck,2020-04-26 13:41,0,4,"Miss seeing you Emil at # AACR20 in beautiful San Diego today! It will be an informative two days though of our @ AACR Virtual Annual Meeting I beginning tomorrow morning. More than 47,000 attendees have registered!",,@,#,"1254465551650430976",https://twitter.com/Rick__Buck/status/1254465551650430976
ADCReview,2020-04-26 13:39,1,0,"Netherlands-based @ Synthon Biopharmaceuticals, developing innovative the anti-HER2 antibody-drug conjugate [vic-] trastuzumab duocarmazine # SYD985 for breast cancer, has been relaunched as @ byondis https://adc.expert/Byondis # ADC # breastcancer @ World_ADC @ ASCO @ AACR @ CPhIWW # biotech",,@ @ @ @ @ @,# # # #,"1254465011394547713",https://twitter.com/ADCReview/status/1254465011394547713
archerdxinc,2020-04-26 13:07,0,2,"In # cancer monitoring, a minimally invasive, yet highly accurate approach to detect # MRD can be valuable to detect # NSCLC relapse in advance of standard of care imaging. # AACR20 # AACR2020 # PrecisionOncologypic.twitter.com/LW24CRnzxE",,,# # # # # #,"1254456958544945155",https://twitter.com/archerdxinc/status/1254456958544945155
fiosgenomics,2020-04-26 13:00,0,1,"With many conferences cancelled, we are pleased that the AACR Annual Meeting has transitioned into a virtual format, being held April 27-28 and June 22-24! For the next two days, we will be looking on work completed for clients presented at previous conferences. # AACR20",,,#,"1254455203799150592",https://twitter.com/fiosgenomics/status/1254455203799150592
ADCReview,2020-04-26 12:51,0,0,"ADC Review | Journal of Antibody-drug Conjugates likes to congratulate @ ImmunomedicsInc with the approval of sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with # mTNBC. https://adc.expert/Sacituzumab_Govitecan_Trodelvy … @ ASCO @ AACR @ World_ADC # ADC # breastcancer @ Trodelvy",,@ @ @ @ @,# # #,"1254452932034125825",https://twitter.com/ADCReview/status/1254452932034125825
ManuelDomine,2020-04-26 12:48,3,11,"Just one day for the most important meeting in Cancer Investigation. # AACR20 virtual meeting, April 27 -28. The cancer research continues. We are ready. Free registration. @ AACR @ OncoAlert @ gecp_org @ AEACaP @ DocenciaFJD # LCSMpic.twitter.com/NsO5vVwU2U",,@ @ @ @ @,# #,"1254452209611411456",https://twitter.com/ManuelDomine/status/1254452209611411456
YaleCancer,2020-04-26 12:37,9,23,"Dr. Lajos Pusztai leads the opening clinical plenary tomorrow at # AACR20 presenting I-SPY 2 # clinicaltrial results on # immunotherapy drugs and high-risk # breastcancer. Watch at 9:35am! @ SmilowCancer @ YaleMed @ YNHH # bcsm # oncoalert https://www.abstractsonline.com/pp8/#!/9045/presentation/10593 …pic.twitter.com/UmrmohFq38",,@ @ @,# # # # # # #,"1254449496039264256",https://twitter.com/YaleCancer/status/1254449496039264256
cancerassassin1,2020-04-26 12:19,0,18,"I wish I were waking up in # SanDiego today preparing to attend the # AACR20 Plenary Session in person...but # cancerresearch doesn’t stop so bring on the theaacr Virtual Meeting tomorrow 4/27 and Tuesday 4/28!… https://www.instagram.com/p/B_c1YFxjHrH/?igshid=racpbzh7dyt8 …",,,# # #,"1254444947698257920",https://twitter.com/cancerassassin1/status/1254444947698257920
AACR,2020-04-26 12:10,23,42,"On the blog: A User’s Guide to # AACR20 Virtual Annual Meeting I. https://bit.ly/2Y4UUbu pic.twitter.com/UxmxfW4XyQ",,,#,"1254442634267017217",https://twitter.com/AACR/status/1254442634267017217
HTawbi_MD,2020-04-26 11:55,0,1,"I’m in Advil! Anything we can do to improve awareness. I would add that some controversy surely anticipated after # AACR20 presentations soon",,,#,"1254439087362265089",https://twitter.com/HTawbi_MD/status/1254439087362265089
cancerassassin1,2020-04-26 11:42,1,6,"I wish I were waking up in # SanDiego today preparing to attend the # AACR20 Plenary Session in person...but # cancerresearch doesn’t stop so bring on the @ AACR Virtual Meeting tomorrow 4/27 and Tuesday 4/28! https://www.aacr.org/meeting/aacr-annual-meeting-2020/schedule-at-a-glance/ …pic.twitter.com/wECYeIOwh0",,@,# # #,"1254435799669538822",https://twitter.com/cancerassassin1/status/1254435799669538822
Gkbioinfo,2020-04-26 11:38,0,4,"User’s guide to the virtual session I starting tomorrow (April 27th) @ AACR https://twitter.com/AACR/status/1254078991524397056 …",,@,,"1254434694109761536",https://twitter.com/Gkbioinfo/status/1254434694109761536
ShainLab,2020-04-26 11:03,1,13,"I would have been presenting @ AACR right now. Sad not to be there https://twitter.com/ShainLab/status/1234850292568481792 …",,@,,"1254425961359011842",https://twitter.com/ShainLab/status/1254425961359011842
MPishvaian,2020-04-26 10:33,0,1,"And while it's on my mind, in addition to virtual @ AACR # AACR20, I'm signing up for virtual @ ASCO # Asco2020",,@ @,# #,"1254418210142720000",https://twitter.com/MPishvaian/status/1254418210142720000
MPishvaian,2020-04-26 10:22,3,13,"Oh! Thank you for the reminder @ OncoAlert. # AACR20 should have been a very normal part of my calendar as an oncologist, but got lost in all the # COVID craziness. Now I'm looking forward to clearing my schedule for 2 days, and prepare for some serious virtual learning https://twitter.com/OncoAlert/status/1254405917174620162 …",,@,# #,"1254415502933397504",https://twitter.com/MPishvaian/status/1254415502933397504
msmoneymoves,2020-04-26 10:20,1,1,"Less than 14 hours for $ VSTM here is what to expect! $ MRTI $ AMGN # stocks # money # trading # AACR20 https://msmoneymoves.com/2020/04/26/all-eyes-on-verastem/ …",,,# # # #,"1254415076175622145",https://twitter.com/msmoneymoves/status/1254415076175622145
ppisters,2020-04-26 09:55,11,43,"Our @ MDAndersonNews researchers are committed to pioneering work that will # endcancer. Though our research is on pause, our passion is not. This week our teams join in # AACR20 to share and learn about the latest research innovations. Visit http://mdanderson.org/aacr to learn more.pic.twitter.com/E1NAhqfuax",,@,# #,"1254408832622657536",https://twitter.com/ppisters/status/1254408832622657536
milosicevic,2020-04-26 09:51,0,2,"@ AACR opens virtual oncology congresses season https://twitter.com/OncoAlert/status/1254405917174620162 …",,@,,"1254407716593905665",https://twitter.com/milosicevic/status/1254407716593905665
OncoAlert,2020-04-26 09:44,21,60,"Less than 24Hrs until # AACR20 We thank @ AACR for the organization in order to make this the 1st # Cancer virtual meeting of 2020. We got our start in # AACR19 & now looking forward to continuing with those Global # OncoAlert tweets from ALL our colleagues, WE ARE ALL ONCOALERT pic.twitter.com/Gyr6xrH688",,@,# # # #,"1254405917174620162",https://twitter.com/OncoAlert/status/1254405917174620162
CRUKresearch,2020-04-26 09:16,2,9,"Abstract on MicroRNA deregulation, co-authored by @ icr_london’s Nicola Valeri is being presented at next week’s # AACR20 Virtual Meeting I. Register for free to access: https://www.abstractsonline.com/pp8/#!/9045/presentation/10833 …pic.twitter.com/wFEdcZqI8Z",,@,# #,"1254398831548076032",https://twitter.com/CRUKresearch/status/1254398831548076032
CRUKresearch,2020-04-26 08:00,1,9,"We're looking forward to having # CRUKFunded researchers present and co-chair at next week's # AACR20 Virtual Meeting I (27-28 April). Register for free today: https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/?utm_medium=twitter_crukresearch&utm_source=cruksocialmedia&utm_campaign=annualmeeting&utm_content=2020vam1&sf121161878=1 …",,,# #,"1254379719836999680",https://twitter.com/CRUKresearch/status/1254379719836999680
GripNetworking,2020-04-26 07:31,0,0,"One more day to go: The American Association for Cancer Research has launched a major transformation of its signature event, the AACR Annual Meeting. @ AACR Register for free: https://buff.ly/3a6nMCt # AACR20 # meetings # aipoweredpic.twitter.com/wb0UcINHkn",,@,# # #,"1254372407328022528",https://twitter.com/GripNetworking/status/1254372407328022528
ChallengeEvery4,2020-04-26 07:02,0,0,"Start looking into atom frequency. If you need any help just check out Royal Raymond Rife's genius work 90 YEARS AGO when he CURED cancer and many other diseases!!",,,,"1254365270589747200",https://twitter.com/ChallengeEvery4/status/1254365270589747200
CRUKresearch,2020-04-26 06:26,1,5,". @ TheCrick’s @ TurajlicLab is chairing a Molecular and Cellular Biology/Genetics session at the # AACR20 Annual Meeting I. Join on Tuesday and get a front row seat for the discussion. https://www.abstractsonline.com/pp8/#!/9045/session/838 …pic.twitter.com/fQpOKNK4S2",,@ @,# #,"1254356048338698246",https://twitter.com/CRUKresearch/status/1254356048338698246
healthhashtags,2020-04-26 06:00,3,9,"Top Influencers of # AACR20: @ AACR @ VivekSubbiah @ OncoAlert @ JackWestMD @ oncologician @ UmutDisel @ tmprowell More https://hcsm.io/2TPswt7",,@ @ @ @ @ @ @,#,"1254349731402309638",https://twitter.com/healthhashtags/status/1254349731402309638
ErinGillespieMD,2020-04-26 05:28,0,3,"Oh interesting! Or a shared google doc to organize comments and facilitate conversation? Could even group similar projects to try to foster collaboration. @ d_golden @ JillGunther",,@ @,,"1254341539792289792",https://twitter.com/ErinGillespieMD/status/1254341539792289792
healthhashtags,2020-04-26 02:00,1,1,"Today's Health Conferences: # ASRASPRING20 # AACR20 # HealtheVoicesLIVE http://hcsm.io/healthconfs # hcsm",,,# # # #,"1254289242156609538",https://twitter.com/healthhashtags/status/1254289242156609538
NicoleKuderer,2020-04-25 22:21,0,15,"While heading to our 1. Virtual Conference @ aacr # aacr20 (for free) missing terribly in person meetings & our @grasptweet & @ oncoalert friends https://twitter.com/stage4kelly/status/1205571595638648840 …pic.twitter.com/LoDGuWJhmO",,@ @grasptweet @,#,"1254234124912476160",https://twitter.com/NicoleKuderer/status/1254234124912476160
MattSakumoto,2020-04-25 21:44,0,1,"Google slides with comments/questions attached in the presenter notes",,,,"1254224712995008512",https://twitter.com/MattSakumoto/status/1254224712995008512
tmprowell,2020-04-25 21:36,0,3,"Tweet 2/2: Registration for # AACR20 open now & free to all: https://cloud.aacr-outbound.com/virtual-am20",,,#,"1254222705030844416",https://twitter.com/tmprowell/status/1254222705030844416
tmprowell,2020-04-25 21:35,3,24,"Looking forward to part 1 of virtual # AACR20 on 4/27-4/28. Registration required but is free (heads up # advocacy colleagues & # MedStudentTwitter & # MedEd). Remembering # AACR16. I also wore a mask during that one, but seem to remember that time as way more fun. # NOLA # NewOrleanspic.twitter.com/ATBab9zwou",,,# # # # # # #,"1254222517113257984",https://twitter.com/tmprowell/status/1254222517113257984
PortalOnconews,2020-04-25 21:22,0,1,"Um modelo de predição de risco que combina fatores genéticos e clínicos com biomarcadores circulantes identificou indivíduos com risco significativamente maior de câncer de pâncreas - https://tinyurl.com/y6w8lnkf @ AACR # PÂNCREAS # RISCO # RASTREAMENTO # AACR # ONCONEWSpic.twitter.com/9YV7Po3GCm",,@,# # # # #,"1254219365353959432",https://twitter.com/PortalOnconews/status/1254219365353959432
larrywabrams,2020-04-25 20:43,2,1,"# AACR20 of interest>> early results on additional checkpoint inhibitors paired with PD-L1 >> Monday $ CGEN pairing their COM701 anti-PVRIG with $ BMS Opdivo >> Tuesday $ RHHBY pairing their RG6058 anti-TIGIT their own Tencentriq. Any predictions?",,,#,"1254209538531581952",https://twitter.com/larrywabrams/status/1254209538531581952
MacerolloMD,2020-04-25 20:07,0,0,"Would need to be an invited- secure event so no outside folks. Don’t know how to give all host access so they can move from room to room (poster to poster)",,,,"1254200507863896066",https://twitter.com/MacerolloMD/status/1254200507863896066
MacerolloMD,2020-04-25 20:06,0,0,"I was at a cool live poster event where each poster was actually on a computer screen and had up to 3 slides. Thinking u could do that in break out rooms. Put title and abstract and let people browse....",,,,"1254200088517320706",https://twitter.com/MacerolloMD/status/1254200088517320706
LibrarianTL,2020-04-25 19:45,0,1,"Does that include those with the KRAS mutation, G12v? @ AACR @ aicrtweets @ ColonCancerFdn",,@ @ @,,"1254194784144691201",https://twitter.com/LibrarianTL/status/1254194784144691201
montypal,2020-04-25 19:24,0,2,"Thanks!",,,,"1254189516031582209",https://twitter.com/montypal/status/1254189516031582209
montypal,2020-04-25 19:18,5,14,"Will be following the virtual # AACR20 meeting closely. Looking fwd to seeing abstracts from @ NickSalgia @ NazliDizman & members of our # kidneycancer research team at @ cityofhope. @ TDorffOnc @ YungLyou @ ClaytonLauMD @ COHurolhttps://twitter.com/cityofhope/status/1254187105787547649 …",,@ @ @ @ @ @ @,# #,"1254188058489925632",https://twitter.com/montypal/status/1254188058489925632
cityofhope,2020-04-25 19:14,1,16,"City of Hope's Yuman Fong, M.D., will present a poster at # AACR20 on April 27. Watch to learn about Dr. Fong’s phase 1 study findings on Vaxinia, an oncolytic poxvirus administered through two routes in adult patients with mixed advanced solid tumors. https://bddy.me/2zqCBTH pic.twitter.com/ZgQhPTc1zd",,,#,"1254187105787547649",https://twitter.com/cityofhope/status/1254187105787547649
AACR,2020-04-25 19:00,5,11,"Abstracts presented in # AACR20 Virtual Meeting I will post at 12:01 am ET on Monday, April 27.",,,#,"1254183578407178240",https://twitter.com/AACR/status/1254183578407178240
montypal,2020-04-25 18:59,0,2,"Thanks so much for posting these - do you know when the abstracts will be available?",,,,"1254183159534456832",https://twitter.com/montypal/status/1254183159534456832
princetongb,2020-04-25 18:43,1,10,"$ IOVA. Maybe they'll finally be acquired this week? April 28 presentation. # AACR2020 registration is free this year. pic.twitter.com/Vz9KhLdV87",,,#,"1254179330168676353",https://twitter.com/princetongb/status/1254179330168676353
Rick__Buck,2020-04-25 18:12,0,1,"Miss seeing you this year Dr. Curran at # AACR20. I am sure it would have been a beautiful San Diego night. Hope to see you online at our Virtual Meetings on Monday and Tuesday.",,,#,"1254171428519317506",https://twitter.com/Rick__Buck/status/1254171428519317506
HerrickMartina,2020-04-25 17:42,0,1,"Getting rid of a lot of the " 'cides " & other chemicals in our lives, would definitely cut down on the rate of cancers. They are everywhere!!! From birth to death, we are inundated with some form of them. Now, we aren't even told how many ways these poisons enter our systems.",,,,"1254163911353315328",https://twitter.com/HerrickMartina/status/1254163911353315328
Lauren_Langbein,2020-04-25 14:45,0,2,"Looking forward to # AACR20 next week. Who else will be attending or presenting? https://twitter.com/AACR/status/1250775269067145216 …",,,#,"1254119321938415617",https://twitter.com/Lauren_Langbein/status/1254119321938415617
fumikochino,2020-04-25 14:30,0,1,"Oh I love the idea of a twitter poster session! Having a tweet chat sounds like a great way of fostering great discussion!",,,,"1254115659199504384",https://twitter.com/fumikochino/status/1254115659199504384
FutureDocs,2020-04-25 14:28,1,5,"@ WrayCharles and I batted around ideas for a tweet chat poster session. We are planning a virtual poster session for our medical school but in a closed learning management system. considering how each person will ask ?s to 2 others and each “presenter” has all day to answer.",,@,,"1254114965692309504",https://twitter.com/FutureDocs/status/1254114965692309504
d_golden,2020-04-25 14:10,0,4,"pic.twitter.com/kvRxuQpe4J",,,,"1254110620351266816",https://twitter.com/d_golden/status/1254110620351266816
d_golden,2020-04-25 13:50,1,5,"Registration for the @ roecsg symposium is free: https://voices.uchicago.edu/roecsg/events/symposium2020/ …. The meeting log in info will be sent a day in advance to minimize the risk of # RadOnc Zoom bombing (gotta watch out for those prankster med oncs and surgeons ).",,@,#,"1254105641385426955",https://twitter.com/d_golden/status/1254105641385426955
ADCReview,2020-04-25 13:38,1,1,"Netherlands-based @ Synthon Biopharmaceuticals, developing innovative the anti-HER2 antibody-drug conjugate [vic-] trastuzumab duocarmazine # SYD985 for breast cancer, has been relaunched as @ byondis https://adc.expert/Byondis # ADC # breastcancer @ World_ADC @ ASCO @ AACR @ CPhIWW # biotech",,@ @ @ @ @ @,# # # #,"1254102372059676672",https://twitter.com/ADCReview/status/1254102372059676672
shilpaonc,2020-04-25 13:33,0,0,"Thanks!",,,,"1254101248103583746",https://twitter.com/shilpaonc/status/1254101248103583746
RonKorkut,2020-04-25 13:18,0,2,"The BEST PROTECTION AGAINST CANCER is our IMMUNE SYSTEM that is the DESIRE TO LIVE. Yet, CROOKS destroy it, by FORCEDTAX, VIRUS FEARS, RACKETEERING BUSINESSES, parking tickets, driving fines, interests, rents, forced sales.... http://Www.ilaw.site NATURAL RIGHTS",,,,"1254097339804835840",https://twitter.com/RonKorkut/status/1254097339804835840
nuenojpn,2020-04-25 13:00,2,5,"4月27日と28日は米国癌学会2020年の総会です @ AACR 今年は新型コロナウイルスの関係上すべてがバーチャルで行われます。誰でも参加でき無料です。興味のある方は下記のサイトで登録を https://cloud.aacr-outbound.com/virtual-am20",,@,,"1254092859608834049",https://twitter.com/nuenojpn/status/1254092859608834049
teamoncology,2020-04-25 12:56,1,2,"Next Monday and Tuesday will be the @ AACR virtual meeting (1st of 2 meetings), and it is completely free to attend. Register at the following link before 9am ET on Monday when it starts. The link is https://cloud.aacr-outbound.com/virtual-am20 . Anyone can join. # bcsm",,@,#,"1254092027194736642",https://twitter.com/teamoncology/status/1254092027194736642
ADCReview,2020-04-25 12:50,0,0,"ADC Review | Journal of Antibody-drug Conjugates likes to congratulate @ ImmunomedicsInc with the approval of sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with # mTNBC. https://adc.expert/Sacituzumab_Govitecan_Trodelvy … @ ASCO @ AACR @ World_ADC # ADC # breastcancer @ Trodelvy",,@ @ @ @ @,# # #,"1254090292665503745",https://twitter.com/ADCReview/status/1254090292665503745
ChaurasiaMD,2020-04-25 12:05,0,1,"Last message: definitely do a test ahead of time to try out all the features, and spend a lot of time in the meeting settings to enable/disable all the things you want. You can also save your test meeting as a template, so it can be duplicated and used for the real thing.",,,,"1254079114228760576",https://twitter.com/ChaurasiaMD/status/1254079114228760576
AACR,2020-04-25 12:05,1,14,"On the blog: A User’s Guide to # AACR20 Virtual Annual Meeting I. https://bit.ly/2S58pE4 pic.twitter.com/lUkVtlLbEF",,,#,"1254078991524397056",https://twitter.com/AACR/status/1254078991524397056
Sushilberiwal,2020-04-25 12:03,0,1,"Can we get link to the meeting",,,,"1254078509510791171",https://twitter.com/Sushilberiwal/status/1254078509510791171
ChaurasiaMD,2020-04-25 12:02,0,3,"Having spent some time playing around with Zoom to set up our Virtual Mock Orals, this is what I've learned. The Zoom video tutorials and YouTube are quite helpful.",,,,"1254078223857704962",https://twitter.com/ChaurasiaMD/status/1254078223857704962
ChaurasiaMD,2020-04-25 12:01,0,1,"I don't think doing a normal Zoom meeting vs a webinar changes the breakout room features. The other issue is that of you do cloud recording it only records the main room. So if you want to record simultaneous sessions for later viewing, that has to be done on a local computer.",,,,"1254078033520201729",https://twitter.com/ChaurasiaMD/status/1254078033520201729
ChaurasiaMD,2020-04-25 11:59,0,1,"If someone new has joined, they have to be assigned by a host (you can assign > 1 host) to one of the rooms, attendees can only go into assigned room or back out to the main room (if enabled by the host). Main drawback is that attendees can't go into a room w/o host assignment.",,,,"1254077533760479248",https://twitter.com/ChaurasiaMD/status/1254077533760479248
d_golden,2020-04-25 11:43,1,7,"We are planning for the upcoming virtual @ roecsg symposium. Breakout rooms can be recreated with the same participants for continuity, but what if someone new has joined the meeting @ zoom_us? Do they get assigned automatically to a new room? # radonc # MedEd",,@ @,# #,"1254073634752278529",https://twitter.com/d_golden/status/1254073634752278529
NeliMUlrich,2020-04-25 11:43,1,6,"Thank you @ AACRPres and all of the Board for your service! Your commitment and time handling @ AACR matters, esp. during the # Covid_19 outbreak is greatly appreciated. # CancerResearch won’t stop! Onward with a virtual meeting! @ AACR_CEOhttps://twitter.com/AACRPres/status/1253768200006832135 …",,@ @ @,# #,"1254073552493395969",https://twitter.com/NeliMUlrich/status/1254073552493395969
cbtadvisors,2020-04-25 11:42,1,3,"Good list re # AACR20 cc @ bradloncar @ PDRennert @ JacobPlieth @ syinvesting @ binneystreetbiohttps://twitter.com/semodough/status/1254066500228562946 …",,@ @ @ @ @,#,"1254073208535482368",https://twitter.com/cbtadvisors/status/1254073208535482368
roecsg,2020-04-25 11:35,0,2,"@ zoom_us",,@,,"1254071664364662784",https://twitter.com/roecsg/status/1254071664364662784
semodough,2020-04-25 11:15,3,17,"LIFESCI # AACR20 Virtual Meeting Part 1 titles that caught our attention Virtual meeting (April 27th and 28th). Remember that abstracts from these presentations come out at midnight on April 27th, first day of Part 1. Even though will not see Roche's anti-TIGIT data until Part 2,",,,#,"1254066500228562946",https://twitter.com/semodough/status/1254066500228562946
medwireNews,2020-04-25 10:20,2,3,"We are looking forward to reporting from the # AACR20 virtual meeting next week for @ MM_Oncology! It's going to be a novel experience for us, as indeed for so many. Keep an eye on http://bit.ly/2zyNNu3 for all the # BreastCancer, # GUcancer & # ThoracicCancer news. @ AACR",,@ @,# # # #,"1254052553588985856",https://twitter.com/medwireNews/status/1254052553588985856
CRUKresearch,2020-04-25 07:31,4,5,"Sign-up for # AACR20 Virtual Meeting I, taking place next week 27-28 April 2020. It's open to the community and free to attend. # Register today:https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/?utm_medium=twitter_crukresearch&utm_source=cruksocialmedia&utm_campaign=annualmeeting&utm_content=2020vam1&sf121161878=1 …",,,# #,"1254010014559322113",https://twitter.com/CRUKresearch/status/1254010014559322113
UmutDisel,2020-04-25 06:36,0,3,"“Waiting eagerly with all CovidienScientist” First chapter after COvIDisaster-Second will be # ASCO20",,,#,"1253996307779330048",https://twitter.com/UmutDisel/status/1253996307779330048
healthhashtags,2020-04-25 06:05,1,0,"Top Influencers of # AACR20: @ AACR_CEO @ AACR @ OncoAlert @ Kristel_GT @ ErikaHamilton9 @ SWOG @ NicoleKuderer More https://hcsm.io/2TPswt7",,@ @ @ @ @ @ @,#,"1253988475935825921",https://twitter.com/healthhashtags/status/1253988475935825921
XRBustelo,2020-04-25 05:44,1,5,"@ ASEICAnews celebrates today the 15th Anniversary of the Human Genome Project. # DNADay2020 @ CienciaGob @ LluisMontoliu @ ELCOLLAZO @ astro_duque @ Nunodomin @ NIH @ AACR @ EACRnews @ EMBO @ ERC_Research @ CIBERONC @ SaludISCIII @ rtve @ sextaNoticias @ antena3compic.twitter.com/cYjjAyYKII",,@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @,#,"1253983242866364416",https://twitter.com/XRBustelo/status/1253983242866364416
CRUKresearch,2020-04-25 05:15,1,5,". @ uclcancer’s @ squezadd will be chairing the Predictive Biomarkers for Immunotherapeutics session at the # AACR20 Virtual Annual Meeting I. Join on Tuesday to hear about emerging clinical research in immunology. https://www.abstractsonline.com/pp8/#!/9045/session/834 …pic.twitter.com/CO1jRFKIun",,@ @,# #,"1253975792603795456",https://twitter.com/CRUKresearch/status/1253975792603795456
tnewsomdavis,2020-04-25 05:02,0,2,"La Belle France ahead of the game, comme toujours. Will be joining online: look forward to seeing the data.",,,,"1253972676152098818",https://twitter.com/tnewsomdavis/status/1253972676152098818
_B_I_O_T_E_C_H_,2020-04-25 04:58,9,33,"# Biotech Abstract releases next week: 4/27 # AACR20 4/28 # ASGCT20 4/29 # ASCO20 titles",,,# # # #,"1253971678591365120",https://twitter.com/_B_I_O_T_E_C_H_/status/1253971678591365120
oncologician,2020-04-25 04:47,12,46,"A new chapter begins in the history of oncology -First virtual @ AACR meeting- Monday 27th April 2020, 9.30 am EDT (7 pm IST), opening clinical plenary session # AACR20 @ tmprowell @ JackWestMD @ VivekSubbiah @ UmutDiselpic.twitter.com/tXMildN9G3",,@ @ @ @ @,#,"1253968758231584768",https://twitter.com/oncologician/status/1253968758231584768
barlesi,2020-04-25 04:11,0,0,"Very interesting dataset. Hope to see an extended report to compare UK data with our own experience in @ GustaveRoussy that will be presented at @ AACR on Tuesday.",,@ @,,"1253959932430385152",https://twitter.com/barlesi/status/1253959932430385152
KMBussard,2020-04-25 04:05,1,3,"@ AlisonShupp from the @ KMBussard Lab won a Women in Cancer Research Scholar in Training Award for her work to be presented at the @ AACR Virtual Annual Meeting! @ ResearchAtJeff @ JeffersonUniv @ SKCCDirector @ KimmelCancerCtr # CancerResearchhttps://www.aacr.org/professionals/meetings/aacr-travel-grants/women-in-cancer-research-scholar-awards/%E2%80%8B2020-women-in-cancer-research-scholar-awards/ …",,@ @ @ @ @ @ @,#,"1253958277995597824",https://twitter.com/KMBussard/status/1253958277995597824
DianaNrco,2020-04-25 03:30,0,0,"In the world before # COVID19 we would not have been able to attend # AACR20 because travelling to San Diego was complex for the journal editors this year. Thus, we’re looking forward to the meeting! (2/2)",,,# #,"1253949431218610176",https://twitter.com/DianaNrco/status/1253949431218610176
DianaNrco,2020-04-25 03:30,1,8,"# AACR20 starts in two days and @ NatRevClinOncol editors will be there! In the world before # COVID19 i would have tweeted “say hi to us in San Diego”. Now I’m not sure how virtual networking will work but we hope to make the most of it. (1/2)",,@,# #,"1253949429708722177",https://twitter.com/DianaNrco/status/1253949429708722177
healthhashtags,2020-04-25 02:00,1,0,"Today's Health Conferences: # IamAMCP # ASRASPRING20 # AACR20 # FromTheFrontlines # VAcovid19 http://hcsm.io/healthconfs # hcsm",,,# # # # # #,"1253926951091417093",https://twitter.com/healthhashtags/status/1253926951091417093
ADCReview,2020-04-25 01:09,0,0,"Netherlands-based @ Synthon Biopharmaceuticals, developing innovative the anti-HER2 antibody-drug conjugate [vic-] trastuzumab duocarmazine # SYD985 for breast cancer, has been relaunched as @ byondis https://adc.expert/Byondis # ADC # breastcancer @ World_ADC @ ASCO @ AACR @ CPhIWW # biotech",,@ @ @ @ @ @,# # # #,"1253913935129894912",https://twitter.com/ADCReview/status/1253913935129894912
ADCReview,2020-04-25 00:29,0,0,"ADC Review | Journal of Antibody-drug Conjugates likes to congratulate @ ImmunomedicsInc with the approval of sacituzumab govitecan (Trodelvy™) for the treatment of adult patients with # mTNBC. https://adc.expert/Sacituzumab_Govitecan_Trodelvy … @ ASCO @ AACR @ World_ADC # ADC # breastcancer @ Trodelvy",,@ @ @ @ @,# # #,"1253903887213268992",https://twitter.com/ADCReview/status/1253903887213268992
DrJNaidoo,2020-04-24 23:22,2,35,"Recorded my # LCSM discussant for # AACR2020...15min recording interrupted 21x by emails/pages/meeting alerts. Lessons: 1. Having truly ‘protected’ time happens even less than we think, but 2. Maintaining focus in the midst of competing priorities, is a key skill in medicine",,,# #,"1253887124493000704",https://twitter.com/DrJNaidoo/status/1253887124493000704
BioCentury,2020-04-24 22:30,3,1,"Target and technology trends that have built momentum over the last year are showing up at # AACR20 https://buff.ly/2yDKyEW",,,#,"1253873911734964226",https://twitter.com/BioCentury/status/1253873911734964226
fumikochino,2020-04-24 20:20,0,1,"pic.twitter.com/iUHXrqDz3u",,,,"1253841395254587393",https://twitter.com/fumikochino/status/1253841395254587393
ChaurasiaMD,2020-04-24 20:12,0,1,"Yeah, I do think they have some other features that may fulfill your purposes, but some of them require a corporate account. I'm not sure if @ MSKCC has a subscription, but that might help.",,@,,"1253839294902476801",https://twitter.com/ChaurasiaMD/status/1253839294902476801
ErinGillespieMD,2020-04-24 20:06,0,3,"Yes the Breakout Rooms are great! But I don’t think the participants can pick which room they go to - so no ability to browse and then choose a poster “room”. Although that would be awesome @ zoom",,@,,"1253837780226052097",https://twitter.com/ErinGillespieMD/status/1253837780226052097
ChaurasiaMD,2020-04-24 19:52,0,2,"Note, I had to pay the $10/month fee to get access to these features. But they have a lot of nifty features which can be helpful! Try exploring here:https://support.zoom.us/hc/en-us/articles/206618765-Zoom-Video-Tutorials …",,,,"1253834136118272001",https://twitter.com/ChaurasiaMD/status/1253834136118272001
ChaurasiaMD,2020-04-24 19:50,0,3,"We actually are about Zoom for our mock oral boards, and it has a feature called "Breakout Rooms", where you stay within the same meeting but have separate (up to 50-100 I think) rooms people can be assigned to. They also have a webinar feature, but I haven't used that.",,,,"1253833682919526400",https://twitter.com/ChaurasiaMD/status/1253833682919526400
ErinGillespieMD,2020-04-24 19:41,0,3,"Haha blowing our cover!!",,,,"1253831431358427136",https://twitter.com/ErinGillespieMD/status/1253831431358427136
fumikochino,2020-04-24 19:25,0,2,"Maybe the upcoming @ roecsg symposium May 15?",,@,,"1253827483989876736",https://twitter.com/fumikochino/status/1253827483989876736
tmprowell,2020-04-24 19:21,1,7,"Reminder that # oncology research is still going on in the background during # COVID19 # pandemic & part 1 of # AACR20 takes place virtually 4/27-4/28/20. Attention to this important project to harmonize TMB biomarker. # ImmunoOnc. cc @ CancerResrch @ AACR https://twitter.com/CancerResrch/status/1253028355340996608 …",,@ @,# # # # #,"1253826390824288256",https://twitter.com/tmprowell/status/1253826390824288256
Rick__Buck,2020-04-24 19:02,0,0,"Thanks for the coverage @ adamfeuerstein and glad we could help give you a “distraction” from the # Covid_19 coverage. # AACR20 https://twitter.com/adamfeuerstein/status/1253784555124908033 …",,@,# #,"1253821690993414145",https://twitter.com/Rick__Buck/status/1253821690993414145
DrMedPhys,2020-04-24 18:49,0,0,"No experience, but what’s the setting?",,,,"1253818367544184834",https://twitter.com/DrMedPhys/status/1253818367544184834
BahoSidiqiMDMPH,2020-04-24 18:37,0,1,"Can share a screen and do a Prezi so you can zoom thru parts of the poster like they would at ASTRO.",,,,"1253815272739348489",https://twitter.com/BahoSidiqiMDMPH/status/1253815272739348489
fumikochino,2020-04-24 18:29,0,2,"Could be great if it were in an interactive format like the ASTRO poster presentations! Would love to involved in the beta test of this!",,,,"1253813431750328320",https://twitter.com/fumikochino/status/1253813431750328320
ErinGillespieMD,2020-04-24 18:26,3,10,"Anyone have experience or ideas for running poster sessions in a virtual @ Zoom conference? @ DrMedPhys @ ACKoongMDPhD @ fumikochino @ cd_fuller @ aapmHQ @ AACR @ roecsg # AcademicTwitter",,@ @ @ @ @ @ @ @,#,"1253812554712973313",https://twitter.com/ErinGillespieMD/status/1253812554712973313
jamienholloway,2020-04-24 17:17,0,2,"YES!! to all of the above",,,,"1253795105556893699",https://twitter.com/jamienholloway/status/1253795105556893699
tmprowell,2020-04-24 17:06,0,12,"Dearly love this # bcsm # advocacy trailblazer @ christeeny513 & love @ AACR for putting her in the # AACR20 promo photo. Total # respect all around. https://twitter.com/JaniceTNBCmets/status/1253756405171064834 …",,@ @,# # # #,"1253792467259924483",https://twitter.com/tmprowell/status/1253792467259924483
gary_lyman,2020-04-24 17:00,0,0,"@ AACR https://twitter.com/gary_lyman/status/1253771446351917056 …",,@,,"1253790963710849025",https://twitter.com/gary_lyman/status/1253790963710849025
adamfeuerstein,2020-04-24 16:35,2,36,"In non-Covid news, # AACR20 starts on Monday morning. I will have some stories for you! It’s been nice returning to “regular” reporting on cancer drug development.",,,#,"1253784555124908033",https://twitter.com/adamfeuerstein/status/1253784555124908033
webofmeetings,2020-04-24 16:26,0,0,"Are you at # AACR20 @ AACR? Web of Meetings wishes you very successful time in San Diego. Remember that you can share your thoughts about the meeting following the link https://webofmeetings.com/2019/biomedicine/cancer/american-association-for-cancer-research-annual-meeting-2020 … @ AACR",,@ @,#,"1253782501342003200",https://twitter.com/webofmeetings/status/1253782501342003200
SPSuehnholz,2020-04-24 15:50,0,3,"Excited to attend the # AACR20 (virtual) meeting next week! https://twitter.com/sloan_kettering/status/1253753091486294016 …",,,#,"1253773367779491840",https://twitter.com/SPSuehnholz/status/1253773367779491840
AACR,2020-04-24 15:45,2,8,"RT @ AACRPres: As we adjourn the final Board of Directors Meeting of my term as @ AACR President, I would like to thank the Board for their leadership during the past year, and especially during the recent COVID-19 crisis. It has been a pleasure to work with this outstanding team. pic.twitter.com/GacF7ZOQaG",,@ @,,"1253771966391164928",https://twitter.com/AACR/status/1253771966391164928
SKCCDirector,2020-04-24 15:44,2,12,"Thank you for your leadership @ AACRPres and @ AACR_CEO . I know that I speak for the entire Board in reaffirming how proud and honored we are to support @ aacr. Cancer research saves lives! https://twitter.com/AACRPres/status/1253768200006832135 …",,@ @ @,,"1253771777962135553",https://twitter.com/SKCCDirector/status/1253771777962135553
JCellBiol,2020-04-24 15:41,1,1,"Read short summaries of articles in JCB’s new cancer collection for # AACR20 (https://bit.ly/2Vv9GXj )—now available as a freely downloadable PDF: https://bit.ly/2XYckGS",,,#,"1253770942163099648",https://twitter.com/JCellBiol/status/1253770942163099648
AACRPres,2020-04-24 15:30,1,57,"As we adjourn the final Board of Directors Meeting of my term as @ AACR President, I would like to thank the Board for their leadership during the past year, and especially during the recent COVID-19 crisis. It has been a pleasure to work with this outstanding team. pic.twitter.com/qSetyWSB51",,@,,"1253768200006832135",https://twitter.com/AACRPres/status/1253768200006832135
DrHelenMa,2020-04-24 15:24,1,8,"Super proud to be a part of the abstract that will be presented at @ AACR. Dedicated to our # Lymphoma patients who have enrolled on # clinicaltrials # columbia @ ColumbiaMed @ nyphospitalpic.twitter.com/Qe7USX6aDj",,@ @ @,# # #,"1253766881498083328",https://twitter.com/DrHelenMa/status/1253766881498083328
RibonTx,2020-04-24 14:47,1,4,"Attending # AACR20 virtually? Check out our oral sessions where we will be presenting preclinical data from our PARP7 and PARP14 programs. Details accessible here: https://bit.ly/3eIzcjv pic.twitter.com/qYhAorZ1CP",,,#,"1253757528896409600",https://twitter.com/RibonTx/status/1253757528896409600
GantosJ,2020-04-24 14:42,0,1,"AACR this year is a virtual conference & the reference to # AACR20 is strictly scientific event and only open to members. So, $ APTO will present poster that got accepted on Jan, then it would be about first 2 doses only, and no updates about 450mg or AML IMHO",,,#,"1253756108495257602",https://twitter.com/GantosJ/status/1253756108495257602
GantosJ,2020-04-24 14:42,4,25,"I'm getting many DM asking me what about $ APTO going into AACR next week? We all know that # AACR20 abstracts submission dealine was in Jan-2020, so these days we actually know more than what the abstract & poster might present next week!",,,#,"1253756105500569602",https://twitter.com/GantosJ/status/1253756105500569602
CBarnesPT,2020-04-24 14:34,0,0,"A lot of conferences going online & free nowadays, including @ AACR next week (4/27-28) - some nice content on their program, including a series of platforms on # COVID19 and # cancer https://www.abstractsonline.com/pp8/#!/9045/",,@,# # #,"1253754108479037440",https://twitter.com/CBarnesPT/status/1253754108479037440
JExpMed,2020-04-24 14:31,1,1,"NEW @ JExpMed Download - Brief summaries of articles with insight from authors in the NEW Cancer Collection 2020. Find it here: https://bit.ly/2XYhG4z # cancer # AACR20 pic.twitter.com/E45TYrlLOI",,@,# #,"1253753331161464832",https://twitter.com/JExpMed/status/1253753331161464832
sloan_kettering,2020-04-24 14:30,3,5,"# AACR20 kicks-off 4/27! This year's theme “Turning Science into Lifesaving Care” celebrates the incredible science and research informing patient care. For more info on the virtual meeting & what MSK experts will be featured please visit our website. https://bit.ly/3cLMwSs",,,#,"1253753091486294016",https://twitter.com/sloan_kettering/status/1253753091486294016
CellSignal,2020-04-24 14:12,0,1,"Less than a week left left to register for our immune cell signaling # webinar with @ GENbio. Learn how to use Flow cytometry to reveal essential signaling insights about rare immune cell subsets without having to attend # AACR20. https://hubs.ly/H0pqsq10 pic.twitter.com/KUKwGx0eM0",,@,# #,"1253748782262562821",https://twitter.com/CellSignal/status/1253748782262562821
JAMANetwork,2020-04-24 14:00,1,0,"Getting ready for # AACR20? Read Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort, just published in @ JAMANetworkOpen, and other recent # oncology articles from the JAMA Network https://ja.ma/2x18uSa",,@,# #,"1253745523174989824",https://twitter.com/JAMANetwork/status/1253745523174989824
JacobPlieth,2020-04-24 13:57,2,4,"Abstracts for # AACR20 II drop 15 May.",,,#,"1253744953097949184",https://twitter.com/JacobPlieth/status/1253744953097949184
theNCI,2020-04-24 13:22,25,33,"NCI is participating in the American Association for Cancer Research Virtual Annual Meeting next week. Here's information on NCI-related presentations: https://www.cancer.gov/news-events/events/conferences/aacr-2020 … @ AACR # AACR20 pic.twitter.com/iVgSeBUeB9",,@,#,"1253736181994524672",https://twitter.com/theNCI/status/1253736181994524672
PDRennert,2020-04-24 13:22,0,6,"yesterday's live stream conversation between @ bradloncar and @ JacobPlieth re # AACR20 in particular and oncology in general was a great listen. thanks to you both for doing it!",,@ @,#,"1253735997860392960",https://twitter.com/PDRennert/status/1253735997860392960
cbtadvisors,2020-04-24 13:20,1,1,"Thanks! Abstracts from the June # AACR20 II meeting become available on May 15, according to @ AACR web site https://www.aacr.org/meeting/aacr-annual-meeting-2020/termination-and-rescheduling-faq/ …https://twitter.com/JacobPlieth/status/1253731720165232643 …",,@,#,"1253735659900211206",https://twitter.com/cbtadvisors/status/1253735659900211206
webofmeetings,2020-04-24 13:14,0,0,"# AACR20 Are you attending the world-class conference "American Association for Cancer Research Annual Meeting 2020"? Leave your review of 2020 edition @ webofmeetings and share your opinion https://webofmeetings.com/2019/biomedicine/cancer/american-association-for-cancer-research-annual-meeting-2020 … @ AACR",,@ @,#,"1253734180984442882",https://twitter.com/webofmeetings/status/1253734180984442882
JacobPlieth,2020-04-24 13:05,1,10,"Exact wording from $ RHHBY: We are planning to present Ph1a/b solid tumour Tigit data at # AACR20 II in June.",,,#,"1253731720165232643",https://twitter.com/JacobPlieth/status/1253731720165232643
sonpavde,2020-04-24 12:59,1,3,"Wonderful Opportunity to support # bladdercancer # research while maintaining social distance # COVID19 - inviting anyone and everyone! @ ASCO @ AACR @ AmerUrological @ UroOnc @ SWOGhttps://twitter.com/bcan_chisolm/status/1249413558728826883 …",,@ @ @ @ @,# # #,"1253730189491789830",https://twitter.com/sonpavde/status/1253730189491789830
cbtadvisors,2020-04-24 12:57,0,2,"Thanks, @ bradloncar. Some key papers (e.g. @ Roche @ genentech TIGIT antibody Ph 1 data) have been withdrawn from @ AACR & shifted to (virtual) @ ASCO but there should still be plenty to watch for, esp. in # IO, bispecifics. # AACR20 # biotechhttps://twitter.com/bradloncar/status/1253720051628343296 …",,@ @ @ @ @,# # #,"1253729702180786183",https://twitter.com/cbtadvisors/status/1253729702180786183
LChard_FSG,2020-04-24 12:39,3,3,"Looking forward to Monday for the # AACR20 virtual preview, make sure to keep up with @ NanomedZone @ OncologyCentral and @ MyBioTechniques as we cover the conference live!",,@ @ @,#,"1253725218591440902",https://twitter.com/LChard_FSG/status/1253725218591440902
ajf324MD,2020-04-24 12:19,0,0,"@ AACR any speculation to whether this year's Clinical Research Methods Workshop is still tentatively scheduled, or if a virtual workshop is being discussed?",,@,,"1253720325214306304",https://twitter.com/ajf324MD/status/1253720325214306304
genomenon,2020-04-24 12:03,0,1,"Attending next week's @ AACR Virtual Annual Meeting? Register today for free and connect with our team at # AACR20! https://twitter.com/AACR/status/1253715388162027521 …",,@,#,"1253716302180597761",https://twitter.com/genomenon/status/1253716302180597761
AmgenOncology,2020-04-24 12:01,0,2,"Although we were looking forward to connecting with everyone in person, we are excited to attend the first ever @ AACR Virtual Annual Meeting. See you Monday! # AACR20",,@,#,"1253715627904204802",https://twitter.com/AmgenOncology/status/1253715627904204802
AACR,2020-04-24 12:00,3,6,"On the blog: A User’s Guide to # AACR20 Virtual Annual Meeting I. https://bit.ly/3azViBp pic.twitter.com/j57QKE0RhE",,,#,"1253715388162027521",https://twitter.com/AACR/status/1253715388162027521
LMClinical,2020-04-24 12:00,0,0,"Researchers found a higher rate of infection in the six years before individuals were diagnosed with malignant cancer compared with the control group, with the largest differences occurring in the year before cancer diagnosis. @ AACR https://bit.ly/3cLgJkz",,@,,"1253715340141486080",https://twitter.com/LMClinical/status/1253715340141486080
JAMANetwork,2020-04-24 12:00,0,0,"Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women in @ JAMANetworkOpen, is free online. Read it and other recent # oncology articles from the JAMA Network starting now and throughout the # AACR20 meeting https://ja.ma/3eFtOgT",,@,# #,"1253715325553709062",https://twitter.com/JAMANetwork/status/1253715325553709062
GrahamAnderLes,2020-04-24 11:38,0,0,"@ MPN_RF @ MPNCanada @ MPNVoice @ MGUS_Info @ DrOlaLandgren @ OesophagealCF @ macmillancancer @ actioncancer @ CancerFocusNI @ AACR @ bloodcancer_uk @ theNCI @ IrishCancerReghttps://twitter.com/GrahamAnderLes/status/1253676381214515201 …",,@ @ @ @ @ @ @ @ @ @ @ @ @,,"1253709954898329606",https://twitter.com/GrahamAnderLes/status/1253709954898329606
DFBC_PedCare,2020-04-24 11:38,0,1,"Planning on attending the # AACR20 presentation on "Mechanisms and therapeutic implications of hypermutation in gliomas" next week? Check out the @ nature paper this research is based on: http://ms.spr.ly/6018TgPOg And learn more about the April 28 talk here: http://ms.spr.ly/6019TgPO9",,@,#,"1253709786778152963",https://twitter.com/DFBC_PedCare/status/1253709786778152963
AkoyaBio,2020-04-24 11:21,0,0,"Nice report! RT @ AACRPres The @ AACR Annual Report, which outlines the AACR’s programs and initiatives over the past year, is now available. https://bit.ly/2yzOpCK",,@ @,,"1253705511976996864",https://twitter.com/AkoyaBio/status/1253705511976996864
yuki_yuna_321,2020-04-24 11:12,1,5,"本当なら明日明後日はAACRの日程ですね。。。くっそーー(⁎⁍̴̆Ɛ⁍̴̆⁎) # AACR # AACR2020 pic.twitter.com/mrlM2gHzey",,,# #,"1253703400677490690",https://twitter.com/yuki_yuna_321/status/1253703400677490690
Allscience1,2020-04-24 11:10,0,0,"Únete al # AACR20 de @ abcam, un evento virtual para discutir los desafíos actuales de la industria, y cómo avanzar en la investigación del # cáncer. Del 27 de abril al 1 de mayo. Más info aquí >> https://bit.ly/2yAQpun pic.twitter.com/8DtMfw0KHG",,@,# #,"1253702760471711749",https://twitter.com/Allscience1/status/1253702760471711749
cindy_perettie,2020-04-24 11:09,0,5,"Congratulations to everyone at @ CancerResrch for this outstanding accomplishment. I can’t wait to hear more during your presentation at # AACR20! https://twitter.com/CancerResrch/status/1249706476324761601 …",,@,#,"1253702515134259201",https://twitter.com/cindy_perettie/status/1253702515134259201
lymphomahub,2020-04-24 11:05,1,8,"The # AACR20 Annual Meeting is being covered virtually by the @ lymphomahub next week, to provide you with the latest news and updates on # lymphoma and # CLL! # lymsmpic.twitter.com/PWhTINqrW7",,@,# # # #,"1253701698905833474",https://twitter.com/lymphomahub/status/1253701698905833474
AACR,2020-04-24 10:30,8,21,"# ICYMI: The # AACR20 Virtual Annual Meeting I will begin with an Opening Session in which @ AACRPres Elaine R. Mardis will review the AACR’s accomplishments for the past year and Program Chair Antoni Ribas will review the meeting program. pic.twitter.com/X0L54JOZvzpic.twitter.com/r92GGazNoo",,@,# #,"1253692696188854277",https://twitter.com/AACR/status/1253692696188854277
CellPressNews,2020-04-24 10:30,4,5,"Don't miss the # CancerResearchWeek Hub. Check back in throughout the week as we'll be adding new and exciting # cancer research, videos, collections, and more. # AACR2020",,,# # #,"1253692673325592583",https://twitter.com/CellPressNews/status/1253692673325592583
CRUKresearch,2020-04-24 10:14,1,4,"Abstract on Targeting chromatin remodeling-associated genetic vulnerabilities in cancer, co-authored by @ ICR_London's @ IcrLordLab is being presented at next week’s # AACR20 Virtual Meeting I. Register for free access: https://www.abstractsonline.com/pp8/#!/9045/presentation/10550 …pic.twitter.com/jUuG61UVaP",,@ @,# #,"1253688652292554752",https://twitter.com/CRUKresearch/status/1253688652292554752
WinshipAtEmory,2020-04-24 10:05,2,13,"ICYMI: @ AACR will hold the first of its two-part virtual annual meeting April 27-28. Suresh Ramalingam, MD will chair a # lungcancer clinical trials plenary session on April 27 featuring Taofeek Owonikoko, MD, PhD as a discussant. # AACR20 # lcsm https://fal.cn/37JgD pic.twitter.com/uhqeYy3Erw",,@,# # #,"1253686446168461312",https://twitter.com/WinshipAtEmory/status/1253686446168461312
CRUKresearch,2020-04-24 09:18,2,3,"The phase I Mov18 study, developed by @ KingsCollegeLon, and sponsored by our Centre for Drug Development, is being presented at the # AACR20 Virtual Annual Meeting I next week. Register for free now to access the poster here: https://www.abstractsonline.com/pp8/#!/9045/presentation/10640 …pic.twitter.com/rE6JAfFdJl",,@,# #,"1253674667350675456",https://twitter.com/CRUKresearch/status/1253674667350675456
MM_Hub,2020-04-24 09:00,1,3,"The # AACR20 Annual Meeting is fast approaching! The @ MM_Hub is looking forward to covering the meeting virtually and bringing you the latest updates on multiple # myeloma. # mmsmpic.twitter.com/kmj6Fl5Xde",,@,# # #,"1253670062080303105",https://twitter.com/MM_Hub/status/1253670062080303105
SurfaceOncology,2020-04-24 08:46,0,3,"Congrats to Surface SAB member, David Tuveson, for becoming President-Elect of @ AACR for # AACR21. David is a valued member of our team as we work to deliver transformative treatments for patients, and we’re excited to see what his leadership and drive will bring to the industry.pic.twitter.com/JLs68e9Obs",,@,#,"1253666531491397632",https://twitter.com/SurfaceOncology/status/1253666531491397632
evaluatevantage,2020-04-24 08:25,0,0,"Check out the # AACR20 preview below and a recording of @ JacobPlieth's chat with @ bradloncar is available here: https://twitter.com/bradloncar/status/1253322895260033025 …https://twitter.com/JacobPlieth/status/1252967091302514688 …",,@ @,#,"1253661449773133825",https://twitter.com/evaluatevantage/status/1253661449773133825
YaleCancer,2020-04-24 08:02,7,24,". @ YaleCancer scientists including @ politikaterina Dr. Lajos Pusztai @ RanjitBindra Dr. Pat LoRusso are preparing to present the latest developments in # cancer research at # AACR20 Virtual Annual Meeting I starting Monday, April 27. @ SmilowCancer @ YaleMed @ YNHH # oncoalertpic.twitter.com/Sfq8iEbB9E",,@ @ @ @ @ @,# # #,"1253655610199101440",https://twitter.com/YaleCancer/status/1253655610199101440
AML_Hub,2020-04-24 07:06,0,0,"The @ AML_Hub will be bringing you virtual coverage of the # AACR20 Annual Meeting next week! Follow us for all the latest information on AML! # leusmpic.twitter.com/VVzMDYCEwk",,@,# #,"1253641481937616896",https://twitter.com/AML_Hub/status/1253641481937616896
JCellBiol,2020-04-24 07:00,1,8,"The highly-conserved tumor suppressor genes Scribbled and Discs large work together with 14-3-3 proteins to control mitotic spindle positioning. JCB’s cancer collection for # AACR20 (https://bit.ly/2Vv9GXj ) has short summaries of articles in this PDF: https://bit.ly/2XYckGS pic.twitter.com/Qml99lINd3",,,#,"1253639889977040896",https://twitter.com/JCellBiol/status/1253639889977040896
CRUKresearch,2020-04-24 06:49,1,9,"Have you registered for the free # AACR20 Virtual Annual Meeting I next week? Join our # CRUKFunded researchers - @ uclcancer’s @ squezadd and @ TheCrick’s @ TurajlicLab – as they chair discussions on predictive biomarkers and cancer genomics. https://www.abstractsonline.com/pp8/#!/9045 pic.twitter.com/BHrWg14B0l",,@ @ @ @,# # #,"1253637268255932416",https://twitter.com/CRUKresearch/status/1253637268255932416
1stOncology,2020-04-24 06:25,0,0,"# Bayer to Highlight Clinical Data on # Vitrakvi® ( # Larotrectinib) and Research on Investigational # AhRInhibitor at # AACR20 https://www.1stoncology.com/blog/bayer-to-highlight-clinical-data-on-vitrakvi-larotrectinibresearch-on-investigational-ahr-inhibitor-at-aacr-2020-virtual-meeting1234556551 …",,,# # # # #,"1253631213593456640",https://twitter.com/1stOncology/status/1253631213593456640
1stOncology,2020-04-24 06:18,0,0,"# IderaPharmaceuticals Announces # Tilsotolimod Program Updates To Be Presented At # AACR20 $ IDRA https://www.1stoncology.com/blog/idera-pharmaceuticals-announces-tilsotolimod-program-updates-to-be-presented-at-aacr-virtual-annual-meeting-20201234556543 …",,,# # #,"1253629476426022913",https://twitter.com/1stOncology/status/1253629476426022913
healthhashtags,2020-04-24 06:10,3,5,"Top Influencers of # AACR20: @ AACR_CEO @ OncoAlert @ AACR @ NicoleKuderer @ ErikaHamilton9 @ Kristel_GT @ SWOG More https://hcsm.io/2TPswt7",,@ @ @ @ @ @ @,#,"1253627375788666880",https://twitter.com/healthhashtags/status/1253627375788666880
almudawaraladna,2020-04-24 05:37,0,0,"¿Ahora solamente?",,,,"1253619143057854465",https://twitter.com/almudawaraladna/status/1253619143057854465
XRBustelo,2020-04-24 05:21,2,4,"It was funny for a while. But, now, this guy is getting dangerous. His behavior qualifies for impeachment right away. His idiocy can kill thousands. @ ASEICAnews @ NIH @ CNN @ FoxNews @ realDonaldTrump @ AACR @ WhiteHouse @ BBCWorld # StayHome # Covid_19 # COVIDUSAhttps://twitter.com/joshtpm/status/1253451487415619586 …",,@ @ @ @ @ @ @ @,# # #,"1253614933520105472",https://twitter.com/XRBustelo/status/1253614933520105472
raquelvn8,2020-04-24 04:59,0,3,"Turns out we’re attending # AACR20 ! Slightly different plan from the one I had in mind but still @ samsuresh94https://twitter.com/samsuresh94/status/1253407657215455232 …",,@,#,"1253609480392192000",https://twitter.com/raquelvn8/status/1253609480392192000
ACSNews,2020-04-23 17:27,0,3,"We will miss you in San Diego, friends. Your work is immeasurably important.",,,,"1253435378846990338",https://twitter.com/ACSNews/status/1253435378846990338
AACR,2020-04-23 16:44,0,2,"Thank you for emphasizing the importance of scientific meetings like the # AACR20 Virtual Annual Meeting-- even during a pandemic.",,,#,"1253424510084104192",https://twitter.com/AACR/status/1253424510084104192
NP_Rudqvist,2020-04-23 16:16,0,1,"This is going to be so great! We should really all have a virtual coffee room during this meeting :D",,,,"1253417467235323906",https://twitter.com/NP_Rudqvist/status/1253417467235323906
CancerResrch,2020-04-23 16:01,0,2,"This year, # AACR20 is free to register. Make sure you sign up here https://bit.ly/2VmQtH4 so you can see the Phase 2 results of our TMB Harmonization Project be presented. For more on our project, visit https://bit.ly/3bs7mWK .",,,#,"1253413604717498368",https://twitter.com/CancerResrch/status/1253413604717498368
samsuresh94,2020-04-23 15:37,0,1,"Just registered for the # virtualannualmeeting # AACR20 looking forward to interesting sessions! https://twitter.com/AACR/status/1253337878114955267 …",,,# #,"1253407657215455232",https://twitter.com/samsuresh94/status/1253407657215455232
ASCOPost,2020-04-23 15:20,2,1,"David A. Tuveson, MD, PhD, FAACR, Named @ AACR President-Elect for 2020–2021 https://www.ascopost.com/news/april-2020/david-a-tuveson-md-phd-faacr-elected-aacr-president-elect-for-2020-2021/ … @ cshlnews @ CSHLpic.twitter.com/jzc9w6GB6N",,@ @ @,,"1253403266030895104",https://twitter.com/ASCOPost/status/1253403266030895104
DFBC_PedCare,2020-04-23 15:19,0,3,"On April 27 from 9:00 a.m to 6:00 pm. EST, David Shulman, MD, will present on "A phase 2 clinical trial of palbociclib and ganitumab for relapsed/refractory Ewing sarcoma" as part of the # AACR20 virtual meeting trials in progress session. Learn more: http://ms.spr.ly/6011TgGtJ pic.twitter.com/uyA1HQryFN",,,#,"1253403023893766151",https://twitter.com/DFBC_PedCare/status/1253403023893766151
zaccoop,2020-04-23 14:20,0,0,"Superstar!!! Should be a great session",,,,"1253388240876437505",https://twitter.com/zaccoop/status/1253388240876437505
CSpencerPhD,2020-04-23 14:12,0,9,"Excited to chair the @ AACR minisymposium on Therapeutic modification of the # tumor # microenvironment or # microbiome Monday at 4:50ET! Register for free here:https://cloud.aacr-outbound.com/virtual-am20",,@,# # #,"1253386334259089408",https://twitter.com/CSpencerPhD/status/1253386334259089408
RockUPress,2020-04-23 14:00,0,1,". @ JExpMed celebrates progress made in understanding the interplay of # cancer with # immune system, & the development of highly innovative therapies, in a NEW special collection: https://bit.ly/3avNaBK # AACR20 pic.twitter.com/lejdY4xxHk",,@,# # #,"1253383214242004993",https://twitter.com/RockUPress/status/1253383214242004993
NatConte,2020-04-23 13:44,2,2,"Free registration to virtual # AACR20 meeting - Unique chance to access latest cancer research advances and insights # AACRhttps://twitter.com/AACR/status/1253375604512026624 …",,,# #,"1253379121960439809",https://twitter.com/NatConte/status/1253379121960439809
AACR,2020-04-23 13:30,5,7,"Join us for the Lung Cancer Targeted Therapy Clinical Plenary Session at the # AACR20 Virtual Annual Meeting I on April 27. Registration is free: https://bit.ly/2yzfeam pic.twitter.com/vSEDbRStiL",,,#,"1253375604512026624",https://twitter.com/AACR/status/1253375604512026624
achursov,2020-04-23 13:07,0,0,"AACR Annual Meeting 2020 will move to a virtual format this year. On April 27-28 the AACR Virtual Meeting I is available free: https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/ … # AACR20 # CancerResearch # Conference",,,# # #,"1253369810995437574",https://twitter.com/achursov/status/1253369810995437574
cityofhope,2020-04-23 13:01,0,0,"City of Hope's Kimlin Tam Ashing, Ph.D., will present, "A geospatial approach to explore the socioecological context of tobacco and vape shop locations" at # AACR20 Virtual Annual Meeting I on 4/27 at 4:15 p.m. EDT. Don't miss it! https://bddy.me/3aAySzU pic.twitter.com/O5JUbcYh9z",,,#,"1253368352271216642",https://twitter.com/cityofhope/status/1253368352271216642
AACRPres,2020-04-23 13:00,1,17,"RT @ AACR_CEO: Thanks to the 75 reporters who registered for today’s press preview for the # AACR20 Virtual Annual Meeting I, where @ AACRPres Elaine Mardis and Program Chair Toni Ribas highlighted the cutting-edge science to be presented this Monday and Tuesday.pic.twitter.com/qEElR1HgF5",,@ @,#,"1253368099530854401",https://twitter.com/AACRPres/status/1253368099530854401
Rick__Buck,2020-04-23 12:58,0,2,"We just held our @ AACR Virtual Annual Meeting I Press Preview with more than 80 members of the media. Kudos to our # PublicRelations team on a great job!https://twitter.com/AACR/status/1253364282521276417 …",,@,#,"1253367660378808322",https://twitter.com/Rick__Buck/status/1253367660378808322
AACR,2020-04-23 12:45,1,4,"RT @ AACR_CEO: Thanks to the 75 reporters who registered for today’s press preview for the # AACR20 Virtual Annual Meeting I, where @ AACRPres Elaine Mardis and Program Chair Toni Ribas highlighted the cutting-edge science to be presented this Monday and Tuesday.pic.twitter.com/tDvmBpZ8hz",,@ @,#,"1253364282521276417",https://twitter.com/AACR/status/1253364282521276417
MaverickNY,2020-04-23 12:36,2,3,"Our latest # AACR20 Preview looks at 10 agents in early development to watch out for: https://pxlme.me/Is8p_jB8 there are a variety of targets and modalities in the mix here - which directions should we be going in?pic.twitter.com/nwIDUGAKVx",,,#,"1253362191287410688",https://twitter.com/MaverickNY/status/1253362191287410688
AACR_CEO,2020-04-23 12:30,5,18,"Thanks to the 75 reporters who registered for today’s press preview for the # AACR20 Virtual Annual Meeting I, where @ AACRPres Elaine Mardis and Program Chair Toni Ribas highlighted the cutting-edge science to be presented this Monday and Tuesday.pic.twitter.com/pkDLY7WOpc",,@,#,"1253360514002038784",https://twitter.com/AACR_CEO/status/1253360514002038784
RockUPress,2020-04-23 12:18,1,1,"Read the NEW special collection of @ JCellBiol articles on Cancer Cell Biology, timed to coincide with Virtual # AACR20 - https://bit.ly/3eEUkHb pic.twitter.com/upwM2Hdf7T",,@,#,"1253357679919144964",https://twitter.com/RockUPress/status/1253357679919144964
JExpMed,2020-04-23 12:17,1,2,"Celebrating progress made in understanding the interplay of # cancer with # immune system, & the development of highly innovative therapies. https://bit.ly/3avNaBK Read the NEW special collection on Cancer Research, timed to coincide with # AACR20. pic.twitter.com/aXLLEveGYN",,,# # #,"1253357324498096128",https://twitter.com/JExpMed/status/1253357324498096128
JCellBiol,2020-04-23 12:16,3,3,"Celebrating works advancing our understanding of fundamental molecular & cellular events shaping tumors & suggesting novel potential therapeutic avenues. https://bit.ly/3eEUkHb Read the NEW collection of articles on Cancer Cell Biology, timed to coincide with Virtual # AACR20. pic.twitter.com/2D9tEVy9WQ",,,#,"1253357014929092612",https://twitter.com/JCellBiol/status/1253357014929092612
genomejunkie,2020-04-23 11:51,2,4,"Great article summarizing the clinical data on targeted therapies and biologics being presented at the upcoming virtual # AACR20 sessions. # CancerResearch # PrecisionMedicine # Oncology # DrugDiscovery # ClinicalTrials # AACR2020 https://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-preview-no-tigit-plenty-novel-mechanisms …",,,# # # # # # #,"1253350725561835520",https://twitter.com/genomejunkie/status/1253350725561835520
marianascarant1,2020-04-23 11:48,0,13,"IceCAP dose escalation data soon to be present @ AACR! Proof-of-concept evidence of immune modulation by blockade of the PI3K-AKT signaling pathway . https://twitter.com/ICR_DDU_IIT/status/1253293252486275072 …",,@,,"1253350155585282049",https://twitter.com/marianascarant1/status/1253350155585282049
JacobPlieth,2020-04-23 11:33,0,1,"No, $ RHHBY specifially told me ph1 solid tumour data at # AACR20 II. Ph2 data "at an upcoming meeting".",,,#,"1253346163836817408",https://twitter.com/JacobPlieth/status/1253346163836817408
JacobPlieth,2020-04-23 11:12,0,4,"If you missed it on my call, $ RHHBY has told me it's planning to present the long-awaited tiragolumab (Tigit) data at # AACR20 II (22-24 June) https://twitter.com/JacobPlieth/status/1252967091302514688 … $ RCUS $ CGEN $ GILD",,,#,"1253341024480444419",https://twitter.com/JacobPlieth/status/1253341024480444419
MaverickNY,2020-04-23 11:07,1,4,"About to post our 4th # AACR20 Preview, but for those asking you can catch all of them here - includes both targeted & IO agents in development across many tumour types: https://pxlme.me/qCyA1N7m Still feels weird writing about interesting posters for a virtual, not a live meeting!pic.twitter.com/tYoMrJMFYp",,,#,"1253339670689099781",https://twitter.com/MaverickNY/status/1253339670689099781
lisaksheldon,2020-04-23 11:03,0,1,"@ OncologyNursing Great opportunity - thanks @ AACR https://twitter.com/AACR/status/1253337878114955267 …",,@ @,,"1253338611417624577",https://twitter.com/lisaksheldon/status/1253338611417624577
AACR,2020-04-23 11:00,11,12,"Tune in to the # AACR20 Virtual Annual Meeting I April 27 for a Plenary Session on Immunotherapy Clinical Trials 1. Registration is free: https://bit.ly/2KrLTkT pic.twitter.com/cLPONaKGG7",,,#,"1253337878114955267",https://twitter.com/AACR/status/1253337878114955267
JacobPlieth,2020-04-23 10:42,7,30,"Thanks for joining, everyone! A recording of my # AACR20 chat with @ bradloncar is available via this link.https://twitter.com/bradloncar/status/1253322895260033025 …",,@,#,"1253333352603545601",https://twitter.com/JacobPlieth/status/1253333352603545601
BertrandBio,2020-04-23 10:40,0,0,"For those who wants a rapid tour of what to look at at the Virtual # AACR20 early next week https://twitter.com/bradloncar/status/1253322895260033025 …",,,#,"1253332873274200066",https://twitter.com/BertrandBio/status/1253332873274200066
dhovekamp42,2020-04-23 10:32,0,2,"Thanks a lot 4 sharing ur insights @ JacobPlieth & @ bradloncar - looking forward to # AACR20 now!",,@ @,#,"1253331005856870400",https://twitter.com/dhovekamp42/status/1253331005856870400
ConceptLSGroup,2020-04-23 10:03,5,7,"Whilst the Covid-19 pandemic has resulted in many unprecedented actions, we are really excited to be taking part in session 1 of @ AACR two part virtual event. Learn more : https://bit.ly/34VXIsX # AACR # virtualevent # immunology # oncology # CancerResearch # drugdiscoverypic.twitter.com/TiFlU27Ydj",,@,# # # # # #,"1253323718845030401",https://twitter.com/ConceptLSGroup/status/1253323718845030401
bradloncar,2020-04-23 10:00,17,34,"Live discussion: talking oncology trends and # AACR20 with @ JacobPlieth.https://www.pscp.tv/w/cXBFgzg4NDI5fDF2QXhSQldXWFhreGxH-mJOVkkc7AHLuadBfpuK-GwTkBre1ohgcx6iSSg6nA== …",,@,#,"1253322895260033025",https://twitter.com/bradloncar/status/1253322895260033025
evaluatepharma,2020-04-23 09:50,0,3,"A Twitter live-stream preview of # AACR20 with @ JacobPlieth and @ bradloncar starts in 10 minutes. Join them as they discuss all the latest # oncology news.",,@ @,# #,"1253320230195146752",https://twitter.com/evaluatepharma/status/1253320230195146752
JacobPlieth,2020-04-23 09:02,1,5,"60 minutes to go # AACR20 https://twitter.com/evaluatepharma/status/1253308043741323265 …",,,#,"1253308240198111233",https://twitter.com/JacobPlieth/status/1253308240198111233
evaluatepharma,2020-04-23 09:01,2,3,"The live-stream conversation between @ JacobPlieth and @ bradloncar will begin in an hour. Join them for a preview of # AACR20 and a discussion on the latest developments in # oncology - 3pm BST / 10am ET.",,@ @,# #,"1253308043741323265",https://twitter.com/evaluatepharma/status/1253308043741323265
BayerUS,2020-04-23 08:33,1,7,"Bayer to highlight new clinical trial data from # cancer portfolio at # AACR20’s virtual meeting. https://bit.ly/2XZ5tww pic.twitter.com/VWfEoYtx8c",,,# #,"1253301039517757442",https://twitter.com/BayerUS/status/1253301039517757442
BayerPharma,2020-04-23 08:15,4,11,"# NEWS: # Bayer to share latest data from novel # cancer treatment approaches at # AACR20 Virtual Meeting I . http://bit.ly/News_Bayer",,,# # # #,"1253296519824003074",https://twitter.com/BayerPharma/status/1253296519824003074
UMRogelCancer,2020-04-23 07:32,2,2,"Several # RogelCancer research efforts will be presented at the # AACR20 Virtual Meeting on Monday, April 27. Registration for the event is free. Here's the schedule of Rogel Cancer Center research presentations: http://michmed.org/AACR2020 pic.twitter.com/3611p6yiwG",,,# #,"1253285632065056768",https://twitter.com/UMRogelCancer/status/1253285632065056768
evaluatepharma,2020-04-23 07:05,4,7,"Join @ evaluatevantage journalist @ JacobPlieth for a live-stream on Twitter with @ bradloncar, discussing the latest # oncology news and previewing # AACR20. The conversation begins at 3pm BST / 10am ET today.",,@ @ @,# #,"1253278708242276352",https://twitter.com/evaluatepharma/status/1253278708242276352
DeepOnCar,2020-04-23 06:24,0,0,"@ AACR is holding it's annual meeting remotely and part 1 (scheduled on Apr 27-28) is free to participate in. Registration: https://cloud.aacr-outbound.com/virtual-am20 Info: https://www.aacr.org/meeting/aacr-annual-meeting-2020/coronavirus-information/ … Don't miss out on the opportunity to catch up on the latest and greatest in # CancerResearch",,@,#,"1253268500048678912",https://twitter.com/DeepOnCar/status/1253268500048678912
haven_dove,2020-04-23 04:21,0,1,"We're a voice to the voiceless. Join us in this interactive session with Prof Mark Beresford. @ fmoh, @ kogireports @ MobilePunch @ Sekundayo90 @ CancerResearch @ AACR @ WHO @ CDCDirector @ CR_UKpic.twitter.com/Qoo9d5ypDy",,@ @ @ @ @ @ @ @ @,,"1253237451306532864",https://twitter.com/haven_dove/status/1253237451306532864
MeenakshiGJ,2020-04-23 01:39,0,1,"Good news",,,,"1253196866868649984",https://twitter.com/MeenakshiGJ/status/1253196866868649984
tmprowell,2020-04-22 17:37,1,41,"First & only time I’ve ever met @ marklewis in real life was at # ASCO19. Proof that digital friendships are no less real. The face-to-face connection w/ colleagues from around the world is still what I’ll miss most from a virtual # AACR20 & # ASCO20...& ??? # SABCS20https://twitter.com/marklewismd/status/1253047193977499648 …",,@,# # # #,"1253075359370747905",https://twitter.com/tmprowell/status/1253075359370747905
cdanicas,2020-04-22 17:19,0,0,"@ _SEOM @ aecc_es @ solti @ myESMO @ aaoncoclinica @ AACR @ PCF_Science @ OncoAlert @ weoncologists @ Uromigos @ apolo_andrea @ geicam @ FundacionFero @ DrYukselUrun @ PGrivasMDPhD @ IKCCorg @ BCAN_NCT @ theNCI",,@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @,,"1253070885059203074",https://twitter.com/cdanicas/status/1253070885059203074
BiodesixInc,2020-04-22 17:14,0,1,"We're excited to help # flattenthecurve by attending # AACR20 virtually. Looking forward to discussions on cancer research while continuing # socialdistancing. # COVID19 # coronavirus @ AACR",,@,# # # # #,"1253069776252895233",https://twitter.com/BiodesixInc/status/1253069776252895233
mtmdphd,2020-04-22 17:06,0,0,"Schooling Herself & Others on Myeloma..." @ MyelomaTeacher is a social media rock star" [Aug 25, 2015] @ AACR http://ow.ly/RZGKR # mmsm HT @ DanaHolmes911",,@ @ @,#,"1253067571617808387",https://twitter.com/mtmdphd/status/1253067571617808387
d2merino,2020-04-22 16:44,4,12,"Very excited to present the latest on our # TMB Harmonization Project next week at the @ AACR Virtual Annual Meeting # AACR20!!! A great effort from so many of our wonderful collaborative partners! https://twitter.com/CancerResrch/status/1253028355340996608 …",,@,# #,"1253062145908117509",https://twitter.com/d2merino/status/1253062145908117509
AACR,2020-04-22 16:30,4,11,"RT @ AACRPres: Working with the @ AACR staff to get ready for the # AACR20 Virtual Annual Meeting I. I hope you will join more than 30,000 of your colleagues at 9:00 a.m. on Monday, April 27. https://bit.ly/2VtgTHb pic.twitter.com/tTAwIDOsg6",,@ @,#,"1253058527012311040",https://twitter.com/AACR/status/1253058527012311040
LoriAndersonEDS,2020-04-22 16:15,1,0,"So amazing that this will be available as a virtual conference # AACR20 https://twitter.com/AACRPres/status/1253043424158244871 …",,,#,"1253054781230284800",https://twitter.com/LoriAndersonEDS/status/1253054781230284800
MDA_UTHGrad,2020-04-22 16:05,2,7,"GSBS Quantitative Sciences PhD student Tapsi Kumar will be presenting an online talk on April 28, 2:55 p.m. CDT, at the 2020 @ AACR Virtual Annual Meeting. http://ow.ly/8yxf50zltNL # WeAreGSBS",,@,#,"1253052239033315329",https://twitter.com/MDA_UTHGrad/status/1253052239033315329
RockUPress,2020-04-22 16:00,0,2,"Congratulations to @ JExpMed Editor David Tuveson of @ CSHL & @ lustgartenfdn for being named @ AACR President-Elect for 2020–2021! Read the news here: https://bit.ly/2VU4Cuq pic.twitter.com/aXDccYbMU5",,@ @ @ @,,"1253051013277286401",https://twitter.com/RockUPress/status/1253051013277286401
AACRPres,2020-04-22 15:30,2,52,"Working with the @ AACR staff to get ready for the # AACR20 Virtual Annual Meeting I. I hope you will join more than 30,000 of your colleagues at 9:00 a.m. on Monday, April 27. https://bit.ly/2S2xtvI pic.twitter.com/5sJ2bxjFN0",,@,#,"1253043424158244871",https://twitter.com/AACRPres/status/1253043424158244871
JExpMed,2020-04-22 15:17,3,7,"Congratulations to @ JExpMed Editor David Tuveson of @ CSHL & @ lustgartenfdn for being named @ AACR President-Elect for 2020–2021! Read the news here: https://bit.ly/2VU4Cuq pic.twitter.com/wCocFqbwsA",,@ @ @ @,,"1253040280229609472",https://twitter.com/JExpMed/status/1253040280229609472
RielyMD,2020-04-22 15:15,1,3,"Nice episode of Oncology Today from @ DrNeilLove with Tom Lynch, talking about Fred Hutch's response to COVID, treating people with EGFR mut lung cancer and need for more translational science (with plug for @ AACR GENIE). http://createsend.com/t/y-FDFD0FFD155329CF …",,@ @,,"1253039721615327234",https://twitter.com/RielyMD/status/1253039721615327234
syinvesting,2020-04-22 14:45,14,39,"# AACR20 preview from @ JacobPlieth @ evaluatevantage: https://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-preview-no-tigit-plenty-novel-mechanisms … Abstracts go live at 12:01am on 4/27. $ VSTM $ NVS $ BMY $ SPPI $ GSK $ MRNA $ CGEN $ ATORX $ ABBV $ IMMP $ ATNM $ ALPMY $ RHHBY $ IOVA $ AZN $ SNDX $ BAYN $ IPSEY @ KarusTx @ iTeosTx @ rgenix @ Boehringer @ RibonTxpic.twitter.com/xFVxODXtbt",,@ @ @ @ @ @ @,#,"1253032069766230026",https://twitter.com/syinvesting/status/1253032069766230026
CancerResrch,2020-04-22 14:30,4,11,"Next Tues. (4/28) starting at 4:40pm, our Director of Research Partnerships, @ d2merino, will be presenting the Phase 2 findings of our TMB Harmonization Project at # AACR20. Learn more about our project at https://bit.ly/3bs7mWK & register for AACR here: https://bit.ly/3bk4kUh pic.twitter.com/SJGFWgm4xg",,@,#,"1253028355340996608",https://twitter.com/CancerResrch/status/1253028355340996608
Dr_JJ_Berenguer,2020-04-22 14:10,0,2,"Great opportunity for everyone interested in cancer. Thank you Margaret @ AACR_CEO",,@,,"1253023441449619461",https://twitter.com/Dr_JJ_Berenguer/status/1253023441449619461
schedule1movie,2020-04-22 13:51,0,1,"Please Dr. Tuveson, I am pleading. Look at the preclinical Cannabis data. After 4 years of SOC treatment I am out of options for my recurrent Ovarain cancer (BRCA1/2-, P53+) But on no other chemo Cannabis shrank my tumor! This is real.http://www.schedule1movie.com",,,,"1253018686606073856",https://twitter.com/schedule1movie/status/1253018686606073856
AACR,2020-04-22 13:30,4,9,"Evaluating Cancer Genomics from Normal Tissues through Evolution to Metastatic Disease: The # AACR20 Virtual Annual Meeting I will present this minisymposium on April 28. Register for free now: https://bit.ly/2VKX3X0 pic.twitter.com/slBViO7CNK",,,#,"1253013218647257093",https://twitter.com/AACR/status/1253013218647257093
HayleyJLuxton,2020-04-22 11:35,0,0,"Congratulations David",,,,"1252984389006438402",https://twitter.com/HayleyJLuxton/status/1252984389006438402
w2felix,2020-04-22 11:28,0,0,"Is the time zone of the scheduled talks EDT?",,,,"1252982624844382210",https://twitter.com/w2felix/status/1252982624844382210
DFBC_PedCare,2020-04-22 11:21,1,4,"On April 28, work on "Mechanisms and therapeutic implications of hypermutation in gliomas" by researchers including Pratiti Bandopadhayay, MBBS, PhD, will be presented at 4:40 p.m. EST at # AACR20. Learn more: http://ms.spr.ly/6019T5Cc7 pic.twitter.com/SdSWpT2iHH",,,#,"1252980737218879488",https://twitter.com/DFBC_PedCare/status/1252980737218879488
jfais20,2020-04-22 11:20,0,6,"Am liking the charts for both our # AACR20 ideas ahead of presentations (sitting on full size positions and 45% ish gains each). $ APTO well above major moving averages and $ VSTM already making new 52s- risk is there as always, but looking good so far..pic.twitter.com/KOJvtNeGtl",,,#,"1252980707556655104",https://twitter.com/jfais20/status/1252980707556655104
pezcoller,2020-04-22 11:12,0,2,"Congratulazioni a David Tuveson, membro e chairman del Selection Committee del premio Pezcoller- @ AACR, e relatore ai Simposi Pezcoller, per la sua elezione a Presidente AACR 2020-2021 ! https://twitter.com/CSHL/status/1252620640651272192 …",,@,,"1252978526921404417",https://twitter.com/pezcoller/status/1252978526921404417
JExpMed,2020-04-22 11:03,1,6,"NEW special collection on Cancer Research, timed to coincide with Virtual # AACR20. Celebrating progress made in understanding the interplay of # cancer with # immune system, & the development of highly innovative therapies. https://bit.ly/3avNaBK pic.twitter.com/OM28xQSFhI",,,# # #,"1252976327323537408",https://twitter.com/JExpMed/status/1252976327323537408
JCellBiol,2020-04-22 11:00,4,4,"NEW special collection of articles on Cancer Cell Biology, timed to coincide with Virtual # AACR20. Celebrating works advancing our understanding of fundamental molecular & cellular events shaping tumors & suggesting novel potential therapeutic avenues. https://bit.ly/3eEUkHb pic.twitter.com/hVZoq8twjb",,,#,"1252975536583966720",https://twitter.com/JCellBiol/status/1252975536583966720
AACR,2020-04-22 11:00,9,20,"The # AACR20 Virtual Annual Meeting I will feature a Clinical Plenary Session on Breast Cancer Therapy on April 27. Register for free now: https://bit.ly/3atuEtV pic.twitter.com/Q03YtE6sUg",,,#,"1252975498210271232",https://twitter.com/AACR/status/1252975498210271232
BroeckelmannPJ,2020-04-22 10:53,0,4,"Very much looking forward to an exciting Annual Meeting held virtually by @ AACR featuring many timely minisymposia e.g. on immunotherapies and # COVID19 in cancer patients.https://twitter.com/AACR/status/1252333752421933056 …",,@,#,"1252973803166187520",https://twitter.com/BroeckelmannPJ/status/1252973803166187520
sloan_kettering,2020-04-22 10:47,4,12,"We're excited to participate in # AACR20. Be sure to register to hear from MSK experts @ CharlesSawyers, @ DRathkopf, @ RielyMD, @ alexdrilon, @ MPostow, Nancy Lee, Matthew Hellman, and many more.https://twitter.com/AACR/status/1250136790574514179 …",,@ @ @ @ @,#,"1252972400158945280",https://twitter.com/sloan_kettering/status/1252972400158945280
lustgartenfdn,2020-04-22 10:40,2,6,"A recent study funded in part by the Lustgarten Foundation and published in an @ AACR journal has found that a new risk prediction model could identify those at higher risk of # PancreaticCancer.http://ow.ly/wyoA30qzPMv",,@,#,"1252970618619940865",https://twitter.com/lustgartenfdn/status/1252970618619940865
precisiondiagn4,2020-04-22 10:30,0,0,"RT @ CD_AACR: From the April issue: Characteristics and outcome of AKT1 E17K–mutant # BreastCancer defined through @ AACR GENIE, a clinicogenomic registry. # PrecisionMedicine # RealWorldData https://bit.ly/2x0ZqN8 pic.twitter.com/xM5Y6Bx2JM",,@ @,# # #,"1252968013533458432",https://twitter.com/precisiondiagn4/status/1252968013533458432
JacobPlieth,2020-04-22 10:26,8,16,"Here it is: your # AACR20 (part I) preview, via @ evaluatevantage https://www.evaluate.com/vantage/articles/events/conferences/aacr-2020-preview-no-tigit-plenty-novel-mechanisms … $ VSTM $ MRNA $ ATORX.ST $ IOVA $",,@,#,"1252967091302514688",https://twitter.com/JacobPlieth/status/1252967091302514688
EdgeforScholars,2020-04-22 10:19,0,0,"NextGen Grants from @ AACR support creative, paradigm-shifting cancer research with $450,000 over three years: https://tinyurl.com/uz9moup # grantfunding # cancerresearchpic.twitter.com/g8tYCwVxWI",,@,# #,"1252965141915844609",https://twitter.com/EdgeforScholars/status/1252965141915844609
mtmdphd,2020-04-22 10:17,0,0,"Schooling Herself & Others on Myeloma..." @ MyelomaTeacher is a social media rock star" [Aug 25, 2015] @ AACR http://ow.ly/RZGKR # mmsm HT @ DanaHolmes911",,@ @ @,#,"1252964739912589313",https://twitter.com/mtmdphd/status/1252964739912589313
ExumaBiotech,2020-04-22 09:49,2,3,"Wonderful to hear @ AACR is holding their annual meeting for free online. Sessions include treating # cancer # patients with # COVID19 and new approaches to # immunotherapy.https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/ …",,@,# # # #,"1252957706547314688",https://twitter.com/ExumaBiotech/status/1252957706547314688
domespo,2020-04-22 09:49,0,0,"An excellent choice to be the next President of @ AACR. https://twitter.com/CSHL/status/1252620640651272192 …",,@,,"1252957664507834368",https://twitter.com/domespo/status/1252957664507834368
evaluatepharma,2020-04-22 09:42,0,1,"Don't miss @ EvaluateVantage journalist @ JacobPlieth discuss # AACR20 and # oncology news with @ bradloncar tomorrow at 3pm BST / 10am ET.https://twitter.com/bradloncar/status/1252943989004578816 …",,@ @ @,# #,"1252956053752483841",https://twitter.com/evaluatepharma/status/1252956053752483841
CureNETs,2020-04-22 09:27,0,0,"Wonderful news! Congratulations Dr. Tuveson. We are pleased to learn of this appointment and proud to have you as a previously-funded @ CureNETs researcher of # NETcancer.",,@,#,"1252952288202817536",https://twitter.com/CureNETs/status/1252952288202817536
LandryCancerBio,2020-04-22 09:21,2,2,"This year @ AACR is hosting a virtual meeting. # AACR20 April 27-28 For more info and registration see info below https://twitter.com/AACR/status/1250053726615810050 …",,@,#,"1252950608044269568",https://twitter.com/LandryCancerBio/status/1252950608044269568
WinshipAtEmory,2020-04-22 09:05,2,11,". @ AACR will hold the first of its two-part virtual annual meeting April 27-28. Suresh Ramalingam, MD will chair a # lungcancer clinical trials plenary session on April 27 featuring Taofeek Owonikoko, MD, PhD as a discussant. # AACR20 # lcsm https://fal.cn/37H3v pic.twitter.com/3y3pxkPwO8",,@,# # #,"1252946515292835840",https://twitter.com/WinshipAtEmory/status/1252946515292835840
oncodistinct,2020-04-22 08:59,1,2,"# AACR20 @ AACR Virtual Meeting April 27-28 FREE REGISTRATION https://twitter.com/AACR_CEO/status/1250421796601356290 …",,@,#,"1252945051157749760",https://twitter.com/oncodistinct/status/1252945051157749760
JacobPlieth,2020-04-22 08:56,5,17,"Must listen for # AACR20 followers! https://twitter.com/bradloncar/status/1252943989004578816 …",,,#,"1252944250133778432",https://twitter.com/JacobPlieth/status/1252944250133778432
bradloncar,2020-04-22 08:55,13,53,"Tomorrow at 10:00AM ET I'm going to experiment with trying to live-stream on twitter a conversation with @ JacobPlieth. He'll give some thoughts on recent oncology news and what to watch at next week's # AACR20. Check it out (hope it works).",,@,#,"1252943989004578816",https://twitter.com/bradloncar/status/1252943989004578816
UMRogelCancer,2020-04-22 08:52,3,1,"Several # RogelCancer research efforts will be presented at the # AACR20 Virtual Meeting on Monday, April 27. Registration for the event is free. Here's the schedule of Rogel Cancer Center research presentations: http://michmed.org/AACR2020 pic.twitter.com/peIh49amhL",,,# #,"1252943266212974593",https://twitter.com/UMRogelCancer/status/1252943266212974593
1stOncology,2020-04-22 07:53,0,0,"# ChiMed Highlights Presentations of # Surufatinib at the Upcoming # AACR20 https://www.1stoncology.com/blog/chi-med-highlights-presentations-of-surufatinib-at-the-upcoming-aacr-virtual-annual-meetings1234556491 …",,,# # #,"1252928548601389057",https://twitter.com/1stOncology/status/1252928548601389057
1stOncology,2020-04-22 07:52,0,0,"# AchillesTherapeutics to present a manufacturing update at the virtual # AACR20 https://www.1stoncology.com/blog/achilles-therapeutics-to-present-a-manufacturing-update-at-the-virtual-2020-aacr-annual-meeting1234556490 …",,,# #,"1252928142789894144",https://twitter.com/1stOncology/status/1252928142789894144
1stOncology,2020-04-22 07:35,0,0,"# TarvedaTherapeutics to Present Data from First in Human Study of # PEN866 at the 2020 # AACR20 Virtual Annual Meeting https://www.1stoncology.com/blog/tarveda-therapeutics-to-present-data-from-first-in-human-study-of-pen-866-at-the-2020-aacr-virtual-annual-meeting1234556471 …",,,# # #,"1252924014600712193",https://twitter.com/1stOncology/status/1252924014600712193
DrSarcoma,2020-04-22 06:23,0,2,"@ CSHL So well deserved! Congratulations to Dr Tuveson - looking forward to working with him in this leadership role!",,@,,"1252905898542075904",https://twitter.com/DrSarcoma/status/1252905898542075904
BairdAM,2020-04-22 06:06,8,18,"Free registration to the @ AACR Virtual Annual Meetings I https://www.aacr.org/meeting/aacr-annual-meeting-2020/ … # cancer # AACR20",,@,# #,"1252901707182456833",https://twitter.com/BairdAM/status/1252901707182456833
ICR_DDU_IIT,2020-04-22 06:04,3,13,"HyPeR explores the combination of Guadecitabine, a 2nd generation hypo-methylating agent, in combination with Pembrolizumab in patients with refractory solid tumours. The dose-finding escalation and expansion phases are now complete and results will be presented at # AACR20. pic.twitter.com/2eLgS0psC6",,,#,"1252901176531656704",https://twitter.com/ICR_DDU_IIT/status/1252901176531656704
achillestx,2020-04-22 05:53,3,7,"Achilles therapeutics will present an update on using the VELOS™ manufacturing platform for its lead programs at the 2020 @ AACR Virtual Meeting. To find out more, including how you can join the session, see here: https://bit.ly/34VZMkq # AACR20 # clonalneoantigens # immunooncologypic.twitter.com/e2KKR7VmHB",,@,# # #,"1252898315181740033",https://twitter.com/achillestx/status/1252898315181740033
GraneOShady,2020-04-22 05:04,0,5,"Just realised I was due to be catching a flight to San Diego in about an hour to attend # AACR2020, which is obviously not happening now. Hopefully it will be be back, bigger and better next year and looking forward to the virtual meeting next week",,,#,"1252886061421924352",https://twitter.com/GraneOShady/status/1252886061421924352
mjauk,2020-04-22 04:07,0,0,"Some, much needed, positive news New risk prediction model could identify those at higher risk of pancreatic cancer https://eurekalert.org/e/9w87 via @ aacr @ EurekAlert",,@ @,,"1252871525289480201",https://twitter.com/mjauk/status/1252871525289480201
OncoAlert,2020-04-22 03:21,5,14,"On behalf of the @ OncoAlert Network, our heartfelt Congratulations to @ AACR and president elect Tuveson https://twitter.com/AACR/status/1252629029913604096 …",,@ @,,"1252859937706795008",https://twitter.com/OncoAlert/status/1252859937706795008
1stOncology,2020-04-22 01:49,0,0,"# SpectrumPharmaceuticals to Present Data from Phase 2 Clinical Trial for # Poziotinib at # AACR20 $ SPPI https://www.1stoncology.com/blog/spectrum-pharmaceuticals-to-present-data-from-phase-2-clinical-trial-for-poziotinib-at-american-association-for-cancer-research-virtual-annual-meeting-20201234556452 …",,,# # #,"1252836818275295234",https://twitter.com/1stOncology/status/1252836818275295234
1stOncology,2020-04-22 01:47,0,0,"# FormaTherapeutics Announces Preclinical Data Demonstrating # Antitumor Activity of a Potent and Selective Inhibitor of CBP/p300 for # AndrogenReceptor Positive # Cancers to be Presented at # AACR20 https://www.1stoncology.com/blog/forma-therapeutics-announces-preclinical-data-demonstrating-antitumor-activity-of-a-potentselective-inhibitor-of-cbpp300-for-androgen-receptor-positive-cancers-to-be-presented-at-the-american-associa1234556451 …",,,# # # # #,"1252836310898757639",https://twitter.com/1stOncology/status/1252836310898757639
1stOncology,2020-04-22 01:26,0,0,"# AlpineImmuneSciences Announces Poster Presentation at # AACR20 Virtual Annual Meeting I https://www.1stoncology.com/blog/alpine-immune-sciences-announces-poster-presentation-at-aacr-virtual-annual-meeting-i1234556439 …",,,# #,"1252831061484007426",https://twitter.com/1stOncology/status/1252831061484007426
1stOncology,2020-04-22 01:20,0,0,"# GenetronHealth Announces Forthcoming Unveiling of Its # Cancer Research Papers at the # AACR20 Annual Meeting https://www.1stoncology.com/blog/genetron-health-announces-forthcoming-unveiling-of-its-cancer-research-papers-at-the-aacr-annual-meeting1234556434 …",,,# # #,"1252829646061596687",https://twitter.com/1stOncology/status/1252829646061596687
1stOncology,2020-04-22 01:08,1,0,"# AlpineImmuneSciences Announces Poster Presentation at # AACR20 Virtual Annual Meeting I $ ALPN https://www.1stoncology.com/blog/alpine-immune-sciences-announces-poster-presentation-at-aacr-virtual-annual-meeting-i1234556426 …",,,# #,"1252826632101879815",https://twitter.com/1stOncology/status/1252826632101879815
iannisaifantis1,2020-04-21 23:17,0,1,"A really amazing scientist at the head of an impressive organization. Congrats Dave!",,,,"1252798656207437826",https://twitter.com/iannisaifantis1/status/1252798656207437826
chr_reinhardt,2020-04-21 23:10,0,0,"Congrats, David!",,,,"1252796982671835136",https://twitter.com/chr_reinhardt/status/1252796982671835136
DrAdatya,2020-04-21 22:19,0,1,"Wow, what a line up! Thanks for the share! The presentations are very brief, under 15 mins followed by 5 min discussions. I hope it's archived for replay ;)",,,,"1252784038122672128",https://twitter.com/DrAdatya/status/1252784038122672128
DrR_DUNNE,2020-04-21 21:18,0,1,"Excellent choice @ AACR ! https://twitter.com/AACR_CEO/status/1252673492576763904 …",,@,,"1252768703046914050",https://twitter.com/DrR_DUNNE/status/1252768703046914050
precision_ru,2020-04-21 20:40,2,10,"Congratulations David!...and AACR. A great scientist and superb human being! @ AACR @ MCWCancerCenter @ MCWSurgery @ MedicalCollege @ CSHL @ lustgartenfdn @ letswinpc @ PanCAN @ PanCANMilwaukee @ PancanMadisonhttps://twitter.com/lustgartenfdn/status/1252645793963614208 …",,@ @ @ @ @ @ @ @ @ @,,"1252759199370620928",https://twitter.com/precision_ru/status/1252759199370620928
naturopathiconc,2020-04-21 20:21,0,1,"Awesome! 2 days, no CME's but the price?FREE! Here are some lecture topics I hope to attend: Cancer Chemistry Experimental & Molecular Therapeutics Immunology Molecular & Cellular Biology/Genetics Prevention Research Tumor Biology Click the @ AACR tweet for more info & to register https://twitter.com/AACR/status/1252650827233341440 …",,@,,"1252754238859550725",https://twitter.com/naturopathiconc/status/1252754238859550725